
<html lang="en"     class="pb-page"  data-request-id="ae339d8e-45b5-4075-85d7-750caacb6383"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01507;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products" /></meta><meta name="dc.Creator" content="Cheng-Peng  Sun" /></meta><meta name="dc.Creator" content="Xin-Yue  Zhang" /></meta><meta name="dc.Creator" content="Christophe  Morisseau" /></meta><meta name="dc.Creator" content="Sung Hee  Hwang" /></meta><meta name="dc.Creator" content="Zhan-Jun  Zhang" /></meta><meta name="dc.Creator" content="Bruce D.  Hammock" /></meta><meta name="dc.Creator" content="Xiao-Chi  Ma" /></meta><meta name="dc.Description" content="Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively maintain end..." /></meta><meta name="Description" content="Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively maintain end..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 28, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01507" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01507" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01507" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01507" /></link>
        
    
    

<title>Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01507" /></meta><meta property="og:title" content="Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0037.jpeg" /></meta><meta property="og:description" content="Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively maintain endogenous epoxyeicosatrienoic acids (EETs) levels and reduce dihydroxyeicosatrienoic acids (DHETs) levels, resulting in therapeutic potentials for cardiovascular, central nervous system, and metabolic diseases. Therefore, since the beginning of this century, the development of sEH inhibitors is a hot research topic. A variety of potent sEH inhibitors have been developed by chemical synthesis or isolated from natural sources. In this review, we mainly summarized the interconnected aspects of sEH with cardiovascular, central nervous system, and metabolic diseases and then focus on representative inhibitors, which would provide some useful guidance for the future development of potential sEH inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01507"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01507">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01507&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01507&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01507&amp;href=/doi/10.1021/acs.jmedchem.0c01507" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 184-215</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01473" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01530" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Cheng-Peng Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheng-Peng Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention, College (Institute) of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Peng++Sun">Cheng-Peng Sun</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6801-3439" title="Orcid link">http://orcid.org/0000-0001-6801-3439</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xin-Yue Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin-Yue Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention, College (Institute) of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin-Yue++Zhang">Xin-Yue Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Morisseau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Morisseau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Morisseau">Christophe Morisseau</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sung Hee Hwang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sung Hee Hwang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sung+Hee++Hwang">Sung Hee Hwang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhan-Jun Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhan-Jun Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing 100875, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhan-Jun++Zhang">Zhan-Jun Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce D. Hammock</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce D. Hammock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</div></div><span class="conrtib-corresp"><strong>*</strong>B.D.H.: phone, +1 530 752-7519; email, <a href="/cdn-cgi/l/email-protection#ee8c8a868f8383818d85ae9b8d8a8f98879dc08b8a9b"><span class="__cf_email__" data-cfemail="fb999f939a9696949890bb8e989f9a8d9288d59e9f8e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+D.++Hammock">Bruce D. Hammock</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1408-8317" title="Orcid link">http://orcid.org/0000-0003-1408-8317</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiao-Chi Ma</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Chi Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention, College (Institute) of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, People’s Republic of China</div><div class="loa-info-affiliations-info">College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou 311121, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>X.-C.M.: phone, +86-411-86110418; email, <a href="/cdn-cgi/l/email-protection#c8a5a9b0abf9f1fff088f9fefbe6aba7a5"><span class="__cf_email__" data-cfemail="197478617a28202e2159282f2a377a7674">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Chi++Ma">Xiao-Chi Ma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4397-537X" title="Orcid link">http://orcid.org/0000-0003-4397-537X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01507&amp;href=/doi/10.1021%2Facs.jmedchem.0c01507" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 184–215</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2020</li><li><span class="item_label"><b>Published</b> online</span>28 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01507" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01507</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D184%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCheng-Peng%2BSun%252C%2BXin-Yue%2BZhang%252C%2BChristophe%2BMorisseau%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01507%26title%3DDiscovery%2Bof%2BSoluble%2BEpoxide%2BHydrolase%2BInhibitors%2Bfrom%2BChemical%2BSynthesis%2Band%2BNatural%2BProducts%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D215%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01507"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1519</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01507" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cheng-Peng&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Xin-Yue&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Morisseau&quot;},{&quot;first_name&quot;:&quot;Sung&quot;,&quot;last_name&quot;:&quot;Hee Hwang&quot;},{&quot;first_name&quot;:&quot;Zhan-Jun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;D. Hammock&quot;},{&quot;first_name&quot;:&quot;Xiao-Chi&quot;,&quot;last_name&quot;:&quot;Ma&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;184-215&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01507&quot;},&quot;abstract&quot;:&quot;Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively maintain endogenous epoxyeicosatrienoic acids (EETs) levels and reduce dihydroxyeicosatrienoic acids (DHETs) levels, resulting in therapeutic potentials for cardiovascular, central nervous system, and metabolic diseases. Therefore, since the beginning of this century, the development of sEH inhibitors is a hot research topic. A variety of potent sEH inhibitors have been developed by chemical synthesis or isolated from natural sources. In this review, we mainly summarized the interconnected aspects of sEH with cardiovascular, central nervous system, and metabolic diseases and then focus on representative inhibitors, which would provide some useful guidance for the future development of potential sEH inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01507&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01507" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01507&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01507" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01507&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01507" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01507&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01507&amp;href=/doi/10.1021/acs.jmedchem.0c01507" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01507" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01507" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01507%26sid%3Dliteratum%253Aachs%26pmid%3D33369424%26genre%3Darticle%26aulast%3DSun%26date%3D2021%26atitle%3DDiscovery%2Bof%2BSoluble%2BEpoxide%2BHydrolase%2BInhibitors%2Bfrom%2BChemical%2BSynthesis%2Band%2BNatural%2BProducts%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D184%26epage%3D215%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0037.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively maintain endogenous epoxyeicosatrienoic acids (EETs) levels and reduce dihydroxyeicosatrienoic acids (DHETs) levels, resulting in therapeutic potentials for cardiovascular, central nervous system, and metabolic diseases. Therefore, since the beginning of this century, the development of sEH inhibitors is a hot research topic. A variety of potent sEH inhibitors have been developed by chemical synthesis or isolated from natural sources. In this review, we mainly summarized the interconnected aspects of sEH with cardiovascular, central nervous system, and metabolic diseases and then focus on representative inhibitors, which would provide some useful guidance for the future development of potential sEH inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Epoxide hydrolases are widely distributed enzymes responsible for the rapid hydrolysis of epoxides to the corresponding vicinal diols.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In mammals, soluble epoxide hydrolase (sEH), an α/β hydrolase fold protein, is expressed in the cytosol, and sometimes also in the peroxisome, of numerous tissues, such as liver, kidney, lung, heart, brain, spleen, adrenal, and intestine.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Besides mammals, the sEH is present in all vertebrates; however, only the mammalian sEH has phosphatase activity.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14">(4−14)</a> Expression levels vary among species; for example, the sEH is much lower in rats than in mice.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Furthermore, the sEH expression can be induced by angiotensin II (Ang II) and peroxisome proliferator-activated receptor α (PPARα) and PPARγ agonists, such as fibrates and glitazones,<a onclick="showRef(event, 'ref3 ref16'); return false;" href="javascript:void(0);" class="ref ref3 ref16">(3,16)</a> but also by sexual hormones.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Notably, the expression of sEH is upregulated by PPARγ agonists in adipose tissues, while the oppositive result is observed in cardiomyocytes.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Additionally, inflammation also increases its expression; therefore, sEH can be considered a marker of inflammation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The mammalian sEH comprises two 62.5 kDa monomers, containing 555 amino acids each, and it is a bifunctional enzyme that possesses a 25 kDa N-terminal phosphatase region and a 35 kDa C-terminal hydrolase domain (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The C-terminal hydrolase catalyzes the hydrolysis of epoxy-fatty acids (EpFAs), such as epoxyeicosatrienoic acids (EETs), metabolized from arachidonic acid (AA) to the corresponding diols, such as dihydroxyeicosatrienoic acids (DHETs) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The hydrolase catalytic pocket of the C-terminal hydrolase consists of two tyrosine residues (Tyr381 and Tyr465) that interact with the oxygen atom of the epoxide via two hydrogen bonds. The nucleophilic carboxylic acid Asp333 of the catalytic triad Asp333-Asp495-His523, located on the opposite side of Tyr381 and Tyr465, is oriented and activated by His523 and Asp495 and attacks the epoxide carbon backbone to form an ester bond with the opened epoxide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). The following hydrolysis of this ester results in the production of the corresponding diols.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Compared with the well-understood function of the C-terminal hydrolase domain, the role of the N-terminal phosphatase domain is still unclear.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Cronin et al. and Newman et al. independently discovered that the N-terminal domain of sEH exhibits phosphatase activity to hydrolyze diverse lipid phosphates <i>in vitro</i>, including farnesyl pyrophosphate, sphingosine 1-phosphate, and lysophosphatidic acid, whereas its physiological and possibly pathophysiological roles are still not well understood.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) X-ray cocrystal structure of a single subunit of the human sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4">1ZD4</a>). (B) X-ray cocrystal structure of human sEH C-domain showing the binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4">1ZD4</a>). (C) Potential interactions between epoxides and human sEH C-domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolic pathways of AA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>EPHX2</i>, the human gene encoding sEH, is a 19-exon gene (45 kb) localized in the chromosomal region 8p21-12.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> So far, seven single-nucleotide polymorphisms (SNPs) of sEH have been discovered, including K55R, R103C, C154Y, R287Q, R287Q/R103C, V422A, and E470G.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compared with the wild-type (WT) protein, the mutant’s strong reduction of its phosphatase activity in R103C and R287Q significantly decreased the phosphatase activity of sEH, and its hydrolase activity is increased in R287Q/R103C, while increasing its N-terminal activity in K55R and C154Y.<a onclick="showRef(event, 'ref12 ref27'); return false;" href="javascript:void(0);" class="ref ref12 ref27">(12,27)</a> Among them, K55R, R103C, and R287Q have been verified in connection with several diseases,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> including heart failure, ischemic stroke, anorexia nervosa, and nephropathy.</div><div class="NLM_p">In response to infection or damage, the body generates an inflammatory response. Central to this response is the production of bioactive lipids from AA (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Eicosanoids possess a series of protective effects and are defined to be vital metabolites from AA via three metabolic pathways: (1) the cytochrome P450 (CYP) pathway forms EETs and hydroxy eicosatetraenoic acids (HETEs); (2) lipoxygenases (LOXs) catalyze the formation of lipoxins (LXs) and leukotrienes (LTs);<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (3) cyclooxygenases (COXs) pathway produces prostanoids.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The above-mentioned pathways can also metabolize eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and other unsaturated fatty acids.<a onclick="showRef(event, 'ref30 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33 ref34">(30,32−34)</a></div><div class="NLM_p">All these bioactive lipids, called oxylipins, have strong roles in the inflammatory response.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For example, EETs, synthesized by CYP450s, such as CYP2C8, CYP2C9, and CYP2J2, activate guanine nucleotide-binding protein (G-protein) Gαs via ADP-ribosylation, resulting in the activation of the smooth muscle large conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels (BK<sub>Ca</sub>) to produce vasodilation and lowering blood pressure.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a> Furthermore, EETs increase Ca<sup>2+</sup> influx, enhance fibrinolysis, and stimulate tube formation in the endothelium.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In addition, EETs prevent IκB degradation via suppressing of IκB kinase, inhibit nuclear transcription factor-κB (NF-κB) responsible for cytokine-mediated inflammation, and further inhibit NF-κB-mediated gene transcription, allowing the anti-inflammatory effect.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Compared with bioactive substrate EETs, DHETs are inactivation products of EETs<a onclick="showRef(event, 'ref37 ref44'); return false;" href="javascript:void(0);" class="ref ref37 ref44">(37,44)</a> because their activities are reduced in many systems, such as relaxation of the preglomerular vasculature and the bovine coronary artery,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> inhibition of Na<sup>+</sup> channel and cyclooxygenase,<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> and Ca<sup>2+</sup> uptake.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In addition, DHETs produce functional effects in several other systems as well, including the inhibition of hydroosmotic action of arginine vasopressin,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> relaxation of canine and porcine coronary arterioles,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> and activation of the BK<sub>Ca</sub> channel.<a onclick="showRef(event, 'ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50 ref51">(48−51)</a></div><div class="NLM_p last">Because sEH can rapidly metabolize or inactivate EETs to produce DHETs, nowadays, sEH inhibition or knockout has become an experimental approach to investigate the biological roles of EpFAs, especially EETs. For example, inflammatory pain can be ameliorated by increasing levels of EETs or inhibiting sEH to stabilize EETs.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Furthermore, the sEH expression level is upregulated in Ang II-induced lung injury mice, levels of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are significantly increased, and the <i>Ephx2</i> (the gene name of mouse sEH) knockout can remarkably alleviate the lung injury.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In addition, sEH is found to be expressed in the cerebral cortex and hippocampus as well as striatum (STR). Therefore, it is speculated that sEH is closely related to central nervous system (CNS) diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), depression, and stroke.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this review, we summarized recent findings of sEH inhibitors from chemical synthesis and natural products, which provided useful guidance for the future development of potential sEH inhibitors, and the relationship between sEH and cardiovascular, CNS, and metabolic diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  sEH Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">EETs exhibit potential biological functions in dilating blood vessels and protecting neurons. Numerous studies indicated that inhibiting sEH to stabilize EETs can significantly reduce inflammation and pain.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> Therefore, sEH inhibitors are considered a promising and effective treatment for various diseases and its development has become a hot topic in the research field since the beginning of this century. So far, sEH inhibitors have been discovered from a variety of pathways, such as synthesis and natural products;<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> therefore, we summarized the recent progress in the design and development of sEH inhibitors.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Targeting sEH Only</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">2.1.1.  Urea sEH Inhibitors</h4><div class="NLM_p">The earliest selective sEH inhibitors reported are substituted chalcone oxides (such as compound <b>1</b>) and phenylglycidols rather than ureas. 4-Phenylchalcone oxide (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) is a sEH substrate and forms a covalent intermediate, allowing low turnover and transient inhibition. However, they are unstable in the presence of glutathione and slowly hydrolyzed by sEH; therefore, their use <i>in vivo</i> is limited.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The first potent and stable inhibitors of sEH were reported in 1999 based on the urea skeleton (<b>I</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), such as <i>N</i>,<i>N</i>′-dicyclohexyl-urea (<b>2</b>, DCU) and <i>N</i>-cyclohexyl-<i>N</i>′-(3-phenylpropyl)urea (<b>3</b>, CPU).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> They display significant inhibitory potency against the mouse and human sEH with IC<sub>50</sub> values in the tens of nanomolar. Their kinetic constants (<i>K</i><sub>i</sub>) are in the low nanomolar and are 20- to 150-fold better than <b>1</b> (<i>K</i><sub>d</sub> = 430 nM), revealing that compounds like DCU (<b>2</b>) or CPU (<b>3</b>)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> act as competitive inhibitors at stoichiometric concentrations<a onclick="showRef(event, 'ref56 ref60'); return false;" href="javascript:void(0);" class="ref ref56 ref60">(56,60)</a> and have a tight association with the target enzyme.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> DCU (<b>2</b>) was the first to be used <i>in vivo</i> and could significantly inhibit the conversion from 14,15-EET to 14,15-DHET in spontaneously hypertensive rat, then leading to an antihypertensive effect.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In porcine coronary endothelial cells, DCU (<b>2</b>) led to the decrease of the EETs conversion rate by 3-fold.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> While it demonstrated the usefulness of the urea inhibitors to affect the metabolism of EpFAs <i>in vitro</i> and <i>in vivo</i>, the early sEH inhibitors, such as DCU (<b>2</b>), had poor water solubility and high melting point (mp) due to its rigid structure and nonpolar groups, which affected its oral availability and bioavailability. To date, the urea derivatives are the most abundant and effective sEH inhibitors because the central urea group can bind strongly to the catalytic pocket of sEH (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The oxygen atom on the urea group formed two hydrogen bonds with amino acid residues Tyr381 and Tyr465 in the catalytic pocket of sEH.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Moreover, the N–H of the urea group acts as the hydrogen bond donor of Asp333.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Because of their high potency, urea derivatives have been continuously developed, especially to improve solubility and bioavailability to apply them for the treatment of EpFA-related diseases.<a onclick="showRef(event, 'ref56 ref64'); return false;" href="javascript:void(0);" class="ref ref56 ref64">(56,64)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative sEH inhibitors and development of early sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From DCU (<b>2</b>), the first improvement in the design of sEH inhibitors was the introduction on one side of the urea function of a flexible chain, such as 12-(3-adamantan-1-ylureido)dodecanoic acid (<b>4</b>, AUDA). The introduction of a flexible side chain significantly improved the water solubility of AUDA (<b>4</b>) and reduced the mp while maintaining the inhibitory effect.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> AUDA (<b>4</b>) was continuously administered to mice via drinking water (25 mg/L) for 14 days and finally achieved the purpose of reducing blood pressure. Although AUDA (<b>4</b>) was easier to formulate and to dose animals with (it could be given in the drinking water at 25 mg/L),<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> it was extremely sensitive to β-oxidation, and therefore it was easily metabolized and excreted,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> thus limiting its application in the clinic. Nevertheless, AUDA <i>n</i>-butyl ester prodrug (<b>5</b>, AUDA-nBE) has relatively good pharmacokinetics (PK)<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> allowing <i>in vivo</i> application. AUDA-nBE (<b>5</b>) and its <i>in vivo</i> metabolite AUDA (<b>4</b>) reduced ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats and prevented death and restored systolic blood pressure in lipopolysaccharide (LPS)-stimulated mice as well as the inhibition on the tumor growth.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a></div><div class="NLM_p">On the basis of the analysis of the structure–activity of 348 urea-based inhibitors<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and in order to improve physical properties while reducing metabolism, polar functional groups were incorporated into one of the alkyl chains of 1,3-disubstituted ureas.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> This study revealed that a representative sEH inhibitor could possess a secondary pharmacophore (a polar functional group) that incorporated at least five atoms (about 7.5 Å) from the primary pharmacophore (the central urea carbonyl) which effectively improved aqueous solubility and PK properties (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) while maintaining potency. Solubility could even be enhanced with a polar tertiary pharmacophore that is 13 atoms or ∼17 Å away from the primary pharmacophore, without affecting much the inhibitor potency.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">To reduce metabolism, in addition to the introduction of polar groups, Jones et al. proposed in 2006 conformationally constrained human sEH inhibitors,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> which have the central pharmacophore and secondary pharmacophore connected by saturated rings, such as piperidine or other unsaturated rings. APAU (<b>6</b>) and TPAU (<b>7</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) are examples of the first series of piperidine-based urea inhibitors. These compounds are not only very potent inhibitors (IC<sub>50</sub> values in the low nanomolar region) but have better PK characteristics, such as 10-fold higher area under the curve (AUC)<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> compared to AUDA (<b>4</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), underlying the benefits of conformationally constrained inhibitors.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">In order to further investigate the influence of conformationally constrained groups toward sEH inhibition, Hwang et al. used a cyclohexyl group as a linker instead of a piperidinyl group because of their structural similarity and designed a series of <i>cis</i>- or <i>trans</i>-1,4-cyclohexyloxy-<i>N</i>,<i>N′</i>-disubstituted urea derivatives based on the skeleton of APAU (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> These inhibitors not only have good water solubility but also resolve the problem that flexible alkyl chains are easily oxidized and metabolized rapidly, increase bioavailability <i>in vivo</i>, and significantly improve metabolic stability.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Among them, a pair of epimers <i>trans</i>-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (<b>8</b>, <i>t</i>-AUCB) and <i>cis</i>-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (<b>9</b>, <i>c</i>-AUCB) show low nanomolar inhibitory effects (<b>8</b>, IC<sub>50</sub> = 1.3 nM; <b>9</b>, IC<sub>50</sub> = 0.89 nM) and desired PK properties, especially <i>t</i>-AUCB (<b>8</b>). It is notable that the 1,4-<i>trans</i> cyclohexane urea <i>t</i>-AUCB (<b>8</b>) is more stable than its isomer <i>c</i>-AUCB (<b>9</b>) in human liver microsome (HLM), and the AUC of the former in dogs increases by about 40-fold compared with that of AUDA (<b>4</b>). <i>t</i>-AUCB (<b>8</b>) at a dose of 1 mg/kg also shows the same therapeutic effect of returning blood pressure to normal as AUDA-nBE (<b>5</b>) at a dose of 10 mg/kg in the LPS-induced hypotension model. An analysis of their structures indicates that the introduced free carboxyl group forms an additional hydrogen bond with Met418 in addition to the classical hydrogen bonds of the urea function with Asp333 and Tyr381.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> In addition, <i>t</i>-AUCB (<b>8</b>) displays remarkable biological effects, including antifibrosis and anti-inflammatory activities, as well as protective effects against liver and cardiovascular diseases.<a onclick="showRef(event, 'ref74 ref75 ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref77 ref78">(74−78)</a><i>t</i>-AUCB (<b>8</b>) can downregulate muscle-specific miR-133 expression level in the myocardial infarction mouse established by ligating the coronary artery, allowing the reducing infarct size and preventing the development of cardiac arrhythmias.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Moreover, <i>t</i>-AUCB (<b>8</b>) reduces adipose tissue inflammation, prevents hepatic steatosis and the increased fasting glycemia, improves glucose tolerance, and decreases gluconeogenesis in high-fat diet (HFD) mice.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">In addition to the cyclohexyl group, an aromatic ring and an isoxazolyl group were also used as the replacement of the piperidinyl group at the right side of <i>N</i>-adamantyl-<i>N</i>′-piperidinyl-ureas such as APAU (<b>6</b>) in view of their limited solubility and rapid metabolism (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), which reduced the mp of the inhibitors and should enhance the stability.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Despite the potent inhibitory activity observed in this series of compounds, such as 1-(adamant-1-ylmethyl)-3-{[5-(furan-2-yl)isoxazol-3-yl]methyl}urea (<b>10</b>, AFMU) and 1-(adamant-1-ylmethyl)-3-[(3-methylisoxazol-5-yl)methyl]urea (<b>11</b>, AMMU), their stability was not improved in HLM with nicotinamide adenine dinucleotide phosphate (NADPH).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">The next step in sEH inhibitor development involved the optimization of the adamantyl-ureas via adding the substitution to the bridgehead of the adamantane to afford a library of this type compound (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Interestingly, the substitution influenced greatly the potency, physical properties, and metabolic stability of ureas and diureas. Interestingly, a methyl or chloride substitution on the bridgehead of the adamantane is to the benefit of the potency, and the adamantane and urea functions are linked via a methylene, which is in favor of potency and physical properties. These findings provide a new path to further design sEH inhibitors.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Optimization of adamantyl-ureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the above-mentioned adamantyl-urea sEH inhibitors have excellent potency, this type of inhibitor is easily oxidized and metabolized, resulting in low drug concentrations and short <i>in vivo</i> half-life (<i>t</i><sub>1/2</sub>). Therefore, in the next iteration of compound design, aromatic or other aliphatic moieties were used instead of the adamantyl group based on the structure of <i>t</i>-AUCB (<b>8</b>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> A library of aromatic- and other aliphatic-ureas were synthesized (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>; compounds <b>14</b>–<b>20</b>). While the replacement of the adamantyl group by aromatic groups did not significantly improve the inhibitory potencies, the PK properties were dramatically improved, especially for TPPU (<b>19</b>) and TPCU (<b>20</b>). The AUC/IC<sub>50</sub> of TPCU (<b>20</b>), a metric of the inhibitory effect, is 5500-fold higher than that of APAU (<b>6</b>), and a similar result is obtained in the PK of TPPU (<b>19</b>) as well. These compounds have become commercial inhibitors of sEH and been used in a wide variety of studies to test for sEH biological activities.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative urea sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although acyl piperidine ureas have good inhibitory effects, they show unsatisfactory PK properties in a dog model.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Hammock’s team designed a series of piperidyl-urea derivatives for the treatment of diabetic neuropathic pain based on the skeleton of <i>N</i>-phenyl-<i>N</i>′-piperidyl-urea in 2014.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The potency of sEH inhibitors does not only consider IC<sub>50</sub> or <i>K</i><sub>i</sub>, but also depend on how long the target is occupied by the inhibitor, because the catalysis is blocked only when the enzyme is occupied. In these 1,3-disubstituted ureas (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), the dissociation rate constants (<i>k</i><sub>off</sub>) of compounds <b>21</b>–<b>23</b> increase 2.4- to 4.4-fold compared with that of a previous inhibitor TPAU (<b>7</b>, <i>k</i><sub>off</sub> = 19.2 × 10<sup>–4</sup> s<sup>–1</sup>). An analysis of the interaction between their analog TPPU (<b>19</b>, <i>k</i><sub>off</sub> = 10.2 × 10<sup>–4</sup> s<sup>–1</sup>) and human sEH reveals a small secondary binding site next to the α-carbon of its amide, which provides the possibility of additional binding. The hydrophobic 4-trimethoxyphenyl group binds closely to the right side of the binding pocket with a little extra binding space, which may be the reason why it stays on the target for a long time and shows excellent inhibitory effect.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">CYP enzymes can metabolize AA to produce four regioisomers, and each isomer has different proportions of <i>S</i>/<i>R</i>- or <i>R</i>/<i>S</i>-enantiomers (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Because the production rate and ratio of stereoisomers of these diol products are closely related to the stereochemistry of substrates and epoxy ring substitution, stereoselectivity is also an important factor in the design of sEH inhibitors.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Manickam et al. designed a series of pairs of enantiomers with a chiral center close to urea nitrogen atoms.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> There are significant differences in the inhibitory activity of enantiomers; for example, the inhibitory activity of (<i>S</i>)-1-(1-phenylethyl)-3-(3-phenylpropyl)urea (<b>24</b>, <i>S</i>-PPU) is 40-fold higher than that of its enantiomer (<b>25</b>). This similar result is also observed by Lukin et al., which indicates that the chirality of the α-carbon of urea nitrogen atoms can affect the inhibition of inhibitors on sEH.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Among the synthesized compounds, ITBU (<b>26</b>) possesses a potent sEH inhibitory activity and an excellent bioavailability in mice. However, the further analysis reveals that ITBU (<b>26</b>) is a racemic inhibitor and can be isolated to afford (+)-ITBU [(+)-<b>26</b>] and (−)-ITBU [(−)-<b>26</b>]. The inhibitory potency of the former is 11-fold higher than that of the latter. All the above-mentioned suggests that the selective sEH inhibition by different enantiomers provides more possibilities for the binding sites of sEH and a new direction for the development of sEH inhibitors.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Influence of stereoconfigurations on inhibitory potentials and representative sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Except for the above-mentioned modification, the urea moiety was also altered by replacing the oxygen atom of urea with the sulfur atom to afford thiourea-based sEH inhibitors (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Among the thioureas, 1-(adamantan-2-yl)-3-phenethylthiourea (<b>27</b>, APU) and 1,1<i>’</i>-(heptane-1,7-diyl)bis(3-(adamantan-1-yl)thiourea) (<b>28</b>, HBAU) are found to be potent sEH inhibitors. Although their potencies are less than the previously described TPPU (<b>19</b>), they have better water solubility and are easier to be prepared, which is one of the ideal properties of an ideal inhibitor.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative thiourea-based sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.1.2.  Amide sEH Inhibitors</h4><div class="NLM_p">In addition to the urea-based sEH inhibitors, amides have been also widely developed as sEH inhibitors by removing one of the NH group of the ureas (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), yielding compounds <b>29</b>–<b>32</b>.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The primary structure–activity relationship (SAR) indicates that their inhibition potencies almost does not affect mouse sEH compared to the corresponding ureas, whereas this modification leads to the 2.5-fold decrease inhibition potency for human sEH. On the other hand, the amide function can significantly improve the physical property compared to the corresponding ureas, such as solubility and mp, for example, AABA-PE (<b>31</b>; mp, oil; solubility, 17.4 μg/mL).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Modification of adamantyl-ureas to afford amide inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Eldrup and colleagues screened in-house compounds with drug-like characteristics for sEH inhibition and found that <i>N</i>-(3,3-diphenylpropyl)nicotinamide (<b>33</b>, DPN) could be regarded as a new starting point for an optimization process.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> According to the X-ray crystal result of DPN (<b>33</b>) and sEH as shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, a library of amide inhibitors were designed and synthesized via the introduction of methanesulfonyl and fluorine at two benzene rings based on the structural core of DPN (<b>33</b>), yielding compounds <b>34</b>–<b>37</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). They showed similar inhibitory potencies as DPN (<b>33</b>), whereas their metabolic stability was significantly improved in HLM and rat liver microsome (RLM).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> CFMB (<b>36</b>) as a potential sEH inhibitor was found to have a low drug–drug interaction potential with selectivity for CYP enzymes.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> In addition, DPN (<b>33</b>) was further optimized based on the structure of urea analog (<b>38</b>) with good metabolic stabilities (<i>t</i><sub>1/2</sub>, 185 min in HLM; 105 min in RLM), resulting in the production of a series of nicotinamide analogs.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Among them, nicotinamide analog (<b>39</b>) showed a low nanomolar inhibitory effect and a great metabolic stability and had also acceptable (<i>t</i><sub>1/2</sub>, 185 min in HLM and 105 min in RLM) plasma exposure.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray cocrystal structure of DPN (<b>33</b>) with sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3I1Y">3I1Y</a>) and its optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Anandan et al. analyzed previous urea inhibitors, such as CPU (<b>3</b>),<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> AUDA (<b>4</b>), and TPPU (<b>19</b>), and summarized the pharmacophore model comprising primary, secondary, and tertiary pharmacophores and two linkers; therefore, they developed a series of urea, amide, sulfonamide, thiourea, sulfonyl urea, hydroxyamide, and ketoamide inhibitors based on the skeleton (<b>II</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> A detailed analysis of SAR reveals that no loss of inhibitory potency is observed when the N atom on the left side of the carbonyl group of urea is replaced by a C atom, whereas the decrease of inhibitory potency is present when the urea group is substituted with other groups, such as sulfonamide, thiourea, sulfonyl urea, hydroxyamide, and ketoamide. A methylene group occurs between adamantyl and hydroxyamide or ketoamide group, which will be to the benefit of inhibitory potency except for amides (<b>40</b> and <b>45</b>). However, the inhibition potency is decreased when the adamantyl group is replaced by other groups, including cyclohexyl, 4-trifluoromethylphenyl, 4-chlorophenyl, and 4-trifluoromethoxyphenyl groups.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Modification based on the skeleton.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of these findings, subsequent research focused on the secondary pharmacophore to optimize the inhibition potency of amides.<a onclick="showRef(event, 'ref92 ref93 ref94 ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94 ref95 ref96">(92−96)</a> First, an oxyoxalamide functional group was used to design and develop sEH inhibitors as the secondary pharmacophore according to the skeleton (<b>III</b>) by Kim and co-workers (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Among the synthesized compounds, <b>50</b> (MMMO) and <b>51</b> (PMMO) show low nanomolar inhibitory activities similar to that of AUDA (<b>4</b>), and their physical property has been greatly improved compared to AUDA (<b>4</b>), especially their solubility. The new skeleton (<b>IV</b>) by modifying the secondary pharmacophore was constructed using the phosphonate function in place of the oxyoxalamide group<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> to afford potent sEH inhibitors, such as <b>52</b> (DPDP) and <b>53</b> (DAPDP). In addition, Zavareh et al. also tried to develop the novel skeleton (<b>V</b>) via using an oxadiazole ring as a novel secondary pharmacophore,<a onclick="showRef(event, 'ref93 ref96'); return false;" href="javascript:void(0);" class="ref ref93 ref96">(93,96)</a> yielding a series of potent oxadiazole-base amide inhibitors, such as oxadiazole analogs <b>54</b> (IC<sub>50</sub> = 0.91 nM) and <b>55</b> (IC<sub>50</sub> = 0.83 nM). Molecular docking indicates that amino acid residues Asp335, Tyr383, and Tyr466 play a crucial role in the interaction with sEH, and Val498, His524, and Trp525 also form additional hydrogen bond interactions with an oxadiazole group. These findings have great importance in the design of sEH inhibitors.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Modification of the secondary pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Kim and co-workers carried out the structural modification on both sides of the amide pharmacophore of 1,3-bicycloalkyl substituted amides to improve the inhibitory effect on sEH.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> According to the SAR result (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), potent sEH inhibitors <b>56</b> (TPNC) and <b>57</b> (MTCMB) are obtained with reasonable physical properties. For example, the mp of MTCMB (<b>57</b>) is reduced (115 °C) and the water solubility (125 μM) is 2-fold higher than that of AUDA (<b>4</b>). This shows that amide inhibitors can achieve similar inhibitory potency as urea inhibitors while having better physical properties. In addition, this study opened the door to numerous possibilities for the design of potent amide inhibitors, especially through combinatorial chemistry.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SAR of amide inhibitors summarized by Kim et al.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For finding new structures, Landry et al. tested a library of 130 000 chemicals, provided by the National Institutes of Health Roadmap project, for sEH inhibition. They obtained a lead compound <b>58</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) with nanomolar potency that contains a sulfonyl isonipecotamide that is resembling APAU (<b>6</b>). Further optimization of <b>58</b> resulted in the production of three subnanomolar inhibitors (<b>59</b>–<b>61</b>).<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98,99)</a> Xing et al. designed a combinatorial library of benzoxazole derivatives and screened the potential sEH inhibitors via a virtual screening (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> The X-ray crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PDC">3PDC</a>) of the human sEH with compound <b>62</b> revealed unique interactions between the enzyme and the benzoxazole group. In addition to the classic hydrogen bonds between the amide group and active site residues (Asp333, Tyr381, and Tyr465), the oxygen of the benzoxazole ring forms a hydrogen bond interaction with His523, one of the catalytic triad Asp333-Asp495-His523 (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). These additional hydrogen bonds may account for the enhanced potency of the amide-based inhibitors containing a benzoxazolyl group.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of sulfonyl isonipecotamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray crystal structure of sEH complexed with the benzoxazole (<b>62</b>) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PDC">3PDC</a>) and its optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Marino and co-workers used encoded library technology to discover a sEH inhibitor (<b>64</b>) featuring a piperidinecarboxamide skeleton via high throughput screening (HTS, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>)<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101,102)</a> and optimized this skeleton to yield compounds <b>65</b> and <b>66</b> displaying low nanomolar inhibitory potencies.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The X-ray crystal structure of MTTP (<b>65</b>) with sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JNC">4JNC</a>) showed that <b>65</b> formed H-bonds with Asp335, Tyr383, and Tyr466 at the active site (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). The further optimization of this skeleton led to the production of a low picomolar sEH inhibitor GSK2256294 (<b>67</b>). The results of the <i>in vivo</i> study indicated that GSK2256294 (<b>67</b>) could dose-dependent reduce pulmonary leukocyte and keratinocyte chemoattractant levels in cigarette-smoke-induced mice, suggesting that GSK2256294 (<b>67</b>) would be an appropriate agent for the treatment of chronic obstructive pulmonary and cardiovascular diseases.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> This compound has been tested in clinical trials.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Modification based on the structure of the amide (<b>64</b>) and cocrystal structure of MTTP (<b>65</b>) and sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JNC">4JNC</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Multitarget Inhibitors</h3><div class="NLM_p">Highly effective drugs with a single biological target are the mainstream of drug research and development.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> However, they also have some limitations. By targeting a single enzyme or receptor only, a drug could lack efficacy on complex diseases and may cause additional adverse reactions when used in combination with other drugs.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> In order to solve these problems, research is focusing now on multitarget drugs with higher safety and effectiveness.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> In recent years, several multitarget drugs have shown excellent therapeutic ability in meddling with the AA cascade. The sEH plays a crucial role in the AA cascade and participates in the pathological process of numerous diseases. In addition, the effectiveness of sEH inhibitors has been verified <i>in vivo</i>.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> By combining the inhibition of sEH with the inhibition of another actor of the AA cascade, such as COX-2, 5-LOX, and 5-LOX-activating protein (FLAP), one could expect a greater effect for the treatment of complex diseases, such as neuroinflammation or cancer.<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.2.1.  sEH/COX-2 Dual Inhibitors</h4><div class="NLM_p">COX-2 is an enzyme in which expression is induced by the stimulation of inflammation, hormones, or growth factors.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> COX-2 is highly expressed in inflammation and proliferative diseases, such as various cancers; therefore, it is a target to develop anti-inflammatory and antitumor agents.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> A recent study has demonstrated that coadministration of EETs and COX inhibitors exerts a better effect than the single administration of COX inhibitors to reduce LPS-induced pain and hypotension.<a onclick="showRef(event, 'ref79 ref84'); return false;" href="javascript:void(0);" class="ref ref79 ref84">(79,84)</a> Accordingly, a series of sEH/COX-2 dual inhibitors based on the structural skeletons of celecoxib and <i>t</i>-AUCB (<b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) were designed, and it was found that <b>68</b> (PTUPB) displayed potent inhibitory activities against both sEH and COX-2. Molecular stimulation shows that PTUPB (<b>68</b>) forms hydrogen bond interactions with amino acid residues Asp333, Tyr381, and Tyr465 of human sEH, and His90 and Tyr335 of mouse COX-2. In a nociceptive assay, PTUPB (<b>68</b>) enhances <i>in vivo</i> antiallodynia effects compared to both the individual and combination therapies of celecoxib and <i>t</i>-AUCB (<b>8</b>).<a onclick="showRef(event, 'ref107 ref110'); return false;" href="javascript:void(0);" class="ref ref107 ref110">(107,110)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Design principle of an sEH/COX-2 dual inhibitor PTUPB (<b>68</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">PTUPB (<b>68</b>) was found to be beneficial to sepsis, nonalcoholic fatty liver disease (NAFLD), pulmonary fibrosis, and cancer.<a onclick="showRef(event, 'ref33 ref107 ref111 ref112 ref113 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref33 ref107 ref111 ref112 ref113 ref114 ref115 ref116">(33,107,111−116)</a> PTUPB (<b>68</b>) inhibits tumor growth and metastasis by suppressing endothelial cell proliferation, and it also improves survival rate, delays the onset of debris-stimulated ovarian tumor growth, and reduces ascites.<a onclick="showRef(event, 'ref107 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref107 ref115 ref116">(107,115,116)</a> In addition to the treatment of cancers, PTUPB (<b>68</b>) suppresses the activation of NLRP3 inflammasome,<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> allowing for improving the survival rate, reducing the clinical scores and systemic inflammatory response, and alleviating the multiple-organ injury in sepsis mice.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Therefore, sEH and COX-2 dual inhibition may be an approach to treat inflammation and cancer diseases.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.2.2.  sEH/5-LOX Dual Inhibitors</h4><div class="NLM_p">5-LOX as a dioxygenase plays a catalytic role in two steps of the biosynthesis of LTs which regulate the innate immune response and play a pathophysiological role in chronic inflammatory diseases, such as asthma and atherosclerosis.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> To date, a 5-LOX inhibitor zileuton is used in the clinic for the treatment of asthma with restrictions.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Coadministration of an sEH inhibitor <i>t</i>-AUCB (<b>8</b>) with a 5-LOX inhibitor showed a significant enhancement of the anti-inflammatory response.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Therefore, the sEH/5-LOX dual inhibitor has caught the attention of medicinal chemists. Moser and co-workers applied the pharmacophores of sEH and 5-LOX for screening 37 429 compounds <i>in silico</i> to afford a poor sEH/5-LOX dual inhibitor (sEH IC<sub>50</sub> = 3.5 μM; 5-LOX IC<sub>50</sub> = 36 μM), which nevertheless led to the new era of discovery dual inhibitors.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> On the basis of the key pharmacophores, an imidazo[1,2-<i>a</i>]pyridine motif of a 5-LOX inhibitor EP6 (5-LOX IC<sub>50</sub> = 59 nM) and a urea group of AUDA (<b>4</b>), a library of compounds were designed and synthesized by Meirer et al.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The SAR indicated that two pharmacophores required an <i>n</i>-propyl linker to maintain both sEH and 5-LOX inhibition. Among them, compound <b>69</b> showed high inhibitory potency against both 5-LOX and sEH (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). Although CMMPPU (<b>69</b>) exhibited high potency <i>in vitro</i>, it was not stable in plasma.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Subsequently, Meirer et al. designed KM55 (<b>70</b>), which showed a strong anti-inflammatory effect <i>in vitro</i>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. sEH/5-LOX dual inhibitors that linked two pharmacophores for sEH and 5-LOX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Achenbach et al. used saturation transfer difference (STD)-NMR and activity-based assays (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) and found that a compound featuring an aminothiazole skeleton had better inhibitory activities toward sEH (IC<sub>50</sub> = 170 nM) and 5-LOX (IC<sub>50</sub> = 30 nM).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Nandha et al. designed and developed a potential sEH/5-LOX dual inhibitor (FFBMB, <b>71</b>) based on the structure of the 5-LOX inhibitor RWJ-63556 (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>), a benzimidazole analog, and the sEH inhibitor <i>t</i>-TUCB. The <i>in vivo</i> study confirmed that FFBMB (<b>71</b>) possessed significant inhibition of carrageenan-induced rat paw edema.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. sEH/5-LOX dual inhibitor with an amide and an aminothiazole moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. sEH/5-LOX dual inhibitor FFBMB (<b>71</b>) based on an aryl ether and a benzoic acid motif and a benzimidazole core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.2.3.  sEH/FLAP Dual Inhibitors</h4><div class="NLM_p">FLAP is a nuclear membrane-anchored protein responsible for transferring AA to 5-LOX that produces proinflammatory LTs. The inhibition of FLAP by FLAP inhibitors or genetic knockout can abolish the production of proinflammatory LTs. Meanwhile, a FLAP inhibitor, GSK2190915, has completed phase II trials for the treatment of asthma.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a> Recent studies have indicated that coadministration of a sEH inhibitor <i>t</i>-AUCB (<b>8</b>) and MK886, a FLAP inhibitor, enhances anti-inflammatory activities in a murine model, yielding interest in sEH/FLAP dual inhibitors.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Temml et al. used a pharmacophore-based virtual screening to afford a first sEH/FLAP dual inhibitor diflapolin (<b>72</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>), which did not affect other enzymes of the AA cascade, suggesting that <b>72</b> is very selective for sEH and FLAP.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Investigation of its <i>in vivo</i> biological effects indicates that diflapolin (<b>72</b>) ameliorates vascular permeability, inhibits the formation of proinflammatory factors cysteinyl-LTs and leukotriene B<sub>4</sub> (LTB<sub>4</sub>), and suppresses neutrophil infiltration in the zymosan-induced peritonitis mouse model.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Subsequently, Vieider and colleagues designed a library of diflapolin derivatives, leading to BPDU (<b>73</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>), a more potent sEH/FLAP dual inhibitor.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. sEH/FLAP dual inhibitors diflapolin analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">2.2.4.  sEH/FAAH Dual Inhibitors</h4><div class="NLM_p">Fatty acid amide hydrolase (FAAH) is a membrane-bound serine hydrolase responsible for the deactivating metabolism of endogenous cannabinoids, such as oleamide, anandamide, and myristic amide.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Both EpFAs and endocannabinoids exert anti-inflammatory effects; therefore, elevating their concentrations by inhibiting both sEH and FAAH should be a good method to treat inflammation and neuropathic pain.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Indeed, coadministration of a FAAH inhibitor and a sEH inhibitor elicited a synergistic analgesic response in acute inflammatory and chronic pain mice,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and thus, sEH/FAAH dual inhibitors had attracted more attention. Interestingly, because <i>t</i>-TUCB, a potent sEH inhibitor (IC<sub>50</sub> = 0.4 nM), has a <i>N</i>-(3-trifluoromethoxyphenyl) moiety, which is a good leaving group for FAAH, it has also reasonable inhibitory potency against FAAH (IC<sub>50</sub> = 260 nM).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Further chemical modifications resulted in a 6-fold increase potency against FAAH while retaining <i>t</i>-TUCB intrinsic sEH inhibitory effect (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. sEH/FAAH dual inhibitor derived from <i>t</i>-TUCB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Separately, a series of sEH/FAAH dual inhibitors were developed based on the cores of a FAAH inhibitor PF-3845 and sEH inhibitor TPPU (<b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). Kodani et al. found that TPPPC (<b>74</b>) is a low nanomolar inhibitor for both FAAH and sEH inhibitions (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). Further investigation suggested that TPPPC (<b>74</b>) possesses a good target selectivity, PK property (AUC = 1200 nM·h; <i>C</i><sub>max</sub> = 98 nM; <i>t</i><sub>1/2</sub> = 4.9 h in mice), and <i>in vivo</i> target engagement.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Selective sEH/FAAH dual inhibitor TPPPC (<b>74</b>) derived from TPPU (<b>19</b>) and PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.2.5.  sEH/PPARγ Dual Modulators</h4><div class="NLM_p">PPARγ is a nuclear receptor that can be activated by EETs allowing the inhibition of NF-κB pathway and anti-inflammatory effects.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Some studies have indicated that the sEH expression level is increased and the PPARγ transcriptional activity is decreased in obese patients, suggesting that simultaneous regulation of sEH and PPARγ has a therapeutic potential for metabolic diseases.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Recently, Imig and co-workers coadministrated thiazolidinedione (TZD), a PPARγ agonist, and <i>t</i>-AUCB(<b>8</b>), a sEH inhibitor, to spontaneously hypertensive obese rats, resulting in protective effects toward vascular function and kidney,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> supporting the idea of sEH/PPAR dual modulators.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Proschak et al. designed a library of sEH/PPAR dual modulators based on the sEH pharmacophore 4-(trifluoromethoxy)phenyl ureas and PPAR modulator structures and obtained compounds, such as TPUBPC (<b>75</b>) and AUBPC (<b>76</b>), that display inhibition on sEH and activation on PPARα/γ (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Selective sEH/PPAR dual modulators TPUBPC (<b>75</b>) and AUBPC (<b>76</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. SAR of <i>N</i>-benzylbenzamides with sEH and PPARγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, Blöcher et al. also designed a series of sEH/PPAR dual modulators with a benzylamide structure, a merged pharmacophore for sEH and PPARγ, on the basis of the structure of the PPARγ agonist GSK1997132B, such as RB394 (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) with good potencies against sEH and PPARγ. In addition to its good PK and pharmacodynamic profile,<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> RB394 could also ameliorate the development of hypertension, insulin resistance, and hyperlipidemia in obese spontaneously hypertensive and obese diabetic Zucker fatty/spontaneously hypertensive heart failure F1 hybrid rats, which suggested that it could be regarded as a potential agent to treat metabolic syndromes.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">Afterward Schierle et al. found that zafirlukast, an antagonist of cysteinyl leukotriene receptor 1, also possesses an agonistic effect toward PPARγ and inhibitory effect toward sEH (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>). Further structural optimization led to the production of compound <b>77</b>. Its potencies on sEH and PPARγ were increased by 46.5- and 8.1-fold compared to zafirlukast, respectively, and it also exerted an anti-inflammatory potency in the zymosan-induced paw edema.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Selective sEH/PPAR dual modulator CMMMB (<b>77</b>) derived from zafirlukast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.2.6.  sEH/FXR Dual Modulators</h4><div class="NLM_p">Farnesoid X receptor (FXR), known as the bile acid receptor, is a ligand-activated nuclear receptor.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Clinical trials have reported that administration of FXR agonists could improve histological features and clinical markers of NAFLD as well as metabolic parameters, revealing that FXR can be served as a potential target for fatty liver disorders and metabolic diseases.</div><div class="NLM_p">Interestingly, an antagonist of cysteinyl leukotriene receptor 1, zafirlukast, also has an agonistic effect against FXR (EC<sub>50</sub> = 3.9 μM) and inhibitory effect against sEH (IC<sub>50</sub> = 2.0 μM). The optimization of zafirlukast structure lead to a 15-fold increase of its agonistic effect against FXR with a similar potency toward sEH (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. sEH/FXR dual modulator BBIMM (<b>78</b>) derived from zafirlukast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Separately, on the basis of the structure of a sEH inhibitor (GSK2188931B, <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>) and a FXR agonist, Schmidt et al. extracted their similar structural characteristics and combined them in the dual pharmacophore <i>N</i>-benzylamide. This finding led to the production of a sEH/FXR dual modulator BCMBB (<b>79</b>).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Extensive <i>in vitro</i> characterization confirmed its potency and favorable PK (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. sEH/FXR dual modulator BCMBB (<b>79</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.2.7.  sEH/c-RAF Dual Inhibitors</h4><div class="NLM_p">RAF is a proto-oncogene serine/threonine-protein kinase (c-RAF or RAF1)<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> and is the target for antitumor drugs because its inhibition or knockout regulates the RAS-RAF-MEK-ERK pathway to suppress lung and ovarian tumors growth.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Sorafenib (<b>80</b>), the first FDA-approved inhibitor of c-RAF,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> possesses a similar urea pharmacophore as a selective sEH inhibitor <i>t</i>-TUCB, and it was found to exhibit potent inhibitory activity toward sEH as well (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Structural optimization leads to the design and synthesis of a sEH/c-RAF dual inhibitor <i>t</i>-CUPM (<b>81</b>, <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Compared to sorafenib (<b>80</b>), <i>t</i>-CUPM (<b>81</b>) is 25-fold more potent toward sEH while displaying similar potency toward c-RAF, while having satisfying PK properties. The subsequent <i>in vivo</i> study in LSL-KrasG<sup>12</sup>D/Pdx-1-Cre mice indicated that <i>t</i>-CUPM (<b>81</b>) significantly alleviated chronic pancreatitis by suppressing mutant Kras-transmitted phosphorylations of RAF/MEK/ERK.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. sEH/c-RAF dual modulator <i>t</i>-CUPM (<b>81</b>) derived from <i>t</i>-TUCB and sorafenib (<b>80</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.3.  Natural (or Naturally Occurring) Products as sEH Inhibitors</h3><div class="NLM_p">Natural products play an important role in drug discovery, and about 50% of drugs in the clinic are natural products, such as artemisinin, paclitaxel (Taxol), andrographolide, and penicillin.<a onclick="showRef(event, 'ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref141 ref142">(141,142)</a> Accordingly, numerous compounds from natural resources also display inhibition of sEH, including natural ureas, triterpenoids, flavonoids, and phenylpropionic acids.<a onclick="showRef(event, 'ref143 ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref143 ref144 ref145 ref146">(143−146)</a> Interestingly, numerous compounds reported as sEH inhibitors have a weak potency with IC<sub>50</sub> or <i>K</i><sub>i</sub> in the micromolar range, thus limiting their usefulness for eventually treating patients.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.3.1.  Natural Ureas and Amides</h4><div class="NLM_p">So far, as described above, ureas and amides have been most widely studied as sEH inhibitors. To date, natural urea-containing compounds also are discovered from the genera <i>Pentadiplandra</i>, <i>Salvadora</i>, <i>Lepidium</i>, and <i>Moringa</i> (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>),<a onclick="showRef(event, 'ref145 ref147 ref148 ref149 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref145 ref147 ref148 ref149 ref150 ref151">(145,147−151)</a> whereas only five ureas (<b>82</b>–<b>86</b>), isolated from <i>P. brazzeana</i> and <i>L. meyenii</i>, were screened for their sEH inhibitory activities and possess potent human and rat sEH inhibitory activities (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> These are the only reported natural compounds that inhibit sEH with IC<sub>50</sub> in the nanomolar range.</div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of naturally occurring sEH inhibitors: ureas (<b>82</b>–<b>86</b>) and amides (<b>87</b>–<b>91</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Capsaicin (<b>87</b>) and dihyrocapsainin (<b>88</b>), isolated from <i>Capsicum chinense</i>, are competitive-type inhibitors with <i>K</i><sub>i</sub> values of 7.3 and 4.7 μM, respectively.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> In addition, three amide derivatives piperlonguminine (<b>89</b>), piperlonguminine (<b>90</b>), and futoamide (<b>91</b>) from the traditional Chinese medicine <i>Scutellaria baicalensis</i>, are weak sEH inhibitors.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.3.2.  Flavonoids</h4><div class="NLM_p">Some of flavonoids, isolated and identified from the genera <i>Scutellaria</i>, <i>Tetrastigma</i>, <i>Epimedium</i>, <i>Apios</i>, <i>Kaempferia</i>, <i>Boscia</i>, and so on, exhibited sEH inhibitory potencies (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>).<a onclick="showRef(event, 'ref144 ref145 ref154 ref155 ref156 ref157 ref158'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref154 ref155 ref156 ref157 ref158">(144,145,154−158)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structures of naturally occurring sEH inhibitors: flavonoids (<b>92</b>–<b>98</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The investigation on <i>T. hemsleyanum</i> led to the isolation of kaempferol (<b>92</b>) and apigenine (<b>93</b>), and they were defined as noncompetitive-type inhibitors with <i>K</i><sub>i</sub> values of 18.6 and 24.4 μM, respectively.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> In addition, 3,5,7-trimethoxyflavone (<b>94</b>), 5,7,4′-trimethoxyflavone (<b>95</b>), 3,5,7,4′-tetramethoxyflavone (<b>96</b>), 3,5,7,3′,4′-pentamethoxyflavone (<b>97</b>), and 4′,5-dihydroxy-3,3′,7-trimethoxyflavone (<b>98</b>), isolated from <i>K. parviflora</i>, displayed potent inhibitory potentials with <i>K</i><sub>i</sub> values ranging from 0.1 μM to 1.7 μM.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.3.3.  Triterpenoids</h4><div class="NLM_p">Thao and co-workers studied the constituents of <i>Cimicifuga dahurica</i> to afford cycloartuane-type triterpenoids (<b>99</b>–<b>107</b>, <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>).<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a> It was found that compounds <b>99</b>–<b>107</b> were mixed-type inhibitors and their IC<sub>50</sub> values were 0.4–4.8 μM. Protostane-type triterpenoids are characteristic constituents of the genus <i>Alimsa</i>, and 25 of them were assayed for their inhibitory effects against sEH.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Among them, 11-deoxy-25-anhydroalisol E (<b>108</b>, IC<sub>50</sub> = 3.4 μM) and 11-deoxyalisol B (<b>109</b>, IC<sub>50</sub> = 5.9 μM) significantly suppressed sEH activity. As mixed-type inhibitors, 11-deoxy-25-anhydroalisol E (<b>108</b>, <i>K</i><sub>i</sub> = 12.6 μM) and 11-deoxyalisol B (<b>109</b>, <i>K</i><sub>i</sub> = 3.5 μM) are hypothesized to form hydrogen bonds with amino acid residues Asp335, Trp336, Tyr383, and Tyr466, respectively.</div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of naturally occurring sEH inhibitors: triterpenoids (<b>99</b>–<b>109</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.3.4.  Phenylpropionic Acids</h4><div class="NLM_p">Six phenylpropionic acids from <i>T. hemsleyanum</i>, such as (1α,3<i>R</i>,4α,5<i>R</i>)-4-<i>O</i>-(<i>E</i>)-caffeoylquinic acid methyl ester (<b>110</b>) and caffeic acid (<b>111</b>, <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>), showed weak inhibitory activities toward sEH.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> In order to discover more potent sEH inhibitors from natural resources, the subsequent investigation on <i>Polygala tenuifolia</i> led to the isolation of nine analogs, such as 6-<i>O</i>-(<i>O</i>-methyl-pbenzoyl)-3′-<i>O</i>-(<i>O</i>-methylsinapoyl)sucrose (<b>112</b>), and 6,3′-di-<i>O</i>-sinapoylsucrose (<b>113</b>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Kim and co-workers investigated the constituents of <i>C. dahurica</i> and <i>Gentiana scabra</i> to obtain cimiciphenone (<b>114</b>), cimiracemate A (<b>115</b>), 3,5-di-<i>O</i>-caffeoylquinic acid (<b>116</b>), and ferulic acid methyl ester (<b>117</b>).<a onclick="showRef(event, 'ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref162 ref163">(162,163)</a> Compounds <b>114</b>–<b>117</b> could significantly inhibit sEH activity (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>).</div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Chemical structures of naturally occurring sEH inhibitors: phenylpropionic acids (<b>110</b>–<b>117</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">2.3.5.  Anthraquinones</h4><div class="NLM_p"><i>Aloe</i> is a short-stemmed succulent herb mainly used in traditional medicine to treat various diseases. Anthraquinones are considered as the major active constituents of the genus <i>Aloe</i> (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>). Sun et al. obtained three anthraquinones, desoxyaloin (<b>118</b>), aloinoside C (<b>119</b>), and elgonica dimer A (<b>120</b>), from <i>Aloe</i>.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Among them, desoxyaloin (<b>118</b>) showed the most potent inhibitory activity against sEH with a mixed-type inhibitor behavior. Molecular docking suggested that desoxyaloin (<b>118</b>) could bond to sEH with hydrogen bond interactions with Tyr343 and Pro361. Besides, emodin (<b>121</b>), an anthraquinone derivative isolated from <i>P. multiflorum</i>, also displayed inhibitory potency against sEH.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0033.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Chemical structures of naturally occurring sEH inhibitors: anthraquinones (<b>118</b>–<b>121</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">2.3.6.  Stilbenes</h4><div class="NLM_p">The investigation on <i>Rheum undulatum</i> resulted in the isolation of astringin (<b>122</b>, <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>), which was found to inhibit sEH.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Molecular docking suggests seven hydrogen bonds between astringin (<b>122</b>) and Ser415, Leu417, Met419, Tyr466, Lys495, and His524 residues of sEH. In addition, three noncompetitive inhibitors of sEH, selaginellin A (<b>123</b>), selaginellin B (<b>124</b>), and selaginellin (<b>125</b>) were isolated from <i>Selaginella tamariscina</i>.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a><i>In silico</i> investigation suggests that they bonded to a complex of sEH and substrate via hydrogen bond interactions.</div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0034.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Chemical structures of naturally occurring sEH inhibitors: stilbenes (<b>122</b>–<b>125</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">2.3.7.  Alkaloids</h4><div class="NLM_p">Investigation of the phytochemical constituents of traditional Chinese medicines <i>C. dahurica</i> and <i>Glycosmis stenocarpa</i> resulted in the isolation and identification of four alkaloids (<b>126</b>–<b>129</b>) (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>) that inhibit sEH.<a onclick="showRef(event, 'ref160 ref167'); return false;" href="javascript:void(0);" class="ref ref160 ref167">(160,167)</a></div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0035.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Chemical structures of naturally occurring sEH inhibitors: alkaloids (<b>126</b>–<b>129</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">2.3.8.  Others</h4><div class="NLM_p">Besides all of the above-mentioned compounds, some other type of compounds isolated from <i>G. scabra</i>, <i>Magnolia officinalis</i>, <i>Callistemon citrinus</i>, and <i>Cassia tora</i><a onclick="showRef(event, 'ref163 ref168 ref169'); return false;" href="javascript:void(0);" class="ref ref163 ref168 ref169">(163,168,169)</a> also displayed some inhibition on sEH, such as berchemol (<b>130</b>), honokiol (<b>131</b>), callistenone B (<b>132</b>), and cassitoroside (<b>133</b>) (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>).</div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0036.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Chemical structures of naturally occurring sEH inhibitors: others (<b>130</b>–<b>133</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">2.4.  Selectivity of sEH Inhibitors</h3><div class="NLM_p last">High selectivity of pharmacological inhibitors as an important factor limits off-target nondesirable side effects in the clinic. Here, we are mostly concentrating on the urea-based sEH inhibitors. Because urea function is also the central pharmacophore for compounds that inhibit proteases and kinases<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> and bind to canabinoid receptors 1,<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> it is possible that inhibitors for sEH could also alter the function of these other proteins. It is interesting that the Raf-1 kinase inhibitor sorafenib (<b>80</b>), used to treat some cancer, was found to inhibit sEH also.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> A commonly used sEH inhibitor, TPPU (<b>19</b>), was recently reported to also inhibit significantly the p38 kinase, influencing its action in an AD model.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> The selectivity of a particular compound is dependent not only on the central pharmacopohore but also on the chemical groups present on both sides of the urea. As these groups are becoming more complex and establishing additional bonds with sEH, the likelihood of a compound to bind to another protein decreases. However, any compound developed as a pharmacological sEH inhibitor should be tested for it selectivity especially for its ability to inhibit or not proteases and kinases.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">3.  Biological Potentials for sEH Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">EpFAs play a crucial role in biological functions, such as reducing inflammation and pain, dilating blood vessels, and protecting neurons. A growing body of studies indicated that many cardiovascular, CNS, and metabolic diseases, such as hypertension, arteriosclerosis, AD, PD, NAFLD, and diabetes, are related to the level of EpFAs in the human body and the expression of sEH.<a onclick="showRef(event, 'ref32 ref174 ref175 ref176'); return false;" href="javascript:void(0);" class="ref ref32 ref174 ref175 ref176">(32,174−176)</a> Moreover, chemical inhibition and genetic knockout sEH, which yields a steady state of EpFAs level in the body, have beneficial effects on the physiological environment and greatly influence the above-mentioned diseases.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">3.1.  Cardiovascular Diseases</h3><div class="NLM_p">The abnormal function of vascular endothelial cells plays a crucial role in the occurrence and development of cardiovascular diseases. The prevention of endothelial cell dysfunction is one of the key problems related to cardiovascular diseases to solve. EETs synthesized in endothelial cells act as an autocrine and paracrine mediator of cardiovascular system, which has vasodilation and anti-inflammatory effects.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Therefore, sEH is considered in the treatment of cardiovascular diseases via improving the bioavailability of endothelium-derived hyperpolarization and relaxing factor EETs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">Hypertension is caused by a complex interaction of genes and several environmental factors and is also one of the important causes of heart remodeling. Hypertension not only reduces the quality of life but also increases the risk of other cardiovascular diseases.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Extensive research has verified that endogenic EETs contribute to vasodilation in various organs, such as brain, kidney, intestine, and heart,<a onclick="showRef(event, 'ref45 ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref45 ref179 ref180">(45,179,180)</a> especially 14,15-EET. They activate BK<sub>Ca</sub> in vascular smooth muscle cells to promote K<sup>+</sup> efflux and membrane hyperpolarization via modulation of cAMP-mediated protein kinase A and ADP ribosylation of the Gαs pathway, leading to the relaxation of blood vessels.<a onclick="showRef(event, 'ref40 ref181 ref182 ref183 ref184 ref185'); return false;" href="javascript:void(0);" class="ref ref40 ref181 ref182 ref183 ref184 ref185">(40,181−185)</a> However, DHETs, sEH-mediated hydrolysates of EETs, exhibit a weak relaxant effect,<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> which suggests that inhibition of sEH to stabilize levels of EETs is a therapeutic strategy for hypertension.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The present series of studies provide evidence that the expression level of sEH is increased in hypertensive rats.<a onclick="showRef(event, 'ref61 ref186'); return false;" href="javascript:void(0);" class="ref ref61 ref186">(61,186)</a> For example, the increasing of sEH expression was observed in the kidney of spontaneously hypertensive rats and Ang II-induced hypertension rodent model.<a onclick="showRef(event, 'ref187 ref188'); return false;" href="javascript:void(0);" class="ref ref187 ref188">(187,188)</a> The similar result was also found in aortic specimens from saline-fed and Ang II-infused rats,<a onclick="showRef(event, 'ref189 ref190'); return false;" href="javascript:void(0);" class="ref ref189 ref190">(189,190)</a> demonstrating the presence of the relationship between sEH and hypertension. The <i>Ephx2</i> abolishment significantly decreases systolic blood pressure and enhances the ratio of EETs/DHETs in a saline-fed-induced hypertensive model.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Moreover, a great increase of evidence demonstrated that administration of sEH inhibitors, such as AUDA (<b>4</b>), TPPU (<b>19</b>), and <i>c</i>-AUCB (<b>9</b>), lowered blood pressure in the hypertensive mice model.<a onclick="showRef(event, 'ref67 ref192 ref193'); return false;" href="javascript:void(0);" class="ref ref67 ref192 ref193">(67,192,193)</a> An orally administered sEH inhibitor AR9281 (APAU, <b>6</b>) developed by Arête Therapeutics Inc. finished the phase I and phase II clinical trials. AR9281 is safe and well tolerated for healthy volunteers, even administration with a high dose (single oral dose, 1000 mg; multiple dose, 400 mg every 8 h for 7 days) in the phase I clinical trial, whereas it does not display thrilling efficacy in early-stage hypertension during the phase II clinical trial.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a></div><div class="NLM_p">Atherosclerotic diseases are the major causes of mortality worldwide. Atherosclerosis is a progressive disease characterized by the formation of foam cells, dyslipidemia, and accumulation of lipid plaques in the arterial wall.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> Extensive epidemiological studies clearly revealed the correlation of the plasma cholesterol profile with atherosclerosis. In the course of atherosclerosis, low-density lipoprotein (LDL), especially oxidized LDL, activates inflammation and foam cell formation, but high-density lipoprotein (HDL) has a protective effect on atherosclerosis. sEH inhibitors reduced atherosclerotic lesion formation in the deficient apolipoprotein E (<i>ApoE</i><sup>–/–</sup>) or LDL receptor (<i>Ldlr</i><sup><i>–/–</i></sup>) mice; these mice exhibited advanced lesions and increases in the LDL level.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> In <i>ApoE</i><sup><i>–/–</i></sup> mice, administration of a sEH inhibitor significantly decreased serum LDL concentrations and secretion of inflammatory factors.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> In order to reveal the protective mechanism for inhibition of sEH, a study by Xu et al. reported that administration of <i>t</i>-AUCB (<b>8</b>) could enhance CD36-mediated recognition and interpretation of oxidized-LDL through the activation of PPARγ and further improve cholesterol outflow by increasing the ATP cassette A1 expression level, which reduced the formation of atherosclerotic lesions in <i>Ldlr</i><sup><i>–/-</i></sup>mice.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Similarly, Shen et al. found that <i>t</i>-AUCB (<b>8</b>) treatment alleviated atherosclerosis symptoms in <i>Ldlr</i><sup><i>–/–</i></sup> mice as well via modulation of the expression of ATP binding cassette transporter A1, cholesterol efflux, and plasma HDL levels.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> In addition, inhibition of sEH with <i>t</i>-TUCB delayed the formation of hyperlipidemia and atherosclerosis in <i>Ldlr</i><sup><i>–/-</i></sup> mice, and <i>Ephx2</i> genetic abolishment significantly alleviated the symptoms of atherosclerosis as well.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a></div><div class="NLM_p">Heart failure is caused by blocking blood flow to the heart, resulting in coronary heart disease, myocardial infarction, arrhythmia, viral myocarditis, and genetic cardiomyopathies.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> A study by Seubert et al. has demonstrated the increasing of sEH activity in animal models of myocardial infarction, and the increasing of sEH expression was observed in the human hearts of patients with ischemic cardiomyopathy. Moreover, increasing EET levels protected against myocardial infarction and left ventricular dysfunction after ischemic injury in <i>Ephx2</i><sup><i>–/–</i></sup> mice.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Inhibition of sEH with GSK2188931B and TUPS both protected heart failure.<a onclick="showRef(event, 'ref201 ref202'); return false;" href="javascript:void(0);" class="ref ref201 ref202">(201,202)</a> For example, TUPS treatment reduced the thickness of the heart wall, downregulated the expression of hypertrophy markers atrial and brain natriuretic peptides, and regulated negative autophagy via activation of mammalian target of rapamycin (mTOR) signaling, allowing prevention of myocardial hypertrophy induced by isoproterenol.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> These data all suggested the therapeutic potential of sEH in heart failure.</div><div class="NLM_p last">Preclinical results have demonstrated that inhibition of sEH by inhibitors or <i>Ephx2</i> genetic knockout possesses beneficial effects, such as vasodilation, antihypertension, and antiatherosclerotic effects. Although inhibition of sEH to treat human diseases still remains to be demonstrated in clinical trials, the increasing of positive effects of sEH inhibitors in cardiovascular diseases strongly supports the clinical role of sEH in cardiovascular diseases.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">3.2.  CNS Diseases</h3><div class="NLM_p">EETs play an important role in CNS diseases. They can regulate angiogenesis and cerebral blood flow (CBF) and affect signal transduction process. Because of the abundant expression of sEH in various parts of the brain, the neuroprotective effect of sEH inhibitors has become an important research direction in the treatment of CNS diseases. In recent years, sEH inhibitors have been used in the treatment of CNS diseases, such as AD, PD, and depression with satisfactory performance.<a onclick="showRef(event, 'ref175 ref203 ref204 ref205'); return false;" href="javascript:void(0);" class="ref ref175 ref203 ref204 ref205">(175,203−205)</a></div><div class="NLM_p">PD, one of the most common neurodegenerative diseases, leads to progressive motor deficits and nonmotor symptoms, including speech, motor, and mental disorders.<a onclick="showRef(event, 'ref203 ref204'); return false;" href="javascript:void(0);" class="ref ref203 ref204">(203,204)</a> In the course of onset, dopaminergic neurons in substantia nigra (SN) prematurely die and Lewy bodies accumulate in the brain.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The current treatment works by increasing dopamine concentration and/or stimulating its receptors, but this treatment only targets basal ganglia and dopamine but does not involve more neurons associated with PD. Therefore, this therapy is generally not very effective. In human and animal PD models, the expression level of sEH in brain regions is associated with dopaminergic death, endoplasmic reticulum (ER) stress, and tyrosine hydroxylase positive cell death, which can be alleviated by administration of AUDA (<b>4</b>), TPPU (<b>19</b>), or 14,15-EET.<a onclick="showRef(event, 'ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref206 ref207">(206,207)</a> EETs stimulate astrocytes to secrete nerve growth factors (NGFs), including vascular endothelial growth factor and brain-derived neurotrophic factor (BDNF), which promotes the growth and differentiation of nerve cells and protects neurons.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> Administration of AUDA (<b>4</b>) reduced MPTP-mediated loss of TH positive cells in SN.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Furthermore, the <i>Ephx2</i> abolishment protected against MPTP-induced neurotoxicity in STR, while overexpression of sEH in STR significantly enhanced MPTP-induced neurotoxicity.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Moreover, the expression of the sEH protein in STR from MPTP-treated mice was significantly higher than the control group. Interestingly, there was a positive correlation between sEH expression and the phosphorylation of an α-synuclein in STR, suggesting that sEH may play a role in the phosphorylation of α-synuclein in STR. In model animals, administration of TPPU (<b>19</b>) increased dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid levels and inhibited the apoptosis of Parkinson disease protein 2 (PARK2) neurons. Accordingly, it is likely that sEH can act as a potential target for the treatment of PD.</div><div class="NLM_p">AD is a neurodegenerative disease characterized by impaired learning, memory, and cognitive abilities. Neuroinflammation is a critical factor causing AD and plays a crucial role in the development course of AD;<a onclick="showRef(event, 'ref208 ref209 ref210'); return false;" href="javascript:void(0);" class="ref ref208 ref209 ref210">(208−210)</a> therefore, 16% of currently ongoing clinical trials for the treatment of AD is correlated with inflammation.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Neuroinflammation is intimately linked to the oxidative stress associated with AD<a onclick="showRef(event, 'ref212 ref213'); return false;" href="javascript:void(0);" class="ref ref212 ref213">(212,213)</a> and controls the interactions between the immune system and the nervous system.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> The senescence-accelerated mouse prone 8 (SAMP8) is a paradigm of late-onset AD and cognitive impairment in age, causing oxidative stress, neuroinflammation, tau hyperphosphorylation, and proamilodogenic APP processing.<a onclick="showRef(event, 'ref215 ref216 ref217 ref218 ref219'); return false;" href="javascript:void(0);" class="ref ref215 ref216 ref217 ref218 ref219">(215−219)</a> Griñán-Ferré et al. found the increasing of sEH expression in the hippocampus of SAMP8 mice, and inhibition of sEH with TPPU (<b>19</b>), AS2586114, or UB-EV52 could reduce biomarkers of inflammation, oxidative stress, and ER stress.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> Similarly, these positive results were also observed in a 5×FAD mouse model of early onset AD after administration of sEH inhibitors.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> A recent study has revealed that the sEH level was increased in the brain and predominantly appeared in hippocampal astrocytes of <i>APP/PS1 Tg</i> mice.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> Genetic deletion of sEH alleviates behavior outcomes and amyloid β (Aβ) accumulation, increases astrogliosis and the production of anti-inflammatory cytokines IL-4 and IL-10, and inhibits NF-κB signaling pathway, resulting in a protective effect against AD.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Additionally, compared with a healthy human, the analysis of clinical specimens demonstrated that sEH was overexpressed in Braak III and V phases of AD patients’ brains,<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> which confirmed the correlation of sEH with AD.</div><div class="NLM_p">Depression and schizophrenia both have high mortality rates and involve a wide range of severe chronic mental illness.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> The proinflammatory cytokines in serum and cerebrospinal fluid are increased, and the sEH level is significantly increased in the parietal cortex of the brains of deceased patients suffering from these diseases.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> It strongly suggests that sEH is likely involved in the pathophysiological process of depression and schizophrenia. In LPS-treated depressed mice, TPPU (<b>19</b>), a sEH inhibitor, can significantly improve depressive symptoms by reducing the level of TNF-α, upregulating the expression of BDNF in mouse hippocampus and PC12 cells and enhancing NGF-induced neuronal growth in PC12 cells. Moreover, sEH knockout ameliorates symptoms of depression as well.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> Chemical inhibition on sEH by AS2586114 decreases levels of 11,12-DHET and 14,15-DHET and improves hyperactivity and prepulse inhibition defects in phencyclidin-induced schizophrenia.<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a> Thus, the inhibition of sEH appears to exert antidepressant and antischizophrenic effects by increasing the concentration of EETs, regulating the BDNF-tropomyosin receptor kinase B (BDNF-TrkB) signaling pathway, and preventing oxidative stress.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a></div><div class="NLM_p last">Additionally, sEH is also involved in epilepsy and stroke. Administration of sEH inhibitors could prevent neuroinflammation and reduce the number and duration of seizures of epilepsy.<a onclick="showRef(event, 'ref55 ref225'); return false;" href="javascript:void(0);" class="ref ref55 ref225">(55,225)</a> After treatment with AUDA (<b>4</b>), the expression of inflammatory factors decreased and the EETs/DHETs ratio increased, while at the same time, the epileptic induction threshold was increased and the epileptic sensitivity was decreased. There is a correlation between the mutation of R287Q of sEH, which led to a decrease of sEH activity and a reduced risk of stroke.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Chemical inhibition can reduce astrocyte infiltration, glial scar formation, microglial activation, neuronal death, insufficient blood flow, and behavioral disorder after cerebral ischemia.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Put together, sEH has a clear role in CNS health and diseases and represents a potential target for treatment.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">3.3.  Metabolic Diseases</h3><div class="NLM_p">Besides cardiovascular and CNS diseases, sEH is closely related to metabolic diseases, including NAFLD, diabetes, and obesity. Many studies have shown overexpression of sEH in many liver diseases, such as NAFLD, nonalcoholic steatohepatitis (NASH),<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a> and hepatic fibrosis.<a onclick="showRef(event, 'ref227 ref228 ref229 ref230 ref231'); return false;" href="javascript:void(0);" class="ref ref227 ref228 ref229 ref230 ref231">(227−231)</a> NAFLD is caused by excessive fat accumulation in hepatocytes, affecting approximately 25% of the global adult population. Some of preclinical results verified that sEH inhibition was to the benefit of NAFLD and NASH. Iyer et al. investigated the role of sEH inhibition in a high-carbohydrate- and high-fat-diet (HCHFD)-induced rat model.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The inhibition of sEH with <i>t</i>-AUCB (<b>8</b>) alleviated HCHF-induced liver hypertrophy and steatosis, had significant improvements in plasma lipid levels and insulin sensitivity, and suppressed the increasing of aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Similarly, chemical inhibition of sEH or <i>Ephx2</i> genetic abolishment has a protective role in high-fat-diet (HFD)-induced NAFLD.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a><i>t</i>-AUCB (<b>8</b>) could reduce HFD-induced macrophage accumulation and downregulate mRNA expression levels of proinflammatory cytokines TNF-α, IL-6, MCP-1, and IFN, leading to the improvement of HFD-induced inflammation via the activation of MAPK pathway (JNK and p38).<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> However, overexpression of sEH by the injection of adenoviruses encoding human sEH resulted in the aggravation of metabolic syndromes, such as the increasing of triglyceride and proinflammatory cytokine and the upregulation of JNK and p38.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> Conversely, the <i>Ephx2</i> deletion alleviated hepatic steatosis and tissue inflammatory, described as administration of <i>t</i>-AUCB (<b>8</b>), which suggested the role of sEH-mediated hepatic steatosis. The role of sEH in NAFLD also was supported in high-methionine-diet-induced hyperhomocysteinemia and hepatic steatosis.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> Accumulating evidence revealed that hyperhomocysteinemia disturbs lipid metabolism in the liver and is served as a significant risk factor. A study by Yao et al. demonstrated that sEH inhibition by TPPU (<b>19</b>) ameliorated hyperhomocysteinemia-induced lipid accumulation, and further mechanism investigation suggested that the increase of EETs through the inhibition of sEH by TPPU (<b>19</b>), especially 11,12-EET, elevated the expression levels of PPARα target genes and activated PPARα.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> These findings suggested that the increase of sEH activity was a critical threat in hyperhomocysteinemia-induced hepatic steatosis, and sEH inhibition might be regarded as an effective means to treat hyperhomocysteinemia-induced hepatic steatosis.</div><div class="NLM_p">Inflammasome is responsible for the modulation of the adaptive response of the liver to pathogenic challenge, and a library of evidence demonstrated that sEH inhibition could suppress inflammasome activation to reduce hepatic inflammation.<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> Administration of PTUPB (<b>68</b>), a sEH/COX-2 dual inhibitor, could block fibrotic progression by suppressing collagen deposition and down-modulating Col1a1, Col1a11a3, and α-SMA expression levels. The dual inhibition of sEH and COX-2 also suppressed the NLRP3 inflammasome activation through the decrease of Nlrp3/NLRP3 and Asc expression and reduced the downstream target protein of NLRP3, procaspase 1, pro-IL-1β, and pro-IL-18. Besides, PTUPB (<b>68</b>) treatment decreased the release of proinflammatory cytokines IL-6 and MCP-1.<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> Accordingly, it was worth noting that the role of sEH in inflammasome activation still needs to be further studied.</div><div class="NLM_p">Diabetes is mainly due to the lack of insulin produced by pancreatic β-cells or the insensitivity of the target tissue to insulin, leading to the severe injuries to organs.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> A growing body of evidence has demonstrated that the stabilization of EETs, inhibition of sEH by sEH inhibitors, or <i>Ephx2</i> genetic deletion plays a crucial role in diabetes. A study by Schaefer et al. verified that EETs enhanced insulin signaling through the regulation of Akt expression level rather than affecting levels of insulin receptor.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Furthermore, the insulin release was also promoted by 5,6-EET, while 8,9-EET, 11,12-EET, and 14,15-EET might promote the release of glucagon and increase the level of blood glucose, which suggested that increasing the concentration of EETs through inhibition of sEH might be a potential pathway to treat diabetes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In streptozotocin (STZ)-induced diabetic mice, administration of <i>t</i>-AUCB (<b>8</b>) attenuated hyperglycemia and had protective effects against β-cell damage.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> An investigation by Pardeshi et al. has been reported that TPPU (<b>19</b>) reduced the level of fasting blood glucose, improved the cognitive impairment and memory impairment by stabilizing EETs to dilate arterioles, and increased cerebral blood perfusion in STZ-induced diabetes.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a> A similar result was also observed after administration of <i>t</i>-AUCB (<b>8</b>).<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> In addition, inhibition of sEH or <i>Ephx2</i> knockout has been found to alleviate symptoms of hyperglycemia and insulin resistance in HFD-induced type 2 diabetes,<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> which might activate insulin signaling in the liver and adipose tissue.</div><div class="NLM_p">Diabetes also causes many complications, such as retinopathy, nephropathy, and cardiovascular diseases, and seriously affects a patient’s quality of life. A great number of studies have verified that inhibition of sEH by inhibitors or genetic knockout sEH is beneficial to diabetic complications.<a onclick="showRef(event, 'ref228 ref239'); return false;" href="javascript:void(0);" class="ref ref228 ref239">(228,239)</a> Diabetic retinopathy is one of the diabetic complications caused by progressive loss of vascular cells and slow dissolution of vascular junctions.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a> The expression of sEH is increased in human retina and vitreous of diabetic retinopathy. Furthermore, overexpression of sEH in retinal Müller glial cells can result in vascular abnormalities in diabetic retinopathy.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Therefore, the overexpression of sEH is a key factor in the pathogenesis of diabetic retinopathy. Jouihan et al. found that STZ treatment promoted sEH mRNA expression and reduced EET level in cerebral vessels.<a onclick="showRef(event, 'ref228'); return false;" href="javascript:void(0);" class="ref ref228">(228)</a> Furthermore, brain infarction was exacerbated in STZ-treated mice after middle cerebral artery occlusion, which was reversed through the inhibition of sEH by <i>t</i>-AUCB (<b>8</b>). Moreover, sEH is related to diabetic cardiomyopathy since sEH is highly expressed in the heart tissue of type 1 diabetes mice.<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a> In addition, sEH genetic disruption reduced levels of blood urea nitrogen and creatinine as well as via suppressed renal tubular apoptosis and enhanced renal endothelial function, allowing the alleviation of diabetic nephropathy.<a onclick="showRef(event, 'ref229 ref230'); return false;" href="javascript:void(0);" class="ref ref229 ref230">(229,230)</a></div><div class="NLM_p">So far, a selective sEH inhibitor GSK2256294 (<b>67</b>) has finished its phase I clinical trial, whose clinical experimental data demonstrated its safety and sustained inhibitory effect against sEH.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> These results supported further clinical trials in patients with endothelial dysfunction, such as diabetes. In 2018, Vanderbilt University Medical Center sponsored the phase II clinical trial of GSK2256294 (<b>67</b>) to treat diabetes, endocrine system diseases, glucose metabolism disorders, and obesity and started volunteer recruitment.</div><div class="NLM_p last">Obesity is a global public health problem and a major risk factor for diseases, the same as cancer and diabetes. In metabolic disorders, chemical inhibition of sEH or <i>Ephx2</i> deletion is capable of lessening body weight gain, lowering blood pressure, and suppressing the production of inflammatory cytokines.<a onclick="showRef(event, 'ref78 ref241 ref242'); return false;" href="javascript:void(0);" class="ref ref78 ref241 ref242">(78,241,242)</a> Moreover, the increasing of sEH expression has been found in adipose tissue of obese mice,<a onclick="showRef(event, 'ref78 ref241 ref242'); return false;" href="javascript:void(0);" class="ref ref78 ref241 ref242">(78,241,242)</a> revealing the potential correlation of sEH with obese. A growing body of evidence indicates that ER is a known cellular consequence of metabolic diseases, such as obesity and NAFLD.<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> Importantly, sEH deficiency or inhibition in mice attenuated HFD-induced ER stress in liver and adipose tissue. Similarly, the inhibition of sEH in 3T3-L1 preadipocytes mitigated chemical-induced ER stress and activation of JNK, p38, and cell death.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> A study by Lopez-Vicario et al. has reported that <i>t</i>-TUCB could stabilize the levels of EpFAs, 17,18-epoxyeicosatetraenoic acid (17,18-EEQ), and 19,20-epoxydocosapentaenoic (19,20-EDP) derived from ω-3.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> Moreover, <i>t</i>-TUCB promoted the polarization of macrophage to anti-inflammatory M2-type cells, induced hepatic autophagy by increasing Atg12-Atg5 and LC3-II expression levels, and reduced p62 expression and ER stress by suppressing p-IRE-1α and p-eIF2α expression levels.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> The inhibition of sEH to exert a protective effect was also confirmed in palmitate-primed hepatocytes and adipocytes through the incubation of 19,20-EDP or 17,18-EEQ,<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> which suggested that sEH was a physiological modulator of ER stress and a potential target for the treatment of obesity. In short, the inhibition on sEH blocks the progression of obesity and is of great significance for obesity and related diseases.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">4.  Conclusion and Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this review, we described a complete picture of chemically synthesized or naturally obtained sEH inhibitors. Among these inhibitors, urea-based compounds are the most prominent because they can accommodate well the active pocket of sEH and form stable hydrogen bonds and have in general a good selectivity for sEH. Besides potency, the main drivers for improvement have been to increase water solubility and other physical properties as well as better bioavailability and PK parameters. Toward solving these problems, amides are good alternatives to ureas for sEH inhibition. In addition, the introduction of secondary polar groups and tertiary pharmacophore into the structure of the inhibitors would greatly help with the design of a “better” inhibitor. Nowadays, nature is providing more and more structural skeletons on which to build potent sEH inhibitors besides ureas and amides, such as flavonoids and triterpenoids. These compounds have their advantages and disadvantages, which provide more space for the development and optimization of future sEH inhibitors.</div><div class="NLM_p last">Currently, sEH is a potential therapeutic target in multiple diseases related to inflammation, such as cardiovascular (hypertension and arteriosclerosis), CNS (AD, PD, and depression), and metabolic (diabetes, NAFLD, NASH, and obesity) diseases. Moreover, some sEH inhibitors, such as AR9281, EC5026, and GSK2256294, are underway at clinical trials to treat heart failure, insulin resistance, glucose intolerance, hypertension, endothelial dysfunction, and pain, while future research in some key areas is needed to further elucidate its applications and action mechanisms. Compared with the function of C-terminal hydrolase, the role of the N-terminal phosphatase domain is still undetermined. Although Kramer et al. have first discovered <i>in vivo</i> active inhibitors of sEH phosphatase with favorable PK, its N-terminal physiological function needs to be further in-depth investigated. Future studies should consider that inhibition of sEH C-terminal activity remains its phosphatase activity, discovering any differences in phenotype between sEH hydrolase inhibitor-treated and <i>Ephx2</i> deficiency animals.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01507" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce D. Hammock</span> - <span class="hlFld-Affiliation affiliation">Department
of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1408-8317" title="Orcid link">http://orcid.org/0000-0003-1408-8317</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#583a3c30393535373b33182d3b3c392e312b763d3c2d"><span class="__cf_email__" data-cfemail="0361676b626e6e6c60684376606762756a702d666776">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Chi Ma</span> - <span class="hlFld-Affiliation affiliation">Dalian
Key Laboratory of Metabolic Target Characterization and Traditional
Chinese Medicine Intervention, College (Institute) of Integrative
Medicine, College of Pharmacy, Dalian Medical
University, Dalian 116044, People’s Republic
of China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Pharmacy, School of Medicine, Hangzhou
Normal University, Hangzhou 311121, People’s Republic
of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4397-537X" title="Orcid link">http://orcid.org/0000-0003-4397-537X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#365b574e55070f010e760700051855595b"><span class="__cf_email__" data-cfemail="c8a5a9b0abf9f1fff088f9fefbe6aba7a5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Peng Sun</span> - <span class="hlFld-Affiliation affiliation">Dalian
Key Laboratory of Metabolic Target Characterization and Traditional
Chinese Medicine Intervention, College (Institute) of Integrative
Medicine, College of Pharmacy, Dalian Medical
University, Dalian 116044, People’s Republic
of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6801-3439" title="Orcid link">http://orcid.org/0000-0001-6801-3439</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin-Yue Zhang</span> - <span class="hlFld-Affiliation affiliation">Dalian
Key Laboratory of Metabolic Target Characterization and Traditional
Chinese Medicine Intervention, College (Institute) of Integrative
Medicine, College of Pharmacy, Dalian Medical
University, Dalian 116044, People’s Republic
of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Morisseau</span> - <span class="hlFld-Affiliation affiliation">Department
of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sung Hee Hwang</span> - <span class="hlFld-Affiliation affiliation">Department
of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhan-Jun Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing 100875, People’s Republic of China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.-P.S., X.-Y.Z., and C.M. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Cheng-Peng Sun</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3686-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Cheng-Peng Sun</b> graduated from Shenyang Pharmaceutical University in 2016 and received his Ph.D. in Natural Medicinal Chemistry under the guidance of Prof. Feng Qiu. Afterward, he joined the Department of Medicinal Chemistry in Dalian Medical University. In January 2019, he was promoted to Associate Professor of Medicinal Chemistry at Dalian Medical University. So far, he has published more than 40 papers on journals indexed by the Science Citation Index. His major research interests include extraction and isolation of chemical constituents from natural medicines, structural modification of active compositions, and natural modulators of sEH, FXR, and PXR. In addition, he is focusing on the prevention and treatment of neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Xin-Yue Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3691-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xin-Yue Zhang</b> graduated from Dalian Medical University and received her Bachelor’s degree in 2019. She is pursuing a Master’s degree at the Dalian Medical University in the research group of Prof. Xiao-Chi Ma. Her research focuses on the active substances of traditional Chinese medicine and the discovery of sEH inhibitors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Christophe Morisseau</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3696-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christophe Morisseau</b> obtained his Ph.D. in Organic Chemistry in 1995 from the Universitée de la Mditerranée in Marseille, and he has since been working with Prof. Hammock at University of California, Davis. He is now a Professional Researcher faculty. He is working at understanding the mechanism and biological role of EHs and developing selective tight binding inhibitors for EHs. He developed the first stable highly potent inhibitor of human sEH, obtained the first crystal structures for sEH and the first high-throughput assays for the human sEH and mEH, and developed more biochemical tools to study EHs. Some of the inhibitors he obtained are in development for the treatment of inflammation, cardiovascular disease, pain, and cancer. His work has resulted in more than 250 papers and 20 patents.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Sung Hee Hwang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3701-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sung Hee Hwang</b> obtained his Ph.D. in Organic Chemistry in 2004 from the University of California, Davis. He is an accomplished medicinal chemist. He leads the development of highly potent inhibitors of epoxide hydrolase and cyclooxygenase enzymes. In addition, he has synthesized various fatty acids and their cytochrome P450-metabolite analogs to study their biological activities. His work has resulted in more than 100 publications.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Zhan-Jun Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3706-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhan-Jun Zhang</b> received his Ph.D. in Medicine from Beijing University of Chinese Medicine in 2005 and is the Director of the Center for Beijing Aging Brain Rejuvenation Institute and the Vice President of State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University. He has been engaged in a long-term research of digging the pattern of varied human advanced cognitive functions decline, the degradation mode of the brain’s structure and function network, the mechanism of genetic variation toward the brain and cognitive aging, and the contribution of Chinese medicine in protecting the brain from aging. He is the recipient of the National Science Fund for Distinguished Young Scholars and the New Century Excellent Talents Program of China’s Ministry of Education.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Bruce D. Hammock</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3711-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bruce D. Hammock</b> received his Ph.D. in Entomology and Toxicology in 1974 from the University of California, Berkeley. He is now a Distinguished Professor at University of California, Davis. Dr. Hammock is an elected member of the National Academy of Sciences, U.S., since 1999. He discovered the sEH and has devoted his carreer studying the biological roles of this enzyme. He has over 30 years of extensive experience in the field of eicosanoids that has yielded over 1200 publications and 100 issued patents on synthesis, pharmacology, and biological action of eicosanoids and sEH inhibitors.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Xiao-Chi Ma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=BIO-d7e3716-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiao-Chi Ma</b> received his Ph.D. in Phytochemistry from School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, in July 2005, under the guidance of Prof. De-An Guo and Li-Jun Wu. He worked as a postdoc in School of Pharmaceutical Sciences, Peking Unversity, and mainly focused on biological fermentation, tissue culture of endangered plant medicine, biotransformation of natural products by microorganism and plant suspension cells and phytochemistry. In 2008, he joined the Dalian Medical University and was promoted to Professor of Natural Medicinal Chemistry at Dalian Medical University. He is the recipient of the National Science Fund for Excellent Young Scholars. His major research interests include effective substances from traditional Chinese medicine and drug metabolism, development, and application of small molecular probes.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Natural Science Foundation of China (No. 81930112 and 81703769), National Key Research and Development Program of China (2018YFC1705900), Liaoning Provincial Key Research and Development Program (2019JH2/10300022), Distinguished professor of Liaoning Province, Dalian High Level Talents Innovation Support Plan (2019RD15), Revolutionizing Innovative, Visionary Environmental Health Research Program of the National Institute of Environmental Health Sciences (R35 ES030443), Superfund Basic Research Program of the National Institutes of Environmental Health Sciences (P42 ES04699), Liaoning Revitalization Talents Program, Natural Science Foundation of Liaoning Province (No. 2020-MS-256), and Dalian Young Star of Science and Technology (No. 2019RQ123).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AFIMU</td><td class="NLM_def"><p class="first last">1-(adamant-1-ylmethyl)-3-{[5-(furan-2-yl)isoxazol-3-yl]methyl}urea</p></td></tr><tr><td class="NLM_term">AMMU</td><td class="NLM_def"><p class="first last">1-(adamant-1-ylmethyl)-3-[(3-methylisoxazol-5-yl)methyl]urea</p></td></tr><tr><td class="NLM_term">Ang II</td><td class="NLM_def"><p class="first last">angiotensin II</p></td></tr><tr><td class="NLM_term">APU</td><td class="NLM_def"><p class="first last">1-(adamantan-2-yl)-3-phenethylthiourea</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">AUDA</td><td class="NLM_def"><p class="first last">12-(3-adamantan-1-yl-ureido)dodecanoic acid</p></td></tr><tr><td class="NLM_term">AUDA-nBE</td><td class="NLM_def"><p class="first last">AUDA <i>n</i>-butyl ester</p></td></tr><tr><td class="NLM_term">BDNF-TrkB</td><td class="NLM_def"><p class="first last">BDNF-tropomyosin receptor kinase B</p></td></tr><tr><td class="NLM_term"><i>c</i>-AUCB</td><td class="NLM_def"><p class="first last"><i>cis</i>-4-[4-(3-adamantan-1- ylureido)cyclohexyloxy]benzoic acid</p></td></tr><tr><td class="NLM_term">CBF</td><td class="NLM_def"><p class="first last">cerebral blood flow</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CPU</td><td class="NLM_def"><p class="first last"><i>N</i>-cyclohexyl-<i>N</i>′-(3-phenylpropyl)urea</p></td></tr><tr><td class="NLM_term">COXs</td><td class="NLM_def"><p class="first last">cyclooxygenases</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DCU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylurea</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenoic acid</p></td></tr><tr><td class="NLM_term">DHETs</td><td class="NLM_def"><p class="first last">dihydroxyeicosatrienoic acids</p></td></tr><tr><td class="NLM_term">DPN</td><td class="NLM_def"><p class="first last"><i>N</i>-(3,3-diphenyl-propyl)nicotinamide</p></td></tr><tr><td class="NLM_term">EETs</td><td class="NLM_def"><p class="first last">epoxyeicosatrienoic acids</p></td></tr><tr><td class="NLM_term">EpFAs</td><td class="NLM_def"><p class="first last">epoxy-fatty acids</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">FLAP</td><td class="NLM_def"><p class="first last">5-LOX-activating protein</p></td></tr><tr><td class="NLM_term">HBAU</td><td class="NLM_def"><p class="first last">1,1′-(heptane-1,7-diyl)bis(3-(adamantan-1-yl)thiourea)</p></td></tr><tr><td class="NLM_term">HCHFD</td><td class="NLM_def"><p class="first last">high-carbohydrate and high-fat diet</p></td></tr><tr><td class="NLM_term">HDL</td><td class="NLM_def"><p class="first last">high-density lipoprotein</p></td></tr><tr><td class="NLM_term">HETEs</td><td class="NLM_def"><p class="first last">hydroxy eicosatetraenoic acids</p></td></tr><tr><td class="NLM_term">HFD</td><td class="NLM_def"><p class="first last">high-fat diet</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">ITBU</td><td class="NLM_def"><p class="first last"><i>N</i>-[9-(isopropylsulfonyl)-1-oxa-9-azaspiro[5.5]undec-4-yl]-<i>N</i>′-[4-(trifluoromethoxy)benzyl]urea</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">kinetic constant</p></td></tr><tr><td class="NLM_term">koff</td><td class="NLM_def"><p class="first last">dissociation rate constant</p></td></tr><tr><td class="NLM_term">LDL</td><td class="NLM_def"><p class="first last">low-density lipoprotein</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1 beta</p></td></tr><tr><td class="NLM_term">LOXs</td><td class="NLM_def"><p class="first last">lipoxygenases</p></td></tr><tr><td class="NLM_term">LXs</td><td class="NLM_def"><p class="first last">lipoxins</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">LTB<sub>4</sub></td><td class="NLM_def"><p class="first last">leukotriene B<sub>4</sub></p></td></tr><tr><td class="NLM_term">LTs</td><td class="NLM_def"><p class="first last">leukotrienes</p></td></tr><tr><td class="NLM_term">mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NAFLD</td><td class="NLM_def"><p class="first last">nonalcoholic fatty liver disease</p></td></tr><tr><td class="NLM_term">NASH</td><td class="NLM_def"><p class="first last">nonalcoholic steatohepatitis</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor-kappa B</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PARK2</td><td class="NLM_def"><p class="first last">Parkinson disease protein 2</p></td></tr><tr><td class="NLM_term">PPARγ</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor γ</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat live microsome</p></td></tr><tr><td class="NLM_term">sEH</td><td class="NLM_def"><p class="first last">soluble epoxide hydrolase</p></td></tr><tr><td class="NLM_term"><i>S</i>-PPU</td><td class="NLM_def"><p class="first last">(<i>S</i>)-1-(1-phenylethyl)-3-(3-phenylpropyl)urea</p></td></tr><tr><td class="NLM_term">STZ</td><td class="NLM_def"><p class="first last">streptozotocin</p></td></tr><tr><td class="NLM_term"><i>t</i>-AUCB</td><td class="NLM_def"><p class="first last"><i>trans</i>-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">TZD</td><td class="NLM_def"><p class="first last">thiazolidinedione</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 244 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherbeni, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kadi, A. O.</span></span> <span> </span><span class="NLM_article-title">The role of epoxide hydrolases in health and disease</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2032</span>, <span class="refDoi"> DOI: 10.1007/s00204-014-1371-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00204-014-1371-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25248500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=2013-2032&author=A.+A.+El-Sherbeniauthor=A.+O.+El-Kadi&title=The+role+of+epoxide+hydrolases+in+health+and+disease&doi=10.1007%2Fs00204-014-1371-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of epoxide hydrolases in health and disease</span></div><div class="casAuthors">El-Sherbeni, Ahmed A.; El-Kadi, Ayman O. S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2032</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Epoxide hydrolases (EH) are ubiquitously expressed in all living organisms and in almost all organs and tissues.  They are mainly subdivided into microsomal and sol. EH and catalyze the hydration of epoxides, three-membered-cyclic ethers, to their corresponding dihydrodiols.  Owning to the high chem. reactivity of xenobiotic epoxides, microsomal EH is considered protective enzyme against mutagenic and carcinogenic initiation.  Nevertheless, several endogenously produced epoxides of fatty acids function as important regulatory mediators.  By mediating the formation of cytotoxic dihydrodiol fatty acids on the expense of cytoprotective epoxides of fatty acids, sol. EH is considered to have cytotoxic activity.  Indeed, the attenuation of microsomal EH, achieved by chem. inhibitors or preexists due to specific genetic polymorphisms, is linked to the aggravation of the toxicity of xenobiotics, as well as the risk of cancer and inflammatory diseases, whereas sol. EH inhibition has been emerged as a promising intervention against several diseases, most importantly cardiovascular, lung and metabolic diseases.  However, there is reportedly a significant overlap in substrate selectivity between microsomal and sol. EH.  In addn., microsomal and sol. EH were found to have the same catalytic triad and identical mol. mechanism.  Consequently, the physiol. functions of microsomal and sol. EH are also overlapped.  Thus, studying the biol. effects of microsomal or sol. EH alterations needs to include the effects on both the metab. of reactive metabolites, as well as epoxides of fatty acids.  This review focuses on the multifaceted role of EH in the metab. of xenobiotic and endogenous epoxides and the impact of EH modulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn7N-VYHV3ubVg90H21EOLACvtfcHk0lgEAbycmMlsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsb7K&md5=6a1fb6af9726a55af556ab2f2cded345</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00204-014-1371-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-014-1371-y%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Sherbeni%26aufirst%3DA.%2BA.%26aulast%3DEl-Kadi%26aufirst%3DA.%2BO.%26atitle%3DThe%2520role%2520of%2520epoxide%2520hydrolases%2520in%2520health%2520and%2520disease%26jtitle%3DArch.%2520Toxicol.%26date%3D2014%26volume%3D88%26spage%3D2013%26epage%3D2032%26doi%3D10.1007%2Fs00204-014-1371-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sareen, D.</span></span> <span> </span><span class="NLM_article-title">An overview on the enhancement of enantioselectivity and stability of microbial epoxide hydrolases</span>. <i>Mol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/s12033-017-9996-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12033-017-9996-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28271340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=98-116&author=P.+Sainiauthor=D.+Sareen&title=An+overview+on+the+enhancement+of+enantioselectivity+and+stability+of+microbial+epoxide+hydrolases&doi=10.1007%2Fs12033-017-9996-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An overview on the enhancement of enantioselectivity and stability of microbial epoxide hydrolases</span></div><div class="casAuthors">Saini, Priya; Sareen, Dipti</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">98-116</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Epoxide hydrolases (EHs; 3.3.2.x) catalyze the enantioselective ring opening of racemic epoxides to the corresponding enantiopure vicinal diols and remaining equiv. unreacted epoxides.  These epoxides and diols are used for the synthesis of chiral drug intermediates.  With an upsurge in the methods for identification of novel microbial EHs, a lot of EHs have been discovered and utilized for kinetic resoln. of racemic epoxides.  However, there is still a constraint on the account of limited EHs being successfully applied on the preparative scale for industrial biotransformations.  This limitation has to be overcome before application of identified functional EHs on large scale.  Many strategies such as optimizing reaction media, immobilizing EHs and lab.-scale directed evolution of EHs have been adopted for enhancing the industrial potential of EHs.  In this review, these approaches have been highlighted which can serve as a pathway for the enrichment of already identified EHs for their application on an industrial scale in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0S3RnCuClObVg90H21EOLACvtfcHk0lgEAbycmMlsug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyiurs%253D&md5=e0f8ece7f7af25d040d6ba8dba0f0c2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs12033-017-9996-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12033-017-9996-8%26sid%3Dliteratum%253Aachs%26aulast%3DSaini%26aufirst%3DP.%26aulast%3DSareen%26aufirst%3DD.%26atitle%3DAn%2520overview%2520on%2520the%2520enhancement%2520of%2520enantioselectivity%2520and%2520stability%2520of%2520microbial%2520epoxide%2520hydrolases%26jtitle%3DMol.%2520Biotechnol.%26date%3D2017%26volume%3D59%26spage%3D98%26epage%3D116%26doi%3D10.1007%2Fs12033-017-9996-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxide hydrolases: their roles and interactions with lipid metabolism</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2004.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.plipres.2004.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15748653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1-51&author=J.+W.+Newmanauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Epoxide+hydrolases%3A+their+roles+and+interactions+with+lipid+metabolism&doi=10.1016%2Fj.plipres.2004.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide hydrolases: their roles and interactions with lipid metabolism</span></div><div class="casAuthors">Newman, John W.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The epoxide hydrolases (EHs) are enzymes present in all living organisms, which transform epoxide-contg. lipids by the addn. of water.  In plants and animals, many of these lipid substrates have potent biol. activities, such as host defenses, control of development, and regulation of inflammation and blood pressure.  Thus, the EHs have important and diverse biol. roles with profound effects on the physiol. state of the host organisms.  Currently, 7 distinct EH subtypes are recognized in higher organisms.  These include the plant sol. EHs, mammalian sol. EH, hepoxilin hydrolase, leukotriene A4 hydrolase, microsomal EH, and insect juvenile hormone EH.  While the understanding of these enzymes has progressed at different rates, here the authors discuss the current state of knowledge for each of these enzymes, along with a distn. of the current understanding of their endogenous roles.  By reviewing the entire enzyme class together, both commonalities and discrepancies in the understanding are highlighted and important directions for future research pertaining to these enzymes are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7nWZtLlJSrVg90H21EOLACvtfcHk0lh17lEp_s_3Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjtLg%253D&md5=acaeab5f99b7fcf6cfcb59969340ee76</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2004.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2004.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxide%2520hydrolases%253A%2520their%2520roles%2520and%2520interactions%2520with%2520lipid%2520metabolism%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2005%26volume%3D44%26spage%3D1%26epage%3D51%26doi%3D10.1016%2Fj.plipres.2004.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koger, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fish models of soluble epoxide hydrolase inhibition</span>. <i>Environ. Health Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1289/ehp.0110961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1289%2Fehp.0110961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11171526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=61-66&author=J.+W.+Newmanauthor=D.+L.+Dentonauthor=C.+Morisseauauthor=C.+S.+Kogerauthor=C.+E.+Wheelockauthor=D.+E.+Hintonauthor=B.+D.+Hammock&title=Evaluation+of+fish+models+of+soluble+epoxide+hydrolase+inhibition&doi=10.1289%2Fehp.0110961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fish models of soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Newman, John W.; Denton, Debra L.; Morisseau, Christophe; Koger, Cory S.; Wheelock, Craig E.; Hinton, David E.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">EVHPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-6765</span>.
    
            (<span class="NLM_cas:orgname">National Institute of Environmental Health Sciences</span>)
        </div><div class="casAbstract">Substituted ureas and carbamates are mechanistic inhibitors of the sol. epoxide hydrolase (sEH).  A set of chems. contg. these functionalities were screened in larval fathead minnow (Pimphales promelas) and embryo/larval golden medaka (Oryzias latipes) models to evaluate the utility of these systems for investigating sEH inhibition in vivo.  Both fathead minnow and medaka sEHs were functionally similar to the tested mammalian orthologs (murine and human) with respect to substrate hydrolysis and inhibitor susceptibility.  Low lethality was obsd. in either larval or embryonic fish exposed to diuron , desmethyl diuron , or siduron .  Dose-dependent inhibition of sEH was a sublethal effect of substituted urea exposure with the potency of siduron < desmethyl diuron = diuron, differing from the obsd. in vitro sEH inhibition potency of siduron > desmethyl diuron > diuron.  Further, siduron exposure synergized the toxicity of trans-stilbene oxide in fathead minnows.  Medaka embryos exposed to diuron, desmethyl diuron, or siduron displayed dose-dependent delays in hatch, and elevated concns. of diuron and desmethyl diuron produced developmental toxicity.  The dose-dependent toxicity and in vivo sEH inhibition correlated, suggesting a potential, albeit undefined, relationship between these factors.  Addnl., the obsd. inversion of in vitro to in vivo potency suggests that these fish models may provide tools for investigating the in vivo stability of in vitro inhibitors while screening for untoward effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1MD5Xy31rA7Vg90H21EOLACvtfcHk0lh17lEp_s_3Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFKkuw%253D%253D&md5=fd947c2808478ca7779d37f2216b256c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1289%2Fehp.0110961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.0110961%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DDenton%26aufirst%3DD.%2BL.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DKoger%26aufirst%3DC.%2BS.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DHinton%26aufirst%3DD.%2BE.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEvaluation%2520of%2520fish%2520models%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2001%26volume%3D109%26spage%3D61%26epage%3D66%26doi%3D10.1289%2Fehp.0110961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauren, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halarnkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, D. E.</span></span> <span> </span><span class="NLM_article-title">Microsomal and cytosolic epoxide hydrolase and glutathione S-transferase activities in the gill, liver, and kidney of the rainbow trout, <i>Salmo gairdneri</i>. Baseline levels and optimization of assay conditions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(89)90275-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2889%2990275-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2930590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL1MXktVCmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=881-887&author=D.+J.+Laurenauthor=P.+P.+Halarnkarauthor=B.+D.+Hammockauthor=D.+E.+Hinton&title=Microsomal+and+cytosolic+epoxide+hydrolase+and+glutathione+S-transferase+activities+in+the+gill%2C+liver%2C+and+kidney+of+the+rainbow+trout%2C+Salmo+gairdneri.+Baseline+levels+and+optimization+of+assay+conditions&doi=10.1016%2F0006-2952%2889%2990275-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Microsomal and cytosolic epoxide hydrolase and glutathione S-transferase activities in the gill, liver, and kidney of the rainbow trout, Salmo gairdneri</span></div><div class="casAuthors">Lauren, Darrel J.; Halarnkar, Premjit P.; Hammock, Bruce D.; Hinton, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">881-7</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Microsomal and cytosolic epoxide hydrolase (mEH and cEH resp.) and glutathione S-transferase (GST) activities were measured in the liver, kidney, and gills of rainbow trout.  Assays were optimized for time, pH, and temp., by using trans-stilbene oxide (TSO) and cis-stilbene oxide (CSO) as substrates for cEH and mEH, resp.  Optimal pH values for mEH, cEH, and GST were similar to mammalian values (i.e., 8.5, 7.5, and 9).  Temp. optima differed between tissues and cell fractions.  Specific activity of cEH-TSO was 3-14-times greater than mEH-CSO for all three tissues, and 8-60-times greater on a tissue wt. basis.  Liver and, to a lesser extent, kidney mEH were active against benzo[a]pyrene 4,5-oxide, whereas gill mEH was not active against this substrate.  Liver cytosolic GST was active against CSO and 1-chloro-2,4-dinitrobenzene (CDNB) but not TSO, whereas gill and kidney cytosolic GST were active only against CDNB.  Liver and kidney microsomal GST were active against CDNB, but no activity was found in gill microsomes.  The results are discussed in relation to possible endogenous substrates and uninduced xenobiotic metabolizing capacities of different trout tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V34NHbi5T7Vg90H21EOLACvtfcHk0limL8yixWyqWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVCmt78%253D&md5=da6bd4b3cadac8c3518ad1250b2fe2fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2889%2990275-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252889%252990275-X%26sid%3Dliteratum%253Aachs%26aulast%3DLauren%26aufirst%3DD.%2BJ.%26aulast%3DHalarnkar%26aufirst%3DP.%2BP.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHinton%26aufirst%3DD.%2BE.%26atitle%3DMicrosomal%2520and%2520cytosolic%2520epoxide%2520hydrolase%2520and%2520glutathione%2520S-transferase%2520activities%2520in%2520the%2520gill%252C%2520liver%252C%2520and%2520kidney%2520of%2520the%2520rainbow%2520trout%252C%2520Salmo%2520gairdneri.%2520Baseline%2520levels%2520and%2520optimization%2520of%2520assay%2520conditions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D881%26epage%3D887%26doi%3D10.1016%2F0006-2952%2889%2990275-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlezinger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegeman, J. J.</span></span> <span> </span><span class="NLM_article-title">Arachidonic acid metabolism in the marine fish <i>Stenotomus chrysops</i> (Scup) and the effects of cytochrome P450 1A inducers</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1006/abbi.1998.0651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fabbi.1998.0651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9606961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1Kmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1998&pages=265-275&author=J.+J.+Schlezingerauthor=C.+Parkerauthor=D.+C.+Zeldinauthor=J.+J.+Stegeman&title=Arachidonic+acid+metabolism+in+the+marine+fish+Stenotomus+chrysops+%28Scup%29+and+the+effects+of+cytochrome+P450+1A+inducers&doi=10.1006%2Fabbi.1998.0651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic acid metabolism in the marine fish Stenotomus chrysops (scup) and the effects of cytochrome P450 1A inducers</span></div><div class="casAuthors">Schlezinger, Jennifer J.; Parker, Carol; Zeldin, Darryl C.; Stegeman, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Cytochrome P 450-mediated arachidonic acid (AA) metab. was investigated in the marine fish scup, Stenotomus chrysops.  Liver microsomes incubated with AA and NADPH produced epoxyeicosatrienoic acids (EETs) and their hydration products (dihydroxyeicosatrienoic acids, DHETs), midchain conjugated dienols (midchain HETEs), and C16-through C20-alcs. of AA (ω-terminal HETEs), all identified by HPLC and GC/MS.  Gravid females had 4-fold lower AA metab. rates than males but identical metabolite profiles.  The 5,6-EET (inferred from stable metabolites) was most abundant (47% of total EETs) followed by 14,15-, 11,12-, and 8,9-EET (27, 13, and 13%, resp.).  The 12-HETE represented 25% of total HETEs followed in abundance by 16-, 15-, 11-, 19-, 20-, 8-, and 9-HETE.  Antibodies against scup CYP1A and a scup CYP2B-like protein inhibited liver microsomal AA metab. by 30 and 46%, resp.  GC/MS anal. revealed EETs and DHETs as endogenous constituents in scup liver; the predominant EETs were 8,9- and 14,15-EET, followed by a lesser amt. of 11,12-EET.  Chiral anal. showed a preference for the S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-EET (optical purities 80, 64, and 64%, resp.).  Treatment of scup with the CYP1A inducer benzo(a)pyrene (BP) increased liver microsomal formation of EETs and HETEs by 2.7-fold in spring and 1.7-fold in summer.  BP treatment did not affect microsomal EET regioselectivity, but shifted hydroxylation in favor of 19-HETE and induced 17-HETE formation. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment in summer did not induce liver microsomal AA metab. rates, yet BP and TCDD both increased endogenous EET content of liver (5- and 3-fold, resp.), with a shift to 14,15-EET.  BP treatment increased the selectivity for the S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-EET (optical purities 91, 84, and 83%, resp.).  Kidney, gill, and heart microsomes all metabolized AA, at rates 10- to 30-fold less than liver microsomes.  Similar amts. of endogenous 8,9- and 14,15-EET and less 11,12-EET were detected in heart and kidney, and there was a strong enantioselectivity for 8(R),9(S)-EET in heart (optical purity 78%) but not in kidney.  BP treatment did not alter the total EET content in these organs but did shift the regiochem. profile in heart to favor 14,15-EET.  Thus, scup liver and extrahepatic organs metabolize AA via multiple cytochrome P 450 (CYP) forms to eicosanoids in vitro and in vivo.  BP or TCDD induced endogenous AA metab. in liver, altering EET regioselectivity and, with BP, stereoselectivity.  While AhR agonists alter metab. of AA in early diverging vertebrates expressing both CYP1A and AhR, the magnitude of effects may depend upon the type of inducer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL08-YuDYdWrVg90H21EOLACvtfcHk0limL8yixWyqWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1Kmt7c%253D&md5=2f06627beedfa1aabd9eb90294de2d74</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1998.0651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1998.0651%26sid%3Dliteratum%253Aachs%26aulast%3DSchlezinger%26aufirst%3DJ.%2BJ.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DStegeman%26aufirst%3DJ.%2BJ.%26atitle%3DArachidonic%2520acid%2520metabolism%2520in%2520the%2520marine%2520fish%2520Stenotomus%2520chrysops%2520%2528Scup%2529%2520and%2520the%2520effects%2520of%2520cytochrome%2520P450%25201A%2520inducers%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D353%26spage%3D265%26epage%3D275%26doi%3D10.1006%2Fabbi.1998.0651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1126/science.7361100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1126%2Fscience.7361100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7361100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3cXhvFegsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1980&pages=1479-1481&author=K.+Otaauthor=B.+D.+Hammock&title=Cytosolic+and+microsomal+epoxide+hydrolases%3A+differential+properties+in+mammalian+liver&doi=10.1126%2Fscience.7361100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosolic and microsomal epoxide hydrolases:  differential properties in mammalian liver</span></div><div class="casAuthors">Ota, Kenji; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">4438</span>),
    <span class="NLM_cas:pages">1479-81</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Epoxide hydrolase activities of the 100,000 g pellet (microsomal) and 100,000 g sol. (cytosolic) fractions of mouse, rat, and guinea pig liver were detd. with 3 closely related compds. (styrene oxide, trans-β-methylstyrene oxide, and allylbenzene oxide) used as substrates.  Differences between the species in the distribution of the cytosolic and microsomal hydrolase and in their substrate specificities and pH optima demonstrated why epoxide hydrolase activity in the cytosolic fraction was not detected earlier in spite of intensive work on the microsomal epoxide hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjy6XYyEghLVg90H21EOLACvtfcHk0lgUMFl_Mr9Prw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhvFegsr4%253D&md5=4f2324b897ca1fae28ae4c3f01cfbe98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.7361100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7361100%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DCytosolic%2520and%2520microsomal%2520epoxide%2520hydrolases%253A%2520differential%2520properties%2520in%2520mammalian%2520liver%26jtitle%3DScience%26date%3D1980%26volume%3D207%26spage%3D1479%26epage%3D1481%26doi%3D10.1126%2Fscience.7361100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waechter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merdes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staubli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, P.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of a soluble epoxide hydrolase from rabbit liver</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1982.tb06705.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1432-1033.1982.tb06705.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7117244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL38XksFWlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1982&pages=457-461&author=F.+Waechterauthor=M.+Merdesauthor=F.+Bieriauthor=W.+Staubliauthor=P.+Bentley&title=Purification+and+characterization+of+a+soluble+epoxide+hydrolase+from+rabbit+liver&doi=10.1111%2Fj.1432-1033.1982.tb06705.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a soluble epoxide hydrolase from rabbit liver</span></div><div class="casAuthors">Waechter, Felix; Merdes, Marcel; Bieri, Francoise; Staubli, Willi; Bentley, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-61</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A method for the extensive purifn. of rabbit liver cytoplasmic epoxide hydrolase is described.  The end-product, which was purified 550-fold with respect to the cytosolic fraction, appeared to be >85% pure.  The results indicated that the enzyme is a dimer of mol. wt. 110,000 and consists of 2 subunits, which are identical or very similar (mol. wt. = 57,000) and possess N-terminal serine.  Evidence for the existence of aggregates of higher mol. wt. was also obtained.  The catalytic properties of the cytoplasmic enzyme with styrene oxide as substrate (Km = 3.4 mM; Vmax = 3480 nmol mg-1 min-1) differed markedly from the values published for the microsomal hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSX1CG-tUbMrVg90H21EOLACvtfcHk0lgUMFl_Mr9Prw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksFWlsbo%253D&md5=f84dc0df8185992ece8f11854cd684f2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1982.tb06705.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1982.tb06705.x%26sid%3Dliteratum%253Aachs%26aulast%3DWaechter%26aufirst%3DF.%26aulast%3DMerdes%26aufirst%3DM.%26aulast%3DBieri%26aufirst%3DF.%26aulast%3DStaubli%26aufirst%3DW.%26aulast%3DBentley%26aufirst%3DP.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520soluble%2520epoxide%2520hydrolase%2520from%2520rabbit%2520liver%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1982%26volume%3D125%26spage%3D457%26epage%3D461%26doi%3D10.1111%2Fj.1432-1033.1982.tb06705.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundqvist, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePierre, J. W.</span></span> <span> </span><span class="NLM_article-title">Comparison of the sex and subcellular distributions, catalytic and immunochemical reactivities of hepatic epoxide hydrolases in seven mammalian species</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1987.tb13333.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1432-1033.1987.tb13333.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=3113952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFSjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=1987&pages=269-279&author=J.+Meijerauthor=G.+Lundqvistauthor=J.+W.+DePierre&title=Comparison+of+the+sex+and+subcellular+distributions%2C+catalytic+and+immunochemical+reactivities+of+hepatic+epoxide+hydrolases+in+seven+mammalian+species&doi=10.1111%2Fj.1432-1033.1987.tb13333.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the sex and subcellular distributions, catalytic and immunochemical reactivities of hepatic epoxide hydrolases in seven mammalian species</span></div><div class="casAuthors">Meijer, Joahn; Lundqvist, Gerd; DePierre, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-79</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Sex and species differences in hepatic epoxide hydrolase (I) activity toward cis-stilbene oxide (II) and trans-stilbene oxide (III) were examd. in common lab. animals, as well as in monkey and man.  In general, III was found to be a good substrate for I activity in cytosolic fractions, whereas II was selectively hydrated by the microsomal fraction (with the exception of man, where the cytosol also hydrated this isomer efficiently).  The specific cytosol I activity was highest in mouse, followed by hamster and rabbit.  I activity in crude mitochondrial fraction toward III was also highest in mouse and low in all other species examd.  Microsomal I activity was highest in monkey, followed by guinea pig, human and rabbit, which all had similar activities.  Sex differences were generally small, but where significant, male animals had higher catalytic activities than females of the same species in most cases.  Antibodies raised against microsomal I purified from rat liver reacted with microsomes from all species investigated, indicating structural conservation of this protein.  Antibodies directed toward cytosolic I purified from mouse liver reacted only with liver cytosol from mouse and hamster and with the mitochondrial fraction from mouse in immunodiffusion expts.  Immunoblotting also revealed reaction with rat liver cytosol.  The cytosolic and mitochondrial I in all 3 mouse strains and in both sexes for each strain were immunochem. identical.  The anomalies in human liver I activities obsd. here indicated that no single common lab. animal is a good model for man with regard to these activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw6sTFblWk-bVg90H21EOLACvtfcHk0livR1hHoUsDtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFSjs7s%253D&md5=4d318c07666649c3edd2341ce48a220e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1987.tb13333.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1987.tb13333.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DJ.%26aulast%3DLundqvist%26aufirst%3DG.%26aulast%3DDePierre%26aufirst%3DJ.%2BW.%26atitle%3DComparison%2520of%2520the%2520sex%2520and%2520subcellular%2520distributions%252C%2520catalytic%2520and%2520immunochemical%2520reactivities%2520of%2520hepatic%2520epoxide%2520hydrolases%2520in%2520seven%2520mammalian%2520species%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1987%26volume%3D167%26spage%3D269%26epage%3D279%26doi%3D10.1111%2Fj.1432-1033.1987.tb13333.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiratsuka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watabe, T.</span></span> <span> </span><span class="NLM_article-title">Enzymic conversion of 11,12-leukotriene A4 to 11,12-dihydroxy-5,14-<i>cis</i>-7,9-<i>trans</i>-eicosatetraenoic acid. Purification of an epoxide hydrolase from the guinea pig liver cytosol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">5799</span>– <span class="NLM_lpage">5805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0021-9258%2818%2983620-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2925635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL1MXktlGntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=5799-5805&author=I.+Mikiauthor=T.+Shimizuauthor=Y.+Seyamaauthor=S.+Kitamuraauthor=K.+Yamaguchiauthor=H.+Sanoauthor=H.+Uenoauthor=A.+Hiratsukaauthor=T.+Watabe&title=Enzymic+conversion+of+11%2C12-leukotriene+A4+to+11%2C12-dihydroxy-5%2C14-cis-7%2C9-trans-eicosatetraenoic+acid.+Purification+of+an+epoxide+hydrolase+from+the+guinea+pig+liver+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic conversion of 11,12-leukotriene A4 to 11,12-dihydroxy-5,14-cis-7,9-trans-eicosatetraenoic acid. Purification of an epoxide hydrolase from the guinea pig liver cytosol</span></div><div class="casAuthors">Miki, Ichiro; Shimizu, Takao; Seyama, Yousuke; Kitamura, Shigeto; Yamaguchi, Kazuo; Sano, Hiroshi; Ueno, Hideo; Hiratsuka, Akira; Watabe, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5799-805</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">(11S,12S)-Epoxy-5,14-cis-7,9-trans-eicosatetraenoic acid (11,12-leukotriene A4) was nonenzymically converted to 7 compds.: 2 diastereomers of (12S)-hydroxyeicosatetraeno-δ-lactones (major products), 2 diastereomers of (5,12S)-dihydroxyeicosatetraenoic acid and 3 stereoisomers of (11,12S)-dihydroxyeicosatetraenoic acid.  Among these compds., (11R,12S)-dihydroxy-5,14-cis-7,9-trans-eicosatetraenoic acid proved to be the only enzymic product.  This hydrolysis activity was present in the cytosol fractions of various tissues of guinea pig such as liver, adrenal gland, small intestine, and brain.  The epoxide hydrolase was purified to an apparent homogeneity from the guinea pig liver.  The enzyme had a mol. wt. of 60,000 as detd. by SDS-PAGE and an isoelec. point of 7.3.  The partial amino acid sequence was different from that of the microsomal enzyme.  Km And Vmax values for 11,12-leukotriene A4 were 18 μM and 2.4 μmol/min/mg protein, resp.  These results indicate that 11,12-dihydroxyeicosatetraenoic acid is enzymically synthesized from 11,12-leukotriene A4 by the action of the cytosolic epoxide hydrolase in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd8-nQ9GsLbLVg90H21EOLACvtfcHk0livR1hHoUsDtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktlGntbY%253D&md5=90de9414064771854998b01e2ed0e75e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2983620-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252983620-1%26sid%3Dliteratum%253Aachs%26aulast%3DMiki%26aufirst%3DI.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSeyama%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DHiratsuka%26aufirst%3DA.%26aulast%3DWatabe%26aufirst%3DT.%26atitle%3DEnzymic%2520conversion%2520of%252011%252C12-leukotriene%2520A4%2520to%252011%252C12-dihydroxy-5%252C14-cis-7%252C9-trans-eicosatetraenoic%2520acid.%2520Purification%2520of%2520an%2520epoxide%2520hydrolase%2520from%2520the%2520guinea%2520pig%2520liver%2520cytosol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D5799%26epage%3D5805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winder, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noorouz-Zadeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckpitt, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plopper, C. G.</span></span> <span> </span><span class="NLM_article-title">Hepatic and pulmonary enzyme activities in horses</span>. <i>Am. J. Vet. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.2460/ajvr.2000.61.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2460%2Fajvr.2000.61.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10685686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFSgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=152-157&author=J.+Lakritzauthor=B.+S.+Winderauthor=J.+Noorouz-Zadehauthor=T.+L.+Huangauthor=A.+R.+Buckpittauthor=B.+D.+Hammockauthor=C.+G.+Plopper&title=Hepatic+and+pulmonary+enzyme+activities+in+horses&doi=10.2460%2Fajvr.2000.61.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic and pulmonary enzyme activities in horses</span></div><div class="casAuthors">Lakritz, Jeffrey; Winder, Bruce S.; Noorouz-Zadeh, Jaffar; Huang, Tien L.; Buckpitt, Alan R.; Hammock, Bruce D.; Plopper, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Veterinary Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">AJVRAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    
            (<span class="NLM_cas:orgname">American Veterinary Medical Association</span>)
        </div><div class="casAbstract">To det. hepatic and pulmonary phase-I and phase-II enzyme activities in horses.  Pulmonary and hepatic tissues from 22 horses that were 4 mo to 32 yr old.  Pulmonary and hepatic tissues from horses were used to prep. cytosolic (glutathione S-transferase and sol. epoxide hydrolase) and microsomal (cytochrome P 450 monooxygenases) enzymes.  Rates of microsomal metab. of ethoxyresorufin, pentoxyresorufin, and naphthalene were detd. by high-performance liq. chromatog.  Activities of glutathione S-transferase and sol. epoxide hydrolase were detd. spectrophotometrically.  Cytochrome P 450 content was detd. by carbon monoxide bound-difference spectrum of dithionite-reduced microsomes.  Activity was expressed relative to total protein concn.  Microsomal protein and cytochrome P 450 contents were detectable in all horses and did not vary with age.  Hepatic ethoxyresorufin metab. was detected in all horses; by comparison, pulmonary metab. of ethoxyresorufin and hepatic and pulmonary metab. of pentoxyresorufin were detected at lower rates.  Rate of hepatic naphthalene metab. remained const. with increasing age, whereas rate of pulmonary naphthalene metab. was significantly lower in weanlings (ie, horses 4 to 6 mo old), compared with adult horses.  Hepatic glutathione S-transferase activity (cytosol) increased with age; however, these changes were not significant.  Pulmonary glutathione S-transferase activity (cytosol) was significantly lower in weanlings than adult horses.  Hepatic and pulmonary sol. epoxide hydrolase did not vary with age of horses.  Activity of cytochrome P 450 isoforms that metabolize naphthalene and glutathione S-transferases in lungs are significantly lower in weanlings than adult horses, which suggests reduced ability of young horses to metabolize xenobiotics by this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqKVjjdguLC7Vg90H21EOLACvtfcHk0lhCf65loA2MkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFSgsLc%253D&md5=8264e4ff26f1154b6e055fca1bbb8644</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2460%2Fajvr.2000.61.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2460%252Fajvr.2000.61.152%26sid%3Dliteratum%253Aachs%26aulast%3DLakritz%26aufirst%3DJ.%26aulast%3DWinder%26aufirst%3DB.%2BS.%26aulast%3DNoorouz-Zadeh%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DT.%2BL.%26aulast%3DBuckpitt%26aufirst%3DA.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPlopper%26aufirst%3DC.%2BG.%26atitle%3DHepatic%2520and%2520pulmonary%2520enzyme%2520activities%2520in%2520horses%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D2000%26volume%3D61%26spage%3D152%26epage%3D157%26doi%3D10.2460%2Fajvr.2000.61.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beetham, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">cDNA cloning and expression of a soluble epoxide hydrolase from human liver</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1006/abbi.1993.1411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fabbi.1993.1411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8342951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1993&pages=197-201&author=J.+K.+Beethamauthor=T.+Tianauthor=B.+D.+Hammock&title=cDNA+cloning+and+expression+of+a+soluble+epoxide+hydrolase+from+human+liver&doi=10.1006%2Fabbi.1993.1411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA cloning and expression of a soluble epoxide hydrolase from human liver</span></div><div class="casAuthors">Beetham, Jeffrey K.; Tian, Tongyan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-201</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The authors report the cloning and expression of a cDNA that encodes a sol. epoxide hydrolase from human liver.  The 2101-base clone predicts a 554-residue protein (Mr 62,640) with an apparently imperfect peroxisomal targeting signal of Ser-Lys-Met at the carboxy terminus.  The cDNA was expressed in the baculovirus system in the Spodoptera frugiperda 21 cell line.  The recombinant protein was similar to sol. epoxide hydrolase isolated from human liver in terms of mol. wt., hydrolytic activity, inhibition, and immunoreactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1yn_6KiPVMLVg90H21EOLACvtfcHk0lhCf65loA2MkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFynuro%253D&md5=f4f49a19c8db7dec5652649ed2914a96</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1411%26sid%3Dliteratum%253Aachs%26aulast%3DBeetham%26aufirst%3DJ.%2BK.%26aulast%3DTian%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DcDNA%2520cloning%2520and%2520expression%2520of%2520a%2520soluble%2520epoxide%2520hydrolase%2520from%2520human%2520liver%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D305%26spage%3D197%26epage%3D201%26doi%3D10.1006%2Fabbi.1993.1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifici, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, A.</span></span> <span> </span><span class="NLM_article-title">Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=6887015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3sXlslSru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1983&pages=869-875&author=G.+M.+Pacificiauthor=B.+Lindbergauthor=H.+Glaumannauthor=A.+Rane&title=Styrene+oxide+metabolism+in+rhesus+monkey+liver%3A+enzyme+activities+in+subcellular+fractions+and+in+isolated+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Styrene oxide metabolism in rhesus monkey liver:  enzyme activities in subcellular fractions and in isolated hepatocytes</span></div><div class="casAuthors">Pacifici, Gian Maria; Lindberg, Bo; Glaumann, Hans; Rane, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">869-75</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The activity and kinetic behavior of epoxide hydrolase  [9048-63-9] were studied in various subcellular fractions of rhesus monkey liver isolated by differential centrifugation.  The purity of the fractions was estd. by morphometric electron microscopy.  Hydrolase activity was measured by a specific radiometric assay with 7-3H-labeled styrene oxide (I)  [96-09-3] as substrate.  All isolated subcellular fractions catalyzed the hydration of I as a significant rate.  With a satg. concn. of substrate (1 mM), the enzymic activity (nM/min/mg) of protein was 1.51 (nuclear fraction), 3.50 (mitochondrial fraction), 1.48 (microsomal fraction) and 1.69 (sol. fraction).  The hydrolase obeyed Michaelis-Menten kinetics in each fraction.  Vmax (Nm/min/mg) was 1.64 (nuclear fraction), 3.87 (mitochondrial fraction), 19.8 (microsomal fraction), and 2.72 (sol. fraction).  The Km (mM) values in the fractions were 0.09-0.07, 0.23, and 0.64, resp.  I metab. was also studied in isolated hepatocytes from rhesus monkey.  These cells hydrated the substrate easily, whereas the conjugation of I with GSH was not measurable.  Thus, epoxide hydrolase is present in all subcellular fractions of the rhesus monkey liver.  I is preferentially metabolized by hydration to styrene glycol  [93-56-1] in the isolated hepatocytes of this species and no conjugation with GSH was found under the incubation conditions used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLSVEpuzFjbVg90H21EOLACvtfcHk0lhBxPOv2diN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslSru70%253D&md5=a9ef763aee3cd8944aee9a5f36ce607b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacifici%26aufirst%3DG.%2BM.%26aulast%3DLindberg%26aufirst%3DB.%26aulast%3DGlaumann%26aufirst%3DH.%26aulast%3DRane%26aufirst%3DA.%26atitle%3DStyrene%2520oxide%2520metabolism%2520in%2520rhesus%2520monkey%2520liver%253A%2520enzyme%2520activities%2520in%2520subcellular%2520fractions%2520and%2520in%2520isolated%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1983%26volume%3D226%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stok, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, A. J.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450-dependent lipid metabolism in preovulatory follicles</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">5097</span>– <span class="NLM_lpage">5105</span>, <span class="refDoi"> DOI: 10.1210/en.2004-0710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1210%2Fen.2004-0710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15308618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVyhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5097-5105&author=J.+W.+Newmanauthor=J.+E.+Stokauthor=J.+D.+Vidalauthor=C.+J.+Corbinauthor=Q.+Huangauthor=B.+D.+Hammockauthor=A.+J.+Conley&title=Cytochrome+P450-dependent+lipid+metabolism+in+preovulatory+follicles&doi=10.1210%2Fen.2004-0710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450-dependent lipid metabolism in preovulatory follicles</span></div><div class="casAuthors">Newman, J. W.; Stok, J. E.; Vidal, J. D.; Corbin, C. J.; Huang, Q.; Hammock, B. D.; Conley, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5097-5105</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Estrogen biosynthesis and proteolysis are both important processes involved in ovarian follicular development, which may be influenced by cytochrome P 450 (CYP)-dependent fatty acid metabolites.  However, CYP-dependent lipid metab. has not been characterized with respect to follicular maturation in vivo.  Therefore, follicular fluid was collected in the hours before and after the LH surge in pigs, and concns. of epoxy, hydroxy, and dihydroxy lipids were measured by liq. chromatog. tandem mass spectrometry.  Arachidonate oxidn. and epoxyeicosatrienoic acid hydrolysis to dihydroxyeicosatrienoic acids (DHETs) were also assessed in thecal and granulosa tissue fractions, and the expression of CYP epoxygenases was evaluated by immunoblots using available antisera.  To evaluate sol. epoxide hydrolase (sEH) expression, the porcine sEH was cloned from ovarian tissue, expressed and purified for antibody generation.  The follicular fluid oxylipin concns. ranged from 1-150 nM depending on the compd. and estrus stage.  The follicular fluid concns. of CYP-dependent oxylipins increased at estrus, as did sEH expression; however, significant changes in epoxides were not obsd., and the 11,12-DHET peak was delayed.  The ratio of 14,15-DHET:11,12-DHET across all samples correlated with the log of follicular fluid estradiol concns.  Epoxygenase activities were similar in theca and granulosa, varying little with follicular development, whereas the decline of a single CYP2J isoform at ovulation was obsd. by immunoblots.  The sEH activity was higher in granulosa than in theca.  Finally, the dynamic changes in follicular CYP-dependent arachidonic acid metabolites and their modulatory function in vascular models suggest roles for these metabolites in follicular maturation, which may include regulation of estradiol biosynthesis and preovulatory remodeling of the follicular wall that should be fully explored in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-65vBfYcpLVg90H21EOLACvtfcHk0lhBxPOv2diN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVyhurg%253D&md5=5a410a3ab49827eed9f9f8aa42960e5f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-0710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-0710%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DStok%26aufirst%3DJ.%2BE.%26aulast%3DVidal%26aufirst%3DJ.%2BD.%26aulast%3DCorbin%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DConley%26aufirst%3DA.%2BJ.%26atitle%3DCytochrome%2520P450-dependent%2520lipid%2520metabolism%2520in%2520preovulatory%2520follicles%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5097%26epage%3D5105%26doi%3D10.1210%2Fen.2004-0710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Distribution and properties of a mammalian soluble epoxide hydrase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(80)90518-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2880%2990518-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7362652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3cXhslOqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1980&pages=389-395&author=S.+S.+Gillauthor=B.+D.+Hammock&title=Distribution+and+properties+of+a+mammalian+soluble+epoxide+hydrase&doi=10.1016%2F0006-2952%2880%2990518-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and properties of a mammalian soluble epoxide hydrase</span></div><div class="casAuthors">Gill, Sarjeet S.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The highest epoxide hydrase (I) activity in liver subcellular fractions was obsd. in the 100,000 g supernatant (sol.) and mitochondrial fractions, whereas activity in washed microsomes was lower.  The sol. I activity was highest in the liver and kidney of mice and rabbits and was also present in the duodenum, muscle, colon, lung, and spleen in decreasing order of activity.  The level of sol. I activity was highest in female rabbits and male mice and lowest in male rats.  The level of I activity varied with the strain of mice.  I activity in both male and female mice increased with age.  Sol. I activity required no cofactor and had a mol. wt. of ∼130,000.  I activity was inhibited by inorg. ions, esp. Cu, and stabilized by diisopropyl fluorophosphate.  Thus, in most mammalian tissues ≥2 I may be present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB5-6fRB2pjrVg90H21EOLACvtfcHk0liDadC1D8P66A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhslOqsro%253D&md5=8c5eff8c546a30c3a19d23579dec318d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2880%2990518-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252880%252990518-3%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDistribution%2520and%2520properties%2520of%2520a%2520mammalian%2520soluble%2520epoxide%2520hydrase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1980%26volume%3D29%26spage%3D389%26epage%3D395%26doi%3D10.1016%2F0006-2952%2880%2990518-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y.</span></span> <span> </span><span class="NLM_article-title">The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">16747</span>– <span class="NLM_lpage">16752</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508081102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0508081102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16267130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16747-16752&author=Y.+Liuauthor=Y.+Zhangauthor=K.+Schmelzerauthor=T.+S.+Leeauthor=X.+Fangauthor=Y.+Zhuauthor=A.+A.+Spectorauthor=S.+Gillauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=J.+Y.+Shyy&title=The+antiinflammatory+effect+of+laminar+flow%3A+the+role+of+PPARgamma%2C+epoxyeicosatrienoic+acids%2C+and+soluble+epoxide+hydrolase&doi=10.1073%2Fpnas.0508081102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The antiinflammatory effect of laminar flow: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase</span></div><div class="casAuthors">Liu, Yi; Zhang, Yingjia; Schmelzer, Kara; Lee, Tzong-Shyuan; Fang, Xiang; Zhu, Yi; Spector, Arthur A.; Gill, Sarjeet; Morisseau, Christophe; Hammock, Bruce D.; Shyy, John Y.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16747-16752</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We previously reported that laminar flow activates peroxisome proliferator-activated receptor γ (PPARγ) in vascular endothelial cells in a ligand-dependent manner that involves phospholipase A2 and cytochrome P 450 epoxygenases.  In this study, we investigated whether epoxyeicosatrienoic acids (EETs), the catalytic products of cytochrome P 450 epoxygenases, are PPARγ ligands.  Competition and direct binding assays revealed that EETs bind to the ligand-binding domain of PPARγ with Kd in the μM range.  In the presence of adamantyl-ureido-dodecanoic acid (AUDA), a sol. epoxide hydrolase (sEH)-specific inhibitor, EETs increased PPARγ transcription activity in endothelial cells and 3T3-L1 preadipocytes.  Inclusion of AUDA in the perfusing media enhanced, but overexpression of sEH reduced, the laminar flow-induced PPARγ activity.  Furthermore, laminar flow augmented cellular levels of EETs but decreased sEH at the levels of mRNA, protein, and activity.  Blocking PPARγ by GW9662 abolished the EET/AUDA-mediated antiinflammatory effect, which indicates that PPARγ is an effector of EETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohz9z9ImCFfLVg90H21EOLACvtfcHk0liDadC1D8P66A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgsLzE&md5=66de0f5a912f3764516f4db6ebebaaa1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508081102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508081102%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DGill%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%26atitle%3DThe%2520antiinflammatory%2520effect%2520of%2520laminar%2520flow%253A%2520the%2520role%2520of%2520PPARgamma%252C%2520epoxyeicosatrienoic%2520acids%252C%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16747%26epage%3D16752%26doi%3D10.1073%2Fpnas.0508081102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spearow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)00167-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2895%2900167-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7646556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=501-508&author=F.+Pinotauthor=D.+F.+Grantauthor=J.+L.+Spearowauthor=A.+G.+Parkerauthor=B.+D.+Hammock&title=Differential+regulation+of+soluble+epoxide+hydrolase+by+clofibrate+and+sexual+hormones+in+the+liver+and+kidneys+of+mice&doi=10.1016%2F0006-2952%2895%2900167-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice</span></div><div class="casAuthors">Pinot, Franck; Grant, David F.; Spearow, Jimmy L.; Parker, Anthony G.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-8</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) activity was measured in the liver and kidneys of male, female, and castrated male mice to evaluate sex- and tissue-specific differences in enzyme expression.  SEH activity was higher in liver than in kidneys.  Activity increased with age in the liver of females, males and castrated males, but only in males did activity in the kidneys increase.  There was greater activity in both the liver and kidneys of adult males than females.  This sexual dimorphism was more pronounced in the kidneys (283% higher) than in the liver (55% higher).  Castration of males led to a decrease in activity in both organs, but it had a greater effect on renal activity (67% decrease) than on hepatic activity (27% decrease).  Treatment of castrated mice with testosterone led to an increase in sEH activity of 4005 in kidneys and 49% n liver compared with surgical controls.  These results suggest differential regulation of sEH by testosterone in kidneys and liver.  Ovariectomized female mice had renal and hepatic activities approx. 30% greater than control females.  Feeding mice with the hypolipidemic drug clofibrate produced stronger induction of sEH in liver than in kidneys.  Testosterone treatment, however, caused greater induction in kidneys than in liver of females and castrated males and had no effect in either kidneys or liver in males.  When given together, the effects of these two compds. appeared to be additive in both liver and kidneys.  Results from western blot showed that the increase in sEH enzyme activity in kidneys is correlated with an increase in sEH protein.  These results suggest that clofibrate and testosterone independently regulate sEH activity in vivo, and that kidneys and liver respond differently to clofibrate and testosterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVt8TZx_lduLVg90H21EOLACvtfcHk0ljO7WSNGdHlrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFyis7w%253D&md5=cb019f9f8ab704dd61f300948a7bea60</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900167-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900167-X%26sid%3Dliteratum%253Aachs%26aulast%3DPinot%26aufirst%3DF.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26aulast%3DSpearow%26aufirst%3DJ.%2BL.%26aulast%3DParker%26aufirst%3DA.%2BG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDifferential%2520regulation%2520of%2520soluble%2520epoxide%2520hydrolase%2520by%2520clofibrate%2520and%2520sexual%2520hormones%2520in%2520the%2520liver%2520and%2520kidneys%2520of%2520mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D501%26epage%3D508%26doi%3D10.1016%2F0006-2952%2895%2900167-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of peroxisome proliferator-activated receptor-gamma downregulates soluble epoxide hydrolase in cardiomyocytes</span>. <i>Clin. Exp. Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1681.2011.05492.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1440-1681.2011.05492.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21291492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=358-364&author=W.+Pangauthor=N.+Liauthor=D.+Aiauthor=X.+L.+Niuauthor=Y.+F.+Guanauthor=Y.+Zhu&title=Activation+of+peroxisome+proliferator-activated+receptor-gamma+downregulates+soluble+epoxide+hydrolase+in+cardiomyocytes&doi=10.1111%2Fj.1440-1681.2011.05492.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes</span></div><div class="casAuthors">Pang, Wei; Li, Nan; Ai, Ding; Niu, Xiao-Lin; Guan, You-Fei; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antidiabetic agents, thiazolidinediones (TZD), ligands for peroxisome proliferator-activated receptor-γ (PPARγ), were reported to reduce cardiac hypertrophy.  However, the underlying mechanism is still elusive.  We previously reported that sol. epoxide hydrolase (sEH) was specifically upregulated by angiotensin-II (AngII), which directly mediated AngII-induced cardiac hypertrophy.  In the present study, we examd. the role of sEH in PPARγ inhibiting AngII-induced cardiac hypertrophy.  The protein level of sEH was elevated in the left ventricle of AngII-infused Sprague-Dawley rats.  Administration of the TZD rosiglitazone decreased this induction.  In vitro, AngII upregulated the expression of sEH and hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain, in rat neonatal cardiomyocytes and H9c2 cells, which was attenuated by rosiglitazone and pioglitazone.  An elevated level of sEH was also found in the left ventricle of heterozygous PPARγ-deficient mice.  The effect of TZD on sEH level could be reversed by treatment with the PPARγ antagonists, GW9662 and BADGE, which suggests PPARγ activation.  In elucidating the mechanisms by which PPARγ inhibited AngII-induced sEH expression, we found that rosiglitazone inhibited AngII-induced sEH promoter activity in H9c2 cells.  In contrast, the activity of the human sEH 3'UTR was not affected by AngII and TZD.  Our results suggest that the protective role of PPARγ activation in AngII-induced cardiac hypertrophy is, at least in part, through downregulating sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3KgtzmvWz27Vg90H21EOLACvtfcHk0lj_N9SH3ZVLtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegsLo%253D&md5=0e851867c8c6aa8b2f53f7ceb460d3ce</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2011.05492.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2011.05492.x%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DX.%2BL.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DActivation%2520of%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520downregulates%2520soluble%2520epoxide%2520hydrolase%2520in%2520cardiomyocytes%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2011%26volume%3D38%26spage%3D358%26epage%3D364%26doi%3D10.1111%2Fj.1440-1681.2011.05492.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjodin, M. O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunewald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">236</span>, <span class="refDoi"> DOI: 10.1186/s12931-018-0939-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12931-018-0939-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30509266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3crotVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=236&author=M.+O.+D.+Sjodinauthor=A.+Checaauthor=M.+Yangauthor=S.+E.+Dahlenauthor=A.+M.+Wheelockauthor=A.+Eklundauthor=J.+Grunewaldauthor=C.+E.+Wheelock&title=Soluble+epoxide+hydrolase+derived+lipid+mediators+are+elevated+in+bronchoalveolar+lavage+fluid+from+patients+with+sarcoidosis%3A+a+cross-sectional+study&doi=10.1186%2Fs12931-018-0939-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study</span></div><div class="casAuthors">Sjodin Marcus O D; Checa Antonio; Wheelock Craig E; Sjodin Marcus O D; Dahlen Sven-Erik; Yang Mingxing; Wheelock ¡ÑÜAsa M; Eklund Anders; Grunewald Johan</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Sarcoidosis is a systemic inflammatory multi-organ disease almost always affecting the lungs.  The etiology remains unknown, but the hallmark of sarcoidosis is formation of non-caseating epithelioid cells granulomas in involved organs.  In Scandinavia, > 30% of sarcoidosis patients have Lofgren's syndrome (LS), an acute disease onset mostly indicating a favorable prognosis.  The impact of dysregulation of lipid mediators, which has been investigated in other inflammatory disorders, is still unknown.  METHODS:  Using three different liquid chromatography coupled to tandem mass spectrometry targeted platforms (LC-MS/MS), we quantified a broad suite of lipid mediators including eicosanoids, sphingolipids and endocannabinoids in bronchoalveolar lavage (BAL) fluid from pulmonary sarcoidosis patients (n = 41) and healthy controls (n = 16).  RESULTS:  A total of 47 lipid mediators were consistently detected in BAL fluid of patients and controls.  After false discovery rate adjustment, two products of the soluble epoxide hydrolase (sEH) enzyme, 11,12-dihydroxyeicosa-5,8,14-trienoic acid (11,12-DiHETrE, p = 4.4E-5, q = 1.2E-3, median fold change = 6.0) and its regioisomer 14,15-dihydroxyeicosa-5,8,11-trienoic acid (14,15-DiHETrE, p = 3.6E-3, q = 3.2E-2, median fold change = 1.8) increased in patients with sarcoidosis.  Additional shifts were observed in sphingolipid metabolism, with a significant increase in palmitic acid-derived sphingomyelin (SM16:0, p = 1.3E-3, q = 1.7E-2, median fold change = 1.3).  No associations were found between these 3 lipid mediators and LS, whereas levels of SM 16:0 and 11,12-DiHETrE associated with radiological stage (p < 0.05), and levels of 14,15-DiHETrE were associated with the BAL fluid CD4/CD8 ratio.  CONCLUSIONS:  These observed shifts in lipid mediators provide new insights into the pathobiology of sarcoidosis and in particular highlight the sEH pathway to be dysregulated in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8xUXck0YaLDdblLE_E9PWfW6udTcc2eZ4LTF2l26jIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crotVKnuw%253D%253D&md5=97e029f30bab5c29d861fb595d1fd17e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2Fs12931-018-0939-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-018-0939-0%26sid%3Dliteratum%253Aachs%26aulast%3DSjodin%26aufirst%3DM.%2BO.%2BD.%26aulast%3DCheca%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DDahlen%26aufirst%3DS.%2BE.%26aulast%3DWheelock%26aufirst%3DA.%2BM.%26aulast%3DEklund%26aufirst%3DA.%26aulast%3DGrunewald%26aufirst%3DJ.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520derived%2520lipid%2520mediators%2520are%2520elevated%2520in%2520bronchoalveolar%2520lavage%2520fluid%2520from%2520patients%2520with%2520sarcoidosis%253A%2520a%2520cross-sectional%2520study%26jtitle%3DRespir.%2520Res.%26date%3D2018%26volume%3D19%26spage%3D236%26doi%3D10.1186%2Fs12931-018-0939-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.45.120403.095920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1146%2Fannurev.pharmtox.45.120403.095920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15822179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=311-333&author=C.+Morisseauauthor=B.+D.+Hammock&title=Epoxide+hydrolases%3A+mechanisms%2C+inhibitor+designs%2C+and+biological+roles&doi=10.1146%2Fannurev.pharmtox.45.120403.095920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-333, 3 plates</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Organisms are exposed to epoxide-contg. compds. from both exogenous and endogenous sources.  In mammals, the hydration of these compds. by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chem. mediators.  Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases.  Knowledge of the EH reaction mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of EHs.  Although the overall EH reaction mechanism is now known, the mol. basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved.  Finally, recent development in the design of EH inhibitors and the biol. roles of EHs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgu-XChp4zKbVg90H21EOLACvtfcHk0lj_tPYl6CR3ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWjt7k%253D&md5=faf96336e9373dd089c5eae29804f1bb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.45.120403.095920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.45.120403.095920%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxide%2520hydrolases%253A%2520mechanisms%252C%2520inhibitor%2520designs%252C%2520and%2520biological%2520roles%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D311%26epage%3D333%26doi%3D10.1146%2Fannurev.pharmtox.45.120403.095920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Phosphatase activity of soluble epoxide hydrolase</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2017.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2017.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWksLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=88-92&author=J.+Kramerauthor=E.+Proschak&title=Phosphatase+activity+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.prostaglandins.2017.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatase activity of soluble epoxide hydrolase</span></div><div class="casAuthors">Kramer, Jan; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a bifunctional enzyme that exhibits lipid epoxide hydrolase (sEH-H) and lipid phosphatase activity (sEH-P), with each being located in its own distinct domain.  While the epoxide hydrolase activity is well-investigated, the role of the phosphatase domain remains unclear.  This article briefly summarizes the evolution, structure and SNPs of the human sEH, with a special focus on the function and postulated role of the N-terminal domain of sEH.  Furthermore, the article provides an overview of tools to study sEH-P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-ym_22cFMzrVg90H21EOLACvtfcHk0lj_tPYl6CR3ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWksLvM&md5=8cc942976d3c79294e23884a22e4f553</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2017.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2017.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DPhosphatase%2520activity%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2017%26volume%3D133%26spage%3D88%26epage%3D92%26doi%3D10.1016%2Fj.prostaglandins.2017.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayengbam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.compbiolchem.2018.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.compbiolchem.2018.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29522918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2018&pages=1-11&author=A.+B.+Gurungauthor=B.+Mayengbamauthor=A.+Bhattacharjee&title=Discovery+of+novel+drug+candidates+for+inhibition+of+soluble+epoxide+hydrolase+of+arachidonic+acid+cascade+pathway+implicated+in+atherosclerosis&doi=10.1016%2Fj.compbiolchem.2018.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis</span></div><div class="casAuthors">Gurung, Arun Bahadur; Mayengbam, Bishwarjit; Bhattacharjee, Atanu</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH), a key enzyme belonging to cytochrome P 450 pathway of arachidonic acid cascade is a novel therapeutic drug target against atherosclerosis.  The enzyme breaks down epoxyeicosatrienoic acid (EETs) to dihydroxy-eicosatrienoic acids (DHETs) and reduces beneficial cardiovascular properties of EETs.  Thus, the present work is aimed at identification of potential leads as sEH inhibitors which will sustain the beneficial properties of EETs in vivo.  PubChem and ZINC databases were screened for drug-like compds. based on Lipinski's rule of five and in silico toxicity filters.  The binding potential of the drug-like compds. with sEH was explored using mol. docking.  The top ranked lead (ZINC23099069) showed higher GOLD score compared with that of the control, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid Bu ester (AUDA-BE) and displayed two hydrogen bonds with Tyr383 and His420 and eleven residues involved in hydrophobic interactions with sEH.  The apo_sEH and sEH_ZINC23099069 complex showed stable trajectories during 20 ns time scale of mol. dynamics (MD) simulation.  Mol. Mechanics Poisson-Boltzmann Surface Area (MM/PBSA) binding free energy anal. showed that electrostatic energy is the driving energy component for interaction of the lead with sEH.  These results demonstrate ZINC23099069 to be a promising drug candidate as sEH inhibitor against atherosclerosis instead of the present urea-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnF_dsDbaRH7Vg90H21EOLACvtfcHk0lj_tPYl6CR3ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKls7s%253D&md5=7c30d7873f977288df81206d98060281</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2018.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2018.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DGurung%26aufirst%3DA.%2BB.%26aulast%3DMayengbam%26aufirst%3DB.%26aulast%3DBhattacharjee%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520drug%2520candidates%2520for%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520of%2520arachidonic%2520acid%2520cascade%2520pathway%2520implicated%2520in%2520atherosclerosis%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D74%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.compbiolchem.2018.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homburg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisslthaler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arand, M.</span></span> <span> </span><span class="NLM_article-title">The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437829100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0437829100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12574508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1552-1557&author=A.+Croninauthor=S.+Mowbrayauthor=H.+Durkauthor=S.+Homburgauthor=I.+Flemingauthor=B.+Fisslthalerauthor=F.+Oeschauthor=M.+Arand&title=The+N-terminal+domain+of+mammalian+soluble+epoxide+hydrolase+is+a+phosphatase&doi=10.1073%2Fpnas.0437829100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase</span></div><div class="casAuthors">Cronin, Annette; Mowbray, Sherry; Durk, Heike; Homburg, Shirli; Fleming, Ingrid; Fisslthaler, Beate; Oesch, Franz; Arand, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1552-1557</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mammalian sol. epoxide hydrolase (sEH) is an enzyme with multiple functions, being implicated in detoxification of xenobiotic epoxides as well as in regulation of physiol. processes such as blood pressure.  The enzyme is a homodimer, in which each subunit is composed of two domains.  The 35-kDa C-terminal domain has an α/β hydrolase fold and harbors the catalytic center for the EH activity.  The 25-kDa N-terminal domain has a different α/β fold and belongs to the haloacid dehalogenase superfamily of enzymes.  The catalytic properties of the enzyme reported so far can all be explained by the action of the C-terminal domain alone.  The function of the N-terminal domain, other than in structural stabilization of the dimer, has therefore remained unclear.  By structural comparison of this domain to other haloacid dehalogenase family members, we identified a putative active site contg. all necessary components for phosphatase activity.  Subsequently, we found rat sEH hydrolyzed 4-nitrophenyl phosphate with a rate const. of 0.8 s-1 and a Km of 0.24 mM.  Recombinant human sEH lacking the C-terminal domain also displayed phosphatase activity.  Presence of a phosphatase substrate did not affect epoxide turnover nor did epoxides affect dephosphorylation by the intact enzyme, indicating both catalytic sites act independently.  The enzyme was unable to hydrolyze 4-nitrophenyl sulfate, suggesting its role in xenobiotic metab. does not extend beyond phosphates.  Thus, we propose this domain participates instead in the regulation of the physiol. functions assocd. with sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDq5TEmwWKC7Vg90H21EOLACvtfcHk0lhvHmjG7lPMjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt74%253D&md5=e03c11c09660edaf1d8ddf4d36e93906</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437829100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437829100%26sid%3Dliteratum%253Aachs%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DMowbray%26aufirst%3DS.%26aulast%3DDurk%26aufirst%3DH.%26aulast%3DHomburg%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DFisslthaler%26aufirst%3DB.%26aulast%3DOesch%26aufirst%3DF.%26aulast%3DArand%26aufirst%3DM.%26atitle%3DThe%2520N-terminal%2520domain%2520of%2520mammalian%2520soluble%2520epoxide%2520hydrolase%2520is%2520a%2520phosphatase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1552%26epage%3D1557%26doi%3D10.1073%2Fpnas.0437829100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1558</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437724100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0437724100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12574510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1558-1563&author=J.+W.+Newmanauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=B.+D.+Hammock&title=The+soluble+epoxide+hydrolase+encoded+by+EPXH2+is+a+bifunctional+enzyme+with+novel+lipid+phosphate+phosphatase+activity&doi=10.1073%2Fpnas.0437724100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity</span></div><div class="casAuthors">Newman, John W.; Morisseau, Christophe; Harris, Todd R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1558-1563</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The gene EPXH2 encodes for the sol. epoxide hydrolase (sEH), an enzyme involved in the regulation of cardiovascular and renal physiol. contg. two distinct domains connected via a proline-rich linker.  The C-terminal domain contg. the EH catalytic activity has been well studied.  In contrast, a function for the N-terminal domain, which has high homol. to the haloacid dehalogenase family of phosphatases, has not been definitively reported.  In this study we describe the N-terminal domain as a functional phosphatase unaffected by a no. of classic phosphatase inhibitors.  Assuming a functional assocn. between these catalytic activities, dihydroxy lipid phosphates were rationalized as potential endogenous substrates.  A series of phosphorylated hydroxy lipids were therefore synthesized and found to be excellent substrates for the human sEH.  The best substrate tested was the monophosphate of dihydroxy stearic acid (threo-9/10-phosphonoxy-hydroxy-octadecanoic acid) with Km = 21±0.3 μM, VMax = 338±12 nmol·min-1·mg-1, and kcat = 0.35±0.01 s-1.  Therefore dihydroxy lipid phosphates are possible candidates for the endogenous substrates of the sEH N-terminal domain, which would represent a novel branch of fatty acid metab. with potential signaling functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKrVMg8wVS17Vg90H21EOLACvtfcHk0lhvHmjG7lPMjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt78%253D&md5=4ba57aa7ac5f01a77123a0b520312206</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437724100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437724100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DThe%2520soluble%2520epoxide%2520hydrolase%2520encoded%2520by%2520EPXH2%2520is%2520a%2520bifunctional%2520enzyme%2520with%2520novel%2520lipid%2520phosphate%2520phosphatase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1558%26epage%3D1563%26doi%3D10.1073%2Fpnas.0437724100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of the human soluble epoxide hydrolase gene (EPHX2)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>221</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.0596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fbbrc.1996.0596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8619856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK28XisVahtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1996&pages=333-339&author=M.+Sandbergauthor=J.+Meijer&title=Structural+characterization+of+the+human+soluble+epoxide+hydrolase+gene+%28EPHX2%29&doi=10.1006%2Fbbrc.1996.0596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of the human soluble epoxide hydrolase gene (EPHX2)</span></div><div class="casAuthors">Sandberg, Martin; Meijer, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-9</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The structural organization of the human gene encoding sol. epoxide hydrolase (EPHX2) was detd.  Cosmid clones contg. the EPHX2 gene were identified by hybridization of a human genomic library with PCR amplified cDNA to the mouse or human sol. epoxide hydrolase as probes.  The gene consists of 19 exons and is approx. 45 kb of which more than 15 kb were sequenced.  The coding sequence corresponds to 555 amino acid residues, i.e., one addnl. residue to those in the reported cDNA sequence.  The sizes of the introns were defined by sequencing or PCR anal. and they contained various repetitive structure elements as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoil2OjI8QoS7Vg90H21EOLACvtfcHk0lj9RmhiMcBWPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVahtLo%253D&md5=caed0489f88a4966c12da36f4dc8909e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.0596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.0596%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DJ.%26atitle%3DStructural%2520characterization%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%2520gene%2520%2528EPHX2%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D221%26spage%3D333%26epage%3D339%26doi%3D10.1006%2Fbbrc.1996.0596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Przybyla-Zawislak, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Matias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohrenweiser, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enayetallah, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span> <span> </span><span class="NLM_article-title">Polymorphisms in human soluble epoxide hydrolase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1124/mol.64.2.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fmol.64.2.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12869654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVCnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=482-490&author=B.+D.+Przybyla-Zawislakauthor=P.+K.+Srivastavaauthor=J.+Vazquez-Matiasauthor=H.+W.+Mohrenweiserauthor=J.+E.+Maxwellauthor=B.+D.+Hammockauthor=J.+A.+Bradburyauthor=A.+E.+Enayetallahauthor=D.+C.+Zeldinauthor=D.+F.+Grant&title=Polymorphisms+in+human+soluble+epoxide+hydrolase&doi=10.1124%2Fmol.64.2.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphisms in human soluble epoxide hydrolase</span></div><div class="casAuthors">Przybyla-Zawislak, Beata D.; Srivastava, Punit K.; Vazquez-Matias, Johana; Mohrenweiser, Harvey W.; Maxwell, Joseph E.; Hammock, Bruce D.; Bradbury, J. Alyce; Enayetallah, Ahmed E.; Zeldin, Darryl C.; Grant, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">482-490</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human sol. epoxide hydrolase (hsEH) metabolizes a variety of epoxides to the corresponding vicinal diols.  Arachidonic and linoleic acid epoxides are thought to be endogenous substrates for hsEH.  Enzyme activity in humans shows high interindividual variation (e.g., 500-fold in liver) suggesting the existence of regulatory and/or structural gene polymorphisms.  We resequenced each of the 19 exons of the hsEH gene (EPHX2) from 72 persons representing black, Asian, and white populations.  A variety of polymorphisms was found, six of which result in amino acid substitutions.  Amino acid variants were localized on the crystal structure of the mouse sEH, resulting in the prediction that at least two of these (Arg287Gln and Arg103Cys) might significantly affect enzyme function.  The six variants of the hsEH cDNA corresponding to each single polymorphism and one corresponding to a double polymorphism were then constructed by site-directed mutagenesis and expressed in insect cells.  As predicted, Arg287Gln and the double mutant Arg287Gln/Arg103Cys showed decreased enzyme activity using trans-stilbene oxide, trans-diphenylpropene oxide, and 14,15-epoxyeicosatrienoic acid as substrates.  Lys55Arg and Cys154Tyr mutants had elevated activity for all three substrates.  Detailed kinetic studies revealed that the double mutant Arg287Gln/Arg103Cys showed significant differences in Km and Vmax.  In addn., stability studies showed that the double mutant was less stable than wild-type protein when incubated at 37°.  These results suggest that at least six hsEH variants exist in the human population and that at least four of these may influence hsEH-mediated metab. of exogenous and endogenous epoxide substrates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbIYnbOqGerbVg90H21EOLACvtfcHk0lj9RmhiMcBWPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVCnsLY%253D&md5=9564abd3101d57a3490b6d5986c585c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.2.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.2.482%26sid%3Dliteratum%253Aachs%26aulast%3DPrzybyla-Zawislak%26aufirst%3DB.%2BD.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DVazquez-Matias%26aufirst%3DJ.%26aulast%3DMohrenweiser%26aufirst%3DH.%2BW.%26aulast%3DMaxwell%26aufirst%3DJ.%2BE.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DEnayetallah%26aufirst%3DA.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26atitle%3DPolymorphisms%2520in%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D482%26epage%3D490%26doi%3D10.1124%2Fmol.64.2.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical</span>. <i>Pest Manage. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1002/ps.1583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fps.1583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=18383502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlWhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=594-609&author=C.+Morisseauauthor=B.+D.+Hammock&title=Gerry+Brooks+and+epoxide+hydrolases%3A+four+decades+to+a+pharmaceutical&doi=10.1002%2Fps.1583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Pest Management Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">594-609</span>CODEN:
                <span class="NLM_cas:coden">PMSCFC</span>;
        ISSN:<span class="NLM_cas:issn">1526-498X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The pioneering work of Gerry Brooks on cyclodiene insecticides led to the discovery of a class of enzymes known as epoxide hydrolases.  The results from 4 decades of work confirm Brooks' 1st observations that the microsomal epoxide hydrolase is important in foreign compd. metab.  Brooks and assocs. went on to be the first to carry out a systematic study of the inhibition of this enzyme.  A 2nd role for this enzyme family was in the degrdn. of insect juvenile hormone (JH).  JH epoxide hydrolases have now been cloned and expressed from several species, and there is interest in developing inhibitors for them.  Interestingly, the distantly related mammalian sol. epoxide hydrolase has emerged as a promising pharmacol. target for treating hypertension, inflammatory disease, and pain.  Tight-binding transition-state inhibitors were developed with good ADME (absorption, distribution, metab., and excretion).  These compds. stabilize endogenous epoxides of fatty acids, including arachidonic acid, which have profound therapeutic effects.  Now EHs from microorganisms and plants are used in green chem.  From his seminal work, Dr. Brooks opened the field of epoxide hydrolase research in many directions including xenobiotic metab., insect physiol., and human health, as well as asym. org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcNMy-FVYB7Vg90H21EOLACvtfcHk0lhRwsYFDbd7fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlWhsLs%253D&md5=c98be78c94a46aa7b0a9b0a3ee8041e7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fps.1583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fps.1583%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DGerry%2520Brooks%2520and%2520epoxide%2520hydrolases%253A%2520four%2520decades%2520to%2520a%2520pharmaceutical%26jtitle%3DPest%2520Manage.%2520Sci.%26date%3D2008%26volume%3D64%26spage%3D594%26epage%3D609%26doi%3D10.1002%2Fps.1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Van
Zeeland, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloss, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewhey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torkamani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libiger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvvuri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wineinger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darst, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarasa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichter, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Via, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treasure, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodside, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulik, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klump, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilenfeld, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnicov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topol, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistretti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrettini, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for the role of EPHX2 gene variants in anorexia nervosa</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1038/mp.2013.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fmp.2013.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23999524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosV2gt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=724-732&author=A.+A.+Scott-Van%0AZeelandauthor=C.+S.+Blossauthor=R.+Tewheyauthor=V.+Bansalauthor=A.+Torkamaniauthor=O.+Libigerauthor=V.+Duvvuriauthor=N.+Wineingerauthor=L.+Galvezauthor=B.+F.+Darstauthor=E.+N.+Smithauthor=A.+Carsonauthor=P.+Phamauthor=T.+Phillipsauthor=N.+Villarasaauthor=R.+Tischauthor=G.+Zhangauthor=S.+Levyauthor=S.+Murrayauthor=W.+Chenauthor=S.+Srinivasanauthor=G.+Berensonauthor=H.+Brandtauthor=S.+Crawfordauthor=S.+Crowauthor=M.+M.+Fichterauthor=K.+A.+Halmiauthor=C.+Johnsonauthor=A.+S.+Kaplanauthor=M.+La+Viaauthor=J.+E.+Mitchellauthor=M.+Stroberauthor=A.+Rotondoauthor=J.+Treasureauthor=D.+B.+Woodsideauthor=C.+M.+Bulikauthor=P.+Keelauthor=K.+L.+Klumpauthor=L.+Lilenfeldauthor=K.+Plotnicovauthor=E.+J.+Topolauthor=P.+B.+Shihauthor=P.+Magistrettiauthor=A.+W.+Bergenauthor=W.+Berrettiniauthor=W.+Kayeauthor=N.+J.+Schork&title=Evidence+for+the+role+of+EPHX2+gene+variants+in+anorexia+nervosa&doi=10.1038%2Fmp.2013.91"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of EPHX2 gene variants in anorexia nervosa</span></div><div class="casAuthors">Scott-Van Zeeland, A. A.; Bloss, C. S.; Tewhey, R.; Bansal, V.; Torkamani, A.; Libiger, O.; Duvvuri, V.; Wineinger, N.; Galvez, L.; Darst, B. F.; Smith, E. N.; Carson, A.; Pham, P.; Phillips, T.; Villarasa, N.; Tisch, R.; Zhang, G.; Levy, S.; Murray, S.; Chen, W.; Srinivasan, S.; Berenson, G.; Brandt, H.; Crawford, S.; Crow, S.; Fichter, M. M.; Halmi, K. A.; Johnson, C.; Kaplan, A. S.; La Via, M.; Mitchell, J. E.; Strober, M.; Rotondo, A.; Treasure, J.; Woodside, D. B.; Bulik, C. M.; Keel, P.; Klump, K. L.; Lilenfeld, L.; Plotnicov, K.; Topol, E. J.; Shih, P. B.; Magistretti, P.; Bergen, A. W.; Berrettini, W.; Kaye, W.; Schork, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-732</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Anorexia nervosa (AN) and related eating disorders are complex, multifactorial neuropsychiatric conditions with likely rare and common genetic and environmental determinants.  To identify genetic variants assocd. with AN, we pursued a series of sequencing and genotyping studies focusing on the coding regions and upstream sequence of 152 candidate genes in a total of 1205 AN cases and 1948 controls.  We identified individual variant assocns. in the Estrogen Receptor-ss (ESR2) gene, as well as a set of rare and common variants in the Epoxide Hydrolase 2 (EPHX2) gene, in an initial sequencing study of 261 early-onset severe AN cases and 73 controls (P=0.0004).  The assocn. of EPHX2 variants was further delineated in: (1) a pooling-based replication study involving an addnl. 500 AN patients and 500 controls (replication set P=0.00000016); (2) single-locus studies in a cohort of 386 previously genotyped broadly defined AN cases and 295 female population controls from the Bogalusa Heart Study (BHS) and a cohort of 58 individuals with self-reported eating disturbances and 851 controls (combined smallest single locus P<0.01).  As EPHX2 is known to influence cholesterol metab., and AN is often assocd. with elevated cholesterol levels, we also investigated the assocn. of EPHX2 variants and longitudinal body mass index (BMI) and cholesterol in BHS female and male subjects (N=229) and found evidence for a modifying effect of a subset of variants on the relationship between cholesterol and BMI (P<0.01).  These findings suggest a novel assocn. of gene variants within EPHX2 to susceptibility to AN and provide a foundation for future study of this important yet poorly understood condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71F_z_GLN7rVg90H21EOLACvtfcHk0lhRwsYFDbd7fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosV2gt7k%253D&md5=7ee72b62ea14ebd2a9208009a1ec907e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fmp.2013.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2013.91%26sid%3Dliteratum%253Aachs%26aulast%3DScott-Van%2BZeeland%26aufirst%3DA.%2BA.%26aulast%3DBloss%26aufirst%3DC.%2BS.%26aulast%3DTewhey%26aufirst%3DR.%26aulast%3DBansal%26aufirst%3DV.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DLibiger%26aufirst%3DO.%26aulast%3DDuvvuri%26aufirst%3DV.%26aulast%3DWineinger%26aufirst%3DN.%26aulast%3DGalvez%26aufirst%3DL.%26aulast%3DDarst%26aufirst%3DB.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BN.%26aulast%3DCarson%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DP.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DVillarasa%26aufirst%3DN.%26aulast%3DTisch%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DBerenson%26aufirst%3DG.%26aulast%3DBrandt%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DCrow%26aufirst%3DS.%26aulast%3DFichter%26aufirst%3DM.%2BM.%26aulast%3DHalmi%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DA.%2BS.%26aulast%3DLa%2BVia%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DJ.%2BE.%26aulast%3DStrober%26aufirst%3DM.%26aulast%3DRotondo%26aufirst%3DA.%26aulast%3DTreasure%26aufirst%3DJ.%26aulast%3DWoodside%26aufirst%3DD.%2BB.%26aulast%3DBulik%26aufirst%3DC.%2BM.%26aulast%3DKeel%26aufirst%3DP.%26aulast%3DKlump%26aufirst%3DK.%2BL.%26aulast%3DLilenfeld%26aufirst%3DL.%26aulast%3DPlotnicov%26aufirst%3DK.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DShih%26aufirst%3DP.%2BB.%26aulast%3DMagistretti%26aufirst%3DP.%26aulast%3DBergen%26aufirst%3DA.%2BW.%26aulast%3DBerrettini%26aufirst%3DW.%26aulast%3DKaye%26aufirst%3DW.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520EPHX2%2520gene%2520variants%2520in%2520anorexia%2520nervosa%26jtitle%3DMol.%2520Psychiatry%26date%3D2014%26volume%3D19%26spage%3D724%26epage%3D732%26doi%3D10.1038%2Fmp.2013.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy</span>. <i>Am. J. Physiol. Renal. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">F1283</span>– <span class="NLM_lpage">F1290</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00733.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajprenal.00733.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21429967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=F1283-F1290&author=J.+P.+Leeauthor=S.+H.+Yangauthor=D.+K.+Kimauthor=H.+Leeauthor=B.+Kimauthor=J.+Y.+Choauthor=K.+S.+Yuauthor=J.+H.+Paikauthor=M.+Kimauthor=C.+S.+Limauthor=Y.+S.+Kim&title=In+vivo+activity+of+epoxide+hydrolase+according+to+sequence+variation+affects+the+progression+of+human+IgA+nephropathy&doi=10.1152%2Fajprenal.00733.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00733.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00733.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DYu%26aufirst%3DK.%2BS.%26aulast%3DPaik%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DIn%2520vivo%2520activity%2520of%2520epoxide%2520hydrolase%2520according%2520to%2520sequence%2520variation%2520affects%2520the%2520progression%2520of%2520human%2520IgA%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal.%2520Physiol.%26date%3D2011%26volume%3D300%26spage%3DF1283%26epage%3DF1290%26doi%3D10.1152%2Fajprenal.00733.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarriello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuazon, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incontri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlongan, C. V.</span></span> <span> </span><span class="NLM_article-title">Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2018.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pneurobio.2018.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30447256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKmu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2019&pages=23-39&author=S.+Zarrielloauthor=J.+P.+Tuazonauthor=S.+Coreyauthor=S.+Schimmelauthor=M.+Rajaniauthor=A.+Gorskyauthor=D.+Incontriauthor=B.+D.+Hammockauthor=C.+V.+Borlongan&title=Humble+beginnings+with+big+goals%3A+Small+molecule+soluble+epoxide+hydrolase+inhibitors+for+treating+CNS+disorders&doi=10.1016%2Fj.pneurobio.2018.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders</span></div><div class="casAuthors">Zarriello, Sydney; Tuazon, Julian P.; Corey, Sydney; Schimmel, Samantha; Rajani, Mira; Gorsky, Anna; Incontri, Diego; Hammock, Bruce D.; Borlongan, Cesar V.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sol. epoxide hydrolase (sEH) degrades epoxides of fatty acids including epoxyeicosatrienoic acid isomers (EETs), which are produced as metabolites of the cytochrome P 450 branch of the arachidonic acid pathway.  EETs exert a variety of largely beneficial effects in the context of inflammation and vascular regulation.  SEH inhibition is shown to be therapeutic in several cardiovascular and renal disorders, as well as in peripheral analgesia, via the increased availability of anti-inflammatory EETs.  The success of sEH inhibitors in peripheral systems suggests their potential in targeting inflammation in the central nervous system (CNS) disorders.  Here, we describe the current roles of sEH in the pathol. and treatment of CNS disorders such as stroke, traumatic brain injury, Parkinson's disease, epilepsy, cognitive impairment, dementia and depression.  In view of the robust anti-inflammatory effects of stem cells, we also outlined the potency of stem cell treatment and sEH inhibitors as a combination therapy for these CNS disorders.  This review highlights the gaps in current knowledge about the pathol. and therapeutic roles of sEH in CNS disorders, which should guide future basic science research towards translational and clin. applications of sEH inhibitors for treatment of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqdZcOhjwZrVg90H21EOLACvtfcHk0lj0WzqlM_roqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKmu7%252FE&md5=9886ffcff040fae7e960416c6f5d4f0e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2018.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2018.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DZarriello%26aufirst%3DS.%26aulast%3DTuazon%26aufirst%3DJ.%2BP.%26aulast%3DCorey%26aufirst%3DS.%26aulast%3DSchimmel%26aufirst%3DS.%26aulast%3DRajani%26aufirst%3DM.%26aulast%3DGorsky%26aufirst%3DA.%26aulast%3DIncontri%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBorlongan%26aufirst%3DC.%2BV.%26atitle%3DHumble%2520beginnings%2520with%2520big%2520goals%253A%2520Small%2520molecule%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520for%2520treating%2520CNS%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2019%26volume%3D172%26spage%3D23%26epage%3D39%26doi%3D10.1016%2Fj.pneurobio.2018.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afanador, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roltsch, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, D. B.</span></span> <span> </span><span class="NLM_article-title">The Ca<sup>2+</sup> sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer’s disease mouse model</span>. <i>Cell Calcium</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.ceca.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ceca.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24931125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=68-80&author=L.+Afanadorauthor=E.+A.+Roltschauthor=L.+Holcombauthor=K.+S.+Campbellauthor=D.+A.+Keelingauthor=Y.+Zhangauthor=D.+B.+Zimmer&title=The+Ca2%2B+sensor+S100A1+modulates+neuroinflammation%2C+histopathology+and+Akt+activity+in+the+PSAPP+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1016%2Fj.ceca.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model</span></div><div class="casAuthors">Afanador, Lauriaselle; Roltsch, Emily A.; Holcomb, Leigh; Campbell, Kerry S.; Keeling, David A.; Zhang, Yan; Zimmer, Danna B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Calcium</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-80</span>CODEN:
                <span class="NLM_cas:coden">CECADV</span>;
        ISSN:<span class="NLM_cas:issn">0143-4160</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The contribution of the Ca2+ sensor S100A1 to in vivo Alzheimer's disease (AD) pathobiol. has not been elucidated although S100A1 regulates numerous cellular processes linked to AD.  This study uses genetic ablation to ascertain the effects of S100A1 on neuroinflammation, beta-amyloid (Aβ) plaque deposition and Akt activity in the PSAPP AD mouse model.  PSAPP/S100A1-/- mice exhibited decreases in astrocytosis (GFAP burden), microgliosis (Iba1 burden) and plaque load/no. when compared to PSAPP/S100A1+/+ mice at six and twelve months of age.  The presence of detectable S100A1 staining in human AD specimens is consistent with a detrimental gain of S100A1 function in AD.  S100A1 ablation also reduced plaque assocd. and increased non-plaque assocd. PO4-Akt and PO4-GSK3β staining.  S100A1·Akt complexes were undetectable in PC12 cells and AD brain tissue suggesting that S100A1 indirectly modulates Akt activity.  In contrast, S100A1·RyR (ryanodine receptor) complexes were present in human/mouse AD brain and exhibited Ca2+-dependent formation in neuronal cells.  This is the first direct demonstration of an S100A1· target protein complex in tissue/cells and identifies the RyR as a primary S100A1 target protein in the brain.  Collectively, these data suggest that S100A1 inhibition may be a novel strategy for normalizing aberrant Ca2+ signaling in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDhoES9DBRbVg90H21EOLACvtfcHk0ljLpYVZx6waOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWntbk%253D&md5=c2bdb9ac0bac095b91e731b1e6b5ad62</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ceca.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceca.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DAfanador%26aufirst%3DL.%26aulast%3DRoltsch%26aufirst%3DE.%2BA.%26aulast%3DHolcomb%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DK.%2BS.%26aulast%3DKeeling%26aufirst%3DD.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZimmer%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Ca2%252B%2520sensor%2520S100A1%2520modulates%2520neuroinflammation%252C%2520histopathology%2520and%2520Akt%2520activity%2520in%2520the%2520PSAPP%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DCell%2520Calcium%26date%3D2014%26volume%3D56%26spage%3D68%26epage%3D80%26doi%3D10.1016%2Fj.ceca.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duflot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellien, J.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1517/17460441.2014.881354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1517%2F17460441.2014.881354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24490654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1agsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=229-243&author=T.+Duflotauthor=C.+Rocheauthor=F.+Lamoureuxauthor=D.+Guerrotauthor=J.+Bellien&title=Design+and+discovery+of+soluble+epoxide+hydrolase+inhibitors+for+the+treatment+of+cardiovascular+diseases&doi=10.1517%2F17460441.2014.881354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases</span></div><div class="casAuthors">Duflot, Thomas; Roche, Clothilde; Lamoureux, Fabien; Guerrot, Dominique; Bellien, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-243</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Cardiovascular diseases are a leading cause of death in developed countries.  Increasing evidence shows that the alteration in the normal functions of the vascular endothelium plays a major role in the development of cardiovascular diseases.  However, specific agents designed to prevent endothelial dysfunction and related cardiovascular complications are still lacking.  One emerging strategy is to increase the bioavailability of epoxyeicosatrienoic acids (EETs), synthesized by cytochrome P 450 epoxygenases from arachidonic acid.  EETs are endothelium-derived hyperpolarising and relaxing factors and display attractive anti-inflammatory and metabolic properties.  Genetic polymorphism studies in humans, and expts. in animal models of diseases, have identified sol. epoxide hydrolase (sEH), the major enzyme involved in EET degrdn., as a potential pharmacol. target.  Areas covered: This review presents EET pathway and its functions and summarises the data supporting the development of sEH inhibitors for the treatment of cardiovascular and metabolic diseases.  Furthermore, the authors present the different chem. families of sEH inhibitors developed and their effects in animal models of cardiovascular and metabolic diseases.  Expert opinion: Several generations of sEH inhibitors have now been designed to treat endothelial dysfunction and cardiovascular complications for a variety of diseases.  The safety of these drugs remains to be carefully investigated, particularly in relation to carcinogenesis.  The increasing knowledge of the biol. role of each of the EET isomers and of their metabolites may improve their pharmacol. profile.  This, in turn, could potentially lead to the identification of new pharmacol. agents that achieve the cellular effects needed without the deleterious side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm7bKJfYgr9LVg90H21EOLACvtfcHk0ljLpYVZx6waOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1agsb4%253D&md5=62a5437b9d54428cb3d73404cbc1faed</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.881354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.881354%26sid%3Dliteratum%253Aachs%26aulast%3DDuflot%26aufirst%3DT.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DLamoureux%26aufirst%3DF.%26aulast%3DGuerrot%26aufirst%3DD.%26aulast%3DBellien%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520discovery%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cardiovascular%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D229%26epage%3D243%26doi%3D10.1517%2F17460441.2014.881354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dileepan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastle-Simpson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijesinghe, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriramarao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span> <span> </span><span class="NLM_article-title">Effect of dual sEH/COX-2 inhibition on allergen-induced airway inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1118</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.01118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.01118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31611798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFahur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1118&author=M.+Dileepanauthor=S.+Rastle-Simpsonauthor=Y.+Greenbergauthor=D.+S.+Wijesingheauthor=N.+G.+Kumarauthor=J.+Yangauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=P.+Sriramaraoauthor=S.+P.+Rao&title=Effect+of+dual+sEH%2FCOX-2+inhibition+on+allergen-induced+airway+inflammation&doi=10.3389%2Ffphar.2019.01118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of dual sEH/COX-2 inhibition on allergen-induced airway inflammation</span></div><div class="casAuthors">Dileepan, Mythili; Rastle-Simpson, Stephanie; Greenberg, Yana; Wijesinghe, Dayanjan S.; Kumar, Naren Gajenthra; Yang, Jun; Hwang, Sung Hee; Hammock, Bruce D.; Sriramarao, P.; Rao, Savita P.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1118</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Arachidonic acid metabolites resulting from the cyclooxygenase (COX), lipoxygenase, and cytochrome P 450 oxidase enzymic pathways play pro- and anti-inflammatory roles in allergic airway inflammation (AAI) and asthma.  Expression of COX-2 and sol. epoxide hydrolase (sEH) are elevated in allergic airways and their enzymic products (e.g., prostaglandins and diols of epoxyeicosatrienoic acids, resp.) have been shown to participate in the pathogenesis of AAI.  Here, we evaluated the outcome of inhibiting the COX-2 and sEH enzymic pathways with a novel dual inhibitor, PTUPB, in A. alternata-induced AAI.  Allergen-challenged mice were administered with 10 or 30 mg/kg of PTUPB, celecoxib (selective COX-2 inhibitor), t-TUCB (selective sEH inhibitor) or vehicle daily by gavage and evaluated for various features of AAI.  PTUPB and t-TUCB at 30 mg/kg, but not celecoxib, inhibited eosinophilic infiltration and significantly increased levels of anti-inflammatory EETs in the lung tissue of allergen-challenged mice. t-TUCB significantly inhibited allergen-induced IL-4 and IL-13, while a less pronounced redn. was noted with PTUPB and celecoxib.  Addnl., t-TUCB markedly inhibited eotaxin-2, an eosinophil-specific chemokine, which was only marginally reduced by PTUPB and remained elevated in celecoxib-treated mice.  PTUPB or t-TUCB administration reversed allergen-induced redn. in levels of various lipid mediators in the lungs, with only a minimal effect noted with celecoxib.  Despite the anti-inflammatory effects, PTUPB or t-TUCB did not reduce allergen-induced airway hyperresponsiveness (AHR).  However, development of structural changes in the allergic airways, such as mucus hypersecretion and smooth muscle hypertrophy, was significantly inhibited by both inhibitors.  Celecoxib, on the other hand, inhibited only airway smooth muscle hypertrophy, but not mucus hypersecretion.  In conclusion, dual inhibition of COX-2 and sEH offers no addnl. advantage relative to sEH inhibition alone in attenuating various features assocd. with A. alternata-induced AAI, while COX-2 inhibition exerts only moderate or no effect on several of these features.  Dual sEH/COX-2 inhibition may be useful in treating conditions where eosinophilic inflammation co-exists with pain-assocd. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCUwbEbSa11rVg90H21EOLACvtfcHk0lgs3edONCcE6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFahur8%253D&md5=50e934c04de307d90dbe5de94278f4f8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.01118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.01118%26sid%3Dliteratum%253Aachs%26aulast%3DDileepan%26aufirst%3DM.%26aulast%3DRastle-Simpson%26aufirst%3DS.%26aulast%3DGreenberg%26aufirst%3DY.%26aulast%3DWijesinghe%26aufirst%3DD.%2BS.%26aulast%3DKumar%26aufirst%3DN.%2BG.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSriramarao%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DS.%2BP.%26atitle%3DEffect%2520of%2520dual%2520sEH%252FCOX-2%2520inhibition%2520on%2520allergen-induced%2520airway%2520inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D1118%26doi%3D10.3389%2Ffphar.2019.01118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30761004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlWktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=36&author=K.+Hashimoto&title=Role+of+soluble+epoxide+hydrolase+in+metabolism+of+PUFAs+in+psychiatric+and+neurological+disorders&doi=10.3389%2Ffphar.2019.00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders</span></div><div class="casAuthors">Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Inflammation plays a key role in the pathogenesis of a no. of psychiatric and neurol. disorders.  Sol. epoxide hydrolases (sEH), enzymes present in all living organisms, metabolize epoxy fatty acids (EpFAs) to corresponding 1,2-diols by the addn. of a mol. of water.  Accumulating evidence suggests that sEH in the metab. of polyunsatd. fatty acids (PUFAs) plays a key role in inflammation.  Preclin. studies demonstrated that protein expression of sEH in the prefrontal cortex, striatum, and hippocampus from mice with depression-like phenotype was higher than control mice.  Furthermore, protein expression of sEH in the parietal cortex from patients with major depressive disorder was higher than controls.  Interestingly, Ephx2 knockout (KO) mice exhibit stress resilience after chronic social defeat stress.  Furthermore, the sEH inhibitors have antidepressant effects in animal models of depression.  In addn., pharmacol. inhibition or gene KO of sEH protected against dopaminergic neurotoxicity in the striatum after repeated administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in an animal model of Parkinson's disease (PD).  Protein expression of sEH in the striatum from MPTP-treated mice was higher than control mice.  A no. of studies using postmortem brain samples showed that the deposition of protein aggregates of a-synuclein, termed Lewy bodies, is evident in multiple brain regions of patients from PD and dementia with Lewy bodies (DLB).  Moreover, the expression of the sEH protein in the striatum from patients with DLB was significantly higher compared with controls.  Interestingly, there was a pos. correlation between sEH expression and the ratio of phosphorylated a-synuclein to a-synuclein in the striatum.  In the review, the author discusses the role of sEH in the metab. of PUFAs in inflammation-related psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr772OTSLm0zrVg90H21EOLACvtfcHk0lgs3edONCcE6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlWktLfF&md5=8486be8b656715c9f89daed8bb6cacd2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00036%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520metabolism%2520of%2520PUFAs%2520in%2520psychiatric%2520and%2520neurological%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D36%26doi%3D10.3389%2Ffphar.2019.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Role of oxylipins in cardiovascular diseases</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1142</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1038/aps.2018.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Faps.2018.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29877318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOmsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=1142-1154&author=M.+A.+Nayeem&title=Role+of+oxylipins+in+cardiovascular+diseases&doi=10.1038%2Faps.2018.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxylipins in cardiovascular diseases</span></div><div class="casAuthors">Nayeem, Mohammed A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1142-1154</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Globally, cardiovascular diseases (CVDs) are the no. one cause of mortality.  Approx. 18 million people died from CVDs in 2015, representing more than 30% of all global deaths.  New diagnostic tools and therapies are eagerly required to decrease the prevalence of CVDs related to mortality and/or risk factors leading to CVDs.  Oxylipins are a group of metabolites, generated via oxygenation of polyunsatd. fatty acids that are involved in inflammation, immunity, and vascular functions, etc.  Thus far, over 100 oxylipins have been identified, and have overlapping and interconnected roles.  Important CVD pathologies such as hyperlipidemia, hypertension, thrombosis, hemostasis and diabetes have been linked to abnormal oxylipin signaling.  Oxylipins represent a new era of risk markers and/or therapeutic targets in several diseases including CVDs.  The role of many oxylipins in the progression or regression in CVD, however, is still not fully understood.  An increased knowledge of the role of these oxygenated polyunsatd. fatty acids in cardiovascular dysfunctions or CVDs including hypertension could possibly lead to the development of biomarkers for the detection and their treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJwUGqfuP5dbVg90H21EOLACvtfcHk0lgQzEcxkU3FCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOmsrrE&md5=847d5829a5906b5d6ed49d38e7ed3c54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Faps.2018.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2018.24%26sid%3Dliteratum%253Aachs%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DRole%2520of%2520oxylipins%2520in%2520cardiovascular%2520diseases%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2018%26volume%3D39%26spage%3D1142%26epage%3D1154%26doi%3D10.1038%2Faps.2018.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span> <span> </span><span class="NLM_article-title">Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone</span>. <i>J. Vasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1159/000159080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1159%2F000159080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7537544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2MXmslSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1995&pages=79-92&author=D.+R.+Harderauthor=W.+B.+Campbellauthor=R.+J.+Roman&title=Role+of+cytochrome+P-450+enzymes+and+metabolites+of+arachidonic+acid+in+the+control+of+vascular+tone&doi=10.1159%2F000159080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone</span></div><div class="casAuthors">Harder, D. R.; Campbell, W. B.; Roman, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Vascular Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-92</span>CODEN:
                <span class="NLM_cas:coden">JVREE9</span>;
        ISSN:<span class="NLM_cas:issn">1018-1172</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review, with 114 refs., the metab. of arachidonic acid (AA) into vasoactive products by cytochrome P 450 enzymes and the regulation of vascular tone by the arachidonic acid metabolites, epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids.  The authors also discuss the large diversity of P 450 enzyme isoforms and how such diversity can provide for precise physiol. control of vascular tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPjbLjTlJHurVg90H21EOLACvtfcHk0lgQzEcxkU3FCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmslSrtrs%253D&md5=4a8ba055d119550a7bb5f469e3606e11</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000159080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000159080%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DD.%2BR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520cytochrome%2520P-450%2520enzymes%2520and%2520metabolites%2520of%2520arachidonic%2520acid%2520in%2520the%2520control%2520of%2520vascular%2520tone%26jtitle%3DJ.%2520Vasc.%2520Res.%26date%3D1995%26volume%3D32%26spage%3D79%26epage%3D92%26doi%3D10.1159%2F000159080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span> <span> </span><span class="NLM_article-title">P-450 metabolites of arachidonic acid in the control of cardiovascular function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1152/physrev.00021.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fphysrev.00021.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11773611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFSisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=131-185&author=R.+J.+Roman&title=P-450+metabolites+of+arachidonic+acid+in+the+control+of+cardiovascular+function&doi=10.1152%2Fphysrev.00021.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-450 metabolites of arachidonic acid in the control of cardiovascular function</span></div><div class="casAuthors">Roman, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-185</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review on the metab. of arachidonic acid by cytochrome P 450 enzymes in the kidney, brain, lung, heart, and pancreas, and the effects of the 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acid metabolites on vascular tone and hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI7QTr-9S_k7Vg90H21EOLACvtfcHk0lgQzEcxkU3FCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFSisQ%253D%253D&md5=86db052d39f5cc50ed9c8cba1ae43466</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00021.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00021.2001%26sid%3Dliteratum%253Aachs%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26atitle%3DP-450%2520metabolites%2520of%2520arachidonic%2520acid%2520in%2520the%2520control%2520of%2520cardiovascular%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D131%26epage%3D185%26doi%3D10.1152%2Fphysrev.00021.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span> <span> </span><span class="NLM_article-title">Activation of K<sup>+</sup> channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(93)90805-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0014-2999%2893%2990805-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8422904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3sXhsVCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1993&pages=215-221&author=S.+Huauthor=H.+S.+Kim&title=Activation+of+K%2B+channel+in+vascular+smooth+muscles+by+cytochrome+P450+metabolites+of+arachidonic+acid&doi=10.1016%2F0014-2999%2893%2990805-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of potassium channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid</span></div><div class="casAuthors">Hu, Shiling; Kim, Helen S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-21</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Arachidonic acid can be oxidatively metabolized by cytochrome P 450 epoxygenase to 4 regioisomeric epoxyeicosatrienoic acids (5,6-, 8,9-, 11,12-, and 14,15-EET), which exhibit vasorelaxant effects in vivo and in vitro with unknown mechanisms.  In this study, the patch-clamp method was used to examine the effects of EETs on the Ca2+-activated K+ channel in cells from rabbit portal vein, rat caudal artery, guinea pig aorta, and porcine coronary artery.  In all 4 cell types, EETs in the bath activated the K+ channel in cell-attached patches by increasing the single channel open-state probability.  Potencies of the 4 EETs did not differ for each cell type.  The concns. for doubling open-state probability were 0.1 μM in portal vein and coronary artery, 0.3-1 μM in aorta, and 1-3 μM in caudal artery.  In caudal artery cells, K+ channel activation by 3 μM 5,6- and 1 μM 11,12-EET was blocked and reversed by glyburide at 0.5 μM.  In aorta, coronary artery, and caudal artery cells, micromolar EETs induced a dose-dependent and reversible augmentation of whole-cell K+ current by 50-120% and a 5-12 mV hyperpolarization.  EETs on the cytosolic side of inside-out patches produced little or no potentiation of K+ channels, implying an interaction of receptor-mediated nature.  Thus, EETs may promote vasodilation by functioning as endogenous K+ channel openers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ4dRW-WFFELVg90H21EOLACvtfcHk0lg7qvnN4l-lwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsVCht7c%253D&md5=eeb0d8ce1c0c9aad526621fbe9faf6e4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990805-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990805-R%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BS.%26atitle%3DActivation%2520of%2520K%252B%2520channel%2520in%2520vascular%2520smooth%2520muscles%2520by%2520cytochrome%2520P450%2520metabolites%2520of%2520arachidonic%2520acid%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D230%26spage%3D215%26epage%3D221%26doi%3D10.1016%2F0014-2999%2893%2990805-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 pathways of arachidonic acid metabolism</span>. <i>Curr. Opin. Lipidol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1097/00041433-200206000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1097%2F00041433-200206000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12045397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlWjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=273-283&author=D.+L.+Kroetzauthor=D.+C.+Zeldin&title=Cytochrome+P450+pathways+of+arachidonic+acid+metabolism&doi=10.1097%2F00041433-200206000-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 pathways of arachidonic acid metabolism</span></div><div class="casAuthors">Kroetz, Deanna L.; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-283</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450s metabolize arachidonic acid to hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.  These eicosanoids are formed in a tissue and cell-specific manner and have numerous biol. functions.  Of major interest are the opposing actions of hydroxyeicosatetraenoic and epoxyeicosatrienoic acids within the vasculature.  Regio- and stereoisomeric epoxyeicosatrienoic acids have potent vasodilatory properties while 20-hydroxyeicosatetraenoic acid is a potent vasoconstrictor.  Both effects are mediated through actions on large-conductance Ca2+-activated K+ channels.  Cytochrome P 450-derived eicosanoids are also important in the regulation of ion transport, and have recently been shown to influence a no. of fundamental biol. processes including cellular proliferation, apoptosis, inflammation, and hemostasis.  The formation of these functionally relevant eicosanoids is tightly controlled by the expression and activity of the cytochrome P 450 epoxygenases and hydroxylases.  In addn., sol. epoxide hydrolase catalyzes the hydrolysis of epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids, and the activity of this enzyme is a crit. determinant of tissue epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels.  The intracellular balance between epoxyeicosatrienoic, dihydroxyeicosatrienoic and hydroxyeicosatetraenoic acids influences the biol. response to these eicosanoids and alterations in their levels have recently been assocd. with certain pathol. conditions.  The involvement of the cytochrome P 450-derived eicosanoids in a wide array of biol. functions and the observation that levels are altered in pathol. conditions suggest that the enzymes involved in the formation and degrdn. of these fatty acids may be novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopORL4MTqm5LVg90H21EOLACvtfcHk0lg7qvnN4l-lwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlWjsbY%253D&md5=66b4494323d6c84517068b83b27b7574</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2F00041433-200206000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041433-200206000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DCytochrome%2520P450%2520pathways%2520of%2520arachidonic%2520acid%2520metabolism%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D2002%26volume%3D13%26spage%3D273%26epage%3D283%26doi%3D10.1097%2F00041433-200206000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">15983</span>– <span class="NLM_lpage">15989</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100439200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M100439200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11279071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFaksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=15983-15989&author=K.+Nodeauthor=X.+L.+Ruanauthor=J.+Daiauthor=S.+X.+Yangauthor=L.+Grahamauthor=D.+C.+Zeldinauthor=J.+K.+Liao&title=Activation+of+Galpha+s+mediates+induction+of+tissue-type+plasminogen+activator+gene+transcription+by+epoxyeicosatrienoic+acids&doi=10.1074%2Fjbc.M100439200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Gαs mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Node, Koichi; Ruan, Xiu-Lu; Dai, Jianwu; Yang, Shui-Xiang; Graham, LeRae; Zeldin, Darryl C.; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">15983-15989</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 (CYP) epoxygenases that have vasodilatory and anti-inflammatory properties.  Here the authors report that EETs have addnl. fibrinolytic properties.  In vascular endothelial cells, physiol. concns. of EETs, particularly 11,12-EET, or overexpression of the endothelial epoxygenase, CYP2J2, increased tissue plasminogen activator (t-PA) expression by 2.5-fold without affecting plasminogen activator inhibitor-1 expression.  This increase in t-PA expression correlated with a 4-fold induction in t-PA gene transcription and a 3-fold increase in t-PA fibrinolytic activity and was blocked by the CYP inhibitor, SKF525A, but not by the calcium-activated potassium channel blocker, charybdotoxin, indicating a mechanism that does not involve endothelial cell hyperpolarization.  The t-PA promoter is cAMP-responsive, and induction of t-PA gene transcription by EETs correlated with increases in intracellular cAMP levels and, functionally, with cAMP-driven promoter activity.  To det. whether increases in intracellular cAMP levels were due to modulation of guanine nucleotide-binding proteins, the authors assessed the effects of EETs on Gαs and Gαi2.  Treatment with EETs increased Gαs, but not Gαi2, GTP-binding activity by 3.5-fold.  These findings indicate that EETs possess fibrinolytic properties through the induction of t-PA and suggest that endothelial CYP2J2 may play an important role in regulating vascular hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6rgEE-fndLVg90H21EOLACvtfcHk0liQzdpIl7R-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFaksbc%253D&md5=8f3e5d6ed9b847453ac6372656024891</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100439200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100439200%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DK.%26aulast%3DRuan%26aufirst%3DX.%2BL.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DGraham%26aufirst%3DL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3DActivation%2520of%2520Galpha%2520s%2520mediates%2520induction%2520of%2520tissue-type%2520plasminogen%2520activator%2520gene%2520transcription%2520by%2520epoxyeicosatrienoic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D15983%26epage%3D15989%26doi%3D10.1074%2Fjbc.M100439200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munzenmaier, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span> <span> </span><span class="NLM_article-title">Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">H1163</span>– <span class="NLM_lpage">H1167</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.2000.278.4.H1163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.2000.278.4.H1163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10749710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2000&pages=H1163-H1167&author=D.+H.+Munzenmaierauthor=D.+R.+Harder&title=Cerebral+microvascular+endothelial+cell+tube+formation%3A+role+of+astrocytic+epoxyeicosatrienoic+acid+release&doi=10.1152%2Fajpheart.2000.278.4.H1163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release</span></div><div class="casAuthors">Munzenmaier, Diane H.; Harder, David R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">4, Pt. 2</span>),
    <span class="NLM_cas:pages">H1163-H1167</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Cerebral microvascular endothelial cells (CMVEC) form tubes when cocultured with astrocytes (AS).  Therefore, it appears that AS may be important in mediating angiogenesis in the brain.  We hypothesized that AS modulate CMVEC tube formation by releasing a sol. factor.  Thymidine incorporation in cultured CMVEC increased 305% when incubated with 50% conditioned AS medium for 24 h [control: 52,755 ± 4,838 counts per min (cpm) per well, conditioned 161,082 ± 12,099 cpm/well, n = 8].  Because our lab. has previously shown that AS can produce epoxyeicosatrienoic acids (EETs), which are known mitogens, we investigated whether release of EETs by AS is responsible for tube formation in the CMVEC-AS coculture.  AS were seeded on Lab-Tek slides, CMVEC were seeded on the AS the next day, and cultures were allowed to progress for another 5 days with and without cytochrome P 450 epoxygenase blockade by 17-octadecynoic acid (17-ODYA).  Tube formation in cocultures receiving 17-ODYA was significantly inhibited compared with control (93.8%).  These data suggest that tube formation requires the release of EETs by AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsN7dSjUuj77Vg90H21EOLACvtfcHk0liQzdpIl7R-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSlur0%253D&md5=e1b57622a375c9085a382c7594278c53</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.2000.278.4.H1163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.2000.278.4.H1163%26sid%3Dliteratum%253Aachs%26aulast%3DMunzenmaier%26aufirst%3DD.%2BH.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26atitle%3DCerebral%2520microvascular%2520endothelial%2520cell%2520tube%2520formation%253A%2520role%2520of%2520astrocytic%2520epoxyeicosatrienoic%2520acid%2520release%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2000%26volume%3D278%26spage%3DH1163%26epage%3DH1167%26doi%3D10.1152%2Fajpheart.2000.278.4.H1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1276</span>– <span class="NLM_lpage">1279</span>, <span class="refDoi"> DOI: 10.1126/science.285.5431.1276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1126%2Fscience.285.5431.1276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10455056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Siur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1276-1279&author=K.+Nodeauthor=Y.+Huoauthor=X.+Ruanauthor=B.+Yangauthor=M.+Spieckerauthor=K.+Leyauthor=D.+C.+Zeldinauthor=J.+K.+Liao&title=Anti-inflammatory+properties+of+cytochrome+P450+epoxygenase-derived+eicosanoids&doi=10.1126%2Fscience.285.5431.1276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids</span></div><div class="casAuthors">Node, Koichi; Huo, Yuqing; Ruan, Z. Xiulu; Yang, Baichun; Spiecker, Martin; Ley, Klaus; Zeldin, Darryl C.; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5431</span>),
    <span class="NLM_cas:pages">1276-1279</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 epoxygenases that have vasodilatory properties similar to that of endothelium-derived hyperpolarizing factor.  The cytochrome P 450 isoform CYP2J2 was cloned and identified as a potential source of EETs in human endothelial cells.  Physiol. concns. of EETs or overexpression of CYP2J2 decreased cytokine-induced endothelial cell adhesion mol. expression, and EETs prevented leukocyte adhesion to the vascular wall by a mechanism involving inhibition of transcription factor NF-κB and IκB kinase.  The inhibitory effects of EETs were independent of their membrane-hyperpolarizing effects, suggesting that these mols. play an important nonvasodilatory role in vascular inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvTzrmgnTpJrVg90H21EOLACvtfcHk0liQzdpIl7R-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Siur0%253D&md5=bab4dd51931632408fc7d43fbe87759f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5431.1276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5431.1276%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DK.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DSpiecker%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520cytochrome%2520P450%2520epoxygenase-derived%2520eicosanoids%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D1276%26epage%3D1279%26doi%3D10.1126%2Fscience.285.5431.1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">New role for epoxyeicosatrienoic acids as anti-inflammatory mediators</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(00)01472-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0165-6147%2800%2901472-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10740283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=125-127&author=W.+B.+Campbell&title=New+role+for+epoxyeicosatrienoic+acids+as+anti-inflammatory+mediators&doi=10.1016%2FS0165-6147%2800%2901472-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New role for epoxyeicosatrienoic acids as anti-inflammatory mediators</span></div><div class="casAuthors">Campbell, W. B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">125-127</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 12 refs., on the autocrine role for epoxyeicosatrienoic acids in endothelial cells as anti-inflammatory mediators.  This autocrine effect is owing to inhibition of both IKK activity and cytokine-induced CAM expression, which reduces adhesion of inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_cyly58E3rVg90H21EOLACvtfcHk0lj9S0yYa48JBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGgs7k%253D&md5=96c1c7411cfa631b19ef74438eb2952e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2800%2901472-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252800%252901472-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DNew%2520role%2520for%2520epoxyeicosatrienoic%2520acids%2520as%2520anti-inflammatory%2520mediators%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26spage%3D125%26epage%3D127%26doi%3D10.1016%2FS0165-6147%2800%2901472-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Epoxygenase pathways of arachidonic acid metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">36059</span>– <span class="NLM_lpage">36062</span>, <span class="refDoi"> DOI: 10.1074/jbc.R100030200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.R100030200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11451964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36059-36062&author=D.+C.+Zeldin&title=Epoxygenase+pathways+of+arachidonic+acid+metabolism&doi=10.1074%2Fjbc.R100030200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxygenase pathways of arachidonic acid metabolism</span></div><div class="casAuthors">Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36059-36062</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The author provides a general overview of the arachidonic acid epoxygenase pathway with emphasis on the P 450 enzymes involved in epoxyeicosatrienoic acids (EETs) biosynthesis, the metabolic fate of the EETs once they are formed, and the biol. relevance of the EETs in the kidney and cardiovascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKqDIvtxVoF7Vg90H21EOLACvtfcHk0lj9S0yYa48JBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yku7o%253D&md5=65f033ed163b5daa30b10f767ab8d134</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R100030200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R100030200%26sid%3Dliteratum%253Aachs%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DEpoxygenase%2520pathways%2520of%2520arachidonic%2520acid%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36059%26epage%3D36062%26doi%3D10.1074%2Fjbc.R100030200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navar, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Actions of epoxygenase metabolites on the preglomerular vasculature</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2364</span>– <span class="NLM_lpage">2370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8959626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2sXltFylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=2364-2370&author=J.+D.+Imigauthor=L.+G.+Navarauthor=R.+J.+Romanauthor=K.+K.+Reddyauthor=J.+R.+Falck&title=Actions+of+epoxygenase+metabolites+on+the+preglomerular+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of epoxygenase metabolites on the preglomerular vasculature</span></div><div class="casAuthors">Imig, John D.; Navar, L. G.; Roman, Richard J.; Reddy, K. Kishta; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2364-2370</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow.  This study examd. the preglomerular actions of various epoxyeicosatrienoic acid (EET).  By use of the in vitro blood-perfused juxtamedullary nephron prepn., interlobular and different arteriolar diam. responses to 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET were detd.  Diams. of interlobular and afferent arterioles preconstricted with 0.5μM norepinephrine averaged 24±1 μM(N=27) and 17±1 μM(N=32), resp., at a renal perfusion pressure of 100 mm Hg.  Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diams. of the interlobular and afferent arterioles.  At a dose of 100 nM, 11,12-EET increased the diams. of the interlobular and afferent arterioles by 18±2% (N=10) and 20±3% (N=9), resp.  The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diams. of the interlobular and afferent arterioles.  14,15-EET had a much smaller effect and increased the diams. of the these vessels by 10%;8,9-EET did not significantly affect vascular diams.  In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16±3% (N=6) and 21±3% (N=7), resp.  The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diams. of the interlobular and afferent arterioles at concns. up to 1 μM.  The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin.  In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition.  The thromboxane/enderoxperoxide receptor inhibitor, SQ 29,548, resulted in 60% attenuation of the afferent arteriolar vasconstriction to 5,6-EET.  These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent ad requires an intact endothelium, whereas the vasodilation of 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoojB5As8pW77Vg90H21EOLACvtfcHk0ljZHyaCXhTkzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFylsw%253D%253D&md5=c312b42f5180f77fad282e9adf17b721</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DNavar%26aufirst%3DL.%2BG.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BK.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DActions%2520of%2520epoxygenase%2520metabolites%2520on%2520the%2520preglomerular%2520vasculature%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D1996%26volume%3D7%26spage%3D2364%26epage%3D2370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hittner, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">H337</span>– <span class="NLM_lpage">H349</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00831.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.00831.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12388250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvF2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=H337-H349&author=J.+R.+Falckauthor=U.+M.+Krishnaauthor=Y.+K.+Reddyauthor=P.+S.+Kumarauthor=K.+M.+Reddyauthor=S.+B.+Hittnerauthor=C.+Deeterauthor=K.+K.+Sharmaauthor=K.+M.+Gauthierauthor=W.+B.+Campbell&title=Comparison+of+vasodilatory+properties+of+14%2C15-EET+analogs%3A+structural+requirements+for+dilation&doi=10.1152%2Fajpheart.00831.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of vasodilatory properties of 14,15-EET analogs: Structural requirements for dilation</span></div><div class="casAuthors">Falck, J. R.; Krishna, U. Murali; Reddy, Y. Krishna; Kumar, P. Srinagesh; Reddy, K. Malla; Hittner, Sarah B.; Deeter, Christine; Sharma, Kamalesh K.; Gauthier, Kathryn M.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">H337-H349</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are endothelium-derived eicosanoids that activate potassium channels, hyperpolarize the membrane, and cause relaxation.  The authors tested 19 analogs of 14,15-EET on vascular tone to det. the structural features required for activity.  14,15-EET relaxed bovine coronary arterial rings in a concn.-related manner (ED50 = 10-6 M).  Changing the carboxyl to an alc. eliminated dilator activity, whereas 14,15-EET-Me ester and 14,15-EET-methylsulfonimide retained full activity.  Shortening the distance between the carboxyl and epoxy groups reduced the agonist potency and activity.  Removal of all three double bonds decreased potency.  An analog with a Δ8 double bond had full activity and potency.  However, the analogs with only a Δ5 or Δ11 double bond had reduced potency.  Conversion of the epoxy oxygen to a sulfur or nitrogen resulted in loss of activity.  14(S),15(R)-EET was more potent than 14(R),15(S)-EET, and 14,15-(cis)-EET was more potent than 14,15-(trans)-EET.  These studies indicate that the structural features of 14,15-EET required for relaxation of the bovine coronary artery include a carbon-1 acidic group, a Δ8 double bond, and a 14(S),15(R)-(cis)-epoxy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogeldh5uWxr7Vg90H21EOLACvtfcHk0ljZHyaCXhTkzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvF2hsw%253D%253D&md5=3026bb96cd495fa7d18b5e132a864665</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00831.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00831.2001%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DKrishna%26aufirst%3DU.%2BM.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DKumar%26aufirst%3DP.%2BS.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DHittner%26aufirst%3DS.%2BB.%26aulast%3DDeeter%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DK.%2BK.%26aulast%3DGauthier%26aufirst%3DK.%2BM.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DComparison%2520of%2520vasodilatory%2520properties%2520of%252014%252C15-EET%2520analogs%253A%2520structural%2520requirements%2520for%2520dilation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DH337%26epage%3DH349%26doi%3D10.1152%2Fajpheart.00831.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, E. F.</span></span> <span> </span><span class="NLM_article-title">Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1111/j.1469-7793.1999.0153o.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1469-7793.1999.0153o.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10432346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=1999&pages=153-168&author=H.+C.+Leeauthor=T.+Luauthor=N.+L.+Weintraubauthor=M.+VanRollinsauthor=A.+A.+Spectorauthor=E.+F.+Shibata&title=Effects+of+epoxyeicosatrienoic+acids+on+the+cardiac+sodium+channels+in+isolated+rat+ventricular+myocytes&doi=10.1111%2Fj.1469-7793.1999.0153o.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes</span></div><div class="casAuthors">Lee, Hon-Chi; Lu, Tong; Weintraub, Neal L.; VanRollins, Mike; Spector, Arthur A.; Shibata, Erwin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">1. Whole-cell Na+ currents (holding potential, -80 mV; test potential, -30 mV) in rat myocytes were inhibited by 8,9-epoxyeicosatrienoic acid (8,9-EET) in a dose-dependent manner with 22±4% inhibition at 0.5 μM, 48±5% at 1 μM, and 73±5% at 5 μM (mean ± S.E.M., n = 10, P < 0.05 for each dose vs. control).  Similar results were obtained with 5,6-, 11,12-, and 14,15-EETs, while 8,9-dihydroxyeicosatrienoic acid (DHET) was 3-fold less potent and arachidonic acid was 10- to 20-fold less potent.  2. 8,9-EET produced a dose-dependent, hyperpolarized shift in the steady-state membrane potential at half-max. inactivation (V1/2), without changing the slope factor.  8,9-EET had no effect on the steady-state activation of Na+ currents.  3. Inhibition of Na+ currents by 8,9-EET was use dependent, and channel recovery was slowed.  The effects of 8,9-EET were greater at depolarized potentials.  4. Single channel recordings showed 8,9-EET did not change the conductance or the no. of active Na+ channels, but markedly decreased the probability of Na+ channel opening.  These results were assocd. with a decrease in the channel open time and an increase in the channel closed times.  5. Incubation of cultured cardiac myocytes with 1 μM [3H]8,9-EET showed that 25% of the radioactivity was taken up by the cells over a 2 h period, and most of the uptake was incorporated into phospholipids, principally phosphatidylcholine.  Anal. of the medium after a 2 h incubation indicated that 86% of the radioactivity remained as [3H]8,9-EET while 13% was converted into [3H]8,9-DHET.  After a 30 min incubation, 1-2% of the [3H]8,9-EET uptake by cells remained as unesterified EET.  6. These results demonstrate that cardiac cells have a high capacity to take up and metabolize 8,9-EET.  8,9-EET is a potent use- and voltage-dependent inhibitor of the cardiac Na+ channels through modulation of the channel gating behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxMcbTRHpbDLVg90H21EOLACvtfcHk0ljZHyaCXhTkzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVWisbg%253D&md5=82bd803dc816d4319d071a046eac4fa9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-7793.1999.0153o.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-7793.1999.0153o.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DShibata%26aufirst%3DE.%2BF.%26atitle%3DEffects%2520of%2520epoxyeicosatrienoic%2520acids%2520on%2520the%2520cardiac%2520sodium%2520channels%2520in%2520isolated%2520rat%2520ventricular%2520myocytes%26jtitle%3DJ.%2520Physiol.%26date%3D1999%26volume%3D519%26spage%3D153%26epage%3D168%26doi%3D10.1111%2Fj.1469-7793.1999.0153o.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">H2113</span>– <span class="NLM_lpage">H2121</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.1998.275.6.H2113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.1998.275.6.H2113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9843811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXht1yitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1998&pages=H2113-H2121&author=X.+Fangauthor=S.+A.+Mooreauthor=L.+L.+Stollauthor=G.+Richauthor=T.+L.+Kaduceauthor=N.+L.+Weintraubauthor=A.+A.+Spector&title=14%2C15-Epoxyeicosatrienoic+acid+inhibits+prostaglandin+E2+production+in+vascular+smooth+muscle+cells&doi=10.1152%2Fajpheart.1998.275.6.H2113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells</span></div><div class="casAuthors">Fang, Xiang; Moore, Steven A.; Stoll, Lynn L.; Rich, Gretchen; Kaduce, Terry L.; Weintraub, Neal L.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6, Pt. 2</span>),
    <span class="NLM_cas:pages">H2113-H2121</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">4,15-Epoxyeicosatrienoic acid (EET), a cytochrome P 450 epoxygenase product of arachidonic acid (AA), reduced PGE2 formation by 40-75% in porcine aortic and murine brain microvascular smooth muscle cells.  The inhibition was reversed 6-10 h after removal of 14,15-EET from the medium and was regioisomeric specific; 8,9-EET produced a smaller effect, whereas 11,12- and 5,6-EET were ineffective.  Although the cells converted 14,15-EET to 14,15-dihydroxyeicosatrienoic acid (14,15-DHET), 14,15-DHET did not inhibit PGE2 formation, and the 14,15-EET-induced inhibition was potentiated by 4-phenylchalcone oxide, an epoxide hydrolase inhibitor.  The inhibition occurred when substrate amts. of arachidonic acid (AA) were used and was not accompanied by enhanced prodn. of other prostaglandins, suggesting an effect on PGH synthase; however, in murine cells, 14,15-EET did not reduce PGH synthase mRNA or protein.  Moreover, the 14,15-EET-induced decrease in PGE2 prodn. was overcome by increasing the concn. of AA, but not oleic acid (which is not a substrate for PGH synthase).  These findings suggest that 14,15-EET competitively inhibits PGH synthase activity in vascular smooth muscle cells.  The 14,15-EET-induced inhibition of PGE2 prodn. resulted in potentiation of platelet-derived growth factor-induced smooth muscle cell proliferation, suggesting that the competitive inhibition of PGH synthase by 14,15-EET can affect growth responses in smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHmZqUjnUjPrVg90H21EOLACvtfcHk0lj05JXg6iGzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1yitA%253D%253D&md5=5dc07fab2eb568f0ca12fab74c7a5dc9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.1998.275.6.H2113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.1998.275.6.H2113%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DStoll%26aufirst%3DL.%2BL.%26aulast%3DRich%26aufirst%3DG.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3D14%252C15-Epoxyeicosatrienoic%2520acid%2520inhibits%2520prostaglandin%2520E2%2520production%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1998%26volume%3D275%26spage%3DH2113%26epage%3DH2121%26doi%3D10.1152%2Fajpheart.1998.275.6.H2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.34.6.1242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.34.6.1242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10601125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=1242-1246&author=X.+Fangauthor=N.+L.+Weintraubauthor=L.+L.+Stollauthor=A.+A.+Spector&title=Epoxyeicosatrienoic+acids+increase+intracellular+calcium+concentration+in+vascular+smooth+muscle+cells&doi=10.1161%2F01.HYP.34.6.1242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells</span></div><div class="casAuthors">Fang, Xiang; Weintraub, Neal L.; Stoll, Lynn L.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1242-1246</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are cytochrome P 450-derived metabolites of arachidonic acid.  They are potent endogenous vasodilator compds. produced by vascular cells, and EET-induced vasodilation has been attributed to activation of vascular smooth muscle cell (SMC) K+ channels.  However, in some cells, EETs activate Ca2+ channels, resulting in Ca2+ influx and increased intracellular Ca2+ concn. ([Ca2+]i).  We investigated whether EETs also can activate Ca2+ channels in vascular SMC and whether the resultant Ca2+ influx can influence vascular tone.  The 4 EET regioisomers (1 μmol/L) increased porcine aortic SMC [CA2+]i by 52% to 81%, whereas arachidonic acid, dihydroxyeicosatrienoic acids, and 15-hydroxyeicosatetraenoic acid (1 μmol/L) produced little effect.  The increases in [Ca2+]i produced by 14,15-EET were abolished by removal of extracellular Ca2+ and by pretreatment with verapamil (10 μmol/L), an inhibitor of voltage-dependent (L-type) Ca2+ channels.  14,15-EET did not alter Ca2+ signaling induced by norepinephrine and thapsigargin.  When administered to porcine coronary artery rings precontracted with a thromboxane mimetic, 14,15-EET produced relaxation.  However, when administered to rings precontracted with acetylcholine or KCl, 14,15-EET produced addnl. contractions.  In rings exposed to 10 mmol/L KCl, a concn. that did not affect resting ring tension, 14,15-EET produced small contractions that were abolished by EGTA (3 mmol/L) or verapamil (10 μmol/L).  These observations indicate that 14,15-EET enhances [Ca2+]i influx in vascular SMC through voltage-dependent Ca2+ channels.  This 14,15-EET-induced increase in [Cai2+] can produce vasoconstriction and therefore may act to modulate EET-induced vasorelaxation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0F6mR09qP3LVg90H21EOLACvtfcHk0lj05JXg6iGzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFCksQ%253D%253D&md5=b3f0d1cfe635ce9c05f5e7fc54f53818</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.34.6.1242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.34.6.1242%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DStoll%26aufirst%3DL.%2BL.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520increase%2520intracellular%2520calcium%2520concentration%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DHypertension%26date%3D1999%26volume%3D34%26spage%3D1242%26epage%3D1246%26doi%3D10.1161%2F01.HYP.34.6.1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirt, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, H. R.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1805</span>– <span class="NLM_lpage">1812</span>, <span class="refDoi"> DOI: 10.1172/JCI114365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1172%2FJCI114365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2556446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1989&pages=1805-1812&author=D.+L.+Hirtauthor=J.+Capdevilaauthor=J.+R.+Falckauthor=M.+D.+Breyerauthor=H.+R.+Jacobson&title=Cytochrome+P450+metabolites+of+arachidonic+acid+are+potent+inhibitors+of+vasopressin+action+on+rabbit+cortical+collecting+duct&doi=10.1172%2FJCI114365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct</span></div><div class="casAuthors">Hirt, Darrell L.; Capdevila, Jorge; Falck, J. R.; Breyer, Matthew D.; Jacobson, Harry R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1805-12</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Arachidonic acid is metabolized by a cytochrome P 450, NADPH-dependent epoxygenase to 4 regioisomeric epoxyeicosatrienoic acids (EETs).  The EETs are further hydrated enzymically to their resp. diols, vic-dihydroxyeicosatrienoic acids (DHETs).  The effect of pretreatment with DHETs on 10 microunits AVP/cm2-stimulated hydraulic cond. (Lp) (Lp × 10-7 cm/atm/s) was studied in rabbit cortical collecting ducts perfused in vitro at 37°.  At 10-6M, all 4 DHETs were potent inhibitors of the hydroosmotic effect of AVP.  14,15-DHET was the most potent isomer; it reduced AVP-induced Lp from a control value of 234.75 to a value of 95.2, a redn. of AVP-mediated water flow of 60%.  The inhibitory effect of 14,15-DHET was dose dependent and significant to nanomolar concns.  14,15-DHET at 10-7M was as potent an inhibitor of AVP's activity as was 10-7M PGE2.  AVP's hydroosmotic effect is mediated through its intracellular 2nd messenger, cAMP.  The cAMP analog 8-p-chlorophenylthio-cAMP (CcAMP) at 10-4M induced a peak Lp of 189.6; pretreatment with 10-6M 14,15-DHET reduced the CcAMP-peak Lp to 132.0, demonstrating a post-cAMP effect.  Gas chromatog./mass spectroscopy suggests that EETs are present in exts. purified from cortical collecting ducts.  Cytochrome P 450 epoxygenase eicosanoids are apparently potent inhibitors of the hydroosmotic effect of vasopressin and are endogenous constituents of normal cortical collecting ducts, the major target tissue for AVP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftqQ_9IpgR7Vg90H21EOLACvtfcHk0lg4Hygmy4fyag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFertQ%253D%253D&md5=42376245a9d0006f64028f26f669850e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1172%2FJCI114365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114365%26sid%3Dliteratum%253Aachs%26aulast%3DHirt%26aufirst%3DD.%2BL.%26aulast%3DCapdevila%26aufirst%3DJ.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26aulast%3DJacobson%26aufirst%3DH.%2BR.%26atitle%3DCytochrome%2520P450%2520metabolites%2520of%2520arachidonic%2520acid%2520are%2520potent%2520inhibitors%2520of%2520vasopressin%2520action%2520on%2520rabbit%2520cortical%2520collecting%2520duct%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1989%26volume%3D84%26spage%3D1805%26epage%3D1812%26doi%3D10.1172%2FJCI114365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1161/01.RES.81.2.258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.81.2.258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9242187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1997&pages=258-267&author=N.+L.+Weintraubauthor=X.+Fangauthor=T.+L.+Kaduceauthor=M.+VanRollinsauthor=P.+Chatterjeeauthor=A.+A.+Spector&title=Potentiation+of+endothelium-dependent+relaxation+by+epoxyeicosatrienoic+acids&doi=10.1161%2F01.RES.81.2.258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Weintraub, Neal L.; Fang, Xiang; Kaduce, Terry L.; Vanrollins, Mike; Chatterjee, Papri; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">American Heart Association</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are potent endothelium-derived vasodilators formed from cytochrome P 450 metab. of arachidonic acid.  EETs and their diol products (DHETs) are also avidly taken up by endothelial cells and incorporated into phospholipids that participate in signal transduction.  To investigate the possible functional significance of EET and DHET incorporation into cell lipids, we examd. the capacity of EETs and DHETs to relax porcine coronary arterial rings and detd. responses to bradykinin (which potently activates endothelial phospholipases) before and after incubating the rings with these eicosanoids.  14,15-EET and 11,12-EET (5 μmol/L) produced 75% and 52% relaxation, resp., of U 46619-contracted rings, whereas 8,9-EET and 5,6-EET did not produce significant relaxation.  The corresponding DHET regioisomers produced comparable relaxation responses.  Preincubation with 14,15-EET, 11,12-EET, 14,15-DHET, and 11,12-DHET augmented the magnitude and duration of bradykinin-induced relaxation, whereas endothelium-independent relaxations to aprikalim and sodium nitroprusside were not potentiated.  Pretreatment with 2 μmol/L triacsin C (an inhibitor of acyl CoA synthases) inhibited [3H]14,15-EET incorporation into endothelial phospholipids and blocked 11,12-EET- and 14,15-DHET-induced potentiation of relaxation to bradykinin.  Exposure of [3H]14,15-EET-labeled endothelial cells to the Ca2+ ionophore A 23187 (2 μmol/L) resulted in a 4-fold increased release of EET and DHET into the medium.  We conclude that incorporation of EETs and DHETs into cell lipids results in potentiation of bradykinin-induced relaxation in porcine coronary arteries, providing the first evidence that incorporated EETs and DHETs are capable of modulating vascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2nKS5VTwKBbVg90H21EOLACvtfcHk0lg4Hygmy4fyag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFyksb4%253D&md5=5b0e345d8abf5d99dc70d0252354ed21</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1161%2F01.RES.81.2.258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.81.2.258%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DP.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DPotentiation%2520of%2520endothelium-dependent%2520relaxation%2520by%2520epoxyeicosatrienoic%2520acids%26jtitle%3DCirc.%2520Res.%26date%3D1997%26volume%3D81%26spage%3D258%26epage%3D267%26doi%3D10.1161%2F01.RES.81.2.258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltman, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellsperger, K. C.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1161/01.RES.83.9.932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.83.9.932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9797342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1yjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=932-939&author=C.+L.+Oltmanauthor=N.+L.+Weintraubauthor=M.+VanRollinsauthor=K.+C.+Dellsperger&title=Epoxyeicosatrienoic+acids+and+dihydroxyeicosatrienoic+acids+are+potent+vasodilators+in+the+canine+coronary+microcirculation&doi=10.1161%2F01.RES.83.9.932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation</span></div><div class="casAuthors">Oltman, Christine L.; Weintraub, Neal L.; VanRollins, Mike; Dellsperger, Kevin C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Cytochrome P450 epoxygenases convert arachidonic acid into 4 epoxyeicosatrienoic acid (EET) regioisomers, which were recently identified as endothelium-derived hyperpolarizing factors in coronary blood vessels.  Both EETs and their dihydroxyeicosatrienoic acid (DHET) metabolites have been shown to relax conduit coronary arteries at micromolar concns., whereas the plasma concns. of EETs are in the nanomolar range.  However, the effects of EETs and DHETs on coronary resistance arterioles have not been examd.  The authors administered EETs and DHETs to isolated canine coronary arterioles (diam., 90.0 μm; distending pressure, 20 mm Hg) preconstricted by 30% to 60% of the resting diam. with endothelin.  All 4 EET regioisomers produced potent, concn.-dependent vasodilation (EC50 values ranging from -12.7 to -10.1 log [M]) and were approx. 1000 times more potent than reported in conduit coronary arteries.  The vasodilation produced by 14,15-EET was not attenuated by removal of the endothelium and indicated a direct action of 14,15-EET on microvascular smooth muscle.  Likewise, 14,15-DHET, 11,12-DHET, 8,9-DHET, and the δ-lactone of 5,6-EET produced extremely potent vasodilation (EC50 values ranging from -15.8 to -13.1 log [M]).  The vasodilation produced by these eicosanoids was highly potent in comparison to that produced by other vasodilators, including arachidonic acid (EC50 = -7.5 log [M]).  The epoxide hydrolase inhibitor, 4-phenylchalone oxide, which blocked the conversion of [3H]14,15-EET to [3H]14,15-DHET by canine coronary arteries, did not alter arteriolar dilation to 11,12-EET; thus, the potent vasodilation induced by EETs does not require formation of DHETs.  In contrast, charybdotoxin (a KCa channel inhibitor) and KCl (a depolarizing agent) blocked vasodilation by 11,12-EET and 11,12-DHET.  The authors conclude that EETs and DHETs potently dilate canine coronary arterioles via activation of KCa channels.  The preferential ability of these compds. to dilate resistance blood vessels suggests that they may be important regulators of coronary circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwoTXKoRAb7Vg90H21EOLACvtfcHk0lgwcJpjlZ8hTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1yjurY%253D&md5=8f503829c63281cfbf790865bc2171a6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1161%2F01.RES.83.9.932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.83.9.932%26sid%3Dliteratum%253Aachs%26aulast%3DOltman%26aufirst%3DC.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DDellsperger%26aufirst%3DK.%2BC.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520and%2520dihydroxyeicosatrienoic%2520acids%2520are%2520potent%2520vasodilators%2520in%2520the%2520canine%2520coronary%2520microcirculation%26jtitle%3DCirc.%2520Res.%26date%3D1998%26volume%3D83%26spage%3D932%26epage%3D939%26doi%3D10.1161%2F01.RES.83.9.932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Epoxy-oxylipins and soluble epoxide hydrolase metabolic pathway as targets for NSAID-induced gastroenteropathy and inflammation-associated carcinogenesis</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">731</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31293429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt12itrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=731&author=R.+D.+Jonesauthor=J.+Liaoauthor=X.+Tongauthor=D.+D.+Xuauthor=L.+Y.+Sunauthor=H.+N.+Liauthor=G.+Y.+Yang&title=Epoxy-oxylipins+and+soluble+epoxide+hydrolase+metabolic+pathway+as+targets+for+NSAID-induced+gastroenteropathy+and+inflammation-associated+carcinogenesis&doi=10.3389%2Ffphar.2019.00731"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxy-oxylipins and soluble epoxide hydrolase metabolic pathway as targets for NSAID-induced gastroenteropathy and inflammation-associated carcinogenesis</span></div><div class="casAuthors">Jones, Ryan D.; Liao, Jie; Tong, Xin; Xu, Dandan; Sun, Leyu; Li, Haonan; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">731</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Polyunsatd. fatty acids (PUFAs) including epoxide-modified ω-3 and ω-6 fatty acids are made via oxidn. to create highly polarized carbon-oxygen bonds crucial to their function as signaling mols.  A crit. PUFA, arachidonic acid (ARA), is metabolized to a diverse set of lipids signaling mols. through cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P 450 epoxygenase, or cytochrome P 450 hydroxylase; however, the majority of ARA is metabolized into anti-inflammatory epoxides via cytochrome P 450 enzymes.  These short-lived epoxide lipids are rapidly metabolized or inactivated by the sol. epoxide hydrolase (sEH) into diol-contg. products. sEH inhibition or knockout has been a practical approach to study the biol. of the epoxide lipids, and has been shown to effectively treat inflammatory conditions in the preclin. models including gastrointestinal ulcers and colitis by shifting oxylipins to epoxide profiles, inhibiting inflammatory cell infiltration and activation, and enhancing epithelial cell defense via increased mucin prodn., thus providing further evidence for the role of sEH as a pro-inflammatory protein.  Non-steroidal anti-inflammatory drugs (NSAIDs) with COXinhibitor activity are among the most commonly used analgesics and have demonstrated applications in the management of cardiovascular disease and intriguingly cancer.  Major side effects of NSAIDs however are gastrointestinal ulcers which frequently precludes their long-term application.  In this review, we hope to bridge the gap between NSAID toxicity and sEH-mediated metabolic pathways to focus on the role of epoxy fatty acid metabolic pathway of PUFAs in NSAIDS-ulcer formation and healing as well as inflammation-related carcinogenesis.  Specifically we address the potential application of sEH inhibition to enhance ulcer healing at the site of inflammation via their activity on altered lipid signaling, mitochondrial function, and diminished reactive oxygen species, and further discuss the significance of dual COX and sEH inhibitor in anti-inflammation and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdoAHzK6S3yrVg90H21EOLACvtfcHk0lgwcJpjlZ8hTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt12itrY%253D&md5=dd7d06befee0bdf3f4d0d192035ed3f4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00731%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DD.%2BD.%26aulast%3DSun%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DH.%2BN.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DEpoxy-oxylipins%2520and%2520soluble%2520epoxide%2520hydrolase%2520metabolic%2520pathway%2520as%2520targets%2520for%2520NSAID-induced%2520gastroenteropathy%2520and%2520inflammation-associated%2520carcinogenesis%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D731%26doi%3D10.3389%2Ffphar.2019.00731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase: gene structure, expression and deletion</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.gene.2013.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23701967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVahtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2013&pages=61-74&author=T.+R.+Harrisauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase%3A+gene+structure%2C+expression+and+deletion&doi=10.1016%2Fj.gene.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase: Gene structure, expression and deletion</span></div><div class="casAuthors">Harris, Todd R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-74</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mammalian sol. epoxide hydrolase (sEH) converts epoxides to their corresponding diols through the addn. of a water mol. sEH readily hydrolyzes lipid signaling mols., including the epoxyeicosatrienoic acids (EETs), epoxidized lipids produced from arachidonic acid by the action of cytochrome p450s.  Through its metab. of the EETs and other lipid mediators, sEH contributes to the regulation of vascular tone, nociception, angiogenesis and the inflammatory response.  Because of its central physiol. role in disease states such as cardiac hypertrophy, diabetes, hypertension, and pain sEH is being investigated as a therapeutic target.  This review begins with a brief introduction to sEH protein structure and function. sEH evolution and gene structure are then discussed before human small nucleotide polymorphisms and mammalian gene expression are described in the context of several disease models.  The review ends with an overview of studies that have employed the sEH knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0pHtaHhQB7Vg90H21EOLACvtfcHk0lgwcJpjlZ8hTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVahtbo%253D&md5=a62cfc7c361b9515e618d5ba8dd31a61</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%253A%2520gene%2520structure%252C%2520expression%2520and%2520deletion%26jtitle%3DGene%26date%3D2013%26volume%3D526%26spage%3D61%26epage%3D74%26doi%3D10.1016%2Fj.gene.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pharmthera.2017.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28642117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyntLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2017&pages=62-76&author=K.+M.+Wagnerauthor=C.+B.+McReynoldsauthor=W.+K.+Schmidtauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+as+a+therapeutic+target+for+pain%2C+inflammatory+and+neurodegenerative+diseases&doi=10.1016%2Fj.pharmthera.2017.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases</span></div><div class="casAuthors">Wagner, Karen M.; McReynolds, Cindy B.; Schmidt, William K.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-76</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Eicosanoids are biol. active lipid signaling mols. derived from polyunsatd. fatty acids.  Many of the actions of eicosanoid metabolites formed by cyclooxygenase and lipoxygenase enzymes have been characterized, however, the epoxy-fatty acids (EpFAs) formed by cytochrome P 450 enzymes are newly described by comparison.  The EpFA metabolites modulate a diverse set of physiol. functions that include inflammation and nociception among others.  Regulation of EpFAs occurs primarily via release, biosynthesis and enzymic transformation by the sol. epoxide hydrolase (sEH).  Targeting sEH with small mol. inhibitors has enabled observation of the biol. activity of the EpFAs in vivo in animal models, greatly contributing to the overall understanding of their role in the inflammatory response.  Their role in modulating inflammation has been demonstrated in disease models including cardiovascular pathol. and inflammatory pain, but extends to neuroinflammation and neuroinflammatory disease.  Moreover, while EpFAs demonstrate activity against inflammatory pain, interestingly, this action extends to blocking chronic neuropathic pain as well.  This review outlines the role of modulating sEH and the biol. action of EpFAs in models of pain and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpflNfJFI-LVg90H21EOLACvtfcHk0liSHOWowdt1WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyntLzN&md5=cce7ef34908084360e85c153a0c428ee</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DMcReynolds%26aufirst%3DC.%2BB.%26aulast%3DSchmidt%26aufirst%3DW.%2BK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520as%2520a%2520therapeutic%2520target%2520for%2520pain%252C%2520inflammatory%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D180%26spage%3D62%26epage%3D76%26doi%3D10.1016%2Fj.pharmthera.2017.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.484804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1517%2F13543776.2010.484804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20429668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=941-956&author=H.+C.+Shen&title=Soluble+epoxide+hydrolase+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2010.484804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors: a patent review</span></div><div class="casAuthors">Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-956</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Sol. epoxide hydrolase (sEH) inhibitors have been shown to effectively increase the levels of epoxyeicosatrienoic acids and reduce the levels of dihydroxyeicosatrienoic acids, which may be translated to therapeutic potentials for multiple disease indications.  It has been claimed that sEH inhibitors can be used to treat hypertension, diabetes, stroke, dyslipidemia, pain, immunol. disorders, eye diseases, neurol. diseases and other indications.Areas covered in this review: A comprehensive synopsis of patent literature on sEH inhibitors is provided.What the reader will gain: A total of more than 100 patent publications describing multiple classes of sEH inhibitors are analyzed.  These include amides, ureas, thioamides, thioureas, carbamates, acyl hydrazones, chalcone oxdies, etc.  In addn. to selected in vitro and in vivo data of representative sEH inhibitors, a wide range of proposed applications of sEH inhibitors are also summarized.Take home message: Several sEH inhibitors with potent in vitro and in vivo target inhibition appear promising, including one Phase II clin. candidate.  The clin. evaluation will be crit. to assess the proclaimed therapeutic utility of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWIUYe5yHfVLVg90H21EOLACvtfcHk0liSHOWowdt1WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVyjurs%253D&md5=01f393eb892f762b0fc1abf6fb26d829</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.484804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.484804%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D941%26epage%3D956%26doi%3D10.1517%2F13543776.2010.484804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Chalcone oxides - potent selective inhibitors of cytosolic epoxide hydrolase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(82)90231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0003-9861%2882%2990231-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7114846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL38XktlGht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=423-439&author=C.+A.+Mullinauthor=B.+D.+Hammock&title=Chalcone+oxides+-+potent+selective+inhibitors+of+cytosolic+epoxide+hydrolase&doi=10.1016%2F0003-9861%2882%2990231-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone oxides - potent selective inhibitors of cytosolic epoxide hydrolase</span></div><div class="casAuthors">Mullin, Christopher A.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-39</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The systematic screening of >150 compds. for inhibitory activity on mammalian cytosolic epoxide hydrolase (I) led to identification of chalcone oxide (trans-1-benzoyl-2-phenyloxirane) as an optimal inhibitory structure.  Important structural features for inhibition include 2 hydrophobic moieties preferably orientating in a trans manner from an electrophilic center such as an activated olefin or epoxide, with the epoxide giving max. activity.  Synthesis of chalcone oxide derivs. bearing a single p-substituent on either Ph ring has led to very potent inhibitors of the enzyme, the best being 4-phenylchalcone oxide (50% inhibition at 6.4 × 10-8M).  Multiple factorial anal. on the inhibition data for the 2 series of chalcone oxides prepd. (Ph or Bz substituted) revealed both the essentiality of hydrophobic interactions and the apparent nonequivalence of the 2 hydrophobic sites involved in the inhibitory process.  Steric factors were considerably less crucial, whereas electronic effects were unimportant in the compds. examd.  The chalcone oxides were either inactive or only weak inhibitors of the other major epoxide-metabolizing enzymes in mouse liver, cytosolic glutathione S-transferase and microsomal I.  The nature of the inhibition of cytosolic I by chalcone oxides was further investigated through steady-state kinetic anal. and the use of amino acid modifiers.  Chalcone oxides give a slowly reversible mixed-noncompetitive inhibition.  They may interact covalently with a cysteine residue possibly essential to the catalytic action of cytosolic I and may indeed be alternative substrates with very low turnover.  The cytosolic and microsomal I activities can be clearly distinguished by these inhibitors, further indicating different catalytic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquT5U7DvCzzLVg90H21EOLACvtfcHk0lj66Bnx9hT9KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktlGht70%253D&md5=88b432a3e831403e676c199e4f6ba0bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2882%2990231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252882%252990231-4%26sid%3Dliteratum%253Aachs%26aulast%3DMullin%26aufirst%3DC.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DChalcone%2520oxides%2520-%2520potent%2520selective%2520inhibitors%2520of%2520cytosolic%2520epoxide%2520hydrolase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1982%26volume%3D216%26spage%3D423%26epage%3D439%26doi%3D10.1016%2F0003-9861%2882%2990231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8854</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.16.8849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.96.16.8849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10430859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8849-8854&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=D.+Dowdyauthor=J.+Zhengauthor=J.+F.+Greeneauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=Potent+urea+and+carbamate+inhibitors+of+soluble+epoxide+hydrolases&doi=10.1073%2Fpnas.96.16.8849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Dowdy, Deanna; Zheng, Jiang; Greene, Jessica F.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8849-8854</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations.  Herein, the authors report the discovery of substituted ureas and carbamates as potent inhibitors of sEH.  Some of these selective, competitive tight-binding inhibitors with nanomolar Ki values interacted stoichiometrically with the homogeneous recombinant murine and human sEHs.  These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol.  They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome.  These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chem. mediation in vitro or in vivo systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOIwuI01SYLVg90H21EOLACvtfcHk0lj66Bnx9hT9KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D&md5=eeff85f27c1a33e2da6fb7f8f2ae91de</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.16.8849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.16.8849%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DDowdy%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520urea%2520and%2520carbamate%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8849%26epage%3D8854%26doi%3D10.1073%2Fpnas.96.16.8849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galop, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurali, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnette, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth-Genthe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> characterization of a novel soluble epoxide hydrolase inhibitor</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104-105</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23434473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104-105&publication_year=2013&pages=25-31&author=P.+L.+Podolinauthor=B.+J.+Bologneseauthor=J.+F.+Foleyauthor=E.+Longauthor=B.+Peckauthor=S.+Umbrechtauthor=X.+Zhangauthor=P.+Zhuauthor=B.+Schwartzauthor=W.+Xieauthor=C.+Quinnauthor=H.+Qiauthor=S.+Sweitzerauthor=S.+Chenauthor=M.+Galopauthor=Y.+Dingauthor=S.+L.+Belyanskayaauthor=D.+I.+Israelauthor=B.+A.+Morganauthor=D.+J.+Behmauthor=J.+P.+Marinoauthor=E.+Kuraliauthor=M.+S.+Barnetteauthor=R.+J.+Mayerauthor=C.+L.+Booth-Gentheauthor=J.+F.+Callahan&title=In+vitro+and+in+vivo+characterization+of+a+novel+soluble+epoxide+hydrolase+inhibitor&doi=10.1016%2Fj.prostaglandins.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor</span></div><div class="casAuthors">Podolin, Patricia L.; Bolognese, Brian J.; Foley, Joseph F.; Long, Edward; Peck, Brian; Umbrecht, Sandra; Zhang, Xiaojun; Zhu, Penny; Schwartz, Benjamin; Xie, Wensheng; Quinn, Chad; Qi, Hongwei; Sweitzer, Sharon; Chen, Stephanie; Galop, Marc; Ding, Yun; Belyanskaya, Svetlana L.; Israel, David I.; Morgan, Barry A.; Behm, David J.; Marino, Joseph P.; Kurali, Edit; Barnette, Mary S.; Mayer, Ruth J.; Booth-Genthe, Catherine L.; Callahan, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104-105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH, EPHX2) metabolizes eicosanoid epoxides, including epoxyeicosatrienoic acids (EETs) to the corresponding dihydroxyeicosatrienoic acids (DHETs), and leukotoxin (LTX) to leukotoxin diol (LTX diol).  EETs, endothelium-derived hyperpolarizing factors, exhibit potentially beneficial properties, including anti-inflammatory effects and vasodilation.  A novel, potent, selective inhibitor of recombinant human, rat and mouse sEH, GSK2256294A, exhibited potent cell-based activity, a concn.-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET in human, rat and mouse whole blood in vitro, and a dose-dependent increase in the LTX/LTX diol ratio in rat plasma following oral administration.  Mice receiving 10 days of cigarette smoke exposure concomitant with oral administration of GSK2256294A exhibited significant, dose-dependent redns. in pulmonary leukocytes and keratinocyte chemoattractant (KC, CXCL1) levels.  Mice receiving oral administration of GSK2256294A following 10 days of cigarette smoke exposure exhibited significant redns. in pulmonary leukocytes compared to vehicle-treated mice.  These data indicate that GSK2256294A attenuates cigarette smoke-induced inflammation by both inhibiting its initiation and/or maintenance and promoting its resoln.  Collectively, these data indicate that GSK2256294A would be an appropriate agent to evaluate the role of sEH in clin. studies, for example in diseases where cigarette smoke is a risk factor, such as chronic obstructive pulmonary disease (COPD) and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXL0W8Yob67Vg90H21EOLACvtfcHk0lh0EZLIVLxb7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFCgu7s%253D&md5=e7842bc2d88795ef4a7fae1b0988454b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DFoley%26aufirst%3DJ.%2BF.%26aulast%3DLong%26aufirst%3DE.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGalop%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DKurali%26aufirst%3DE.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520a%2520novel%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D104-105%26spage%3D25%26epage%3D31%26doi%3D10.1016%2Fj.prostaglandins.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinchenkova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnyukova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhurilo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihalainen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auriola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leppanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoryelov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dar’in, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasavin, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2018.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30059891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=655-667&author=A.+Lukinauthor=J.+Kramerauthor=M.+Hartmannauthor=L.+Weizelauthor=V.+Hernandez-Olmosauthor=K.+Falahatiauthor=I.+Burghardtauthor=N.+Kalinchenkovaauthor=D.+Bagnyukovaauthor=N.+Zhuriloauthor=J.+Rautioauthor=M.+Forsbergauthor=J.+Ihalainenauthor=S.+Auriolaauthor=J.+Leppanenauthor=I.+Konstantinovauthor=D.+Pogoryelovauthor=E.+Proschakauthor=D.+Dar%E2%80%99inauthor=M.+Krasavin&title=Discovery+of+polar+spirocyclic+orally+bioavailable+urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bioorg.2018.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Lukin, Alexey; Kramer, Jan; Hartmann, Markus; Weizel, Lilia; Hernandez-Olmos, Victor; Falahati, Konstantin; Burghardt, Irene; Kalinchenkova, Natalia; Bagnyukova, Darya; Zhurilo, Nikolay; Rautio, Jarkko; Forsberg, Markus; Ihalainen, Jouni; Auriola, Seppo; Leppanen, Jukka; Konstantinov, Igor; Pogoryelov, Denys; Proschak, Ewgenij; Dar'in, Dmitry; Krasavin, Mikhail</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">655-667</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Spirocyclic 1-oxa-9-azaspiro[5.5]undecan-4-amine scaffold was explored as a basis for the design of potential inhibitors of sol. epoxide hydrolase (sEH).  Synthesis and testing of the initial SAR-probing library followed by biochem. testing against sEH allowed nominating a racemic lead compd. (±)-22.  The latter showed remarkable (> 0.5 mM) soly. in aq. phosphate buffer soln., unusually low (for sEH inhibitors) lipophilicity as confirmed by exptl. detd. logD7.4 of 0.99, and an excellent oral bioavailability in mice (as well as other pharmacokinetic characteristics).  Individual enantiomer profiling revealed that the inhibitory potency primarily resided with the dextrorotatory eutomer (+)-22 (IC50 4.9 ± 0.18 nM).  For the latter, a crystal structure of its complex with a C-terminal domain of sEH was obtained and resolved.  These data fully validate (+)-22 as a new non-racemic advanced lead compd. for further development as a potential therapeutic agent for use in such areas as cardiovascular disease, inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGfaRrJqIhJLVg90H21EOLACvtfcHk0lh0EZLIVLxb7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtL%252FP&md5=25e30e957e043e65cdc9463bbf2328f0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DLukin%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DFalahati%26aufirst%3DK.%26aulast%3DBurghardt%26aufirst%3DI.%26aulast%3DKalinchenkova%26aufirst%3DN.%26aulast%3DBagnyukova%26aufirst%3DD.%26aulast%3DZhurilo%26aufirst%3DN.%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DIhalainen%26aufirst%3DJ.%26aulast%3DAuriola%26aufirst%3DS.%26aulast%3DLeppanen%26aufirst%3DJ.%26aulast%3DKonstantinov%26aufirst%3DI.%26aulast%3DPogoryelov%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DDar%25E2%2580%2599in%26aufirst%3DD.%26aulast%3DKrasavin%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520polar%2520spirocyclic%2520orally%2520bioavailable%2520urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D80%26spage%3D655%26epage%3D667%26doi%3D10.1016%2Fj.bioorg.2018.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engler, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1161/01.RES.87.11.992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.87.11.992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11090543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslygsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2000&pages=992-998&author=Z.+Yuauthor=F.+Xuauthor=L.+M.+Huseauthor=C.+Morisseauauthor=A.+J.+Draperauthor=J.+W.+Newmanauthor=C.+Parkerauthor=L.+Grahamauthor=M.+M.+Englerauthor=B.+D.+Hammockauthor=D.+C.+Zeldinauthor=D.+L.+Kroetz&title=Soluble+epoxide+hydrolase+regulates+hydrolysis+of+vasoactive+epoxyeicosatrienoic+acids&doi=10.1161%2F01.RES.87.11.992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids</span></div><div class="casAuthors">Yu, Zhigang; Xu, Fengyun; Huse, Linn M.; Morisseau, Christophe; Draper, Alison J.; Newman, John W.; Parker, Carol; Graham, LeRae; Engler, Marguerite M.; Hammock, Bruce D.; Zeldin, Darryl C.; Kroetz, Deanna L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">992-998</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The cytochrome P 450-derived epoxyeicosatrienoic acids (EETs) have potent effects on renal vascular reactivity and tubular sodium and water transport; however, the role of these eicosanoids in the pathogenesis of hypertension is controversial.  The current study examd. the hydrolysis of the EETs to the corresponding dihydroxyeicosatrienoic acids (DHETs) as a mechanism for regulation of EET activity and blood pressure.  EET hydrolysis was increased 5- to 54-fold in renal cortical S9 fractions from the spontaneously hypertensive rat (SHR) relative to the normotensive Wistar-Kyoto (WKY) rat.  This increase was most significant for the 14,15-EET regioisomer, and there was a clear preference for hydrolysis of 14,15-EET over the 8,9- and 11,12-EETs.  Increased EET hydrolysis was consistent with increased expression of sol. epoxide hydrolase (sEH) in the SHR renal microsomes and cytosol relative to the WKY samples.  The urinary excretion of 14,15-DHET was 2.6-fold higher in the SHR than in the WKY rat, confirming increased EET hydrolysis in the SHR in vivo.  Blood pressure was decreased 22 mm Hg 6 h after treatment of SHRs with the selective sEH inhibitor N,N'-dicyclohexylurea; this treatment had no effect on blood pressure in the WKY rat.  These studies identify sEH as a novel therapeutic target for control of blood pressure.  The identification of a potent and selective inhibitor of EET hydrolysis will be invaluable in sepg. the vascular effects of the EET and DHET eicosanoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhSHVOsx5QLVg90H21EOLACvtfcHk0li4lNkpUr7KAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslygsb8%253D&md5=ac79e222d25f48bbb570f6fe1b092f6a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1161%2F01.RES.87.11.992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.87.11.992%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DHuse%26aufirst%3DL.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DDraper%26aufirst%3DA.%2BJ.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DL.%26aulast%3DEngler%26aufirst%3DM.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520regulates%2520hydrolysis%2520of%2520vasoactive%2520epoxyeicosatrienoic%2520acids%26jtitle%3DCirc.%2520Res.%26date%3D2000%26volume%3D87%26spage%3D992%26epage%3D998%26doi%3D10.1161%2F01.RES.87.11.992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesch, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">14867</span>– <span class="NLM_lpage">14874</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011761200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M011761200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11278979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Orsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14867-14874&author=X.+Fangauthor=T.+L.+Kaduceauthor=N.+L.+Weintraubauthor=S.+Harmonauthor=L.+M.+Teeschauthor=C.+Morisseauauthor=D.+A.+Thompsonauthor=B.+D.+Hammockauthor=A.+A.+Spector&title=Pathways+of+epoxyeicosatrienoic+acid+metabolism+in+endothelial+cells.+Implications+for+the+vascular+effects+of+soluble+epoxide+hydrolase+inhibition&doi=10.1074%2Fjbc.M011761200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Fang, Xiang; Kaduce, Terry L.; Weintraub, Neal L.; Harmon, Shawn; Teesch, Lynn M.; Morisseau, Christophe; Thompson, David A.; Hammock, Bruce D.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">14867-14874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 epoxygenase that possess important vasodilating and anti-inflammatory properties.  EETs are converted to the corresponding dihydroxyeicosatrienoic acid (DHET) by sol. epoxide hydrolase (sEH) in mammalian tissues, and inhibition of sEH has been proposed as a novel approach for the treatment of hypertension.  The authors obsd. that sEH is present in porcine coronary endothelial cells (PCEC), and the authors found that low concns. of N,N'-dicyclohexylurea (DCU), a selective sEH inhibitor, have profound effects on EET metab. in PCEC cultures.  Treatment with 3 μM DCU reduced cellular conversion of 14,15-EET to 14,15-DHET by 3-fold after 4 h of incubation, with a concomitant increase in the formation of the novel β-oxidn. products 10,11-epoxy-16:2 and 8,9-epoxy-14:1.  DCU also markedly enhanced the incorporation of 14,15-EET and its metabolites into PCEC lipids.  The most abundant product in DCU-treated cells was 16,17-epoxy-22:3, the elongation product of 14,15-EET.  Another novel metabolite, 14,15-epoxy-20:2, was present in DCU-treated cells.  DCU also caused a 4-fold increase in release of 14,15-EET when the cells were stimulated with a calcium ionophore.  Furthermore, DCU decreased the conversion of [3H]11,12-EET to 11,12-DHET, increased 11,12-EET retention in PCEC lipids, and produced an accumulation of the partial β-oxidn. product 7,8-epoxy-16:2 in the medium.  These findings suggest that in addn. to being metabolized by sEH, EETs are substrates for β-oxidn. and chain elongation in endothelial cells and that there is considerable interaction among the three pathways.  The modulation of EET metab. by DCU provides novel insight into the mechanisms by which pharmacol. or mol. inhibition of sEH effectively treats hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH3CDy6ke5rVg90H21EOLACvtfcHk0li4lNkpUr7KAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Orsr8%253D&md5=23bcc4a615dc8806daa70ade0b6cbbf4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011761200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011761200%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DTeesch%26aufirst%3DL.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DPathways%2520of%2520epoxyeicosatrienoic%2520acid%2520metabolism%2520in%2520endothelial%2520cells.%2520Implications%2520for%2520the%2520vascular%2520effects%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14867%26epage%3D14874%26doi%3D10.1074%2Fjbc.M011761200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1110/ps.051720206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1110%2Fps.051720206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16322563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=58-64&author=G.+A.+Gomezauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Christianson&title=Human+soluble+epoxide+hydrolase%3A+structural+basis+of+inhibition+by+4-%283-cyclohexylureido%29-carboxylic+acids&doi=10.1110%2Fps.051720206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span></div><div class="casAuthors">Gomez, German A.; Morisseau, Christophe; Hammock, Bruce D.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">X-ray crystal structures of human sol. epoxide hydrolase (sEH) complexed with four different dialkylurea inhibitors bearing pendant carboxylate "tails" of varying length have been detd. at 2.3-3.0 Å resoln.  Similarities among inhibitor binding modes reinforce the proposed roles of Y381 and/or Y465 as general acids that protonate the epoxide ring of the substrate in concert with nucleophilic attack of D333 at the electrophilic epoxide carbon.  Addnl., the binding of these inhibitors allows us to model the binding mode of the endogenous substrate 14,15-epoxyeicosatrienoic acid.  Contrasts among inhibitor binding modes include opposite orientations of inhibitor binding in the active-site hydrophobic tunnel.  Alternative binding orientations obsd. for this series of inhibitors to human sEH, as well as the binding of certain dialkylurea inhibitors to human sEH and murine sEH, complicate the structure-based design of human sEH inhibitors with potential pharmaceutical applications in the treatment of hypertension.  Thus, with regard to the optimization of inhibitor designs targeting human sEH, it is crit. that human sEH and not murine sEH be utilized for inhibitor screening, and it is crit. that structures of human sEH-inhibitor complexes be detd. to verify inhibitor binding orientations that correlate with measured affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrqO7mSzRPrVg90H21EOLACvtfcHk0lj3cr44uC9TrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D&md5=b16bb0c99a177acc885cbbb789374f2b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1110%2Fps.051720206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.051720206%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DG.%2BA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHuman%2520soluble%2520epoxide%2520hydrolase%253A%2520structural%2520basis%2520of%2520inhibition%2520by%25204-%25283-cyclohexylureido%2529-carboxylic%2520acids%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D58%26epage%3D64%26doi%3D10.1110%2Fps.051720206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1021/jm030514j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030514j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2110-2122&author=I.+H.+Kimauthor=C.+Morisseauauthor=T.+Watanabeauthor=B.+D.+Hammock&title=Design%2C+synthesis%2C+and+biological+activity+of+1%2C3-disubstituted+ureas+as+potent+inhibitors+of+the+soluble+epoxide+hydrolase+of+increased+water+solubility&doi=10.1021%2Fjm030514j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of 1,3-Disubstituted Ureas as Potent Inhibitors of the Soluble Epoxide Hydrolase of Increased Water Solubility</span></div><div class="casAuthors">Kim, In-Hae; Morisseau, Christophe; Watanabe, Takaho; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2110-2122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of endogenous chem. mediators that play an important role in blood pressure regulation and inflammation.  1,3-Disubstituted ureas are potent inhibitors of sEH that are active both in vitro and in vivo.  However, their poor soly. in either water or lipid reduces their in vivo efficacy and makes them difficult to formulate.  To improve these phys. properties, the effect of incorporating polar functional groups into one of the alkyl chains was evaluated on their inhibitor potencies, water soly., octanol/water partition coeffs. (log P), and m.ps.  No loss of inhibition potency was obsd. when a polar functional group was incorporated at least five atoms (∼7.5 Å) from the central urea carbonyl.  In addn., the presence of a polar group at least 11 atoms away from the urea carbonyl group for the mouse and human sEHs, resp., did not alter the inhibitor potency.  The resulting compds. have better water soly. and generally lower log P values and m.ps. than nonfunctionalized lipophilic ureas.  These properties will make the compds. more bioavailable and more sol. in either water- or oil-based formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDG4_y35pKLVg90H21EOLACvtfcHk0lj3cr44uC9TrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qtrs%253D&md5=d80753310c34a3374ad7e6c61e721e19</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm030514j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030514j%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%25201%252C3-disubstituted%2520ureas%2520as%2520potent%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%2520of%2520increased%2520water%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2110%26epage%3D2122%26doi%3D10.1021%2Fjm030514j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural refinement of inhibitors of urea-based souble epoxide hydrolases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(02)00952-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0006-2952%2802%2900952-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12007563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=1599-1608&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=J.+W.+Newmanauthor=C.+E.+Wheelockauthor=D.+L.+Dowdyauthor=B.+D.+Hammock&title=Structural+refinement+of+inhibitors+of+urea-based+souble+epoxide+hydrolases&doi=10.1016%2FS0006-2952%2802%2900952-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Newman, John W.; Wheelock, Craig E.; Dowdy, Deanna L.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1599-1608</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of arachidonic, linoleic, and other fatty acid epoxides, endogenous chem. mediators that play an important role in blood pressure regulation and inflammation. 1,3-Disubstituted ureas, carbamates, and amides are new potent and stable inhibitors of sEH.  However, the poor soly. of the lead compds. limits their use.  Inhibitor structure-activity relationships were investigated to better define the structural requirements for inhibition and to identify points in the mol. topog. that could accept polar groups without diminishing inhibition potency.  Results indicate that lipophilicity is an important factor controlling inhibitor potency.  Polar groups could be incorporated into one of the alkyl groups without loss of activity if they were placed at a sufficient distance from the urea function.  The resulting compds. had a 2-fold higher water soly.  These findings will facilitate the rational design and optimization of sEH inhibitors with better phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZUVkekez5rVg90H21EOLACvtfcHk0lgbrzKWkpv2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D&md5=9d9aa4d7254d7fe156719d17fb80e0ad</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2900952-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252900952-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DDowdy%26aufirst%3DD.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520refinement%2520of%2520inhibitors%2520of%2520urea-based%2520souble%2520epoxide%2520hydrolases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D1599%26epage%3D1608%26doi%3D10.1016%2FS0006-2952%2802%2900952-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1161/hy0202.103788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2Fhy0202.103788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11882632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1WqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=690-694&author=J.+D.+Imigauthor=X.+Zhaoauthor=J.+H.+Capdevilaauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+lowers+arterial+blood+pressure+in+angiotensin+II+hypertension&doi=10.1161%2Fhy0202.103788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension</span></div><div class="casAuthors">Imig, John D.; Zhao, Xueying; Capdevila, Jorge H.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">690-694</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) have antihypertensive properties and play a part in the maintenance of renal microvascular function.  A novel approach to increase EET levels is to inhibit epoxide hydrolase enzymes that are responsible for conversion of biol. active EETs to dihydroxyeicosatrienoic acids (DHETs) that are void of effects on the preglomerular vasculature.  We hypothesized that inhibition of sol. epoxide hydrolase (sEH) would lower blood pressure in angiotensin II (Ang II) hypertension.  Rat renal cortical tissue was harvested and urine collected 2 wk following implantation of an osmotic minipump contg. Ang II (60 ng/min).  Renal cortical sEH protein expression was significantly higher in Ang II hypertension compared with normotensive animals.  Likewise, urinary 14,15-DHET levels were significantly increased in hypertensive compared with normotensive animals and averaged 8.1±1.3 and 2.7±1.1 ng/d; resp.  In addnl. expts., the sEH inhibitor N-cyclohexyl-N-dodecyl urea (NCND; 3 mg/d) or vehicle (corn oil, 0.5 mL) was administered daily by i.p. injection starting on day 10.  Administration of NCND for 4 days lowered systolic blood pressure by 30 mm Hg in Ang II hypertensive animals, whereas the corn oil vehicle had no effect on blood pressure in normotensive or Ang II hypertensive animals.  Measurement of blood pressure by indwelling arterial catheters in conscious animals with free movement in their cages confirmed that NCND had antihypertensive properties.  Arterial blood pressure averaged 119±5 mm Hg in normotensive, 170±3 mm Hg in hypertensive and 149±10 mm Hg in NCND-treated, Ang II-infused animals.  Administration of the potential metabolite of NCND, N-cyclohexylformamide to Ang II hypertensive rats did not lower the systolic blood pressure.  These studies demonstrate that increased sEH expression in the Ang II hypertensive kidney leads to increased EET hydration.  Moreover, sEH plays a role in the regulation of blood pressure, and inhibition of sEH during Ang II hypertension is antihypertensive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou360SDFrqPrVg90H21EOLACvtfcHk0lgbrzKWkpv2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1WqurY%253D&md5=859488f03618128f22a259863526f658</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1161%2Fhy0202.103788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhy0202.103788%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520lowers%2520arterial%2520blood%2520pressure%2520in%2520angiotensin%2520II%2520hypertension%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3D690%26epage%3D694%26doi%3D10.1161%2Fhy0202.103788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honetschlagerova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporkova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopkan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huskova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kujal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernerova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabova, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervenka, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats</span>. <i>J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1601</span>, <span class="refDoi"> DOI: 10.1097/HJH.0b013e328349062f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1097%2FHJH.0b013e328349062f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21720266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1590-1601&author=Z.+Honetschlagerovaauthor=A.+Sporkovaauthor=L.+Kopkanauthor=Z.+Huskovaauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=J.+D.+Imigauthor=H.+J.+Kramerauthor=P.+Kujalauthor=Z.+Vernerovaauthor=V.+C.+Chabovaauthor=V.+Tesarauthor=L.+Cervenka&title=Inhibition+of+soluble+epoxide+hydrolase+improves+the+impaired+pressure-natriuresis+relationship+and+attenuates+the+development+of+hypertension+and+hypertension-associated+end-organ+damage+in+Cyp1a1-Ren-2+transgenic+rats&doi=10.1097%2FHJH.0b013e328349062f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats</span></div><div class="casAuthors">Honetschlagerova, Zuzana; Sporkova, Alexandra; Kopkan, Libor; Huskova, Zuzana; Hwang, Sung H.; Hammock, Bruce D.; Imig, John D.; Kramer, Herbert J.; Kujal, Petr; Vernerova, Zdenka; Chabova, Vera C.; Tesar, Vladimir; Cervenka, Ludek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1590-1601</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: In the present study, we compared the effects of treatment with the novel sol. epoxide hydrolase (sEH) inhibitor (c-AUCB) with those of the AT1 receptor antagonist losartan on blood pressure (BP), autoregulation of renal blood flow (RBF) and on glomerular filtration rate (GFR) and the pressure-natriuresis relationship in response to stepwise redn. in renal arterial pressure (RAP) in Cyp1a1-Ren-2 transgenic rats.  Methods: Hypertension was induced in Cyp1a1-Ren-2 rats through dietary administration for 11 days of the natural xenobiotic indole-3-carbinol (I3C) which activates the renin gene.  Treatment with c-AUCB and losartan was started 48 h before initiating administration of the diet contg. I3C.  Rats were prepd. for renal functional studies to evaluate in-vivo renal autoregulatory efficiency when RAP was gradually decreased by an aortic clamp.  Results: I3C administration resulted in the development of severe hypertension which was assocd. with markedly lower basal RBF and GFR and substantially impaired autoregulatory efficiency as well as a suppression of the pressure-natriuresis relationship when compared with noninduced rats.  Treatment with c-AUCB significantly decreased BP, improved autoregulatory efficiency of RBF and GFR and the slope of pressure-natriuresis relationship.  Treatment with losartan completely prevented the impaired autoregulation and pressure-natriuresis relationship as well as the development of hypertension in I3C-induced rats.  Conclusion: Our present findings indicate that chronic treatment with the sEH inhibitor c-AUCB substantially attenuates the development of malignant hypertension in I3C-induced rats likely via improvement of the renal autoregulatory efficiency and the pressure-natriuresis relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdW_B7qIBQubVg90H21EOLACvtfcHk0lgbrzKWkpv2NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOisbk%253D&md5=7c30f9615c4c4dbebeb321b8a1755d07</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e328349062f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e328349062f%26sid%3Dliteratum%253Aachs%26aulast%3DHonetschlagerova%26aufirst%3DZ.%26aulast%3DSporkova%26aufirst%3DA.%26aulast%3DKopkan%26aufirst%3DL.%26aulast%3DHuskova%26aufirst%3DZ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DKramer%26aufirst%3DH.%2BJ.%26aulast%3DKujal%26aufirst%3DP.%26aulast%3DVernerova%26aufirst%3DZ.%26aulast%3DChabova%26aufirst%3DV.%2BC.%26aulast%3DTesar%26aufirst%3DV.%26aulast%3DCervenka%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520improves%2520the%2520impaired%2520pressure-natriuresis%2520relationship%2520and%2520attenuates%2520the%2520development%2520of%2520hypertension%2520and%2520hypertension-associated%2520end-organ%2520damage%2520in%2520Cyp1a1-Ren-2%2520transgenic%2520rats%26jtitle%3DJ.%2520Hypertens.%26date%3D2011%26volume%3D29%26spage%3D1590%26epage%3D1601%26doi%3D10.1097%2FHJH.0b013e328349062f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nithipatikom, K.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase: a new target for cardioprotection</span>. <i>Curr. Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19333883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=253-258&author=G.+J.+Grossauthor=K.+Nithipatikom&title=Soluble+epoxide+hydrolase%3A+a+new+target+for+cardioprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase: a new target for cardioprotection</span></div><div class="casAuthors">Gross, Garrett J.; Nithipatikom, Kasem</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (BioMed Central)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-258</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">2040-3429</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Arachidonic acid is metabolized to a no. of bioactive eicosanoid mols. by several enzymes, including enzymes of the COX, lipoxygenase and cytochrome P 450 (CYP) monooxygenase pathways.  Inhibition of the CYP ω-hydroxylase pathway, stimulation of the CYP-epoxygenase pathway and administration of exogenous epoxyeicosatrienoic acids resulted in cardioprotection in animal models of ischemia; contractile function was improved in mouse hearts subjected to global ischemia/reperfusion, and infarct size was reduced in canine and rat hearts.  Cardioprotective effects were also achieved when metab. of the endogenous epoxyeicosatrienoic acids (EETs) by their major enzymic hydrolysis pathway was blocked in gene knockout mice (EPHX2-/-) or by inhibitors of sol. epoxide hydrolase (sEH), such as 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA).  Pretreatment of canine hearts with AUDA dose-dependently reduced infarct size, and AUDA enhanced the infarct-sparing effect of treatment with exogenous EETs.  The preliminary results of studies in rodent hearts have also demonstrated that AUDA and AUDA-Bu ester reduce infarct size.  These results and others obtained in models of myocardial stunning and hypertrophy suggest that inhibitors of EPHX2 or sEH have therapeutic potential in a broad range of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-c5zaWj8cOLVg90H21EOLACvtfcHk0liD7de6XjUS2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitbg%253D&md5=53b740a39cd790438f3f8760c4a54bc6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DNithipatikom%26aufirst%3DK.%26atitle%3DSoluble%2520epoxide%2520hydrolase%253A%2520a%2520new%2520target%2520for%2520cardioprotection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D253%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiserich, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase is a therapeutic target for acute inflammation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">9772</span>– <span class="NLM_lpage">9777</span>, <span class="refDoi"> DOI: 10.1073/pnas.0503279102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0503279102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15994227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9772-9777&author=K.+R.+Schmelzerauthor=L.+Kubalaauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=J.+P.+Eiserichauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+is+a+therapeutic+target+for+acute+inflammation&doi=10.1073%2Fpnas.0503279102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase is a therapeutic target for acute inflammation</span></div><div class="casAuthors">Schmelzer, Kara R.; Kubala, Lukas; Newman, John W.; Kim, In-Hae; Eiserich, Jason P.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9772-9777</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">As of 2004, >73 million people were prescribed antiinflammatory medication.  Despite the extensive no. of current products, many people still suffer from their diseases or the pharmacol. properties (side effects) of the medications.  Therefore, developing therapeutic strategies to treat inflammation remains an important endeavor.  Here, we demonstrate that the sol. epoxide hydrolase (sEH) is a key pharmacol. target for treating acute systemic inflammation.  Lipopolysaccharide-induced mortality, systemic hypotension, and histol. evaluated tissue injury were substantially diminished by administration of urea-based, small-mol. inhibitors of sEH to C57BL/6 mice.  Moreover, sEH inhibitors decreased plasma levels of proinflammatory cytokines and nitric oxide metabolites while promoting the formation of lipoxins, thus supporting inflammatory resoln.  These data suggest that sEH inhibitors have therapeutic efficacy in the treatment and management of acute inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-XGKhNB1YLrVg90H21EOLACvtfcHk0liD7de6XjUS2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFartb0%253D&md5=4abeedd569a3d36e20e06bfcc94b6a98</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503279102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503279102%26sid%3Dliteratum%253Aachs%26aulast%3DSchmelzer%26aufirst%3DK.%2BR.%26aulast%3DKubala%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DEiserich%26aufirst%3DJ.%2BP.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520is%2520a%2520therapeutic%2520target%2520for%2520acute%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D9772%26epage%3D9777%26doi%3D10.1073%2Fpnas.0503279102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurs, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1021/jm020269o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020269o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Ont7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1066-1080&author=N.+R.+McElroyauthor=P.+C.+Jursauthor=C.+Morisseauauthor=B.+D.+Hammock&title=QSAR+and+classification+of+murine+and+human+soluble+epoxide+hydrolase+inhibition+by+urea-like+compounds&doi=10.1021%2Fjm020269o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR and Classification of Murine and Human Soluble Epoxide Hydrolase Inhibition by Urea-Like Compounds</span></div><div class="casAuthors">McElroy, Nathan R.; Jurs, Peter C.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A data set of 348 urea-like compds. that inhibit the sol. epoxide hydrolase enzyme in mice and humans is examd.  Compds. having IC50 values ranging from 0.06 to >500 μM (murine) and 0.10 to >500 μM (human) are categorized as active or inactive for classification, while quantitation is performed on smaller compd. subsets ranging from 0.07 to 431 μM (murine) and 0.11 to 490 μM (human).  Each compd. is represented by calcd. structural descriptors that encode topol., geometrical, electronic, and polar surface features.  Multiple linear regression (MLR) and computational neural networks (CNNs) are employed for quant. models.  Three classification algorithms, k-nearest neighbor (kNN), linear discriminant anal. (LDA), and radial basis function neural networks (RBFNN), are used to categorize compds. as active or inactive based on selected data split points.  Quant. modeling of human enzyme inhibition results in a nonlinear, five-descriptor model with root-mean-square errors (log units of IC50 [μM]) of 0.616 (r2 = 0.66), 0.674 (r2 = 0.61), and 0.914 (r2 = 0.33) for training, cross-validation, and prediction sets, resp.  The best classification results for human and murine enzyme inhibition are found using kNN.  Human classification rates using a seven-descriptor model for training and prediction sets are 89.1% and 91.4%, resp.  Murine classification rates using a five-descriptor model for training and prediction sets are 91.5% and 88.6%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLn1CSySMibVg90H21EOLACvtfcHk0lhecJbB-onMLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Ont7Y%253D&md5=c969df03fb82e707476baddd884676c3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm020269o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020269o%26sid%3Dliteratum%253Aachs%26aulast%3DMcElroy%26aufirst%3DN.%2BR.%26aulast%3DJurs%26aufirst%3DP.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DQSAR%2520and%2520classification%2520of%2520murine%2520and%2520human%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520by%2520urea-like%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1066%26epage%3D1080%26doi%3D10.1021%2Fjm020269o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5212</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2006.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16870439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslCnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5212-5216&author=P.+D.+Jonesauthor=H.+J.+Tsaiauthor=Z.+N.+Doauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Synthesis+and+SAR+of+conformationally+restricted+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2006.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Jones, Paul D.; Tsai, Hsing-Ju; Do, Zung N.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5212-5216</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of conformationally restricted inhibitors of human sol. epoxide hydrolase (sEH) was synthesized.  Inhibition potency of the described compds. was studied against recombinant sEH.  N-(1-Acetylpiperidin-4-yl)-N'-(adamant-1-yl) urea (I) was found to be a potent inhibitor that was also orally bioavailable in canines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-6I7WMkpm7Vg90H21EOLACvtfcHk0lhecJbB-onMLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslCnur0%253D&md5=d18b1510f26ea62837a63e93556d20a0</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520conformationally%2520restricted%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5212%26epage%3D5216%26doi%3D10.1016%2Fj.bmcl.2006.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neschen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarioglu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaisbauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span> <span> </span><span class="NLM_article-title">The epoxyeicosatrienoic acid pathway enhances hepatic insulin signaling and is repressed in insulin-resistant mouse liver</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2764</span>– <span class="NLM_lpage">2774</span>, <span class="refDoi"> DOI: 10.1074/mcp.M115.049064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fmcp.M115.049064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26070664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GkurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2764-2774&author=A.+Schaferauthor=S.+Neschenauthor=M.+Kahleauthor=H.+Sariogluauthor=T.+Gaisbauerauthor=A.+Imhofauthor=J.+Adamskiauthor=S.+M.+Hauckauthor=M.+Ueffing&title=The+epoxyeicosatrienoic+acid+pathway+enhances+hepatic+insulin+signaling+and+is+repressed+in+insulin-resistant+mouse+liver&doi=10.1074%2Fmcp.M115.049064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The Epoxyeicosatrienoic Acid Pathway Enhances Hepatic Insulin Signaling and is Repressed in Insulin-Resistant Mouse Liver</span></div><div class="casAuthors">Schafer, Alexander; Neschen, Susanne; Kahle, Melanie; Sarioglu, Hakan; Gaisbauer, Tobias; Imhof, Axel; Adamski, Jerzy; Hauck, Stefanie M.; Ueffing, Marius</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2764-2774</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Here we employed time resolved quant. proteomic profiling of mice fed a high fat diet to det. which pathways were affected during the transition of the liver to an insulin-resistant state.  We identified several metabolic pathways underlying altered protein expression.  In order to test the functional impact of a crit. subset of these alterations, we focused on the epoxyeicosatrienoic acid (EET) eicosanoid pathway, whose deregulation coincided with the onset of hepatic insulin resistance.  These results suggested that EETs may be pos. modulators of hepatic insulin signaling.  Analyzing EET activity in primary hepatocytes, we found that EETs enhance insulin signaling on the level of Akt.  In contrast, EETs did not influence insulin receptor or insulin receptor substrate-1 phosphorylation.  This effect was mediated through the eicosanoids, as overexpression of the deregulated enzymes in absence of arachidonic acid had no impact on insulin signaling.  The stimulation of insulin signaling by EETs and depression of the pathway in insulin resistant liver suggest a likely role in hepatic insulin resistance.  Our findings support therapeutic potential for inhibiting EET degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2OVPK7i_ebVg90H21EOLACvtfcHk0lgDIc12lJDTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GkurzM&md5=7a8ebdf0ecec9f2cb1dcb3d2982d5067</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M115.049064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M115.049064%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DA.%26aulast%3DNeschen%26aufirst%3DS.%26aulast%3DKahle%26aufirst%3DM.%26aulast%3DSarioglu%26aufirst%3DH.%26aulast%3DGaisbauer%26aufirst%3DT.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DAdamski%26aufirst%3DJ.%26aulast%3DHauck%26aufirst%3DS.%2BM.%26aulast%3DUeffing%26aufirst%3DM.%26atitle%3DThe%2520epoxyeicosatrienoic%2520acid%2520pathway%2520enhances%2520hepatic%2520insulin%2520signaling%2520and%2520is%2520repressed%2520in%2520insulin-resistant%2520mouse%2520liver%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2015%26volume%3D14%26spage%3D2764%26epage%3D2774%26doi%3D10.1074%2Fmcp.M115.049064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.+J.+Tsaiauthor=J.+Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0lgDIc12lJDTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors, <i>t</i>-AUCB, downregulated miR-133 in a mouse model of myocardial infarction</span>. <i>Lipids Health Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">129</span>, <span class="refDoi"> DOI: 10.1186/s12944-018-0780-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12944-018-0780-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29843720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=129&author=Y.+Guiauthor=D.+Liauthor=J.+Chenauthor=Y.+Wangauthor=J.+Huauthor=C.+Liaoauthor=L.+Dengauthor=Q.+Xiangauthor=T.+Yangauthor=X.+Duauthor=S.+Zhangauthor=D.+Xu&title=Soluble+epoxide+hydrolase+inhibitors%2C+t-AUCB%2C+downregulated+miR-133+in+a+mouse+model+of+myocardial+infarction&doi=10.1186%2Fs12944-018-0780-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction</span></div><div class="casAuthors">Gui, Yajun; Li, Da; Chen, Jingyuan; Wang, Yating; Hu, Jiahui; Liao, Caixiu; Deng, Limin; Xiang, Qunyan; Yang, Tao; Du, Xiao; Zhang, Shilan; Xu, Danyan</div><div class="citationInfo"><span class="NLM_cas:title">Lipids in Health and Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129/1-129/10</span>CODEN:
                <span class="NLM_cas:coden">LHDIA7</span>;
        ISSN:<span class="NLM_cas:issn">1476-511X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: It has been demonstrated that sol. epoxide hydrolase inhibitors (sEHIs) are protective against ischemia-induced lethal arrhythmias, but the mechanisms involved are unknown.  Previously, we showed that sEHIs might reduce the incidence of ischemic arrhythmias by suppressing microRNA-1 (miR-1) in the myocardium.  As miR-1 and miR-133 have the same proarrhythmic effects in the heart, we assumed that the beneficial effects of sEHIs might also relate to the regulation of miR-133.  Methods: A mouse model of myocardial infarction (MI) was established by ligating the coronary artery.  The sEHI t- AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid) was administered daily for 7 days before MI.  Myocardial infarct size and cardiac function was assessed at 24 h post-MI.  The miRNA expression profiles of sham and MI mice treated with or without t-AUCB were detd. by microarray and verified by real-time PCR.  The incidence of arrhythmias was assessed by in vivo electrophysiol. studies.  The mRNA levels of miR-133, its target genes (KCNQ1 [potassium voltage-gated channel subfamily Q member 1] and KCNH2 [potassium voltage-gated channel subfamily H member 2]), and serum response factor (SRF) were measured by real-time PCR; KCNQ1, KCNH2, and SRF protein levels were assessed by western blotting.  Results: We demonstrated that the treatment with sEHIs could reduce infarct size, improve cardia function, and prevent the development of cardiac arrhythmias in MI mice.  The expression levels of 14 miRNAs differed between the sham and MI groups. t-AUCB treatment altered the expression of eight miRNAs: two were upregulated and six were downregulated.  Of these, the muscle-specific miR-133 was downregulated in the ischemic myocardium.  In line with this, up-regulation of miR-133 and down-regulation of KCNQ1 and KCNH2 mRNA/protein were obsd. in ischemic myocaridum, whereas administration of sEHIs produced an opposite effect.  In addn., miR-133 overexpression inhibited expression of the target mRNA, whereas t-AUCB reversed the effects.  Furthermore, SRF might participate in the neg. regulation of miR-133 by t-AUCB.  Conclusions: In MI mice, sEHI t-AUCB can repress miR-133, consequently stimulating KCNQ1 and KCNH2 mRNA and protein expression, suggesting a possible mechanism for its potential therapeutic application in ischemic arrhythmias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYp18zlN7pVbVg90H21EOLACvtfcHk0lgDIc12lJDTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFKmsrw%253D&md5=aef126bbfe174902a1d5d21b610edf04</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12944-018-0780-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12944-018-0780-y%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%252C%2520t-AUCB%252C%2520downregulated%2520miR-133%2520in%2520a%2520mouse%2520model%2520of%2520myocardial%2520infarction%26jtitle%3DLipids%2520Health%2520Dis.%26date%3D2018%26volume%3D17%26spage%3D129%26doi%3D10.1186%2Fs12944-018-0780-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin sensitizes glioblastoma to <i>t</i>-AUCB by dual inhibition of Hsp27 and COX-2 <i>in vitro</i> and <i>in vivo</i></span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0331-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs13046-016-0331-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27039073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGitL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=61&author=J.+Liauthor=C.+Tangauthor=L.+Liauthor=R.+Liauthor=Y.+Fan&title=Quercetin+sensitizes+glioblastoma+to+t-AUCB+by+dual+inhibition+of+Hsp27+and+COX-2+in+vitro+and+in+vivo&doi=10.1186%2Fs13046-016-0331-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo</span></div><div class="casAuthors">Li, Junyang; Tang, Chao; Li, Liwen; Li, Rujun; Fan, Youwu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/11</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Evidences indicate that inflammatory process plays pivotal role in tumor disease.  Sol. epoxide hydrolase inhibitors (sEHIs) have been shown to participate in anti-inflammation and tumorigenesis by protecting epoxyeicosatrienoic acids (EETs).  Although we have previously revealed some effects of t-AUCB on glioma in vitro, further investigations are needed to demonstrate its effects on glioblastoma growth in vivo and how to strengthen its antitumor effect.  Methods: CCK-8 kit was used to test cell growth.  Cell migration capacity was performed by wound healing assays.  Transwell assay was used to test cell invasion potency.  Cell-cycle anal. and cell apoptosis was performed by flow cytometry.  The activity of caspase-3 in cells was measured using caspase-3 activity assay kits.  Total RNA was extd. from cells lysated by TRIzol reagent. qRT-PCR was performed by ABI 7500 fast RT- PCR system.  Lipofectamine RNAiMAX Transfection Reagent (Invitrogen) was used for siRNA transfection.  Western blotting was used to test protein expression.  Tumor cell xenograft mouse models were used for in vivo study.  The SPSS version 17.0 software was applied for statistical anal.  Results: Our data shown that t-AUCB inhibits cell proliferation, migration and invasion and induces cell cycle G1 phase arrest in vitro but induces no cell apoptosis; increased Hsp27 activation and following COX-2 overexpression confer resistance to t-AUCB treatment in glioblastoma both in vitro and in vivo; quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo.  Conclusions: These results indicate that combination of t-AUCB and quercetin may be a potential approach to treating glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3JNFecgv377Vg90H21EOLACvtfcHk0liZipK1No52DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGitL3J&md5=dcd89a7e2609469dd83718a218d391a7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0331-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0331-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DY.%26atitle%3DQuercetin%2520sensitizes%2520glioblastoma%2520to%2520t-AUCB%2520by%2520dual%2520inhibition%2520of%2520Hsp27%2520and%2520COX-2%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D61%26doi%3D10.1186%2Fs13046-016-0331-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. Y.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, <i>t</i>-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes <i>in vitro</i></span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1515/hsz-2013-0251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1515%2Fhsz-2013-0251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24225128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFOlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2014&pages=443-451&author=L.+Shenauthor=H.+C.+Pengauthor=S.+P.+Zhaoauthor=D.+Y.+Xu&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+modulates+cholesterol+balance+and+oxidized+low+density+lipoprotein+metabolism+in+adipocytes+in+vitro&doi=10.1515%2Fhsz-2013-0251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro</span></div><div class="casAuthors">Shen, Li; Peng, Hongchun; Zhao, Shuiping; Xu, Danyan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">The cholesterol metab. in adipose tissue is dependent on the balance between cholesterol uptake and efflux.  Adipocytes dysfunction and its cholesterol imbalance are assocd. with obesity.  Adipocytes are the site for clearance of oxidized low d. lipoprotein (oxLDL) in blood.  Sol. epoxide hydrolase (sEH) is highly expressed in adipocytes. sEH converts epoxyeicosatrienoic acids (EETs) into less bioactive dihydroxyeicosatrienoic acids, which regulate cholesterol metab. in adipocytes and block the development of atherosclerosis.  In vitro, 3T3-L1 differentiated adipocytes were incubated with the sEH inhibitor t-AUCB (0, 1, 10, 50 or 100 mmol/l) for 24 h with or without the PPARγ inhibitor GW9662.  To det. the effect of t-AUCB on oxLDL endocytosis, degrdn. and cholesterol efflux from adipocytes, we demonstrated that t-AUCB enhances the CD36-mediated recognition and degrdn. of oxLDL and improves cholesterol efflux via the upregulation of ABCA1 expression.  Furthermore, t-AUCB blocked TNF-α secretion and increased adiponectin levels found in adipocytes culture medium.  We provide evidence that these effects are PPARγ-dependent.  These results suggest that an increase in EETs because of sEH inhibition could maintain cellular cholesterol homeostasis by the regulation of oxLDL clearance and cholesterol efflux via the EETs-PPARγ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2317pOOoVa7Vg90H21EOLACvtfcHk0liZipK1No52DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFOlu70%253D&md5=9d01e225885316057102fdd916f56438</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0251%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%2BC.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DXu%26aufirst%3DD.%2BY.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520modulates%2520cholesterol%2520balance%2520and%2520oxidized%2520low%2520density%2520lipoprotein%2520metabolism%2520in%2520adipocytes%2520in%2520vitro%26jtitle%3DBiol.%2520Chem.%26date%3D2014%26volume%3D395%26spage%3D443%26epage%3D451%26doi%3D10.1515%2Fhsz-2013-0251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harouki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duflot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remy-Jouet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumesnil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellien, J.</span></span> <span> </span><span class="NLM_article-title">Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2015&pages=148-154&author=C.+Rocheauthor=D.+Guerrotauthor=N.+Haroukiauthor=T.+Duflotauthor=M.+Besnierauthor=I.+Remy-Jouetauthor=S.+Renetauthor=A.+Dumesnilauthor=A.+Lejeuneauthor=C.+Morisseauauthor=V.+Richardauthor=J.+Bellien&title=Impact+of+soluble+epoxide+hydrolase+inhibition+on+early+kidney+damage+in+hyperglycemic+overweight+mice&doi=10.1016%2Fj.prostaglandins.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice</span></div><div class="casAuthors">Roche, Clothilde; Guerrot, Dominique; Harouki, Najah; Duflot, Thomas; Besnier, Marie; Remy-Jouet, Isabelle; Renet, Sylvanie; Dumesnil, Anais; Lejeune, Annie; Morisseau, Christophe; Richard, Vincent; Bellien, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study addressed the hypothesis that inhibition of the EETs degrading enzyme sol. epoxide hydrolase affords renal protection in the early stage of diabetic nephropathy.  The renal effects of the sEH inhibitor t-AUCB (10 mg/l in drinking water) were compared to those of the sulfonylurea glibenclamide (80 mg/l), both administered for 8 wk in FVB mice subjected to a high-fat diet (HFD, 60% fat) for 16 wk.  Mice on control chow diet (10% fat) and non-treated HFD mice served as controls.  Compared with non-treated HFD mice, HFD mice treated with t-AUCB had a decreased EET degrdn., as shown by their higher plasma EETs-to-DHETs ratio, and an increased EET prodn., as shown by the increase in EETs + DHETs levels, which was assocd. with induction of CYP450 epoxygenase expression.  Both agents similarly reduced fasting glycemia but only t-AUCB prevented the increase in the urinary albumine-to-creatinine ratio in HFD mice.  Histopathol. anal. showed that t-AUCB reduced renal inflammation, which was assocd. with an increased mRNA expression of the NFκB inhibitor Iκ≃ and related decrease in MCP-1, COX2 and VCAM-1 expressions.  Finally, there was a marginally significant increase in reactive oxygen species prodn. in HFD mice, together with an enhanced NOX2 expression.  Both agents did not modify these parameters but t-AUCB increased the expression of the antioxidant enzyme superoxide dismutase 1.  These results demonstrate that, independently from its glucose-lowering effect, sEH inhibition prevents microalbuminuria and renal inflammation in overweight hyperglycemic mice, suggesting that this pharmacol. strategy could be useful in the management of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCcbQQhKm_LbVg90H21EOLACvtfcHk0liAZXY25mwTcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOlu7o%253D&md5=d4ed470d0b4e35f4a5b61059ea95ea90</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DGuerrot%26aufirst%3DD.%26aulast%3DHarouki%26aufirst%3DN.%26aulast%3DDuflot%26aufirst%3DT.%26aulast%3DBesnier%26aufirst%3DM.%26aulast%3DRemy-Jouet%26aufirst%3DI.%26aulast%3DRenet%26aufirst%3DS.%26aulast%3DDumesnil%26aufirst%3DA.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DRichard%26aufirst%3DV.%26aulast%3DBellien%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520on%2520early%2520kidney%2520damage%2520in%2520hyperglycemic%2520overweight%2520mice%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2015%26volume%3D120%26spage%3D148%26epage%3D154%26doi%3D10.1016%2Fj.prostaglandins.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">758614</span>, <span class="refDoi"> DOI: 10.1155/2012/758614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1155%2F2012%2F758614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22007192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=758614&author=A.+Iyerauthor=K.+Kauterauthor=M.+A.+Alamauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=L.+Brown&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+ameliorates+diet-induced+metabolic+syndrome+in+rats&doi=10.1155%2F2012%2F758614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span></div><div class="casAuthors">Iyer Abishek; Kauter Kathleen; Alam Md Ashraful; Hwang Sung Hee; Morisseau Christophe; Hammock Bruce D; Brown Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">758614</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signs of metabolic syndrome following chronic excessive macronutrient intake include body weight gain, excess visceral adipose deposition, hyperglycaemia, glucose and insulin intolerances, hypertension, dyslipidaemia, endothelial damage, cardiovascular hypertrophy, inflammation, ventricular contractile dysfunction, fibrosis, and fatty liver disease.  Recent studies show increased activity of soluble epoxide hydrolase (sEH) during obesity and metabolic dysfunction.  We have tested whether sEH inhibition has therapeutic potential in a rat model of diet-induced metabolic syndrome.  In these high-carbohydrate, high-fat-fed rats, chronic oral treatment with trans-4-[4-(3-adamantan-1-ylureido)-cyclohexyloxy]-benzoic acid (t-AUCB), a potent sEH inhibitor, alleviated the signs of metabolic syndrome in vivo including glucose, insulin, and lipid abnormalities, changes in pancreatic structure, increased systolic blood pressure, cardiovascular structural and functional abnormalities, and structural and functional changes in the liver.  The present study describes the pharmacological responses to this selective sEH inhibitor in rats with the signs of diet-induced metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1vi0lpx2a9IJKJbLTgsvCfW6udTcc2eZBGaXZNBYVX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D&md5=225f1e58564b2942facc133619680a62</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1155%2F2012%2F758614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F758614%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DKauter%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBrown%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520diet-induced%2520metabolic%2520syndrome%2520in%2520rats%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D758614%26doi%3D10.1155%2F2012%2F758614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danilov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalinger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatsadze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shkineva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5514</span>– <span class="NLM_lpage">5519</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2015.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26520661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5514-5519&author=V.+Burmistrovauthor=C.+Morisseauauthor=D.+Danilovauthor=T.+R.+Harrisauthor=I.+Dalingerauthor=I.+Vatsadzeauthor=T.+Shkinevaauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=1%2C3-Disubstituted+and+1%2C3%2C3-trisubstituted+adamantyl-ureas+with+isoxazole+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2015.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Danilov, Dmitry; Harris, Todd R.; Dalinger, Igor; Vatsadze, Irina; Shkineva, Tatiana; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5514-5519</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adamantyl ureas are good sol. epoxide hydrolase (sEH) inhibitors; however they have limited soly. and rapid metab., thus limiting their usefulness in some therapeutic indications.  Herein, we test the hypothesis that nodal substitution on the adamantane will help solubilize and stabilize the compds.  A series of compds. contg. adamantane derivs. and isoxazole functional groups were developed.  Overall, the presence of Me on the nodal positions of adamantane yields higher water soly. than previously reported urea-based sEH inhibitors while maintaining high inhibition potency.  However, it did not improve microsomal stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-QXbYS1fQArVg90H21EOLACvtfcHk0lgAiG452vql2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCms7nL&md5=b379bfe223ec4e7c2f85f84159d15bc9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DDanilov%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DDalinger%26aufirst%3DI.%26aulast%3DVatsadze%26aufirst%3DI.%26aulast%3DShkineva%26aufirst%3DT.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1%252C3-Disubstituted%2520and%25201%252C3%252C3-trisubstituted%2520adamantyl-ureas%2520with%2520isoxazole%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5514%26epage%3D5519%26doi%3D10.1016%2Fj.bmcl.2015.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2017.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29310082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=510-527&author=V.+Burmistrovauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=G.+Butovauthor=B.+D.+Hammock&title=Effects+of+adamantane+alterations+on+soluble+epoxide+hydrolase+inhibition+potency%2C+physical+properties+and+metabolic+stability&doi=10.1016%2Fj.bioorg.2017.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Harris, Todd R.; Butov, Gennady; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">510-527</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adamantyl groups are widely used in medicinal chem.  However, metab. limits their usage.  Herein, the authors report the first systematic study of adamantyl ureas and diureas bearing substituents in bridgehead positions of adamantane and/or spacers between urea groups and adamantane group, and tested their effects on sol. epoxide hydrolase inhibitor potency and metabolic stability.  Interestingly, the effect on activity against human and murine sEH varied in opposite ways with each new Me group introduced into the mol.  Compds. with three Me substituents in adamantane were very poor inhibitors of murine sEH while still very potent against human sEH.  In addn., diureas with terminal groups bigger than sEH catalytic tunnel diam. were still good inhibitors suggesting that the active site of sEH opens to capture the substrate or inhibitor mol.  The introduction of one Me group leads to 4-fold increase in potency without noticeable loss of metabolic stability compared to the unsubstituted adamantane.  However, introduction of two or three Me groups leads to 8-fold and 98-fold decrease in stability in human liver microsomes for the corresponding compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-EeWH8Z5rnrVg90H21EOLACvtfcHk0lgAiG452vql2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslynsg%253D%253D&md5=99606b28e4cfb186d40c19f553c60ef1</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DButov%26aufirst%3DG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEffects%2520of%2520adamantane%2520alterations%2520on%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520potency%252C%2520physical%2520properties%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D510%26epage%3D527%26doi%3D10.1016%2Fj.bioorg.2017.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7067</span>– <span class="NLM_lpage">7075</span>, <span class="refDoi"> DOI: 10.1021/jm100691c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100691c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7067-7075&author=T.+E.+Roseauthor=C.+Morisseauauthor=J.+Y.+Liuauthor=B.+Inceogluauthor=P.+D.+Jonesauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=1-Aryl-3-%281-acylpiperidin-4-yl%29urea+inhibitors+of+human+and+murine+soluble+epoxide+hydrolase%3A+structure-activity+relationships%2C+pharmacokinetics%2C+and+reduction+of+inflammatory+pain&doi=10.1021%2Fjm100691c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain</span></div><div class="casAuthors">Rose, Tristan E.; Morisseau, Christophe; Liu, Jun-Yan; Inceoglu, Bora; Jones, Paul D.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7067-7075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,3-Disubstituted ureas possessing a piperidyl moiety have been synthesized to investigate their structure-activity relationships as inhibitors of the human and murine sol. epoxide hydrolase (sEH).  Oral administration of 13 1-aryl-3-(1-acylpiperidin-4-yl)urea inhibitors in mice revealed substantial improvements in pharmacokinetic parameters over previously reported 1-adamantylurea based inhibitors.  For example, 1-(1-(cyclopropanecarbonyl)piperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea showed a 7-fold increase in potency, a 65-fold increase in Cmax, and a 3300-fold increase in AUC over its adamantane analog 1-(1-adamantyl)-3-(1-propionylpiperidin-4-yl)urea.  This novel sEH inhibitor showed a 1000-fold increase in potency when compared to morphine by reducing hyperalgesia as measured by mech. withdrawal threshold using the in vivo carrageenan induced inflammatory pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokUmpG9nURobVg90H21EOLACvtfcHk0lgAiG452vql2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb%252FL&md5=bc2b151553d732942c1ac7e2e963d524</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm100691c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100691c%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DT.%2BE.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1-Aryl-3-%25281-acylpiperidin-4-yl%2529urea%2520inhibitors%2520of%2520human%2520and%2520murine%2520soluble%2520epoxide%2520hydrolase%253A%2520structure-activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520reduction%2520of%2520inflammatory%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7067%26epage%3D7075%26doi%3D10.1021%2Fjm100691c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasagami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2010.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejps.2010.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20359531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVCru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=222-238&author=H.+J.+Tsaiauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=J.+Yangauthor=P.+D.+Jonesauthor=T.+Kasagamiauthor=I.+H.+Kimauthor=B.+D.+Hammock&title=Pharmacokinetic+screening+of+soluble+epoxide+hydrolase+inhibitors+in+dogs&doi=10.1016%2Fj.ejps.2010.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs</span></div><div class="casAuthors">Tsai, Hsing-Ju; Hwang, Sung Hee; Morisseau, Christophe; Yang, Jun; Jones, Paul D.; Kasagami, Takeo; Kim, In-Hae; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-238</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids that have anti-hypertensive and anti-inflammatory properties are mainly metabolized by sol. epoxide hydrolase (sEH, EC 3.3.2.3).  Therefore, sEH has emerged as a therapeutic target for treating various cardiovascular diseases and inflammatory pain.  N,N'-Disubstituted ureas are potent sEH inhibitors in vitro.  However, in vivo usage of early sEH inhibitors has been limited by their low bioavailability and poor physiochem. properties.  Therefore, a group of highly potent compds. with more drug-like physiochem. properties were evaluated by monitoring their plasma profiles in dogs treated orally with sEH inhibitors.  Urea compds. with an adamantyl or a 4-trifluoromethoxyphenyl group on one side and a piperidyl or a cyclohexyl ether group on the other side of the urea function showed pharmacokinetic profiles with high plasma concns. and long half lives.  In particular, the inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB) not only is very potent with good physiochem. properties, but also shows high oral bioavailability for doses ranging from 0.01 to 1 mg/kg.  This compd. is also very potent against the sEH of several mammals, suggesting that t-AUCB will be an excellent tool to evaluate the biol. of sEH in multiple animal models.  Such compds. may also be a valuable lead for the development of veterinary therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5KDRLd00iLbVg90H21EOLACvtfcHk0lhaMC7vV0oykA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVCru7c%253D&md5=c078acc807d5bcffeeac0b77df28c4e3</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2010.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2010.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DKasagami%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPharmacokinetic%2520screening%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520in%2520dogs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D40%26spage%3D222%26epage%3D238%26doi%3D10.1016%2Fj.ejps.2010.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakhomova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mara, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Optimized inhibitors of soluble epoxide hydrolase improve <i>in vitro</i> target residence time and <i>in vivo</i> efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7016</span>– <span class="NLM_lpage">7030</span>, <span class="refDoi"> DOI: 10.1021/jm500694p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500694p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7016-7030&author=K.+S.+Leeauthor=J.+Y.+Liuauthor=K.+M.+Wagnerauthor=S.+Pakhomovaauthor=H.+Dongauthor=C.+Morisseauauthor=S.+H.+Fuauthor=J.+Yangauthor=P.+Wangauthor=A.+Uluauthor=C.+A.+Mateauthor=L.+V.+Nguyenauthor=S.+H.+Hwangauthor=M.+L.+Edinauthor=A.+A.+Maraauthor=H.+Wulffauthor=M.+E.+Newcomerauthor=D.+C.+Zeldinauthor=B.+D.+Hammock&title=Optimized+inhibitors+of+soluble+epoxide+hydrolase+improve+in+vitro+target+residence+time+and+in+vivo+efficacy&doi=10.1021%2Fjm500694p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy</span></div><div class="casAuthors">Lee, Kin Sing Stephen; Liu, Jun-Yan; Wagner, Karen M.; Pakhomova, Svetlana; Dong, Hua; Morisseau, Christophe; Fu, Samuel H.; Yang, Jun; Wang, Peng; Ulu, Arzu; Mate, Christina A.; Nguyen, Long V.; Hwang, Sung Hee; Edin, Matthew L.; Mara, Alexandria A.; Wulff, Heike; Newcomer, Marcia E.; Zeldin, Darryl C.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7016-7030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diabetes is affecting the life of millions of people.  A large proportion of diabetic patients suffer from severe complications such as neuropathic pain, and current treatments for these complications have deleterious side effects.  Thus, alternate therapeutic strategies are needed.  Recently, the elevation of epoxy-fatty acids through inhibition of sol. epoxide hydrolase (sEH) was shown to reduce diabetic neuropathic pain in rodents.  In this report, the authors describe a series of newly synthesized sEH inhibitors I [R1 = 4-CF3C6H4, 4-CF3OC6H4; (CF3)2CFC6H4, etc.; R2 = MeCO, MeCH2CO, MeCH2CH2CO, etc.] with at least 5-fold higher potency and doubled residence time inside both the human and rodent sEH enzyme than previously reported inhibitors.  These inhibitors also have better phys. properties and optimized pharmacokinetic profiles.  The optimized inhibitor selected from this new series displayed improved efficacy of almost 10-fold in relieving pain perception in diabetic neuropathic rats as compared to the approved drug, gabapentin, and previously published sEH inhibitors.  Therefore, these new sEH inhibitors could be an attractive alternative to treat diabetic neuropathy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_j6x9O0dsd7Vg90H21EOLACvtfcHk0lhaMC7vV0oykA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77K&md5=1f57ad6909389ac8d101fb548b64c2e2</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm500694p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500694p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DMate%26aufirst%3DC.%2BA.%26aulast%3DNguyen%26aufirst%3DL.%2BV.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DMara%26aufirst%3DA.%2BA.%26aulast%3DWulff%26aufirst%3DH.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOptimized%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520improve%2520in%2520vitro%2520target%2520residence%2520time%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7016%26epage%3D7030%26doi%3D10.1021%2Fjm500694p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manickam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillaiyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswararao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalani, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2016.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27092411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1els7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=113-124&author=M.+Manickamauthor=T.+Pillaiyarauthor=P.+Bogguauthor=E.+Venkateswararaoauthor=H.+B.+Jalaniauthor=N.+D.+Kimauthor=S.+K.+Leeauthor=J.+S.+Jeonauthor=S.+K.+Kimauthor=S.+H.+Jung&title=Discovery+of+enantioselectivity+of+urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.ejmech.2016.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Manickam, Manoj; Pillaiyar, Thanigaimalai; Boggu, PullaReddy; Venkateswararao, Eeda; Jalani, Hitesh B.; Kim, Nam-Doo; Lee, Seul Ki; Jeon, Jang Su; Kim, Sang Kyum; Jung, Sang-Hun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) hydrolyzes epoxyeicosatrienoic acids (EETs) in the metabolic pathway of arachidonic acid and has been considered as an important therapeutic target for chronic diseases such as hypertension, diabetes and inflammation.  Although many urea derivs. are known as sEH inhibitors, the enantioselectivity of the inhibitors is not highlighted in spite of the stereoselective hydrolysis of EETs by sEH.  In an effort to explore the importance of enantioselectivity in the urea scaffold, a series of enantiomers with the stereocenter adjacent to the urea nitrogen atom were prepd.  The selectivity of enantiomers of 1-(α-alkyl-α-phenylmethyl)-3-(3-phenylpropyl)ureas showed wide range differences up to 125 fold with the low IC50 value up to 13 nM.  The S-configuration with planar Ph and small alkyl groups at α-position is crucial for the activity and selectivity.  However, restriction of the free rotation of two α-groups with indan-1-yl or 1,2,3,4-tetrahydronaphthalen-1-yl moiety abolishes the selectivity between the enantiomers, despite the increase in activity up to 13 nM.  The hydrophilic group like sulfonamido group at para position of 3-phenylpropyl motif of 1-(α-alkyl-α-phenylmethyl-3-(3-phenylpropyl))urea improves the activity as well as enantiomeric selectivity.  All these ureas are proved to be specific inhibitor of sEH without inhibition against microsomal EH (mEH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwGD384-NtQLVg90H21EOLACvtfcHk0liRFrwic3xkvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1els7o%253D&md5=5a6e7123953136c74243b09de211acc3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DManickam%26aufirst%3DM.%26aulast%3DPillaiyar%26aufirst%3DT.%26aulast%3DBoggu%26aufirst%3DP.%26aulast%3DVenkateswararao%26aufirst%3DE.%26aulast%3DJalani%26aufirst%3DH.%2BB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJeon%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJung%26aufirst%3DS.%2BH.%26atitle%3DDiscovery%2520of%2520enantioselectivity%2520of%2520urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D113%26epage%3D124%26doi%3D10.1016%2Fj.ejmech.2016.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayzullin, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Adamantyl thioureas as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2302</span>– <span class="NLM_lpage">2313</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2018.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29803731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2302-2313&author=V.+Burmistrovauthor=C.+Morisseauauthor=D.+Pitushkinauthor=D.+Karlovauthor=R.+R.+Fayzullinauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=Adamantyl+thioureas+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2018.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl thioureas as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry; Karlov, Dmitry; Fayzullin, Robert R.; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2302-2313</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of inhibitors of the sol. epoxide hydrolase (sEH) contg. one or two thiourea groups has been developed.  Inhibition potency of the described compds. ranges from 50 μM to 7.2 nM.  1,7-(Heptamethylene)bis[(adamant-1-yl)thiourea] (6f) was found to be the most potent sEH inhibitor, among the thioureas tested.  The inhibitory activity of the thioureas against the human sEH is closer to the value of activity against rat sEH rather than murine sEH.  While being less active, thioureas are up to 7-fold more sol. than ureas, which makes them more bioavailable and thus promising as sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRaEGaCWfq7Vg90H21EOLACvtfcHk0liRFrwic3xkvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgtbnN&md5=81d98ca6f15c96140ee9bd95da868ca8</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DPitushkin%26aufirst%3DD.%26aulast%3DKarlov%26aufirst%3DD.%26aulast%3DFayzullin%26aufirst%3DR.%2BR.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DAdamantyl%2520thioureas%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2302%26epage%3D2313%26doi%3D10.1016%2Fj.bmcl.2018.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heirtzler, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3621</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1021/jm0500929</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0500929" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVGgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3621-3629&author=I.+H.+Kimauthor=F.+R.+Heirtzlerauthor=C.+Morisseauauthor=K.+Nishiauthor=H.+J.+Tsaiauthor=B.+D.+Hammock&title=Optimization+of+amide-based+inhibitors+of+soluble+epoxide+hydrolase+with+improved+water+solubility&doi=10.1021%2Fjm0500929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water Solubility</span></div><div class="casAuthors">Kim, In-Hae; Heirtzler, Fenton R.; Morisseau, Christophe; Nishi, Kosuke; Tsai, Hsing-Ju; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3621-3629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) plays an important role in the metab. of endogenous chem. mediators involved in the regulation of blood pressure and inflammation.  1,3-Disubstituted ureas with a polar group located on the fifth atom from the carbonyl group of urea function are active inhibitors of sEH both in vitro and in vivo.  However, their limited soly. in water and relatively high m.p. lead to difficulties in formulating the compds. and poor in vivo efficacy.  To improve these phys. properties, the effect of structural modification of the urea pharmacophore on the inhibition potencies, water solubilities, octanol/water partition coeffs. (log P), and m.ps. of a series of compds. was evaluated.  For murine sEH, no loss of inhibition potency was obsd. when the urea pharmacophore was modified to an amide function, while for human sEH 2.5-fold decreased inhibition was obtained in the amide compds.  In addn., a NH group on the right side of carbonyl group of the amide pharmacophore substituted with an adamantyl group (such as compd. 14) and a methylene carbon present between the adamantyl and amide groups were essential to produce potent inhibition of sEH.  The resulting amide inhibitors have 10-30-fold better soly. and lower m.p. than the corresponding urea compds.  These findings will facilitate synthesis of sEH inhibitors that are easier to formulate and more bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJIRSgHMUoULVg90H21EOLACvtfcHk0lj6q5Waz8Iihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVGgtrs%253D&md5=b0bcc8346e1bdb1ba6ca5d80bb425923</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0500929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500929%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHeirtzler%26aufirst%3DF.%2BR.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOptimization%2520of%2520amide-based%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520with%2520improved%2520water%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3621%26epage%3D3629%26doi%3D10.1021%2Fjm0500929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleymanzadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKellop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5880</span>– <span class="NLM_lpage">5895</span>, <span class="refDoi"> DOI: 10.1021/jm9005302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9005302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWqurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5880-5895&author=A.+B.+Eldrupauthor=F.+Soleymanzadehauthor=S.+J.+Taylorauthor=I.+Mueggeauthor=N.+A.+Farrowauthor=D.+Josephauthor=K.+McKellopauthor=C.+C.+Manauthor=A.+Kukulkaauthor=S.+De+Lombaert&title=Structure-based+optimization+of+arylamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1021%2Fjm9005302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Eldrup, Anne B.; Soleymanzadeh, Fariba; Taylor, Steven J.; Muegge, Ingo; Farrow, Neil A.; Joseph, David; McKellop, Keith; Man, Chuk C.; Kukulka, Alison; De Lombaert, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5880-5895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylamides, particularly N-diarylethyl arylamides such as I, are prepd. as sol. epoxide hydrolase (sEH) inhibitors for potential use as antiinflammatory agents; their inhibition of human and rat sol. epoxide hydrolases and their half-lives on exposure to microsomes are detd., and the in vivo concns. in rats for selected compds. are detd.  While N-(3,3-diphenyl-propyl)nicotinamide (II) is found to be a potent inhibitor of sEH, it has short metabolic half-lives in microsomes and is cleared rapidly from the bodies of rats; the in vitro metabolic profile of II in rat liver microsomes shows extensive oxidative metab. and a propensity for metabolite switching.  The conformation of N-(3,3-diphenyl-propyl)-3-pyridinesulfonamide bound to sEH is detd. to understand its lack of activity and for further structure optimization; the conformation of N-(3,3-diphenyl-propyl)-2-pyridinecarboxamide bound to human sEH is also detd.  Based on the calcd. structures of compds. bound to sEH, N-diarylethyl arylamides such as I are prepd.  The racemate of I shows an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration; the structure of racemic I bound to sEH is also detd. by X-ray crystallog.  I and its enantiomer differ significantly in sEH-inhibiting activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm33erk-C157Vg90H21EOLACvtfcHk0lj6q5Waz8Iihw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWqurvL&md5=ceedf0d50217a4bb8b6fc87c34a65b27</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm9005302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005302%26sid%3Dliteratum%253Aachs%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DMcKellop%26aufirst%3DK.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DKukulka%26aufirst%3DA.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26atitle%3DStructure-based%2520optimization%2520of%2520arylamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5880%26epage%3D5895%26doi%3D10.1021%2Fjm9005302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. B.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation and myelin status in Alzheimer’s disease, Parkinson’s disease, and normal aging brains: a small sample study</span>. <i>Parkinson's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">7975407</span>, <span class="refDoi"> DOI: 10.1155/2019/7975407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1155%2F2019%2F7975407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31354934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3Mvit1ersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=7975407&author=F.+Hanauthor=R.+J.+Perrinauthor=Q.+Wangauthor=Y.+Wangauthor=J.+S.+Perlmutterauthor=J.+C.+Morrisauthor=T.+L.+S.+Benzingerauthor=J.+B.+Xu&title=Neuroinflammation+and+myelin+status+in+Alzheimer%E2%80%99s+disease%2C+Parkinson%E2%80%99s+disease%2C+and+normal+aging+brains%3A+a+small+sample+study&doi=10.1155%2F2019%2F7975407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study</span></div><div class="casAuthors">Han Fei; Wang Qing; Wang Yong; Perlmutter Joel S; Benzinger Tammie L S; Xu Jinbin; Perrin Richard J; Perrin Richard J; Perlmutter Joel S; Morris John C; Perlmutter Joel S; Perlmutter Joel S; Perlmutter Joel S</div><div class="citationInfo"><span class="NLM_cas:title">Parkinson's disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7975407</span>
        ISSN:<span class="NLM_cas:issn">2090-8083</span>.
    </div><div class="casAbstract">Microglia and astrocytes play important roles in mediating the immune processes and nutritional support in the central nervous system (CNS).  Neuroinflammation has been indicated in the progression of neurodegenerative diseases Alzheimer's disease (AD) and Parkinson's disease (PD).  Chronic neuroinflammation with sustained activation of microglia and astrocytes may affect white matter tracts and disrupt communication between neurons.  Recent studies indicate astrogliosis may inhibit remyelination in demyelinating disorders such as multiple sclerosis.  In this study, we investigated the relationship between neuroinflammation and myelin status in postmortem human brain tissue (n = 15 including 6 AD, 5 PD, and 4 age-matched, neurologically normal controls (NC)).  We conducted systematic and quantitative immunohistochemistry for glial fibrillary acidic protein (GFAP), ionized calcium-binding adaptor molecule 1 (Iba1), amyloid beta, and highly phosphorylated tau (tauopathy).  White matter intactness was evaluated by myelin and axon staining in adjacent brain tissue sections.  Eight of 15 cases (4 AD, 3 PD, and 1 NC) showed increased immunoreactivity for microglia and astrocytes in the white matter that connects striatum and cortex.  Quantitative analysis of these 8 cases showed a significant negative correlation between GFAP (but not Iba-1) and myelin (but not axon) staining in white matter (r(2) = 0.78, p < 0.005).  Tau, but not amyloid beta plaques, is significantly higher in AD vs.  PD and NC.  Tau burden increases with age in AD cases.  These observations indicate that astrocytosis in white matter is associated with loss of myelin in AD, PD, and normal aging and that tau is a potent biomarker for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIewER0TWRce_Q9URG6Dx8fW6udTcc2ebL2DPWVirVvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mvit1ersA%253D%253D&md5=3d2111e601d1c9a8d9aabed3c4c632b0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1155%2F2019%2F7975407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F7975407%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DXu%26aufirst%3DJ.%2BB.%26atitle%3DNeuroinflammation%2520and%2520myelin%2520status%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520and%2520normal%2520aging%2520brains%253A%2520a%2520small%2520sample%2520study%26jtitle%3DParkinson%2527s%2520Dis.%26date%3D2019%26volume%3D2019%26spage%3D7975407%26doi%3D10.1155%2F2019%2F7975407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleymanzadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabcenell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5864</span>– <span class="NLM_lpage">5868</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.08.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19758802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5864-5868&author=S.+J.+Taylorauthor=F.+Soleymanzadehauthor=A.+B.+Eldrupauthor=N.+A.+Farrowauthor=I.+Mueggeauthor=A.+Kukulkaauthor=A.+K.+Kabcenellauthor=S.+De+Lombaert&title=Design+and+synthesis+of+substituted+nicotinamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2009.08.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Taylor, Steven J.; Soleymanzadeh, Fariba; Eldrup, Anne B.; Farrow, Neil A.; Muegge, Ingo; Kukulka, Alison; Kabcenell, Alisa K.; DeLombaert, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5864-5868</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of potent nicotinamide inhibitors, e.g., I, of sol. epoxides hydrolase (sEH) is disclosed.  This series was designed using structure-based deconstruction and a combination of two HTS hit series, resulting in hybrid analogs that retained the optimal potency from one series, and acceptable in vitro metabolic stability from the other.  Structure-guided optimization of these analogs gave rise to nanomolar inhibitors of human sEH that had acceptable plasma exposure to qualify them as probes to det. the in vivo phenotypic consequences of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-17dcwxDBr7Vg90H21EOLACvtfcHk0lgc-_dcjl-eLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurvM&md5=1c070392280c569fcf4d6149f2f643b3</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.074%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DKukulka%26aufirst%3DA.%26aulast%3DKabcenell%26aufirst%3DA.%2BK.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520substituted%2520nicotinamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5864%26epage%3D5868%26doi%3D10.1016%2Fj.bmcl.2009.08.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R. D.</span></span> <span> </span><span class="NLM_article-title">Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19168352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1WrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1066-1070&author=S.+K.+Anandanauthor=Z.+N.+Doauthor=H.+K.+Webbauthor=D.+V.+Patelauthor=R.+D.+Gless&title=Non-urea+functionality+as+the+primary+pharmacophore+in+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2009.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Anandan, Sampath-Kumar; Do, Zung N.; Webb, Heather K.; Patel, Dinesh V.; Gless, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1066-1070</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of sol. epoxide hydrolase has been proposed as a promising new pharmaceutical target for diseases involving hypertension and vascular inflammation.  The most potent sEH inhibitors reported to date contain a urea or amide moiety as the central or 'primary' pharmacophore.  We evaluated replacing the urea pharmacophore with other functional groups such as thiourea, sulfonamide, sulfonylurea, aminomethylene amide, hydroxyamide, and ketoamide to identify novel and potent inhibitors.  The hydroxyamide moiety was identified as a novel pharmacophore affording potency comparable to urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFPHiTb2V57Vg90H21EOLACvtfcHk0lgc-_dcjl-eLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1WrtrY%253D&md5=b93de8c049e914d71cb6655a0edc4968</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DGless%26aufirst%3DR.%2BD.%26atitle%3DNon-urea%2520functionality%2520as%2520the%2520primary%2520pharmacophore%2520in%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1066%26epage%3D1070%26doi%3D10.1016%2Fj.bmcl.2009.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R. D.</span></span> <span> </span><span class="NLM_article-title">Unsymmetrical non-adamantyl N,N’-diaryl urea and amide inhibitors of soluble expoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4259</span>– <span class="NLM_lpage">4263</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.05.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19520575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4259-4263&author=S.+K.+Anandanauthor=H.+K.+Webbauthor=Z.+N.+Doauthor=R.+D.+Gless&title=Unsymmetrical+non-adamantyl+N%2CN%E2%80%99-diaryl+urea+and+amide+inhibitors+of+soluble+expoxide+hydrolase&doi=10.1016%2Fj.bmcl.2009.05.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Anandan, Sampath-Kumar; Webb, Heather K.; Do, Zung N.; Gless, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4259-4263</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Incorporation of an adamantyl group in prototypical sol. epoxide hydrolase (sEH) inhibitors afforded improved enzyme potency.  Replacement of the adamantyl group in unsym. ureas and amides with substituted aryl rings to identify equipotent and metabolically stable sEH inhibitors, e.g., I and II, is explored.  Aryl rings, esp. those substituted in the para position with a strongly electron withdrawing substituent, afforded enzyme IC50 values comparable to the adamantyl compds. in an ether substituted, unsym. N,N'-diaryl urea or amide scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZK8ABpNO59bVg90H21EOLACvtfcHk0lhzaPdKLtDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGmtbw%253D&md5=3b3988eb23541b04bb854a84cef0bc86</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.102%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DGless%26aufirst%3DR.%2BD.%26atitle%3DUnsymmetrical%2520non-adamantyl%2520N%252CN%25E2%2580%2599-diaryl%2520urea%2520and%2520amide%2520inhibitors%2520of%2520soluble%2520expoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4259%26epage%3D4263%26doi%3D10.1016%2Fj.bmcl.2009.05.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piirainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalueff, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span> <span> </span><span class="NLM_article-title">Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer’s disease: the emerging role for microglia?</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2017.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.neubiorev.2017.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28185874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=148-164&author=S.+Piirainenauthor=A.+Youssefauthor=C.+Songauthor=A.+V.+Kalueffauthor=G.+E.+Landrethauthor=T.+Malmauthor=L.+Tian&title=Psychosocial+stress+on+neuroinflammation+and+cognitive+dysfunctions+in+Alzheimer%E2%80%99s+disease%3A+the+emerging+role+for+microglia%3F&doi=10.1016%2Fj.neubiorev.2017.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?</span></div><div class="casAuthors">Piirainen, Sami; Youssef, Andrew; Song, Cai; Kalueff, Allan V.; Landreth, Gary E.; Malm, Tarja; Tian, Li</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-164</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chronic psychosocial stress is increasingly recognized as a risk factor for late-onset Alzheimer's disease (LOAD) and assocd. cognitive deficits.  Chronic stress also primes microglia and induces inflammatory responses in the adult brain, thereby compromising synapse-supportive roles of microglia and deteriorating cognitive functions during aging.  Substantial evidence demonstrates that failure of microglia to clear abnormally accumulating amyloid-beta (Aβ) peptide contributes to neuroinflammation and neurodegeneration in AD.  Moreover, genome-wide assocn. studies have linked variants in several immune genes, such as TREM2 and CD33, the expression of which in the brain is restricted to microglia, with cognitive dysfunctions in LOAD.  Thus, inflammation-promoting chronic stress may create a vicious cycle of aggravated microglial dysfunction accompanied by increased Aβ accumulation, collectively exacerbating neurodegeneration.  Surprisingly, however, little is known about whether and how chronic stress contributes to microglia-mediated neuroinflammation that may underlie cognitive impairments in AD.  This review aims to summarize the currently available clin. and preclin. data and outline potential mol. mechanisms linking stress, microglia and neurodegeneration, to foster future research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvSXjK7P3fObVg90H21EOLACvtfcHk0lhzaPdKLtDr7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVGlu7g%253D&md5=bcfee6d599b5a35064e1875371153a8c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2017.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2017.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DPiirainen%26aufirst%3DS.%26aulast%3DYoussef%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DKalueff%26aufirst%3DA.%2BV.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DMalm%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DL.%26atitle%3DPsychosocial%2520stress%2520on%2520neuroinflammation%2520and%2520cognitive%2520dysfunctions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520emerging%2520role%2520for%2520microglia%253F%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2017%26volume%3D77%26spage%3D148%26epage%3D164%26doi%3D10.1016%2Fj.neubiorev.2017.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboury, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, S. A.</span></span> <span> </span><span class="NLM_article-title">Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1007/s00249-016-1188-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00249-016-1188-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27928588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyjt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=445-459&author=L.+Karamiauthor=A.+A.+Sabouryauthor=E.+Rezaeeauthor=S.+A.+Tabatabai&title=Investigation+of+the+binding+mode+of+1%2C+3%2C+4-oxadiazole+derivatives+as+amide-based+inhibitors+for+soluble+epoxide+hydrolase+%28sEH%29+by+molecular+docking+and+MM-GBSA&doi=10.1007%2Fs00249-016-1188-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA</span></div><div class="casAuthors">Karami, Leila; Saboury, Ali Akbar; Rezaee, Elham; Tabatabai, Sayyed Abbas</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-459</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) enzyme plays an important role in the metab. of endogenous chem. mediators involved in the regulation of blood pressure and inflammation.  Inhibition of sEH provides a new approach to the treatment of inflammation, hypertension and atherosclerosis.  In this study, the binding modes and inhibition mechanisms of the new oxadiazole-based amide inhibitors of the human sol. epoxide hydrolase were investigated by mol. docking and mol. dynamics (MD) simulation followed by the MM-GBSA method to calc. the binding free energy of each inhibitor to sEH.  The results obtained from the binding free energy (ΔGbinding) calcn. and normal mode anal. indicate that the major favorable contributors are the van der Waals and electrostatic terms, whereas the polar solvation term opposes binding.  In addn., a good agreement between the calcd. ΔGbinding and the exptl. IC50 was obtained [correlation coeff., r2 = 0.89 (with) and 0.87 (without) entropy].  Besides, comparison of the enthalpy changes (ΔGMM-GBSA) with entropy changes (-TΔS) indicates that binding process of all inhibitors to sEH is enthalpy-driven.  Based on the ΔGbinding on per residue decompn., Asp335 and Tyr383 residues from the active site and Trp336, Leu499 and His524 residues from hydrophobic pockets contribute the most to ΔGbinding.  Moreover, hydrogen bond anal. reveals that Tyr383, Tyr466 and Asp335 residues have an important role in the binding to inhibitors by forming hydrogen bonds with high occupancies.  Our obtained results are useful for the understanding of the sEH-inhibitor interactions and may have great importance in the design of future sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_b1ej0nkjwbVg90H21EOLACvtfcHk0ljjEYjWXOqfgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyjt7%252FO&md5=c60209daa424f0a66cf80dd192a04d1c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs00249-016-1188-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-016-1188-0%26sid%3Dliteratum%253Aachs%26aulast%3DKarami%26aufirst%3DL.%26aulast%3DSaboury%26aufirst%3DA.%2BA.%26aulast%3DRezaee%26aufirst%3DE.%26aulast%3DTabatabai%26aufirst%3DS.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520binding%2520mode%2520of%25201%252C%25203%252C%25204-oxadiazole%2520derivatives%2520as%2520amide-based%2520inhibitors%2520for%2520soluble%2520epoxide%2520hydrolase%2520%2528sEH%2529%2520by%2520molecular%2520docking%2520and%2520MM-GBSA%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2017%26volume%3D46%26spage%3D445%26epage%3D459%26doi%3D10.1007%2Fs00249-016-1188-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1163</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2013.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24433964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1163-1175&author=I.+H.+Kimauthor=I.+H.+Leeauthor=H.+Nishiwakiauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+substituted+oxyoxalamides+as+inhibitors+of+the+human+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmc.2013.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Lee, In-Hee; Nishiwaki, Hisashi; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1163-1175</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We explored both structure-activity relationships among substituted oxyoxalamides used as the primary pharmacophore of inhibitors of the human sEH and as a secondary pharmacophore to improve water soly. of inhibitors.  When the oxyoxalamide function was modified with a variety of alkyls or substituted alkyls, compd. 6 with a 2-adamantyl group and a benzyl group was found to be a potent sEH inhibitor, suggesting that the substituted oxyoxalamide function is a promising primary pharmacophore for the human sEH, and compd. 6 can be a novel lead structure for the development of further improved oxyoxalamide or other related derivs.  In addn., introduction of substituted oxyoxalamide to inhibitors with an amide or urea primary pharmacophore produced significant improvements in inhibition potency and water soly.  In particular, the N,N,O-trimethyloxyoxalamide group in amide or urea inhibitors (26 and 31) was most effective among those tested for both inhibition and soly.  The results indicate that substituted oxyoxalamide function incorporated into amide or urea inhibitors is a useful secondary pharmacophore, and the resulting structures will be an important basis for the development of bioavailable sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wDMYplfb-bVg90H21EOLACvtfcHk0ljjEYjWXOqfgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWitbk%253D&md5=044f7ff87270757ad55a0496d735b791</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BH.%26aulast%3DNishiwaki%26aufirst%3DH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520substituted%2520oxyoxalamides%2520as%2520inhibitors%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1163%26epage%3D1175%26doi%3D10.1016%2Fj.bmc.2013.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7199</span>– <span class="NLM_lpage">7210</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2015.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26507430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7199-7210&author=I.+H.+Kimauthor=Y.+K.+Parkauthor=H.+Nishiwakiauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+amide-phosphonate+derivatives+as+inhibitors+of+the+human+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmc.2015.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Park, Yong-Kyu; Nishiwaki, Hisashi; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7199-7210</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure-activity relationships of amide-phosphonate derivs. as inhibitors of the human sol. epoxide hydrolase (sEH) were investigated.  First, a series of alkyl or aryl groups were substituted on the carbon alpha to the phosphonate function in amide compds. to see whether substituted phosphonates can act as a secondary pharmacophore.  A tert-Bu group (16) on the alpha carbon was found to yield most potent inhibition on the target enzyme.  A 4-50-fold drop in inhibition was induced by other substituents such as aryls, substituted aryls, cycloalkyls, and alkyls.  Then, the modification of the O-substituents on the phosphonate function revealed that di-Et groups were preferable for inhibition to other longer alkyls or substituted alkyls.  In amide compds. with the optimized diethylphosphonate moiety and an alkyl substitution such as adamantane, tetrahydronaphthalene, or adamantanemethane, highly potent inhibitions were gained.  In addn., the resulting potent amide-phosphonate compds. had reasonable water soly., suggesting that substituted phosphonates in amide inhibitors are effective for both inhibition potency on the human sEH and water soly. as a secondary pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40fqBW177KrVg90H21EOLACvtfcHk0ljjEYjWXOqfgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWhurzF&md5=e23ca5c7f90bd0d699cff12e720d432f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DNishiwaki%26aufirst%3DH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520amide-phosphonate%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7199%26epage%3D7210%26doi%3D10.1016%2Fj.bmc.2015.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavareh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedayati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahhosseini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of some oxadiazole derivatives as novel amide-based inhibitors of soluble epoxide hydrolase</span>. <i>Lett. Drug Des. Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.2174/1570180811666140220005530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1570180811666140220005530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=721-730&author=E.+Zavarehauthor=M.+Hedayatiauthor=L.+Radauthor=A.+Kianiauthor=S.+Shahhosseiniauthor=M.+Faiziauthor=S.+Tabatabai&title=Design%2C+synthesis+and+biological+evaluation+of+some+oxadiazole+derivatives+as+novel+amide-based+inhibitors+of+soluble+epoxide+hydrolase&doi=10.2174%2F1570180811666140220005530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis and Biological Evaluation of Some Oxadiazole Derivatives as Novel Amide-Based Inhibitors of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Zavareh, Elham Rezaee; Hedayati, Mahdi; Rad, Laleh Hoghooghi; Kiani, Azin; Shahhosseini, Soraya; Faizi, Mehrdad; Tabatabai, Sayyed Abbas</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-730</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1875-628X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) enzyme plays an important role in the metab. of endogenous chem. mediators which are involved in the regulation of blood pressure and inflammation.  Although the most reported potent sEH inhibitors are urea derivs., these compds. have limited pharmacokinetic profile.  In order to improve physicochem. properties, besides having favorable potency, amide non-urea derivs. with oxadiazole ring as a novel secondary pharmacophore against sEH enzyme were developed.  Most of the novel compds. with appropriate phys. properties, had comparable in vitro sEH inhibitory activity to 12-(3-Adamantan-1-yl-ureido)-dodecanoic acid (AUDA), a potent urea-based sEH inhibitor.  The IC50 value of the most potent compd. (15c) was 0.43 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_yCqx_odqkrVg90H21EOLACvtfcHk0liXXdraSle2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVakur8%253D&md5=5a8f726e1ee2f3d16c23be94ce483de4</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.2174%2F1570180811666140220005530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180811666140220005530%26sid%3Dliteratum%253Aachs%26aulast%3DZavareh%26aufirst%3DE.%26aulast%3DHedayati%26aufirst%3DM.%26aulast%3DRad%26aufirst%3DL.%26aulast%3DKiani%26aufirst%3DA.%26aulast%3DShahhosseini%26aufirst%3DS.%26aulast%3DFaizi%26aufirst%3DM.%26aulast%3DTabatabai%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520some%2520oxadiazole%2520derivatives%2520as%2520novel%2520amide-based%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2014%26volume%3D11%26spage%3D721%26epage%3D730%26doi%3D10.2174%2F1570180811666140220005530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1021/jm101431v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101431v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1752-1761&author=I.+H.+Kimauthor=Y.+K.+Parkauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+cycloalkylamide+derivatives+as+inhibitors+of+the+soluble+epoxide+hydrolase&doi=10.1021%2Fjm101431v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Cycloalkylamide Derivatives as Inhibitors of the Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Park, Yong-Kyu; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1752-1761</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationships of cycloalkylamide compds. as inhibitors of human sEH were investigated.  When the left side of amide function was modified by a variety of cycloalkanes, at least a C6 like cyclohexane was necessary to yield reasonable inhibition potency on the target enzyme.  In compds. with a smaller cycloalkane or with a polar group on the left side of amide function, no inhibition was obsd.  Increased hydrophobicity dramatically improved inhibition potency.  Esp., a tetrahydronaphthalene (20) effectively increased the potency.  When a series of alkyl or aryl derivs. of cycloalkylamide were investigated to continuously optimize the right side of the amide pharmacophore, a benzyl moiety functionalized with a polar group produced highly potent inhibition.  A nonsubstituted benzyl, alkyl, aryl, or biaryl structure present on the right side of the cycloalkylamide function induced a big decrease in inhibition potency.  Also, the resulting potent cycloalkylamide (32) showed reasonable phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwCVBettgWDLVg90H21EOLACvtfcHk0liXXdraSle2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gis7s%253D&md5=517ef48a514f6aaaf35b6b52729b7305</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm101431v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101431v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520cycloalkylamide%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1752%26epage%3D1761%26doi%3D10.1021%2Fjm101431v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinderspacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent non-urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2354</span>– <span class="NLM_lpage">2359</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2008.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19303288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2354-2359&author=Y.+Xieauthor=Y.+Liuauthor=G.+Gongauthor=D.+H.+Smithauthor=F.+Yanauthor=A.+Rinderspacherauthor=Y.+Fengauthor=Z.+Zhuauthor=X.+Liauthor=S.+X.+Dengauthor=L.+Brandenauthor=D.+Vidovicauthor=C.+Chungauthor=S.+Schurerauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Landry&title=Discovery+of+potent+non-urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2008.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent non-urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Xie, Yuli; Liu, Yidong; Gong, Gangli; Smith, Deborah H.; Yan, Fang; Rinderspacher, Alison; Feng, Yan; Zhu, Zhengxiang; Li, Xiangpo; Deng, Shi-Xian; Branden, Lars; Vidovic, Dusica; Chung, Caty; Schuerer, Stephan; Morisseau, Christophe; Hammock, Bruce D.; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2354-2359</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation.  A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chem. modification.  IC50s of the most potent compds. range from micromolar to low nanomolar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKbATsv12p_bVg90H21EOLACvtfcHk0liXXdraSle2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjur4%253D&md5=b8ad4e02402338154feb22e56eb662c3</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%2BH.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DRinderspacher%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DBranden%26aufirst%3DL.%26aulast%3DVidovic%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DSchurer%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520non-urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2354%26epage%3D2359%26doi%3D10.1016%2Fj.bmcl.2008.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pecic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">605</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22079754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=601-605&author=S.+Pecicauthor=S.+X.+Dengauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Landry&title=Design%2C+synthesis+and+evaluation+of+non-urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Pecic, Stevan; Deng, Shi-Xian; Morisseau, Christophe; Hammock, Bruce D.; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">601-605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of sol. epoxide hydrolase (sEH) has been proposed as a new pharmaceutical approach for treating hypertension and vascular inflammation.  The most potent sEH inhibitors reported in literature to date are urea derivs.  However, these compds. have limited pharmacokinetic profiles.  We investigated non-urea amide derivs. as sEH inhibitors and identified a potent human sEH inhibitor I having potency comparable to urea-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9kGoa5StNQLVg90H21EOLACvtfcHk0liKAFybpFkBGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyrtA%253D%253D&md5=e1c2ff96b9a2546e2869258787451cdb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DPecic%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520non-urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D601%26epage%3D605%26doi%3D10.1016%2Fj.bmcl.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziej, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberds, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1021/jm101382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1211-1222&author=L.+Xingauthor=J.+J.+McDonaldauthor=S.+A.+Kolodziejauthor=R.+G.+Kurumbailauthor=J.+M.+Williamsauthor=C.+J.+Warrenauthor=J.+M.+O%E2%80%99Nealauthor=J.+E.+Skepnerauthor=S.+L.+Roberds&title=Discovery+of+potent+inhibitors+of+soluble+epoxide+hydrolase+by+combinatorial+library+design+and+structure-based+virtual+screening&doi=10.1021%2Fjm101382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening</span></div><div class="casAuthors">Xing, Li; McDonald, Joseph J.; Kolodziej, Steve A.; Kurumbail, Ravi G.; Williams, Jennifer L.; Warren, Chad J.; O'Neal, Janet M.; Skepner, Jill E.; Roberds, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1211-1222</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based virtual screening was applied to design combinatorial libraries to discover novel and potent sol. epoxide hydrolase (sEH) inhibitors.  X-ray crystal structures revealed unique interactions for a benzoxazole template in addn. to the conserved hydrogen bonds with the catalytic machinery of sEH.  By exploitation of the favorable binding elements, two iterations of library design based on amide coupling were employed, guided principally by the docking results of the enumerated virtual products.  Biol. screening of the libraries demonstrated as high as 90% hit rate, of which over two dozen compds. were single digit nanomolar sEH inhibitors by IC50 detn.  In total the library design and synthesis produced more than 300 submicromolar sEH inhibitors.  In cellular systems consistent activities were demonstrated with biochem. measurements.  The SAR understanding of the benzoxazole template provides valuable insights into discovery of novel sEH inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tpDmXCJWBLVg90H21EOLACvtfcHk0liKAFybpFkBGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqu7s%253D&md5=01775ad103a3a5e153b77157ef184608</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm101382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101382t%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DWarren%26aufirst%3DC.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DJ.%2BM.%26aulast%3DSkepner%26aufirst%3DJ.%2BE.%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520by%2520combinatorial%2520library%2520design%2520and%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1211%26epage%3D1222%26doi%3D10.1021%2Fjm101382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7061</span>– <span class="NLM_lpage">7079</span>, <span class="refDoi"> DOI: 10.1021/jm300449x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300449x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7061-7079&author=H.+Dengauthor=H.+O%E2%80%99Keefeauthor=C.+P.+Davieauthor=K.+E.+Lindauthor=R.+A.+Acharyaauthor=G.+J.+Franklinauthor=J.+Larkinauthor=R.+Maticoauthor=M.+Neebauthor=M.+M.+Thompsonauthor=T.+Lohrauthor=J.+W.+Grossauthor=P.+A.+Centrellaauthor=G.+K.+O%E2%80%99Donovanauthor=K.+L.+Bedardauthor=K.+van+Vlotenauthor=S.+Mataruseauthor=S.+R.+Skinnerauthor=S.+L.+Belyanskayaauthor=T.+Y.+Carpenterauthor=T.+W.+Shearerauthor=M.+A.+Clarkauthor=J.+W.+Cuozzoauthor=C.+C.+Arico-Muendelauthor=B.+A.+Morgan&title=Discovery+of+highly+potent+and+selective+small+molecule+ADAMTS-5+inhibitors+that+inhibit+human+cartilage+degradation+via+encoded+library+technology+%28ELT%29&doi=10.1021%2Fjm300449x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT)</span></div><div class="casAuthors">Deng, Hongfeng; O'Keefe, Heather; Davie, Christopher P.; Lind, Kenneth E.; Acharya, Raksha A.; Franklin, G. Joseph; Larkin, Jonathan; Matico, Rosalie; Neeb, Michael; Thompson, Monique M.; Lohr, Thomas; Gross, Jeffrey W.; Centrella, Paolo A.; O'Donovan, Gary K.; Bedard, Katie L.; van Vloten, Kurt; Mataruse, Sibongile; Skinner, Steven R.; Belyanskaya, Svetlana L.; Carpenter, Tiffany Y.; Shearer, Todd W.; Clark, Matthew A.; Cuozzo, John W.; Arico-Muendel, Christopher C.; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7061-7079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metalloprotease ADAMTS-5 is considered a potential target for the treatment of osteoarthritis.  To identify selective inhibitors of ADAMTS-5, the authors employed encoded library technol. (ELT), which enables affinity selection of small mol. binders from complex mixts. by DNA tagging.  Selection of ADAMTS-5 against a four-billion member ELT library led to a novel inhibitor scaffold not contg. a classical zinc-binding functionality.  One exemplar, (R)-N-((1-(4-(but-3-en-1-ylamino)-6-(((2-(thiophen-2-yl)thiazol-4-yl)methyl)amino)-1,3,5-triazin-2-yl)pyrrolidin-2-yl)methyl)-4-propylbenzenesulfonamide (I), inhibited ADAMTS-5 with IC50 = 30 nM, showing >50-fold selectivity against ADAMTS-4 and >1000-fold selectivity against ADAMTS-1, ADAMTS-13, MMP-13, and TACE.  Extensive SAR studies showed that potency and physicochem. properties of the scaffold could be further improved.  Furthermore, in a human osteoarthritis cartilage explant study, compds. I and II inhibited aggrecanase-mediated 374ARGS neoepitope release from aggrecan and glycosaminoglycan in response to IL-1β/OSM stimulation.  This study provides the first small mol. evidence for the crit. role of ADAMTS-5 in human cartilage degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOEaetEOSWLVg90H21EOLACvtfcHk0lh6Qnfe2kGOYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM&md5=9f7d1a265c7f8089f9fa505f9974483e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm300449x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300449x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DNeeb%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DM.%2BM.%26aulast%3DLohr%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DG.%2BK.%26aulast%3DBedard%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DCarpenter%26aufirst%3DT.%2BY.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small%2520molecule%2520ADAMTS-5%2520inhibitors%2520that%2520inhibit%2520human%2520cartilage%2520degradation%2520via%2520encoded%2520library%2520technology%2520%2528ELT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7061%26epage%3D7079%26doi%3D10.1021%2Fjm300449x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering drugs with DNA-encoded library technology: from concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+drugs+with+DNA-encoded+library+technology%3A+from+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0lh6Qnfe2kGOYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520drugs%2520with%2520DNA-encoded%2520library%2520technology%253A%2520from%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thalji, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costell, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisennagel, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fries, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolivette, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krosky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandichak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnackenberg, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3584</span>– <span class="NLM_lpage">3588</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23664879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3584-3588&author=R.+K.+Thaljiauthor=J.+J.+McAteeauthor=S.+Belyanskayaauthor=M.+Brandtauthor=G.+D.+Brownauthor=M.+H.+Costellauthor=Y.+Dingauthor=J.+W.+Dodsonauthor=S.+H.+Eisennagelauthor=R.+E.+Friesauthor=J.+W.+Grossauthor=M.+R.+Harpelauthor=D.+A.+Holtauthor=D.+I.+Israelauthor=L.+J.+Jolivetteauthor=D.+Kroskyauthor=H.+Liauthor=Q.+Luauthor=T.+Mandichakauthor=T.+Roethkeauthor=C.+G.+Schnackenbergauthor=B.+Schwartzauthor=L.+M.+Shewchukauthor=W.+Xieauthor=D.+J.+Behmauthor=S.+A.+Douglasauthor=A.+L.+Shawauthor=J.+P.+Marino&title=Discovery+of+1-%281%2C3%2C5-triazin-2-yl%29piperidine-4-carboxamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Thalji, Reema K.; McAtee, Jeff J.; Belyanskaya, Svetlana; Brandt, Martin; Brown, Gregory D.; Costell, Melissa H.; Ding, Yun; Dodson, Jason W.; Eisennagel, Steve H.; Fries, Rusty E.; Gross, Jeffrey W.; Harpel, Mark R.; Holt, Dennis A.; Israel, David I.; Jolivette, Larry J.; Krosky, Daniel; Li, Hu; Lu, Quinn; Mandichak, Tracy; Roethke, Theresa; Schnackenberg, Christine G.; Schwartz, Benjamin; Shewchuk, Lisa M.; Xie, Wensheng; Behm, David J.; Douglas, Stephen A.; Shaw, Ami L.; Marino, Joseph P., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3584-3588</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1-(1,3,5-Triazin-yl)piperidine-4-carboxamide inhibitors of sol. epoxide hydrolase were identified from high through-put screening using encoded library technol.  The triazine heterocycle proved to be a crit. functional group, essential for high potency and P 450 selectivity.  Ph group substitution was important for reducing clearance, and establishing good oral exposure.  Based on this lead optimization work, 1-[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]-N-{[[4-bromo-2-(trifluoromethoxy)]-phenyl]methyl}-4-piperidinecarboxamide (27) was identified as a useful tool compd. for in vivo investigation.  Robust effects on a serum biomarker, 9, 10-epoxyoctadec-12(Z)-enoic acid (the epoxide derived from linoleic acid) were obsd., which provided evidence of robust in vivo target engagement and the suitability of 27 as a tool compd. for study in various disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLHfTPGdnzrVg90H21EOLACvtfcHk0lhBlvRBnDQJOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVyjt7c%253D&md5=1062478cb50db4ce0046992545428753</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DThalji%26aufirst%3DR.%2BK.%26aulast%3DMcAtee%26aufirst%3DJ.%2BJ.%26aulast%3DBelyanskaya%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DCostell%26aufirst%3DM.%2BH.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DDodson%26aufirst%3DJ.%2BW.%26aulast%3DEisennagel%26aufirst%3DS.%2BH.%26aulast%3DFries%26aufirst%3DR.%2BE.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKrosky%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DMandichak%26aufirst%3DT.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSchnackenberg%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDouglas%26aufirst%3DS.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BL.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%25201-%25281%252C3%252C5-triazin-2-yl%2529piperidine-4-carboxamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3584%26epage%3D3588%26doi%3D10.1016%2Fj.bmcl.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span> <span> </span><span class="NLM_article-title">Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2018.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2018.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2019&pages=31-39&author=K.+Hiesingerauthor=K.+M.+Wagnerauthor=B.+D.+Hammockauthor=E.+Proschakauthor=S.+H.+Hwang&title=Development+of+multitarget+agents+possessing+soluble+epoxide+hydrolase+inhibitory+activity&doi=10.1016%2Fj.prostaglandins.2018.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity</span></div><div class="casAuthors">Hiesinger, Kerstin; Wagner, Karen M.; Hammock, Bruce D.; Proschak, Ewgenij; Hwang, Sung Hee</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Over the last two decades polypharmacol. has emerged as a new paradigm in drug discovery, even though developing drugs with high potency and selectivity toward a single biol. target is still a major strategy.  Often, targeting only a single enzyme or receptor shows lack of efficacy.  High levels of inhibitor of a single target also can lead to adverse side effects.  A second target may offer additive or synergistic effects to affecting the first target thereby reducing on- and off-target side effects.  Therefore, drugs that inhibit multiple targets may offer a great potential for increased efficacy and reduced the adverse effects.  In this review we summarize recent findings of rationally designed multitarget compds. that are aimed to improve efficacy and safety profiles compared to those that target a single enzyme or receptor.  We focus on dual inhibitors/modulators that target the sol. epoxide hydrolase (sEH) as a common part of their design to take advantage of the beneficial effects of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV_jK3eUex7bVg90H21EOLACvtfcHk0lhBlvRBnDQJOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsg%253D%253D&md5=1aca2c841ac683c62de22c93155394d0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2018.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2018.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26atitle%3DDevelopment%2520of%2520multitarget%2520agents%2520possessing%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2019%26volume%3D140%26spage%3D31%26epage%3D39%26doi%3D10.1016%2Fj.prostaglandins.2018.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakhomova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29366648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=762-768&author=S.+D.+Kodaniauthor=S.+Bhaktaauthor=S.+H.+Hwangauthor=S.+Pakhomovaauthor=M.+E.+Newcomerauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Identification+and+optimization+of+soluble+epoxide+hydrolase+inhibitors+with+dual+potency+towards+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase</span></div><div class="casAuthors">Kodani, Sean D.; Bhakta, Saavan; Hwang, Sung Hee; Pakhomova, Svetlana; Newcomer, Marcia E.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">762-768</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multi-target inhibitors have become increasing popular as a means to leverage the advantages of poly-pharmacol. while simplifying drug delivery.  Here, we describe dual inhibitors for sol. epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH), two targets known to synergize when treating inflammatory and neuropathic pain.  The structure activity relationship (SAR) study described herein initially started with t-TUCB (trans-4-[4-(3-trifluoromethoxyphenyl-l-ureido)-cyclohexyloxy]-benzoic acid), a potent sEH inhibitor that was previously shown to weakly inhibit FAAH.  Inhibitors with a 6-fold increase of FAAH potency while maintaining high sEH potency were developed by optimization.  Interestingly, compared to most FAAH inhibitors that inhibit through time-dependent covalent modification, t-TUCB and related compds. appear to inhibit FAAH through a time-independent, competitive mechanism.  These inhibitors are selective for FAAH over other serine hydrolases.  In addn., FAAH inhibition by t-TUCB appears to be higher in human FAAH over other species; however, the new dual sEH/FAAH inhibitors have improved cross-species potency.  These dual inhibitors may be useful for future studies in understanding the therapeutic application of dual sEH/FAAH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpATW2xwOkDr7Vg90H21EOLACvtfcHk0ljHPBLcn3ENVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOrtbs%253D&md5=adca53fce25060a570e20b1cd81d6199</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520with%2520dual%2520potency%2520towards%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D762%26epage%3D768%26doi%3D10.1016%2Fj.bmcl.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Computer-aided fragment growing strategies to design dual inhibitors of soluble epoxide hydrolase and LTA4 hydrolase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms1yjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1244-1249&author=L.+Hefkeauthor=K.+Hiesingerauthor=W.+F.+Zhuauthor=J.+S.+Kramerauthor=E.+Proschak&title=Computer-aided+fragment+growing+strategies+to+design+dual+inhibitors+of+soluble+epoxide+hydrolase+and+LTA4+hydrolase&doi=10.1021%2Facsmedchemlett.0c00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase</span></div><div class="casAuthors">Hefke, Lena; Hiesinger, Kerstin; Zhu, W. Felix; Kramer, Jan S.; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1244-1249</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitarget ligands are interesting candidates for drug discovery and development due to improved safety and efficacy.  However, rational design and optimization of multitarget ligands is tedious because affinity optimization for two or more targets has to be performed simultaneously.  In this study, we demonstrate that, given a mol. fragment, which binds to two targets of interest, computer-aided fragment growing can be applied to optimize compd. potency, relying on either ligand- or structure-derived information.  This methodol. is applied to the design of dual inhibitors of sol. epoxide hydrolase and leukotriene A4 hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOGBsqvMSsZLVg90H21EOLACvtfcHk0ljHPBLcn3ENVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms1yjtr4%253D&md5=ac22514a975d2ff66d41234aa8844307</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00102%26sid%3Dliteratum%253Aachs%26aulast%3DHefke%26aufirst%3DL.%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DW.%2BF.%26aulast%3DKramer%26aufirst%3DJ.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DComputer-aided%2520fragment%2520growing%2520strategies%2520to%2520design%2520dual%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520LTA4%2520hydrolase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1244%26epage%3D1249%26doi%3D10.1021%2Facsmedchemlett.0c00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1410432111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1410432111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11127-11132&author=G.+Zhangauthor=D.+Panigrahyauthor=S.+H.+Hwangauthor=J.+Yangauthor=L.+M.+Mahakianauthor=H.+I.+Wetterstenauthor=J.+Y.+Liuauthor=Y.+Wangauthor=E.+S.+Inghamauthor=S.+Tamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Dual+inhibition+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase+synergistically+suppresses+primary+tumor+growth+and+metastasis&doi=10.1073%2Fpnas.1410432111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span></div><div class="casAuthors">Zhang, Guodong; Panigrahy, Dipak; Hwang, Sung Hee; Yang, Jun; Mahakian, Lisa M.; Wettersten, Hiromi I.; Liu, Jun-Yan; Wang, Yanru; Ingham, Elizabeth S.; Tam, Sarah; Kieran, Mark W.; Weiss, Robert H.; Ferrara, Katherine W.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">11127-11132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P 450/sol. epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis.  COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH inhibitors, which increase endogenous EETs, stimulate primary tumor growth and metastasis.  However, the functional interactions of these two pathways in cancer are unknown.  Using pharmacol. inhibitors as probes, we show here that dual inhibition of COX-2 and sEH synergistically inhibits primary tumor growth and metastasis by suppressing tumor angiogenesis.  COX-2/sEH dual pharmacol. inhibitors also potently suppress primary tumor growth and metastasis by inhibiting tumor angiogenesis via selective inhibition of endothelial cell proliferation.  These results demonstrate a crit. interaction of these two lipid metab. pathways on tumorigenesis and suggest dual inhibition of COX-2 and sEH as a potential therapeutic strategy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96zPXS3W5_LVg90H21EOLACvtfcHk0ljHPBLcn3ENVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J&md5=928fc9973909898ae94dbf2f3e087677</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1410432111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1410432111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%2520synergistically%2520suppresses%2520primary%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11127%26epage%3D11132%26doi%3D10.1073%2Fpnas.1410432111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">la Buscato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10771</span>– <span class="NLM_lpage">10775</span>, <span class="refDoi"> DOI: 10.1021/jm301194c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301194c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3s7htlelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10771-10775&author=E.+la+Buscatoauthor=R.+Blocherauthor=C.+Lamersauthor=F.+M.+Klinglerauthor=S.+Hahnauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=E.+Proschak&title=Design+and+synthesis+of+dual+modulators+of+soluble+epoxide+hydrolase+and+peroxisome+proliferator-activated+receptors&doi=10.1021%2Fjm301194c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors</span></div><div class="casAuthors">la Buscato Estel; Blocher Rene; Lamers Christina; Klingler Franca-Maria; Hahn Steffen; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Proschak Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10771-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome is a complex condition which often requires the use of multiple medications as a treatment.  The resulting problems of polypharmacy are increase in side effects, drug-drug interactions, and its high economic cost.  Development of multitarget compounds is a promising strategy to avoid the complications arising from administration of multiple drugs.  Modulators of peroxisome proliferator-activated receptors (PPARs) are established agents in the treatment of dyslipidaemia, hyperglycaemia, and insulin resistance.  Inhibitors of soluble epoxide hydrolase (sEH) are under evaluation for their use in cardiovascular diseases.  In the present study, a series of dual sEH/PPAR modulators containing a pyrrole acidic headgroup and a urea pharmacophore were designed, synthesized, and evaluated in vitro using recombinant enzyme and cell-based assays.  Compounds with different activity profiles were obtained which could be used in the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ44wz9IvHE-f3jf77P2BG3fW6udTcc2eaw3MBtAT4Idrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7htlelug%253D%253D&md5=50f42905d28bce4b6298d098408b3532</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm301194c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301194c%26sid%3Dliteratum%253Aachs%26aulast%3Dla%2BBuscato%26aufirst%3DE.%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520modulators%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520peroxisome%2520proliferator-activated%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10771%26epage%3D10775%26doi%3D10.1021%2Fjm301194c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodl, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewska, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buscato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berressem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1777</span>– <span class="NLM_lpage">1781</span>, <span class="refDoi"> DOI: 10.1021/jm301617j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301617j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1777-1781&author=K.+Meirerauthor=C.+B.+Rodlauthor=J.+M.+Wisniewskaauthor=S.+Georgeauthor=A.+K.+Hafnerauthor=E.+Buscatoauthor=F.+M.+Klinglerauthor=S.+Hahnauthor=D.+Berressemauthor=S.+K.+Wittmannauthor=D.+Steinhilberauthor=B.+Hofmannauthor=E.+Proschak&title=Synthesis+and+structure-activity+relationship+studies+of+novel+dual+inhibitors+of+soluble+epoxide+hydrolase+and+5-lipoxygenase&doi=10.1021%2Fjm301617j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase</span></div><div class="casAuthors">Meirer, Karin; Roedl, Carmen B.; Wisniewska, Joanna M.; George, Sven; Haefner, Ann-Kathrin; Buscato, Estel·la; Klingler, Franca-Maria; Hahn, Steffen; Berressem, Dirk; Wittmann, Sandra K.; Steinhilber, Dieter; Hofmann, Bettina; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1777-1781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current research leads to the assumption that drugs affecting more than one target could result in a more efficient treatment of diseases and fewer safety concerns.  Administration of drugs inhibiting only one branch of the arachidonic acid cascade is usually accompanied by side effects.  We therefore designed and synthesized a library of hybrid mols. incorporating an imidazo[1,2-a]pyridine and an urea moiety as novel sol. epoxide hydrolase (sEH)/5-lipoxygenase (5-LO) dual inhibitors.  Evaluation of the compds. was accomplished by in vitro testing using recombinant enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7_8oVx_4lw7Vg90H21EOLACvtfcHk0lh2bo_LwgLasw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqu7s%253D&md5=d7aa0212864592ccdff5b431004a010a</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm301617j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301617j%26sid%3Dliteratum%253Aachs%26aulast%3DMeirer%26aufirst%3DK.%26aulast%3DRodl%26aufirst%3DC.%2BB.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHafner%26aufirst%3DA.%2BK.%26aulast%3DBuscato%26aufirst%3DE.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DBerressem%26aufirst%3DD.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520novel%2520dual%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1777%26epage%3D1781%26doi%3D10.1021%2Fjm301617j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wecksler, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3037</span>– <span class="NLM_lpage">3050</span>, <span class="refDoi"> DOI: 10.1021/jm2001376</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2001376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlOrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3037-3050&author=S.+H.+Hwangauthor=K.+M.+Wagnerauthor=C.+Morisseauauthor=J.+Y.+Liuauthor=H.+Dongauthor=A.+T.+Weckslerauthor=B.+D.+Hammock&title=Synthesis+and+structure-activity+relationship+studies+of+urea-containing+pyrazoles+as+dual+inhibitors+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase&doi=10.1021%2Fjm2001376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase</span></div><div class="casAuthors">Hwang, Sung Hee; Wagner, Karen M.; Morisseau, Christophe; Liu, Jun-Yan; Dong, Hua; Wecksler, Aaron T.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3037-3050</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dual inhibitors contg. a 1,5-diarylpyrazole and a urea were designed, synthesized, and evaluated as novel COX-2/sEH dual inhibitors in vitro using recombinant enzyme assays and in vivo using a lipopolysaccharide (LPS) induced model of pain in rats.  The best inhibition potencies and selectivity for sEH and COX-2 over COX-1 were obtained with compds. I (R = 3-CF3, 4-CF3, 4-OCF3) in which both the 1,5-diaryl-pyrazole group and the urea group are linked with a three-methylene group.  Compd. I (R = 4-CF3) showed the best pharmacokinetic profiles in both mice and rats (higher AUC and longer half-life).  Following s.c. administration at 10 mg/kg, compd. I (R = 4-CF3) exhibited antiallodynic activity that is more effective than the same dose of either a COX-2 inhibitor (celecoxib) or a sEH inhibitor (t-AUCB) alone, as well as coadministration of both inhibitors.  Thus, these novel dual inhibitors exhibited enhanced in vivo antiallodynic activity in a nociceptive behavioral assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlGixCVsv09bVg90H21EOLACvtfcHk0ljE8MeSb7E9lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlOrtL8%253D&md5=f32356bf3f1d3f4237e1674a961680c8</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm2001376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2001376%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWecksler%26aufirst%3DA.%2BT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520urea-containing%2520pyrazoles%2520as%2520dual%2520inhibitors%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3037%26epage%3D3050%26doi%3D10.1021%2Fjm2001376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2019.12.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bbrc.2019.12.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31973813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2020&pages=1020-1026&author=C.+C.+Sunauthor=C.+Y.+Zhangauthor=J.+X.+Duanauthor=X.+X.+Guanauthor=H.+H.+Yangauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guanauthor=S.+K.+Liuauthor=J.+Zhang&title=PTUPB+ameliorates+high-fat+diet-induced+non-alcoholic+fatty+liver+disease+via+inhibiting+NLRP3+inflammasome+activation+in+mice&doi=10.1016%2Fj.bbrc.2019.12.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice</span></div><div class="casAuthors">Sun, Chen-Chen; Zhang, Chen-Yu; Duan, Jia-Xi; Guan, Xin-Xin; Yang, Hui-Hui; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang; Liu, Shao-Kun; Zhang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1020-1026</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-alc. fatty liver disease (NAFLD) affects 25% of the global adult population, and no effective pharmacol. treatment has been found.  Products of arachidonic acid metab. have been developed into a novel therapy for metabolic syndrome and diabetes.  It has been demonstrated that protective actions of a novel dual cyclooxygenase-2 (COX-2) and sol. epoxide hydrolase (sEH) inhibitor, PTUPB, on the metabolic abnormalities.  Here, we investigated the effects of PTUPB on hepatic steatosis in high-fat diet (HFD)-induced obese mice, as well as in hepatocytes in vitro.  We found that PTUPB treatment reduced body wt., liver wt., liver triglyceride and cholesterol content, and the expression of lipolytic/lipogenic and lipid uptake related genes (Acc, Cd36, and Cidec) in HFD mice.  In addn., PTUPB treatment arrested fibrotic progression with a decrease of collagen deposition and expression of Col1a1, Col1a3, and a-SMA.  In vitro, PTUPB decreased palmitic acid-induced lipid deposition and downregulation of lipolytic/lipogenic genes (Acc and Cd36) in hepatocytes.  Addnl., we found that PTUPB reduced the prodn. of pro-inflammatory cytokines and suppressed the NLRP3 inflammasome activation in HFD mice and hepatocytes.  In conclusion, dual inhibition of COX-2/sEH attenuates hepatic steatosis by inhibiting the NLRP3 inflammasome activation.  PTUPB might be a promising potential therapy for liver steatosis assocd. with obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEB3zkrRaw27Vg90H21EOLACvtfcHk0ljE8MeSb7E9lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKqtb0%253D&md5=942c4c8f06613309adccee2d36413428</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2019.12.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2019.12.131%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26aulast%3DLiu%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DPTUPB%2520ameliorates%2520high-fat%2520diet-induced%2520non-alcoholic%2520fatty%2520liver%2520disease%2520via%2520inhibiting%2520NLRP3%2520inflammasome%2520activation%2520in%2520mice%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2020%26volume%3D523%26spage%3D1020%26epage%3D1026%26doi%3D10.1016%2Fj.bbrc.2019.12.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span> <span> </span><span class="NLM_article-title">A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">109907</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.109907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.biopha.2020.109907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32114358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFejsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2020&pages=109907&author=Y.+F.+Zhangauthor=C.+C.+Sunauthor=J.+X.+Duanauthor=H.+H.+Yangauthor=C.+Y.+Zhangauthor=J.+B.+Xiongauthor=W.+J.+Zhongauthor=C.+Zuauthor=X.+X.+Guanauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guan&title=A+COX-2%2FsEH+dual+inhibitor+PTUPB+ameliorates+cecal+ligation+and+puncture-induced+sepsis+in+mice+via+anti-inflammation+and+anti-oxidative+stress&doi=10.1016%2Fj.biopha.2020.109907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress</span></div><div class="casAuthors">Zhang, Yan-Feng; Sun, Chen-Chen; Duan, Jia-Xi; Yang, Hui-Hui; Zhang, Chen-Yu; Xiong, Jian-Bing; Zhong, Wen-Jing; Zu, Cheng; Guan, Xin-Xin; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109907</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Arachidonic acid can be metabolized to prostaglandins and epoxyeicosatrienoic acids (EETs) by cyclooxygenase-2 (COX-2) and cytochrome P 450 (CYP), resp.  While protective EETs are degraded by sol. epoxide hydrolase (sEH) very fast.  We have reported that dual inhibition of COX-2 and sEH with specific inhibitor PTUPB shows anti-pulmonary fibrosis and renal protection.  However, the effect of PTUPB on cecal ligation and puncture (CLP)-induced sepsis remains unclear.  The current study aimed to investigate the protective effects of PTUPB against CLP-induced sepsis in mice and the underlying mechanisms.  We found that COX-2 expressions were increased, while CYPs expressions were decreased in the liver, lung, and kidney of mice undergone CLP.  PTUPB treatment significantly improved the survival rate, reduced the clin. scores and systemic inflammatory response, alleviated liver and kidney dysfunction, and ameliorated the multiple-organ injury of the mice with sepsis.  Besides, PTUPB treatment reduced the expression of hypoxia-inducible factor-1α in the liver, lung, and kidney of septic mice.  Importantly, we found that PTUPB treatment suppressed the activation of NLRP3 inflammasome in the liver and lung of septic mice.  Meanwhile, we found that PTUPB attenuated the oxidative stress, which contributed to the activation of NLRP3 inflammasome.  Altogether, our data, for the first time, demonstrate that dual inhibition of COX-2 and sEH with PTUPB ameliorates the multiple organ dysfunction in septic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkHstn3Uty0rVg90H21EOLACvtfcHk0liEVw6Cauu1fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFejsrk%253D&md5=75cd4f705fedbcdf7b2a21dc0782b3f6</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.109907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.109907%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BF.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DXiong%26aufirst%3DJ.%2BB.%26aulast%3DZhong%26aufirst%3DW.%2BJ.%26aulast%3DZu%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26atitle%3DA%2520COX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520ameliorates%2520cecal%2520ligation%2520and%2520puncture-induced%2520sepsis%2520in%2520mice%2520via%2520anti-inflammation%2520and%2520anti-oxidative%2520stress%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2020%26volume%3D126%26spage%3D109907%26doi%3D10.1016%2Fj.biopha.2020.109907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span> <span> </span><span class="NLM_article-title">COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1111/febs.15105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Ffebs.15105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31646730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFaku77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2020&pages=1666-1680&author=C.+Y.+Zhangauthor=J.+X.+Duanauthor=H.+H.+Yangauthor=C.+C.+Sunauthor=W.+J.+Zhongauthor=J.+H.+Taoauthor=X.+X.+Guanauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guan&title=COX-2%2FsEH+dual+inhibitor+PTUPB+alleviates+bleomycin-induced+pulmonary+fibrosis+in+mice+via+inhibiting+senescence&doi=10.1111%2Ffebs.15105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence</span></div><div class="casAuthors">Zhang, Chen-Yu; Duan, Jia-Xi; Yang, Hui-Hui; Sun, Chen-Chen; Zhong, Wen-Jing; Tao, Jia-Hao; Guan, Xin-Xin; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1666-1680</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pulmonary fibrosis (PF) is a senescence-assocd. disease with poor prognosis.  Currently, there is no effective therapeutic strategy for preventing and treating the disease process.  Mounting evidence suggests that arachidonic acid (ARA) metabolites are involved in the pathogenesis of various fibrosis.  However, the relationship between the metab. of ARA and PF is still elusive.  In this study, we obsd. a disorder in the cyclooxygenase-2/cytochrome P 450 (COX-2/CYP) metab. of ARA in the lungs of PF mice induced by bleomycin (BLM).  Therefore, we aimed to explore the role of COX-2/CYP-derived ARA metabolic disorders in PF.  PTUPB, a dual COX-2 and sol. epoxide hydrolase (sEH) inhibitor, was used to restore the balance of COX-2/CYP metab. sEH is an enzyme hydrolyzing epoxyeicosatrienoic acids derived from ARA by CYP.  We found that PTUPB alleviated the pathol. changes in lung tissue and collagen deposition, as well as reduced senescence marker mols. (p16Ink4a and p53-p21Waf1/Cip1) in the lungs of mice treated by BLM.  In vitro, we found that PTUPB pretreatment remarkably reduced the expression of senescence-related mols. in the alveolar epithelial cells (AECs) induced by BLM.  In conclusion, our study supports the notion that the COX-2/CYP-derived ARA metabolic disorders may be a potential therapeutic target for PF via inhibiting the cellular senescence in AECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpWBjLnA38k7Vg90H21EOLACvtfcHk0liEVw6Cauu1fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFaku77J&md5=4f5e7ee2ac5db669455c6133e17b418e</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Ffebs.15105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.15105%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DZhong%26aufirst%3DW.%2BJ.%26aulast%3DTao%26aufirst%3DJ.%2BH.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26atitle%3DCOX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520alleviates%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%2520via%2520inhibiting%2520senescence%26jtitle%3DFEBS%2520J.%26date%3D2020%26volume%3D287%26spage%3D1666%26epage%3D1680%26doi%3D10.1111%2Ffebs.15105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakkappa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamjala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2017.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.jpba.2017.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29169114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=457-464&author=N.+Lakkappaauthor=P.+T.+Krishnamurthyauthor=K.+Yamjalaauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=B.+Babu&title=Evaluation+of+antiparkinson+activity+of+PTUPB+by+measuring+dopamine+and+its+metabolites+in+Drosophila+melanogaster%3A+LC-MS%2FMS+method+development&doi=10.1016%2Fj.jpba.2017.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development</span></div><div class="casAuthors">Lakkappa, Navya; Krishnamurthy, Praveen T.; Yamjala, Karthik; Hwang, Sung Hee; Hammock, Bruce D.; Babu, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">457-464</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) inhibition is reported to elevate endogenous epoxyeicosatrienoic acids (EET's), which are known to play an important role in neuroprotection by inhibiting oxidative stress and neuroinflammation.  In the present study, PTUPB, a dual inhibitor of sEH and COX-2, has been tested for its antiparkinson activity against rotenone (ROT) induced neurodegeneration in Drosophila model of Parkinson's disease (PD).  To det. the efficacy and brain bioavailability of PTUPB a simple, rapid and sensitive LC-MS/MS method was developed and validated for the estn. of PTUPB (Method-I), dopamine (DA) and its metabolites (Method-II) in fly head.  Mass spectrometric acquisitions of analytes signals were performed in pos. and neg. electron spray ionization MRM mode by monitoring the daughter ions.  The isocratic elution using formic acid (0.1% vol./vol.) and acetonitrile (20:80 vol./vol.) (for method I), and acetic acid (0.1% vol./vol.) and methanol (for method II) on Jones C18 was carried out to achieve the sepn.  The results of brain PTUPB, DA and its metabolites estn. shows a dose dependent increase in PTUPB concn. and a dose dependent prevention of ROT induced changes in DA and its metabolites levels (p < 0.05), indicating a significant neuroprotection activity of PTUPB.  In the present study, the authors have successfully developed and validated LC-MS/MS methods to identify and quantify PTUPB, DA and its metabolites using a UFLC-ESI-QqQ mass spectrometer for the screening of neuroprotective agents in Drosophila Melanogaster.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJ7KK-XDYu7Vg90H21EOLACvtfcHk0ljSR72f7tMM2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrsb7E&md5=bbde36476ec5fe6778a7740032fbb29b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2017.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2017.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DLakkappa%26aufirst%3DN.%26aulast%3DKrishnamurthy%26aufirst%3DP.%2BT.%26aulast%3DYamjala%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBabu%26aufirst%3DB.%26atitle%3DEvaluation%2520of%2520antiparkinson%2520activity%2520of%2520PTUPB%2520by%2520measuring%2520dopamine%2520and%2520its%2520metabolites%2520in%2520Drosophila%2520melanogaster%253A%2520LC-MS%252FMS%2520method%2520development%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2018%26volume%3D149%26spage%3D457%26epage%3D464%26doi%3D10.1016%2Fj.jpba.2017.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">87353</span>– <span class="NLM_lpage">87363</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.18632%2Foncotarget.20928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29152086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1M3is1CjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=87353-87363&author=J.+Liauthor=Y.+Zhouauthor=H.+Wangauthor=Y.+Gaoauthor=L.+Liauthor=S.+H.+Hwangauthor=X.+Jiauthor=B.+D.+Hammock&title=COX-2%2FsEH+dual+inhibitor+PTUPB+suppresses+glioblastoma+growth+by+targeting+epidermal+growth+factor+receptor+and+hyaluronan+mediated+motility+receptor&doi=10.18632%2Foncotarget.20928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor</span></div><div class="casAuthors">Li Junyang; Zhou Yali; Wang Handong; Gao Yongyue; Li Liwen; Ji Xiangjun; Hwang Sung Hee; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">87353-87363</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aims:  Cyclooxygenase-2 (COX-2)/soluble epoxide hydrolase (sEH) dual inhibitor, PTUPB, has been demonstrated to inhibit angiogenesis, primary tumor growth and metastasis.  The aim of this study is to investigate the effects of PTUPB on glioblastoma cells and xenograft model.  Results:  We show here that PTUPB inhibits glioblastoma cell proliferation and G1 phase cell cycle arrest in vitro, and suppresses the tumor growth and angiogenesis in vivo.  The expression and activation of epidermal growth factor receptor (EGFR) and its downstream kinases, ERK1/2 and AKT, are reduced by PTUPB, indicating that the EGF/EGFR signaling pathway is a potential target.  Moreover, PTUPB dramatically suppresses expression of hyaluronan mediated motility receptor (HMMR) in the glioblastoma cell lines and xenograft mouse model, suggesting that the HMMR is the other potential target.  Materials and Methods:  Cellular immunofluorescence assays were used for cell staining of actin fibers and HMMR.  CCK-8 kit was used for cell proliferation assay.  Cell-cycle analysis was performed by flow cytometry.  Quantitative real-time PCR assay was performed to test mRNA level.  Western blot analysis was used to test protein expression.  Immunohistochemical staining assay was used for xenograft tumor tissue staining of Ki-67, CD31 and HMMR.  The SPSS version 17.0 software was applied for statistical analysis.  Conclusions:  Our data demonstrate that PTUPB is a potential therapeutic agent to treat glioblastomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtczqLBkChQEwlCcfExbvbfW6udTcc2eYY1vatuLnugbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3is1CjtA%253D%253D&md5=234bb48f0d09fa40cf925012af0c2aaf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20928%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DCOX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520suppresses%2520glioblastoma%2520growth%2520by%2520targeting%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520hyaluronan%2520mediated%2520motility%2520receptor%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D87353%26epage%3D87363%26doi%3D10.18632%2Foncotarget.20928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gartung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhatme, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielenberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurakowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span> <span> </span><span class="NLM_article-title">Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1073/pnas.1803999116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1803999116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30647111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVylsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=1698-1703&author=A.+Gartungauthor=J.+Yangauthor=V.+P.+Sukhatmeauthor=D.+R.+Bielenbergauthor=D.+Fernandesauthor=J.+Changauthor=B.+A.+Schmidtauthor=S.+H.+Hwangauthor=D.+Zurakowskiauthor=S.+Huangauthor=M.+W.+Kieranauthor=B.+D.+Hammockauthor=D.+Panigrahy&title=Suppression+of+chemotherapy-induced+cytokine%2Flipid+mediator+surge+and+ovarian+cancer+by+a+dual+COX-2%2FsEH+inhibitor&doi=10.1073%2Fpnas.1803999116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor</span></div><div class="casAuthors">Gartung, Allison; Yang, Jun; Sukhatme, Vikas P.; Bielenberg, Diane R.; Fernandes, Djanira; Chang, Jaimie; Schmidt, Birgitta A.; Hwang, Sung Hee; Zurakowski, David; Huang, Sui; Kieran, Mark W.; Hammock, Bruce D.; Panigrahy, Dipak</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1698-1703</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although chemotherapy is a conventional cancer treatment, it may induce a protumorigenic microenvironment by triggering the release of proinflammatory mediators.  In this study, we demonstrate that ovarian tumor cell debris generated by first-line platinum- and taxane-based chemotherapy accelerates tumor progression by stimulating a macrophage-derived "surge" of proinflammatory cytokines and bioactive lipids.  Thus, targeting a single inflammatory mediator or pathway is unlikely to prevent therapy-induced tumor progression.  Here, we show that combined pharmacol. abrogation of the cyclooxygenase-2 (COX-2) and sol. epoxide hydrolase (sEH) pathways prevented the debris-induced surge of both cytokines and lipid mediators by macrophages.  In animal models, the dual COX-2/sEH inhibitor PTUPB delayed the onset of debris-stimulated ovarian tumor growth and ascites leading to sustained survival over 120 days postinjection.  Therefore, dual inhibition of COX-2/sEH may be an approach to suppress debris-stimulated ovarian tumor growth by preventing the therapy-induced surge of cytokines and lipid mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-do9HWwkQRrVg90H21EOLACvtfcHk0ljSR72f7tMM2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVylsLk%253D&md5=0fc650b42181286a0efaefc882efe214</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803999116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803999116%26sid%3Dliteratum%253Aachs%26aulast%3DGartung%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26aulast%3DBielenberg%26aufirst%3DD.%2BR.%26aulast%3DFernandes%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DB.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZurakowski%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPanigrahy%26aufirst%3DD.%26atitle%3DSuppression%2520of%2520chemotherapy-induced%2520cytokine%252Flipid%2520mediator%2520surge%2520and%2520ovarian%2520cancer%2520by%2520a%2520dual%2520COX-2%252FsEH%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D1698%26epage%3D1703%26doi%3D10.1073%2Fpnas.1803999116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glatzel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and cellular characterization of a dual inhibitor of 5-lipoxygenase and soluble epoxide hydrolase</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3390/molecules22010045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fmolecules22010045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=45&author=K.+Meirerauthor=D.+Glatzelauthor=S.+Kretschmerauthor=S.+K.+Wittmannauthor=M.+Hartmannauthor=R.+Bl%C3%B6cherauthor=C.+Angioniauthor=G.+Geisslingerauthor=D.+Steinhilberauthor=B.+Hofmannauthor=R.+F%C3%BCrstauthor=E.+Proschak&title=Design%2C+synthesis+and+cellular+characterization+of+a+dual+inhibitor+of+5-lipoxygenase+and+soluble+epoxide+hydrolase&doi=10.3390%2Fmolecules22010045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and cellular characterization of a dual inhibitor of 5-lipoxygenase and soluble epoxide hydrolase</span></div><div class="casAuthors">Meirer, Karin; Glatzel, Daniel; Kretschmer, Simon; Wittmann, Sandra K.; Hartmann, Markus; Bloecher, Rene; Angioni, Carlo; Geisslinger, Gerd; Steinhilber, Dieter; Hofmann, Bettina; Fuerst, Robert; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45/1-45/10</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A novel prototype of a dual 5-lipoxygenase (5-LO)/sol. epoxide hydrolase inhibitor (I) was rationally designed and synthesized.  Compd. I was evaluated in enzyme activity assays with recombinant enzymes.  Furthermore, activity of compd. I in human whole blood and endothelial cells was investigated.  Compd. I potently inhibited both enzymes in-vitro and attenuated the formation of leukotrienes in human whole blood.  Compd. I was also tested in a cell function-based assay.  Compd. I significantly inhibited the LPS-induced adhesion of leukocytes to endothelial cells by blocking leukocyte activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkS9gBTWQ-LVg90H21EOLACvtfcHk0lifysIwArNCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlWntrc%253D&md5=24c1b299a3d583a6771c9f8fe1f94f50</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22010045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22010045%26sid%3Dliteratum%253Aachs%26aulast%3DMeirer%26aufirst%3DK.%26aulast%3DGlatzel%26aufirst%3DD.%26aulast%3DKretschmer%26aufirst%3DS.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%2520and%2520cellular%2520characterization%2520of%2520a%2520dual%2520inhibitor%2520of%25205-lipoxygenase%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D45%26doi%3D10.3390%2Fmolecules22010045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewska, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buscató, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1021/ml200286e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200286e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=155-158&author=D.+Moserauthor=J.+M.+Wisniewskaauthor=S.+Hahnauthor=J.+Achenbachauthor=E.+L.+Buscat%C3%B3author=F.+M.+Klinglerauthor=B.+Hofmannauthor=D.+Steinhilberauthor=E.+Proschak&title=Dual-target+virtual+screening+by+pharmacophore+elucidation+and+molecular+shape+filtering&doi=10.1021%2Fml200286e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Target Virtual Screening by Pharmacophore Elucidation and Molecular Shape Filtering</span></div><div class="casAuthors">Moser, Daniel; Wisniewska, Joanna M.; Hahn, Steffen; Achenbach, Janosch; Buscato, Estella; Klingler, Franca-Maria; Hofmann, Bettina; Steinhilber, Dieter; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-158</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual-target inhibitors gained increased attention in the past years.  A novel in silico approach was employed for the discovery of dual 5-lipoxygenase/sol. epoxide hydrolase inhibitors.  The ligand-based approach uses excessive pharmacophore elucidation and pharmacophore alignment in conjunction with shape-based scoring.  The virtual screening results were verified in vitro, leading to nine novel inhibitors including a dual-target compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUfWwnhy-PbVg90H21EOLACvtfcHk0lifysIwArNCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWqtA%253D%253D&md5=c3b1f98838976f54cc1a38c82096443d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fml200286e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200286e%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DBuscat%25C3%25B3%26aufirst%3DE.%2BL.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDual-target%2520virtual%2520screening%2520by%2520pharmacophore%2520elucidation%2520and%2520molecular%2520shape%2520filtering%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D155%26epage%3D158%26doi%3D10.1021%2Fml200286e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häfner, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rödl, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löhr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Exploring the chemical space of multitarget ligands using aligned self-organizing maps</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/ml4002562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kkt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1169-1172&author=J.+Achenbachauthor=F.+M.+Klinglerauthor=R.+Bl%C3%B6cherauthor=D.+Moserauthor=A.+K.+H%C3%A4fnerauthor=C.+B.+R%C3%B6dlauthor=S.+Kretschmerauthor=B.+Kr%C3%BCgerauthor=F.+L%C3%B6hrauthor=H.+Starkauthor=B.+Hofmannauthor=D.+Steinhilberauthor=E.+Proschak&title=Exploring+the+chemical+space+of+multitarget+ligands+using+aligned+self-organizing+maps&doi=10.1021%2Fml4002562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps</span></div><div class="casAuthors">Achenbach, Janosch; Klingler, Franca-Maria; Bloecher, Rene; Moser, Daniel; Haefner, Ann-Kathrin; Roedl, Carmen B.; Kretschmer, Simon; Krueger, Bjoern; Loehr, Frank; Stark, Holger; Hofmann, Bettina; Steinhilber, Dieter; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1169-1172</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Design of multitarget drugs and polypharmacol. compds. has become popular during the past decade.  However, the main approach to design such compds. is to link two selective ligands via a flexible linker.  Although such chimeric ligands often have reasonable potency in vitro, the in vivo efficacy is low due to high mol. wt., low ligand efficiency, and poor pharmacokinetic profile.  We developed an unprecedented in silico approach for fragment-based design of multitarget ligands.  It relies on superposition of the chem. spaces related to the affinity on single targets represented by self-organizing maps.  We used this approach for screening of mol. fragments, which bind to the enzymes 5-lipoxygenase (5-LO) and sol. epoxide hydrolase (sEH).  Using STD-NMR and activity-based assays, we were able to identify fragments binding to both targets.  Furthermore, we were able to expand one of the fragments to a potent dual inhibitor bearing a reasonable mol. wt. (MW = 446) and high affinity to both targets (IC50 of 0.03 μM toward 5-LO and 0.17 μM toward sEH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp120TeMy83c7Vg90H21EOLACvtfcHk0lhGXzVi7fuz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kkt7fL&md5=4231074e150dd7db7b92242d4c1664ff</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fml4002562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002562%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DH%25C3%25A4fner%26aufirst%3DA.%2BK.%26aulast%3DR%25C3%25B6dl%26aufirst%3DC.%2BB.%26aulast%3DKretschmer%26aufirst%3DS.%26aulast%3DKr%25C3%25BCger%26aufirst%3DB.%26aulast%3DL%25C3%25B6hr%26aufirst%3DF.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DExploring%2520the%2520chemical%2520space%2520of%2520multitarget%2520ligands%2520using%2520aligned%2520self-organizing%2520maps%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1169%26epage%3D1172%26doi%3D10.1021%2Fml4002562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nandha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramareddy, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuntal, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>351</i></span>, <span class="NLM_elocation-id">1800030</span> <span class="refDoi"> DOI: 10.1002/ardp.201800030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fardp.201800030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2018&author=B.+Nandhaauthor=S.+A.+Ramareddyauthor=H.+Kuntal&title=Synthesis+of+substituted+fluorobenzimidazoles+as+inhibitors+of+5-lipoxygenase+and+soluble+epoxide+hydrolase+for+anti-inflammatory+activity&doi=10.1002%2Fardp.201800030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fardp.201800030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201800030%26sid%3Dliteratum%253Aachs%26aulast%3DNandha%26aufirst%3DB.%26aulast%3DRamareddy%26aufirst%3DS.%2BA.%26aulast%3DKuntal%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520substituted%2520fluorobenzimidazoles%2520as%2520inhibitors%2520of%25205-lipoxygenase%2520and%2520soluble%2520epoxide%2520hydrolase%2520for%2520anti-inflammatory%2520activity%26jtitle%3DArch.%2520Pharm.%26date%3D2018%26volume%3D351%26doi%3D10.1002%2Fardp.201800030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klegeris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeer, P. L.</span></span> <span> </span><span class="NLM_article-title">Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1189/jlb.1002482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1189%2Fjlb.1002482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12629151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=369-378&author=A.+Klegerisauthor=P.+L.+McGeer&title=Toxicity+of+human+monocytic+THP-1+cells+and+microglia+toward+SH-SY5Y+neuroblastoma+cells+is+reduced+by+inhibitors+of+5-lipoxygenase+and+its+activating+protein+FLAP&doi=10.1189%2Fjlb.1002482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP</span></div><div class="casAuthors">Klegeris, Andis; McGeer, Patrick L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-378</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">To explore whether the proinflammatory products of the 5-lipoxygenase (5-LOX) pathway are involved in microglia-mediated toxicity toward neuronal cells, we evaluated the effects of 5-LOX inhibitors using an in vitro assay system where human neuronal SH-SY5Y cells are exposed to toxic secretions from THP-1 monocytic cells or human microglia.  The specific 5-LOX inhibitors, REV 5901, zileuton, and 5-hydroxyeicosatetraenoic acid lactone; the nonselective LOX inhibitors, phenidone and dapsone; the dual 5-LOX/cyclooxygenase inhibitor, tepoxalin; and the selective inhibitor of the 5-LOX-activating protein (FLAP), MK-886, inhibited such toxicity.  The toxicity was enhanced by the 5-LOX product leukotriene (LT)D4 and reduced by the selective cysteinyl LT receptor (CysLT1) antagonist MK-571.  The mRNAs for 5-LOX and FLAP were detected in THP-1 cells and human microglia but not in SH-SY5Y cells.  The data suggest that inhibition of proinflammatory LT prodn. by 5-LOX inhibition could selectively reduce toxicity of microglial cells and thus be beneficial in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4lbvgfThT7Vg90H21EOLACvtfcHk0lhGXzVi7fuz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCgtLc%253D&md5=7c9ce845548c856db4e6b86137ac41f3</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1002482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1002482%26sid%3Dliteratum%253Aachs%26aulast%3DKlegeris%26aufirst%3DA.%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26atitle%3DToxicity%2520of%2520human%2520monocytic%2520THP-1%2520cells%2520and%2520microglia%2520toward%2520SH-SY5Y%2520neuroblastoma%2520cells%2520is%2520reduced%2520by%2520inhibitors%2520of%25205-lipoxygenase%2520and%2520its%2520activating%2520protein%2520FLAP%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2003%26volume%3D73%26spage%3D369%26epage%3D378%26doi%3D10.1189%2Fjlb.1002482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kent, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamant, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saggu, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, S.</span></span> <span> </span><span class="NLM_article-title">The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma</span>. <i>Clin. Exp. Allergy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1111/cea.12002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fcea.12002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23331559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Chtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=177-186&author=S.+E.+Kentauthor=M.+Boyceauthor=Z.+Diamantauthor=D.+Singhauthor=B.+J.+O%E2%80%99Connorauthor=P.+S.+Sagguauthor=S.+Norris&title=The+5-lipoxygenase-activating+protein+inhibitor%2C+GSK2190915%2C+attenuates+the+early+and+late+responses+to+inhaled+allergen+in+mild+asthma&doi=10.1111%2Fcea.12002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma</span></div><div class="casAuthors">Kent, S. E.; Boyce, M.; Diamant, Z.; Singh, D.; O'Connor, B. J.; Saggu, P. S.; Norris, V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Allergy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">GSK2190915, a potent 5-lipoxygenase-activating protein inhibitor, prevents the synthesis of leukotrienes and 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE).  To assess the effect of GSK2190915 on the allergen-induced asthmatic responses.  Nineteen eligible male subjects with mild asthma were enrolled in and completed this four-center, double-blind, two-way crossover study (ClinicalTrials.gov NCT00748306).  Subjects took GSK2190915 100 mg and placebo orally once daily for 5 days in randomized order.  On Day 1 and 4 they had a methacholine challenge, on Day 3 they had an inhaled allergen challenge, and on Days 4 and 6 they had sputum induction.  GSK2190915 attenuated the early (0-2 h) and late (4-10 h) asthmatic responses to inhaled allergen compared with placebo.  There was a statistically significant attenuation of the early asthmatic response (EAR) by GSK2190915; treatment difference of GSK2190915 vs. placebo for the min. FEV1 EAR was 0.408 L (0.205, 0.611).  There was a statistically significant attenuation of the late asthmatic response (LAR) by GSK2190915; the treatment difference of GSK2190915 vs. placebo for the min. FEV1 LAR was 0.229 L (0.041, 0.417).  There was a statistically significant attenuation of allergen-induced sputum eosinophil count on Day 4 following GSK2190915: mean treatment difference (95% CI) between GSK2190915 and placebo was -9.95% (-18.15%, -1.77%).  Compared with placebo, GSK2190915 100 mg reduced median sputum LTB4 by > 90% on Days 4 and 6.  There was no effect on methacholine PC20 post allergen.  GSK2190915 was generally well tolerated.  GSK2190915 shows potential as a treatment for patients with asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXmDUnaRPW2bVg90H21EOLACvtfcHk0ljp2IS35OPJXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Chtr0%253D&md5=22e222700ebee90a001fa921342ff500</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fcea.12002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcea.12002%26sid%3Dliteratum%253Aachs%26aulast%3DKent%26aufirst%3DS.%2BE.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DDiamant%26aufirst%3DZ.%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BJ.%26aulast%3DSaggu%26aufirst%3DP.%2BS.%26aulast%3DNorris%26aufirst%3DS.%26atitle%3DThe%25205-lipoxygenase-activating%2520protein%2520inhibitor%252C%2520GSK2190915%252C%2520attenuates%2520the%2520early%2520and%2520late%2520responses%2520to%2520inhaled%2520allergen%2520in%2520mild%2520asthma%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2013%26volume%3D43%26spage%3D177%26epage%3D186%26doi%3D10.1111%2Fcea.12002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bcp.2009.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19896470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=880-887&author=J.+Y.+Liuauthor=J.+Yangauthor=B.+Inceogluauthor=H.+Qiuauthor=A.+Uluauthor=S.+H.+Hwangauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=Inhibition+of+soluble+epoxide+hydrolase+enhances+the+anti-inflammatory+effects+of+aspirin+and+5-lipoxygenase+activation+protein+inhibitor+in+a+murine+model&doi=10.1016%2Fj.bcp.2009.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model</span></div><div class="casAuthors">Liu, Jun-Yan; Yang, Jun; Inceoglu, Bora; Qiu, Hong; Ulu, Arzu; Hwang, Sung-Hee; Chiamvimonvat, Nipavan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">880-887</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inflammation is a multi-staged process whose expansive phase is thought to be driven by acutely released arachidonic acid (AA) and its metabolites.  Inhibition of cyclooxygenase (COX), lipoxygenase (LOX), or sol. epoxide hydrolase (sEH) is known to be anti-inflammatory.  Inhibition of sEH stabilizes the cytochrome P 450 (CYP450) products epoxyeicosatrienoic acids (EETs).  Here we used a non-selective COX inhibitor aspirin, a 5-lipoxygenase activation protein (FLAP) inhibitor MK886, and a sEH inhibitor t-AUCB to selectively modulate the branches of AA metab. in a lipopolysaccharide (LPS)-challenged murine model.  We used metabolomic profiling to simultaneously monitor representative AA metabolites of each branch.  In addn. to the significant crosstalk among branches of the AA cascade during selective modulation of COX, LOX, or sEH, we demonstrated that co-administration of t-AUCB enhanced the anti-inflammatory effects of aspirin or MK886, which was evidenced by the observations that co-administration resulted in favorable eicosanoid profiles and better control of LPS-mediated hypotension as well as hepatic protein expression of COX-2 and 5-LOX.  Targeted disruption of the sEH gene displayed a parallel profile to that produced by t-AUCB.  These observations demonstrate a significant level of crosstalk among the three major branches of the AA cascade and that they are not simply parallel pathways.  These data illustrate that inhibition of sEH by both pharmacol. intervention and gene knockout enhances the anti-inflammatory effects of aspirin and MK886, suggesting the possibility of modulating multiple branches to achieve better therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNys3Qohu2SbVg90H21EOLACvtfcHk0ljp2IS35OPJXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFGjsA%253D%253D&md5=b2c07c47ac46c982c996c4a7e136ebdb</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520enhances%2520the%2520anti-inflammatory%2520effects%2520of%2520aspirin%2520and%25205-lipoxygenase%2520activation%2520protein%2520inhibitor%2520in%2520a%2520murine%2520model%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D880%26epage%3D887%26doi%3D10.1016%2Fj.bcp.2009.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garscha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temml, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstmeier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liening, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinigel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scriba, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautebin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">9398</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-09795-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fs41598-017-09795-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28839250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhsVOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=9398&author=U.+Garschaauthor=E.+Rompauthor=S.+Paceauthor=A.+Rossiauthor=V.+Temmlauthor=D.+Schusterauthor=S.+K%C3%B6nigauthor=J.+Gerstmeierauthor=S.+Lieningauthor=M.+Wernerauthor=H.+Atzeauthor=S.+Wittmannauthor=C.+Weinigelauthor=S.+Rummlerauthor=G.+K.+Scribaauthor=L.+Sautebinauthor=O.+Werz&title=Pharmacological+profile+and+efficiency+in+vivo+of+diflapolin%2C+the+first+dual+inhibitor+of+5-lipoxygenase-activating+protein+and+soluble+epoxide+hydrolase&doi=10.1038%2Fs41598-017-09795-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase</span></div><div class="casAuthors">Garscha Ulrike; Romp Erik; Pace Simona; Konig Stefanie; Gerstmeier Jana; Liening Stefanie; Werner Markus; Atze Heiner; Scriba Gerhard K; Werz Oliver; Rossi Antonietta; Sautebin Lidia; Temml Veronika; Schuster Daniela; Wittmann Sandra; Weinigel Christina; Rummler Silke</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9398</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Arachidonic acid (AA) is metabolized to diverse bioactive lipid mediators.  Whereas the 5-lipoxygenase-activating protein (FLAP) facilitates AA conversion by 5-lipoxygenase (5-LOX) to pro-inflammatory leukotrienes (LTs), the soluble epoxide hydrolase (sEH) degrades anti-inflammatory epoxyeicosatrienoic acids (EETs).  Accordingly, dual FLAP/sEH inhibition might be advantageous drugs for intervention of inflammation.  We present the in vivo pharmacological profile and efficiency of N-[4-(benzothiazol-2-ylmethoxy)-2-methylphenyl]-N'-(3,4-dichlorophenyl)urea (diflapolin) that dually targets FLAP and sEH.  Diflapolin inhibited 5-LOX product formation in intact human monocytes and neutrophils with IC50 = 30 and 170 nM, respectively, and suppressed the activity of isolated sEH (IC50 = 20 nM).  Characteristic for FLAP inhibitors, diflapolin (I) failed to inhibit isolated 5-LOX, (II) blocked 5-LOX product formation in HEK cells only when 5-LOX/FLAP was co-expressed, (III) lost potency in intact cells when exogenous AA was supplied, and (IV) prevented 5-LOX/FLAP complex assembly in leukocytes.  Diflapolin showed target specificity, as other enzymes related to AA metabolism (i.e., COX1/2, 12/15-LOX, LTA4H, LTC4S, mPGES1, and cPLA2) were not inhibited.  In the zymosan-induced mouse peritonitis model, diflapolin impaired vascular permeability, inhibited cysteinyl-LTs and LTB4 formation, and suppressed neutrophil infiltration.  Diflapolin is a highly active dual FLAP/sEH inhibitor in vitro and in vivo with target specificity to treat inflammation-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxLyW0tp5b8IvKgEt20y1XfW6udTcc2eYLlTdJAzsexLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhsVOntw%253D%253D&md5=d6c11708cd9ac8cba4d2828b9d7ce6d9</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-09795-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-09795-w%26sid%3Dliteratum%253Aachs%26aulast%3DGarscha%26aufirst%3DU.%26aulast%3DRomp%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DS.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DTemml%26aufirst%3DV.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DK%25C3%25B6nig%26aufirst%3DS.%26aulast%3DGerstmeier%26aufirst%3DJ.%26aulast%3DLiening%26aufirst%3DS.%26aulast%3DWerner%26aufirst%3DM.%26aulast%3DAtze%26aufirst%3DH.%26aulast%3DWittmann%26aufirst%3DS.%26aulast%3DWeinigel%26aufirst%3DC.%26aulast%3DRummler%26aufirst%3DS.%26aulast%3DScriba%26aufirst%3DG.%2BK.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DWerz%26aufirst%3DO.%26atitle%3DPharmacological%2520profile%2520and%2520efficiency%2520in%2520vivo%2520of%2520diflapolin%252C%2520the%2520first%2520dual%2520inhibitor%2520of%25205-lipoxygenase-activating%2520protein%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D9398%26doi%3D10.1038%2Fs41598-017-09795-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vieider, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temml, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garscha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszczak, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and structure-activity relationships of diflapolin analogues as dual sEH/FLAP inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlOksL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=62-66&author=L.+Vieiderauthor=E.+Rompauthor=V.+Temmlauthor=J.+Fischerauthor=C.+Kretzerauthor=M.+Schoenthalerauthor=A.+Tahaauthor=V.+Hern%C3%A1ndez-Olmosauthor=S.+Sturmauthor=D.+Schusterauthor=O.+Werzauthor=U.+Garschaauthor=B.+Matuszczak&title=Synthesis%2C+biological+evaluation+and+structure-activity+relationships+of+diflapolin+analogues+as+dual+sEH%2FFLAP+inhibitors&doi=10.1021%2Facsmedchemlett.8b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors</span></div><div class="casAuthors">Vieider, Lisa; Romp, Erik; Temml, Veronika; Fischer, Jana; Kretzer, Christian; Schoenthaler, Martin; Taha, Abdulla; Hernandez-Olmos, Victor; Sturm, Sonja; Schuster, Daniela; Werz, Oliver; Garscha, Ulrike; Matuszczak, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-66</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of derivs. of the potent dual sol. epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesized, and characterized by 1H NMR, 13C NMR, and elemental anal.  These novel compds. were biol. evaluated for their inhibitory activity against sEH and FLAP.  Mol. modeling tools were applied to analyze structure-activity relationships (SAR) on both targets.  Results show that even small modifications on the lead compd. diflapolin markedly influence the inhibitory potential, esp. on FLAP, suggesting very narrow SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGWh-lGghCLVg90H21EOLACvtfcHk0ljhFoWRZr4VZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlOksL7M&md5=78cba7e08adb5604350570d2a61d5e79</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00415%26sid%3Dliteratum%253Aachs%26aulast%3DVieider%26aufirst%3DL.%26aulast%3DRomp%26aufirst%3DE.%26aulast%3DTemml%26aufirst%3DV.%26aulast%3DFischer%26aufirst%3DJ.%26aulast%3DKretzer%26aufirst%3DC.%26aulast%3DSchoenthaler%26aufirst%3DM.%26aulast%3DTaha%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez-Olmos%26aufirst%3DV.%26aulast%3DSturm%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DGarscha%26aufirst%3DU.%26aulast%3DMatuszczak%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520structure-activity%2520relationships%2520of%2520diflapolin%2520analogues%2520as%2520dual%2520sEH%252FFLAP%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D62%26epage%3D66%26doi%3D10.1021%2Facsmedchemlett.8b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Design and potency of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">14076</span>– <span class="NLM_lpage">14086</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b01625</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b01625" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFymsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=14076-14086&author=S.+D.+Kodaniauthor=D.+Wanauthor=K.+M.+Wagnerauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Design+and+potency+of+dual+soluble+epoxide+hydrolase%2Ffatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Facsomega.8b01625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors</span></div><div class="casAuthors">Kodani, Sean D.; Wan, Debin; Wagner, Karen M.; Hwang, Sung Hee; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">14076-14086</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is responsible for regulating concns. of the endocannabinoid arachidonoyl ethanolamide (AEA).  Multiple FAAH inhibitors have been developed for clin. trials and have failed to demonstrate efficacy at treating pain, despite promising preclin. data.  One approach towards increasing the efficacy of FAAH inhibitors is to concurrently inhibit other targets responsible for regulating pain.  Here, the authors designed dual inhibitors targeting the enzymes FAAH and sol. epoxide hydrolase (sEH), which are targets previously shown to synergize at reducing inflammatory and neuropathic pain.  Exploration of the sEH/FAAH inhibitor structure activity relationship started with PF-750, a FAAH inhibitor (IC50 = 19 nM) that weakly inhibited sEH (IC50 = 640 nM).  Potency was optimized resulting in an inhibitor with improved potency on both targets (11, sEH IC50 = 5 nM, FAAH IC50 = 8 nM).  This inhibitor demonstrated good target selectivity, pharmacokinetic properties (AUC = 1200 h*nM, t1/2=4.9 h in mice) and in vivo target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7TM5odPLPg7Vg90H21EOLACvtfcHk0ljhFoWRZr4VZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFymsrbN&md5=0d864e41ccf5c70800d399f89801d23e</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b01625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b01625%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DWan%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDesign%2520and%2520potency%2520of%2520dual%2520soluble%2520epoxide%2520hydrolase%252Ffatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D14076%26epage%3D14086%26doi%3D10.1021%2Facsomega.8b01625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.phrs.2015.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25882247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslCqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=7-15&author=O.+Sassoauthor=K.+Wagnerauthor=C.+Morisseauauthor=B.+Inceogluauthor=B.+D.+Hammockauthor=D.+Piomelli&title=Peripheral+FAAH+and+soluble+epoxide+hydrolase+inhibitors+are+synergistically+antinociceptive&doi=10.1016%2Fj.phrs.2015.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive</span></div><div class="casAuthors">Sasso, Oscar; Wagner, Karen; Morisseau, Christophe; Inceoglu, Bora; Hammock, Bruce D.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-15</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We need better medicines to control acute and chronic pain.  Fatty acid amide hydrolase (FAAH) and sol. epoxide hydrolase (sEH) catalyze the deactivating hydrolysis of two classes of bioactive lipid mediators - fatty acid ethanolamides (FAEs) and epoxidized fatty acids (EpFAs), resp. - which are biogenetically distinct but share the ability to attenuate pain responses and inflammation.  In these expts., we evaluated the antihyperalgesic activity of small-mol. inhibitors of FAAH and sEH, administered alone or in combination, in two pain models: carrageenan-induced hyperalgesia in mice and streptozocin-induced allodynia in rats.  When administered sep., the sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea (TPPU) and the peripherally restricted FAAH inhibitor URB937 were highly active in the two models.  The combination TPPU plus URB937 was markedly synergistic, as assessed using isobolog. analyses.  The results of these expts. reveal the existence of a possible functional crosstalk between FAEs and EpFAs in regulating pain responses.  Addnl., the results suggest that combinations of sEH and FAAH inhibitors might be exploited therapeutically to achieve greater analgesic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KqHflti6UbVg90H21EOLACvtfcHk0lg8yXhoX8eSHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslCqt7s%253D&md5=541ae75edcabea753005fafa96d3dc76</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPeripheral%2520FAAH%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520are%2520synergistically%2520antinociceptive%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D97%26spage%3D7%26epage%3D15%26doi%3D10.1016%2Fj.phrs.2015.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, A. W.</span></span> <span> </span><span class="NLM_article-title">Action of epoxyeicosatrienoic acids on cellular function</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">C996</span>– <span class="NLM_lpage">C1012</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00402.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpcell.00402.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16987999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFeqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C996-C1012&author=A.+A.+Spectorauthor=A.+W.+Norris&title=Action+of+epoxyeicosatrienoic+acids+on+cellular+function&doi=10.1152%2Fajpcell.00402.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Action of epoxyeicosatrienoic acids on cellular function</span></div><div class="casAuthors">Spector, Arthur A.; Norris, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">C996-C1012</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Epoxyeicosatrienoic acids (EETs), which function primarily as autocrine and paracrine mediators in the cardiovascular and renal systems, are synthesized from arachidonic acid by cytochrome P 450 epoxygenases.  They activate smooth muscle large-conductance Ca2+-activated K+ channels, producing hyperpolarization and vasorelaxation.  EETs also have anti-inflammatory effects in the vasculature and kidney, stimulate angiogenesis, and have mitogenic effects in the kidney.  Many of the functional effects of EETs occur through activation of signal transduction pathways and modulation of gene expression, events probably initiated by binding to a putative cell surface EET receptor.  However, EETs are rapidly taken up by cells and are incorporated into and released from phospholipids, suggesting that some functional effects may occur through a direct interaction between the EET and an intracellular effector system.  In this regard, EETs and several of their metabolites activate peroxisome proliferator-activated receptor α (PPARα) and PPARγ, suggesting that some functional effects may result from PPAR activation.  EETs are metabolized primarily by conversion to dihydroxyeicosatrienoic acids (DHETs), a reaction catalyzed by sol. epoxide hydrolase (sEH).  Many potentially beneficial actions of EETs are attenuated upon conversion to DHETs, which do not appear to be essential under routine conditions.  Therefore, sEH is considered a potential therapeutic target for enhancing the beneficial functions of EETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYZxuyWlpL_LVg90H21EOLACvtfcHk0lg8yXhoX8eSHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFeqs74%253D&md5=6ef20b6f3eefdcb1c54d62f1cb10904d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00402.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00402.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DNorris%26aufirst%3DA.%2BW.%26atitle%3DAction%2520of%2520epoxyeicosatrienoic%2520acids%2520on%2520cellular%2520function%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC996%26epage%3DC1012%26doi%3D10.1152%2Fajpcell.00402.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hye Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian-Shaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span>. <i>Exp. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1258/ebm.2012.012225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1258%2Febm.2012.012225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=1402-1412&author=J.+D.+Imigauthor=K.+A.+Walshauthor=M.+A.+Hye+Khanauthor=T.+Nagasawaauthor=M.+Cherian-Shawauthor=S.+M.+Shawauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+and+peroxisome+proliferator+activated+receptor+%CE%B3+agonist+improve+vascular+function+and+decrease+renal+injury+in+hypertensive+obese+rats&doi=10.1258%2Febm.2012.012225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span></div><div class="casAuthors">Imig, John D.; Walsh, Katie A.; Abdul Hye Khan, Md; Nagasawa, Tasuku; Cherian-Shaw, Mary; Shaw, Sean M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1402-1412</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Cardiometabolic syndrome occurs with obesity and consists of pathophysiol. factors that increase the risk for cardiovascular events.  Sol. epoxide hydrolase inhibition (sEHi) is a novel therapeutic approach that exerts renal and cardiovascular protection.  Although sEHi as a therapeutic approach is promising, it could be more effective for the treatment of cardiometabolic syndrome when combined with peroxisome proliferator activated receptor γ (PPARγ) agonists.  We hypothesized that the PPARγ agonist, rosiglitazone in combination with a sEHi (tAUCB) will provide synergistic actions to decrease blood pressure, improve vascular function, decrease inflammation, and prevent renal damage in spontaneously hypertensive obese rats (SHROB).  SHROB were treated with rosiglitazone, tAUCB or the combination of tAUCB and rosiglitazone for four-weeks and compared with spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats.  Blood pressure increased in SHROB (164 ± 7 mmHg) and decreased 10 mmHg when treated with rosiglitazone, tAUCB, or tAUCB and rosiglitazone.  Mesenteric artery dilation to the KATP channel opener pinacidil was attenuated in SHROB (EMax = 77 ± 7%), compared with WKY (EMax = 115 ± 19) and SHR (EMax = 93 ± 12%).  Vasodilation to pinacidil was improved by rosiglitazone (EMax = 92 ± 14%) but not tAUCB.  Renal macrophage infiltration increased in SHROB and significantly decreased with rosiglitazone or tAUCB and rosiglitazone treatment.  Albuminuria was increased in SHROB (90 ± 20 mg/d) and was significantly decreased by the combination of tAUCB and rosiglitazone (37 ± 9 mg/d).  Glomerular injury in SHROB was also significantly decreased by tAUCB and rosiglitazone.  These results indicate that even though sEHi or PPARγ agonist have benefits when used individually, the combination is more beneficial for the multidisease features in cardiometabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq2SjZgeqAHrVg90H21EOLACvtfcHk0lhJcKAfacnBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D&md5=d22fb0c9e2e8acf30dd6ce7614ad403c</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.012225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.012225%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DWalsh%26aufirst%3DK.%2BA.%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DCherian-Shaw%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DS.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520and%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%25CE%25B3%2520agonist%2520improve%2520vascular%2520function%2520and%2520decrease%2520renal%2520injury%2520in%2520hypertensive%2520obese%2520rats%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2012%26volume%3D237%26spage%3D1402%26epage%3D1412%26doi%3D10.1258%2Febm.2012.012225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggerhoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor gamma modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=61-81&author=R.+Blocherauthor=C.+Lamersauthor=S.+K.+Wittmannauthor=D.+Merkauthor=M.+Hartmannauthor=L.+Weizelauthor=O.+Diehlauthor=A.+Bruggerhoffauthor=M.+Bossauthor=A.+Kaiserauthor=T.+Schaderauthor=T.+Gobelauthor=M.+Grundmannauthor=C.+Angioniauthor=J.+Heeringauthor=G.+Geisslingerauthor=M.+Wurglicsauthor=E.+Kostenisauthor=B.+Bruneauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=A.+S.+Kahntauthor=E.+Proschak&title=N-Benzylbenzamides%3A+a+novel+merged+scaffold+for+orally+available+dual+soluble+epoxide+hydrolase%2Fperoxisome+proliferator-activated+receptor+gamma+modulators&doi=10.1021%2Facs.jmedchem.5b01239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators</span></div><div class="casAuthors">Blocher Rene; Lamers Christina; Wittmann Sandra K; Merk Daniel; Hartmann Markus; Weizel Lilia; Diehl Olaf; Bruggerhoff Astrid; Kaiser Astrid; Schader Tim; Gobel Tamara; Wurglics Mario; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Kahnt Astrid S; Proschak Ewgenij; Boss Marcel; Brune Bernhard; Grundmann Manuel; Kostenis Evi; Angioni Carlo; Geisslinger Gerd; Heering Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome (MetS) is a multifactorial disease cluster that consists of dyslipidemia, cardiovascular disease, type 2 diabetes mellitus, and obesity.  MetS patients are strongly exposed to polypharmacy; however, the number of pharmacological compounds required for MetS treatment can be reduced by the application of multitarget compounds.  This study describes the design of dual-target ligands that target soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type γ (PPARγ).  Simultaneous modulation of sEH and PPARγ can improve diabetic conditions and hypertension at once.  N-Benzylbenzamide derivatives were determined to fit a merged sEH/PPARγ pharmacophore, and structure-activity relationship studies were performed on both targets, resulting in a submicromolar (sEH IC50 = 0.3 μM/PPARγ EC50 = 0.3 μM) modulator 14c.  In vitro and in vivo evaluations revealed good ADME properties qualifying 14c as a pharmacological tool compound for long-term animal models of MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEKlCRcJ5_1JcXNb62YGmbfW6udTcc2ebwRZuL7742X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D&md5=86c5861a77820ae8878382eae893b116</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01239%26sid%3Dliteratum%253Aachs%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DDiehl%26aufirst%3DO.%26aulast%3DBruggerhoff%26aufirst%3DA.%26aulast%3DBoss%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DGobel%26aufirst%3DT.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DBrune%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DN-Benzylbenzamides%253A%2520a%2520novel%2520merged%2520scaffold%2520for%2520orally%2520available%2520dual%2520soluble%2520epoxide%2520hydrolase%252Fperoxisome%2520proliferator-activated%2520receptor%2520gamma%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D61%26epage%3D81%26doi%3D10.1021%2Facs.jmedchem.5b01239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hye Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skibba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">A novel dual PPAR-gamma agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2235</span>– <span class="NLM_lpage">2246</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4685-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00125-018-4685-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30032428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2235-2246&author=M.+A.+Hye+Khanauthor=L.+Kolbauthor=M.+Skibbaauthor=M.+Hartmannauthor=R.+Blocherauthor=E.+Proschakauthor=J.+D.+Imig&title=A+novel+dual+PPAR-gamma+agonist%2FsEH+inhibitor+treats+diabetic+complications+in+a+rat+model+of+type+2+diabetes&doi=10.1007%2Fs00125-018-4685-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span></div><div class="casAuthors">Hye Khan, Md Abdul; Kolb, Lauren; Skibba, Melissa; Hartmann, Markus; Blocher, Rene; Proschak, Ewgenij; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2235-2246</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes.  The present study aims to evaluate a novel mol. with a dual action against the metabolic syndrome and type 2 diabetes.  Methods: We developed and tested a novel dual modulator, RB394, which acts as a sol. epoxide hydrolase (sEH) inhibitor and a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist in rat models of the metabolic syndrome-the obese spontaneously hypertensive (SHROB) rat and the obese diabetic Zucker fatty/spontaneously hypertensive heart failure F1 hybrid (ZSF1) rat.  In SHROB rats we studied the ability of RB394 to prevent metabolic syndrome phenotypes, while in ZSF1 obese diabetic rats we compared RB394 with the ACE inhibitor enalapril in the treatment of type 2 diabetes and assocd. comorbid conditions.  RB394 (10 mg/kg daily) and enalapril (10 mg/kg daily) were administered orally for 8 wk.  Results: RB394 blunted the development of hypertension, insulin resistance, hyperlipidemia and kidney injury in SHROB rats and reduced fasting blood glucose and HbA1c, improved glucose tolerance, reduced blood pressure and improved lipid profiles in obese ZSF1 rats.  A redn. in liver fibrosis and hepatosteatosis was evident in RB394-treated obese ZSF1 rats.  Unlike RB394, enalapril did not demonstrate any pos. effects in relation to diabetes, hyperlipidemia or liver dysfunction in obese ZSF1 rats.  RB394 ameliorated diabetic nephropathy by reducing renal interstitial fibrosis and renal tubular and glomerular injury in obese diabetic ZSF1 rats.  Intriguingly, enalapril demonstrated a weaker action against diabetic nephropathy in obese ZSF1 rats.  Conclusions/interpretation: These findings demonstrate that a novel sHE inhibitor/PPAR-γ agonist mol. targets multiple risk factors of the metabolic syndrome and is a glucose-lowering agent with a strong ability to treat diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbjByYxgOqLVg90H21EOLACvtfcHk0lhJcKAfacnBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL&md5=b5c538cfa9fe0b8040e19fe230547202</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4685-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4685-0%26sid%3Dliteratum%253Aachs%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DKolb%26aufirst%3DL.%26aulast%3DSkibba%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DA%2520novel%2520dual%2520PPAR-gamma%2520agonist%252FsEH%2520inhibitor%2520treats%2520diabetic%2520complications%2520in%2520a%2520rat%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26spage%3D2235%26epage%3D2246%26doi%3D10.1007%2Fs00125-018-4685-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flauaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovati, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Boosting anti-inflammatory potency of zafirlukast by designed polypharmacology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5758</span>– <span class="NLM_lpage">5764</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVylur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5758-5764&author=S.+Schierleauthor=C.+Flauausauthor=P.+Heitelauthor=S.+Willemsauthor=J.+Schmidtauthor=A.+Kaiserauthor=L.+Weizelauthor=T.+Goebelauthor=A.+S.+Kahntauthor=G.+Geisslingerauthor=D.+Steinhilberauthor=M.+Wurglicsauthor=G.+E.+Rovatiauthor=A.+Schmidtkoauthor=E.+Proschakauthor=D.+Merk&title=Boosting+anti-inflammatory+potency+of+zafirlukast+by+designed+polypharmacology&doi=10.1021%2Facs.jmedchem.8b00458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology</span></div><div class="casAuthors">Schierle, Simone; Flauaus, Cathrin; Heitel, Pascal; Willems, Sabine; Schmidt, Jurema; Kaiser, Astrid; Weizel, Lilia; Goebel, Tamara; Kahnt, Astrid S.; Geisslinger, Gerd; Steinhilber, Dieter; Wurglics, Mario; Rovati, G. Enrico; Schmidtko, Achim; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5758-5764</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitarget design offers access to bioactive small mols. with potentially superior efficacy and safety.  Particularly multifactorial chronic inflammatory diseases demand multiple pharmacol. interventions for stable treatment.  By minor structural changes, we have developed a close analog of the cysteinyl-leukotriene receptor antagonist zafirlukast that simultaneously inhibits sol. epoxide hydrolase and activates peroxisome proliferator-activated receptor γ.  The triple modulator exhibits robust anti-inflammatory activity in vivo and highlights the therapeutic potential of designed multitarget agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLILgsL-gje7Vg90H21EOLACvtfcHk0ljqJmp2A1epkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVylur%252FJ&md5=7a4f670bb356f8db33957b80de57eee3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00458%26sid%3Dliteratum%253Aachs%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DFlauaus%26aufirst%3DC.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DWillems%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DSchmidtko%26aufirst%3DA.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DBoosting%2520anti-inflammatory%2520potency%2520of%2520zafirlukast%2520by%2520designed%2520polypharmacology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5758%26epage%3D5764%26doi%3D10.1021%2Facs.jmedchem.8b00458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Highly potent non-steroidal FXR agonists protostane-type triterpenoids: structure-activity relationship and mechanism</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">111652</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2019.111652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31494470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslGntLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2019&pages=111652&author=Z.+L.+Luanauthor=X.+K.+Huoauthor=P.+P.+Dongauthor=X.+G.+Tianauthor=C.+P.+Sunauthor=X.+Lvauthor=L.+Fengauthor=J.+Ningauthor=C.+Wangauthor=B.+J.+Zhangauthor=X.+C.+Ma&title=Highly+potent+non-steroidal+FXR+agonists+protostane-type+triterpenoids%3A+structure-activity+relationship+and+mechanism&doi=10.1016%2Fj.ejmech.2019.111652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism</span></div><div class="casAuthors">Luan, Zhi-Lin; Huo, Xiao-Kui; Dong, Pei-Pei; Tian, Xiang-Ge; Sun, Cheng-Peng; Lv, Xia; Feng, Lei; Ning, Jing; Wang, Chao; Zhang, Bao-Jing; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111652</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Farnesoid X receptor (FXR) is a key regulator in charge of bile acid synthesis, transport, and metab.  Activation of FXR represses bile acid synthesis and increases its excretion and transport, consequently protecting the liver functions.  Thus, FXR is considered as a crit. therapeutic target of cholestasis and nonalcoholic steatohepatitis.  Herein, we isolated and identified fourteen new protostane-type triterpenoids (1-14) and four known analogs (15-18) from Alisma orientale, and finally constructed a small library of protostane-type triterpenoids (1-70) to investigate their structure-activity relationship with FXR, further leading to obtain compd. 15 with potent agonistic activity against FXR (EC50 = 90 nM).  Extensive in vitro investigation confirmed high efficacy of compd. 15 against FXR in living cell, and revealed its underlying mechanism for FXR activation (amino acid residues Arg331 and Ser332) by mol. docking and site-directed mutagenesis technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5y6EOmYrwZbVg90H21EOLACvtfcHk0ljqJmp2A1epkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslGntLrI&md5=71514c7aa4bcbfbcafb8243175158344</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111652%26sid%3Dliteratum%253Aachs%26aulast%3DLuan%26aufirst%3DZ.%2BL.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DDong%26aufirst%3DP.%2BP.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DLv%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DHighly%2520potent%2520non-steroidal%2520FXR%2520agonists%2520protostane-type%2520triterpenoids%253A%2520structure-activity%2520relationship%2520and%2520mechanism%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D182%26spage%3D111652%26doi%3D10.1016%2Fj.ejmech.2019.111652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmstädter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Dual farnesoid X receptor/soluble epoxide hydrolase modulators derived from zafirlukast</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fcmdc.201900576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31670489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOru7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=50-67&author=S.+Schierleauthor=M.+Helmst%C3%A4dterauthor=J.+Schmidtauthor=M.+Hartmannauthor=M.+Horzauthor=A.+Kaiserauthor=L.+Weizelauthor=P.+Heitelauthor=A.+Proschakauthor=V.+Hernandez-Olmosauthor=E.+Proschakauthor=D.+Merk&title=Dual+farnesoid+X+receptor%2Fsoluble+epoxide+hydrolase+modulators+derived+from+zafirlukast&doi=10.1002%2Fcmdc.201900576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast</span></div><div class="casAuthors">Schierle, Simone; Helmstaedter, Moritz; Schmidt, Jurema; Hartmann, Markus; Horz, Maximiliane; Kaiser, Astrid; Weizel, Lilia; Heitel, Pascal; Proschak, Anna; Hernandez-Olmos, Victor; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-67</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear farnesoid X receptor (FXR) and the enzyme sol. epoxide hydrolase (sEH) are validated mol. targets to treat metabolic disorders such as non-alc. steatohepatitis (NASH).  Their simultaneous modulation in vivo has demonstrated a triad of anti-NASH effects and thus may generate synergistic efficacy.  Here we report dual FXR activators/sEH inhibitors derived from the anti-asthma drug Zafirlukast.  Systematic structural optimization of the scaffold has produced favorable dual potency on FXR and sEH while depleting the original cysteinyl leukotriene receptor antagonism of the lead drug.  The resulting polypharmacol. activity profile holds promise in the treatment of liver-related metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiiU9ia6YqjLVg90H21EOLACvtfcHk0liVejgdZzL9tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOru7zK&md5=e9342428c2654ee1072bb0045b7719a7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900576%26sid%3Dliteratum%253Aachs%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DHelmst%25C3%25A4dter%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DHorz%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DProschak%26aufirst%3DA.%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DDual%2520farnesoid%2520X%2520receptor%252Fsoluble%2520epoxide%2520hydrolase%2520modulators%2520derived%2520from%2520zafirlukast%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D50%26epage%3D67%26doi%3D10.1002%2Fcmdc.201900576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7703</span>– <span class="NLM_lpage">7724</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2ls73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7703-7724&author=J.+Schmidtauthor=M.+Rotterauthor=T.+Weiserauthor=S.+Wittmannauthor=L.+Weizelauthor=A.+Kaiserauthor=J.+Heeringauthor=T.+Goebelauthor=C.+Angioniauthor=M.+Wurglicsauthor=A.+Paulkeauthor=G.+Geisslingerauthor=A.+Kahntauthor=D.+Steinhilberauthor=E.+Proschakauthor=D.+Merk&title=A+dual+modulator+of+farnesoid+X+receptor+and+soluble+epoxide+hydrolase+to+counter+nonalcoholic+steatohepatitis&doi=10.1021%2Facs.jmedchem.7b00398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis</span></div><div class="casAuthors">Schmidt, Jurema; Rotter, Marco; Weiser, Tim; Wittmann, Sandra; Weizel, Lilia; Kaiser, Astrid; Heering, Jan; Goebel, Tamara; Angioni, Carlo; Wurglics, Mario; Paulke, Alexander; Geisslinger, Gerd; Kahnt, Astrid; Steinhilber, Dieter; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7703-7724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonalcoholic steatohepatitis arising from Western diet and lifestyle is characterized by accumulation of fat in liver causing inflammation and fibrosis.  It evolves as serious health burden with alarming incidence, but there is no satisfying pharmacol. therapy to date.  Considering the disease's multifactorial nature, modulation of multiple targets might provide superior therapeutic efficacy.  In particular, farnesoid X receptor (FXR) activation that revealed antisteatotic and antifibrotic effects in clin. trials combined with inhibition of sol. epoxide hydrolase (sEH) as anti-inflammatory strategy promises synergies.  To exploit this dual concept, we developed agents exerting partial FXR agonism and sEH inhibitory activity.  Merging known pharmacophores and systematic exploration of the structure-activity relationship on both targets produced dual modulators with low nanomolar potency.  Extensive in vitro characterization confirmed high dual efficacy in cellular context combined with low toxicity, and pilot in vivo data revealed favorable pharmacokinetics as well as engagement on both targets in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUx3OFEKCgyrVg90H21EOLACvtfcHk0liVejgdZzL9tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2ls73J&md5=a35ceea141c78ed9885d7f9a99f4852b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00398%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DRotter%26aufirst%3DM.%26aulast%3DWeiser%26aufirst%3DT.%26aulast%3DWittmann%26aufirst%3DS.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DKahnt%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DA%2520dual%2520modulator%2520of%2520farnesoid%2520X%2520receptor%2520and%2520soluble%2520epoxide%2520hydrolase%2520to%2520counter%2520nonalcoholic%2520steatohepatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7703%26epage%3D7724%26doi%3D10.1021%2Facs.jmedchem.7b00398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Activation of rat and human c-raf(-1) by rearrangement</span>. <i>Princess Takamatsu Symp.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=3332022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADyaL1czjtVOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=75-84&author=M.+Nagaoauthor=F.+Ishikawaauthor=T.+Tahiraauthor=M.+Ochiaiauthor=T.+Sugimura&title=Activation+of+rat+and+human+c-raf%28-1%29+by+rearrangement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of rat and human c-raf(-1) by rearrangement</span></div><div class="casAuthors">Nagao M; Ishikawa F; Tahira T; Ochiai M; Sugimura T</div><div class="citationInfo"><span class="NLM_cas:title">Princess Takamatsu symposia</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activated c-raf(-1) gene was found in three transformants obtained by transfecting DNAs from rat hepatocellular carcinoma, metastasis of human colon cancer in mesocolon and normal mucosa from a different colon cancer patient.  Rat and human activated c-raf(-1) genes were cloned into cosmid vectors; restriction enzyme mapping revealed both activated c-raf(-1) genes to have rearrangement in the center of the normal form of the gene, and the upstream sequences were replaced by unrelated sequences.  Using genomic DNA fragments located immediately downstream of the recombination points, the activations of all these c-raf(-1) were shown to have occurred during the transfection process.  The recombination points in both the rat and human clones isolated were located in the intron between exons 7 and 8, and nucleotide sequencing around these recombination points showed there to be an inverted repeat which could be involved in inducing in vitro recombination.  Nucleotide sequencing of rat and human c-raf(-1) cDNAs revealed the upstream sequences, recombined to the 3' half of c-raf(-1), to be expressed as fusion mRNAs; the production of fused proteins was predicted from a long open reading frame, which is in-frame with the kinase domain encoded from the 3' half of the c-raf(-1) gene.  There is a cysteine clustering region in an N-terminal region of the c-raf(-1) product deduced from the nucleotide sequence, and this cysteine clustering region was found to be highly homologous to that present in an N-terminal region of protein kinase C, although, in the latter cysteine clusters are present in duplicate.  From analogy with the activation mechanism of protein kinase C, the N-terminal region of serine/threonine kinase coded by the c-raf(-1) gene is suggested to be a regulatory part of the enzyme activity, and it proposed that the replacement or truncation of this regulatory part could be the mechanism whereby c-raf(-1) is activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5bkb48VdTX7GbPKh4T9eAfW6udTcc2ebC8pxLbXpoobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czjtVOhtg%253D%253D&md5=1d024622fcd8c54a7321e5d497a20ff8</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagao%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DF.%26aulast%3DTahira%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DM.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DActivation%2520of%2520rat%2520and%2520human%2520c-raf%2528-1%2529%2520by%2520rearrangement%26jtitle%3DPrincess%2520Takamatsu%2520Symp.%26date%3D1986%26volume%3D17%26spage%3D75%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steelman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navolanic, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blalock, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCubrey, J. A.</span></span> <span> </span><span class="NLM_article-title">Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review)</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12579299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslKrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=469-480&author=F.+Changauthor=L.+S.+Steelmanauthor=J.+G.+Sheltonauthor=J.+T.+Leeauthor=P.+M.+Navolanicauthor=W.+L.+Blalockauthor=R.+Franklinauthor=J.+A.+McCubrey&title=Regulation+of+cell+cycle+progression+and+apoptosis+by+the+Ras%2FRaf%2FMEK%2FERK+pathway+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review)</span></div><div class="casAuthors">Chang, Fumin; Steelman, Linda S.; Shelton, John G.; Lee, John T.; Navolanic, Patrick M.; Blalock, William L.; Franklin, Richard; McCubrey, James A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-480</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  The Ras/Raf/MEK/ERK signal transduction pathway regulates cell cycle progression and apoptosis in diverse types of cells.  Mutations in this pathway are often obsd. in transformed cell lines and frequently linked with human cancers.  The Ras/Raf/MEK/ERK pathway can induce events both assocd. with cell proliferation and cell cycle arrest.  The particular course chosen may depend on the strength and the particular Raf gene activated by Ras.  This pathway also is involved in maintaining cell survival by modulating the activity of apoptotic mols. including Bad and Bcl-2.  This review will discuss the regulation of the Ras/Raf/MEK/ERK pathway and how it modulates cell cycle progression and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkNzwwNV5N1LVg90H21EOLACvtfcHk0li8ATEmJNahkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslKrtbo%253D&md5=7edac4057b0506e100b773af70378a3a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DF.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DShelton%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DNavolanic%26aufirst%3DP.%2BM.%26aulast%3DBlalock%26aufirst%3DW.%2BL.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26atitle%3DRegulation%2520of%2520cell%2520cycle%2520progression%2520and%2520apoptosis%2520by%2520the%2520Ras%252FRaf%252FMEK%252FERK%2520pathway%2520%2528review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2003%26volume%3D22%26spage%3D469%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D. S.</span></span> <span> </span><span class="NLM_article-title">BAY 43-9006: Preclinical data</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2255</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.2174/1381612023393026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1381612023393026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12369853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2255-2257&author=S.+Wilhelmauthor=D.+S.+Chien&title=BAY+43-9006%3A+Preclinical+data&doi=10.2174%2F1381612023393026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 43-9006: Preclinical data</span></div><div class="casAuthors">Wilhelm, Scott; Chien, Du-Shieng</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2255-2257</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  The drug design and discovery efforts described in the previous section led to the development of a novel, small mol. Raf-1 kinase inhibitor, BAY 43-9006, which belongs to a class that can be broadly described as bis-aryl ureas.  BAY 43-9006 was identified during a large medicinal chem. optimization program, and this compd. was selected for further pharmacol. characterization based on its potent inhibition of Raf-1 (IC50 12 nM) and its favorable kinase selectivity profile [2, 3].  In vitro and in vivo expts. were designed to demonstrate effective blockade of the Raf/MEK/ERK signaling pathway in tumor cells and for antitumor efficacy in human xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZVjpBzRa6BbVg90H21EOLACvtfcHk0li8ATEmJNahkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrs%253D&md5=687511d0a99c9d9cf4960be714b55ff5</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2174%2F1381612023393026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393026%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%2BS.%26atitle%3DBAY%252043-9006%253A%2520Preclinical%2520data%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2255%26epage%3D2257%26doi%3D10.2174%2F1381612023393026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span> <span> </span><span class="NLM_article-title">Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile <i>in vivo</i></span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2203</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1158%2F1535-7163.MCT-09-0119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19671760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2193-2203&author=J.+Y.+Liuauthor=S.+H.+Parkauthor=C.+Morisseauauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=R.+H.+Weiss&title=Sorafenib+has+soluble+epoxide+hydrolase+inhibitory+activity%2C+which+contributes+to+its+effect+profile+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo</span></div><div class="casAuthors">Liu, Jun-Yan; Park, See-Hyoung; Morisseau, Christophe; Hwang, Sung Hee; Hammock, Bruce D.; Weiss, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2193-2203</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The advent of multikinase inhibitors targeting the vascular endothelial growth factor (VEGF) receptor has revolutionized the treatment of highly angiogenic malignancies such as renal cell carcinoma.  Interestingly, several such inhibitors are com. available, and they each possess diverse specific beneficial and adverse effect profiles.  In examg. the structure of sorafenib, it was hypothesized that this compd. would possess inhibitory effects on the sol. epoxide hydrolase, an enzyme with pleiotropic effects on inflammation and vascular disease.  We now show that sorafenib but not another VEGF receptor targeted inhibitor sunitinib is a potent inhibitor of the human sol. epoxide hydrolase in vitro (Ki = 17±4 nmol/L).  Furthermore, sorafenib causes the expected in vivo shift in oxylipid profile resulting from sol. epoxide hydrolase inhibition, evidence of a redn. in the acute inflammatory response.  Lipopolysaccharide-induced hypotension was reversed with sorafenib but not sunitinib treatment, suggesting that sol. epoxide hydrolase inhibition accounts for at least part of the anti-inflammatory effect of sorafenib.  The pharmacokinetic studies presented here in light of the known potency of sorafenib as a sol. epoxide hydrolase inhibitor indicate that the sol. epoxide hydrolase will be largely inhibited at therapeutic doses of sorafenib.  Thus, it is likely that sol. epoxide hydrolase inhibition contributes to the beneficial effects from the inhibition of the VEGF receptor and other kinases during treatment with sorafenib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtvp4vXxyXgLVg90H21EOLACvtfcHk0lidzLz9R7FI-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCnu70%253D&md5=68eba7f914d5d71157744320bb253da3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0119%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26atitle%3DSorafenib%2520has%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%252C%2520which%2520contributes%2520to%2520its%2520effect%2520profile%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2193%26epage%3D2203%26doi%3D10.1158%2F1535-7163.MCT-09-0119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wecksler, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.11.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.canlet.2015.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26683769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSkur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2016&pages=187-193&author=J.+Liaoauthor=S.+H.+Hwangauthor=H.+Liauthor=Y.+Yangauthor=J.+Yangauthor=A.+T.+Weckslerauthor=J.+Y.+Liuauthor=B.+D.+Hammockauthor=G.+Y.+Yang&title=Inhibition+of+mutant+KrasG12D-initiated+murine+pancreatic+carcinoma+growth+by+a+dual+c-Raf+and+soluble+epoxide+hydrolase+inhibitor+t-CUPM&doi=10.1016%2Fj.canlet.2015.11.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM</span></div><div class="casAuthors">Liao, Jie; Hwang, Sung Hee; Li, Haonan; Yang, Yihe; Yang, Jun; Wecksler, Aaron T.; Liu, Jun-Yan; Hammock, Bruce D.; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutant Kras and chronic pancreatitis are the most common pathol. events involved in human pancreatic cancer.  It has been demonstrated that c-Raf is responsible for transmitting signals from mutant Ras to its downstream signals including MEK-ERK and for initiating carcinogenesis.  The sol. epoxide hydrolase (sEH), a pro-inflammatory enzyme, generally inactivates anti-inflammatory and anti-pain epoxyeicosatrienoic acids (EETs).  Herein, we have synthesized a novel compd. of trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide (t-CUPM) via modifying the central Ph ring of sorafenib and confirmed its dual inhibition of sEH and c-Raf by recombinant kinase activity assay.  Pharmacokinetic anal. revealed that oral dosing of t-CUPM resulted in higher blood levels than that of sorafenib throughout the complete time course (48 h).  The effect of t-CUPM on the inhibition of mutant KrasG12D-initiated murine pancreatic cancer cell growth was detd. using the mouse pancreatic carcinoma cell model obtained from LSL-KrasG12D/Pdx1-Cre mice and showed that t-CUPM significantly inhibited this murine pancreatic carcinoma cell growth both in vitro and in mice in vivo.  Inhibition of mutant Kras-transmitted phosphorylations of cRAF/MEK/ERK was demonstrated in these pancreatic cancer cells using Western blot assay and immunohistochem. approach.  Modulation of oxylipin profile, particularly increased EETs/DHET ratio by sEH inhibition, was obsd. in mice treated with t-CUPM.  These results indicate that t-CUPM is a highly potential agent to treat pancreatic cancer via simultaneously targeting c-Raf and sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFbI76KQDKrVg90H21EOLACvtfcHk0lidzLz9R7FI-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSkur%252FF&md5=e55e1f92fb55e534bba78d245c97b042</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWecksler%26aufirst%3DA.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DInhibition%2520of%2520mutant%2520KrasG12D-initiated%2520murine%2520pancreatic%2520carcinoma%2520growth%2520by%2520a%2520dual%2520c-Raf%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520t-CUPM%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D371%26spage%3D187%26epage%3D193%26doi%3D10.1016%2Fj.canlet.2015.11.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0lidzLz9R7FI-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span> <span> </span><span class="NLM_article-title">The role of natural product chemistry in drug discovery</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2153</span>, <span class="refDoi"> DOI: 10.1021/np040106y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np040106y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSmtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2141-2153&author=M.+S.+Butler&title=The+role+of+natural+product+chemistry+in+drug+discovery&doi=10.1021%2Fnp040106y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Natural Product Chemistry in Drug Discovery</span></div><div class="casAuthors">Butler, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2141-2153</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although traditionally natural products have played an important role in drug discovery, in the past few years most Big Pharma companies have either terminated or considerably scaled down their natural product operations.  This is despite a significant no. of natural product-derived drugs being ranked in the top 35 worldwide selling ethical drugs in 2000, 2001, and 2002.  There were 15 new natural product-derived drugs launched from 2000 to 2003, as well as 15 natural product-derived compds. in Phase III clin. trials or registration at the end of 2003.  Recently, there has been a renewed interest in natural product research due to the failure of alternative drug discovery methods to deliver many lead compds. in key therapeutic areas such as immunosuppression, anti-infectives, and metabolic diseases.  To continue to be competitive with other drug discovery methods, natural product research needs to continually improve the speed of the screening, isolation, and structure elucidation processes, as well addressing the suitability of screens for natural product exts. and dealing with issues involved with large-scale compd. supply.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8J4i-bFUB77Vg90H21EOLACvtfcHk0ljLYLnsKrntYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSmtLvK&md5=0e072912f9070bc24fddb28dcb5555df</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fnp040106y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp040106y%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520natural%2520product%2520chemistry%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D2141%26epage%3D2153%26doi%3D10.1021%2Fnp040106y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of soluble epoxide hydrolase inhibitors from natural products</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2013.11.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.fct.2013.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24309146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=225-230&author=G.+H.+Leeauthor=S.+J.+Ohauthor=S.+Y.+Leeauthor=J.+Y.+Leeauthor=J.+Y.+Maauthor=Y.+H.+Kimauthor=S.+K.+Kim&title=Discovery+of+soluble+epoxide+hydrolase+inhibitors+from+natural+products&doi=10.1016%2Fj.fct.2013.11.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of soluble epoxide hydrolase inhibitors from natural products</span></div><div class="casAuthors">Lee, Gwan Ho; Oh, Soo Jin; Lee, Sang Yoon; Lee, Ji-Yoon; Ma, Jin Yeul; Kim, Young Ho; Kim, Sang Kyum</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">With the goal of developing sol. epoxide hydrolase (sEH) inhibitors with novel chem. structures, the sEH inhibitory activities of 30 natural compds. were evaluated using both a fluorescent substrate, 3-phenyl-cyano(6-methoxy-2-naphthalenyl)methyl ester- 2-oxiraneacetic acid, and a physiol. substrate, 14,15-epoxyeicosatrienoic acid.  To evaluate the selectivity of sEH inhibition, the inhibition of microsomal epoxide hydrolase (mEH), which plays a crit. role in detoxification of toxic epoxides, was detd. using human liver microsomes.  Honokiol and β-amyrin acetate, isolated from Magnolia officinalis and Acer mandshuricum, resp., displayed strong inhibition of sEH activity, with resp. IC50 values of 0.57 μM and 3.4 μM detd. using the fluorescent substrate, and 1.7 μM and 6.1 μM detd. using 14,15-epoxyeicosatrienoic acid. mEH activity was decreased to 49% or 61% of control activity by 25 μM honokiol or β-amyrin acetate, resp.  These results suggest that β-amyrin acetate and honokiol exhibit sEH inhibitory activity, although their sEH selectivity should be improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8LJIETEfy7Vg90H21EOLACvtfcHk0ljLYLnsKrntYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVygsLw%253D&md5=31bc18c54cb12c3a10d693c5a933d504</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2013.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2013.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DDiscovery%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520natural%2520products%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2014%26volume%3D64%26spage%3D225%26epage%3D230%26doi%3D10.1016%2Fj.fct.2013.11.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span> <span> </span><span class="NLM_article-title">Phytochemical constituents from <i>Scutellaria baicalensis</i> in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2019.04.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2019.04.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30980876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=1187-1193&author=Z.+B.+Liuauthor=C.+P.+Sunauthor=J.+X.+Xuauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=F.+Qiu&title=Phytochemical+constituents+from+Scutellaria+baicalensis+in+soluble+epoxide+hydrolase+inhibition%3A+Kinetics+and+interaction+mechanism+merged+with+simulations&doi=10.1016%2Fj.ijbiomac.2019.04.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations</span></div><div class="casAuthors">Liu, Zhong-Bo; Sun, Cheng-Peng; Xu, Jian-Xia; Morisseau, Christophe; Hammock, Bruce D.; Qiu, Feng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our search for sol. epoxide hydrolase (sEH) inhibitors from plants, we found that water exts. of Scutellaria baicalensis Georgi displayed significant inhibitory activity against sEH in vitro.  Exts. of S. baicalensiswere sepd., resulting in the isolation of thirty compds. (1-30), including six lignins (1-6), sixteen flavones (7-22), and five amides (23-27).  Their structures were detd. on the basis of1H and13C NMR and MS spectra.  Compds. 1-6 were first reported in the genus Scutellaria.  All the isolated compds. were assayed for their inhibitory activities against sEH.  Compds. 25-27 showed significant inhibitory activities against sEH with IC50 values of 6.06 ± 0.12, 7.83 ± 0.52, and 6.32 ± 0.31 μM, resp., and compds. 3-6, 12, 18, and 22 displayed moderate inhibitory activities against sEH with IC50 values from 20.82 ± 0.78 μM to 56.61 ± 0.98 μM.  The inhibition kinetic anal. results indicated that compds. 25-27 were all uncompetitive.  Mol. docking studies were performed to get insights into inhibition mechanisms of compds. 25-27 against sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCmQN70ArDTbVg90H21EOLACvtfcHk0lip65hPxEHMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFWgu7k%253D&md5=155098de905fecd11272f3f87875487a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2019.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2019.04.055%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BB.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BX.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DQiu%26aufirst%3DF.%26atitle%3DPhytochemical%2520constituents%2520from%2520Scutellaria%2520baicalensis%2520in%2520soluble%2520epoxide%2520hydrolase%2520inhibition%253A%2520Kinetics%2520and%2520interaction%2520mechanism%2520merged%2520with%2520simulations%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2019%26volume%3D133%26spage%3D1187%26epage%3D1193%26doi%3D10.1016%2Fj.ijbiomac.2019.04.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition potential of phenolic constituents from the aerial parts of <i>Tetrastigma hemsleyanum</i> against soluble epoxide hydrolase and nitric oxide synthase</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1584621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F14756366.2019.1584621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30829084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktVKqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=753-760&author=C.+Y.+Wangauthor=S.+Leeauthor=H.+J.+Jangauthor=X.+D.+Suauthor=H.+S.+Wangauthor=Y.+H.+Kimauthor=S.+Y.+Yang&title=Inhibition+potential+of+phenolic+constituents+from+the+aerial+parts+of+Tetrastigma+hemsleyanum+against+soluble+epoxide+hydrolase+and+nitric+oxide+synthase&doi=10.1080%2F14756366.2019.1584621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase</span></div><div class="casAuthors">Wang, Cai Yi; Lee, Sunggun; Jang, Hyun-Jae; Su, Xiang Dong; Wang, Heng-Shan; Kim, Young Ho; Yang, Seo Young</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">753-760</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aerial parts of Tetrastigma hemsleyanum (APTH) have been used as a functional tea in China.  The purpose of the current study was to identify the bioactive constituents with inhibitory activity against sol. epoxide hydrolase (sEH) and inducible nitric oxide synthase (iNOS), which are jointly considered potential therapeutic targets for vascular system diseases.  In the present study, 39 compds. (-) were isolated from the APTH.  Among them, compds. 8,10,12,16,17,19,32 displayed potential activities, with IC50 values ranging from 4.5 to 9.5 μM, resp., and all in non-competitive inhibition mode.  Compds. 5, 10, 12, 19, 32 displayed potent iNOS inhibitory effects, with IC50 values ranging from 15.6 to 47.3 μM.  The results obtained in this work contribute to a better understanding of the pharmacol. activities of T. hemsleyanum and its potential application as a functional food.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqczoEgwjqBLVg90H21EOLACvtfcHk0lip65hPxEHMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktVKqsLs%253D&md5=dfc2f271c7dedc5f0ed43be6ad01badb</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1584621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1584621%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DH.%2BJ.%26aulast%3DSu%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DInhibition%2520potential%2520of%2520phenolic%2520constituents%2520from%2520the%2520aerial%2520parts%2520of%2520Tetrastigma%2520hemsleyanum%2520against%2520soluble%2520epoxide%2520hydrolase%2520and%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26spage%3D753%26epage%3D760%26doi%3D10.1080%2F14756366.2019.1584621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyet, N. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from <i>Polygala tenuifolia</i> and in silico approach</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-2096-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-017-2096-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yhtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=726-734&author=L.+B.+Vinhauthor=J.+H.+Kimauthor=J.+S.+Leeauthor=N.+T.+M.+Nguyetauthor=S.+Y.+Yangauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+phenolic+glycosides+from+Polygala+tenuifolia+and+in+silico+approach&doi=10.1007%2Fs00044-017-2096-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from Polygala tenuifolia and in silico approach</span></div><div class="casAuthors">Vinh, Le Ba; Kim, Jang Hoon; Lee, Ji Sun; Nguyet, Nguyen Thi Minh; Yang, Seo Young; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">726-734</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The goal of this study was to identify sol. epoxide hydrolase (sEH) inhibitors from plants.  The authors' efforts led to the isolation of nine phenolic glycosides from the roots of Polygala tenuifolia Willd.  The structures of compds. were detd. by spectroscopic methods, including mass spectroscopy and one-dimensional and two-dimensional NMR, and compared with published data.  All the isolated compds. were evaluated for their inhibitory activity against sEH.  The IC50 values for inhibition ranged 6.4±0.4 to 27.2±0.3 μM.  Inhibitors were confirmed the interaction with receptor as competitive type.  Mol. docking demonstrated that inhibitors could bind sufficiently to the right pocket.  Addnl., potential inhibitors (tenuifoliside A, 6-O-(O-methyl-p-benzoyl)-3'-O-(O-methylsinapoyl)sucrose, and 6,3'-di-O-sinapoylsucrose) were confirmed to show the flexible movement with the protein in these sites of receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SFiZRnYUhrVg90H21EOLACvtfcHk0lip65hPxEHMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yhtbrJ&md5=a005b5f2508d62687a5081de17afb657</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-2096-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-2096-2%26sid%3Dliteratum%253Aachs%26aulast%3DVinh%26aufirst%3DL.%2BB.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNguyet%26aufirst%3DN.%2BT.%2BM.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520phenolic%2520glycosides%2520from%2520Polygala%2520tenuifolia%2520and%2520in%2520silico%2520approach%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2018%26volume%3D27%26spage%3D726%26epage%3D734%26doi%3D10.1007%2Fs00044-017-2096-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamita, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Nicola, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyegue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent natural soluble epoxide hydrolase inhibitors from <i>Pentadiplandra brazzeana</i> Baillon: Synthesis, quantification, and measurement of biological activities <i>in vitro</i> and <i>in vivo</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0117438</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0117438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0117438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25659109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGrs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=S.+Kitamuraauthor=C.+Morisseauauthor=B.+Inceogluauthor=S.+G.+Kamitaauthor=G.+R.+De+Nicolaauthor=M.+Nyegueauthor=B.+D.+Hammock&title=Potent+natural+soluble+epoxide+hydrolase+inhibitors+from+Pentadiplandra+brazzeana+Baillon%3A+Synthesis%2C+quantification%2C+and+measurement+of+biological+activities+in+vitro+and+in+vivo&doi=10.1371%2Fjournal.pone.0117438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Potent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivo</span></div><div class="casAuthors">Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; De Nicola, Gina R.; Nyegue, Maximilienne; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0117438/1-e0117438/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We describe here three urea-based sol. epoxide hydrolase (sEH) inhibitors from the root of the plant Pentadiplandra brazzeana.  The concn. of these ureas in the root was quantified by LC-MS/MS, showing that 1, 3-bis (4-methoxybenzyl) urea (MMU) is the most abundant (42.3 μg/g dry root wt.).  All of the ureas were chem. synthesized, and their inhibitory activity toward recombinant human and recombinant rat sEH was measured.  The most potent compd., MMU, showed an IC50 of 92 nM via fluorescent assay and a Ki of 54 nM via radioactivity-based assay on human sEH.  MMU effectively reduced inflammatory pain in a rat nociceptive pain assay.  These compds. are among the most potent sEH inhibitors derived from natural sources.  Moreover, inhibition of sEH by these compds. may mechanistically explain some of the therapeutic effects of P. brazzeana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofZxftJl6ePrVg90H21EOLACvtfcHk0licbX9iFW9HRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGrs77O&md5=4e4a1da5430babd48d88388d8e604b98</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0117438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0117438%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DKamita%26aufirst%3DS.%2BG.%26aulast%3DDe%2BNicola%26aufirst%3DG.%2BR.%26aulast%3DNyegue%26aufirst%3DM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520natural%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520Pentadiplandra%2520brazzeana%2520Baillon%253A%2520Synthesis%252C%2520quantification%252C%2520and%2520measurement%2520of%2520biological%2520activities%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0117438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsopmo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngnokam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngamga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayafor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, O.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives from <i>Pentadiplandra brazzeana</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1021/np990111f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np990111f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXmt12nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=1435-1436&author=A.+Tsopmoauthor=D.+Ngnokamauthor=D.+Ngamgaauthor=J.+F.+Ayaforauthor=O.+Sterner&title=Urea+derivatives+from+Pentadiplandra+brazzeana&doi=10.1021%2Fnp990111f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Urea derivatives from Pentadiplandra brazzeana</span></div><div class="casAuthors">Tsopmo, Apollinaire; Ngnokam, David; Ngamga, Dieudonne; Ayafor, Johnson F.; Sterner, Olov</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1435-1436</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four urea derivs. were isolated from the roots of Pentadiplandra brazzeana, and their structures were elucidated by spectroscopic techniques.  N-Benzyl-N'-(4-methoxybenzyl)urea is a new compd., although N,N'-di-(4-methoxybenzyl)urea , N,N'-dibenzylurea, and p-methoxythiobenzaldehyde are reported from a natural source for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytu3GPukR-rVg90H21EOLACvtfcHk0licbX9iFW9HRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt12nu7s%253D&md5=f2290b3c42fca5ed4f4acde5912a932f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fnp990111f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp990111f%26sid%3Dliteratum%253Aachs%26aulast%3DTsopmo%26aufirst%3DA.%26aulast%3DNgnokam%26aufirst%3DD.%26aulast%3DNgamga%26aufirst%3DD.%26aulast%3DAyafor%26aufirst%3DJ.%2BF.%26aulast%3DSterner%26aufirst%3DO.%26atitle%3DUrea%2520derivatives%2520from%2520Pentadiplandra%2520brazzeana%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D1435%26epage%3D1436%26doi%3D10.1021%2Fnp990111f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, S. C.</span></span> <span> </span><span class="NLM_article-title">Salvadourea: New urea derivative from <i>Salvadora persica</i></span>. <i>Chem. Ind.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1975&pages=517-518&author=A.+Rayauthor=L.+Chandauthor=S.+C.+Dutta&title=Salvadourea%3A+New+urea+derivative+from+Salvadora+persica"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DA.%26aulast%3DChand%26aufirst%3DL.%26aulast%3DDutta%26aufirst%3DS.%2BC.%26atitle%3DSalvadourea%253A%2520New%2520urea%2520derivative%2520from%2520Salvadora%2520persica%26jtitle%3DChem.%2520Ind.%26date%3D1975%26volume%3D12%26spage%3D517%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahroun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damak, M.</span></span> <span> </span><span class="NLM_article-title">Contribution to the study of <i>Lepidium sativum</i> (Cruciferae). Structure of a new compound isolated from the seed: lepidine</span>. <i>J. Soc. Chim. Tunis.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL28XmsF2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1985&pages=15-24&author=A.+Bahrounauthor=M.+Damak&title=Contribution+to+the+study+of+Lepidium+sativum+%28Cruciferae%29.+Structure+of+a+new+compound+isolated+from+the+seed%3A+lepidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution to the study of Lepidium sativum (Cruciferae). Structure of a new compound isolated from the seed: lepidine</span></div><div class="casAuthors">Bahroun, A.; Damak, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal de la Societe Chimique de Tunisie</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">JSCTDP</span>;
        ISSN:<span class="NLM_cas:issn">0253-1208</span>.
    </div><div class="casAbstract">Seeds of L. sativum afforded sinapic acid Et ester, N,N'-dibenzylthiourea, N,N'-dibenzylurea, and the new alkaloid lepidine (I).  Structures were assigned from spectral characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB80yh0aLdhrVg90H21EOLACvtfcHk0liOkDbuJhw3nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmsF2isg%253D%253D&md5=180c288a0f1d0b0e931cd4440d6665e9</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBahroun%26aufirst%3DA.%26aulast%3DDamak%26aufirst%3DM.%26atitle%3DContribution%2520to%2520the%2520study%2520of%2520Lepidium%2520sativum%2520%2528Cruciferae%2529.%2520Structure%2520of%2520a%2520new%2520compound%2520isolated%2520from%2520the%2520seed%253A%2520lepidine%26jtitle%3DJ.%2520Soc.%2520Chim.%2520Tunis.%26date%3D1985%26volume%3D2%26spage%3D15%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sashidhara, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosaiah, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghubir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, S. M.</span></span> <span> </span><span class="NLM_article-title">Rare dipeptide and urea derivatives from roots of <i>Moringa oleifera</i> as potential anti-inflammatory and antinociceptive agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">436</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=18243423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=432-436&author=K.+V.+Sashidharaauthor=J.+N.+Rosaiahauthor=E.+Tyagiauthor=R.+Shuklaauthor=R.+Raghubirauthor=S.+M.+Rajendran&title=Rare+dipeptide+and+urea+derivatives+from+roots+of+Moringa+oleifera+as+potential+anti-inflammatory+and+antinociceptive+agents&doi=10.1016%2Fj.ejmech.2007.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents</span></div><div class="casAuthors">Sashidhara, Koneni V.; Rosaiah, Jammikuntla N.; Tyagi, Ethika; Shukla, Rakesh; Raghubir, Ram; Rajendran, Siron M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">432-436</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the course of our studies on the isolation of bioactive compds. from the roots of Moringa oleifera, a traditional herb in southeast Asia, rare aurantiamide acetate 4 and 1,3-dibenzyl urea 5 have been isolated and characterized.  And also, this is the first report of isolation from this genus.  Isolated compd. inhibited the prodn. of TNF-α and IL-2; further compd. 5 showed significant analgesic activities in a dose dependant manner.  These findings may help in understanding the mechanism of action of this traditional plant leading to control of activated mast cells on inflammatory conditions like arthritis, for which the crude ext. has been used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0QgUv1wZHz7Vg90H21EOLACvtfcHk0liOkDbuJhw3nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFal&md5=85a13626a3c9162703e002608c1a29c1</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DSashidhara%26aufirst%3DK.%2BV.%26aulast%3DRosaiah%26aufirst%3DJ.%2BN.%26aulast%3DTyagi%26aufirst%3DE.%26aulast%3DShukla%26aufirst%3DR.%26aulast%3DRaghubir%26aufirst%3DR.%26aulast%3DRajendran%26aufirst%3DS.%2BM.%26atitle%3DRare%2520dipeptide%2520and%2520urea%2520derivatives%2520from%2520roots%2520of%2520Moringa%2520oleifera%2520as%2520potential%2520anti-inflammatory%2520and%2520antinociceptive%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D432%26epage%3D436%26doi%3D10.1016%2Fj.ejmech.2007.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0176571</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0176571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0176571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28472063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wjt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=S.+Kitamuraauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=B.+Inceogluauthor=B.+D.+Hammock&title=Occurrence+of+urea-based+soluble+epoxide+hydrolase+inhibitors+from+the+plants+in+the+order+Brassicales&doi=10.1371%2Fjournal.pone.0176571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales</span></div><div class="casAuthors">Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0176571/1-e0176571/25</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Recently, dibenzylurea-based potent sol. epoxide hydrolase (sEH) inhibitors were identified in Pentadiplandra brazzeana, a plant in the order Brassicales.  In an effort to generalize the concept, we hypothesized that plants that produce benzyl glucosinolates and corresponding isothiocyanates also produce these dibenzylurea derivs.  Our overall aim here was to examine the occurrence of urea derivs. in Brassicales, hoping to find biol. active urea derivs. from plants.  First, plants in the order Brassicales were analyzed for the presence of 1, 3-dibenzylurea (compd. 1), showing that three addnl. plants in the order Brassicales produce the urea derivs.  Based on the hypothesis, three dibenzylurea derivs. with sEH inhibitory activity were isolated from maca (Lepidium meyenii) roots.  Topical application of one of the identified compds. (compd. 3, human sEH IC50 = 222 nM) effectively reduced pain in rat inflammatory pain model, and this compd. was bioavailable after oral administration in mice.  The biosynthetic pathway of these urea derivs. was investigated using papaya (Carica papaya) seed as a model system.  Finally, a small collection of plants from the Brassicales order was grown, collected, extd. and screened for sEH inhibitory activity.  Results show that several plants of the Brassicales order could be potential sources of urea-based sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMA3Grmjmt4bVg90H21EOLACvtfcHk0liOkDbuJhw3nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wjt7nI&md5=3396219c1e211d67267a992c40f4dbaf</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0176571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0176571%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOccurrence%2520of%2520urea-based%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520the%2520plants%2520in%2520the%2520order%2520Brassicales%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0176571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C. H.</span></span> <span> </span><span class="NLM_article-title">Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from <i>Capsicum chinense</i> Jacq. cv. Habanero</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1207</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2019.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2019.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31175899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFOrs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2019&pages=1202-1207&author=J.+H.+Kimauthor=Y.+D.+Joauthor=C.+H.+Jin&title=Isolation+of+soluble+epoxide+hydrolase+inhibitor+of+capsaicin+analogs+from+Capsicum+chinense+Jacq.+cv.+Habanero&doi=10.1016%2Fj.ijbiomac.2019.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from Capsicum chinense Jacq. cv. Habanero</span></div><div class="casAuthors">Kim, Jang Hoon; Jo, Yeong Deuk; Jin, Chang Hyun</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1202-1207</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Capsaicin (1) and dihydrocapsaicin (2) were isolated from the aerial parts of Capsicum chinense Jacq. cv.  Habanero. In in vitro studies, the exhibited potent inhibitory activity against sol. epoxide hydrolase (sEH), with IC50 values of 5.6 ± 1.2 and 7.3 ± 0.7μM.  Enzyme kinetics suggested that the two compds. (1 and 2) were competitive inhibitors with Ki values of 2.5 ± 1.0 and 4.7 ± 2.3μM, resp.  Mol. docking and mol. dynamic studies showed that capsaicin analogs (1 and 2) bound strongly with Asp335, Tyr383, and Tyr466 residues in the active site.  These results suggest that the two inhibitors (1 and 2) represent potentially therapeutic inhibitors of sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhVuaTaeDTjbVg90H21EOLACvtfcHk0lhmKIKPiTg-_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFOrs7vP&md5=c54f042dc0bbce2c1ffbcebb47549fb9</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2019.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2019.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJo%26aufirst%3DY.%2BD.%26aulast%3DJin%26aufirst%3DC.%2BH.%26atitle%3DIsolation%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520of%2520capsaicin%2520analogs%2520from%2520Capsicum%2520chinense%2520Jacq.%2520cv.%2520Habanero%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2019%26volume%3D135%26spage%3D1202%26epage%3D1207%26doi%3D10.1016%2Fj.ijbiomac.2019.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of components isolated from <i>Apios americana</i> Medik</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1432</span>, <span class="refDoi"> DOI: 10.3390/molecules22091432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fmolecules22091432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1432&author=J.+H.+Kimauthor=H.+Y.+Kimauthor=S.+Y.+Kangauthor=Y.+H.+Kimauthor=C.+H.+Jin&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+components+isolated+from+Apios+americana+Medik&doi=10.3390%2Fmolecules22091432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of components isolated from Apios americana medik</span></div><div class="casAuthors">Kim, Jang Hoon; Kim, Hyo Young; Kang, Si Yong; Kim, Young Ho; Jin, Chang Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1432/1-1432/10</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A new compd. 1, 5-methoxy-2,5,7,4'-tetrahydroxy-coumaronochromone, along with seven known compds. (2-8), were isolated from Apios americana using open column chromatog.  Their structures were established based on an anal. of 1D and 2D NMR, and MS spectra.  Among these, two compds. 1 and 2 showed inhibitory activity on sol. epoxide hydrolase (sEH) at a concn. below 50μM.  The resp. competitive (1) and mixed (2) inhibitors were revealed to have Ki values of 21.0 ± 0.8 and 14.5 ± 1.5μM, based on the Dixon plot.  The potential inhibitor (2) was visually presented in a predicted binding pose in the receptor by mol. docking.  Addnl., mol. dynamics were performed for a detailed understanding of their complex by Gromacs 4.6.5 package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomg-I19YHxibVg90H21EOLACvtfcHk0lgYSW7UyhO8HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhsLzF&md5=335fd187086a9c091d8919b38d334e42</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091432%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DKang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DJin%26aufirst%3DC.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520components%2520isolated%2520from%2520Apios%2520americana%2520Medik%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1432%26doi%3D10.3390%2Fmolecules22091432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minh, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity by rhizomes of <i>Kaempferia parviflora</i> Wall. ex Baker</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1007/s00044-016-1525-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-016-1525-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=704-711&author=N.+P.+Thaoauthor=B.+T.+T.+Luyenauthor=J.+H.+Kimauthor=A.+R.+Joauthor=S.+Y.+Yangauthor=N.+T.+Datauthor=C.+V.+Minhauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+by+rhizomes+of+Kaempferia+parviflora+Wall.+ex+Baker&doi=10.1007%2Fs00044-016-1525-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1007%2Fs00044-016-1525-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-016-1525-y%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520by%2520rhizomes%2520of%2520Kaempferia%2520parviflora%2520Wall.%2520ex%2520Baker%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2016%26volume%3D25%26spage%3D704%26epage%3D711%26doi%3D10.1007%2Fs00044-016-1525-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">A new flavonol glycoside from the leaves of <i>Boscia senegalensis</i></span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3452</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2014.35.12.3447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.5012%2Fbkcs.2014.35.12.3447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1arsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=3447-3452&author=A.+M.+A.+Morganauthor=J.+H.+Kimauthor=S.+K.+Kimauthor=C.-H.+Limauthor=Y.+H.+Kim&title=A+new+flavonol+glycoside+from+the+leaves+of+Boscia+senegalensis&doi=10.5012%2Fbkcs.2014.35.12.3447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A new flavonol glycoside from the leaves of Boscia senegalensis</span></div><div class="casAuthors">Morgan, Abubaker M. A.; Kim, Jang Hoon; Kim, Sang Kyum; Lim, Chi-Hwan; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3447-3452</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Detailed chem. investigation of Boscia senegalensis (Per) Lam. ex Poir. led to the isolation of one new flavonol glycoside, rhamnocitrin-3-O-β-D-(6''-O-E-feruloyl)-glucopyranoside named bosenegaloside A (1), with seven known compds., rhamnocitrin-3-O-β-D-(6''-O-E-p-coumaroyl)-glucopyranoside (2), rhamnocitrin-3-O-β-D-glucopyranoside (3), 3,4,5-trimethoxyphenol-β-D-glucopyrinoside (4), lasianthionoside A (5), 3,7-dimethyl-1-octene-3,6,7-triol-6-O-β-D-glucopyranoside (6), syringin (7), and austroside B (8).  The chem. structures of these compds. were elucidated from spectroscopic data and by comparison of these data with previously published results.  The inhibitory activity of the isolated compds. on sol. epoxide hydrolase (sEH) was assessed.  Compds. 1-3 potently inhibited sEH activity with IC50 values of 12.8 ± 0.5, 18.4 ± 0.2, and 11.3 ± 0.9 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrux-0OoyAWXLVg90H21EOLACvtfcHk0lhiZ_8pAV0t9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1arsb%252FI&md5=ff35aa0af29a16e05879f50ac12efa28</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2014.35.12.3447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2014.35.12.3447%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DA.%2BM.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLim%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DA%2520new%2520flavonol%2520glycoside%2520from%2520the%2520leaves%2520of%2520Boscia%2520senegalensis%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2014%26volume%3D35%26spage%3D3447%26epage%3D3452%26doi%3D10.5012%2Fbkcs.2014.35.12.3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Prenyl-flavonoids from <i>Epimedium koreanum</i> Nakai and their soluble epoxide hydrolase and tyrosinase inhibitory activities</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2761</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-1975-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-017-1975-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWktbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=2761-2767&author=X.+D.+Suauthor=W.+Liauthor=J.+E.+Kimauthor=S.+Y.+Yangauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Prenyl-flavonoids+from+Epimedium+koreanum+Nakai+and+their+soluble+epoxide+hydrolase+and+tyrosinase+inhibitory+activities&doi=10.1007%2Fs00044-017-1975-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Prenyl-flavonoids from Epimedium koreanum Nakai and their soluble epoxide hydrolase and tyrosinase inhibitory activities</span></div><div class="casAuthors">Su, Xiang Dong; Li, Wei; Kim, Ji Eun; Yang, Seo Young; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2761-2767</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A new 8-prenyl-flavonoid, epimedokoreanoside III (I), and 11 other flavonoids, were isolated from the aerial parts of Epimedium koreanum Nakai.  Their chem. structures were elucidated by NMR and mass analyses.  All isolates were evaluated for their sol. epoxide hydrolase and tyrosinase inhibitory activities.  Among the isolates, compds. 1, 5, 9, 10, and 12 exerted sol. epoxide hydrolase inhibitory activity in dose-dependent manner, with IC50 values ranging from 26.0 ± 1.2 to 37.6 ± 1.0 μM, whereas compds. 4 and 9 showed potent inhibition of tyrosinase in a dose-dependent manner, having IC50 values of 16.8 ± 2.7 and 8.7 ± 2.7 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwlyM0Ubzn7Vg90H21EOLACvtfcHk0lhiZ_8pAV0t9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWktbjK&md5=1e6832d376ef8887e23a5b1793c0ecb5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-1975-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-1975-x%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DX.%2BD.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DPrenyl-flavonoids%2520from%2520Epimedium%2520koreanum%2520Nakai%2520and%2520their%2520soluble%2520epoxide%2520hydrolase%2520and%2520tyrosinase%2520inhibitory%2520activities%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D2761%26epage%3D2767%26doi%3D10.1007%2Fs00044-017-1975-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J. M.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory and anti-inflammatory components from the leaves of <i>Eucommia ulmoides</i> Oliver (duzhong)</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2198</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.5b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.5b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1KnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=2198-2205&author=M.+M.+Baiauthor=W.+Shiauthor=J.+M.+Tianauthor=M.+Leiauthor=J.+H.+Kimauthor=Y.+N.+Sunauthor=Y.+H.+Kimauthor=J.+M.+Gao&title=Soluble+epoxide+hydrolase+inhibitory+and+anti-inflammatory+components+from+the+leaves+of+Eucommia+ulmoides+Oliver+%28duzhong%29&doi=10.1021%2Facs.jafc.5b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Inhibitory and Anti-inflammatory Components from the Leaves of Eucommia ulmoides Oliver (Duzhong)</span></div><div class="casAuthors">Bai, Meng-Meng; Shi, Wei; Tian, Jun-Mian; Lei, Ming; Kim, Jang Hoon; Sun, Ya Nan; Kim, Young Ho; Gao, Jin-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2198-2205</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Eucommia ulmoides leaves have been used as a functional food and drink in China.  The purpose of this study was to identify the bioactive constituents with sol. epoxide hydrolase (sEH) inhibitory activity and anti-inflammatory properties.  Twenty-seven known compds. (1-27) were isolated from the leaves of E. ulmoides Oliver, and their structures were identified by NMR and ESIMS anal.; three of these, 2,5-dimethoxy-3-glucopyranosyl cinnamic alc. (11), foliasalacioside E2 (26), and icariside F2 (27), were obtained from this plant for the first time.  Compds. 1-7 exhibited sol. epoxide hydrolase (sEH) inhibitory activity at 100 μM; among them, quercetin (1) and kaempferol (5) displayed potential activities with IC50 values of 22.5 ± 0.9 and 31.3 ± 2.6 μM, resp., with noncompetitive inhibition mode.  Nuclear factor kappa B (NF-κB) inhibitory activity of the isolated compds. was evaluated by the NF-κB liciferase assay in HepG2 cells.  Compds. 1, 9, 20, and 27 displayed potent NF-κB inhibitory effects, with IC50 values of 15.14 ± 2.29, 15.23 ± 2.34, 16.88 ± 2.17, and 16.25 ± 2.19 μM, resp., whereas other compds. showed weak inhibition of NF-κB transcriptional activity ranging from 17.54 to 92.6 μM.  A structure-activity relationship of flavonoids 1-9 was also discussed.  The results obtained in this work might contribute to the understanding of pharmacol. activities of E. ulmoides leaves and further investigation on its potential application values for food and drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYiBod8egnrVg90H21EOLACvtfcHk0lhiZ_8pAV0t9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1KnsrY%253D&md5=2dc380f585eb20c13c4e835c3f148814</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.5b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.5b00055%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DM.%2BM.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DJ.%2BM.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DJ.%2BM.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520and%2520anti-inflammatory%2520components%2520from%2520the%2520leaves%2520of%2520Eucommia%2520ulmoides%2520Oliver%2520%2528duzhong%2529%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2015%26volume%3D63%26spage%3D2198%26epage%3D2205%26doi%3D10.1021%2Facs.jafc.5b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition potential of cycloartane-type glycosides from the roots of <i>Cimicifuga dahurica</i> against soluble epoxide hydrolase</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1867</span>– <span class="NLM_lpage">1875</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=1867-1875&author=N.+P.+Thaoauthor=B.+T.+T.+Luyenauthor=J.+S.+Leeauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+H.+Kim&title=Inhibition+potential+of+cycloartane-type+glycosides+from+the+roots+of+Cimicifuga+dahurica+against+soluble+epoxide+hydrolase&doi=10.1021%2Facs.jnatprod.7b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition potential of cycloartane-type glycosides from the roots of Cimicifuga dahurica against soluble epoxide hydrolase</span></div><div class="casAuthors">Thao, Nguyen Phuong; Luyen, Bui Thi Thuy; Lee, Ji Sun; Kim, Jang Hoon; Dat, Nguyen Tien; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1867-1875</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A phytochem. assay-guided fractionation of the 95% ethanol ext. of Cimicifuga dahurica roots afforded 29 9,19-cycloartane triterpenoid glycosides, including the new cimiricasides A-F (1-6).  The structures of 1-6 were established using contemporary NMR methods and from the HRESIMS data, and the sugar moiety in each case was confirmed by acid hydrolysis and subsequent GC/MS anal.  Compds. 2, 4, 5, 7-9, 18, 25, and 29 showed sol. epoxide hydrolase inhibitory effects with IC50 values of 0.4 ± 0.1 to 24.0 ± 0.2 μM.  The compds. were analyzed by enzyme kinetic studies to explore the binding mode between the ligand and receptor.  Compds. 4 (mixed type), 8, 18, and 29 (noncompetitive type) bound to a preferred allosteric site, while compds. 2, 5, 7, 9, and 25 had competitive interactions at the active site.  The binding mechanism of selected inhibitors was investigated using mol. docking and dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxFdCmQJooirVg90H21EOLACvtfcHk0lgeumRV_4O81A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWrs7s%253D&md5=6fd2db1e79bd92f20d41837f1b79a45f</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00166%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DInhibition%2520potential%2520of%2520cycloartane-type%2520glycosides%2520from%2520the%2520roots%2520of%2520Cimicifuga%2520dahurica%2520against%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D1867%26epage%3D1875%26doi%3D10.1021%2Facs.jnatprod.7b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy
Luyen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">In silico investigation of cycloartane triterpene derivatives from <i>Cimicifuga dahurica</i> (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2017.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2017.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28188798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1c3lvVKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2017&pages=526-534&author=N.+P.+Thaoauthor=J.+H.+Kimauthor=B.+T.+Thuy%0ALuyenauthor=N.+T.+Datauthor=Y.+H.+Kim&title=In+silico+investigation+of+cycloartane+triterpene+derivatives+from+Cimicifuga+dahurica+%28Turcz.%29+Maxim.+roots+for+the+development+of+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.ijbiomac.2017.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Thao Nguyen Phuong; Kim Jang Hoon; Thuy Luyen Bui Thi; Dat Nguyen Tien; Kim Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">International journal of biological macromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">526-534</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In our search for natural soluble epoxide hydrolase (sEH) inhibitors from plants, we found that an ethanolic extract of the roots of Cimicifuga dahurica (Turcz.) Maxim. significantly inhibits sEH in vitro.  A phytochemical study on the dichloromethane fraction of C. dahurica resulted in the isolation of two new cycloartane triterpenoids (1 and 6), together with 13 known cycloartane analogues (2-5 and 7-15).  The structures of compounds were determined by spectroscopic methods.  All of the triterpenoid derivatives inhibited sEH enzymatic activity in a concentration-dependent manner, and 13 of the tested compounds showed significant activity.  Among them, compounds 1, 3, 5, 7, 9, and 12 showed the highest levels of inhibitory activity, with IC50 values of about 5μM or less.  Kinetic analysis of compounds 1, 3, 5-9, 11, 12, and 14 revealed that compounds 3, 6, 7, 11, and 14 were non-competitive; 1, 5, 9, and 12 were mixed-type; and 8 was a competitive inhibitor.  Furthermore, in silico molecular docking indicated that compounds 3, 6-9, 11, 12, and 14 bound to sEH in a similar manner and had stable binding energies, as calculated by AutoDock 4.2 and processed in a 10,000-ps molecular dynamics simulation to assess the binding stability of compounds 5, 7, and 9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-nOOaOK18OkPI-fCgwosgfW6udTcc2eYWPEQstee9m7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3lvVKjtQ%253D%253D&md5=0fb61588f55c85a5a0a850d9dba8dd99</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2017.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DThuy%2BLuyen%26aufirst%3DB.%2BT.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DIn%2520silico%2520investigation%2520of%2520cycloartane%2520triterpene%2520derivatives%2520from%2520Cimicifuga%2520dahurica%2520%2528Turcz.%2529%2520Maxim.%2520roots%2520for%2520the%2520development%2520of%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2017%26volume%3D98%26spage%3D526%26epage%3D534%26doi%3D10.1016%2Fj.ijbiomac.2017.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103637</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2020.103637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32032849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103637&author=C.+P.+Sunauthor=J.+Zhangauthor=W.+Y.+Zhaoauthor=J.+Yiauthor=J.+K.+Yanauthor=Y.+L.+Wangauthor=C.+Morisseauauthor=Z.+B.+Liuauthor=B.+D.+Hammockauthor=X.+C.+Ma&title=Protostane-type+triterpenoids+as+natural+soluble+epoxide+hydrolase+inhibitors%3A+Inhibition+potentials+and+molecular+dynamics&doi=10.1016%2Fj.bioorg.2020.103637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics</span></div><div class="casAuthors">Sun, Cheng-Peng; Zhang, Juan; Zhao, Wen-Yu; Yi, Jing; Yan, Jian-Kun; Wang, Ya-Li; Morisseau, Christophe; Liu, Zhong-Bo; Hammock, Bruce D.; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103637</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of sol. epoxide hydrolase (sEH) is a promising therapeutic approach to treat inflammation and other disorders.  In our present investigation on searching for sEH inhibitors from traditional Chinese medicines, we found that Alisma orientale displayed inhibition of sEH.  We constructed a small library of protostane-type triterpenoids (1-25) isolated from A. orientale, and screened their inhibitory activities.  Alismanin B (1), 11-deoxy-25-anhydro alisol E (4), 11-deoxy alisol B (5), and 25-O-Et alisol A (15) displayed concn.-dependently inhibitory activities against sEH with IC50 values from 3.40 ± 0.57μM to 9.57 ± 0.88μM. 11-Deoxy-25-anhydro alisol E (4) and 11-deoxy alisol B (5) were defined as mixed-type competitive inhibitors with Ki values of 12.6 and 3.48μM, resp., based on the result of inhibition kinetics.  The potential interaction mechanism of 11-deoxy alisol B (5) with sEH was analyzed by mol. docking and mol. dynamics, revealing that amino acid residues Trp336 and Tyr466 were vital for its inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmVe2j3nZnbVg90H21EOLACvtfcHk0ljGyP206D68kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7Y%253D&md5=47ac08fa371a13217b760ec41437d64e</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103637%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%2BY.%26aulast%3DYi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%2BB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DProtostane-type%2520triterpenoids%2520as%2520natural%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%253A%2520Inhibition%2520potentials%2520and%2520molecular%2520dynamics%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103637%26doi%3D10.1016%2Fj.bioorg.2020.103637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from <i>Cimicifuga dahurica</i> (Turcz.) Maxim</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1874</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2017.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28279529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1czkvVSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1874-1879&author=N.+P.+Thaoauthor=B.+T.+Luyenauthor=J.+S.+Leeauthor=J.+H.+Kimauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitors+of+indolinone+alkaloids+and+phenolic+derivatives+from+Cimicifuga+dahurica+%28Turcz.%29+Maxim&doi=10.1016%2Fj.bmcl.2017.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim</span></div><div class="casAuthors">Thao Nguyen Phuong; Luyen Bui Thi Thuy; Lee Ji Sun; Kim Young Ho; Kim Jang Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1874-1879</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this study was to search for potential therapeutic agents by identifying novel inhibitors of soluble epoxide hydrolase (sEH) from natural plants using an in silico approach.  We found that an ethanolic extract from the roots of Cimicifuga dahurica (Turcz.) Maxim. significantly inhibited sEH in vitro.  In a phytochemical investigation using assay-guided fractionation of the dichloromethane extract of C. dahurica, we isolated two new indolinone alkaloids (5 and 6) and five related constituents (1-4, and 7) and established their structures based on an extensive analysis using 1D and 2D NMR, and MS methods.  All of the isolated compounds inhibited sEH enzymatic activity in a dose-dependent manner, with IC50 values ranging from 0.8±0.0 to 2.8±0.4μM.  A kinetic analysis of compounds 1-7 revealed that compound 2 was non-competitive; 1, 3, and 7 were mixed-type; and 4-6 were competitive inhibitors.  Molecular docking was employed to further elucidate their receptor-ligand binding characteristics.  These results demonstrated that compounds from C. dahurica are potential sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlN7h30Bt1h1m8bhe6roZYfW6udTcc2eYKHiGtKYorJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czkvVSltg%253D%253D&md5=a41740573fc8aeb41d71e32bacdaa1cc</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%2520of%2520indolinone%2520alkaloids%2520and%2520phenolic%2520derivatives%2520from%2520Cimicifuga%2520dahurica%2520%2528Turcz.%2529%2520Maxim%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1874%26epage%3D1879%26doi%3D10.1016%2Fj.bmcl.2017.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of <i>Gentiana scabra</i></span>. <i>Biosci., Biotechnol., Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1080/09168451.2014.1002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F09168451.2014.1002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25588498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=907-911&author=W.+Liauthor=J.+H.+Kimauthor=W.+Zhouauthor=S.+H.+Shimauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+phenolic+components+from+the+rhizomes+and+roots+of+Gentiana+scabra&doi=10.1080%2F09168451.2014.1002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of Gentiana scabra</span></div><div class="casAuthors">Li, Wei; Kim, Jang Hoon; Zhou, Wei; Shim, Sang Hee; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience, Biotechnology, and Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-911</span>CODEN:
                <span class="NLM_cas:coden">BBBIEJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-6947</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Two new (1 and 2) and seven known phenolic compds. were isolated from a methanol ext. of the rhizomes and roots of Gentiana scabra.  Their structures were identified by spectroscopic anal. and comparing with reported values.  The inhibitory effects of each compd. on sol. epoxide hydrolase (sEH) were evaluated.  Among them, compds. 2, 6, and 9 potently inhibited sEH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhROR5oSpBFrVg90H21EOLACvtfcHk0ljGyP206D68kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGjtro%253D&md5=3e76b4a4d4acb4ad7dab45cfd5cfe32d</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1080%2F09168451.2014.1002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09168451.2014.1002451%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShim%26aufirst%3DS.%2BH.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520phenolic%2520components%2520from%2520the%2520rhizomes%2520and%2520roots%2520of%2520Gentiana%2520scabra%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D2015%26volume%3D79%26spage%3D907%26epage%3D911%26doi%3D10.1080%2F09168451.2014.1002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of anthraquinone components from <i>Aloe</i></span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6659</span>– <span class="NLM_lpage">6665</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2015.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26372074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6659-6665&author=Y.+N.+Sunauthor=J.+H.+Kimauthor=W.+Liauthor=A.+R.+Joauthor=X.+T.+Yanauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+anthraquinone+components+from+Aloe&doi=10.1016%2Fj.bmc.2015.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe</span></div><div class="casAuthors">Sun, Ya Nan; Kim, Jang Hoon; Li, Wei; Jo, A. Reum; Yan, Xi Tao; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6659-6665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aloe is a short-stemmed succulent herb widely used in traditional medicine to treat various diseases and as raw material in cosmetics and heath foods.  In this study, we isolated and identified two new anthraquinone derivs., aloinoside C (6) and aloinoside D (7), together with six known compds. from an aq. dissolved Aloe exudate.  Their structures were identified by spectroscopic anal.  The inhibitory effects of the isolated compds. on sol. epoxide hydrolase (sEH) were evaluated.  Compds. 1-8 inhibited sEH activity potently, with IC50 values ranging from 4.1 ± 0.6 to 41.1 ± 4.2 μM.  A kinetic anal. of compds. 1-8 revealed that the inhibitory actions of compds. 1, 6 and 8 were non-competitive, whereas those of compds. 2-5 and 7 were the mixed-type.  Mol. docking increases our understanding of receptor-ligand binding of all compds.  These results demonstrate that compds. 1-8 from Aloe are potential sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX__-X9hBtW7Vg90H21EOLACvtfcHk0lgJ8G8KAGI5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbnF&md5=d175ef822ea07ee1dfce9f2a9d14b082</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520anthraquinone%2520components%2520from%2520Aloe%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6659%26epage%3D6665%26doi%3D10.1016%2Fj.bmc.2015.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Chemical constituents from the root of <i>Polygonum multiflorum</i> and their soluble epoxide hydrolase inhibitory activity</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1007/s12272-014-0520-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12272-014-0520-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25413971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=998-1004&author=Y.+N.+Sunauthor=W.+Liauthor=J.+H.+Kimauthor=X.+T.+Yanauthor=J.+E.+Kimauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Chemical+constituents+from+the+root+of+Polygonum+multiflorum+and+their+soluble+epoxide+hydrolase+inhibitory+activity&doi=10.1007%2Fs12272-014-0520-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activity</span></div><div class="casAuthors">Sun, Ya Nan; Li, Wei; Kim, Jang Hoon; Yan, Xi Tao; Kim, Ji Eun; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">998-1004</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Fourteen compds. were isolated from a methanol ext. of Polygonum multiflorum roots, and their structures were elucidated by comparing spectroscopic data to published spectra.  The inhibitory effects of the isolated compds. on sol. epoxide hydrolase (sEH) were then evaluated.  Compds. 1-7 inhibited sEH activity potently, with IC50 values ranging from 6.2±0.5 to 48.6±3.1 μM.  Moreover, a kinetic anal. of compds. 1-7 revealed that the inhibitory actions of compds. 1, 3 and 4 were non-competitive, whereas those of compds. 2 and 5-7 were mixed-type.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjFYO-6MbvI7Vg90H21EOLACvtfcHk0lgJ8G8KAGI5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtLrJ&md5=be2b2b3bc5d757d1feb5fe24aea808e7</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1007%2Fs12272-014-0520-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-014-0520-4%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DChemical%2520constituents%2520from%2520the%2520root%2520of%2520Polygonum%2520multiflorum%2520and%2520their%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2015%26volume%3D38%26spage%3D998%26epage%3D1004%26doi%3D10.1007%2Fs12272-014-0520-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory components from <i>Rheum undulatum</i> and in silico approach</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1189421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F14756366.2016.1189421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27555350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=70-78&author=A.+R.+Joauthor=J.+H.+Kimauthor=X.+T.+Yanauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+components+from+Rheum+undulatum+and+in+silico+approach&doi=10.1080%2F14756366.2016.1189421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach</span></div><div class="casAuthors">Jo, Ah Reum; Kim, Jang Hoon; Yan, Xi-Tao; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup2</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Continuous efforts to identify sol. epoxide hydrolase (sEH) inhibitors using activity-guided fractionation revealed 12 known compds. from R. undulatum root.  The compds. were tested for inhibitory activity against sEH.  Eleven of the compds. were shown to have inhibitory activity, with IC50 values ranging from 2.5 ± 0.5 to 53.2 ± 4.4 μM.  They were subjected to enzyme kinetic studies to explore the binding mode between the ligand and receptor.  Based on these results, 10 compds. had a preferred allosteric site.  One compd. was identified as a competitive-type inhibitor.  Mol. docking studies revealed the interacting residues and binding energy between sEH and inhibitors.  Addnl., mol. dynamics simulation provided detailed information on the interaction between the ligand and receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8AAIlu7QmXLVg90H21EOLACvtfcHk0lgJ8G8KAGI5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmt77P&md5=804f71a47e3b93b2c44a8c5a288b164a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1189421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1189421%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520components%2520from%2520Rheum%2520undulatum%2520and%2520in%2520silico%2520approach%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D70%26epage%3D78%26doi%3D10.1080%2F14756366.2016.1189421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of <i>Glycosmis stenocarpa</i></span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1057719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3109%2F14756366.2015.1057719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26444316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFCmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=640-644&author=J.+H.+Kimauthor=A.+M.+Morganauthor=B.+H.+Taiauthor=D.+T.+Vanauthor=N.+M.+Cuongauthor=Y.+H.+Kim&title=Inhibition+of+soluble+epoxide+hydrolase+activity+by+compounds+isolated+from+the+aerial+parts+of+Glycosmis+stenocarpa&doi=10.3109%2F14756366.2015.1057719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of Glycosmis stenocarpa</span></div><div class="casAuthors">Kim, Jang Hoon; Morgan, Abubaker M. A.; Tai, Bui Huu; Doan, Thi Van; Nguyen, Manh Cuong; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">640-644</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aim of this study is to search for sol. epoxide hydrolase (sEH) inhibitors from natural plants, bioassay-guided fractionation of lipophilic n-hexane and chloroform layers of an ext. of the aerial parts of Glycosmis stenocarpa led to the isolation of 12 compds., including murrayafoline-A, isomahanine, bisisomahanine, saropeptate, (24S)-ergost-4-en-3,6-dione, stigmasta-4-en-3,6-dion, stigmast-4-en-3-one, β-sitosterol, 24-methylpollinastanol, trans-phytol, neosarmentol III and (+)-epiloliolide.  Their structures were elucidated on the basis of spectroscopic data.  Among them, neosarmentol III was isolated from nature for the first time.  All the isolated compds. were evaluated for their inhibitory activity against sEH.  Among isolated carbazole-type compds., isomahanine and bisisomahanine were identified as a potent inhibitor of sEH, with IC50 values of 22.5 ± 1.7 and 7.7 ± 1.2 μM, resp.  Moreover, the inhibitory action of and represented mixed-type enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDBFjf6_AnHLVg90H21EOLACvtfcHk0ljqRcAYXeR32w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFCmu7w%253D&md5=3d2d257d7c8a3f1aeebfd73e1b934c71</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1057719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1057719%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMorgan%26aufirst%3DA.%2BM.%26aulast%3DTai%26aufirst%3DB.%2BH.%26aulast%3DVan%26aufirst%3DD.%2BT.%26aulast%3DCuong%26aufirst%3DN.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520activity%2520by%2520compounds%2520isolated%2520from%2520the%2520aerial%2520parts%2520of%2520Glycosmis%2520stenocarpa%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D640%26epage%3D644%26doi%3D10.3109%2F14756366.2015.1057719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duc, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huong, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, N. M.</span></span> <span> </span><span class="NLM_article-title">Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from <i>Callistemon citrinus</i></span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.fitote.2015.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26548595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeju7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=39-44&author=P.+N.+Khanhauthor=H.+V.+Ducauthor=T.+T.+Huongauthor=N.+T.+Sonauthor=V.+T.+Haauthor=D.+T.+Vanauthor=B.+H.+Taiauthor=J.+E.+Kimauthor=A.+R.+Joauthor=Y.+H.+Kimauthor=N.+M.+Cuong&title=Alkylphloroglucinol+derivatives+and+triterpenoids+with+soluble+epoxide+hydrolase+inhibitory+activity+from+Callistemon+citrinus&doi=10.1016%2Fj.fitote.2015.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from Callistemon citrinus</span></div><div class="casAuthors">Khanh, Pham Ngoc; Duc, Ho Viet; Huong, Tran Thu; Son, Ninh The; Ha, Vu Thi; Van, Doan Thi; Tai, Bui Huu; Kim, Ji Eun; Jo, Ah Reum; Kim, Young Ho; Cuong, Nguyen Manh</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-44</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phytochem. anal. of the leaves and stems of Callistemon citrinus (Curtis) Skeels led to the isolation of two new alkylphloroglucinols, gallomyrtucommulone E and F (1 and 2), along with four other known alkylphloroglucinol derivs., gallomyrtucommulone A (3), endoperoxide G3 (4), myrtucommulone B (5), callistenone B (6) and five known triterpenoids, including betulinic acid (7), 3β-acetylmorolic acid (8), 3β-hydroxy-urs-11-en-13(28)-olide (9), diospyrolide (10) and ursolic acid (11).  The structures of the natural compds. were detd. from the spectroscopic evidences including 1D-/2D-NMR and HR-MS spectrometry.  All the isolated compds. were assessed for the effects on the sEH inhibitory activity.  The acylphloroglucinols myrtucommulone B (5)/callistenone B (6) (in mixt.), and two triterpenoids, ursolic acid (11) and 3β-hydroxy-urs-11-en-13(28)-olide (9) displayed strong inhibition of sEH activity, with IC50 values of 0.7, 11.2 and 24.8 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7D9NUnZAaaLVg90H21EOLACvtfcHk0ljqRcAYXeR32w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeju7nO&md5=41029d900ae4c673e7e634e167f7ea8b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhanh%26aufirst%3DP.%2BN.%26aulast%3DDuc%26aufirst%3DH.%2BV.%26aulast%3DHuong%26aufirst%3DT.%2BT.%26aulast%3DSon%26aufirst%3DN.%2BT.%26aulast%3DHa%26aufirst%3DV.%2BT.%26aulast%3DVan%26aufirst%3DD.%2BT.%26aulast%3DTai%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DCuong%26aufirst%3DN.%2BM.%26atitle%3DAlkylphloroglucinol%2520derivatives%2520and%2520triterpenoids%2520with%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520from%2520Callistemon%2520citrinus%26jtitle%3DFitoterapia%26date%3D2016%26volume%3D109%26spage%3D39%26epage%3D44%26doi%3D10.1016%2Fj.fitote.2015.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Constituents of the seeds of <i>Cassia tora</i> with inhibitory activity on soluble expoxide hydrolease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5097</span>– <span class="NLM_lpage">5101</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26483136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5097-5101&author=G.+Y.+Leeauthor=J.+H.+Kimauthor=S.+K.+Choiauthor=Y.+H.+Kim&title=Constituents+of+the+seeds+of+Cassia+tora+with+inhibitory+activity+on+soluble+expoxide+hydrolease&doi=10.1016%2Fj.bmcl.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Constituents of the seeds of Cassia tora with inhibitory activity on soluble epoxide hydrolase</span></div><div class="casAuthors">Lee, Ga Young; Kim, Jang Hoon; Choi, Seung-Kook; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5097-5101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Efforts to ext. sol. epoxide hydrolase (sEH) inhibitors from food sources through bioactivity-guided fractionation of Cassia tora seed exts. led to the isolation of one new compd., 1, and 15 known compds., 2-16.  Structural elucidations were performed using 1D/2D NMR spectroscopy and mass spectrometry.  Compds. 1, 3, 4, 6, 10, 11, and 13-16 exhibited inhibitory activities on sEH with IC50 values of 2.2 ± 2.1-40.6 ± 3.4 μM.  Compd. 13 was particularly active and exhibited a reversible-uncompetitive behavior in enzyme kinetic studies.  A binding site on the enzyme for compd. 13 was also predicted by Autodock 4.2 simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhxuxzpaCQ0LVg90H21EOLACvtfcHk0ljqRcAYXeR32w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqu7%252FE&md5=66ed41806c4f9f7dbe556acac4fea7c6</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DConstituents%2520of%2520the%2520seeds%2520of%2520Cassia%2520tora%2520with%2520inhibitory%2520activity%2520on%2520soluble%2520expoxide%2520hydrolease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5097%26epage%3D5101%26doi%3D10.1016%2Fj.bmcl.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. L.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives as anticancer agents</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.2174/1871520610909040471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1871520610909040471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19442045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=471-480&author=H.+Q.+Liauthor=P.+C.+Lvauthor=T.+Yanauthor=H.+L.+Zhu&title=Urea+derivatives+as+anticancer+agents&doi=10.2174%2F1871520610909040471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Urea derivatives as anticancer agents</span></div><div class="casAuthors">Li, Huan-Qiu; Lv, Peng-Cheng; Yan, Tao; Zhu, Hai-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-480</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Within the past ten years, a huge vol. of research on the synthesis, structure-activity relationships (SAR), and anticancer activities of the urea derivs. was reported.  Many arom. urea derivs. such as N-phenyl-N'-(2-chloroethyl)ureas (CEUs) and benzoylureas (BUs) show good anticancer activity, and these compds. have mainly been proved to be tubulin ligands that inhibit the polymn. of tubulin.  Heterocyclic urea derivs. play an important role in anticancer agents because of their good inhibitory activity against receptor tyrosine kinases (RTKs), raf kinases, protein tyrosine kinases (PTKs), and NADH oxidase, which play crit. roles in many aspects of tumorigenesis.  Thiourea derivs. are also of wide interest because of their diverse anticancer activity against various leukemias and solid tumors.  In this review, the anticancer activity of the urea derivs. mentioned above is summarized in detail.  It is hoped that increasing knowledge of the SAR and cellular processes underlying the antitumor-activity of urea derivs. will be beneficial to the rational design of new generation of urea anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2E0VPDqvojbVg90H21EOLACvtfcHk0lh9bQnZ_hSePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrc%253D&md5=028eb5bfbe09b8d9c34b1817ebc71c95</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.2174%2F1871520610909040471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909040471%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BQ.%26aulast%3DLv%26aufirst%3DP.%2BC.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DUrea%2520derivatives%2520as%2520anticancer%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D471%26epage%3D480%26doi%3D10.2174%2F1871520610909040471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, C. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo-Semidey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinyl biphenylureas act as allosteric modulators to activate cannabinoid receptor 1 and initiate beta-arrestin-dependent responses</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1124/mol.118.112854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fmol.118.112854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30322873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt1Shu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2019&pages=1-10&author=C.+A.+D.+Jaglaauthor=C.+E.+Scottauthor=Y.+Tangauthor=C.+Qiaoauthor=G.+E.+Mateo-Semideyauthor=G.+A.+Yudowskiauthor=D.+Luauthor=D.+A.+Kendall&title=Pyrimidinyl+biphenylureas+act+as+allosteric+modulators+to+activate+cannabinoid+receptor+1+and+initiate+beta-arrestin-dependent+responses&doi=10.1124%2Fmol.118.112854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinyl biphenylureas act as allosteric modulators to activate cannabinoid receptor 1 and initiate β-arrestin-dependent responses</span></div><div class="casAuthors">Jagla, Caitlin A. D.; Scott, Caitlin E.; Tang, Yaliang; Qiao, Changjiang; Mateo-Semidey, Gabriel E.; Yudowski, Guillermo A.; Lu, Dai; Kendall, Debra A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is a G-protein-coupled receptor that is abundant in the central nervous system.  It binds several compds. in its orthosteric site, including the endocannabinoids, arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol, and the plant-derived Δ9-tetrahydrocannabinol, one of the main psychoactive components of marijuana.  It primarily couples to Gi/oproteins to inhibit adenylate cyclase activity and typically induces downstream signaling that is Gi-dependent.  Since this receptor is implicated in several maladies, such as obesity, pain, and neurodegenerative disorders, there is interest in developing therapeutics that selectively target this receptor.  Allosteric modulators of CB1 offer one new approach that has tremendous therapeutic potential.  Here, we reveal receptor- and cellular-level properties consistent with receptor activation by a series of pyrimidinyl biphenylureas (LDK1285, LDK1288, LDK1305, and PSNCBAM1), including promoting binding of the agonist CP55940 with pos. cooperativity and inhibiting binding of the inverse agonist SR141716A with neg. cooperativity, demonstrated via radioligand binding studies.  Consistent with these findings, the allosteric modulators induced cellular internalization of the receptor and recruitment of β-arrestin 2 in human embryonic kidney cell line 293 cells monitored with confocal and total internal reflective fluorescence microscopy, resp.  These allosteric modulators, however, caused G-protein-independent but β-arrestin 1-dependent phosphorylation of the downstream kinases extracellular signal-regulated kinase 1/2, mitogen-activated protein kinase, and Src, shown by immunoblotting studies.  These results are consistent with the involvement of β-arrestin and suggest that these allosteric modulators induce biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbx4EnosiAJbVg90H21EOLACvtfcHk0lh9bQnZ_hSePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt1Shu78%253D&md5=461f0df03d21eaf43a6ccc4ab38c1135</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1124%2Fmol.118.112854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.118.112854%26sid%3Dliteratum%253Aachs%26aulast%3DJagla%26aufirst%3DC.%2BA.%2BD.%26aulast%3DScott%26aufirst%3DC.%2BE.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DMateo-Semidey%26aufirst%3DG.%2BE.%26aulast%3DYudowski%26aufirst%3DG.%2BA.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26atitle%3DPyrimidinyl%2520biphenylureas%2520act%2520as%2520allosteric%2520modulators%2520to%2520activate%2520cannabinoid%2520receptor%25201%2520and%2520initiate%2520beta-arrestin-dependent%2520responses%26jtitle%3DMol.%2520Pharmacol.%26date%3D2019%26volume%3D95%26spage%3D1%26epage%3D10%26doi%3D10.1124%2Fmol.118.112854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span> <span> </span><span class="NLM_article-title">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in Alzheimer’s signaling in human nerve cells</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4018</span>– <span class="NLM_lpage">4030</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00271</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00271" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4018-4030&author=Z.+Liangauthor=B.+Zhangauthor=M.+Xuauthor=C.+Morisseauauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=Q.+X.+Li&title=1-Trifluoromethoxyphenyl-3-%281-propionylpiperidin-4-yl%29+urea%2C+a+selective+and+potent+dual+inhibitor+of+soluble+epoxide+hydrolase+and+p38+kinase+intervenes+in+Alzheimer%E2%80%99s+signaling+in+human+nerve+cells&doi=10.1021%2Facschemneuro.9b00271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells</span></div><div class="casAuthors">Liang, Zhibin; Zhang, Bei; Xu, Meng; Morisseau, Christophe; Hwang, Sung Hee; Hammock, Bruce D.; Li, Qing X.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4018-4030</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disorder.  Neuroinflammation is a prevalent pathogenic stress leading to neuronal death in AD.  Targeting neuroinflammation to keep neurons alive is an attractive strategy for AD therapy.  1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) is a potent inhibitor of sol. epoxide hydrolase (sEH) and can enter into the brain.  It has a good efficacy on a wide range of chronic inflammatory diseases in preclin. animal models.  However, the anti-neuroinflammatory effects and mol. mechanisms of TPPU for potential AD interventions remain elusive.  With an aim to develop multi-target therapeutics for neurodegenerative diseases, we screened TPPU against sEH from different vertebrate species and a broad panel of human kinases in vitro for potential new targets relevant to neuroinflammation in AD.  TPPU inhibits both human sEH and p38β kinase, two key regulators of inflammation, with nanomolar potencies and distinct selectivity.  To further elucidate the mol. mechanisms, differentiated SH-SY5Y human neuroblastoma cells were used as an AD cell model and investigated the neuroprotection of TPPU against amyloid oligomers.  We found that TPPU effectively prevents neuronal death by mitigating amyloid neurotoxicity, tau hyperphosphorylation and mitochondrial dysfunction, promoting neurite outgrowth, and suppressing activation and nuclear translocation of NF-κB for inflammatory responses in human nerve cells.  The results indicate that TPPU is a potent and selective dual inhibitor of sEH and p38β kinase, showing a synergistic action in multiple AD signaling pathways.  Our study sheds light upon TPPU and other sEH/p38β dual inhibitors for potential pharmacol. interventions in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs0ueaFZwGrVg90H21EOLACvtfcHk0lh9bQnZ_hSePQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7nM&md5=d48d3991aad60f484894618db9c1a70a</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00271%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26atitle%3D1-Trifluoromethoxyphenyl-3-%25281-propionylpiperidin-4-yl%2529%2520urea%252C%2520a%2520selective%2520and%2520potent%2520dual%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520p38%2520kinase%2520intervenes%2520in%2520Alzheimer%25E2%2580%2599s%2520signaling%2520in%2520human%2520nerve%2520cells%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4018%26epage%3D4030%26doi%3D10.1021%2Facschemneuro.9b00271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boardley, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tal-Singer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyan, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1111/bcp.12855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fbcp.12855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26620151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=971-979&author=A.+L.+Lazaarauthor=L.+Yangauthor=R.+L.+Boardleyauthor=N.+S.+Goyalauthor=J.+Robertsonauthor=S.+J.+Baldwinauthor=D.+E.+Newbyauthor=I.+B.+Wilkinsonauthor=R.+Tal-Singerauthor=R.+J.+Mayerauthor=J.+Cheriyan&title=Pharmacokinetics%2C+pharmacodynamics+and+adverse+event+profile+of+GSK2256294%2C+a+novel+soluble+epoxide+hydrolase+inhibitor&doi=10.1111%2Fbcp.12855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor</span></div><div class="casAuthors">Lazaar, Aili L.; Yang, Lucy; Boardley, Rebecca L.; Goyal, Navin S.; Robertson, Jonathan; Baldwin, Sandra J.; Newby, David E.; Wilkinson, Ian B.; Tal-Singer, Ruth; Mayer, Ruth J.; Cheriyan, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-979</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Endothelial-derived epoxyeicosatrienoic acids may regulate vascular tone and are metabolized by sol. epoxide hydrolase enzymes (sEH).  GSK2256294 is a potent and selective sEH inhibitor that was tested in two phase I studies.  Single escalating doses of GSK2256294 2-20 mg or placebo were administered in a randomized crossover design to healthy male subjects or obese smokers.  Once daily doses of 6 or 18 mg or placebo were administered for 14 days to obese smokers.  Data were collected on safety, pharmacokinetics, sEH enzyme inhibition and blood biomarkers.  Single doses of GSK2256294 10 mg were also administered to healthy younger males or healthy elderly males and females with and without food.  Data on safety, pharmacokinetics and biliary metabolites were collected.  Results : GSK2256294 was well-tolerated with no serious adverse events (AEs) attributable to the drug.  The most frequent AEs were headache and contact dermatitis.  Plasma concns. of GSK2256294 increased with single doses, with a half-life averaging 25-43 h.  There was no significant effect of age, food or gender on pharmacokinetic parameters.  Inhibition of sEH enzyme activity was dose-dependent, from an av. of 41.9% on 2 mg (95% confidence interval [CI] -51.8, 77.7) to 99.8% on 20 mg (95% CI 99.3, 100.0) and sustained for up to 24 h.  There were no significant changes in serum VEGF or plasma fibrinogen.  GSK2256294 was well-tolerated and demonstrated sustained inhibition of sEH enzyme activity.  These data support further investigation in patients with endothelial dysfunction or abnormal tissue repair, such as diabetes, wound healing or COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr37PHmVvZ8A7Vg90H21EOLACvtfcHk0ljXAuhE1rte2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls7w%253D&md5=085db35368f6acb60aef7aa05d4aaa1c</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12855%26sid%3Dliteratum%253Aachs%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBoardley%26aufirst%3DR.%2BL.%26aulast%3DGoyal%26aufirst%3DN.%2BS.%26aulast%3DRobertson%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DS.%2BJ.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DTal-Singer%26aufirst%3DR.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DCheriyan%26aufirst%3DJ.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%2520and%2520adverse%2520event%2520profile%2520of%2520GSK2256294%252C%2520a%2520novel%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D81%26spage%3D971%26epage%3D979%26doi%3D10.1111%2Fbcp.12855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/bs.apha.2016.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fbs.apha.2016.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27451096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12hsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=105-141&author=J.+D.+Imig&title=Epoxyeicosatrienoic+acids+and+20-hydroxyeicosatetraenoic+acid+on+endothelial+and+vascular+function&doi=10.1016%2Fbs.apha.2016.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function</span></div><div class="casAuthors">Imig, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">Endothelium</span>),
    <span class="NLM_cas:pages">105-141</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Endothelial and vascular smooth cells generate cytochrome P 450 (CYP) arachidonic acid metabolites that can impact endothelial cell function and vascular homeostasis.  The objective of this review is to focus on the physiol. and pharmacol. of endothelial CYP metabolites.  The CYP pathway produces two types of eicosanoid products: epoxyeicosatrienoic acids (EETs), formed by CYP epoxygenases, and hydroxyeicosatetraenoic acids (HETEs), formed by CYP hydroxylases.  Advances in CYP enzymes, EETs, and 20-HETE by pharmacol. and genetic means have led to a more complete understanding of how these eicosanoids impact on endothelial cell function.  Endothelial-derived EETs were initially described as endothelial-derived hyperpolarizing factors.  It is now well recognized that EETs importantly contribute to numerous endothelial cell functions.  On the other hand, 20-HETE is the predominant CYP hydroxylase synthesized by vascular smooth muscle cells.  Like EETs, 20-HETE acts on endothelial cells and impacts importantly on endothelial and vascular function.  An important aspect for EETs and 20-HETE endothelial actions is their interactions with hormonal and paracrine factors.  These include interactions with the renin-angiotensin system, adrenergic system, puringeric system, and endothelin.  Alterations in CYP enzymes, 20-HETE, or EETs contribute to endothelial dysfunction and cardiovascular diseases such as ischemic injury, hypertension, and atherosclerosis.  Recent advances have led to the development of potential therapeutics that target CYP enzymes, 20-HETE, or EETs.  Thus, future investigation is required to obtain a more complete understanding of how CYP enzymes, 20-HETE, and EETs regulate endothelial cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTPKNgvl2zc7Vg90H21EOLACvtfcHk0ljXAuhE1rte2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12hsLvO&md5=487b0bf840d6a7dadb5eca648e670dd2</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fbs.apha.2016.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.apha.2016.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520and%252020-hydroxyeicosatetraenoic%2520acid%2520on%2520endothelial%2520and%2520vascular%2520function%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D105%26epage%3D141%26doi%3D10.1016%2Fbs.apha.2016.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. S.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">267</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1635-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1635-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31847859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=267&author=H.+T.+Leeauthor=K.+I.+Leeauthor=C.+H.+Chenauthor=T.+S.+Lee&title=Genetic+deletion+of+soluble+epoxide+hydrolase+delays+the+progression+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-019-1635-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease</span></div><div class="casAuthors">Lee, Hsueh-Te; Lee, Kuan-I.; Chen, Chia-Hui; Lee, Tzong-Shyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">267</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">To examine the role of sEH in pathogenesis of AD, we used wild-type (WT) mice, sol. epoxide hydrolase deficient (sEH-/-) and two mouse models of AD, including amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic (APP/PS1 Tg) and APP/PS1 Tg/sEH-/- mice.  The levels of interleukin (IL)-1β, IL-4, IL-6, and IL-10 and the activities of NF-κB and nuclear factor of activated T cells (NFAT) were measured by com. assay kits.  We demonstrated that the level of sEH was increased in the brain and predominantly appeared in hippocampal astrocytes of APP/PS1 Tg mice.  Genetic ablation of sEH in APP/PS1 Tg mice delayed the progression of AD as evidenced by the alleviation in behavior outcomes and Aβ plaque deposition.  In addn., loss of the function of sEH in APP/PS1 Tg mice increased astrogliosis and the prodn. of astrocyte-derived anti-inflammatory cytokines including IL-1β, IL-4, and IL-10, as well as the activity of NF-kB and NFAT.  Moreover, anal. of gene ontol. in the AD brain revealed that important signaling pathways and processes related to AD pathogenesis such as translational regulation, oxidative stress, cytoskeleton reorganization, and small GTPase signal transduction were altered in APP/PS1 Tg/sEH-/- mice compared with APP/PS1 Tg mice.  Our results suggest that sEH is a crucial regulator in the progression of AD and might be a potential therapeutic target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7pffaZ6WEn7Vg90H21EOLACvtfcHk0ljXAuhE1rte2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyrsr7I&md5=ccf2fc448bbd021b9adada1d00d797e5</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1635-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1635-9%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BS.%26atitle%3DGenetic%2520deletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520delays%2520the%2520progression%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D267%26doi%3D10.1186%2Fs12974-019-1635-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span> <span> </span><span class="NLM_article-title">Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2019.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.biochi.2019.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30716359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2019&pages=59-65&author=S.+D.+Kodaniauthor=C.+Morisseau&title=Role+of+epoxy-fatty+acids+and+epoxide+hydrolases+in+the+pathology+of+neuro-inflammation&doi=10.1016%2Fj.biochi.2019.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation</span></div><div class="casAuthors">Kodani, Sean D.; Morisseau, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-65</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neuroinflammation is a physiol. response aimed at protecting the central nervous system during injury.  However, unresolved and chronic neuroinflammation can lead to long term damage and eventually neurol. disease including Parkinson's disease, Alzheimer's disease and dementia.  Recently, enhancing the concn. of epoxyeicosatrienoic acids (EETs) through blocking their hydrolytic degrdn. by sol. epoxide hydrolase (sEH) has been applied towards reducing the long-term damage assocd. with central neurol. insults.  Evidence suggests this protective effect is mediated, at least in part, through polarization of microglia to an anti-inflammatory phenotype that blocks the inflammatory actions of prostaglandins and promotes wound repair.  This mini-review overviews the epidemiol. basis for using sEH inhibition towards neuroinflammatory disease and pharmacol. studies testing sEH inhibition in several neurol. diseases.  Addnl., the combination of sEH inhibition with other eicosanoid signaling pathways is considered as an enhanced approach for developing potent neuroprotectants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHkm1AvVQT6LVg90H21EOLACvtfcHk0lgyvDkUeahCyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVahtb8%253D&md5=7ff69c1886a8c5ca0f43b2a0e6fc91ed</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2019.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2019.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DMorisseau%26aufirst%3DC.%26atitle%3DRole%2520of%2520epoxy-fatty%2520acids%2520and%2520epoxide%2520hydrolases%2520in%2520the%2520pathology%2520of%2520neuro-inflammation%26jtitle%3DBiochimie%26date%3D2019%26volume%3D159%26spage%3D59%26epage%3D65%26doi%3D10.1016%2Fj.biochi.2019.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2017.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2017.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWgu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=68-78&author=B.+Inceogluauthor=A.+Bettaiebauthor=F.+G.+Hajauthor=A.+V.+Gomesauthor=B.+D.+Hammock&title=Modulation+of+mitochondrial+dysfunction+and+endoplasmic+reticulum+stress+are+key+mechanisms+for+the+wide-ranging+actions+of+epoxy+fatty+acids+and+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.prostaglandins.2017.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Inceoglu, Bora; Bettaieb, Ahmed; Haj, Fawaz G.; Gomes, Aldrin V.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The arachidonic acid cascade is arguably the most widely known biol. regulatory pathway.  Decades after the seminal discoveries involving its cyclooxygenase and lipoxygenase branches, studies of this cascade remain an active area of research.  The third and less widely known branch, the cytochrome P 450 pathway leads to highly active oxygenated lipid mediators, epoxy fatty acids (EpFAs) and hydroxyeicosatetraenoic acids (HETEs), which are of similar potency to prostanoids and leukotrienes.  Unlike the COX and LOX branches, no pharmaceuticals currently are marketed targeting the P 450 branch.  However, data support therapeutic benefits from modulating these regulatory lipid mediators.  This is being approached by stabilizing or mimicking the EpFAs or even by altering the diet.  These approaches lead to predominantly beneficial effects on a wide range of apparently unrelated states resulting in an enigma of how this small group of natural chem. mediators can have such diverse effects.  EpFAs are degraded by sol. epoxide hydrolase (sEH) and stabilized by inhibiting this enzyme.  In this review, we focus on interconnected aspects of reported mechanisms of action of EpFAs and inhibitors of sol. epoxide hydrolase (sEHI).  The sEHI and EpFAs are commonly reported to maintain homeostasis under pathol. conditions while remaining neutral under normal physiol. conditions.  Here we provide a conceptual framework for the unique and broad range of biol. activities ascribed to epoxy fatty acids.  We argue that their mechanism of action pivots on their ability to prevent mitochondrial dysfunction, to reduce subsequent ROS formation and to block resulting cellular signaling cascades, primarily the endoplasmic reticulum stress.  By stabilizing the mitochondrial - ROS - ER stress axis, the range of activity of EpFAs and sEHI display an overlap with the disease conditions including diabetes, fibrosis, chronic pain, cardiovascular and neurodegenerative diseases, for which the above outlined mechanisms play key roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51H_f53xQdLVg90H21EOLACvtfcHk0lgyvDkUeahCyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWgu7vE&md5=b96bbc5c810fce2fbd7a15f8f4a91b25</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2017.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2017.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DHaj%26aufirst%3DF.%2BG.%26aulast%3DGomes%26aufirst%3DA.%2BV.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DModulation%2520of%2520mitochondrial%2520dysfunction%2520and%2520endoplasmic%2520reticulum%2520stress%2520are%2520key%2520mechanisms%2520for%2520the%2520wide-ranging%2520actions%2520of%2520epoxy%2520fatty%2520acids%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2017%26volume%3D133%26spage%3D68%26epage%3D78%26doi%3D10.1016%2Fj.prostaglandins.2017.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKevitt, C.</span></span> <span> </span><span class="NLM_article-title">Lay perspectives on hypertension and drug adherence: systematic review of qualitative research</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>345</i></span>, <span class="NLM_elocation-id">e3953</span> <span class="refDoi"> DOI: 10.1136/bmj.e3953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1136%2Fbmj.e3953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22777025" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2012&author=I.+J.+Marshallauthor=C.+D.+Wolfeauthor=C.+McKevitt&title=Lay+perspectives+on+hypertension+and+drug+adherence%3A+systematic+review+of+qualitative+research&doi=10.1136%2Fbmj.e3953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1136%2Fbmj.e3953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.e3953%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DI.%2BJ.%26aulast%3DWolfe%26aufirst%3DC.%2BD.%26aulast%3DMcKevitt%26aufirst%3DC.%26atitle%3DLay%2520perspectives%2520on%2520hypertension%2520and%2520drug%2520adherence%253A%2520systematic%2520review%2520of%2520qualitative%2520research%26jtitle%3DBMJ.%26date%3D2012%26volume%3D345%26doi%3D10.1136%2Fbmj.e3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1038/nrd2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2kurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=794-805&author=J.+D.+Imigauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+as+a+therapeutic+target+for+cardiovascular+diseases&doi=10.1038%2Fnrd2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases</span></div><div class="casAuthors">Imig, John D.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">794-805</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation, antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions.  These endogenous lipid mediators are broken down into diols by sol. epoxide hydrolase (sEH), and so inhibiting this enzyme would be expected to enhance the beneficial cardiovascular properties of EETs.  SEH inhibitors (sEHIs) that are based on 1,3-disubstituted urea were rapidly developed, and were shown to be antihypertensive and anti-inflammatory, and to protect the brain, heart and kidney from damage.  Although challenges for the future exist - including improving the drug-like properties of sEHIs and finding better ways to target sEHIs to specific tissues - the recent initiation of the first clin. trials of sEHIs has highlighted the therapeutic potential of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFEiIF428mLVg90H21EOLACvtfcHk0ljVVB-sdRkayQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2kurnK&md5=fc2af5b4802701035998e0435c8d2699</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fnrd2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2875%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520as%2520a%2520therapeutic%2520target%2520for%2520cardiovascular%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D794%26epage%3D805%26doi%3D10.1038%2Fnrd2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebremedhin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">H519</span>– <span class="NLM_lpage">H525</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.1992.263.2.H519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.1992.263.2.H519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1510149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK38XlvVyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1992&pages=H519-H525&author=D.+Gebremedhinauthor=Y.+H.+Maauthor=J.+R.+Falckauthor=R.+J.+Romanauthor=M.+VanRollinsauthor=D.+R.+Harder&title=Mechanism+of+action+of+cerebral+epoxyeicosatrienoic+acids+on+cerebral+arterial+smooth+muscle&doi=10.1152%2Fajpheart.1992.263.2.H519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle</span></div><div class="casAuthors">Gebremedhin, Debebe; Ma, Yunn Hwa; Falck, John R.; Roman, Richard J.; VanRollins, Mike; Harder, David R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">H519-H525</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    </div><div class="casAbstract">Microsomal prepns. of cat brain incubated with [14C]arachidonic acid produced epoxyeicosatrienoic acids (EETs) that eluted with the same retention times as synthetically prepd. 5,6-, 8,9-, and 11,12-EETs.  These compds. dilated serotonin-preconstricted, pressurized cat cerebral arteries in a dose-dependent fashion.  Epoxide formation was not found in mitochondrial fractions and was dependent on the presence of NADPH.  The max. effects of 8,9-EET and 11,12-EET were greater than those of 5,6-EET.  The cellular basis of this vasodilation was further investigated by examg. the effects of 8,9-EET and 11,12-EET on K+ channel activity in vascular muscle cells freshly isolated from cat cerebral arteries.  Both 8,9-EET and 11,12-EET increased the frequency of opening, mean open time, and open-state probability of a 98-pS K+ channel recorded in the cell-attached mode with 145 mM KCl in the pipet and 4.7 mM KCl in the bath.  Blockade of K+ channel activity with tetraethylammonium attenuated the vasodilatory effects of 11,12-EET on serotonin-preconstricted cat cerebral arteries.  Apparently, endogenously formed EETs may participate in local regulation of cerebral blood flow by dilating cerebral arteries through a mechanism that involves activation of K+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7CgEUuTMxLVg90H21EOLACvtfcHk0ljVVB-sdRkayQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVyrsbk%253D&md5=45d176549dc8886dad3dc6e14f5dab01</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.1992.263.2.H519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.1992.263.2.H519%26sid%3Dliteratum%253Aachs%26aulast%3DGebremedhin%26aufirst%3DD.%26aulast%3DMa%26aufirst%3DY.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26atitle%3DMechanism%2520of%2520action%2520of%2520cerebral%2520epoxyeicosatrienoic%2520acids%2520on%2520cerebral%2520arterial%2520smooth%2520muscle%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1992%26volume%3D263%26spage%3DH519%26epage%3DH525%26doi%3D10.1152%2Fajpheart.1992.263.2.H519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">H1229</span>– <span class="NLM_lpage">H1236</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00736.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.00736.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11893556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=H1229-H1236&author=P.+L.+Liauthor=D.+X.+Zhangauthor=Z.+D.+Geauthor=W.+B.+Campbell&title=Role+of+ADP-ribose+in+11%2C12-EET-induced+activation+of+K%28Ca%29+channels+in+coronary+arterial+smooth+muscle+cells&doi=10.1152%2Fajpheart.00736.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00736.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00736.2001%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%2BL.%26aulast%3DZhang%26aufirst%3DD.%2BX.%26aulast%3DGe%26aufirst%3DZ.%2BD.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DRole%2520of%2520ADP-ribose%2520in%252011%252C12-EET-induced%2520activation%2520of%2520K%2528Ca%2529%2520channels%2520in%2520coronary%2520arterial%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D282%26spage%3DH1229%26epage%3DH1236%26doi%3D10.1152%2Fajpheart.00736.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1161/01.RES.85.4.349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.85.4.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10455063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXltlehurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=349-356&author=P.+L.+Liauthor=C.+L.+Chenauthor=R.+Bortellauthor=W.+B.+Campbell&title=11%2C12-Epoxyeicosatrienoic+acid+stimulates+endogenous+mono-ADP-ribosylation+in+bovine+coronary+arterial+smooth+muscle&doi=10.1161%2F01.RES.85.4.349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle</span></div><div class="casAuthors">Li, Pin-Lan; Chen, Cai-Lian; Bortell, Rita; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The role of endogenous ADP-ribosylation in mediating the activation of the Ca2+-activated K+ channels was detd. in bovine coronary arteries.  Endogenous ADP-ribosylation was examd. by incubating coronary arterial homogenates or lysates of cultured coronary arterial smooth muscle cells with [adenylate-32P]NAD.  Four 32P-labeled proteins were obsd. at 51, 52, 80, and 124 kDa in the homogenates and lysates.  This reaction was enhanced by the addn. of 11,12-epoxyeicosatrienoic acid (11,12-EET), a cytochrome P 450-derived eicosanoid, and GTP to the incubation.  By Western blot anal., 42- and 70-kDa proteins were recognized by specific antibodies against ADP-ribosyltransferase in the coronary arterial homogenates and smooth muscle cell lysate but not in the lysate of endothelial cells.  The 52-kDa acceptor protein of endogenous ADP-ribosylation comigrated with a protein ADP-ribosylated by cholera toxin and was recognized and immunopptd. by an anti-GSα antibody.  These results suggest that GSα is one of several acceptors of the ADP-ribose moiety.  As shown by the patch-clamp technique, 11,12-EET stimulated the activation of the K+ channels in the smooth muscle cells, and this activation was completely blocked by novobiocin, vitamin K1, 3-aminobenzamide, and m-iodobenzylguanidine, inhibitors of endogenous mono-ADP-ribosyltransferases.  We conclude that endogenous mono-ADP-ribosyltransferases are present in smooth muscle from bovine coronary arteries.  These enzymes transfer ADP-ribose to the cellular proteins such as GSα and may mediate intracellular signal transduction in coronary vascular smooth muscle.  In the coronary circulation, the ADP-ribosylation signaling pathway may play an important role in mediating the activation of the K+ channels induced by 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaMRxGXr6QfbVg90H21EOLACvtfcHk0ljVVB-sdRkayQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlehurs%253D&md5=79775c4feed224b0b17e7fc91e3915f2</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1161%2F01.RES.85.4.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.85.4.349%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%2BL.%26aulast%3DChen%26aufirst%3DC.%2BL.%26aulast%3DBortell%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D11%252C12-Epoxyeicosatrienoic%2520acid%2520stimulates%2520endogenous%2520mono-ADP-ribosylation%2520in%2520bovine%2520coronary%2520arterial%2520smooth%2520muscle%26jtitle%3DCirc.%2520Res.%26date%3D1999%26volume%3D85%26spage%3D349%26epage%3D356%26doi%3D10.1161%2F01.RES.85.4.349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gragasin, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platonov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E. D.</span></span> <span> </span><span class="NLM_article-title">Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000047278.28407.C2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.CIR.0000047278.28407.C2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12578883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=769-776&author=S.+L.+Archerauthor=F.+S.+Gragasinauthor=X.+Wuauthor=S.+Wangauthor=S.+McMurtryauthor=D.+H.+Kimauthor=M.+Platonovauthor=A.+Koshalauthor=K.+Hashimotoauthor=W.+B.+Campbellauthor=J.+R.+Falckauthor=E.+D.+Michelakis&title=Endothelium-derived+hyperpolarizing+factor+in+human+internal+mammary+artery+is+11%2C12-epoxyeicosatrienoic+acid+and+causes+relaxation+by+activating+smooth+muscle+BK%28Ca%29+channels&doi=10.1161%2F01.CIR.0000047278.28407.C2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels</span></div><div class="casAuthors">Archer, Stephen L.; Gragasin, Ferrante S.; Wu, Xichen; Wang, Shaohua; McMurtry, Sean; Kim, Daniel H.; Platonov, Michael; Koshal, Arvind; Hashimoto, Kyoko; Campbell, William B.; Falck, J. R.; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Left internal mammary arteries (LIMAs) synthesize endothelium-derived hyperpolarizing factor (EDHF), a short-lived K+ channel activator that persists after inhibition of nitric oxide (NO) and prostaglandin synthesis.  EDHF hyperpolarizes and relaxes smooth muscle cells (SMCs).  The identity of EDHF in humans is unknown.  The authors hypothesized that EDHF (1) is 11,12-epoxyeicosatrienoic acid (11,12-EET); (2) is generated by cytochrome P 450-2C, CYP450-2C; and (3) causes relaxation by opening SMC large-conductance Ca2+-activated K+ channels (BKCa).  Methods and Results: The identity of EDHF and its mechanism of action were assessed in 120 distal human LIMAs and 20 saphenous veins (SVs) obtained during CABG.  The predominant EET synthesized by LIMAs is 11,12-EET.  Relaxations to exogenous 11,12-EET and endogenous EDHF are of similar magnitudes.  Inhibition of EET synthesis by chem. distinct CYP450 inhibitors (17-octadecynoic acid, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide), or a selective EET antagonist (4,15-epoxyeicosa-5(Z)-enoic acid) impairs EDHF relaxation.  11,12-EET activates a BKCa current and hyperpolarizes LIMA SMCs.  Inhibitors of BKCa but not inward-rectifier or small-conductance KCa channels abolish relaxation to endogenous EDHF and exogenous 11,12-EET.  BKCa and CYP450-2C mRNA and proteins are more abundant in LIMAs than in SVs, perhaps explaining the lack of EDHF activity of the SV.  Laser capture microdissection and quant. RT-PCR demonstrate that BKCa channels are primarily in vascular SMCs, whereas the CYP450-2C enzyme is present in both the endothelium and SMCs.  Conclusions: In human LIMAs, EDHF is 11,12-EET produced by an EDHF synthase CYP450-2C and accounting for 40% of net endothelial relaxation.  11,12-EET causes relaxation by activating SMC BKCa channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKn_YYcs9fhbVg90H21EOLACvtfcHk0ljK1pj-0EG52Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12jtg%253D%253D&md5=dd7bd0ce8af7b343af75caa9b0afb470</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000047278.28407.C2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000047278.28407.C2%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DGragasin%26aufirst%3DF.%2BS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcMurtry%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DPlatonov%26aufirst%3DM.%26aulast%3DKoshal%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DEndothelium-derived%2520hyperpolarizing%2520factor%2520in%2520human%2520internal%2520mammary%2520artery%2520is%252011%252C12-epoxyeicosatrienoic%2520acid%2520and%2520causes%2520relaxation%2520by%2520activating%2520smooth%2520muscle%2520BK%2528Ca%2529%2520channels%26jtitle%3DCirculation%26date%3D2003%26volume%3D107%26spage%3D769%26epage%3D776%26doi%3D10.1161%2F01.CIR.0000047278.28407.C2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisslthaler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busse, R.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 2C is an EDHF synthase in coronary arteries</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1038/46816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2F46816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10519554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADyaK1MvkslSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=493-497&author=B.+Fisslthalerauthor=R.+Poppauthor=L.+Kissauthor=M.+Potenteauthor=D.+R.+Harderauthor=I.+Flemingauthor=R.+Busse&title=Cytochrome+P450+2C+is+an+EDHF+synthase+in+coronary+arteries&doi=10.1038%2F46816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2C is an EDHF synthase in coronary arteries</span></div><div class="casAuthors">Fisslthaler B; Popp R; Kiss L; Potente M; Harder D R; Fleming I; Busse R</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6752</span>),
    <span class="NLM_cas:pages">493-7</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase.  This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF).  Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation.  Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses.  Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSK44sB9FVPKPx2phytoz6_fW6udTcc2ebn9aCf_7WCErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvkslSnsQ%253D%253D&md5=d89fed0c561e99c00e6cc456272046fc</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2F46816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F46816%26sid%3Dliteratum%253Aachs%26aulast%3DFisslthaler%26aufirst%3DB.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DKiss%26aufirst%3DL.%26aulast%3DPotente%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DBusse%26aufirst%3DR.%26atitle%3DCytochrome%2520P450%25202C%2520is%2520an%2520EDHF%2520synthase%2520in%2520coronary%2520arteries%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D493%26epage%3D497%26doi%3D10.1038%2F46816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inscho, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deichmann, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.33.1.408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.33.1.408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9931138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Ggtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=408-413&author=J.+D.+Imigauthor=E.+W.+Inschoauthor=P.+C.+Deichmannauthor=K.+M.+Reddyauthor=J.+R.+Falck&title=Afferent+arteriolar+vasodilation+to+the+sulfonimide+analog+of+11%2C+12-epoxyeicosatrienoic+acid+involves+protein+kinase+A&doi=10.1161%2F01.HYP.33.1.408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A</span></div><div class="casAuthors">Imig, John D.; Inscho, Edward W.; Deichmann, Paul C.; Reddy, K. Malla; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">408-413</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The current study detd. the contribution of protein kinase-A (PKA) and protein kinase-G (PKG) to the vasodilation elicited by the N-methylsulfonimide analog of 11,12-epoxyeicosatrienoic acid (11,12-EET).  Expts. were performed, in vitro, using the juxtamedullary nephron prepn. combined with videomicroscopy.  The response of afferent arterioles to the sulfonimide analog of 11,12-EET, was detd. before and after inhibition of PKA, PKG, or guanylyl cyclase.  Afferent arterioles, preconstricted with 0.5 μmol/L norepinephrine, averaged 18±1 μm (n=25) at a renal perfusion pressure of 100 mm Hg.  Superfusion with 0.01 to 100 nmol/L of the 11,12-EET analog caused a graded increase in diam. of the afferent arteriole.  Vessel diam. increased by 11±1% and 15±1%, resp., in response to 10 and 100 nmol/L of the 11,12-EET analog.  The afferent arteriolar response to 10 and 100 nmol/L of the 11,12-EET analog was significantly attenuated during inhibition of PKA with 10 μmol/L H-89 (n=7) or 5 μmol/L myristolated PKI (n=6), such that afferent arteriolar diam. increased by only 5±2% and 2±1%, resp., in response to 100 nmol/L of the 11,12-EET analog.  In contrast, the afferent arteriolar vasodilatory response to the 11,12-EET analog was unaffected by PKG or guanylyl cyclase inhibition.  In the presence of 200 μmol/L histone H2B (n=5) or 10 μmol/L ODQ (n=7), the afferent arteriolar diam. increased by 16±3% and 12±2%, resp., in response to 100 nmol/L of the 11,12-EET analog.  These results demonstrate that activation of PKA is an important mechanism responsible for the afferent arteriolar vasodilation elicited by the sulfonimide analog of 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNkyAnM3K-7Vg90H21EOLACvtfcHk0lgMJSMRbd0V9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Ggtr8%253D&md5=1cbf3a9e272257ab5cdf895d4f92ad63</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.33.1.408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.33.1.408%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DInscho%26aufirst%3DE.%2BW.%26aulast%3DDeichmann%26aufirst%3DP.%2BC.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DAfferent%2520arteriolar%2520vasodilation%2520to%2520the%2520sulfonimide%2520analog%2520of%252011%252C%252012-epoxyeicosatrienoic%2520acid%2520involves%2520protein%2520kinase%2520A%26jtitle%3DHypertension%26date%3D1999%26volume%3D33%26spage%3D408%26epage%3D413%26doi%3D10.1161%2F01.HYP.33.1.408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15100364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVCnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=1244-1253&author=X.+Y.+Zhaoauthor=T.+Yamamotoauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=T.+Watanabeauthor=B.+D.+Hammockauthor=J.+Stewartauthor=J.+S.+Pollockauthor=D.+M.+Pollockauthor=J.+D.+Imig&title=Soluble+epoxide+hydrolase+inhibition+protects+the+kidney+from+hypertension-induced+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage</span></div><div class="casAuthors">Zhao, Xueying; Yamamoto, Tatsuo; Newman, John W.; Kim, In-Hae; Watanabe, Takaho; Hammock, Bruce D.; Stewart, Janet; Pollock, Jennifer S.; Pollock, David M.; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1244-1253</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EET) have antihypertensive and anti-inflammatory properties and play a role in the maintenance of renal vascular function.  A novel approach to increase EET levels is to inhibit epoxide hydrolase enzymes that are responsible for conversion of biol. active EET to dihydroxyeicosatrienoic acids (DHET).  We hypothesized that sol. epoxide hydrolase (SEH) inhibition would improve renal vascular function and ameliorate hypertension induced renal damage.  Chronic administration of the specific SEH inhibitor 1-cyclohexyl-3-dodecylurea (CDU, 3 mg/d) for 10 d lowered BP in angiotensin hypertensive rats.  The contribution of renal vascular SEH to afferent arteriolar function in angiotensin hypertension was also assessed.  SEH protein expression was increased in renal microvessels from hypertensive rats.  Although CDU did not change afferent arteriolar responsiveness to angiotensin in normotensive animals, CDU treatment significantly attenuated afferent arteriolar diam. responses to angiotensin in hypertensive kidneys from 51% ± 8% to 28% ± 7%.  Protection of the renal vasculature and glomerulus during chronic CDU administration was demonstrated by histol.  Urinary albumin excretion, an index of renal damage, was also lower in CDU-treated hypertensive rats.  These data demonstrate that SEH inhibition has antihypertensive and renal vascular protective effects in angiotensin hypertension and suggests that SEH inhibitors may be a useful therapeutic intervention for cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagPuSJeX7oLVg90H21EOLACvtfcHk0lgMJSMRbd0V9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVCnu7s%253D&md5=a7c12f35296a5765bdc707a799d2e2c3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DPollock%26aufirst%3DJ.%2BS.%26aulast%3DPollock%26aufirst%3DD.%2BM.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520protects%2520the%2520kidney%2520from%2520hypertension-induced%2520damage%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2004%26volume%3D15%26spage%3D1244%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, S. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madkhali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamali, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreto, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, G. M.</span></span> <span> </span><span class="NLM_article-title">Inhibiting effect of zinc oxide nanoparticles on advanced glycation products and oxidative modifications: a potential tool to counteract oxidative stress in neurodegenerative diseases</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7438</span>– <span class="NLM_lpage">7452</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-0935-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12035-018-0935-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29423819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=7438-7452&author=J.+M.+Ashrafauthor=M.+A.+Ansariauthor=S.+Fatmaauthor=S.+M.+S.+Abdullahauthor=J.+Iqbalauthor=A.+Madkhaliauthor=A.+H.+Hamaliauthor=S.+Ahmadauthor=A.+Jerahauthor=V.+Echeverriaauthor=G.+E.+Barretoauthor=G.+M.+Ashraf&title=Inhibiting+effect+of+zinc+oxide+nanoparticles+on+advanced+glycation+products+and+oxidative+modifications%3A+a+potential+tool+to+counteract+oxidative+stress+in+neurodegenerative+diseases&doi=10.1007%2Fs12035-018-0935-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases</span></div><div class="casAuthors">Ashraf, Jalaluddin M.; Ansari, Mohammad Azam; Fatma, Sana; Abdullah, Saleh M. S.; Iqbal, Johar; Madkhali, Aymen; Hamali, Al Hassan; Ahmad, Saheem; Jerah, Ahmed; Echeverria, Valentina; Barreto, George E.; Ashraf, Ghulam Md.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7438-7452</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Advanced glycation end products (AGEs) are implicated in several central nervous system (CNS) pathologies including Alzheimer and Parkinson's diseases.  In the face-off of AGE menace, we have attempted to investigate the zinc oxide nanoparticle (ZnONP) role in inhibition of AGE formation.  Synthesized ZnONPs were used to investigate the inhibitory effects on AGE formation.  The inhibitory effects of ZnONPs on AGE formation were detd. by biophys. immunol. and biochem. techniques.  The results showed that ZnONP is a potential anti-glycating agent inhibiting AGE formation as well as protecting the protein structure from change.  Therefore, our findings suggest ZnONPs may be used as a therapeutic in resolving the AGE role in CNS-related complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgK2TJRo7OLVg90H21EOLACvtfcHk0lgMJSMRbd0V9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKgsLw%253D&md5=5d70cfe258cae502dba0dcce83bcd0b3</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-0935-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-0935-x%26sid%3Dliteratum%253Aachs%26aulast%3DAshraf%26aufirst%3DJ.%2BM.%26aulast%3DAnsari%26aufirst%3DM.%2BA.%26aulast%3DFatma%26aufirst%3DS.%26aulast%3DAbdullah%26aufirst%3DS.%2BM.%2BS.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DMadkhali%26aufirst%3DA.%26aulast%3DHamali%26aufirst%3DA.%2BH.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DJerah%26aufirst%3DA.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DBarreto%26aufirst%3DG.%2BE.%26aulast%3DAshraf%26aufirst%3DG.%2BM.%26atitle%3DInhibiting%2520effect%2520of%2520zinc%2520oxide%2520nanoparticles%2520on%2520advanced%2520glycation%2520products%2520and%2520oxidative%2520modifications%253A%2520a%2520potential%2520tool%2520to%2520counteract%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D7438%26epage%3D7452%26doi%3D10.1007%2Fs12035-018-0935-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors</span>. <i>Cardiovasc. Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2006.00169.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1527-3466.2006.00169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16961727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlalu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=169-188&author=J.+D.+Imig&title=Cardiovascular+therapeutic+aspects+of+soluble+epoxide+hydrolase+inhibitors&doi=10.1111%2Fj.1527-3466.2006.00169.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drug Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-188</span>CODEN:
                <span class="NLM_cas:coden">CDREEA</span>;
        ISSN:<span class="NLM_cas:issn">0897-5957</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Sol. epoxide hydrolase (sEH) is an enzyme responsible for the conversion of lipid epoxides to diols by the addn. of water.  Biol. actions on the cardiovascular system that are attributed to epoxides include vasodilation, antiinflammatory actions and vascular smooth muscle cell antimigratory actions.  Conversion of arachidonic acid epoxides to diols by sEH diminishes the beneficial cardiovascular properties of these epoxyeicosanoids.  Cardiovascular diseases in animal models and humans have been assocd. with decreased epoxygenase activity or increased sEH activity and these changes are responsible for the progression of the disease state.  More recently, sEH gene polymorphisms in the human population have been assocd. with increased risk for cardiovascular diseases.  Thus the biol. actions of epoxyeicosanoids and the sEH enzyme are ideal therapeutic targets for cardiovascular diseases.  The rapid development of 1,3-disubstituted urea based sEH inhibitors over the past five years has resulted in a no. of studies demonstrating cardiovascular protection.  SEH inhibitors have antihypertensive and antiinflammatory actions and have been demonstrated to decrease cerebral ischemic and renal injury in rat models of hypertension.  These findings of beneficial actions in animal models of disease position the sEH enzyme as a promising therapeutic target for cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7y3oPtefp7Vg90H21EOLACvtfcHk0li1HEygXWWrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlalu7vF&md5=e0979b9dd04426648054e58585860c91</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2006.00169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2006.00169.x%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DCardiovascular%2520therapeutic%2520aspects%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2006%26volume%3D24%26spage%3D169%26epage%3D188%26doi%3D10.1111%2Fj.1527-3466.2006.00169.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1038/ki.2009.349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fki.2009.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19847158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Wm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=88-92&author=D.+Aiauthor=J.+Y.+Shyyauthor=Y.+Zhu&title=Linking+an+insect+enzyme+to+hypertension%3A+angiotensin+II-epoxide+hydrolase+interactions&doi=10.1038%2Fki.2009.349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions</span></div><div class="casAuthors">Ai, Ding; Shyy, John Y-J.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Derived from arachidonic acid, epoxyeicosatrienoic acids function as antihypertensive and antihypertrophic mediators in the cardiovascular system.  Epoxyeicosatrienoic acids are generated by sol. epoxide hydrolase, an enzyme hydrolyzing the epoxide moiety of juvenile hormones in insects, and are endothelium-derived hyperpolarizing factors that induce vessel dilation for cardioprotection.  Pharmacol. inhibition and genetic ablation of sol. epoxide hydrolase increases the level of epoxyeicosatrienoic acids.  Recent findings suggest that the level of sol. epoxide hydrolase in the heart and endothelium is upregulated by angiotensin II in vitro in cultured cardiomyocytes and vascular endothelial cells and in vivo in rodent models.  Treatment with sol. epoxide hydrolase-selective inhibitors in angiotensin II-infused hypertensive rats increases the level of epoxyeicosatrienoic acids, with attendant decrease in systolic blood pressure.  Shear stress, the physiol. stimulation of vessel dilation, downregulates sol. epoxide hydrolase and hence increases epoxyeicosatrienoic acid level in endothelial cells.  Because of the close assocn. of the angiotensin II/sol. epoxide hydrolase/epoxyeicosatrienoic acid system and blood pressure regulation, pharmacol. inhibition of sol. epoxide hydrolase would be a useful approach to prevent and treat angiotensin II-induced cardiac hypertrophy and hypertension, as well as vascular impairments.  Kidney International (2010) 77, 88-92; doi:10.1038/ki.2009.349; published online 21 Oct. 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAhpbZu7jNHbVg90H21EOLACvtfcHk0li1HEygXWWrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Wm&md5=713c37e2abe7190737e0c2be657e6d2d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fki.2009.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2009.349%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DLinking%2520an%2520insect%2520enzyme%2520to%2520hypertension%253A%2520angiotensin%2520II-epoxide%2520hydrolase%2520interactions%26jtitle%3DKidney%2520Int.%26date%3D2010%26volume%3D77%26spage%3D88%26epage%3D92%26doi%3D10.1038%2Fki.2009.349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium <i>in vitro</i> and <i>in vivo</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">9018</span>– <span class="NLM_lpage">9023</span>, <span class="refDoi"> DOI: 10.1073/pnas.0703229104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0703229104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=17495027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1ahtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9018-9023&author=D.+Aiauthor=Y.+Fuauthor=D.+L.+Guoauthor=H.+Tanakaauthor=N.+P.+Wangauthor=C.+S.+Tangauthor=B.+D.+Hammockauthor=J.+Y.+J.+Shyyauthor=Y.+Zhu&title=Angiotensin+II+up-regulates+soluble+epoxide+hydrolase+in+vascular+endothelium+in+vitro+and+in+vivo&doi=10.1073%2Fpnas.0703229104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo</span></div><div class="casAuthors">Ai, Ding; Fu, Yi; Guo, Deliang; Tanaka, Hiromasa; Wang, Nanping; Tang, Chaoshu; Hammock, Bruce D.; Shyy, John Y.-J.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9018-9023</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs), as metabolites of arachidonic acid, may function as antihypertensive and antiatherosclerotic mediators for vasculature.  EETs are degraded by sol. epoxide hydrolase (sEH).  Pharmacol. inhibition and genetic ablation of sEH have been shown to increase the level of EETs, and treating angiotensin II (Ang II)-infused hypertension rats with sEH-selective inhibitors increased the levels of EETs, with attendant decrease in systolic blood pressure.  To elucidate the mechanisms by which Ang II regulates sEH expression, we treated human umbilical vein endothelial cells (ECs) and bovine aortic ECs with Ang II and found increased sEH expression at both the mRNA and protein levels.  Transient transfection assays showed that the activity of the human sEH promoter was increased in ECs in response to Ang II.  Further anal. of the promoter region of the sEH gene demonstrated that treatment with Ang II, like overexpression of c-Jun/c-Fos, activates the sEH promoter through an AP-1-binding motif.  The binding of c-Jun to the AP-1 site of the sEH promoter was confirmed by chromatin immunopptn. assays.  In contrast, adenovirus overexpression of the dominant-neg. mutant of c-Jun significantly attenuated the effects of Ang II on sEH induction.  An elevated level of sEH was found in the aortic intima of both spontaneously hypertensive rats and Ang Il-infused Wistar rats.  Blocking Ang II binding to Ang II receptor 1 by losartan abolished the sEH induction.  Thus, AP-1 activation is involved in the transcriptional up-regulation of sEH by Ang II in ECs, which may contribute to Ang II-induced hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqeypLpuIxC7Vg90H21EOLACvtfcHk0li1HEygXWWrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1ahtLs%253D&md5=71a3cc4cc434b30590e76c87a6668be6</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0703229104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0703229104%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%2BL.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DN.%2BP.%26aulast%3DTang%26aufirst%3DC.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%2BJ.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DAngiotensin%2520II%2520up-regulates%2520soluble%2520epoxide%2520hydrolase%2520in%2520vascular%2520endothelium%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D9018%26epage%3D9023%26doi%3D10.1073%2Fpnas.0703229104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bend, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">40504</span>– <span class="NLM_lpage">40510</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008106200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M008106200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11001943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40504-40510&author=C.+J.+Sinalauthor=M.+Miyataauthor=M.+Tohkinauthor=K.+Nagataauthor=J.+R.+Bendauthor=F.+J.+Gonzalez&title=Targeted+disruption+of+soluble+epoxide+hydrolase+reveals+a+role+in+blood+pressure+regulation&doi=10.1074%2Fjbc.M008106200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation</span></div><div class="casAuthors">Sinal, Christopher J.; Miyata, Masaaki; Tohkin, Masahiro; Nagata, Kiyoshi; Bend, John R.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">40504-40510</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Renal microsomal cytochrome P 450 monooxygenase-dependent metab. of arachidonic acid generates a series of regioisomeric epoxyeicosatrienoic acids that can be further metabolized by sol. epoxide hydrolase to the corresponding dihydroxyeicosatrienoic acids.  Evidence exists that these metabolites affect renal function and, in particular, blood pressure regulation.  To examine this possibility, blood pressure and renal arachidonic acid metab. were examd. in mice with a targeted disruption of the sol. epoxide hydrolase gene.  Systolic blood pressure of male sol. epoxide hydrolase-null mice was lower compared with wild-type mice in both the absence and presence of dietary salt loading.  Both female sol. epoxide hydrolase-null and wild-type female mice also had significantly lower systolic blood pressure than male wild-type mice.  Renal formation of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids was markedly lower for sol. epoxide hydrolase-null vs. wild-type mice of both sexes.  Although disruption of sol. epoxide hydrolase in female mice had minimal effects on blood pressure, deletion of this gene feminized male mice by lowering systolic blood pressure and altering arachidonic acid metab.  These data provide the first direct evidence for a role for sol. epoxide hydrolase in blood pressure regulation and identify this enzyme as a novel and attractive target for therapeutic intervention in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXG0fIAkoHrVg90H21EOLACvtfcHk0lj7TYXgeiP_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFeqsQ%253D%253D&md5=ef3f3902a2d357987ff650ed5f52b3ed</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008106200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008106200%26sid%3Dliteratum%253Aachs%26aulast%3DSinal%26aufirst%3DC.%2BJ.%26aulast%3DMiyata%26aufirst%3DM.%26aulast%3DTohkin%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DBend%26aufirst%3DJ.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DTargeted%2520disruption%2520of%2520soluble%2520epoxide%2520hydrolase%2520reveals%2520a%2520role%2520in%2520blood%2520pressure%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40504%26epage%3D40510%26doi%3D10.1074%2Fjbc.M008106200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukhari, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alorainey, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Motrefi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats</span>. <i>Eur. Rev. Med. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">8143</span>– <span class="NLM_lpage">8150</span>, <span class="refDoi"> DOI: 10.26355/eurrev_202008_22501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.26355%2Feurrev_202008_22501" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=8143-8150&author=I.+A.+Bukhariauthor=B.+I.+Aloraineyauthor=A.+A.+Al-Motrefiauthor=A.+Mahmoudauthor=W.+B.+Campbellauthor=B.+D.+Hammock&title=1-Trifluoromethoxyphenyl-3-%281-propionylpiperidin-4-yl%29+urea+%28TPPU%29%2C+a+soluble+epoxide+hydrolase+inhibitor%2C+lowers+L-NAME-induced+hypertension+through+suppression+of+angiotensin-converting+enzyme+in+rats&doi=10.26355%2Feurrev_202008_22501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.26355%2Feurrev_202008_22501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26355%252Feurrev_202008_22501%26sid%3Dliteratum%253Aachs%26aulast%3DBukhari%26aufirst%3DI.%2BA.%26aulast%3DAlorainey%26aufirst%3DB.%2BI.%26aulast%3DAl-Motrefi%26aufirst%3DA.%2BA.%26aulast%3DMahmoud%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1-Trifluoromethoxyphenyl-3-%25281-propionylpiperidin-4-yl%2529%2520urea%2520%2528TPPU%2529%252C%2520a%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520lowers%2520L-NAME-induced%2520hypertension%2520through%2520suppression%2520of%2520angiotensin-converting%2520enzyme%2520in%2520rats%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2020%26volume%3D15%26spage%3D8143%26epage%3D8150%26doi%3D10.26355%2Feurrev_202008_22501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharis, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olearczyk, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000176237.74820.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.0000176237.74820.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16157792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=975-981&author=J.+D.+Imigauthor=X.+Zhaoauthor=C.+Z.+Zaharisauthor=J.+J.+Olearczykauthor=D.+M.+Pollockauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=T.+Watanabeauthor=B.+D.+Hammock&title=An+orally+active+epoxide+hydrolase+inhibitor+lowers+blood+pressure+and+provides+renal+protection+in+salt-sensitive+hypertension&doi=10.1161%2F01.HYP.0000176237.74820.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension</span></div><div class="casAuthors">Imig, John D.; Zhao, Xueying; Zaharis, Constantine Z.; Olearczyk, Jeffrey J.; Pollock, David M.; Newman, John W.; Kim, In-Hae; Watanabe, Takaho; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4, Pt. 2</span>),
    <span class="NLM_cas:pages">975-981</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The present study tested the hypothesis that increasing epoxyeicosatrienoic acids by inhibition of sol. epoxide hydrolase (sEH) would lower blood pressure and ameliorate renal damage in salt-sensitive hypertension.  Rats were infused with angiotensin and fed a normal-salt diet or an 8% NaCl diet for 14 days.  The sEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), was given orally to angiotensin-infused animals during the 14-day period.  Plasma AUDA metabolite levels were measured, and they averaged 10±2 ng/mL in normal-salt angiotensin hypertension and 19±3 ng/mL in high-salt angiotensin hypertension on day 14 in the animals administered the sEH inhibitor.  Mean arterial blood pressure averaged 161±4 mm Hg in normal-salt and 172±5 mm Hg in the high-salt angiotensin hypertension groups on day 14.  EH inhibitor treatment significantly lowered blood pressure to 140±5 mm Hg in the normal-salt angiotensin hypertension group and to 151±6 mm Hg in the high-salt angiotensin hypertension group on day 14.  The lower arterial blood pressures in the AUDA-treated groups were assocd. with increased urinary epoxide-to-diol ratios.  Urinary microalbumin levels were measured, and ED-1 staining was used to det. renal damage and macrophage infiltration in the groups.  Two weeks of AUDA treatment decreased urinary microalbumin excretion in the normal-salt and high-salt angiotensin hypertension groups and macrophage no. in the high-salt angiotensin hypertension group.  These data demonstrate that sEH inhibition lowers blood pressure and ameliorates renal damage in angiotensin-dependent, salt-sensitive hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhzsWUX9rfrVg90H21EOLACvtfcHk0lj7TYXgeiP_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeksbfK&md5=b19bcc6a8a222afd99c3d81c0382f0b9</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000176237.74820.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000176237.74820.75%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZaharis%26aufirst%3DC.%2BZ.%26aulast%3DOlearczyk%26aufirst%3DJ.%2BJ.%26aulast%3DPollock%26aufirst%3DD.%2BM.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DAn%2520orally%2520active%2520epoxide%2520hydrolase%2520inhibitor%2520lowers%2520blood%2520pressure%2520and%2520provides%2520renal%2520protection%2520in%2520salt-sensitive%2520hypertension%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D975%26epage%3D981%26doi%3D10.1161%2F01.HYP.0000176237.74820.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aga, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span> <span> </span><span class="NLM_article-title">Chemical constituents from the aerial parts of <i>Codonopsis nervosa</i></span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(12)60073-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS1875-5364%2812%2960073-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=366-369&author=E.+B.+Agaauthor=H.+J.+Liauthor=J.+Chenauthor=P.+Li&title=Chemical+constituents+from+the+aerial+parts+of+Codonopsis+nervosa&doi=10.1016%2FS1875-5364%2812%2960073-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2812%2960073-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252812%252960073-9%26sid%3Dliteratum%253Aachs%26aulast%3DAga%26aufirst%3DE.%2BB.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DChemical%2520constituents%2520from%2520the%2520aerial%2520parts%2520of%2520Codonopsis%2520nervosa%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D366%26epage%3D369%26doi%3D10.1016%2FS1875-5364%2812%2960073-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(−/−) mice</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.yjmcc.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27496380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlansr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2016&pages=128-137&author=D.+Liauthor=Y.+Liuauthor=X.+Zhangauthor=H.+Lvauthor=W.+Pangauthor=X.+Sunauthor=L.+M.+Ganauthor=B.+D.+Hammockauthor=D.+Aiauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+alleviated+atherosclerosis+by+reducing+monocyte+infiltration+in+Ldlr%28%E2%88%92%2F%E2%88%92%29+mice&doi=10.1016%2Fj.yjmcc.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr-/- mice</span></div><div class="casAuthors">Li, Dan; Liu, Yajin; Zhang, Xu; Lv, Huizhen; Pang, Wei; Sun, Xiaoli; Gan, Li-Ming; Hammock, Bruce D.; Ai, Ding; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-137</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Circulating monocytes play pivotal roles in chronic inflammatory diseases.  Epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid, are known to have anti-inflammatory effects and are hydrolyzed by sol. epoxide hydrolase (sEH).  We aimed to investigate the effect of sEH inhibition in atherogenesis.  Mice with low-d. lipoprotein receptor deficiency (Ldlr-/-) with or without sEH inhibitor, and Ldlr/sEH double-knockout (DK) mice were fed a Western-type diet (WTD) for 6 wk to induce arteriosclerosis.  Both sEH inhibition and gene depletion decreased the WTD-induced hyperlipidemia, plaque area and macrophage infiltration in mice arterial wall.  Ly6Chi infiltration of monocytes remained similar in blood, spleen and bone marrow of DK mice, but was decreased in aortic lesions.  To further assess the role of sEH or EETs in monocyte/macrophage infiltration in atherogenesis, we transplanted DK bone marrow into Ldlr-/- recipients, and then fed mice the WTD.  Aortic lesions and Ly6Chi monocyte infiltration were reduced in mice with transplanted bone marrow of DK mice without diminishing the cholesterol level.  Furthermore, sEH inhibition or gene depletion increased the ratio of EETs/DHETs and diminished the expression of P-selectin glycoprotein ligand 1 (PSGL-1) in mice peripheral-blood mononuclear cells.  Monocyte adhesion to P-selectin and to tumor necrosis factor α-activated endothelial cells was also diminished by sEH inhibition.  SEH inhibition and gene depletion attenuated atherosclerosis in mice by decreasing the infiltration of monocytes into the artery wall.  EET and PSGL-1 may play pivotal roles in monocyte/macrophage infiltration and atherogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe40bnwHuNPLVg90H21EOLACvtfcHk0lgfoEIMFGYN2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlansr7J&md5=bd1ea263423e48ce4694a842170ec4d7</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGan%26aufirst%3DL.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520alleviated%2520atherosclerosis%2520by%2520reducing%2520monocyte%2520infiltration%2520in%2520Ldlr%2528%25E2%2588%2592%252F%25E2%2588%2592%2529%2520mice%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2016%26volume%3D98%26spage%3D128%26epage%3D137%26doi%3D10.1016%2Fj.yjmcc.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincelette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. X.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.109.186064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2FATVBAHA.109.186064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19667112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFyktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1265-1270&author=L.+N.+Zhangauthor=J.+Vinceletteauthor=Y.+Chengauthor=U.+Mehraauthor=D.+Chenauthor=S.+K.+Anandanauthor=R.+Glessauthor=H.+K.+Webbauthor=Y.+X.+Wang&title=Inhibition+of+soluble+epoxide+hydrolase+attenuated+atherosclerosis%2C+abdominal+aortic+aneurysm+formation%2C+and+dyslipidemia&doi=10.1161%2FATVBAHA.109.186064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia</span></div><div class="casAuthors">Zhang, Le-Ning; Vincelette, Jon; Cheng, Ying; Mehra, Upasana; Chen, Dawn; Anandan, Sampath-Kumar; Gless, Richard; Webb, Heather K.; Wang, Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Epoxyeicosatrienoic acids (EETs) have been shown to have antiinflammatory effects and therefore may play a role in preventing vascular inflammatory and atherosclerotic diseases.  Sol. epoxide hydrolase (s-EH) converts EETs into less bioactive dihydroxyeicosatrienoic acids.  Thus, inhibition of s-EH can prevent degrdn. of EETs and prolong their effects.  The present study aimed to test the hypothesis that inhibition of s-EH has vascular protective effects.  Methods and Results: Six-month-old apolipoprotein E-deficient mice were chronically infused with angiotensin II (1.44 mg/kg/d) for 4 wk to induce abdominal aortic aneurysm (AAA), accelerate atherosclerosis development and carotid artery ligation-induced vascular remodeling.  The mice were treated with a novel s-EH inhibitor, AR9276 (1.5 g/L in drinking water) or vehicle for 4 wk.  The results demonstrated that AR9276 significantly reduced the rate of AAA formation and atherosclerotic lesion area, but had no effect on ligation-induced carotid artery remodeling.  These effects were assocd. with a redn. of serum lipid, IL-6, murine IL-8-KC, and IL-1α, and downregulation of gene expressions of ICAM-1, VCAM-1, and IL-6 in the arterial wall.  Conclusions: The present data demonstrate that treatment with an s-EH inhibitor attenuates AAA formation and atherosclerosis development.  The attendant downregulation of inflammatory mediators and lipid lowering effects may both contribute to the obsd. vascular protective effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfzqTd6qxwbVg90H21EOLACvtfcHk0lgfoEIMFGYN2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFyktrk%253D&md5=ae1c4ed1fc69269b8697bed5803d8500</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.186064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.186064%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BN.%26aulast%3DVincelette%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DMehra%26aufirst%3DU.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DGless%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BX.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520attenuated%2520atherosclerosis%252C%2520abdominal%2520aortic%2520aneurysm%2520formation%252C%2520and%2520dyslipidemia%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1265%26epage%3D1270%26doi%3D10.1161%2FATVBAHA.109.186064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, <i>t</i>-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2012.03.167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijcard.2012.03.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22525341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=1298-1304&author=D.+Y.+Xuauthor=B.+B.+Davisauthor=Z.+H.+Wangauthor=S.+P.+Zhaoauthor=B.+Wastiauthor=Z.+L.+Liuauthor=N.+Liauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+acts+through+PPARgamma+to+modulate+the+function+of+endothelial+progenitor+cells+from+patients+with+acute+myocardial+infarction&doi=10.1016%2Fj.ijcard.2012.03.167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span></div><div class="casAuthors">Xu Dan-yan; Davis Benjamin B; Wang Zhen-he; Zhao Shui-ping; Wasti Binaya; Liu Zhe-liang; Li Ning; Morisseau Christophe; Chiamvimonvat Nipavan; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1298-304</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epoxyeicosatrienoic acids (EETs) are natural angiogenic mediators regulated by soluble epoxide hydrolase (sEH).  Inhibitors of sEH can stabilize EETs levels and were reported to reduce atherosclerosis and inhibit myocardial infarction in animal models.  In this work, we investigated whether increasing EETs with the sEH inhibitor t-AUCB would increase angiogenesis related function in endothelial progenitor cells (EPCs) from patients with acute myocardial infarction (AMI).  METHODS AND RESULTS:  EPCs were isolated from 50 AMI patients and 50 healthy subjects (control).  EPCs were treated with different concentrations of t-AUCB for 24h with or without peroxisome proliferator activated receptor γ (PPARγ) inhibitor GW9662.  Migration of EPCs was assayed in trans-well chambers.  Angiogenesis assays were performed using a Matrigel-Matrix in vitro model.  The expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1α (HIF-1α) mRNA and protein in EPCs was measured by real-time PCR or Western blot, respectively.  Also, the concentration of EETs in the culture supernatant was detected by ELISA.  The activity of EPCs in the AMI patient group was reduced compared to healthy controls.  Whereas increasing EET levels with t-AUCB promoted a dose dependent angiogenesis and migration in EPCs from AMI patients.  Additionally, the t-AUCB dose dependently increased the expression of the angiogenic factors VEGF and HIF-α.  Lastly, we provide evidence that these effects were PPARγ dependent.  CONCLUSION:  The results demonstrate that the sEH inhibitor positively modulated the functions of EPCs in patients with AMI through the EETs-PPARγ pathway.  The present study suggests the potential utility of sEHi in the therapy of ischemic heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvyM8pXNI2_xKDYG3bNImrfW6udTcc2eYKRLo4EK6ZA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D&md5=664e589b7aba463a46d40a45ef424ef8</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2012.03.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2012.03.167%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%2BY.%26aulast%3DDavis%26aufirst%3DB.%2BB.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DWasti%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520acts%2520through%2520PPARgamma%2520to%2520modulate%2520the%2520function%2520of%2520endothelial%2520progenitor%2520cells%2520from%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26spage%3D1298%26epage%3D1304%26doi%3D10.1016%2Fj.ijcard.2012.03.167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>239</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.atherosclerosis.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25733327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVShtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2015&pages=557-65&author=L.+Shenauthor=H.+Pengauthor=R.+Pengauthor=Q.+Fanauthor=S.+Zhaoauthor=D.+Xuauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=Inhibition+of+soluble+epoxide+hydrolase+in+mice+promotes+reverse+cholesterol+transport+and+regression+of+atherosclerosis&doi=10.1016%2Fj.atherosclerosis.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis</span></div><div class="casAuthors">Shen, Li; Peng, Hongchun; Peng, Ran; Fan, Qingsong; Zhao, Shuiping; Xu, Danyan; Morisseau, Christophe; Chiamvimonvat, Nipavan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">557-565</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipose tissue is the body largest free cholesterol reservoir and abundantly expresses ATP binding cassette transporter A1 (ABCA1), which maintains plasma high-d. lipoprotein (HDL) levels.  HDLs have a protective role in atherosclerosis by mediating reverse cholesterol transport (RCT).  Sol. epoxide hydrolase (sEH) is a cytosolic enzyme whose inhibition has various beneficial effects on cardiovascular disease.  The sEH is highly expressed in adipocytes, and it converts epoxyeicosatrienoic acids (EETs) into less bioactive dihydroxyeicosatrienoic acids.  We previously showed that increasing EETs levels with a sEH inhibitor (sEHI) (t-AUCB) resulted in elevated ABCA1 expression and promoted ABCA1-mediated cholesterol efflux from 3T3-L1 adipocytes.  The present study investigates the impacts of t-AUCB in mice deficient for the low d. lipoprotein (LDL) receptor (Ldlr-/- mice) with established atherosclerotic plaques.  The sEH inhibitor delivered in vivo for 4 wk decreased the activity of sEH in adipose tissue, enhanced ABCA1 expression and cholesterol efflux from adipose depots, and consequently increased HDL levels.  Furthermore, t-AUCB enhanced RCT to the plasma, liver, bile and feces.  It also showed the redn. of plasma LDL-C levels.  Consistently, t-AUCB-treated mice showed redns. in the size of atherosclerotic plaques.  These studies establish that raising adipose ABCA1 expression, cholesterol efflux, and plasma HDL levels with t-AUCB treatment promotes RCT, decreasing LDL-C and atherosclerosis regression, suggesting that sEH inhibition may be a promising strategy to treat atherosclerotic vascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3h2phoX68BrVg90H21EOLACvtfcHk0lhjFQYY0kRD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVShtb8%253D&md5=37cd3c83c6659fbbb770c9b97483579d</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520mice%2520promotes%2520reverse%2520cholesterol%2520transport%2520and%2520regression%2520of%2520atherosclerosis%26jtitle%3DAtherosclerosis%26date%3D2015%26volume%3D239%26spage%3D557%26epage%3D65%26doi%3D10.1016%2Fj.atherosclerosis.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors and heart failure</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/j.1755-5922.2010.00150.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1755-5922.2010.00150.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20433684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=99-111&author=H.+Qiuauthor=N.+Liauthor=J.+Y.+Liuauthor=T.+R.+Harrisauthor=B.+D.+Hammockauthor=N.+Chiamvimonvat&title=Soluble+epoxide+hydrolase+inhibitors+and+heart+failure&doi=10.1111%2Fj.1755-5922.2010.00150.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors and heart failure</span></div><div class="casAuthors">Qiu, Hong; Li, Ning; Liu, Jun-Yan; Harris, Todd R.; Hammock, Bruce D.; Chiamvimonvat, Nipavan</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-111</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cardiovascular disease remains one of the leading causes of death in the Western societies.  Heart failure (HF) is due primarily to progressive myocardial dysfunction accompanied by myocardial remodeling.  Once HF develops, the condition is, in most cases, irreversible and is assocd. with a very high mortality rate.  Sol. epoxide hydrolase (sEH) is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids (EETs), which are lipid mediators derived from arachidonic acid through the cytochrome P 450 epoxygenase pathway.  EETs have been shown to have vasodilatory, antiinflammatory, and cardioprotective effects.  When EETs are hydrolyzed by sEH to corresponding dihydroxyeicosatrienoic acids, their cardioprotective activities become less pronounced.  In line with the recent genetic study that has identified sEH as a susceptibility gene for HF, the sEH enzyme has received considerable attention as an attractive therapeutic target for cardiovascular diseases.  Indeed, sEH inhibition has been demonstrated to have antihypertensive and antiinflammatory actions, presumably due to the increased bioavailability of endogenous EETs and other epoxylipids, and several potent sEH inhibitors have been developed and tested in animal models of cardiovascular disease including hypertension, cardiac hypertrophy, and ischemia/reperfusion injury.  SEH inhibitor treatment has been shown to effectively prevent pressure overload- and angiotensin II-induced cardiac hypertrophy and reverse the pre-established cardiac hypertrophy caused by chronic pressure overload.  Application of sEH inhibitors in several cardiac ischemia/reperfusion injury models reduced infarct size and prevented the progressive cardiac remodeling.  Moreover, the use of sEH inhibitors prevented the development of elec. remodeling and ventricular arrhythmias assocd. with cardiac hypertrophy and ischemia/reperfusion injury.  The data published to date support the notion that sEH inhibitors may represent a promising therapeutic approach for combating detrimental cardiac remodeling and HF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSY3C1ubMuwbVg90H21EOLACvtfcHk0lhjFQYY0kRD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVehsbo%253D&md5=56a3f56718eb2efed1536b82fc4a1804</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5922.2010.00150.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5922.2010.00150.x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%2520and%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2011%26volume%3D29%26spage%3D99%26epage%3D111%26doi%3D10.1111%2Fj.1755-5922.2010.00150.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goralski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000237390.92932.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.0000237390.92932.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16857962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=442-450&author=J.+M.+Seubertauthor=C.+J.+Sinalauthor=J.+Gravesauthor=L.+M.+DeGraffauthor=J.+A.+Bradburyauthor=C.+R.+Leeauthor=K.+Goralskiauthor=M.+A.+Careyauthor=A.+Luriaauthor=J.+W.+Newmanauthor=B.+D.+Hammockauthor=J.+R.+Falckauthor=H.+Robertsauthor=H.+A.+Rockmanauthor=E.+Murphyauthor=D.+C.+Zeldin&title=Role+of+soluble+epoxide+hydrolase+in+postischemic+recovery+of+heart+contractile+function&doi=10.1161%2F01.RES.0000237390.92932.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function</span></div><div class="casAuthors">Seubert, John M.; Sinal, Christopher J.; Graves, Joan; DeGraff, Laura M.; Bradbury, J. Alyce; Lee, Craig R.; Goralski, Kerry; Carey, Michelle A.; Luria, Ayala; Newman, John W.; Hammock, Bruce D.; Falck, John R.; Roberts, Holly; Rockman, Howard A.; Murphy, Elizabeth; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Cytochrome P 450 epoxygenases metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs) which are converted to dihydroxyeicosatrienoic acids (DHETs) by sol. epoxide hydrolase (Ephx2, sEH).  To examine the functional role of sEH in the heart, mice with targeted disruption of the Ephx2 gene were studied.  Hearts from sEH null mice have undetectable levels of sEH mRNA and protein and cannot convert EETs to DHETs.  SEH null mice have normal heart anatomy and basal contractile function, but have higher fatty acid epoxide:diol ratios in plasma and cardiomyocyte cell culture media compared with wild type (WT).  SEH null hearts have improved recovery of left ventricular developed pressure (LVDP) and less infarction compared with WT hearts after 20 min ischemia.  Perfusion with the putative EET receptor antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (10 to 100 nmol/L) before ischemia abolishes this cardioprotective phenotype.  Inhibitor studies demonstrate that perfusion with phosphatidylinositol-3 kinase (PI3K) inhibitors wortmannin (200 nmol/L) or LY294002 (5 μmol/L), the ATP-sensitive K+ channel (KATP) inhibitor glibenclamide (1 μmol/L), the mitochondrial KATP (mitoKATP) inhibitor 5-hydroxydecanoate (100 to 200 μmol/L), or the Ca2+-sensitive K+ channel (KCa) inhibitor paxilline (10 μmol/L) abolishes the cardioprotection in sEH null hearts.  Consistent with increased activation of the PI3K cascade, sEH null mice exhibit increased cardiac expression of glycogen synthase kinase-3β (GSK-3β) phospho-protein after ischemia.  Together, these data suggest that targeted disruption of sEH increases the availability of cardioprotective EETs that work by activating PI3K signaling pathways and K+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxztpXZpUoh7Vg90H21EOLACvtfcHk0lhjFQYY0kRD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGktr0%253D&md5=54be10f8fbe659c7155a8566f4184781</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000237390.92932.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000237390.92932.37%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DJ.%2BM.%26aulast%3DSinal%26aufirst%3DC.%2BJ.%26aulast%3DGraves%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DL.%2BM.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DGoralski%26aufirst%3DK.%26aulast%3DCarey%26aufirst%3DM.%2BA.%26aulast%3DLuria%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DH.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520postischemic%2520recovery%2520of%2520heart%2520contractile%2520function%26jtitle%3DCirc.%2520Res.%26date%3D2006%26volume%3D99%26spage%3D442%26epage%3D450%26doi%3D10.1161%2F01.RES.0000237390.92932.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kompa, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisennagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalji, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2011.12.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijcard.2011.12.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22236509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC38vgt1Shug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=210-219&author=A.+R.+Kompaauthor=B.+H.+Wangauthor=G.+Xuauthor=Y.+Zhangauthor=P.+Y.+Hoauthor=S.+Eisennagelauthor=R.+K.+Thaljiauthor=J.+P.+Marinoauthor=D.+J.+Kellyauthor=D.+J.+Behmauthor=H.+Krum&title=Soluble+epoxide+hydrolase+inhibition+exerts+beneficial+anti-remodeling+actions+post-myocardial+infarction&doi=10.1016%2Fj.ijcard.2011.12.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction</span></div><div class="casAuthors">Kompa Andrew R; Wang Bing H; Xu Guoying; Zhang Yuan; Ho Pei-Yu; Eisennagel Stephen; Thalji Reema K; Marino Joseph P Jr; Kelly Darren J; Behm David J; Krum Henry</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  A contributory role for soluble epoxide hydrolase (sEH) in cardiac remodeling post-myocardial infarction (MI) has been suggested; however effects of sEH inhibition following MI have not been evaluated.  In this study, we examined in vivo post-MI anti-remodeling effects of a novel sEH inhibitor (GSK2188931B) in the rat, and evaluated its direct in vitro effects on hypertrophy, fibrosis and inflammation.  METHODS AND RESULTS:  Post-MI administered GSK2188931B (80 mg/kg/d in chow) for 5 weeks improved left ventricular (LV) ejection fraction compared to vehicle-treated (Veh) rats (P<0.01; Sham 65 ± 2%, MI+Veh 30 ± 2%, MI+GSK 43 ± 2%) without affecting systolic blood pressure.  Percentage area of LV tissue sections stained positive for picrosirius red (PS) and collagen I (CI) were elevated in LV non-infarct zone (P<0.05; NIZ; PS: Sham 1.46 ± 0.13%, MI+Veh 2.14 ± 0.22%, MI+GSK 1.28 ± 0.14%; CI: Sham 2.57 ± 0.17%, MI+Veh 5.06 ± 0.58%, MI+GSK 2.97 ± 0.34%) and peri-infarct zone (P<0.001; PIZ; PS: Sham 1.46 ± 0.13%, MI+Veh 9.06 ± 0.48%, MI+GSK 6.31 ± 0.63%; CI: Sham 2.57±0.17%, MI+Veh 10.51 ± 0.64%, MI+GSK 7.77 ± 0.57%); GSK2188931B attenuated this increase (P<0.05).  GSK2188931B reduced macrophage infiltration into the PIZ (P<0.05).  GSK2188931B reduced AngII- and TNFα-stimulated myocyte hypertrophy, AngII- and TGFβ-stimulated cardiac fibroblast collagen synthesis, including markers of gene expression ANP, β-MHC, CTGF and CI (P<0.05).  GSK2188931B reduced TNFα gene expression in lipopolysaccharide (LPS)-stimulated monocytes (P<0.05).  CONCLUSION:  sEH inhibition exerts beneficial effects on cardiac function and ventricular remodeling post-MI, and direct effects on fibrosis and hypertrophy in cardiac cells.  These findings suggest that sEH is an important contributor to the pathological remodeling following MI, and may be a useful target for therapeutic blockade in this setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTn2zWSRyKzFjToTC3aBaesfW6udTcc2ebmQQ5V7QTo17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgt1Shug%253D%253D&md5=576dd1ea415dc3a2a144f89110b296af</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2011.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2011.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DKompa%26aufirst%3DA.%2BR.%26aulast%3DWang%26aufirst%3DB.%2BH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DP.%2BY.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DThalji%26aufirst%3DR.%2BK.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DKelly%26aufirst%3DD.%2BJ.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520exerts%2520beneficial%2520anti-remodeling%2520actions%2520post-myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26spage%3D210%26epage%3D219%26doi%3D10.1016%2Fj.ijcard.2011.12.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1300</span>, <span class="refDoi"> DOI: 10.1111/jphp.13113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fjphp.13113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31215026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyktLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=1291-1300&author=H.+Zhangauthor=K.+Zhangauthor=J.+Liangauthor=W.+Yanauthor=F.+Wuauthor=W.+Xuauthor=Z.+Wuauthor=Y.+Chenauthor=R.+Panauthor=G.+Wu&title=Soluble+epoxide+hydrolase+inhibitor%2C+TUPS%2C+attenuates+isoproterenol%2Fangiotensin+II-induced+cardiac+hypertrophy+through+mammalian+target+of+rapamycin-mediated+autophagy+inhibition&doi=10.1111%2Fjphp.13113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition</span></div><div class="casAuthors">Zhang, Huanji; Zhang, Kun; Liang, Jianwen; Yan, Wen; Wu, Fensheng; Xu, Wenmin; Wu, Zhiwen; Chen, Yixi; Pan, Rongquan; Wu, Guifu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1291-1300</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : To investigate the potential role and mechanism of TUPS, a sol. epoxide hydrolase inhibitor, in cardiac hypertrophy.  Methods : Rat and H9C2 cell models of cardiac hypertrophy were induced by isoproterenol and angiotensin II, resp., followed by TUPS treatment.  The expression of hypertrophic markers, ANP and BNP, was detd. by quant. real-time PCR.  The abundance of Beclin-1, LC3, p-AMPK and phosphorylated-mammalian target of rapamycin (p-mTOR) proteins was analyzed by Western blot and immunohistocytol.  Cell morphol. and viability were evaluated by F-actin staining and MTS.  H9C2 cells were transfected with GFP-LC3 to evaluate autophagy flux.  Key findings : TUPS significantly inhibited rat heart size, heart wt.-to-body wt. ratio, heart wall thickness, hypertrophic H9C2 cell swelling and viability suppression as well as the expression of ANP and BNP genes in hypertrophic models.  In addn., autophagic markers Beclin-1 and LC3 were elevated in both cellular and animal models, which were suppressed by TUPS, with corresponding changes of autophagy flux.  The abundance of p-AMPK was increased, while p-mTOR was decreased in hypertrophic cells, which were abolished by TUPS.  Rapamycin decreased p-mTOR level, increased Beclin-1 and LC3 expression and induced cell size enlargement and cell viability inhibition in hypertrophic H9C2 cells treated with TUPS.  Conclusions : TUPS inhibits cardiac hypertrophy by regulating mTOR/autophagy axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY8mBL1HPrLVg90H21EOLACvtfcHk0lgVq1N_EqjCsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyktLfM&md5=360e06ce9c16eccd1cb31bbdfc50996a</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1111%2Fjphp.13113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.13113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DG.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520TUPS%252C%2520attenuates%2520isoproterenol%252Fangiotensin%2520II-induced%2520cardiac%2520hypertrophy%2520through%2520mammalian%2520target%2520of%2520rapamycin-mediated%2520autophagy%2520inhibition%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2019%26volume%3D71%26spage%3D1291%26epage%3D1300%26doi%3D10.1111%2Fjphp.13113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title"><i>Uncaria rhynchophylla</i> ameliorates Parkinson’s disease by inhibiting HSP90 expression: insights from quantitative proteomics</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1159/000490837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1159%2F000490837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29940559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2hu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=1453-1464&author=Y.+L.+Lanauthor=J.+J.+Zhouauthor=J.+Liuauthor=X.+K.+Huoauthor=Y.+L.+Wangauthor=J.+H.+Liangauthor=J.+C.+Zhaoauthor=C.+P.+Sunauthor=Z.+L.+Yuauthor=L.+L.+Fangauthor=X.+G.+Tianauthor=L.+Fengauthor=J.+Ningauthor=B.+J.+Zhangauthor=C.+Wangauthor=X.+Y.+Zhaoauthor=X.+C.+Ma&title=Uncaria+rhynchophylla+ameliorates+Parkinson%E2%80%99s+disease+by+inhibiting+HSP90+expression%3A+insights+from+quantitative+proteomics&doi=10.1159%2F000490837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Uncaria rhynchophylla Ameliorates Parkinson's Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics</span></div><div class="casAuthors">Lan, Yu-Long; Zhou, Jun-Jun; Liu, Jing; Huo, Xiao-Kui; Wang, Ya-Li; Liang, Jia-Hao; Zhao, Jian-Chao; Sun, Cheng-Peng; Yu, Zhen-Long; Fang, Lin-Lin; Tian, Xiang-Ge; Feng, Lei; Ning, Jing; Zhang, Bao-Jing; Wang, Chao; Zhao, Xin-Yu; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1453-1464</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Uncaria rhynchophylla, known as "Gou-teng", is a traditional Chinese medicine (TCM) used to extinguish wind, clear heat, arrest convulsions, and pacify the liver.  Although U. rhynchophylla has a long history of being often used to treat central nervous system (CNS) diseases, its efficacy and potential mechanism are still uncertain.  This study investigated neuroprotective effect and the underlying mechanism of U. rhynchophylla ext. (URE) in MPP+-induced SH-SY5Y cells and MPTP-induced mice.  Methods: MPP+-induced SH-SY5Y cells and MPTP-induced mice were used to established Parkinson's disease (PD) models.  Quant. proteomics and bioinformatics were used to uncover proteomics changes of URE.  Western blotting was used to validate main differentially expressed proteins and test HSP90 client proteins (apoptosis-related, autophagy-related, MAPKs, PI3K, and AKT proteins).  Flow cytometry and JC-1 staining assay were further used to confirm the effect of URE on MPP+-induced apoptosis in SH-SY5Y cells.  Gait anal. was used to detect the behavioral changes in MPTP-induced mice.  The levels of dopamine (DA) and their metabolites were examd. in striatum (STR) by HPLC-EC.  The pos. expression of tyrosine hydroxylase (TH) was detected by immunohischem. staining and Western blotting.  Results: URE dose-dependently increased the cell viability in MPP+-induced SH-SY5Y cells.  Quant. proteomics and bioinformatics results confirmed that HSP90 was an important differentially expressed protein of URE.  URE inhibited the expression of HSP90, which further reversed MPP+-induced cell apoptosis and autophagy by increasing the expressions of Bcl-2, Cyclin D1, p-ERK, p-PI3K p85, PI3K p110α, p-AKT, and LC3-I and decreasing cleaved caspase 3, Bax, p-JNK, p-p38, and LC3-II.  URE also markedly decreased the apoptotic ratio and elevated mitochondrial transmembrane potential (DΨm).  Furthermore, URE treatment ameliorated behavioral impairments, increased the contents of DA and its metabolites and elevated the pos. expressions of TH in SN and STR as well as the TH protein.  Conclusions: URE possessed the neuroprotective effect in vivo and in vitro, regulated MAPK and PI3K-AKT signal pathways, and inhibited the expression of HSP90.  U. rhynchophylla has potentials as therapeutic agent in PD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbYuhIDXQlKLVg90H21EOLACvtfcHk0liqdXzKKI0CQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2hu73L&md5=88cba9544261590d04d368aadfd686d3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1159%2F000490837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000490837%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%2BL.%26aulast%3DZhou%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DLiang%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DYu%26aufirst%3DZ.%2BL.%26aulast%3DFang%26aufirst%3DL.%2BL.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNing%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%2BY.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DUncaria%2520rhynchophylla%2520ameliorates%2520Parkinson%25E2%2580%2599s%2520disease%2520by%2520inhibiting%2520HSP90%2520expression%253A%2520insights%2520from%2520quantitative%2520proteomics%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D47%26spage%3D1453%26epage%3D1464%26doi%3D10.1159%2F000490837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Uncarialins A-I, monoterpenoid indole alkaloids from <i>Uncaria rhynchophylla</i> as natural agonists of the 5-HT<sub>1A</sub> receptor</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3310</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b00532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b00532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1KisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2019&pages=3302-3310&author=J.+H.+Liangauthor=Z.+L.+Luanauthor=X.+G.+Tianauthor=W.+Y.+Zhaoauthor=Y.+L.+Wangauthor=C.+P.+Sunauthor=X.+K.+Huoauthor=S.+Dengauthor=B.+J.+Zhangauthor=Z.+J.+Zhangauthor=X.+C.+Ma&title=Uncarialins+A-I%2C+monoterpenoid+indole+alkaloids+from+Uncaria+rhynchophylla+as+natural+agonists+of+the+5-HT1A+receptor&doi=10.1021%2Facs.jnatprod.9b00532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Uncarialins A-I, Monoterpenoid Indole Alkaloids from Uncaria rhynchophylla as Natural Agonists of the 5-HT1A Receptor</span></div><div class="casAuthors">Liang, Jia-Hao; Luan, Zhi-Lin; Tian, Xiang-Ge; Zhao, Wen-Yu; Wang, Ya-Li; Sun, Cheng-Peng; Huo, Xiao-Kui; Deng, Sa; Zhang, Bao-Jing; Zhang, Zhan-Jun; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3302-3310</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Nine new monoterpenoid indole alkaloids, uncarialins A-I (I-9), were isolated from Uncaria rhynchophylla as well as 14 known analogs (10-23).  Their structures were detd. by HRESIMS, 1D and 2D NMR, and exptl. and calcd. electronic CD data.  Compds. 5, 7, 15, and 22 displayed significant agonistic effects against the 5-HT1A receptor with EC50 values of 2.2 ± 0.1, 0.1 ± 0.1, 1.6 ± 0.3, and 2.0 ± 0.5 μM, resp.  The mechanisms of action of these four compds. with the 5-HT1A receptor were investigated by mol. docking, and the results suggested that amino acid residues Asp116, Thr196, Asn386, and Tyr390 played crit. roles in the obsd. activity of the above-mentioned compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKY-NjorYwrVg90H21EOLACvtfcHk0liqdXzKKI0CQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1KisLjL&md5=025281c63a225d830e5ace7e3237cd3c</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b00532%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BH.%26aulast%3DLuan%26aufirst%3DZ.%2BL.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DZhao%26aufirst%3DW.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BJ.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DUncarialins%2520A-I%252C%2520monoterpenoid%2520indole%2520alkaloids%2520from%2520Uncaria%2520rhynchophylla%2520as%2520natural%2520agonists%2520of%2520the%25205-HT1A%2520receptor%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2019%26volume%3D82%26spage%3D3302%26epage%3D3310%26doi%3D10.1021%2Facs.jnatprod.9b00532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Noort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span> <span> </span><span class="NLM_article-title">Schizophrenia and depression: a systematic review of the effectiveness and the working mechanisms behind acupuncture</span>. <i>Explore</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.explore.2015.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.explore.2015.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC2MfntVSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=281-291&author=P.+Boschauthor=M.+van+den+Noortauthor=H.+Staudteauthor=S.+Lim&title=Schizophrenia+and+depression%3A+a+systematic+review+of+the+effectiveness+and+the+working+mechanisms+behind+acupuncture&doi=10.1016%2Fj.explore.2015.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia and Depression: A systematic Review of the Effectiveness and the Working Mechanisms Behind Acupuncture</span></div><div class="casAuthors">Bosch Peggy; van den Noort Maurits; Staudte Heike; Lim Sabina</div><div class="citationInfo"><span class="NLM_cas:title">Explore (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  This systematic review assessed clinical evidence for the use of acupuncture as an add-on treatment in patients with depression and schizophrenia and for its underlying working mechanisms.  DATA SOURCES:  Four databases (Medline, Scopus, ERIC, and the Cochrane Library) were searched with a cutoff date of March 31, 2014.  STUDY SELECTION:  Systematic reviews and meta-analyses of acupuncture treatment for depression and schizophrenia were considered for inclusion.  The scarcity of acupuncture research involving schizophrenia led to the inclusion of randomized controlled trials and case studies.  DATA EXTRACTION:  The primary and secondary aims of this study were to evaluate the effects of acupuncture in treating patients with depression or schizophrenia and the possible working mechanisms underlying acupuncture through a systematic literature review.  DATA SYNTHESIS:  The overall clinical results on using acupuncture to treat depression are promising, but only limited evidence for its effectiveness in treating schizophrenia was found.  Acupuncture improves the quality of life, particularly that of sleep, in psychiatric patients.  Brain research has revealed that acupuncture has a modulating and normalizing effect on the limbic-paralimbic-neocortical network (LPNN), including the default mode network.  Because the LPNN is related to sleep and emotions, this might explain the improved qualities of life and sleep after acupuncture.  CONCLUSIONS:  From the evidence found in this study, acupuncture seems to be an effective add-on treatment in patients with depression and, to a lesser degree, in patients with schizophrenia, but large well-designed studies are needed to confirm that evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8il2-x50o0Ff1XRtfYM0dfW6udTcc2eZXi2WxW3K2p7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfntVSnsQ%253D%253D&md5=061e5acdfdff334a93f911814edb98aa</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.explore.2015.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.explore.2015.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BNoort%26aufirst%3DM.%26aulast%3DStaudte%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DS.%26atitle%3DSchizophrenia%2520and%2520depression%253A%2520a%2520systematic%2520review%2520of%2520the%2520effectiveness%2520and%2520the%2520working%2520mechanisms%2520behind%2520acupuncture%26jtitle%3DExplore%26date%3D2015%26volume%3D11%26spage%3D281%26epage%3D291%26doi%3D10.1016%2Fj.explore.2015.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akamatsu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E5815</span>– <span class="NLM_lpage">E5823</span>, <span class="refDoi"> DOI: 10.1073/pnas.1802179115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1802179115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29735655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFGks7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E5815-E5823&author=Q.+Renauthor=M.+Maauthor=J.+Yangauthor=R.+Nonakaauthor=A.+Yamaguchiauthor=K.-i.+Ishikawaauthor=K.+Kobayashiauthor=S.+Murayamaauthor=S.+H.+Hwangauthor=S.+Saikiauthor=W.+Akamatsuauthor=N.+Hattoriauthor=B.+D.+Hammockauthor=K.+Hashimoto&title=Soluble+epoxide+hydrolase+plays+a+key+role+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1802179115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Ren, Qian; Maa, Min; Yang, Jun; Nonaka, Risa; Yamaguchi, Akihiro; Ishikawa, Kei-ichi; Kobayashi, Kenta; Murayama, Shigeo; Hwang, Sung Hee; Saiki, Shinji; Akamatsu, Wado; Hattori, Nobutaka; Hammock, Bruce D.; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">E5815-E5823</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized as a chronic and progressive neurodegenerative disorder, and the deposition of specific protein aggregates of α-synuclein, termed Lewy bodies, is evident in multiple brain regions of PD patients.  Although there are several available medications to treat PD symptoms, these medications do not prevent the progression of the disease.  Sol. epoxide hydrolase (sEH) plays a key role in inflammation assocd. with the pathogenesis of PD.  Here we found that MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neurotoxicity in the mouse striatum was attenuated by subsequent repeated administration of TPPU, a potent sEH inhibitor.  Furthermore, deletion of the sEH gene protected against MPTP-induced neurotoxicity, while overexpression of sEH in the striatum significantly enhanced MPTP-induced neurotoxicity.  Moreover, the expression of the sEH protein in the striatum from MPTP-treated mice or postmortem brain samples from patients with dementia of Lewy bodies (DLB) was significantly higher compared with control groups.  Interestingly, there was a pos. correlation between sEH expression and phosphorylation of α-synuclein in the striatum.  Oxylipin anal. showed decreased levels of 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid in the striatum of MPTP-treated mice, suggesting increased activity of sEH in this region.  Interestingly, the expression of sEH mRNA in human PARK2 iPSC-derived neurons was higher than that of healthy control.  Treatment with TPPU protected against apoptosis in human PARK2 iPSC-derived dopaminergic neurons.  These findings suggest that increased activity of sEH in the striatum plays a key role in the pathogenesis of neurodegenerative disorders such as PD and DLB.  Therefore, sEH may represent a promising therapeutic target for α-synuclein-related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqunwmVJR-oHrVg90H21EOLACvtfcHk0lgzH14cJHNNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFGks7bJ&md5=104bee1f86772dd4061061d2f4eac5ff</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1802179115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1802179115%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DNonaka%26aufirst%3DR.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DIshikawa%26aufirst%3DK.-i.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DSaiki%26aufirst%3DS.%26aulast%3DAkamatsu%26aufirst%3DW.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520plays%2520a%2520key%2520role%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE5815%26epage%3DE5823%26doi%3D10.1073%2Fpnas.1802179115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase deficiency or inhibition attenuates MPTP-induced parkinsonism</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-8833-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12035-014-8833-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25128026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2015&pages=187-195&author=X.+Qinauthor=Q.+Wuauthor=L.+Linauthor=A.+Sunauthor=S.+Liuauthor=X.+Liauthor=X.+Caoauthor=T.+Gaoauthor=P.+Luoauthor=X.+Zhuauthor=X.+Wang&title=Soluble+epoxide+hydrolase+deficiency+or+inhibition+attenuates+MPTP-induced+parkinsonism&doi=10.1007%2Fs12035-014-8833-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism</span></div><div class="casAuthors">Qin, Xiaocui; Wu, Qiaoqi; Lin, Lifang; Sun, Aimin; Liu, Shuhu; Li, Xiaowen; Cao, Xiong; Gao, Tianming; Luo, Pengcheng; Zhu, Xinhong; Wang, Xuemin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) inhibition has been demonstrated to have beneficial effects on various diseases, such as hypertension, diabetes, and brain ischemia.  However, whether sEH inhibition has therapeutic potential in Parkinson's disease is still unknown.  In this paper, we found that sEH expression is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine (MPTP)-treated mice, and sEH deficiency and inhibition significantly attenuated tyrosine hydroxylase (TH)-pos. cell loss and improved rotarod performance.  The substrate of sEH, 14,15-epoxyeicosatrienoic acid (14,15-EET), protected TH-pos. cells and alleviated the rotarod performance deficits of wild-type mice but not sEH-knockout mice.  Moreover, the 14,15-EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE) abolished the neuronal protective effects of sEH deficiency.  In primary cultured cortical neurons, MPP+ induced significant Akt inactivation in neurons from sEH wild-type mice, and this effect was not obsd. in neurons from knockout mice.  Our data indicate that sEH deficiency and inhibition increased 14,15-EET in MPTP-treated mice, which activated the Akt-mediated protection of TH-pos. neurons and behavioral functioning.  We also found that sEH deficiency attenuated TH-pos. cell loss in a paraquat-induced mouse model of Parkinson's.  Our data suggest that sEH inhibition might be a powerful tool to protect dopaminergic neurons in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMcbwqJua_LVg90H21EOLACvtfcHk0lgzH14cJHNNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtr%252FM&md5=2a6f214388fcea30b27e049278aac5c3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-8833-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-8833-3%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520deficiency%2520or%2520inhibition%2520attenuates%2520MPTP-induced%2520parkinsonism%26jtitle%3DMol.%2520Neurobiol.%26date%3D2015%26volume%3D52%26spage%3D187%26epage%3D195%26doi%3D10.1007%2Fs12035-014-8833-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krstic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuesel, I.</span></span> <span> </span><span class="NLM_article-title">Deciphering the mechanism underlying late-onset Alzheimer disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2012.236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrneurol.2012.236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23183882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=25-34&author=D.+Krsticauthor=I.+Knuesel&title=Deciphering+the+mechanism+underlying+late-onset+Alzheimer+disease&doi=10.1038%2Fnrneurol.2012.236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the mechanism underlying late-onset Alzheimer disease</span></div><div class="casAuthors">Krstic, Dimitrije; Knuesel, Irene</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite tremendous investments in understanding the complex mol. mechanisms underlying Alzheimer disease (AD), recent clin. trials have failed to show efficacy.  A potential problem underlying these failures is the assumption that the mol. mechanism mediating the genetically detd. form of the disease is identical to the one resulting in late-onset AD.  Here, we integrate exptl. evidence outside the 'spotlight' of the genetic drivers of amyloid-β (Aβ) generation published during the past two decades, and present a mechanistic explanation for the pathophysiol. changes that characterize late-onset AD.  We propose that chronic inflammatory conditions cause dysregulation of mechanisms to clear misfolded or damaged neuronal proteins that accumulate with age, and concomitantly lead to tau-assocd. impairments of axonal integrity and transport.  Such changes have several neuropathol. consequences: focal accumulation of mitochondria, resulting in metabolic impairments; induction of axonal swelling and leakage, followed by destabilization of synaptic contacts; deposition of amyloid precursor protein in swollen neurites, and generation of aggregation-prone peptides; further tau hyperphosphorylation, ultimately resulting in neurofibrillary tangle formation and neuronal death.  The proposed sequence of events provides a link between Aβ and tau-related neuropathol., and underscores the concept that degenerating neurites represent a cause rather than a consequence of Aβ accumulation in late-onset AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYYv4uqHLyLLVg90H21EOLACvtfcHk0lgzH14cJHNNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaj&md5=353d51652349e91d799cd59cbbbc413f</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2012.236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2012.236%26sid%3Dliteratum%253Aachs%26aulast%3DKrstic%26aufirst%3DD.%26aulast%3DKnuesel%26aufirst%3DI.%26atitle%3DDeciphering%2520the%2520mechanism%2520underlying%2520late-onset%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D25%26epage%3D34%26doi%3D10.1038%2Fnrneurol.2012.236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calsolaro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edison, P.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation in Alzheimer’s disease: current evidence and future directions</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.jalz.2016.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27179961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC28bpvVyhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=719-732&author=V.+Calsolaroauthor=P.+Edison&title=Neuroinflammation+in+Alzheimer%E2%80%99s+disease%3A+current+evidence+and+future+directions&doi=10.1016%2Fj.jalz.2016.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Alzheimer's disease: Current evidence and future directions</span></div><div class="casAuthors">Calsolaro Valeria; Edison Paul</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results.  It is clear that the "amyloid cascade hypothesis" alone cannot fully explain the neuronal damage in AD, as evidenced both by autopsy and imaging studies.  Neuroinflammation plays a significant role in neurodegenerative diseases, whereas the debate is ongoing about its precise role, whether it is protective or harmful.  In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease progression.  We focus on neuroinflammation in AD, especially in the earliest stages, a vicious cycle of glial priming, release of pro-inflammatory factors, and neuronal damage.  We review the evidence from imaging studies, regarding the temporal relationship between amyloid deposition and neuroinflammation, the influence of systemic inflammation on glial activation, both in acute and chronic stimulation and the relevance of inflammation as a diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhSnzpo3gNWsAKB7Fa-xrUfW6udTcc2ebMkL2VM78AXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bpvVyhtg%253D%253D&md5=455f22ccbc7a16b20131d4d834935205</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DCalsolaro%26aufirst%3DV.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DNeuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520current%2520evidence%2520and%2520future%2520directions%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3D719%26epage%3D732%26doi%3D10.1016%2Fj.jalz.2016.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, N. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWitLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=872-879&author=W.+Y.+Fuauthor=X.+J.+Wangauthor=N.+Y.+Ip&title=Targeting+neuroinflammation+as+a+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease%3A+mechanisms%2C+drug+candidates%2C+and+new+opportunities&doi=10.1021%2Facschemneuro.8b00402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities</span></div><div class="casAuthors">Fu, Wing-Yu; Wang, Xiujiao; Ip, Nancy Y.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">872-879</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is a progressive neurodegenerative disease, and its incidence is expected to increase owing to the aging population worldwide.  Current therapies merely provide symptomatic relief.  Therefore, interventions for AD that delay the disease onset or progression are urgently required.  Recent genomics and functional studies suggest that immune/inflammatory pathways are involved in the pathogenesis of AD.  Although many anti-inflammatory drug candidates have undergone clin. trials, most have failed.  This might be because of our limited understanding of the pathol. mechanisms of neuroinflammation in AD.  However, recent advances in the understanding of immune/inflammatory pathways in AD and their regulatory mechanisms could open up new avenues for drug development targeting neuroinflammation.  In this Review, we discuss the mechanisms and status of different anti-inflammatory drug candidates for AD that have undergone or are undergoing clin. trials and explore new opportunities for targeting neuroinflammation in AD drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqX4Qot5fsLVg90H21EOLACvtfcHk0lhdrcfDsdmmew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWitLnI&md5=dbb4bb413daea0fdbd9e936cd68db52d</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00402%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DW.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DIp%26aufirst%3DN.%2BY.%26atitle%3DTargeting%2520neuroinflammation%2520as%2520a%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520mechanisms%252C%2520drug%2520candidates%252C%2520and%2520new%2520opportunities%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D872%26epage%3D879%26doi%3D10.1021%2Facschemneuro.8b00402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodamullil, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zekri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann-Apitius, M.</span></span> <span> </span><span class="NLM_article-title">Trial watch: tracing investment in drug development for Alzheimer disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">819</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd.2017.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29056749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=819&author=A.+T.+Kodamullilauthor=F.+Zekriauthor=M.+Soodauthor=B.+Hengererauthor=L.+Canardauthor=D.+McHaleauthor=M.+Hofmann-Apitius&title=Trial+watch%3A+tracing+investment+in+drug+development+for+Alzheimer+disease&doi=10.1038%2Fnrd.2017.169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Trial watch Tracing investment in drug development for Alzheimer disease</span></div><div class="casAuthors">Kodamullil, Alpha Tom; Zekri, Firas; Sood, Meemansa; Hengerer, Bastian; Canard, Luc; McHale, Duncan; Hofmann-Apitius, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">819</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotQcwkb2HD4LVg90H21EOLACvtfcHk0lhdrcfDsdmmew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansbzE&md5=ab3115a6db345227776badc5a4d74cb3</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.169%26sid%3Dliteratum%253Aachs%26aulast%3DKodamullil%26aufirst%3DA.%2BT.%26aulast%3DZekri%26aufirst%3DF.%26aulast%3DSood%26aufirst%3DM.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DCanard%26aufirst%3DL.%26aulast%3DMcHale%26aufirst%3DD.%26aulast%3DHofmann-Apitius%26aufirst%3DM.%26atitle%3DTrial%2520watch%253A%2520tracing%2520investment%2520in%2520drug%2520development%2520for%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D819%26doi%3D10.1038%2Fnrd.2017.169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonnies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trushina, E.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, synaptic dysfunction, and Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.3233/JAD-161088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3233%2FJAD-161088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28059794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ivFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1105-1121&author=E.+Tonniesauthor=E.+Trushina&title=Oxidative+stress%2C+synaptic+dysfunction%2C+and+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-161088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease</span></div><div class="casAuthors">Tonnies Eric; Trushina Eugenia; Trushina Eugenia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1105-1121</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disorder without a cure.  Most AD cases are sporadic where age represents the greatest risk factor.  Lack of understanding of the disease mechanism hinders the development of efficacious therapeutic approaches.  The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss.  Oxidative stress has been recognized as a contributing factor in aging and in the progression of multiple neurodegenerative diseases including AD.  Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction.  In addition, molecular targets affected by ROS include nuclear and mitochondrial DNA, lipids, proteins, calcium homeostasis, mitochondrial dynamics and function, cellular architecture, receptor trafficking and endocytosis, and energy homeostasis.  Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-β (Aβ) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle.  While mounting evidence implicates ROS in the AD etiology, clinical trials with antioxidant therapies have not produced consistent results.  In this review, we will discuss the role of oxidative stress in synaptic dysfunction in AD, innovative therapeutic strategies evolved based on a better understanding of the complexity of molecular mechanisms of AD, and the dual role ROS play in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0B3ieG-NrRbt7lRqEFUJVfW6udTcc2eYw8dvqqyrL6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ivFyjsQ%253D%253D&md5=55605343ed0fa8d474ee49f7fb192ef6</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.3233%2FJAD-161088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-161088%26sid%3Dliteratum%253Aachs%26aulast%3DTonnies%26aufirst%3DE.%26aulast%3DTrushina%26aufirst%3DE.%26atitle%3DOxidative%2520stress%252C%2520synaptic%2520dysfunction%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D57%26spage%3D1105%26epage%3D1121%26doi%3D10.3233%2FJAD-161088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Neurodegenerative diseases and oxidative stress</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+diseases+and+oxidative+stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0ljj0nAuL88YHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520diseases%2520and%2520oxidative%2520stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Dennis, S.</span></span> <span> </span><span class="NLM_article-title">Review of rethinking health care ethics by Stephen Scher and Kasia Kozlowska</span>. <i>Monash. Bioeth. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1007/s40592-020-00107-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs40592-020-00107-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32306202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB38zmvVSrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=83-86&author=S.+Reis-Dennis&title=Review+of+rethinking+health+care+ethics+by+Stephen+Scher+and+Kasia+Kozlowska&doi=10.1007%2Fs40592-020-00107-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Review of Rethinking Health Care Ethics by Stephen Scher and Kasia Kozlowska : Palgrave Macmillan, available open access: https://link.springer.com/content/pdf/10.1007/978-981-13-0830-7.pdf</span></div><div class="casAuthors">Reis-Dennis Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Monash bioethics review</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPY3i6lDJ8sgwxfk_AGB-EfW6udTcc2eYw8dvqqyrL6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zmvVSrug%253D%253D&md5=6e1777cebc35773d41cf3cdd29116053</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1007%2Fs40592-020-00107-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40592-020-00107-z%26sid%3Dliteratum%253Aachs%26aulast%3DReis-Dennis%26aufirst%3DS.%26atitle%3DReview%2520of%2520rethinking%2520health%2520care%2520ethics%2520by%2520Stephen%2520Scher%2520and%2520Kasia%2520Kozlowska%26jtitle%3DMonash.%2520Bioeth.%2520Rev.%26date%3D2020%26volume%3D38%26spage%3D83%26epage%3D86%26doi%3D10.1007%2Fs40592-020-00107-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, J. F.</span></span> <span> </span><span class="NLM_article-title">Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1006/nlme.2001.4047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fnlme.2001.4047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12071671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XksF2gtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2002&pages=125-138&author=J.+E.+Morleyauthor=S.+A.+Farrauthor=J.+F.+Flood&title=Antibody+to+amyloid+beta+protein+alleviates+impaired+acquisition%2C+retention%2C+and+memory+processing+in+SAMP8+mice&doi=10.1006%2Fnlme.2001.4047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice</span></div><div class="casAuthors">Morley, John E.; Farr, Susan A.; Flood, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-138</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">SAMP8 (senescence-accelerated mouse, P8 strain) mice overproduce amyloid precursor protein and β-amyloid and have learning and memory deficits.  Preliminary data have indicated that overprodn. of β-amyloid plays a role in the pathogenesis of acquisition and retention deficits in SAMP8 mice.  In the studies reported here, the authors examd. the effects of polyclonal and monoclonal antibodies to β-amyloid on acquisition and retention in an aversive T-maze testing paradigm when injected intracerebroventricularly (ICV) into 12-mo SAMP8/TaJF mice.  Both the polyclonal and monoclonal antibodies improved acquisition and retention when injected ICV 1 to 14 days prior to acquisition testing.  Injection of all 3 antibodies intrahippocampally immediately following training improved retention on the T-maze when mice were tested 7 days later.  The authors next studied the effect of monoclonal β-amyloid antibody injected 48 h prior to training on the effect on retention in the T-maze of drugs modulating classical neurotransmitters.  Arecoline and glutamate were injected directly into the hippocampus, and ketanserin, methiothepen, bicuculline, and OH-saclofen were injected into the septum.  Previously, the authors have found that the doses of these drugs required to improve retention are markedly altered in 12-mo SAMP8/TkJF mice compared to 4-mo P8 mice.  In these studies, it was demonstrated that antibody to β-amyloid resulted in these drugs improving retention at doses that improved memory in 4-mo SAMP8/TaJF mice.  Based on these findings, the authors conclude that β-amyloid overprodn. is at least in part responsible for the acquisition and memory deficits in 12-mo-old SAMP8/TaJF mice.  Antibody to β-amyloid restores the retention response to neurotransmitter manipulation to that seen in 4-mo-old mice.  β-Amyloid appears to play a key role in the loss of acquisition and retention seen in SAMP8/TaJF mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0xNSYwEN4rVg90H21EOLACvtfcHk0ljQpO6zIm43Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksF2gtL8%253D&md5=57b39d4b2f759e189a845b2c9d291e9c</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1006%2Fnlme.2001.4047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnlme.2001.4047%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BE.%26aulast%3DFarr%26aufirst%3DS.%2BA.%26aulast%3DFlood%26aufirst%3DJ.%2BF.%26atitle%3DAntibody%2520to%2520amyloid%2520beta%2520protein%2520alleviates%2520impaired%2520acquisition%252C%2520retention%252C%2520and%2520memory%2520processing%2520in%2520SAMP8%2520mice%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2002%26volume%3D78%26spage%3D125%26epage%3D138%26doi%3D10.1006%2Fnlme.2001.4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span> <span> </span><span class="NLM_article-title">Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1007/s11064-009-9922-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs11064-009-9922-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19199030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=639-659&author=T.+Takeda&title=Senescence-accelerated+mouse+%28SAM%29+with+special+references+to+neurodegeneration+models%2C+SAMP8+and+SAMP10+mice&doi=10.1007%2Fs11064-009-9922-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice</span></div><div class="casAuthors">Takeda, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-659</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The SAM strains, a group of related inbred strains consisting of senescence-prone inbred strains (SAMP) and senescence-resistant inbred strains (SAMR), have been successfully developed by selective inbreeding of the AKR/J strain of mice donated by the Jackson lab. in 1968.  The characteristic feature of aging common to the SAMP and SAMR is accelerated senescence and normal aging, resp.  Furthermore, SAMP and SAMR strains of mice manifest various pathobiol. phenotypes spontaneously.  Among SAMP strains, SAMP8 and SAMP10 mice show age-related behavioral deterioration such as deficits in learning and memory, emotional disorders (reduced anxiety-like behavior and depressive behavior) and altered circadian rhythm assocd. with certain pathol., biochem. and pharmacol. changes.  Here, the previous and recent literature on SAM mice are reviewed with an emphasis on SAMP8 and SAMP10 mice.  A spontaneous model like SAM with distinct advantages over the gene-modified model is hoped by investigators to be used more widely as a biogerontol. resource to explore the etiopathogenesis of accelerated senescence and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozvIt6wzmXFbVg90H21EOLACvtfcHk0ljQpO6zIm43Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOkurk%253D&md5=e3c4a35ba7e61740626f1ab31be0241a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-9922-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-9922-y%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DT.%26atitle%3DSenescence-accelerated%2520mouse%2520%2528SAM%2529%2520with%2520special%2520references%2520to%2520neurodegeneration%2520models%252C%2520SAMP8%2520and%2520SAMP10%2520mice%26jtitle%3DNeurochem.%2520Res.%26date%3D2009%26volume%3D34%26spage%3D639%26epage%3D659%26doi%3D10.1007%2Fs11064-009-9922-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akiguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda’s legacy and future directions</span>. <i>Neuropathology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1111/neup.12373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fneup.12373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28261874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSrsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=293-305&author=I.+Akiguchiauthor=M.+Pallasauthor=H.+Budkaauthor=H.+Akiyamaauthor=M.+Uenoauthor=J.+Hanauthor=H.+Yagiauthor=T.+Nishikawaauthor=Y.+Chibaauthor=H.+Sugiyamaauthor=R.+Takahashiauthor=K.+Unnoauthor=K.+Higuchiauthor=M.+Hosokawa&title=SAMP8+mice+as+a+neuropathological+model+of+accelerated+brain+aging+and+dementia%3A+Toshio+Takeda%E2%80%99s+legacy+and+future+directions&doi=10.1111%2Fneup.12373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions</span></div><div class="casAuthors">Akiguchi, Ichiro; Pallas, Merce; Budka, Herbert; Akiyama, Haruhiko; Ueno, Masaki; Han, Jingxian; Yagi, Hideo; Nishikawa, Tomohumi; Chiba, Yoichi; Sugiyama, Hiroshi; Takahashi, Ryoya; Unno, Keiko; Higuchi, Keiichi; Hosokawa, Masanori</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-305</span>CODEN:
                <span class="NLM_cas:coden">NOPAFH</span>;
        ISSN:<span class="NLM_cas:issn">1440-1789</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Senescence accelerated mice P8 (SAMP8) show significant age-related deteriorations in memory and learning ability in accordance with early onset and rapid advancement of senescence.  Brains of SAMP8 mice reveal an age-assocd. increase of PAS-pos. granular structures in the hippocampal formation and astrogliosis in the brain stem and hippocampus.  A spongy degeneration in the brain stem appears at 1 mo of age and reaches a max. at 4-8 mo.  In addn., clusters of activated microglia also appear around the vacuoles in the brain stem.  β/A4(Aβ) protein-like immunoreactive granular structures are obsd. in various regions and increase in no. markedly with age.  Other age-assocd. histol. changes include cortical atrophy, neuronal cell loss in locus coeruleus and lateral tegmental nuclei, intraneuronal accumulation of lipopigments in Purkinje cells and eosinophilic inclusion bodies in thalamic neurons.  A blood-brain barrier dysfunction and astrogliosis are also prominent with advancing age in the hippocampus.  These changes are generally similar to the pathomorphol. of aging human brains and characterized by their assocn. with some specific glioneuronal reactions.  As for the hallmarks of Alzheimer brains, tau morphol. has not yet been confirmed regardless of the age-related increase in phosphorylated tau in SAMP8 mice brains, but early age-related Aβ deposition in the hippocampus has recently been published.  SAMP8 mice are, therefore, not only a senescence-accelerated model but also a promising model for Alzheimer's disease and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcUZZ9pccDLbVg90H21EOLACvtfcHk0ljQpO6zIm43Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSrsr%252FJ&md5=53441e182ca9f48176db13f129435fb0</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1111%2Fneup.12373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fneup.12373%26sid%3Dliteratum%253Aachs%26aulast%3DAkiguchi%26aufirst%3DI.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBudka%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DYagi%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DT.%26aulast%3DChiba%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DUnno%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DK.%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DSAMP8%2520mice%2520as%2520a%2520neuropathological%2520model%2520of%2520accelerated%2520brain%2520aging%2520and%2520dementia%253A%2520Toshio%2520Takeda%25E2%2580%2599s%2520legacy%2520and%2520future%2520directions%26jtitle%3DNeuropathology%26date%3D2017%26volume%3D37%26spage%3D293%26epage%3D305%26doi%3D10.1111%2Fneup.12373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinan-Ferre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomera-Avalos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porquet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span> <span> </span><span class="NLM_article-title">Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.exger.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.exger.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27094468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=57-69&author=C.+Grinan-Ferreauthor=V.+Palomera-Avalosauthor=D.+Puigoriol-Illamolaauthor=A.+Caminsauthor=D.+Porquetauthor=V.+Plaauthor=F.+Aguadoauthor=M.+Pallas&title=Behaviour+and+cognitive+changes+correlated+with+hippocampal+neuroinflammaging+and+neuronal+markers+in+female+SAMP8%2C+a+model+of+accelerated+senescence&doi=10.1016%2Fj.exger.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence</span></div><div class="casAuthors">Grinan-Ferre, Christian; Palomera-Avalos, Veronica; Puigoriol-Illamola, Dolors; Camins, Antoni; Porquet, David; Pla, Virginia; Aguado, Fernando; Pallas, Merce</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Senescence accelerated mice P8 (SAMP8) is a phenotypic model of age, characterized by deficits in memory and altered behavior.  Here, we detd. the effect of age in SAMP8, and compared with the resistant strain, SAMR1, in behavior and learning parameters linking these disturbances with oxidative stress environment.  We found impairment in emotional behavior with regard to fear and anxiety in young SAMP8 vs. age-mated SAMR1.  Differences were attenuated with age.  In contrast, learning capabilities are worse in SAMP8, both in young and aged animals, with regard to SAMR1.  These waves in behavior and cognition were correlated with an excess of oxidative stress (OS) in SAMP8 at younger ages that diminished with age.  In this manner, we found changes in the hippocampal expression of ALDH2, IL-6, HMOX1, COX2, CXCL10, iNOS, and MCP-1 with an altered amyloidogenic pathway by increasing the Amyloid beta precursor protein (APP) and BACE1, and reduced ADAM10 expression; in addn., astrogliosis and neuronal markers decreased.  Moreover, Superoxide dismutase 1 (SOD1) and Nuclear factor-kappa beta (NF-kβ) expression and protein levels were higher in younger SAMP8 than in SAMR1.  In conclusion, the accelerated senescence process present in SAMP8 can be linked with an initial deregulation in redox homeostasis, named neuroinflammaging, by inducing mol. changes that lead to neuroinflammation and the neurodegenerative process.  These changes are reflected in the emotional and cognitive behavior of SAMP8 that differs from that of SAMR1 and that highlighted the importance of earlier oxidative processes in the onset of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMTDQUp7e47Vg90H21EOLACvtfcHk0ljzqNovq0sRpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWltrY%253D&md5=9c9430d1048fe3bb93b072ae4ba09213</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DGrinan-Ferre%26aufirst%3DC.%26aulast%3DPalomera-Avalos%26aufirst%3DV.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPorquet%26aufirst%3DD.%26aulast%3DPla%26aufirst%3DV.%26aulast%3DAguado%26aufirst%3DF.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DBehaviour%2520and%2520cognitive%2520changes%2520correlated%2520with%2520hippocampal%2520neuroinflammaging%2520and%2520neuronal%2520markers%2520in%2520female%2520SAMP8%252C%2520a%2520model%2520of%2520accelerated%2520senescence%26jtitle%3DExp.%2520Gerontol.%26date%3D2016%26volume%3D80%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.exger.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span> <span> </span><span class="NLM_article-title">Senescence-accelerated mice P8: a tool to study brain aging and Alzheimer’s disease in a mouse model</span>. <i>ISRN Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">917167</span>, <span class="refDoi"> DOI: 10.5402/2012/917167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.5402%2F2012%2F917167" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=917167&author=M.+Pall%C3%A0s&title=Senescence-accelerated+mice+P8%3A+a+tool+to+study+brain+aging+and+Alzheimer%E2%80%99s+disease+in+a+mouse+model&doi=10.5402%2F2012%2F917167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.5402%2F2012%2F917167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5402%252F2012%252F917167%26sid%3Dliteratum%253Aachs%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26atitle%3DSenescence-accelerated%2520mice%2520P8%253A%2520a%2520tool%2520to%2520study%2520brain%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520a%2520mouse%2520model%26jtitle%3DISRN%2520Cell%2520Biol.%26date%3D2012%26volume%3D2012%26spage%3D917167%26doi%3D10.5402%2F2012%2F917167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinan-Ferre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Companys-Alemany, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corpas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanfeliu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s13311-020-00854-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs13311-020-00854-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32488482" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+Grinan-Ferreauthor=S.+Codonyauthor=E.+Pujolauthor=J.+Yangauthor=R.+Leivaauthor=C.+Escolanoauthor=D.+Puigoriol-Illamolaauthor=J.+Companys-Alemanyauthor=R.+Corpasauthor=C.+Sanfeliuauthor=B.+Perezauthor=M.+I.+Lozaauthor=J.+Breaauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=S.+Vazquezauthor=M.+Pallasauthor=C.+Galdeano&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+as+a+new+therapy+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs13311-020-00854-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1007%2Fs13311-020-00854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-020-00854-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrinan-Ferre%26aufirst%3DC.%26aulast%3DCodony%26aufirst%3DS.%26aulast%3DPujol%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLeiva%26aufirst%3DR.%26aulast%3DEscolano%26aufirst%3DC.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DCompanys-Alemany%26aufirst%3DJ.%26aulast%3DCorpas%26aufirst%3DR.%26aulast%3DSanfeliu%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DVazquez%26aufirst%3DS.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DGaldeano%26aufirst%3DC.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520as%2520a%2520new%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2020%26doi%3D10.1007%2Fs13311-020-00854-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shie, F. S.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1508-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1508-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31176371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ksV2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=123&author=C.+C.+Hungauthor=Y.+H.+Leeauthor=Y.+M.+Kuoauthor=P.+C.+Hsuauthor=H.+J.+Tsayauthor=Y.+T.+Hsuauthor=C.+C.+Leeauthor=J.+J.+Liangauthor=F.+S.+Shie&title=Soluble+epoxide+hydrolase+modulates+immune+responses+in+activated+astrocytes+involving+regulation+of+STAT3+activity&doi=10.1186%2Fs12974-019-1508-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity</span></div><div class="casAuthors">Hung Chia-Chi; Lee Yi-Hsuan; Kuo Yi-Min; Hsu Pei-Chien; Hung Chia-Chi; Lee Chih-Chin; Liang Jia-Jun; Shie Feng-Shiun; Tsay Huey-Jen; Hsu Ying-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Astrocyte activation is a common pathological feature in many brain diseases with neuroinflammation, and revealing the underlying mechanisms might shed light on the regulatory processes of the diseases.  Recently, soluble epoxide hydrolase (sEH) has been proposed to affect neuroinflammation in brain injuries.  However, the roles of astrocytic sEH in brains with neurodegeneration remain unclear.  METHODS:  The expression of astrocytic sEH in the brains of APPswe/PSEN1dE9 (APP/PS1) mice developing Alzheimer's disease (AD)-like pathology was evaluated by confocal imaging.  LPS-activated primary astrocytes with mRNA silencing or overexpression of sEH were used to investigate its regulatory roles in astrocyte activation and the induction of pro-inflammatory markers.  Primary astrocytes isolated from a sEH knockout (sEH(-/-)) background were also applied.  RESULTS:  The immunoreactivity of sEH was increased in activated astrocytes in parallel with the progression of AD in APP/PS1 mice.  Our data from primary astrocyte cultures further demonstrate that the overexpression of sEH ameliorated, while the silencing of sEH mRNA enhanced, the lipopolysaccharides (LPS)-induced expression of pro-inflammatory markers, such as inducible nitric oxide, cyclooxygenase 2 (COX-2), and pro-inflammatory cytokines.  These findings suggest that sEH negatively regulates astrocyte immune responses.  Enhanced immune responses found in LPS-activated sEH(-/-) astrocytes also support the notion that the expression of sEH could suppress the immune responses during astrocyte activation.  Similarly, sEH(-/-) mice that received intraperitoneal injection of LPS showed exacerbated astrocyte activation in the brain, as observed by the elevated expression of glial fibrillary acidic protein (GFAP) and pro-inflammatory markers.  Moreover, our data show that the phosphorylation of the signal transducer and activator of transcription 3 (STAT3) was upregulated in activated astrocytes from sEH mouse brains, and the pharmacological blockade of STAT3 activity alleviated the pro-inflammatory effects of sEH deletion in LPS-activated primary astrocytes.  CONCLUSIONS:  Our results provide evidence, for the first time, showing that sEH negatively regulates astrocytic immune responses and GFAP expression, while the underlying mechanism at least partly involves the downregulation of STAT3 phosphorylation.  The discovery of a novel function for sEH in the negative control of astrocytic immune responses involving STAT3 activation confers further insights into the regulatory machinery of astrocyte activation during the development of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLgYTGAfXc8DW1zwg2yUK5fW6udTcc2eYjkC-pjYOGtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ksV2nsQ%253D%253D&md5=48f947f9461821dc141d03274e3c523e</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1508-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1508-2%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DKuo%26aufirst%3DY.%2BM.%26aulast%3DHsu%26aufirst%3DP.%2BC.%26aulast%3DTsay%26aufirst%3DH.%2BJ.%26aulast%3DHsu%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DLiang%26aufirst%3DJ.%2BJ.%26aulast%3DShie%26aufirst%3DF.%2BS.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520modulates%2520immune%2520responses%2520in%2520activated%2520astrocytes%2520involving%2520regulation%2520of%2520STAT3%2520activity%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D123%26doi%3D10.1186%2Fs12974-019-1508-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitor: a novel potential therapeutic or prophylactic drug for psychiatric disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">420</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31105566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=420&author=Q.+Ren&title=Soluble+epoxide+hydrolase+inhibitor%3A+a+novel+potential+therapeutic+or+prophylactic+drug+for+psychiatric+disorders&doi=10.3389%2Ffphar.2019.00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitor: a novel potential therapeutic or prophylactic drug for psychiatric disorders</span></div><div class="casAuthors">Ren, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">420</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Psychiatric disorders, including depression and schizophrenia, affect millions of individuals worldwide.  However, the precise neurobiol. of psychiatric disorders remains unclear.  Accumulating evidence suggests that various inflammatory processes play a key role in depression and schizophrenia, and that anti-inflammatory drugs exert a therapeutic effect in patients with psychiatric disorders.  Epoxyeicosatrienoic acids (EETs) and epoxydocosapentaenoic acids (EDPs) have potent anti-inflammatory properties.  These mediators are broken down into their corresponding diols by sol. epoxide hydrolase (sEH), and inhibition of sEH enhances the anti-inflammatory effects of EETs.  Therefore, sEH may play a key role in inflammation, which is involved in psychiatric disorders.  Recent studies have shown that abnormal levels of sEH may be involved in the pathogenesis of certain psychiatric diseases, and that sEH inhibitors exhibit antidepressant and antipsychotic activity.  The present review discusses the extensive evidence supporting sEH as a therapeutic target for psychiatric diseases, and the clin. value of sEH inhibitors as therapeutic or prophylactic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolbBcQseGZ0LVg90H21EOLACvtfcHk0lhNed0ZBxjqig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksb3F&md5=15922b2274fffd81baf098c021e53954</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00420%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitor%253A%2520a%2520novel%2520potential%2520therapeutic%2520or%2520prophylactic%2520drug%2520for%2520psychiatric%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D420%26doi%3D10.3389%2Ffphar.2019.00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span> <span> </span><span class="NLM_article-title">The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2483</span>– <span class="NLM_lpage">2492</span>, <span class="refDoi"> DOI: 10.1002/jnr.24080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fjnr.24080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28699310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCqsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=2483-2492&author=Q.+Wuauthor=H.+Caiauthor=J.+Songauthor=Q.+Chang&title=The+effects+of+sEH+inhibitor+on+depression-like+behavior+and+neurogenesis+in+male+mice&doi=10.1002%2Fjnr.24080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice</span></div><div class="casAuthors">Wu, Qiong; Cai, Hongyang; Song, Jingfang; Chang, Quanzhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2483-2492</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Currently antidepressants take several weeks to be effective, which is one of the main reasons why patients with depression quit therapy.  In the present study, we examine the acute and subacute effects of sol. epoxide hydolase (sEH) inhibitor (sEHI), a compd. shown to have antidepressant effects, on mice.  We found that acute administration of sEHI TPPU decreases immobility time in the forced swimming test and reduces latency to feed in the novelty suppressed-feeding test in adult male mice.  I.p. administration of TPPU for seven days also increased interaction time of socially defeated mice in the social defeat test.  Hippocampal BDNF expression and cell proliferation in the dentate gyrus increased six and 24 h after TPPU treatment, resp.  Improvement in antidepressant behavior and cell proliferation were inhibited by BDNF-trkB antagonist K252a, which suggests that anti-depressant effects of sEHI may be involved in BDNF signaling.  Taken together, our findings suggest that sEHI may provide a rapid antidepressant effect through alterations to BDNF-trkB signaling in the hippocampus and may provide an alternative to current slow-acting antidepressants. cpr 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUYklCoVXfbVg90H21EOLACvtfcHk0lhNed0ZBxjqig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCqsrfI&md5=5111a3cf5c1c369fadf6bc4ea688608f</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1002%2Fjnr.24080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.24080%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DQ.%26atitle%3DThe%2520effects%2520of%2520sEH%2520inhibitor%2520on%2520depression-like%2520behavior%2520and%2520neurogenesis%2520in%2520male%2520mice%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2017%26volume%3D95%26spage%3D2483%26epage%3D2492%26doi%3D10.1002%2Fjnr.24080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2013.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pbb.2013.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23792539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kis7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=98-103&author=M.+Maauthor=Q.+Renauthor=Y.+Fujitaauthor=T.+Ishimaauthor=J.+C.+Zhangauthor=K.+Hashimoto&title=Effects+of+AS2586114%2C+a+soluble+epoxide+hydrolase+inhibitor%2C+on+hyperlocomotion+and+prepulse+inhibition+deficits+in+mice+after+administration+of+phencyclidine&doi=10.1016%2Fj.pbb.2013.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine</span></div><div class="casAuthors">Ma, Min; Ren, Qian; Fujita, Yuko; Ishima, Tamaki; Zhang, Ji-Chun; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-103</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that sol. epoxide hydrolase (sEH) plays a key role in controlling levels of lipid signaling mols., and that the potent sEH inhibitors may be potential therapeutic drugs for a no. of diseases assocd. with metab. of epoxyeicosatrienoic acids (EETs).  This study was undertaken to examine whether the potent sEH inhibitor AS2586114 could attenuate behavioral abnormalities (e.g., hyperlocomotion and prepulse inhibition (PPI) deficits) in male ddY mice after a single administration of the N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (PCP).  A single oral administration of AS2586114 (10, 30, or 100 mg/kg) attenuated the hyperlocomotion in mice after the administration of PCP (3.0 mg/kg, s.c.), in a dose dependent manner.  Furthermore, a single oral administration of AS2586114 (10, 30, or 100 mg/kg) improved the PPI deficits in mice after the administration of PCP (3.0 mg/kg, s.c.), in a dose dependent manner.  In addn., the atypical antipsychotic drug clozapine (10 mg/kg, p.o.) significantly attenuated hyperlocomotion and PPI deficits after the administration of PCP (3.0 mg/kg, s.c.).  In conclusion, this study suggests that AS2586114 may have antipsychotic activity in PCP models of schizophrenia.  Therefore, it is likely that the sEH inhibitors may be potential therapeutic drugs for neuropsychiatric diseases such as schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVi2yfQqcf-bVg90H21EOLACvtfcHk0lhNed0ZBxjqig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kis7bF&md5=bbc953d7a79a7c78289ef242911c3340</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%2BC.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DEffects%2520of%2520AS2586114%252C%2520a%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520on%2520hyperlocomotion%2520and%2520prepulse%2520inhibition%2520deficits%2520in%2520mice%2520after%2520administration%2520of%2520phencyclidine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D110%26spage%3D98%26epage%3D103%26doi%3D10.1016%2Fj.pbb.2013.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swardfager, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennebelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, A. Y.</span></span> <span> </span><span class="NLM_article-title">Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.neubiorev.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29407524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=56-66&author=W.+Swardfagerauthor=M.+Hennebelleauthor=D.+Yuauthor=B.+D.+Hammockauthor=A.+J.+Levittauthor=K.+Hashimotoauthor=A.+Y.+Taha&title=Metabolic%2Finflammatory%2Fvascular+comorbidity+in+psychiatric+disorders%3B+soluble+epoxide+hydrolase+%28sEH%29+as+a+possible+new+target&doi=10.1016%2Fj.neubiorev.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target</span></div><div class="casAuthors">Swardfager, W.; Hennebelle, M.; Yu, D.; Hammock, B. D.; Levitt, A. J.; Hashimoto, K.; Taha, A. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The common and severe psychiatric disorders, including major depressive disorder (MDD) and bipolar disorder (BD), are assocd. with inflammation, oxidative stress and changes in peripheral and brain lipid metab.  Those pathways are implicated in the premature development of vascular and metabolic comorbidities, which account for considerable morbidity and mortality, including increased dementia risk.  During endoplasmic reticulum stress, the sol. epoxide hydrolase (sEH) enzyme converts anti-inflammatory fatty acid epoxides generated by cytochrome P 450 enzymes into their corresponding and generally less anti-inflammatory, or even pro-inflammatory, diols, slowing the resoln. of inflammation.  The sEH enzyme and its oxylipin products are elevated post-mortem in MDD, BD and schizophrenia.  Preliminary clin. data suggest that oxylipins increase with symptoms in seasonal MDD and anorexia nervosa, requiring confirmation in larger studies and other cohorts.  In rats, a sol. sEH inhibitor mitigated the development of depressive-like behaviors.  We discuss sEH inhibitors under development for cardiovascular diseases, post-ischemic brain injury, neuropathic pain and diabetes, suggesting new possibilities to address the mood and cognitive symptoms of psychiatric disorders, and their most common comorbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUERCAn0wF7Vg90H21EOLACvtfcHk0lj8O2vThYpD9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegs7k%253D&md5=f8d461a3573c6011b2d552b7bcbab78d</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DSwardfager%26aufirst%3DW.%26aulast%3DHennebelle%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLevitt%26aufirst%3DA.%2BJ.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTaha%26aufirst%3DA.%2BY.%26atitle%3DMetabolic%252Finflammatory%252Fvascular%2520comorbidity%2520in%2520psychiatric%2520disorders%253B%2520soluble%2520epoxide%2520hydrolase%2520%2528sEH%2529%2520as%2520a%2520possible%2520new%2520target%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D87%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fj.neubiorev.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapirstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, R. C.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5279</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-23504-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fs41598-018-23504-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29588470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmtVegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=5279&author=R.+Tuauthor=J.+Armstrongauthor=K.+S.+S.+Leeauthor=B.+D.+Hammockauthor=A.+Sapirsteinauthor=R.+C.+Koehler&title=Soluble+epoxide+hydrolase+inhibition+decreases+reperfusion+injury+after+focal+cerebral+ischemia&doi=10.1038%2Fs41598-018-23504-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia</span></div><div class="casAuthors">Tu Ranran; Tu Ranran; Armstrong Jillian; Sapirstein Adam; Koehler Raymond C; Lee Kin Sing Stephen; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5279</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are produced by cytochrome P450 epoxygenases from arachidonic acid, and their rapid metabolism is mainly through soluble epoxide hydrolase (sEH).  EETs exert vasodilatory, anti-inflammatory, anti-apoptotic, and pro-angiogenic effects.  Administration of sEH inhibitors before or at the onset of stroke is protective, but the effects of post-treatment at reperfusion, when inflammation is augmented, has not been as well studied.  We tested the hypothesis that 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea (TPPU), a potent and highly selective sEH inhibitor, suppresses inflammation and protects the brain when administered at reperfusion.  Vehicle or 1 mg/kg TPPU was administered at reperfusion after 90 minutes of focal ischemia and again 24 hours later.  Protein expression and activity of sEH increased after reperfusion and activity was decreased by TPPU administration.  TPPU decreased infarct volume by 50%, reduced neurologic deficits and improved performance on sensorimotor tasks.  Furthermore, TPPU significantly lowered the mRNA expression of interleukin-1beta by 3.5-fold and tumor necrosis factor-alpha by 2.2-fold, increased transforming growth factor-beta mRNA by 1.8-fold, and augmented immunostaining of vascular endothelial growth factor in peri-infarct cortex.  Thus, inhibition of sEH at reperfusion significantly reduces infarction and improves sensorimotor function, possibly by suppressing early proinflammatory cytokines and promoting reparative cytokines and growth factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVZj-7SBOHm6__Jf7-eMvJfW6udTcc2eZ1vs_9EkAgKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmtVegug%253D%253D&md5=74d3330625341d8d0f6c90282d1678ab</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-23504-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-23504-1%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DR.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%2BS.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSapirstein%26aufirst%3DA.%26aulast%3DKoehler%26aufirst%3DR.%2BC.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520decreases%2520reperfusion%2520injury%2520after%2520focal%2520cerebral%2520ischemia%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D5279%26doi%3D10.1038%2Fs41598-018-23504-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finneran, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. R.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation and fractalkine signaling in Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1412-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1412-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30744705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3cfhsFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=30&author=D.+J.+Finneranauthor=K.+R.+Nash&title=Neuroinflammation+and+fractalkine+signaling+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-019-1412-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation and fractalkine signaling in Alzheimer's disease</span></div><div class="casAuthors">Finneran Dylan J; Nash Kevin R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive, neurodegenerative disorder, and the most common form of dementia.  As the understanding of AD has progressed, it is now believed that AD is an amyloid-initiated tauopathy with neuroinflammation serving as the link between amyloid deposition, tau pathology, and neurodegeneration.  As microglia are the main immune effectors in the central nervous system, they have been the focus of attention in studies investigating the neuroinflammatory component of AD.  Therefore, recent work has focused on immunomodulators, which can alter microglial activation without suppressing activity, as potential therapeutics for AD.  Fractalkine (CX3CL1; FKN), a unique chemokine with a one-to-one relationship with its receptor, signals through its cognate receptor (CX3CR1) to reduce expression of pro-inflammatory genes in activated microglia.  Disrupting FKN signaling has opposing effects on the two hallmark pathologies of AD, but over-expressing a soluble FKN has been shown to reduce tau pathology while not altering amyloid pathology.  Recently, differential signaling has been reported when comparing two cleavage variants of soluble FKN.  These differential effects may explain recent studies reporting seemingly conflicting results regarding the effect of FKN over expression on AD pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd6w3buPoNnDEwO064Z95rfW6udTcc2eZ1vs_9EkAgKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfhsFarsw%253D%253D&md5=ec9145e5cd1e4cb91ce6b6d0dfeaa323</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1412-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1412-9%26sid%3Dliteratum%253Aachs%26aulast%3DFinneran%26aufirst%3DD.%2BJ.%26aulast%3DNash%26aufirst%3DK.%2BR.%26atitle%3DNeuroinflammation%2520and%2520fractalkine%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D30%26doi%3D10.1186%2Fs12974-019-1412-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jouihan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuloaga, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangraw, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasnow, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkayed, N. J.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1650</span>– <span class="NLM_lpage">1656</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2013.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fjcbfm.2013.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23899929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1650-1656&author=S.+A.+Jouihanauthor=K.+L.+Zuloagaauthor=W.+Zhangauthor=R.+E.+Shangrawauthor=S.+M.+Krasnowauthor=D.+L.+Marksauthor=N.+J.+Alkayed&title=Role+of+soluble+epoxide+hydrolase+in+exacerbation+of+stroke+by+streptozotocin-induced+type+1+diabetes+mellitus&doi=10.1038%2Fjcbfm.2013.130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus</span></div><div class="casAuthors">Jouihan, Sari A.; Zuloaga, Kristen L.; Zhang, Wenri; Shangraw, Robert E.; Krasnow, Stephanie M.; Marks, Daniel L.; Alkayed, Nabil J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1650-1656</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hyperglycemia worsens stroke, yet rigorous glycemic control does not improve neurol. outcome.  An alternative is to target downstream mol. mediator(s) triggered by hyperglycemia but independent of prevailing glycemia.  Sol. epoxide hydrolase (sEH) is a potential mediator of injury via its metab. of neuroprotective epoxyeicosatrienoic acids (EETs).  We tested whether hyperglycemia exacerbates cerebral injury by upregulating sEH and decreasing brain EET levels.  Type 1 diabetes mellitus was modeled by streptozotocin (STZ; 50 mg/kg per day i.p., 5 days) in male mice.  At 4 wk, STZ-treated and control mice underwent 45-min middle cerebral artery occlusion (MCAO) with or without sEH blockade by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB; 1 mg/kg i.p. daily for 6 days before MCAO).  The STZ-treated mice had increased sEH mRNA expression in cerebral vessels and decreased EET concns. in brain.  There was no difference in cortical perfusion between groups.  The STZ-treated mice sustained larger brain infarct than controls.  Pretreatment with t-AUCB eliminated the difference in infarct size and EETs concn. between STZ-treated mice and controls, without altering glycemia.  We conclude that type 1 diabetes mellitus upregulates sEH mRNA and decreases concns. of neuroprotective EETs within the brain, leading to worse stroke outcome.  The data indicate that sEH antagonism may be beneficial in the setting of hyperglycemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK3rKIoYlxubVg90H21EOLACvtfcHk0lj8O2vThYpD9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs7fI&md5=ae6f335e36445588b99cda76b435110c</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2013.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2013.130%26sid%3Dliteratum%253Aachs%26aulast%3DJouihan%26aufirst%3DS.%2BA.%26aulast%3DZuloaga%26aufirst%3DK.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DShangraw%26aufirst%3DR.%2BE.%26aulast%3DKrasnow%26aufirst%3DS.%2BM.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DAlkayed%26aufirst%3DN.%2BJ.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520exacerbation%2520of%2520stroke%2520by%2520streptozotocin-induced%2520type%25201%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2013%26volume%3D33%26spage%3D1650%26epage%3D1656%26doi%3D10.1038%2Fjcbfm.2013.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzdev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. W.</span></span> <span> </span><span class="NLM_article-title">Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">E563</span>– <span class="NLM_lpage">E575</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00591.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpendo.00591.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22739108" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=E563-E575&author=G.+Z.+Chenauthor=R.+F.+Xuauthor=Y.+N.+Wangauthor=P.+H.+Wangauthor=G.+Zhaoauthor=X.+Z.+Xuauthor=A.+Gruzdevauthor=D.+C.+Zeldinauthor=D.+W.+Wang&title=Genetic+disruption+of+soluble+epoxide+hydrolase+is+protective+against+streptozotocin-induced+diabetic+nephropathy&doi=10.1152%2Fajpendo.00591.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00591.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00591.2011%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BZ.%26aulast%3DXu%26aufirst%3DR.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DP.%2BH.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DX.%2BZ.%26aulast%3DGruzdev%26aufirst%3DA.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DD.%2BW.%26atitle%3DGenetic%2520disruption%2520of%2520soluble%2520epoxide%2520hydrolase%2520is%2520protective%2520against%2520streptozotocin-induced%2520diabetic%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D303%26spage%3DE563%26epage%3DE575%26doi%3D10.1152%2Fajpendo.00591.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmarakby, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulkner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shabrawey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddipati, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes</span>. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">R1307</span>– <span class="NLM_lpage">R1317</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00759.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpregu.00759.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21832210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3MblvFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=R1307-R1317&author=A.+A.+Elmarakbyauthor=J.+Faulknerauthor=M.+Al-Shabraweyauthor=M.+H.+Wangauthor=K.+R.+Maddipatiauthor=J.+D.+Imig&title=Deletion+of+soluble+epoxide+hydrolase+gene+improves+renal+endothelial+function+and+reduces+renal+inflammation+and+injury+in+streptozotocin-induced+type+1+diabetes&doi=10.1152%2Fajpregu.00759.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes</span></div><div class="casAuthors">Elmarakby Ahmed A; Faulkner Jessica; Al-Shabrawey Mohammed; Wang Mong-Heng; Maddipati Krishna Rao; Imig John D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of physiology. Regulatory, integrative and comparative physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">R1307-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Studies suggest that soluble epoxide hydrolase (sEH) inhibition reduces end-organ damage in cardiovascular diseases.  We hypothesize that sEH gene (Ephx2) knockout (KO) improves endothelial function and reduces renal injury in streptozotocin-induced diabetes.  After 6 wk of diabetes, afferent arteriolar relaxation to acetylcholine was impaired in diabetic wild-type (WT) mice, as the maximum relaxation was 72% of baseline diameter in the WT but only 31% in the diabetic mice.  Ephx2 KO improved afferent arteriolar relaxation to acetylcholine in diabetes as maximum relaxation was 58%.  Urinary monocyte chemoattractant protein-1 (MCP-1) excretion significantly increased in diabetic WT mice compared with control (868 ± 195 vs. 31.5 ± 7 pg/day), and this increase was attenuated in diabetic Ephx2 KO mice (420 ± 98 pg/day).  The renal phospho-IKK-to-IKK ratio and nuclear factor-κB were significantly decreased, and hemeoxygenase-1 (HO-1) expression increased in diabetic Ephx2 KO compared with diabetic WT mice.  Renal NADPH oxidase and urinary thiobarbituric acid reactive substances excretion were reduced in diabetic Ephx2 KO compared with diabetic WT mice.  Albuminuria was also elevated in diabetic WT mice compared with control (170 ± 43 vs. 37 ± 13 μg/day), and Ephx2 KO reduced this elevation (50 ± 15 μg/day).  Inhibition of sEH using trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (tAUCB) also reduced renal inflammation and injury in diabetic WT mice.  Furthermore, inhibition of HO with stannous mesoporphyrin negated the reno-protective effects of tAUCB or Ephx2 KO during diabetes.  These data demonstrate that Ephx2 KO improves endothelial function and reduces renal injury during diabetes.  Additionally, our data also suggest that activation of HO-1 contributes to improved renal injury in diabetic Ephx2 KO mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEtImsudl8SJPlX7E30qdzfW6udTcc2eY46Bb6W-eTnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MblvFeiuw%253D%253D&md5=26c1954f440e622a0433a928dddd862f</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00759.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00759.2010%26sid%3Dliteratum%253Aachs%26aulast%3DElmarakby%26aufirst%3DA.%2BA.%26aulast%3DFaulkner%26aufirst%3DJ.%26aulast%3DAl-Shabrawey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DMaddipati%26aufirst%3DK.%2BR.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DDeletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520gene%2520improves%2520renal%2520endothelial%2520function%2520and%2520reduces%2520renal%2520inflammation%2520and%2520injury%2520in%2520streptozotocin-induced%2520type%25201%2520diabetes%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DR1307%26epage%3DR1317%26doi%3D10.1152%2Fajpregu.00759.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzmann, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. V.</span></span> <span> </span><span class="NLM_article-title">Proteomic analysis of hearts from akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3920</span>– <span class="NLM_lpage">3933</span>, <span class="refDoi"> DOI: 10.1021/pr4004739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr4004739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2kt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=3920-3933&author=S.+Deweyauthor=X.+Y.+Laiauthor=F.+A.+Witzmannauthor=M.+Sohalauthor=A.+V.+Gomes&title=Proteomic+analysis+of+hearts+from+akita+mice+suggests+that+increases+in+soluble+epoxide+hydrolase+and+antioxidative+programming+are+key+changes+in+early+stages+of+diabetic+cardiomyopathy&doi=10.1021%2Fpr4004739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy</span></div><div class="casAuthors">Dewey, Shannamar; Lai, Xianyin; Witzmann, Frank A.; Sohal, Mandeep; Gomes, Aldrin V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3920-3933</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cardiovascular disease is the leading cause of diabetic morbidity with more than 10% of type 1 diabetes mellitus (T1DM) patients dying before they are 40 years old.  This study utilized Akita mice, a murine model with T1DM progression analogous to that of humans.  Diabetic cardiomyopathy in Akita mice presents as cardiac atrophy and diastolic impairment at 3 mo of age, but we obsd. cardiac atrophy in hearts from recently diabetic mice (5 wk old).  Hearts from 5 wk old mice were analyzed with a rigorous label-free quant. proteomic approach to identify proteins that may play a crit. role in the early pathophysiol. of diabetic cardiomyopathy.  Eleven proteins were differentially expressed in diabetic hearts: products of GANC, PLEKHN1, COL1A1, GSTK1, ATP1A3, RAP1A, ACADS, EEF1A1, HRC, EPHX2, and PKP2 (gene names).  These proteins are active in cellular defense, metab., insulin signaling, and calcium handling.  Further anal. of Akita hearts using biochem. assays showed that the cellular defenses against oxidative stress were increased, including antioxidant capacity (2-3-fold) and glutathione levels (20%).  Immunoblots of five and twelve week old Akita heart homogenates showed 30% and 145% increases in expression of sol. epoxide hydrolase (sEH (gene name EPHX2)), resp., and an approx. 100% increase in sEH was seen in gastrocnemius tissue of 12 wk old Akita mice.  In contrast, 12 wk old Akita livers showed no change in sEH expression.  Our results suggest that increases in sEH and antioxidative programming are key factors in the development of type 1 diabetic cardiomyopathy in Akita mice and reveal several other proteins whose expression may be important in this complex pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsuFn_MeiqcLVg90H21EOLACvtfcHk0lihptWKFIMczw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2kt7fP&md5=8965e31b556e5ccd6afc807f0666063d</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fpr4004739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr4004739%26sid%3Dliteratum%253Aachs%26aulast%3DDewey%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DX.%2BY.%26aulast%3DWitzmann%26aufirst%3DF.%2BA.%26aulast%3DSohal%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DA.%2BV.%26atitle%3DProteomic%2520analysis%2520of%2520hearts%2520from%2520akita%2520mice%2520suggests%2520that%2520increases%2520in%2520soluble%2520epoxide%2520hydrolase%2520and%2520antioxidative%2520programming%2520are%2520key%2520changes%2520in%2520early%2520stages%2520of%2520diabetic%2520cardiomyopathy%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2013%26volume%3D12%26spage%3D3920%26epage%3D3933%26doi%3D10.1021%2Fpr4004739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e39165</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0039165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22720061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=Y.+Liuauthor=H.+Dangauthor=D.+Liauthor=W.+Pangauthor=B.+D.+Hammockauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+attenuates+high-fat-diet-induced+hepatic+steatosis+by+reduced+systemic+inflammatory+status+in+mice&doi=10.1371%2Fjournal.pone.0039165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice</span></div><div class="casAuthors">Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Hammock, Bruce D.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e39165</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Non-alc. fatty liver disease is assocd. with obesity and considered an inflammatory disease.  Sol. epoxide hydrolase (sEH) is a major enzyme hydrolyzing epoxyeicosatrienoic acids and attenuates their cardiovascular protective and anti-inflammatory effects.  We examd. whether sEH inhibition can protect against high-fat (HF)-diet-induced fatty liver in mice and the underlying mechanism.  Compared with wild-type littermates, sEH-null mice showed lower diet-induced lipid accumulation in liver, as seen by Oil-red O staining and triglycerides levels.  We studied the effect of sEH inhibition on diet-induced fatty liver by feeding C57BL/6 mice an HF diet for 8 wk (short-term) or 16 wk (long-term) and administering t-AUCB, a selective sEH inhibitor.  SEH inhibition had no effect on the HF-diet-increased body and adipose tissue wt. or impaired glucose tolerance but alleviated the diet-induced hepatic steatosis.  Adenovirus-mediated overexpression of sEH in liver increased the level of triglycerides in liver and the hepatic inflammatory response.  Surprisingly, the induced expression of sEH in liver occurred only with the long-term but not short-term HF diet, which suggests a secondary effect of HF diet on regulating sEH expression.  Furthermore, sEH inhibition attenuated the HF-diet-induced increase in plasma levels of proinflammatory cytokines and their mRNA upregulation in adipose tissue, which was accompanied by increased macrophage infiltration.  Therefore, sEH inhibition could alleviate HF-diet-induced hepatic steatosis, which might involve its anti-inflammatory effect in adipose tissue and direct inhibition in liver.  SEH may be a therapeutic target for HF-diet-induced hepatic steatosis in inhibiting systemic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_Zg0migDv7Vg90H21EOLACvtfcHk0lhTx7NvIi_QrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVOjsbw%253D&md5=9354ab4e573593006cdd3dda5d71aa2e</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039165%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520attenuates%2520high-fat-diet-induced%2520hepatic%2520steatosis%2520by%2520reduced%2520systemic%2520inflammatory%2520status%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0039165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing beta-oxidation of fatty acid in mice</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">G527</span>– <span class="NLM_lpage">G538</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00148.2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpgi.00148.2018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30789748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2019&pages=G527-G538&author=L.+Yaoauthor=B.+Caoauthor=Q.+Chengauthor=W.+Caiauthor=C.+Yeauthor=J.+Liangauthor=W.+Liuauthor=L.+Tanauthor=M.+Yanauthor=B.+Liauthor=J.+Heauthor=S.+H.+Hwangauthor=X.+Zhangauthor=C.+Wangauthor=D.+Aiauthor=B.+D.+Hammockauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+ameliorates+hyperhomocysteinemia-induced+hepatic+steatosis+by+enhancing+beta-oxidation+of+fatty+acid+in+mice&doi=10.1152%2Fajpgi.00148.2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00148.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00148.2018%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520hyperhomocysteinemia-induced%2520hepatic%2520steatosis%2520by%2520enhancing%2520beta-oxidation%2520of%2520fatty%2520acid%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2019%26volume%3D316%26spage%3DG527%26epage%3DG538%26doi%3D10.1152%2Fajpgi.00148.2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira da Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gaitani, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes de Oliveira, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires Bueno, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalheiro, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peporine Lopes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterweck, V.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the intestinal absorption mechanism of casearin X in Caco-2 cells with modified carboxylesterase activity</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XksV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=1084-1090&author=R.+Moreira+da+Silvaauthor=S.+Verjeeauthor=C.+M.+de+Gaitaniauthor=A.+R.+Moraes+de+Oliveiraauthor=P.+C.+Pires+Buenoauthor=A.+J.+Cavalheiroauthor=N.+Peporine+Lopesauthor=V.+Butterweck&title=Evaluation+of+the+intestinal+absorption+mechanism+of+casearin+X+in+Caco-2+cells+with+modified+carboxylesterase+activity&doi=10.1021%2Facs.jnatprod.5b01139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Intestinal Absorption Mechanism of Casearin X in Caco-2 Cells with Modified Carboxylesterase Activity</span></div><div class="casAuthors">Moreira da Silva, Rodrigo; Verjee, Sheela; de Gaitani, Cristiane Masetto; Moraes de Oliveira, Anderson Rodrigo; Pires Bueno, Paula Carolina; Cavalheiro, Alberto Jose; Peporine Lopes, Norberto; Butterweck, Veronika</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The clerodane diterpene casearin X (1), isolated from the leaves of Casearia sylvestris, is a potential new drug candidate due to its potent in vitro cytotoxic activity.  In this work, the intestinal absorption mechanism of 1 was evaluated using Caco-2 cells with and without active carboxylesterases (CES).  An LC-MS method was developed and validated for the quantification of 1.  The estn. of permeability coeffs. was possible only under CES-inhibited conditions in which 1 is able to cross the Caco-2 cell monolayer.  The mechanism is probably by active transport, with no significant efflux, but with a high retention of the compd. inside the cells.  The enzymic hydrolysis assay demonstrates the susceptibility of 1 to first-pass metab. as substrate for specific CES expressed in human intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyG40bsMFw5rVg90H21EOLACvtfcHk0lhTx7NvIi_QrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksV2gtrg%253D&md5=9aa0dee57449ff39d7f797ab3c138b8f</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01139%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%2Bda%2BSilva%26aufirst%3DR.%26aulast%3DVerjee%26aufirst%3DS.%26aulast%3Dde%2BGaitani%26aufirst%3DC.%2BM.%26aulast%3DMoraes%2Bde%2BOliveira%26aufirst%3DA.%2BR.%26aulast%3DPires%2BBueno%26aufirst%3DP.%2BC.%26aulast%3DCavalheiro%26aufirst%3DA.%2BJ.%26aulast%3DPeporine%2BLopes%26aufirst%3DN.%26aulast%3DButterweck%26aufirst%3DV.%26atitle%3DEvaluation%2520of%2520the%2520intestinal%2520absorption%2520mechanism%2520of%2520casearin%2520X%2520in%2520Caco-2%2520cells%2520with%2520modified%2520carboxylesterase%2520activity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D1084%26epage%3D1090%26doi%3D10.1021%2Facs.jnatprod.5b01139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddipati, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2012.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2012.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=42-48&author=L.+Chenauthor=C.+Fanauthor=Y.+Zhangauthor=M.+Bakriauthor=H.+Dongauthor=C.+Morisseauauthor=K.+R.+Maddipatiauthor=P.+Luoauthor=C.+Y.+Wangauthor=B.+D.+Hammockauthor=M.+H.+Wang&title=Beneficial+effects+of+inhibition+of+soluble+epoxide+hydrolase+on+glucose+homeostasis+and+islet+damage+in+a+streptozotocin-induced+diabetic+mouse+model&doi=10.1016%2Fj.prostaglandins.2012.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model</span></div><div class="casAuthors">Chen, Lingdan; Fan, Cheng; Zhang, Yi; Bakri, Mahinur; Dong, Hua; Morisseau, Christophe; Maddipati, Krishna Rao; Luo, Pengcheng; Wang, Cong-Yi; Hammock, Bruce D.; Wang, Mong-Heng</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104-105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in the metab. of endogenous inflammatory and anti-apoptotic mediators.  In the present study, we detd. the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chem.-induced diabetes.  STZ increased daily water intake and decreased visceral (spleen and pancreas) wt. in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral wt.  Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH.  The beneficial effects of sEH inhibition were accompanied, after 2 and 4 wk of initial administration, by improving glucose tolerance.  In contrast, sEH inhibition did not affect insulin tolerance.  Using LC/MS anal., neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels.  Western blot anal. showed that mouse cytochrome P 450 (CYP) 2C enzymes are the major epoxygenases in islets.  On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis.  These studies provide pharmacol. evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAWRWZ8qcJgLVg90H21EOLACvtfcHk0lgVkQ0U6Lk7sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFWg&md5=1ad099f3584763740f8960a25360ef2b</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBakri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DMaddipati%26aufirst%3DK.%2BR.%26aulast%3DLuo%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DBeneficial%2520effects%2520of%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520on%2520glucose%2520homeostasis%2520and%2520islet%2520damage%2520in%2520a%2520streptozotocin-induced%2520diabetic%2520mouse%2520model%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D104%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.prostaglandins.2012.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardeshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolshette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadhave, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfeen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S. K.</span></span> <span> </span><span class="NLM_article-title">Docosahexaenoic acid increases the potency of soluble epoxide hydrolase inhibitor in alleviating streptozotocin-induced Alzheimer’s disease-like complications of diabetes</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">288</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31068802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jslymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=288&author=R.+Pardeshiauthor=N.+Bolshetteauthor=K.+Gadhaveauthor=M.+Arfeenauthor=S.+Ahmedauthor=R.+Jamwalauthor=B.+D.+Hammockauthor=M.+Lahkarauthor=S.+K.+Goswami&title=Docosahexaenoic+acid+increases+the+potency+of+soluble+epoxide+hydrolase+inhibitor+in+alleviating+streptozotocin-induced+Alzheimer%E2%80%99s+disease-like+complications+of+diabetes&doi=10.3389%2Ffphar.2019.00288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes</span></div><div class="casAuthors">Pardeshi Rohit; Bolshette Nityanand; Lahkar Mangala; Gadhave Kundlik; Arfeen Mohammad; Ahmed Sahabuddin; Jamwal Rohitash; Hammock Bruce D; Goswami Sumanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Diabetes is a risk factor for Alzheimer's disease and it is associated with significant memory loss.  In the present study, we hypothesized that the soluble epoxide hydrolase (sEH) inhibitor N-[1-(1-oxopropyl)-4-piperidinyl]-N'-[4-(trifluoromethoxy)phenyl)-urea (also known as TPPU) could alleviate diabetes-aggravated Alzheimer's disease-like symptoms by improving memory and cognition, and reducing the oxidative stress and inflammation associated with this condition.  Also, we evaluated the effect of edaravone, an antioxidant on diabetes-induced Alzheimer's-like complications and the additive effect of docosahexaenoic acid (DHA) on the efficacy of TPPU.  Diabetes was induced in male Sprague-Dawley rats by intraperitoneally administering streptozotocin (STZ).  Six weeks after induction of diabetes, animals were either treated with vehicle, edaravone (3 or 10 mg/kg), TPPU (1 mg/kg) or TPPU (1 mg/kg) + DHA (100 mg/kg) for 2 weeks.  The results demonstrate that the treatments increased the memory response of diabetic rats, in comparison to untreated diabetic rats.  Indeed, DHA + TPPU were more effective than TPPU alone in reducing the symptoms monitored.  All drug treatments reduced oxidative stress and minimized inflammation in the brain of diabetic rats.  Expression of the amyloid precursor protein (APP) was increased in the brain of diabetic rats.  Treatment with edaravone (10 mg/kg), TPPU or TPPU + DHA minimized the level of APP.  The activity of acetylcholinesterase (AChE) which metabolizes acetylcholine was increased in the brain of diabetic rats.  All the treatments except edaravone (3 mg/kg) were effective in decreasing the activity of AChE and TPPU + DHA was more efficacious than TPPU alone.  Intriguingly, the histological changes in hippocampus after treatment with TPPU + DHA showed significant protection of neurons against STZ-induced neuronal damage.  Overall, we found that DHA improved the efficacy of TPPU in increasing neuronal survival and memory, decreasing oxidative stress and inflammation possibly by stabilizing anti-inflammatory and neuroprotective epoxides of DHA.  In the future, further evaluating the detailed mechanisms of action of sEH inhibitor and DHA could help to develop a strategy for the management of Alzheimer's-like complications in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ95Ts_1DsHYrYtC3U5jeOifW6udTcc2eYSTW2T9P_xLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jslymug%253D%253D&md5=5f754569f70f90e6e911ae7601eec4ea</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00288%26sid%3Dliteratum%253Aachs%26aulast%3DPardeshi%26aufirst%3DR.%26aulast%3DBolshette%26aufirst%3DN.%26aulast%3DGadhave%26aufirst%3DK.%26aulast%3DArfeen%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DJamwal%26aufirst%3DR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLahkar%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DS.%2BK.%26atitle%3DDocosahexaenoic%2520acid%2520increases%2520the%2520potency%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520in%2520alleviating%2520streptozotocin-induced%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520complications%2520of%2520diabetes%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D288%26doi%3D10.3389%2Ffphar.2019.00288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inscho, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.167544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fjpet.110.167544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20439437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=430-438&author=P.+C.+Luoauthor=H.+H.+Changauthor=Y.+Q.+Zhouauthor=S.+L.+Zhangauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=C.+Y.+Wangauthor=E.+W.+Inschoauthor=B.+D.+Hammockauthor=M.+H.+Wang&title=Inhibition+or+deletion+of+soluble+epoxide+hydrolase+prevents+hyperglycemia%2C+promotes+insulin+secretion%2C+and+reduces+islet+apoptosis&doi=10.1124%2Fjpet.110.167544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis</span></div><div class="casAuthors">Luo, Pengcheng; Chang, Hsin-Hsin; Zhou, Yiqiang; Zhang, Shali; Hwang, Sung Hee; Morisseau, Christophe; Wang, Cong-Yi; Inscho, Edward W.; Hammock, Bruce D.; Wang, Mong-Heng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in the metab. of endogenous inflammatory and antiapoptotic mediators.  However, the roles of sEH in diabetes and the pancreas are unknown.  Our aims were to det. whether sEH is involved in the regulation of hyperglycemia in diabetic mice and to investigate the reasons for the regulation of insulin secretion by sEH deletion or inhibition in islets.  We used two sep. approaches, targeted disruption of Ephx2 gene [sEH knockout (KO)] and a selective inhibitor of sEH [trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB)], to assess the role of sEH in glucose and insulin homeostasis in streptozotocin (STZ) mice.  We also examd. the effects of sEH KO or t-AUCB on glucose-stimulated insulin secretion (GSIS) and intracellular calcium levels in islets.  Hyperglycemia in STZ mice was prevented by both sEH KO and t-AUCB.  In addn., STZ mice with sEH KO had important, glucose tolerance.  More important, when insulin levels were assessed by hyperglycemic clamp study, sEH KO was found to promote insulin secretion.  In addn., sEH KO and t-AUCB treatment augmented islet GSIS.  Islets with sEH KO had a greater intracellular calcium influx when challenged with high glucose or KCl in the presence of diazoxide.  Moreover, sEH KO reduced islet cell apoptosis in STZ mice.  These results show not only that sEH KO and its inhibition prevent hyperglycemia in diabetes, but also that sEH KO enhances islet GSIS through the amplifying pathway and decreases islet cell apoptosis in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof6-vSBYqyirVg90H21EOLACvtfcHk0lgVkQ0U6Lk7sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KisLfO&md5=d3bde930a877c1b01b3f69805737877a</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167544%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DP.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BH.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DInscho%26aufirst%3DE.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DInhibition%2520or%2520deletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520hyperglycemia%252C%2520promotes%2520insulin%2520secretion%252C%2520and%2520reduces%2520islet%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D430%26epage%3D438%26doi%3D10.1124%2Fjpet.110.167544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">9038</span>– <span class="NLM_lpage">9043</span>, <span class="refDoi"> DOI: 10.1073/pnas.1103482108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1103482108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21571638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=9038-9043&author=A.+Luriaauthor=A.+Bettaiebauthor=Y.+N.+Xiauthor=G.+J.+Shiehauthor=H.+C.+Liuauthor=H.+Inoueauthor=H.+J.+Tsaiauthor=J.+D.+Imigauthor=F.+G.+Hajauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+deficiency+alters+pancreatic+islet+size+and+improves+glucose+homeostasis+in+a+model+of+insulin+resistance&doi=10.1073%2Fpnas.1103482108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance</span></div><div class="casAuthors">Luria, Ayala; Bettaieb, Ahmed; Xi, Yannan; Shieh, Guang-Jong; Liu, Hsin-Chen; Inoue, Hiromi; Tsai, Hsing-Ju; Imig, John D.; Haj, Fawaz G.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9038-9043, S9038/1-S9038/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease.  Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects.  The availability of EETs is limited primarily by the sol. epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols.  In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance.  To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor.  When wild-type mice are fed a high fat diet, insulin resistance develops.  However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose.  These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade.  In addn., pancreatic islets were larger when sEH was disrupted.  This effect was assocd. with an increase in vasculature.  These observations were supported by pharmacol. inhibition of sEH.  These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw_cNpjhoXGLVg90H21EOLACvtfcHk0lg7jNSzD_jrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsV2gsbc%253D&md5=348c8eb003b1154a1d991a12fffee70c</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1103482108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1103482108%26sid%3Dliteratum%253Aachs%26aulast%3DLuria%26aufirst%3DA.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DY.%2BN.%26aulast%3DShieh%26aufirst%3DG.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHaj%26aufirst%3DF.%2BG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520deficiency%2520alters%2520pancreatic%2520islet%2520size%2520and%2520improves%2520glucose%2520homeostasis%2520in%2520a%2520model%2520of%2520insulin%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D9038%26epage%3D9043%26doi%3D10.1073%2Fpnas.1103482108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frömel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1084/jem.20131494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1084%2Fjem.20131494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24446488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=281-295&author=J.+Huauthor=R.+Poppauthor=T.+Fr%C3%B6melauthor=M.+Ehlingauthor=K.+Awwadauthor=R.+H.+Adamsauthor=H.+P.+Hammesauthor=I.+Fleming&title=M%C3%BCller+glia+cells+regulate+Notch+signaling+and+retinal+angiogenesis+via+the+generation+of+19%2C20-dihydroxydocosapentaenoic+acid&doi=10.1084%2Fjem.20131494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Mueller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid</span></div><div class="casAuthors">Hu, Jiong; Popp, Ruediger; Froemel, Timo; Ehling, Manuel; Awwad, Khader; Adams, Ralf H.; Hammes, Hans-Peter; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-295</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) epoxygenases generate bioactive lipid epoxides which can be further metabolized to supposedly less active diols by the sol. epoxide hydrolase (sEH).  As the role of epoxides and diols in angiogenesis is unclear, we compared retinal vasculature development in wild-type and sEH-/- mice.  Deletion of the sEH significantly delayed angiogenesis, tip cell, and filopodia formation, a phenomenon assocd. with activation of the Notch signaling pathway.  In the retina, sEH was localized in Mueller glia cells, and Mueller cell-specific sEH deletion reproduced the sEH-/- retinal phenotype.  Lipid profiling revealed that sEH deletion decreased retinal and Mueller cell levels of 19,20-dihydroxydocosapentaenoic acid (DHDP), a diol of docosahexenoic acid (DHA).  19,20-DHDP suppressed endothelial Notch signaling in vitro via inhibition of the γ-secretase and the redistribution of presenilin 1 from lipid rafts.  Moreover, 19,20-DHDP, but not the parent epoxide, was able to rescue the defective angiogenesis in sEH-/- mice as well as in animals lacking the Fbxw7 ubiquitin ligase, which demonstrate strong basal activity of the Notch signaling cascade.  These studies demonstrate that retinal angiogenesis is regulated by a novel form of neuroretina-vascular interaction involving the sEH-dependent generation of a diol of DHA in Mueller cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPTkpLQr0v_rVg90H21EOLACvtfcHk0lg7jNSzD_jrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFaru78%253D&md5=91fc93eb94d1e44b60b210d53489466c</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131494%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFr%25C3%25B6mel%26aufirst%3DT.%26aulast%3DEhling%26aufirst%3DM.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DHammes%26aufirst%3DH.%2BP.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DM%25C3%25BCller%2520glia%2520cells%2520regulate%2520Notch%2520signaling%2520and%2520retinal%2520angiogenesis%2520via%2520the%2520generation%2520of%252019%252C20-dihydroxydocosapentaenoic%2520acid%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26spage%3D281%26epage%3D295%26doi%3D10.1084%2Fjem.20131494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziumbla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhart, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/nature25013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnature25013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29211719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=248-252&author=J.+Huauthor=S.+Dziumblaauthor=J.+Linauthor=S.+I.+Bibliauthor=S.+Zukunftauthor=J.+de+Mosauthor=K.+Awwadauthor=T.+Fromelauthor=A.+Jungmannauthor=K.+Devrajauthor=Z.+Chengauthor=L.+Wangauthor=S.+Fauserauthor=C.+G.+Eberhartauthor=A.+Sodhiauthor=B.+D.+Hammockauthor=S.+Liebnerauthor=O.+J.+Mullerauthor=C.+Glaubitzauthor=H.+P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Inhibition+of+soluble+epoxide+hydrolase+prevents+diabetic+retinopathy&doi=10.1038%2Fnature25013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span></div><div class="casAuthors">Hu, Jiong; Dziumbla, Sarah; Lin, Jihong; Bibli, Sofia-Iris; Zukunft, Sven; de Mos, Julian; Awwad, Khader; Froemel, Timo; Jungmann, Andreas; Devraj, Kavi; Cheng, Zhixing; Wang, Liya; Fauser, Sascha; Eberhart, Charles G.; Sodhi, Akrit; Hammock, Bruce D.; Liebner, Stefan; Mueller, Oliver J.; Glaubitz, Clemens; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">248-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Diabetic retinopathy is an important cause of blindness in adults, and is characterized by progressive loss of vascular cells and slow dissoln. of inter-vascular junctions, which result in vascular leakage and retinal edema.  Later stages of the disease are characterized by inflammatory cell infiltration, tissue destruction and neovascularization.  Here we identify sol. epoxide hydrolase (sEH) as a key enzyme that initiates pericyte loss and breakdown of endothelial barrier function by generating the diol 19,20-dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.  The expression of sEH and the accumulation of 19,20-dihydroxydocosapentaenoic acid were increased in diabetic mouse retinas and in the retinas and vitreous humor of patients with diabetes.  Mechanistically, the diol targeted the cell membrane to alter the localization of cholesterol-binding proteins, and prevented the assocn. of presenilin 1 with N-cadherin and VE-cadherin, thereby compromising pericyte-endothelial cell interactions and inter-endothelial cell junctions.  Treating diabetic mice with a specific sEH inhibitor prevented the pericyte loss and vascular permeability that are characteristic of non-proliferative diabetic retinopathy.  Conversely, overexpression of sEH in the retinal Muller glial cells of non-diabetic mice resulted in similar vessel abnormalities to those seen in diabetic mice with retinopathy.  Thus, increased expression of sEH is a key determinant in the pathogenesis of diabetic retinopathy, and inhibition of sEH can prevent progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmkpvr75AMbVg90H21EOLACvtfcHk0lg7jNSzD_jrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ&md5=9006381439cc2662b20d97160bfce71b</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1038%2Fnature25013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDziumbla%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.%2BI.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3Dde%2BMos%26aufirst%3DJ.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DFromel%26aufirst%3DT.%26aulast%3DJungmann%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26aulast%3DSodhi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLiebner%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DO.%2BJ.%26aulast%3DGlaubitz%26aufirst%3DC.%26aulast%3DHammes%26aufirst%3DH.%2BP.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520diabetic%2520retinopathy%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D248%26epage%3D252%26doi%3D10.1038%2Fnature25013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011112-140244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1146%2Fannurev-pharmtox-011112-140244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23020295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1WgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=37-58&author=C.+Morisseauauthor=B.+D.+Hammock&title=Impact+of+soluble+epoxide+hydrolase+and+epoxyeicosanoids+on+human+health&doi=10.1146%2Fannurev-pharmtox-011112-140244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-58</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The presence of epoxyeicosatrienoic acids (EETs) in tissues and their metab. by sol. epoxide hydrolase (sEH) to 1,2-diols were first reported 30 years ago.  However, appreciation of their importance in cell biol. and physiol. has greatly accelerated over the past decade with the discovery of metabolically stable inhibitors of sEH, the com. availability of EETs, and the development of anal. methods for the quantification of EETs and their diols.  Numerous roles of EETs in regulatory biol. now are clear, and the value of sEH inhibition in various animal models of disease has been demonstrated.  Here, we review these results and discuss how the pharmacol. stabilization of EETs and other natural epoxy-fatty acids could lead to possible disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcgC0VYHparVg90H21EOLACvtfcHk0lilPn4TwdXKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1WgtLk%253D&md5=00b058792fbbe4856b5a8508bf37c514</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011112-140244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011112-140244%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DImpact%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520epoxyeicosanoids%2520on%2520human%2520health%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D37%26epage%3D58%26doi%3D10.1146%2Fannurev-pharmtox-011112-140244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlinger, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canestraro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthati, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koduru, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, N. G.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">916</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.157545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fjpet.109.157545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19717790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=906-916&author=K.+Sodhiauthor=K.+Inoueauthor=K.+H.+Gotlingerauthor=M.+Canestraroauthor=L.+Vanellaauthor=D.+H.+Kimauthor=V.+L.+Manthatiauthor=S.+R.+Koduruauthor=J.+R.+Falckauthor=M.+L.+Schwartzmanauthor=N.+G.+Abraham&title=Epoxyeicosatrienoic+acid+agonist+rescues+the+metabolic+syndrome+phenotype+of+HO-2-null+mice&doi=10.1124%2Fjpet.109.157545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice</span></div><div class="casAuthors">Sodhi, Komal; Inoue, Kazuyoshi; Gotlinger, Katherine H.; Canestraro, Martina; Vanella, Luca; Kim, Dong Hyun; Manthati, Vijay L.; Koduru, Sreenivasulu Reddy; Falck, John R.; Schwartzman, Michal L.; Abraham, Nader G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-916</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Heme oxygenase (HO) and cytochrome P 450-derived epoxyeicosatrienoic acids (EETs) participate in vascular protection, and recent studies suggest these two systems are functionally linked.  We examd. the consequences of HO deficiency on P 450-derived EETs with regard to body wt., adiposity, insulin resistance, blood pressure, and vascular function in HO-2-null mice.  The HO-2-null mice were obese, displayed insulin resistance, and had high blood pressure.  HO-2 deficiency was assocd. with decreases in cyp2c expression, EET levels, HO-1 expression, and HO activity and with an increase in superoxide prodn. and an impairment in the relaxing response to acetylcholine.  In addn., HO-2-null mice exhibited increases in serum levels of tumor necrosis factor (TNF)-α and macrophage chemoattractant protein (MCP)-1 and a decrease in serum adiponectin levels.  Treatment of HO-2-null mice with a dual-activity EET agonist/sol. epoxide hydrolase inhibitor increased renal and vascular EET levels and HO-1 expression, lowered blood pressure, prevented body wt. gain, increased insulin sensitivity, reduced s.c. and visceral fat, and decreased serum TNF-α and MCP-1, while increasing adiponectin and restoring the relaxing responses to acetylcholine.  The decrease in cyp2c expression and EETs levels in HO-2-null mice underscores the importance of the HO system in the regulation of epoxygenase levels and suggests that protection against obesity-induced cardiovascular complications requires interplay between these two systems.  A deficiency in one of these protective systems may contribute to the adverse manifestations assocd. with the clin. progression of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2GVlGgqEn7Vg90H21EOLACvtfcHk0lilPn4TwdXKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsL3E&md5=55ff5783f76153dada03790467a12f6e</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.157545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.157545%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGotlinger%26aufirst%3DK.%2BH.%26aulast%3DCanestraro%26aufirst%3DM.%26aulast%3DVanella%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DManthati%26aufirst%3DV.%2BL.%26aulast%3DKoduru%26aufirst%3DS.%2BR.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DSchwartzman%26aufirst%3DM.%2BL.%26aulast%3DAbraham%26aufirst%3DN.%2BG.%26atitle%3DEpoxyeicosatrienoic%2520acid%2520agonist%2520rescues%2520the%2520metabolic%2520syndrome%2520phenotype%2520of%2520HO-2-null%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D906%26epage%3D916%26doi%3D10.1124%2Fjpet.109.157545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardesty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirnheld, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpich, I.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition in liver diseases: a review of current research and knowledge gaps</span>. <i>Biology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.3390/biology9060124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fbiology9060124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1SnsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=124&author=J.+Warnerauthor=J.+Hardestyauthor=K.+Zirnheldauthor=C.+McClainauthor=D.+Warnerauthor=I.+Kirpich&title=Soluble+epoxide+hydrolase+inhibition+in+liver+diseases%3A+a+review+of+current+research+and+knowledge+gaps&doi=10.3390%2Fbiology9060124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition in liver diseases: a review of current research and knowledge gaps</span></div><div class="casAuthors">Warner, Jeffrey; Hardesty, Josiah; Zirnheld, Kara; McClain, Craig; Warner, Dennis; Kirpich, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Biology (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">BBSIBX</span>;
        ISSN:<span class="NLM_cas:issn">2079-7737</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Emerging evidence suggests that sol. epoxide hydrolase (sEH) inhibition is a valuable therapeutic strategy for the treatment of numerous diseases, including those of the liver. sEH rapidly degrades cytochrome P 450-produced epoxygenated lipids (epoxy-fatty acids), which are synthesized from omega-3 and omega-6 polyunsatd. fatty acids, that generally exert beneficial effects on several cellular processes. sEH hydrolysis of epoxy-fatty acids produces dihydroxy-fatty acids which are typically less biol. active than their parent epoxide.  Efforts to develop sEH inhibitors have made available numerous compds. that show therapeutic efficacy and a wide margin of safety in a variety of different diseases, including non-alc. fatty liver disease, liver fibrosis, portal hypertension, and others.  This review summarizes research efforts which characterize the applications, underlying effects, and mol. mechanisms of sEH inhibitors in these liver diseases and identifies gaps in knowledge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJTjtB0ao1rVg90H21EOLACvtfcHk0lilPn4TwdXKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1SnsLrN&md5=7d48e2790643d39378c19a9588313378</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.3390%2Fbiology9060124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiology9060124%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DJ.%26aulast%3DHardesty%26aufirst%3DJ.%26aulast%3DZirnheld%26aufirst%3DK.%26aulast%3DMcClain%26aufirst%3DC.%26aulast%3DWarner%26aufirst%3DD.%26aulast%3DKirpich%26aufirst%3DI.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520in%2520liver%2520diseases%253A%2520a%2520review%2520of%2520current%2520research%2520and%2520knowledge%2520gaps%26jtitle%3DBiology%26date%3D2020%26volume%3D9%26spage%3D124%26doi%3D10.3390%2Fbiology9060124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Vicario, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz-Quiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Alonso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rius, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopategi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arroyo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claria, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1073/pnas.1422590112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1422590112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25550510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=536-541&author=C.+Lopez-Vicarioauthor=J.+Alcaraz-Quilesauthor=V.+Garcia-Alonsoauthor=B.+Riusauthor=S.+H.+Hwangauthor=E.+Titosauthor=A.+Lopategiauthor=B.+D.+Hammockauthor=V.+Arroyoauthor=J.+Claria&title=Inhibition+of+soluble+epoxide+hydrolase+modulates+inflammation+and+autophagy+in+obese+adipose+tissue+and+liver%3A+role+for+omega-3+epoxides&doi=10.1073%2Fpnas.1422590112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides</span></div><div class="casAuthors">Lopez-Vicario, Cristina; Alcaraz-Quiles, Jose; Garcia-Alonso, Veronica; Rius, Bibiana; Hwang, Sung H.; Titos, Esther; Lopategi, Aritz; Hammock, Bruce D.; Arroyo, Vicente; Claria, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an emerging therapeutic target in a no. of diseases that have inflammation as a common underlying cause. sEH limits tissue levels of cytochrome P 450 (CYP) epoxides derived from omega-6 and omega-3 polyunsatd. fatty acids (PUFA) by converting these antiinflammatory mediators into their less active diols.  Here, we explored the metabolic effects of a sEH inhibitor (t-TUCB) in fat-1 mice with transgenic expression of an omega-3 desaturase capable of enriching tissues with endogenous omega-3 PUFA.  These mice exhibited increased CYP1A1, CYP2E1, and CYP2U1 expression and abundant levels of the omega-3-derived epoxides 17,18-epoxyeicosatetraenoic acid (17,18-EEQ) and 19,20-epoxydocosapentaenoic (19,20-EDP) in insulin-sensitive tissues, esp. liver, as detd. by LC-ESI-MS/MS.  In obese fat-1 mice, t-TUCB raised hepatic 17,18-EEQ and 19,20-EDP levels and reinforced the omega-3-dependent redn. obsd. in tissue inflammation and lipid peroxidn. t-TUCB also produced a more intense antisteatotic action in obese fat-1 mice, as revealed by magnetic resonance spectroscopy.  Notably, t-TUCB skewed macrophage polarization toward an antiinflammatory M2 phenotype and expanded the interscapular brown adipose tissue vol.  Moreover, t-TUCB restored hepatic levels of Atg12-Atg5 and LC3-II conjugates and reduced p62 expression, indicating up-regulation of hepatic autophagy. t-TUCB consistently reduced endoplasmic reticulum stress demonstrated by the attenuation of IRE-1α and eIF2α phosphorylation.  These actions were recapitulated in vitro in palmitate-primed hepatocytes and adipocytes incubated with 19,20-EDP or 17,18-EEQ.  Relatively similar but less pronounced actions were obsd. with the omega-6 epoxide, 14,15-EET, and nonoxidized DHA.  Together, these findings identify omega-3 epoxides as important regulators of inflammation and autophagy in insulin-sensitive tissues and postulate sEH as a druggable target in metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoea5tQ9MK3HLVg90H21EOLACvtfcHk0lge2MDlxuRtSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlym&md5=2797787a822238a9d966ae13dfb5a630</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422590112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422590112%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Vicario%26aufirst%3DC.%26aulast%3DAlcaraz-Quiles%26aufirst%3DJ.%26aulast%3DGarcia-Alonso%26aufirst%3DV.%26aulast%3DRius%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTitos%26aufirst%3DE.%26aulast%3DLopategi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DArroyo%26aufirst%3DV.%26aulast%3DClaria%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520modulates%2520inflammation%2520and%2520autophagy%2520in%2520obese%2520adipose%2520tissue%2520and%2520liver%253A%2520role%2520for%2520omega-3%2520epoxides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D536%26epage%3D541%26doi%3D10.1073%2Fpnas.1422590112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sandra Codony, Carla Calvó-Tusell, Elena Valverde, Sílvia Osuna, Christophe Morisseau, M. Isabel Loza, José Brea, Concepción Pérez, María Isabel Rodríguez-Franco, Javier Pizarro-Delgado, Rubén Corpas, Christian Griñán-Ferré, Mercè Pallàs, Coral Sanfeliu, Manuel Vázquez-Carrera, Bruce D. Hammock, Ferran Feixas, <span class="NLM_string-name hlFld-ContribAuthor">Santiago Vázquez</span>. </span><span class="cited-content_cbyCitation_article-title">From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5429-5446. <a href="https://doi.org/10.1021/acs.jmedchem.0c01601" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01601%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252Bthe%252BDesign%252Bto%252Bthe%252BIn%252BVivo%252BEvaluation%252Bof%252BBenzohomoadamantane-Derived%252BSoluble%252BEpoxide%252BHydrolase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BPancreatitis%26aulast%3DCodony%26aufirst%3DSandra%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14092020%26date%3D04052021%26volume%3D64%26issue%3D9%26spage%3D5429%26epage%3D5446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Juan-Juan  Yan</span>, <span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Feng</span>, <span class="hlFld-ContribAuthor ">Xia  Lv</span>, <span class="hlFld-ContribAuthor ">Xiao-Kui  Huo</span>, <span class="hlFld-ContribAuthor ">Cheng-Peng  Sun</span>, <span class="hlFld-ContribAuthor ">Li-Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Chi  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: Insight from inhibition kinetics and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2021,</strong> <em>345 </em>, 109571. <a href="https://doi.org/10.1016/j.cbi.2021.109571" title="DOI URL">https://doi.org/10.1016/j.cbi.2021.109571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2021.109571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2021.109571%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DNatural%252Bsoluble%252Bepoxide%252Bhydrolase%252Binhibitors%252Bfrom%252BInula%252Bbritanica%252Band%252Btheir%252Bpotential%252Binteractions%252Bwith%252Bsoluble%252Bepoxide%252Bhydrolase%25253A%252BInsight%252Bfrom%252Binhibition%252Bkinetics%252Band%252Bmolecular%252Bdynamics%26aulast%3DZhao%26aufirst%3DWen-Yu%26date%3D2021%26volume%3D345%26spage%3D109571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Rong  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiang-Ge  Tian</span>, <span class="hlFld-ContribAuthor ">Xia  Lv</span>, <span class="hlFld-ContribAuthor ">Hou-Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Sa  Deng</span>, <span class="hlFld-ContribAuthor ">Bao-Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-Peng  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Chi  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>183 </em>, 811-817. <a href="https://doi.org/10.1016/j.ijbiomac.2021.04.187" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2021.04.187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2021.04.187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2021.04.187%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DNatural%252Bsoluble%252Bepoxide%252Bhydrolase%252Binhibitors%252Bfrom%252BAlisma%252Borientale%252Band%252Btheir%252Bpotential%252Bmechanism%252Bwith%252Bsoluble%252Bepoxide%252Bhydrolase%26aulast%3DZhao%26aufirst%3DWen-Yu%26date%3D2021%26volume%3D183%26spage%3D811%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jang Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Ji Su  Park</span>, <span class="hlFld-ContribAuthor ">Yun Ji  Lee</span>, <span class="hlFld-ContribAuthor ">Sena  Choi</span>, <span class="hlFld-ContribAuthor ">Young Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Seo Young  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of
              Ulmus davidiana var. japonica. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1049-1055. <a href="https://doi.org/10.1080/14756366.2021.1927005" title="DOI URL">https://doi.org/10.1080/14756366.2021.1927005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1927005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1927005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Bsoluble%252Bepoxide%252Bhydrolase%252Bby%252Bphytochemical%252Bconstituents%252Bof%252Bthe%252Broot%252Bbark%252Bof%252BUlmus%252Bdavidiana%252Bvar.%252Bjaponica%26aulast%3DKim%26aufirst%3DJang%2BHoon%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1049%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0037.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) X-ray cocrystal structure of a single subunit of the human sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4">1ZD4</a>). (B) X-ray cocrystal structure of human sEH C-domain showing the binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4">1ZD4</a>). (C) Potential interactions between epoxides and human sEH C-domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolic pathways of AA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative sEH inhibitors and development of early sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Optimization of adamantyl-ureas.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative urea sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Influence of stereoconfigurations on inhibitory potentials and representative sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative thiourea-based sEH inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Modification of adamantyl-ureas to afford amide inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray cocrystal structure of DPN (<b>33</b>) with sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3I1Y">3I1Y</a>) and its optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Modification based on the skeleton.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Modification of the secondary pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SAR of amide inhibitors summarized by Kim et al.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Chemical structures of sulfonyl isonipecotamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray crystal structure of sEH complexed with the benzoxazole (<b>62</b>) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PDC">3PDC</a>) and its optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Modification based on the structure of the amide (<b>64</b>) and cocrystal structure of MTTP (<b>65</b>) and sEH (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JNC">4JNC</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Design principle of an sEH/COX-2 dual inhibitor PTUPB (<b>68</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. sEH/5-LOX dual inhibitors that linked two pharmacophores for sEH and 5-LOX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. sEH/5-LOX dual inhibitor with an amide and an aminothiazole moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. sEH/5-LOX dual inhibitor FFBMB (<b>71</b>) based on an aryl ether and a benzoic acid motif and a benzimidazole core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. sEH/FLAP dual inhibitors diflapolin analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. sEH/FAAH dual inhibitor derived from <i>t</i>-TUCB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Selective sEH/FAAH dual inhibitor TPPPC (<b>74</b>) derived from TPPU (<b>19</b>) and PF-3845.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Selective sEH/PPAR dual modulators TPUBPC (<b>75</b>) and AUBPC (<b>76</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. SAR of <i>N</i>-benzylbenzamides with sEH and PPARγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Selective sEH/PPAR dual modulator CMMMB (<b>77</b>) derived from zafirlukast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. sEH/FXR dual modulator BBIMM (<b>78</b>) derived from zafirlukast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. sEH/FXR dual modulator BCMBB (<b>79</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. sEH/c-RAF dual modulator <i>t</i>-CUPM (<b>81</b>) derived from <i>t</i>-TUCB and sorafenib (<b>80</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Chemical structures of naturally occurring sEH inhibitors: ureas (<b>82</b>–<b>86</b>) and amides (<b>87</b>–<b>91</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structures of naturally occurring sEH inhibitors: flavonoids (<b>92</b>–<b>98</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of naturally occurring sEH inhibitors: triterpenoids (<b>99</b>–<b>109</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Chemical structures of naturally occurring sEH inhibitors: phenylpropionic acids (<b>110</b>–<b>117</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0033.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Chemical structures of naturally occurring sEH inhibitors: anthraquinones (<b>118</b>–<b>121</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0034.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Chemical structures of naturally occurring sEH inhibitors: stilbenes (<b>122</b>–<b>125</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0035.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Chemical structures of naturally occurring sEH inhibitors: alkaloids (<b>126</b>–<b>129</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/medium/jm0c01507_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0036.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Chemical structures of naturally occurring sEH inhibitors: others (<b>130</b>–<b>133</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01507/20210107/images/large/jm0c01507_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01507&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 244 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherbeni, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kadi, A. O.</span></span> <span> </span><span class="NLM_article-title">The role of epoxide hydrolases in health and disease</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2032</span>, <span class="refDoi"> DOI: 10.1007/s00204-014-1371-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00204-014-1371-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25248500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=2013-2032&author=A.+A.+El-Sherbeniauthor=A.+O.+El-Kadi&title=The+role+of+epoxide+hydrolases+in+health+and+disease&doi=10.1007%2Fs00204-014-1371-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of epoxide hydrolases in health and disease</span></div><div class="casAuthors">El-Sherbeni, Ahmed A.; El-Kadi, Ayman O. S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2032</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Epoxide hydrolases (EH) are ubiquitously expressed in all living organisms and in almost all organs and tissues.  They are mainly subdivided into microsomal and sol. EH and catalyze the hydration of epoxides, three-membered-cyclic ethers, to their corresponding dihydrodiols.  Owning to the high chem. reactivity of xenobiotic epoxides, microsomal EH is considered protective enzyme against mutagenic and carcinogenic initiation.  Nevertheless, several endogenously produced epoxides of fatty acids function as important regulatory mediators.  By mediating the formation of cytotoxic dihydrodiol fatty acids on the expense of cytoprotective epoxides of fatty acids, sol. EH is considered to have cytotoxic activity.  Indeed, the attenuation of microsomal EH, achieved by chem. inhibitors or preexists due to specific genetic polymorphisms, is linked to the aggravation of the toxicity of xenobiotics, as well as the risk of cancer and inflammatory diseases, whereas sol. EH inhibition has been emerged as a promising intervention against several diseases, most importantly cardiovascular, lung and metabolic diseases.  However, there is reportedly a significant overlap in substrate selectivity between microsomal and sol. EH.  In addn., microsomal and sol. EH were found to have the same catalytic triad and identical mol. mechanism.  Consequently, the physiol. functions of microsomal and sol. EH are also overlapped.  Thus, studying the biol. effects of microsomal or sol. EH alterations needs to include the effects on both the metab. of reactive metabolites, as well as epoxides of fatty acids.  This review focuses on the multifaceted role of EH in the metab. of xenobiotic and endogenous epoxides and the impact of EH modulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn7N-VYHV3ubVg90H21EOLACvtfcHk0lggK2w57eMfkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsb7K&md5=6a1fb6af9726a55af556ab2f2cded345</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00204-014-1371-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-014-1371-y%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Sherbeni%26aufirst%3DA.%2BA.%26aulast%3DEl-Kadi%26aufirst%3DA.%2BO.%26atitle%3DThe%2520role%2520of%2520epoxide%2520hydrolases%2520in%2520health%2520and%2520disease%26jtitle%3DArch.%2520Toxicol.%26date%3D2014%26volume%3D88%26spage%3D2013%26epage%3D2032%26doi%3D10.1007%2Fs00204-014-1371-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sareen, D.</span></span> <span> </span><span class="NLM_article-title">An overview on the enhancement of enantioselectivity and stability of microbial epoxide hydrolases</span>. <i>Mol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1007/s12033-017-9996-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12033-017-9996-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28271340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=98-116&author=P.+Sainiauthor=D.+Sareen&title=An+overview+on+the+enhancement+of+enantioselectivity+and+stability+of+microbial+epoxide+hydrolases&doi=10.1007%2Fs12033-017-9996-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An overview on the enhancement of enantioselectivity and stability of microbial epoxide hydrolases</span></div><div class="casAuthors">Saini, Priya; Sareen, Dipti</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">98-116</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Epoxide hydrolases (EHs; 3.3.2.x) catalyze the enantioselective ring opening of racemic epoxides to the corresponding enantiopure vicinal diols and remaining equiv. unreacted epoxides.  These epoxides and diols are used for the synthesis of chiral drug intermediates.  With an upsurge in the methods for identification of novel microbial EHs, a lot of EHs have been discovered and utilized for kinetic resoln. of racemic epoxides.  However, there is still a constraint on the account of limited EHs being successfully applied on the preparative scale for industrial biotransformations.  This limitation has to be overcome before application of identified functional EHs on large scale.  Many strategies such as optimizing reaction media, immobilizing EHs and lab.-scale directed evolution of EHs have been adopted for enhancing the industrial potential of EHs.  In this review, these approaches have been highlighted which can serve as a pathway for the enrichment of already identified EHs for their application on an industrial scale in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0S3RnCuClObVg90H21EOLACvtfcHk0lggK2w57eMfkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyiurs%253D&md5=e0f8ece7f7af25d040d6ba8dba0f0c2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs12033-017-9996-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12033-017-9996-8%26sid%3Dliteratum%253Aachs%26aulast%3DSaini%26aufirst%3DP.%26aulast%3DSareen%26aufirst%3DD.%26atitle%3DAn%2520overview%2520on%2520the%2520enhancement%2520of%2520enantioselectivity%2520and%2520stability%2520of%2520microbial%2520epoxide%2520hydrolases%26jtitle%3DMol.%2520Biotechnol.%26date%3D2017%26volume%3D59%26spage%3D98%26epage%3D116%26doi%3D10.1007%2Fs12033-017-9996-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxide hydrolases: their roles and interactions with lipid metabolism</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2004.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.plipres.2004.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15748653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1-51&author=J.+W.+Newmanauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Epoxide+hydrolases%3A+their+roles+and+interactions+with+lipid+metabolism&doi=10.1016%2Fj.plipres.2004.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide hydrolases: their roles and interactions with lipid metabolism</span></div><div class="casAuthors">Newman, John W.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-51</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The epoxide hydrolases (EHs) are enzymes present in all living organisms, which transform epoxide-contg. lipids by the addn. of water.  In plants and animals, many of these lipid substrates have potent biol. activities, such as host defenses, control of development, and regulation of inflammation and blood pressure.  Thus, the EHs have important and diverse biol. roles with profound effects on the physiol. state of the host organisms.  Currently, 7 distinct EH subtypes are recognized in higher organisms.  These include the plant sol. EHs, mammalian sol. EH, hepoxilin hydrolase, leukotriene A4 hydrolase, microsomal EH, and insect juvenile hormone EH.  While the understanding of these enzymes has progressed at different rates, here the authors discuss the current state of knowledge for each of these enzymes, along with a distn. of the current understanding of their endogenous roles.  By reviewing the entire enzyme class together, both commonalities and discrepancies in the understanding are highlighted and important directions for future research pertaining to these enzymes are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7nWZtLlJSrVg90H21EOLACvtfcHk0lgqGYkG7eER0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjtLg%253D&md5=acaeab5f99b7fcf6cfcb59969340ee76</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2004.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2004.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxide%2520hydrolases%253A%2520their%2520roles%2520and%2520interactions%2520with%2520lipid%2520metabolism%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2005%26volume%3D44%26spage%3D1%26epage%3D51%26doi%3D10.1016%2Fj.plipres.2004.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koger, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fish models of soluble epoxide hydrolase inhibition</span>. <i>Environ. Health Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1289/ehp.0110961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1289%2Fehp.0110961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11171526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=61-66&author=J.+W.+Newmanauthor=D.+L.+Dentonauthor=C.+Morisseauauthor=C.+S.+Kogerauthor=C.+E.+Wheelockauthor=D.+E.+Hintonauthor=B.+D.+Hammock&title=Evaluation+of+fish+models+of+soluble+epoxide+hydrolase+inhibition&doi=10.1289%2Fehp.0110961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fish models of soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Newman, John W.; Denton, Debra L.; Morisseau, Christophe; Koger, Cory S.; Wheelock, Craig E.; Hinton, David E.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66</span>CODEN:
                <span class="NLM_cas:coden">EVHPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-6765</span>.
    
            (<span class="NLM_cas:orgname">National Institute of Environmental Health Sciences</span>)
        </div><div class="casAbstract">Substituted ureas and carbamates are mechanistic inhibitors of the sol. epoxide hydrolase (sEH).  A set of chems. contg. these functionalities were screened in larval fathead minnow (Pimphales promelas) and embryo/larval golden medaka (Oryzias latipes) models to evaluate the utility of these systems for investigating sEH inhibition in vivo.  Both fathead minnow and medaka sEHs were functionally similar to the tested mammalian orthologs (murine and human) with respect to substrate hydrolysis and inhibitor susceptibility.  Low lethality was obsd. in either larval or embryonic fish exposed to diuron , desmethyl diuron , or siduron .  Dose-dependent inhibition of sEH was a sublethal effect of substituted urea exposure with the potency of siduron < desmethyl diuron = diuron, differing from the obsd. in vitro sEH inhibition potency of siduron > desmethyl diuron > diuron.  Further, siduron exposure synergized the toxicity of trans-stilbene oxide in fathead minnows.  Medaka embryos exposed to diuron, desmethyl diuron, or siduron displayed dose-dependent delays in hatch, and elevated concns. of diuron and desmethyl diuron produced developmental toxicity.  The dose-dependent toxicity and in vivo sEH inhibition correlated, suggesting a potential, albeit undefined, relationship between these factors.  Addnl., the obsd. inversion of in vitro to in vivo potency suggests that these fish models may provide tools for investigating the in vivo stability of in vitro inhibitors while screening for untoward effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1MD5Xy31rA7Vg90H21EOLACvtfcHk0lgqGYkG7eER0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFKkuw%253D%253D&md5=fd947c2808478ca7779d37f2216b256c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1289%2Fehp.0110961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.0110961%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DDenton%26aufirst%3DD.%2BL.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DKoger%26aufirst%3DC.%2BS.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DHinton%26aufirst%3DD.%2BE.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEvaluation%2520of%2520fish%2520models%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2001%26volume%3D109%26spage%3D61%26epage%3D66%26doi%3D10.1289%2Fehp.0110961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauren, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halarnkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinton, D. E.</span></span> <span> </span><span class="NLM_article-title">Microsomal and cytosolic epoxide hydrolase and glutathione S-transferase activities in the gill, liver, and kidney of the rainbow trout, <i>Salmo gairdneri</i>. Baseline levels and optimization of assay conditions</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(89)90275-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2889%2990275-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2930590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL1MXktVCmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=881-887&author=D.+J.+Laurenauthor=P.+P.+Halarnkarauthor=B.+D.+Hammockauthor=D.+E.+Hinton&title=Microsomal+and+cytosolic+epoxide+hydrolase+and+glutathione+S-transferase+activities+in+the+gill%2C+liver%2C+and+kidney+of+the+rainbow+trout%2C+Salmo+gairdneri.+Baseline+levels+and+optimization+of+assay+conditions&doi=10.1016%2F0006-2952%2889%2990275-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Microsomal and cytosolic epoxide hydrolase and glutathione S-transferase activities in the gill, liver, and kidney of the rainbow trout, Salmo gairdneri</span></div><div class="casAuthors">Lauren, Darrel J.; Halarnkar, Premjit P.; Hammock, Bruce D.; Hinton, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">881-7</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Microsomal and cytosolic epoxide hydrolase (mEH and cEH resp.) and glutathione S-transferase (GST) activities were measured in the liver, kidney, and gills of rainbow trout.  Assays were optimized for time, pH, and temp., by using trans-stilbene oxide (TSO) and cis-stilbene oxide (CSO) as substrates for cEH and mEH, resp.  Optimal pH values for mEH, cEH, and GST were similar to mammalian values (i.e., 8.5, 7.5, and 9).  Temp. optima differed between tissues and cell fractions.  Specific activity of cEH-TSO was 3-14-times greater than mEH-CSO for all three tissues, and 8-60-times greater on a tissue wt. basis.  Liver and, to a lesser extent, kidney mEH were active against benzo[a]pyrene 4,5-oxide, whereas gill mEH was not active against this substrate.  Liver cytosolic GST was active against CSO and 1-chloro-2,4-dinitrobenzene (CDNB) but not TSO, whereas gill and kidney cytosolic GST were active only against CDNB.  Liver and kidney microsomal GST were active against CDNB, but no activity was found in gill microsomes.  The results are discussed in relation to possible endogenous substrates and uninduced xenobiotic metabolizing capacities of different trout tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V34NHbi5T7Vg90H21EOLACvtfcHk0lgqGYkG7eER0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVCmt78%253D&md5=da6bd4b3cadac8c3518ad1250b2fe2fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2889%2990275-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252889%252990275-X%26sid%3Dliteratum%253Aachs%26aulast%3DLauren%26aufirst%3DD.%2BJ.%26aulast%3DHalarnkar%26aufirst%3DP.%2BP.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHinton%26aufirst%3DD.%2BE.%26atitle%3DMicrosomal%2520and%2520cytosolic%2520epoxide%2520hydrolase%2520and%2520glutathione%2520S-transferase%2520activities%2520in%2520the%2520gill%252C%2520liver%252C%2520and%2520kidney%2520of%2520the%2520rainbow%2520trout%252C%2520Salmo%2520gairdneri.%2520Baseline%2520levels%2520and%2520optimization%2520of%2520assay%2520conditions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D881%26epage%3D887%26doi%3D10.1016%2F0006-2952%2889%2990275-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlezinger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegeman, J. J.</span></span> <span> </span><span class="NLM_article-title">Arachidonic acid metabolism in the marine fish <i>Stenotomus chrysops</i> (Scup) and the effects of cytochrome P450 1A inducers</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1006/abbi.1998.0651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fabbi.1998.0651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9606961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1Kmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1998&pages=265-275&author=J.+J.+Schlezingerauthor=C.+Parkerauthor=D.+C.+Zeldinauthor=J.+J.+Stegeman&title=Arachidonic+acid+metabolism+in+the+marine+fish+Stenotomus+chrysops+%28Scup%29+and+the+effects+of+cytochrome+P450+1A+inducers&doi=10.1006%2Fabbi.1998.0651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic acid metabolism in the marine fish Stenotomus chrysops (scup) and the effects of cytochrome P450 1A inducers</span></div><div class="casAuthors">Schlezinger, Jennifer J.; Parker, Carol; Zeldin, Darryl C.; Stegeman, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Cytochrome P 450-mediated arachidonic acid (AA) metab. was investigated in the marine fish scup, Stenotomus chrysops.  Liver microsomes incubated with AA and NADPH produced epoxyeicosatrienoic acids (EETs) and their hydration products (dihydroxyeicosatrienoic acids, DHETs), midchain conjugated dienols (midchain HETEs), and C16-through C20-alcs. of AA (ω-terminal HETEs), all identified by HPLC and GC/MS.  Gravid females had 4-fold lower AA metab. rates than males but identical metabolite profiles.  The 5,6-EET (inferred from stable metabolites) was most abundant (47% of total EETs) followed by 14,15-, 11,12-, and 8,9-EET (27, 13, and 13%, resp.).  The 12-HETE represented 25% of total HETEs followed in abundance by 16-, 15-, 11-, 19-, 20-, 8-, and 9-HETE.  Antibodies against scup CYP1A and a scup CYP2B-like protein inhibited liver microsomal AA metab. by 30 and 46%, resp.  GC/MS anal. revealed EETs and DHETs as endogenous constituents in scup liver; the predominant EETs were 8,9- and 14,15-EET, followed by a lesser amt. of 11,12-EET.  Chiral anal. showed a preference for the S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-EET (optical purities 80, 64, and 64%, resp.).  Treatment of scup with the CYP1A inducer benzo(a)pyrene (BP) increased liver microsomal formation of EETs and HETEs by 2.7-fold in spring and 1.7-fold in summer.  BP treatment did not affect microsomal EET regioselectivity, but shifted hydroxylation in favor of 19-HETE and induced 17-HETE formation. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) treatment in summer did not induce liver microsomal AA metab. rates, yet BP and TCDD both increased endogenous EET content of liver (5- and 3-fold, resp.), with a shift to 14,15-EET.  BP treatment increased the selectivity for the S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-EET (optical purities 91, 84, and 83%, resp.).  Kidney, gill, and heart microsomes all metabolized AA, at rates 10- to 30-fold less than liver microsomes.  Similar amts. of endogenous 8,9- and 14,15-EET and less 11,12-EET were detected in heart and kidney, and there was a strong enantioselectivity for 8(R),9(S)-EET in heart (optical purity 78%) but not in kidney.  BP treatment did not alter the total EET content in these organs but did shift the regiochem. profile in heart to favor 14,15-EET.  Thus, scup liver and extrahepatic organs metabolize AA via multiple cytochrome P 450 (CYP) forms to eicosanoids in vitro and in vivo.  BP or TCDD induced endogenous AA metab. in liver, altering EET regioselectivity and, with BP, stereoselectivity.  While AhR agonists alter metab. of AA in early diverging vertebrates expressing both CYP1A and AhR, the magnitude of effects may depend upon the type of inducer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL08-YuDYdWrVg90H21EOLACvtfcHk0ljeLdbaBXLtMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1Kmt7c%253D&md5=2f06627beedfa1aabd9eb90294de2d74</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1998.0651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1998.0651%26sid%3Dliteratum%253Aachs%26aulast%3DSchlezinger%26aufirst%3DJ.%2BJ.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DStegeman%26aufirst%3DJ.%2BJ.%26atitle%3DArachidonic%2520acid%2520metabolism%2520in%2520the%2520marine%2520fish%2520Stenotomus%2520chrysops%2520%2528Scup%2529%2520and%2520the%2520effects%2520of%2520cytochrome%2520P450%25201A%2520inducers%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1998%26volume%3D353%26spage%3D265%26epage%3D275%26doi%3D10.1006%2Fabbi.1998.0651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1126/science.7361100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1126%2Fscience.7361100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7361100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3cXhvFegsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1980&pages=1479-1481&author=K.+Otaauthor=B.+D.+Hammock&title=Cytosolic+and+microsomal+epoxide+hydrolases%3A+differential+properties+in+mammalian+liver&doi=10.1126%2Fscience.7361100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytosolic and microsomal epoxide hydrolases:  differential properties in mammalian liver</span></div><div class="casAuthors">Ota, Kenji; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">4438</span>),
    <span class="NLM_cas:pages">1479-81</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Epoxide hydrolase activities of the 100,000 g pellet (microsomal) and 100,000 g sol. (cytosolic) fractions of mouse, rat, and guinea pig liver were detd. with 3 closely related compds. (styrene oxide, trans-β-methylstyrene oxide, and allylbenzene oxide) used as substrates.  Differences between the species in the distribution of the cytosolic and microsomal hydrolase and in their substrate specificities and pH optima demonstrated why epoxide hydrolase activity in the cytosolic fraction was not detected earlier in spite of intensive work on the microsomal epoxide hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjy6XYyEghLVg90H21EOLACvtfcHk0ljeLdbaBXLtMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhvFegsr4%253D&md5=4f2324b897ca1fae28ae4c3f01cfbe98</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.7361100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7361100%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DCytosolic%2520and%2520microsomal%2520epoxide%2520hydrolases%253A%2520differential%2520properties%2520in%2520mammalian%2520liver%26jtitle%3DScience%26date%3D1980%26volume%3D207%26spage%3D1479%26epage%3D1481%26doi%3D10.1126%2Fscience.7361100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waechter, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merdes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staubli, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, P.</span></span> <span> </span><span class="NLM_article-title">Purification and characterization of a soluble epoxide hydrolase from rabbit liver</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1982.tb06705.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1432-1033.1982.tb06705.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7117244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL38XksFWlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1982&pages=457-461&author=F.+Waechterauthor=M.+Merdesauthor=F.+Bieriauthor=W.+Staubliauthor=P.+Bentley&title=Purification+and+characterization+of+a+soluble+epoxide+hydrolase+from+rabbit+liver&doi=10.1111%2Fj.1432-1033.1982.tb06705.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a soluble epoxide hydrolase from rabbit liver</span></div><div class="casAuthors">Waechter, Felix; Merdes, Marcel; Bieri, Francoise; Staubli, Willi; Bentley, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-61</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A method for the extensive purifn. of rabbit liver cytoplasmic epoxide hydrolase is described.  The end-product, which was purified 550-fold with respect to the cytosolic fraction, appeared to be >85% pure.  The results indicated that the enzyme is a dimer of mol. wt. 110,000 and consists of 2 subunits, which are identical or very similar (mol. wt. = 57,000) and possess N-terminal serine.  Evidence for the existence of aggregates of higher mol. wt. was also obtained.  The catalytic properties of the cytoplasmic enzyme with styrene oxide as substrate (Km = 3.4 mM; Vmax = 3480 nmol mg-1 min-1) differed markedly from the values published for the microsomal hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSX1CG-tUbMrVg90H21EOLACvtfcHk0ljeLdbaBXLtMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksFWlsbo%253D&md5=f84dc0df8185992ece8f11854cd684f2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1982.tb06705.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1982.tb06705.x%26sid%3Dliteratum%253Aachs%26aulast%3DWaechter%26aufirst%3DF.%26aulast%3DMerdes%26aufirst%3DM.%26aulast%3DBieri%26aufirst%3DF.%26aulast%3DStaubli%26aufirst%3DW.%26aulast%3DBentley%26aufirst%3DP.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520soluble%2520epoxide%2520hydrolase%2520from%2520rabbit%2520liver%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1982%26volume%3D125%26spage%3D457%26epage%3D461%26doi%3D10.1111%2Fj.1432-1033.1982.tb06705.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundqvist, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePierre, J. W.</span></span> <span> </span><span class="NLM_article-title">Comparison of the sex and subcellular distributions, catalytic and immunochemical reactivities of hepatic epoxide hydrolases in seven mammalian species</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1987.tb13333.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1432-1033.1987.tb13333.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=3113952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL2sXlsFSjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=1987&pages=269-279&author=J.+Meijerauthor=G.+Lundqvistauthor=J.+W.+DePierre&title=Comparison+of+the+sex+and+subcellular+distributions%2C+catalytic+and+immunochemical+reactivities+of+hepatic+epoxide+hydrolases+in+seven+mammalian+species&doi=10.1111%2Fj.1432-1033.1987.tb13333.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the sex and subcellular distributions, catalytic and immunochemical reactivities of hepatic epoxide hydrolases in seven mammalian species</span></div><div class="casAuthors">Meijer, Joahn; Lundqvist, Gerd; DePierre, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-79</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Sex and species differences in hepatic epoxide hydrolase (I) activity toward cis-stilbene oxide (II) and trans-stilbene oxide (III) were examd. in common lab. animals, as well as in monkey and man.  In general, III was found to be a good substrate for I activity in cytosolic fractions, whereas II was selectively hydrated by the microsomal fraction (with the exception of man, where the cytosol also hydrated this isomer efficiently).  The specific cytosol I activity was highest in mouse, followed by hamster and rabbit.  I activity in crude mitochondrial fraction toward III was also highest in mouse and low in all other species examd.  Microsomal I activity was highest in monkey, followed by guinea pig, human and rabbit, which all had similar activities.  Sex differences were generally small, but where significant, male animals had higher catalytic activities than females of the same species in most cases.  Antibodies raised against microsomal I purified from rat liver reacted with microsomes from all species investigated, indicating structural conservation of this protein.  Antibodies directed toward cytosolic I purified from mouse liver reacted only with liver cytosol from mouse and hamster and with the mitochondrial fraction from mouse in immunodiffusion expts.  Immunoblotting also revealed reaction with rat liver cytosol.  The cytosolic and mitochondrial I in all 3 mouse strains and in both sexes for each strain were immunochem. identical.  The anomalies in human liver I activities obsd. here indicated that no single common lab. animal is a good model for man with regard to these activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw6sTFblWk-bVg90H21EOLACvtfcHk0lhB3NaaUIiQxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlsFSjs7s%253D&md5=4d318c07666649c3edd2341ce48a220e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1987.tb13333.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1987.tb13333.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DJ.%26aulast%3DLundqvist%26aufirst%3DG.%26aulast%3DDePierre%26aufirst%3DJ.%2BW.%26atitle%3DComparison%2520of%2520the%2520sex%2520and%2520subcellular%2520distributions%252C%2520catalytic%2520and%2520immunochemical%2520reactivities%2520of%2520hepatic%2520epoxide%2520hydrolases%2520in%2520seven%2520mammalian%2520species%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1987%26volume%3D167%26spage%3D269%26epage%3D279%26doi%3D10.1111%2Fj.1432-1033.1987.tb13333.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiratsuka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watabe, T.</span></span> <span> </span><span class="NLM_article-title">Enzymic conversion of 11,12-leukotriene A4 to 11,12-dihydroxy-5,14-<i>cis</i>-7,9-<i>trans</i>-eicosatetraenoic acid. Purification of an epoxide hydrolase from the guinea pig liver cytosol</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">5799</span>– <span class="NLM_lpage">5805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0021-9258%2818%2983620-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2925635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL1MXktlGntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=5799-5805&author=I.+Mikiauthor=T.+Shimizuauthor=Y.+Seyamaauthor=S.+Kitamuraauthor=K.+Yamaguchiauthor=H.+Sanoauthor=H.+Uenoauthor=A.+Hiratsukaauthor=T.+Watabe&title=Enzymic+conversion+of+11%2C12-leukotriene+A4+to+11%2C12-dihydroxy-5%2C14-cis-7%2C9-trans-eicosatetraenoic+acid.+Purification+of+an+epoxide+hydrolase+from+the+guinea+pig+liver+cytosol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic conversion of 11,12-leukotriene A4 to 11,12-dihydroxy-5,14-cis-7,9-trans-eicosatetraenoic acid. Purification of an epoxide hydrolase from the guinea pig liver cytosol</span></div><div class="casAuthors">Miki, Ichiro; Shimizu, Takao; Seyama, Yousuke; Kitamura, Shigeto; Yamaguchi, Kazuo; Sano, Hiroshi; Ueno, Hideo; Hiratsuka, Akira; Watabe, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5799-805</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">(11S,12S)-Epoxy-5,14-cis-7,9-trans-eicosatetraenoic acid (11,12-leukotriene A4) was nonenzymically converted to 7 compds.: 2 diastereomers of (12S)-hydroxyeicosatetraeno-δ-lactones (major products), 2 diastereomers of (5,12S)-dihydroxyeicosatetraenoic acid and 3 stereoisomers of (11,12S)-dihydroxyeicosatetraenoic acid.  Among these compds., (11R,12S)-dihydroxy-5,14-cis-7,9-trans-eicosatetraenoic acid proved to be the only enzymic product.  This hydrolysis activity was present in the cytosol fractions of various tissues of guinea pig such as liver, adrenal gland, small intestine, and brain.  The epoxide hydrolase was purified to an apparent homogeneity from the guinea pig liver.  The enzyme had a mol. wt. of 60,000 as detd. by SDS-PAGE and an isoelec. point of 7.3.  The partial amino acid sequence was different from that of the microsomal enzyme.  Km And Vmax values for 11,12-leukotriene A4 were 18 μM and 2.4 μmol/min/mg protein, resp.  These results indicate that 11,12-dihydroxyeicosatetraenoic acid is enzymically synthesized from 11,12-leukotriene A4 by the action of the cytosolic epoxide hydrolase in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd8-nQ9GsLbLVg90H21EOLACvtfcHk0lhB3NaaUIiQxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktlGntbY%253D&md5=90de9414064771854998b01e2ed0e75e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2983620-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252983620-1%26sid%3Dliteratum%253Aachs%26aulast%3DMiki%26aufirst%3DI.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSeyama%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DHiratsuka%26aufirst%3DA.%26aulast%3DWatabe%26aufirst%3DT.%26atitle%3DEnzymic%2520conversion%2520of%252011%252C12-leukotriene%2520A4%2520to%252011%252C12-dihydroxy-5%252C14-cis-7%252C9-trans-eicosatetraenoic%2520acid.%2520Purification%2520of%2520an%2520epoxide%2520hydrolase%2520from%2520the%2520guinea%2520pig%2520liver%2520cytosol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D5799%26epage%3D5805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winder, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noorouz-Zadeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckpitt, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plopper, C. G.</span></span> <span> </span><span class="NLM_article-title">Hepatic and pulmonary enzyme activities in horses</span>. <i>Am. J. Vet. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.2460/ajvr.2000.61.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2460%2Fajvr.2000.61.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10685686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFSgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=152-157&author=J.+Lakritzauthor=B.+S.+Winderauthor=J.+Noorouz-Zadehauthor=T.+L.+Huangauthor=A.+R.+Buckpittauthor=B.+D.+Hammockauthor=C.+G.+Plopper&title=Hepatic+and+pulmonary+enzyme+activities+in+horses&doi=10.2460%2Fajvr.2000.61.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic and pulmonary enzyme activities in horses</span></div><div class="casAuthors">Lakritz, Jeffrey; Winder, Bruce S.; Noorouz-Zadeh, Jaffar; Huang, Tien L.; Buckpitt, Alan R.; Hammock, Bruce D.; Plopper, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Veterinary Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">AJVRAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    
            (<span class="NLM_cas:orgname">American Veterinary Medical Association</span>)
        </div><div class="casAbstract">To det. hepatic and pulmonary phase-I and phase-II enzyme activities in horses.  Pulmonary and hepatic tissues from 22 horses that were 4 mo to 32 yr old.  Pulmonary and hepatic tissues from horses were used to prep. cytosolic (glutathione S-transferase and sol. epoxide hydrolase) and microsomal (cytochrome P 450 monooxygenases) enzymes.  Rates of microsomal metab. of ethoxyresorufin, pentoxyresorufin, and naphthalene were detd. by high-performance liq. chromatog.  Activities of glutathione S-transferase and sol. epoxide hydrolase were detd. spectrophotometrically.  Cytochrome P 450 content was detd. by carbon monoxide bound-difference spectrum of dithionite-reduced microsomes.  Activity was expressed relative to total protein concn.  Microsomal protein and cytochrome P 450 contents were detectable in all horses and did not vary with age.  Hepatic ethoxyresorufin metab. was detected in all horses; by comparison, pulmonary metab. of ethoxyresorufin and hepatic and pulmonary metab. of pentoxyresorufin were detected at lower rates.  Rate of hepatic naphthalene metab. remained const. with increasing age, whereas rate of pulmonary naphthalene metab. was significantly lower in weanlings (ie, horses 4 to 6 mo old), compared with adult horses.  Hepatic glutathione S-transferase activity (cytosol) increased with age; however, these changes were not significant.  Pulmonary glutathione S-transferase activity (cytosol) was significantly lower in weanlings than adult horses.  Hepatic and pulmonary sol. epoxide hydrolase did not vary with age of horses.  Activity of cytochrome P 450 isoforms that metabolize naphthalene and glutathione S-transferases in lungs are significantly lower in weanlings than adult horses, which suggests reduced ability of young horses to metabolize xenobiotics by this organ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqKVjjdguLC7Vg90H21EOLACvtfcHk0lhB3NaaUIiQxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFSgsLc%253D&md5=8264e4ff26f1154b6e055fca1bbb8644</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2460%2Fajvr.2000.61.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2460%252Fajvr.2000.61.152%26sid%3Dliteratum%253Aachs%26aulast%3DLakritz%26aufirst%3DJ.%26aulast%3DWinder%26aufirst%3DB.%2BS.%26aulast%3DNoorouz-Zadeh%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DT.%2BL.%26aulast%3DBuckpitt%26aufirst%3DA.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPlopper%26aufirst%3DC.%2BG.%26atitle%3DHepatic%2520and%2520pulmonary%2520enzyme%2520activities%2520in%2520horses%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D2000%26volume%3D61%26spage%3D152%26epage%3D157%26doi%3D10.2460%2Fajvr.2000.61.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beetham, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">cDNA cloning and expression of a soluble epoxide hydrolase from human liver</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1006/abbi.1993.1411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fabbi.1993.1411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8342951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1993&pages=197-201&author=J.+K.+Beethamauthor=T.+Tianauthor=B.+D.+Hammock&title=cDNA+cloning+and+expression+of+a+soluble+epoxide+hydrolase+from+human+liver&doi=10.1006%2Fabbi.1993.1411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA cloning and expression of a soluble epoxide hydrolase from human liver</span></div><div class="casAuthors">Beetham, Jeffrey K.; Tian, Tongyan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-201</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The authors report the cloning and expression of a cDNA that encodes a sol. epoxide hydrolase from human liver.  The 2101-base clone predicts a 554-residue protein (Mr 62,640) with an apparently imperfect peroxisomal targeting signal of Ser-Lys-Met at the carboxy terminus.  The cDNA was expressed in the baculovirus system in the Spodoptera frugiperda 21 cell line.  The recombinant protein was similar to sol. epoxide hydrolase isolated from human liver in terms of mol. wt., hydrolytic activity, inhibition, and immunoreactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1yn_6KiPVMLVg90H21EOLACvtfcHk0lhYre9DDJhNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFynuro%253D&md5=f4f49a19c8db7dec5652649ed2914a96</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1411%26sid%3Dliteratum%253Aachs%26aulast%3DBeetham%26aufirst%3DJ.%2BK.%26aulast%3DTian%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DcDNA%2520cloning%2520and%2520expression%2520of%2520a%2520soluble%2520epoxide%2520hydrolase%2520from%2520human%2520liver%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D305%26spage%3D197%26epage%3D201%26doi%3D10.1006%2Fabbi.1993.1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifici, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, A.</span></span> <span> </span><span class="NLM_article-title">Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=6887015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3sXlslSru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1983&pages=869-875&author=G.+M.+Pacificiauthor=B.+Lindbergauthor=H.+Glaumannauthor=A.+Rane&title=Styrene+oxide+metabolism+in+rhesus+monkey+liver%3A+enzyme+activities+in+subcellular+fractions+and+in+isolated+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Styrene oxide metabolism in rhesus monkey liver:  enzyme activities in subcellular fractions and in isolated hepatocytes</span></div><div class="casAuthors">Pacifici, Gian Maria; Lindberg, Bo; Glaumann, Hans; Rane, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">869-75</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The activity and kinetic behavior of epoxide hydrolase  [9048-63-9] were studied in various subcellular fractions of rhesus monkey liver isolated by differential centrifugation.  The purity of the fractions was estd. by morphometric electron microscopy.  Hydrolase activity was measured by a specific radiometric assay with 7-3H-labeled styrene oxide (I)  [96-09-3] as substrate.  All isolated subcellular fractions catalyzed the hydration of I as a significant rate.  With a satg. concn. of substrate (1 mM), the enzymic activity (nM/min/mg) of protein was 1.51 (nuclear fraction), 3.50 (mitochondrial fraction), 1.48 (microsomal fraction) and 1.69 (sol. fraction).  The hydrolase obeyed Michaelis-Menten kinetics in each fraction.  Vmax (Nm/min/mg) was 1.64 (nuclear fraction), 3.87 (mitochondrial fraction), 19.8 (microsomal fraction), and 2.72 (sol. fraction).  The Km (mM) values in the fractions were 0.09-0.07, 0.23, and 0.64, resp.  I metab. was also studied in isolated hepatocytes from rhesus monkey.  These cells hydrated the substrate easily, whereas the conjugation of I with GSH was not measurable.  Thus, epoxide hydrolase is present in all subcellular fractions of the rhesus monkey liver.  I is preferentially metabolized by hydration to styrene glycol  [93-56-1] in the isolated hepatocytes of this species and no conjugation with GSH was found under the incubation conditions used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLSVEpuzFjbVg90H21EOLACvtfcHk0lhYre9DDJhNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslSru70%253D&md5=a9ef763aee3cd8944aee9a5f36ce607b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacifici%26aufirst%3DG.%2BM.%26aulast%3DLindberg%26aufirst%3DB.%26aulast%3DGlaumann%26aufirst%3DH.%26aulast%3DRane%26aufirst%3DA.%26atitle%3DStyrene%2520oxide%2520metabolism%2520in%2520rhesus%2520monkey%2520liver%253A%2520enzyme%2520activities%2520in%2520subcellular%2520fractions%2520and%2520in%2520isolated%2520hepatocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1983%26volume%3D226%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stok, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, A. J.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450-dependent lipid metabolism in preovulatory follicles</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">5097</span>– <span class="NLM_lpage">5105</span>, <span class="refDoi"> DOI: 10.1210/en.2004-0710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1210%2Fen.2004-0710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15308618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVyhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=5097-5105&author=J.+W.+Newmanauthor=J.+E.+Stokauthor=J.+D.+Vidalauthor=C.+J.+Corbinauthor=Q.+Huangauthor=B.+D.+Hammockauthor=A.+J.+Conley&title=Cytochrome+P450-dependent+lipid+metabolism+in+preovulatory+follicles&doi=10.1210%2Fen.2004-0710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450-dependent lipid metabolism in preovulatory follicles</span></div><div class="casAuthors">Newman, J. W.; Stok, J. E.; Vidal, J. D.; Corbin, C. J.; Huang, Q.; Hammock, B. D.; Conley, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5097-5105</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Estrogen biosynthesis and proteolysis are both important processes involved in ovarian follicular development, which may be influenced by cytochrome P 450 (CYP)-dependent fatty acid metabolites.  However, CYP-dependent lipid metab. has not been characterized with respect to follicular maturation in vivo.  Therefore, follicular fluid was collected in the hours before and after the LH surge in pigs, and concns. of epoxy, hydroxy, and dihydroxy lipids were measured by liq. chromatog. tandem mass spectrometry.  Arachidonate oxidn. and epoxyeicosatrienoic acid hydrolysis to dihydroxyeicosatrienoic acids (DHETs) were also assessed in thecal and granulosa tissue fractions, and the expression of CYP epoxygenases was evaluated by immunoblots using available antisera.  To evaluate sol. epoxide hydrolase (sEH) expression, the porcine sEH was cloned from ovarian tissue, expressed and purified for antibody generation.  The follicular fluid oxylipin concns. ranged from 1-150 nM depending on the compd. and estrus stage.  The follicular fluid concns. of CYP-dependent oxylipins increased at estrus, as did sEH expression; however, significant changes in epoxides were not obsd., and the 11,12-DHET peak was delayed.  The ratio of 14,15-DHET:11,12-DHET across all samples correlated with the log of follicular fluid estradiol concns.  Epoxygenase activities were similar in theca and granulosa, varying little with follicular development, whereas the decline of a single CYP2J isoform at ovulation was obsd. by immunoblots.  The sEH activity was higher in granulosa than in theca.  Finally, the dynamic changes in follicular CYP-dependent arachidonic acid metabolites and their modulatory function in vascular models suggest roles for these metabolites in follicular maturation, which may include regulation of estradiol biosynthesis and preovulatory remodeling of the follicular wall that should be fully explored in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-65vBfYcpLVg90H21EOLACvtfcHk0lhYre9DDJhNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVyhurg%253D&md5=5a410a3ab49827eed9f9f8aa42960e5f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-0710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-0710%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DStok%26aufirst%3DJ.%2BE.%26aulast%3DVidal%26aufirst%3DJ.%2BD.%26aulast%3DCorbin%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DConley%26aufirst%3DA.%2BJ.%26atitle%3DCytochrome%2520P450-dependent%2520lipid%2520metabolism%2520in%2520preovulatory%2520follicles%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D5097%26epage%3D5105%26doi%3D10.1210%2Fen.2004-0710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Distribution and properties of a mammalian soluble epoxide hydrase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(80)90518-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2880%2990518-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7362652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL3cXhslOqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1980&pages=389-395&author=S.+S.+Gillauthor=B.+D.+Hammock&title=Distribution+and+properties+of+a+mammalian+soluble+epoxide+hydrase&doi=10.1016%2F0006-2952%2880%2990518-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and properties of a mammalian soluble epoxide hydrase</span></div><div class="casAuthors">Gill, Sarjeet S.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The highest epoxide hydrase (I) activity in liver subcellular fractions was obsd. in the 100,000 g supernatant (sol.) and mitochondrial fractions, whereas activity in washed microsomes was lower.  The sol. I activity was highest in the liver and kidney of mice and rabbits and was also present in the duodenum, muscle, colon, lung, and spleen in decreasing order of activity.  The level of sol. I activity was highest in female rabbits and male mice and lowest in male rats.  The level of I activity varied with the strain of mice.  I activity in both male and female mice increased with age.  Sol. I activity required no cofactor and had a mol. wt. of ∼130,000.  I activity was inhibited by inorg. ions, esp. Cu, and stabilized by diisopropyl fluorophosphate.  Thus, in most mammalian tissues ≥2 I may be present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB5-6fRB2pjrVg90H21EOLACvtfcHk0ljLUgT664eCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhslOqsro%253D&md5=8c5eff8c546a30c3a19d23579dec318d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2880%2990518-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252880%252990518-3%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDistribution%2520and%2520properties%2520of%2520a%2520mammalian%2520soluble%2520epoxide%2520hydrase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1980%26volume%3D29%26spage%3D389%26epage%3D395%26doi%3D10.1016%2F0006-2952%2880%2990518-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y.</span></span> <span> </span><span class="NLM_article-title">The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">16747</span>– <span class="NLM_lpage">16752</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508081102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0508081102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16267130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16747-16752&author=Y.+Liuauthor=Y.+Zhangauthor=K.+Schmelzerauthor=T.+S.+Leeauthor=X.+Fangauthor=Y.+Zhuauthor=A.+A.+Spectorauthor=S.+Gillauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=J.+Y.+Shyy&title=The+antiinflammatory+effect+of+laminar+flow%3A+the+role+of+PPARgamma%2C+epoxyeicosatrienoic+acids%2C+and+soluble+epoxide+hydrolase&doi=10.1073%2Fpnas.0508081102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The antiinflammatory effect of laminar flow: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase</span></div><div class="casAuthors">Liu, Yi; Zhang, Yingjia; Schmelzer, Kara; Lee, Tzong-Shyuan; Fang, Xiang; Zhu, Yi; Spector, Arthur A.; Gill, Sarjeet; Morisseau, Christophe; Hammock, Bruce D.; Shyy, John Y.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16747-16752</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We previously reported that laminar flow activates peroxisome proliferator-activated receptor γ (PPARγ) in vascular endothelial cells in a ligand-dependent manner that involves phospholipase A2 and cytochrome P 450 epoxygenases.  In this study, we investigated whether epoxyeicosatrienoic acids (EETs), the catalytic products of cytochrome P 450 epoxygenases, are PPARγ ligands.  Competition and direct binding assays revealed that EETs bind to the ligand-binding domain of PPARγ with Kd in the μM range.  In the presence of adamantyl-ureido-dodecanoic acid (AUDA), a sol. epoxide hydrolase (sEH)-specific inhibitor, EETs increased PPARγ transcription activity in endothelial cells and 3T3-L1 preadipocytes.  Inclusion of AUDA in the perfusing media enhanced, but overexpression of sEH reduced, the laminar flow-induced PPARγ activity.  Furthermore, laminar flow augmented cellular levels of EETs but decreased sEH at the levels of mRNA, protein, and activity.  Blocking PPARγ by GW9662 abolished the EET/AUDA-mediated antiinflammatory effect, which indicates that PPARγ is an effector of EETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohz9z9ImCFfLVg90H21EOLACvtfcHk0ljLUgT664eCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgsLzE&md5=66de0f5a912f3764516f4db6ebebaaa1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508081102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508081102%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DT.%2BS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DGill%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%26atitle%3DThe%2520antiinflammatory%2520effect%2520of%2520laminar%2520flow%253A%2520the%2520role%2520of%2520PPARgamma%252C%2520epoxyeicosatrienoic%2520acids%252C%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16747%26epage%3D16752%26doi%3D10.1073%2Fpnas.0508081102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spearow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(95)00167-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0006-2952%2895%2900167-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7646556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=501-508&author=F.+Pinotauthor=D.+F.+Grantauthor=J.+L.+Spearowauthor=A.+G.+Parkerauthor=B.+D.+Hammock&title=Differential+regulation+of+soluble+epoxide+hydrolase+by+clofibrate+and+sexual+hormones+in+the+liver+and+kidneys+of+mice&doi=10.1016%2F0006-2952%2895%2900167-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice</span></div><div class="casAuthors">Pinot, Franck; Grant, David F.; Spearow, Jimmy L.; Parker, Anthony G.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-8</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) activity was measured in the liver and kidneys of male, female, and castrated male mice to evaluate sex- and tissue-specific differences in enzyme expression.  SEH activity was higher in liver than in kidneys.  Activity increased with age in the liver of females, males and castrated males, but only in males did activity in the kidneys increase.  There was greater activity in both the liver and kidneys of adult males than females.  This sexual dimorphism was more pronounced in the kidneys (283% higher) than in the liver (55% higher).  Castration of males led to a decrease in activity in both organs, but it had a greater effect on renal activity (67% decrease) than on hepatic activity (27% decrease).  Treatment of castrated mice with testosterone led to an increase in sEH activity of 4005 in kidneys and 49% n liver compared with surgical controls.  These results suggest differential regulation of sEH by testosterone in kidneys and liver.  Ovariectomized female mice had renal and hepatic activities approx. 30% greater than control females.  Feeding mice with the hypolipidemic drug clofibrate produced stronger induction of sEH in liver than in kidneys.  Testosterone treatment, however, caused greater induction in kidneys than in liver of females and castrated males and had no effect in either kidneys or liver in males.  When given together, the effects of these two compds. appeared to be additive in both liver and kidneys.  Results from western blot showed that the increase in sEH enzyme activity in kidneys is correlated with an increase in sEH protein.  These results suggest that clofibrate and testosterone independently regulate sEH activity in vivo, and that kidneys and liver respond differently to clofibrate and testosterone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVt8TZx_lduLVg90H21EOLACvtfcHk0ljLUgT664eCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFyis7w%253D&md5=cb019f9f8ab704dd61f300948a7bea60</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900167-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900167-X%26sid%3Dliteratum%253Aachs%26aulast%3DPinot%26aufirst%3DF.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26aulast%3DSpearow%26aufirst%3DJ.%2BL.%26aulast%3DParker%26aufirst%3DA.%2BG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDifferential%2520regulation%2520of%2520soluble%2520epoxide%2520hydrolase%2520by%2520clofibrate%2520and%2520sexual%2520hormones%2520in%2520the%2520liver%2520and%2520kidneys%2520of%2520mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D501%26epage%3D508%26doi%3D10.1016%2F0006-2952%2895%2900167-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of peroxisome proliferator-activated receptor-gamma downregulates soluble epoxide hydrolase in cardiomyocytes</span>. <i>Clin. Exp. Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1681.2011.05492.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1440-1681.2011.05492.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21291492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=358-364&author=W.+Pangauthor=N.+Liauthor=D.+Aiauthor=X.+L.+Niuauthor=Y.+F.+Guanauthor=Y.+Zhu&title=Activation+of+peroxisome+proliferator-activated+receptor-gamma+downregulates+soluble+epoxide+hydrolase+in+cardiomyocytes&doi=10.1111%2Fj.1440-1681.2011.05492.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes</span></div><div class="casAuthors">Pang, Wei; Li, Nan; Ai, Ding; Niu, Xiao-Lin; Guan, You-Fei; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antidiabetic agents, thiazolidinediones (TZD), ligands for peroxisome proliferator-activated receptor-γ (PPARγ), were reported to reduce cardiac hypertrophy.  However, the underlying mechanism is still elusive.  We previously reported that sol. epoxide hydrolase (sEH) was specifically upregulated by angiotensin-II (AngII), which directly mediated AngII-induced cardiac hypertrophy.  In the present study, we examd. the role of sEH in PPARγ inhibiting AngII-induced cardiac hypertrophy.  The protein level of sEH was elevated in the left ventricle of AngII-infused Sprague-Dawley rats.  Administration of the TZD rosiglitazone decreased this induction.  In vitro, AngII upregulated the expression of sEH and hypertrophy markers, including atrial natriuretic factor and β-myosin heavy chain, in rat neonatal cardiomyocytes and H9c2 cells, which was attenuated by rosiglitazone and pioglitazone.  An elevated level of sEH was also found in the left ventricle of heterozygous PPARγ-deficient mice.  The effect of TZD on sEH level could be reversed by treatment with the PPARγ antagonists, GW9662 and BADGE, which suggests PPARγ activation.  In elucidating the mechanisms by which PPARγ inhibited AngII-induced sEH expression, we found that rosiglitazone inhibited AngII-induced sEH promoter activity in H9c2 cells.  In contrast, the activity of the human sEH 3'UTR was not affected by AngII and TZD.  Our results suggest that the protective role of PPARγ activation in AngII-induced cardiac hypertrophy is, at least in part, through downregulating sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3KgtzmvWz27Vg90H21EOLACvtfcHk0ljqjYWkhPXAuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegsLo%253D&md5=0e851867c8c6aa8b2f53f7ceb460d3ce</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2011.05492.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2011.05492.x%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DX.%2BL.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DActivation%2520of%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520downregulates%2520soluble%2520epoxide%2520hydrolase%2520in%2520cardiomyocytes%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2011%26volume%3D38%26spage%3D358%26epage%3D364%26doi%3D10.1111%2Fj.1440-1681.2011.05492.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjodin, M. O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunewald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">236</span>, <span class="refDoi"> DOI: 10.1186/s12931-018-0939-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12931-018-0939-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30509266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3crotVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=236&author=M.+O.+D.+Sjodinauthor=A.+Checaauthor=M.+Yangauthor=S.+E.+Dahlenauthor=A.+M.+Wheelockauthor=A.+Eklundauthor=J.+Grunewaldauthor=C.+E.+Wheelock&title=Soluble+epoxide+hydrolase+derived+lipid+mediators+are+elevated+in+bronchoalveolar+lavage+fluid+from+patients+with+sarcoidosis%3A+a+cross-sectional+study&doi=10.1186%2Fs12931-018-0939-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study</span></div><div class="casAuthors">Sjodin Marcus O D; Checa Antonio; Wheelock Craig E; Sjodin Marcus O D; Dahlen Sven-Erik; Yang Mingxing; Wheelock ¡ÑÜAsa M; Eklund Anders; Grunewald Johan</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Sarcoidosis is a systemic inflammatory multi-organ disease almost always affecting the lungs.  The etiology remains unknown, but the hallmark of sarcoidosis is formation of non-caseating epithelioid cells granulomas in involved organs.  In Scandinavia, > 30% of sarcoidosis patients have Lofgren's syndrome (LS), an acute disease onset mostly indicating a favorable prognosis.  The impact of dysregulation of lipid mediators, which has been investigated in other inflammatory disorders, is still unknown.  METHODS:  Using three different liquid chromatography coupled to tandem mass spectrometry targeted platforms (LC-MS/MS), we quantified a broad suite of lipid mediators including eicosanoids, sphingolipids and endocannabinoids in bronchoalveolar lavage (BAL) fluid from pulmonary sarcoidosis patients (n = 41) and healthy controls (n = 16).  RESULTS:  A total of 47 lipid mediators were consistently detected in BAL fluid of patients and controls.  After false discovery rate adjustment, two products of the soluble epoxide hydrolase (sEH) enzyme, 11,12-dihydroxyeicosa-5,8,14-trienoic acid (11,12-DiHETrE, p = 4.4E-5, q = 1.2E-3, median fold change = 6.0) and its regioisomer 14,15-dihydroxyeicosa-5,8,11-trienoic acid (14,15-DiHETrE, p = 3.6E-3, q = 3.2E-2, median fold change = 1.8) increased in patients with sarcoidosis.  Additional shifts were observed in sphingolipid metabolism, with a significant increase in palmitic acid-derived sphingomyelin (SM16:0, p = 1.3E-3, q = 1.7E-2, median fold change = 1.3).  No associations were found between these 3 lipid mediators and LS, whereas levels of SM 16:0 and 11,12-DiHETrE associated with radiological stage (p < 0.05), and levels of 14,15-DiHETrE were associated with the BAL fluid CD4/CD8 ratio.  CONCLUSIONS:  These observed shifts in lipid mediators provide new insights into the pathobiology of sarcoidosis and in particular highlight the sEH pathway to be dysregulated in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8xUXck0YaLDdblLE_E9PWfW6udTcc2eaToB-tLKxa9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crotVKnuw%253D%253D&md5=97e029f30bab5c29d861fb595d1fd17e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2Fs12931-018-0939-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12931-018-0939-0%26sid%3Dliteratum%253Aachs%26aulast%3DSjodin%26aufirst%3DM.%2BO.%2BD.%26aulast%3DCheca%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DDahlen%26aufirst%3DS.%2BE.%26aulast%3DWheelock%26aufirst%3DA.%2BM.%26aulast%3DEklund%26aufirst%3DA.%26aulast%3DGrunewald%26aufirst%3DJ.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520derived%2520lipid%2520mediators%2520are%2520elevated%2520in%2520bronchoalveolar%2520lavage%2520fluid%2520from%2520patients%2520with%2520sarcoidosis%253A%2520a%2520cross-sectional%2520study%26jtitle%3DRespir.%2520Res.%26date%3D2018%26volume%3D19%26spage%3D236%26doi%3D10.1186%2Fs12931-018-0939-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.45.120403.095920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1146%2Fannurev.pharmtox.45.120403.095920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15822179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=311-333&author=C.+Morisseauauthor=B.+D.+Hammock&title=Epoxide+hydrolases%3A+mechanisms%2C+inhibitor+designs%2C+and+biological+roles&doi=10.1146%2Fannurev.pharmtox.45.120403.095920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-333, 3 plates</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Organisms are exposed to epoxide-contg. compds. from both exogenous and endogenous sources.  In mammals, the hydration of these compds. by various epoxide hydrolases (EHs) can not only regulate their genotoxicity but also, for lipid-derived epoxides, their endogenous roles as chem. mediators.  Recent findings suggest that the EHs as a family represent novel drug discovery targets for regulation of blood pressure, inflammation, cancer progression, and the onset of several other diseases.  Knowledge of the EH reaction mechanism provides a solid foundation for the rational design of inhibitors, and this review summarizes the current understanding of the catalytic mechanism of EHs.  Although the overall EH reaction mechanism is now known, the mol. basis of substrate selectivity, possible allosteric regulation, and many fine details of the catalytic mechanism remain to be solved.  Finally, recent development in the design of EH inhibitors and the biol. roles of EHs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgu-XChp4zKbVg90H21EOLACvtfcHk0ljqjYWkhPXAuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWjt7k%253D&md5=faf96336e9373dd089c5eae29804f1bb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.45.120403.095920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.45.120403.095920%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEpoxide%2520hydrolases%253A%2520mechanisms%252C%2520inhibitor%2520designs%252C%2520and%2520biological%2520roles%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D311%26epage%3D333%26doi%3D10.1146%2Fannurev.pharmtox.45.120403.095920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Phosphatase activity of soluble epoxide hydrolase</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2017.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2017.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWksLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=88-92&author=J.+Kramerauthor=E.+Proschak&title=Phosphatase+activity+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.prostaglandins.2017.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatase activity of soluble epoxide hydrolase</span></div><div class="casAuthors">Kramer, Jan; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a bifunctional enzyme that exhibits lipid epoxide hydrolase (sEH-H) and lipid phosphatase activity (sEH-P), with each being located in its own distinct domain.  While the epoxide hydrolase activity is well-investigated, the role of the phosphatase domain remains unclear.  This article briefly summarizes the evolution, structure and SNPs of the human sEH, with a special focus on the function and postulated role of the N-terminal domain of sEH.  Furthermore, the article provides an overview of tools to study sEH-P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-ym_22cFMzrVg90H21EOLACvtfcHk0lhYxYI-XYyYSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWksLvM&md5=8cc942976d3c79294e23884a22e4f553</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2017.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2017.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DPhosphatase%2520activity%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2017%26volume%3D133%26spage%3D88%26epage%3D92%26doi%3D10.1016%2Fj.prostaglandins.2017.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurung, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayengbam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1016/j.compbiolchem.2018.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.compbiolchem.2018.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29522918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2018&pages=1-11&author=A.+B.+Gurungauthor=B.+Mayengbamauthor=A.+Bhattacharjee&title=Discovery+of+novel+drug+candidates+for+inhibition+of+soluble+epoxide+hydrolase+of+arachidonic+acid+cascade+pathway+implicated+in+atherosclerosis&doi=10.1016%2Fj.compbiolchem.2018.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis</span></div><div class="casAuthors">Gurung, Arun Bahadur; Mayengbam, Bishwarjit; Bhattacharjee, Atanu</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH), a key enzyme belonging to cytochrome P 450 pathway of arachidonic acid cascade is a novel therapeutic drug target against atherosclerosis.  The enzyme breaks down epoxyeicosatrienoic acid (EETs) to dihydroxy-eicosatrienoic acids (DHETs) and reduces beneficial cardiovascular properties of EETs.  Thus, the present work is aimed at identification of potential leads as sEH inhibitors which will sustain the beneficial properties of EETs in vivo.  PubChem and ZINC databases were screened for drug-like compds. based on Lipinski's rule of five and in silico toxicity filters.  The binding potential of the drug-like compds. with sEH was explored using mol. docking.  The top ranked lead (ZINC23099069) showed higher GOLD score compared with that of the control, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid Bu ester (AUDA-BE) and displayed two hydrogen bonds with Tyr383 and His420 and eleven residues involved in hydrophobic interactions with sEH.  The apo_sEH and sEH_ZINC23099069 complex showed stable trajectories during 20 ns time scale of mol. dynamics (MD) simulation.  Mol. Mechanics Poisson-Boltzmann Surface Area (MM/PBSA) binding free energy anal. showed that electrostatic energy is the driving energy component for interaction of the lead with sEH.  These results demonstrate ZINC23099069 to be a promising drug candidate as sEH inhibitor against atherosclerosis instead of the present urea-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnF_dsDbaRH7Vg90H21EOLACvtfcHk0lhYxYI-XYyYSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFKls7s%253D&md5=7c30d7873f977288df81206d98060281</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2018.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2018.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DGurung%26aufirst%3DA.%2BB.%26aulast%3DMayengbam%26aufirst%3DB.%26aulast%3DBhattacharjee%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520novel%2520drug%2520candidates%2520for%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520of%2520arachidonic%2520acid%2520cascade%2520pathway%2520implicated%2520in%2520atherosclerosis%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D74%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.compbiolchem.2018.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homburg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisslthaler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arand, M.</span></span> <span> </span><span class="NLM_article-title">The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1552</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437829100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0437829100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12574508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1552-1557&author=A.+Croninauthor=S.+Mowbrayauthor=H.+Durkauthor=S.+Homburgauthor=I.+Flemingauthor=B.+Fisslthalerauthor=F.+Oeschauthor=M.+Arand&title=The+N-terminal+domain+of+mammalian+soluble+epoxide+hydrolase+is+a+phosphatase&doi=10.1073%2Fpnas.0437829100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase</span></div><div class="casAuthors">Cronin, Annette; Mowbray, Sherry; Durk, Heike; Homburg, Shirli; Fleming, Ingrid; Fisslthaler, Beate; Oesch, Franz; Arand, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1552-1557</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mammalian sol. epoxide hydrolase (sEH) is an enzyme with multiple functions, being implicated in detoxification of xenobiotic epoxides as well as in regulation of physiol. processes such as blood pressure.  The enzyme is a homodimer, in which each subunit is composed of two domains.  The 35-kDa C-terminal domain has an α/β hydrolase fold and harbors the catalytic center for the EH activity.  The 25-kDa N-terminal domain has a different α/β fold and belongs to the haloacid dehalogenase superfamily of enzymes.  The catalytic properties of the enzyme reported so far can all be explained by the action of the C-terminal domain alone.  The function of the N-terminal domain, other than in structural stabilization of the dimer, has therefore remained unclear.  By structural comparison of this domain to other haloacid dehalogenase family members, we identified a putative active site contg. all necessary components for phosphatase activity.  Subsequently, we found rat sEH hydrolyzed 4-nitrophenyl phosphate with a rate const. of 0.8 s-1 and a Km of 0.24 mM.  Recombinant human sEH lacking the C-terminal domain also displayed phosphatase activity.  Presence of a phosphatase substrate did not affect epoxide turnover nor did epoxides affect dephosphorylation by the intact enzyme, indicating both catalytic sites act independently.  The enzyme was unable to hydrolyze 4-nitrophenyl sulfate, suggesting its role in xenobiotic metab. does not extend beyond phosphates.  Thus, we propose this domain participates instead in the regulation of the physiol. functions assocd. with sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDq5TEmwWKC7Vg90H21EOLACvtfcHk0lhYxYI-XYyYSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt74%253D&md5=e03c11c09660edaf1d8ddf4d36e93906</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437829100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437829100%26sid%3Dliteratum%253Aachs%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DMowbray%26aufirst%3DS.%26aulast%3DDurk%26aufirst%3DH.%26aulast%3DHomburg%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DFisslthaler%26aufirst%3DB.%26aulast%3DOesch%26aufirst%3DF.%26aulast%3DArand%26aufirst%3DM.%26atitle%3DThe%2520N-terminal%2520domain%2520of%2520mammalian%2520soluble%2520epoxide%2520hydrolase%2520is%2520a%2520phosphatase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1552%26epage%3D1557%26doi%3D10.1073%2Fpnas.0437829100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1558</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1073/pnas.0437724100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0437724100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12574510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1558-1563&author=J.+W.+Newmanauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=B.+D.+Hammock&title=The+soluble+epoxide+hydrolase+encoded+by+EPXH2+is+a+bifunctional+enzyme+with+novel+lipid+phosphate+phosphatase+activity&doi=10.1073%2Fpnas.0437724100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity</span></div><div class="casAuthors">Newman, John W.; Morisseau, Christophe; Harris, Todd R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1558-1563</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The gene EPXH2 encodes for the sol. epoxide hydrolase (sEH), an enzyme involved in the regulation of cardiovascular and renal physiol. contg. two distinct domains connected via a proline-rich linker.  The C-terminal domain contg. the EH catalytic activity has been well studied.  In contrast, a function for the N-terminal domain, which has high homol. to the haloacid dehalogenase family of phosphatases, has not been definitively reported.  In this study we describe the N-terminal domain as a functional phosphatase unaffected by a no. of classic phosphatase inhibitors.  Assuming a functional assocn. between these catalytic activities, dihydroxy lipid phosphates were rationalized as potential endogenous substrates.  A series of phosphorylated hydroxy lipids were therefore synthesized and found to be excellent substrates for the human sEH.  The best substrate tested was the monophosphate of dihydroxy stearic acid (threo-9/10-phosphonoxy-hydroxy-octadecanoic acid) with Km = 21±0.3 μM, VMax = 338±12 nmol·min-1·mg-1, and kcat = 0.35±0.01 s-1.  Therefore dihydroxy lipid phosphates are possible candidates for the endogenous substrates of the sEH N-terminal domain, which would represent a novel branch of fatty acid metab. with potential signaling functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKrVMg8wVS17Vg90H21EOLACvtfcHk0liIrNQ1I6mLJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGkt78%253D&md5=4ba57aa7ac5f01a77123a0b520312206</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0437724100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0437724100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DThe%2520soluble%2520epoxide%2520hydrolase%2520encoded%2520by%2520EPXH2%2520is%2520a%2520bifunctional%2520enzyme%2520with%2520novel%2520lipid%2520phosphate%2520phosphatase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1558%26epage%3D1563%26doi%3D10.1073%2Fpnas.0437724100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of the human soluble epoxide hydrolase gene (EPHX2)</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>221</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1996.0596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fbbrc.1996.0596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8619856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK28XisVahtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1996&pages=333-339&author=M.+Sandbergauthor=J.+Meijer&title=Structural+characterization+of+the+human+soluble+epoxide+hydrolase+gene+%28EPHX2%29&doi=10.1006%2Fbbrc.1996.0596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of the human soluble epoxide hydrolase gene (EPHX2)</span></div><div class="casAuthors">Sandberg, Martin; Meijer, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-9</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The structural organization of the human gene encoding sol. epoxide hydrolase (EPHX2) was detd.  Cosmid clones contg. the EPHX2 gene were identified by hybridization of a human genomic library with PCR amplified cDNA to the mouse or human sol. epoxide hydrolase as probes.  The gene consists of 19 exons and is approx. 45 kb of which more than 15 kb were sequenced.  The coding sequence corresponds to 555 amino acid residues, i.e., one addnl. residue to those in the reported cDNA sequence.  The sizes of the introns were defined by sequencing or PCR anal. and they contained various repetitive structure elements as expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoil2OjI8QoS7Vg90H21EOLACvtfcHk0liIrNQ1I6mLJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVahtLo%253D&md5=caed0489f88a4966c12da36f4dc8909e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1996.0596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1996.0596%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DJ.%26atitle%3DStructural%2520characterization%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%2520gene%2520%2528EPHX2%2529%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D221%26spage%3D333%26epage%3D339%26doi%3D10.1006%2Fbbrc.1996.0596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Przybyla-Zawislak, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Matias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohrenweiser, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enayetallah, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, D. F.</span></span> <span> </span><span class="NLM_article-title">Polymorphisms in human soluble epoxide hydrolase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1124/mol.64.2.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fmol.64.2.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12869654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVCnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=482-490&author=B.+D.+Przybyla-Zawislakauthor=P.+K.+Srivastavaauthor=J.+Vazquez-Matiasauthor=H.+W.+Mohrenweiserauthor=J.+E.+Maxwellauthor=B.+D.+Hammockauthor=J.+A.+Bradburyauthor=A.+E.+Enayetallahauthor=D.+C.+Zeldinauthor=D.+F.+Grant&title=Polymorphisms+in+human+soluble+epoxide+hydrolase&doi=10.1124%2Fmol.64.2.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphisms in human soluble epoxide hydrolase</span></div><div class="casAuthors">Przybyla-Zawislak, Beata D.; Srivastava, Punit K.; Vazquez-Matias, Johana; Mohrenweiser, Harvey W.; Maxwell, Joseph E.; Hammock, Bruce D.; Bradbury, J. Alyce; Enayetallah, Ahmed E.; Zeldin, Darryl C.; Grant, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">482-490</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Human sol. epoxide hydrolase (hsEH) metabolizes a variety of epoxides to the corresponding vicinal diols.  Arachidonic and linoleic acid epoxides are thought to be endogenous substrates for hsEH.  Enzyme activity in humans shows high interindividual variation (e.g., 500-fold in liver) suggesting the existence of regulatory and/or structural gene polymorphisms.  We resequenced each of the 19 exons of the hsEH gene (EPHX2) from 72 persons representing black, Asian, and white populations.  A variety of polymorphisms was found, six of which result in amino acid substitutions.  Amino acid variants were localized on the crystal structure of the mouse sEH, resulting in the prediction that at least two of these (Arg287Gln and Arg103Cys) might significantly affect enzyme function.  The six variants of the hsEH cDNA corresponding to each single polymorphism and one corresponding to a double polymorphism were then constructed by site-directed mutagenesis and expressed in insect cells.  As predicted, Arg287Gln and the double mutant Arg287Gln/Arg103Cys showed decreased enzyme activity using trans-stilbene oxide, trans-diphenylpropene oxide, and 14,15-epoxyeicosatrienoic acid as substrates.  Lys55Arg and Cys154Tyr mutants had elevated activity for all three substrates.  Detailed kinetic studies revealed that the double mutant Arg287Gln/Arg103Cys showed significant differences in Km and Vmax.  In addn., stability studies showed that the double mutant was less stable than wild-type protein when incubated at 37°.  These results suggest that at least six hsEH variants exist in the human population and that at least four of these may influence hsEH-mediated metab. of exogenous and endogenous epoxide substrates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbIYnbOqGerbVg90H21EOLACvtfcHk0liIrNQ1I6mLJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVCnsLY%253D&md5=9564abd3101d57a3490b6d5986c585c0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.2.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.2.482%26sid%3Dliteratum%253Aachs%26aulast%3DPrzybyla-Zawislak%26aufirst%3DB.%2BD.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DVazquez-Matias%26aufirst%3DJ.%26aulast%3DMohrenweiser%26aufirst%3DH.%2BW.%26aulast%3DMaxwell%26aufirst%3DJ.%2BE.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DEnayetallah%26aufirst%3DA.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DGrant%26aufirst%3DD.%2BF.%26atitle%3DPolymorphisms%2520in%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D482%26epage%3D490%26doi%3D10.1124%2Fmol.64.2.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical</span>. <i>Pest Manage. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">609</span>, <span class="refDoi"> DOI: 10.1002/ps.1583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fps.1583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=18383502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlWhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=594-609&author=C.+Morisseauauthor=B.+D.+Hammock&title=Gerry+Brooks+and+epoxide+hydrolases%3A+four+decades+to+a+pharmaceutical&doi=10.1002%2Fps.1583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Pest Management Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">594-609</span>CODEN:
                <span class="NLM_cas:coden">PMSCFC</span>;
        ISSN:<span class="NLM_cas:issn">1526-498X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The pioneering work of Gerry Brooks on cyclodiene insecticides led to the discovery of a class of enzymes known as epoxide hydrolases.  The results from 4 decades of work confirm Brooks' 1st observations that the microsomal epoxide hydrolase is important in foreign compd. metab.  Brooks and assocs. went on to be the first to carry out a systematic study of the inhibition of this enzyme.  A 2nd role for this enzyme family was in the degrdn. of insect juvenile hormone (JH).  JH epoxide hydrolases have now been cloned and expressed from several species, and there is interest in developing inhibitors for them.  Interestingly, the distantly related mammalian sol. epoxide hydrolase has emerged as a promising pharmacol. target for treating hypertension, inflammatory disease, and pain.  Tight-binding transition-state inhibitors were developed with good ADME (absorption, distribution, metab., and excretion).  These compds. stabilize endogenous epoxides of fatty acids, including arachidonic acid, which have profound therapeutic effects.  Now EHs from microorganisms and plants are used in green chem.  From his seminal work, Dr. Brooks opened the field of epoxide hydrolase research in many directions including xenobiotic metab., insect physiol., and human health, as well as asym. org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcNMy-FVYB7Vg90H21EOLACvtfcHk0lhgsCTujUPlgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlWhsLs%253D&md5=c98be78c94a46aa7b0a9b0a3ee8041e7</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fps.1583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fps.1583%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DGerry%2520Brooks%2520and%2520epoxide%2520hydrolases%253A%2520four%2520decades%2520to%2520a%2520pharmaceutical%26jtitle%3DPest%2520Manage.%2520Sci.%26date%3D2008%26volume%3D64%26spage%3D594%26epage%3D609%26doi%3D10.1002%2Fps.1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott-Van
Zeeland, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloss, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewhey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torkamani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libiger, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvvuri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wineinger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darst, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarasa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tisch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichter, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Via, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treasure, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodside, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulik, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klump, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilenfeld, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnicov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topol, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magistretti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrettini, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for the role of EPHX2 gene variants in anorexia nervosa</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1038/mp.2013.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fmp.2013.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23999524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosV2gt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=724-732&author=A.+A.+Scott-Van%0AZeelandauthor=C.+S.+Blossauthor=R.+Tewheyauthor=V.+Bansalauthor=A.+Torkamaniauthor=O.+Libigerauthor=V.+Duvvuriauthor=N.+Wineingerauthor=L.+Galvezauthor=B.+F.+Darstauthor=E.+N.+Smithauthor=A.+Carsonauthor=P.+Phamauthor=T.+Phillipsauthor=N.+Villarasaauthor=R.+Tischauthor=G.+Zhangauthor=S.+Levyauthor=S.+Murrayauthor=W.+Chenauthor=S.+Srinivasanauthor=G.+Berensonauthor=H.+Brandtauthor=S.+Crawfordauthor=S.+Crowauthor=M.+M.+Fichterauthor=K.+A.+Halmiauthor=C.+Johnsonauthor=A.+S.+Kaplanauthor=M.+La+Viaauthor=J.+E.+Mitchellauthor=M.+Stroberauthor=A.+Rotondoauthor=J.+Treasureauthor=D.+B.+Woodsideauthor=C.+M.+Bulikauthor=P.+Keelauthor=K.+L.+Klumpauthor=L.+Lilenfeldauthor=K.+Plotnicovauthor=E.+J.+Topolauthor=P.+B.+Shihauthor=P.+Magistrettiauthor=A.+W.+Bergenauthor=W.+Berrettiniauthor=W.+Kayeauthor=N.+J.+Schork&title=Evidence+for+the+role+of+EPHX2+gene+variants+in+anorexia+nervosa&doi=10.1038%2Fmp.2013.91"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of EPHX2 gene variants in anorexia nervosa</span></div><div class="casAuthors">Scott-Van Zeeland, A. A.; Bloss, C. S.; Tewhey, R.; Bansal, V.; Torkamani, A.; Libiger, O.; Duvvuri, V.; Wineinger, N.; Galvez, L.; Darst, B. F.; Smith, E. N.; Carson, A.; Pham, P.; Phillips, T.; Villarasa, N.; Tisch, R.; Zhang, G.; Levy, S.; Murray, S.; Chen, W.; Srinivasan, S.; Berenson, G.; Brandt, H.; Crawford, S.; Crow, S.; Fichter, M. M.; Halmi, K. A.; Johnson, C.; Kaplan, A. S.; La Via, M.; Mitchell, J. E.; Strober, M.; Rotondo, A.; Treasure, J.; Woodside, D. B.; Bulik, C. M.; Keel, P.; Klump, K. L.; Lilenfeld, L.; Plotnicov, K.; Topol, E. J.; Shih, P. B.; Magistretti, P.; Bergen, A. W.; Berrettini, W.; Kaye, W.; Schork, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-732</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Anorexia nervosa (AN) and related eating disorders are complex, multifactorial neuropsychiatric conditions with likely rare and common genetic and environmental determinants.  To identify genetic variants assocd. with AN, we pursued a series of sequencing and genotyping studies focusing on the coding regions and upstream sequence of 152 candidate genes in a total of 1205 AN cases and 1948 controls.  We identified individual variant assocns. in the Estrogen Receptor-ss (ESR2) gene, as well as a set of rare and common variants in the Epoxide Hydrolase 2 (EPHX2) gene, in an initial sequencing study of 261 early-onset severe AN cases and 73 controls (P=0.0004).  The assocn. of EPHX2 variants was further delineated in: (1) a pooling-based replication study involving an addnl. 500 AN patients and 500 controls (replication set P=0.00000016); (2) single-locus studies in a cohort of 386 previously genotyped broadly defined AN cases and 295 female population controls from the Bogalusa Heart Study (BHS) and a cohort of 58 individuals with self-reported eating disturbances and 851 controls (combined smallest single locus P<0.01).  As EPHX2 is known to influence cholesterol metab., and AN is often assocd. with elevated cholesterol levels, we also investigated the assocn. of EPHX2 variants and longitudinal body mass index (BMI) and cholesterol in BHS female and male subjects (N=229) and found evidence for a modifying effect of a subset of variants on the relationship between cholesterol and BMI (P<0.01).  These findings suggest a novel assocn. of gene variants within EPHX2 to susceptibility to AN and provide a foundation for future study of this important yet poorly understood condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp71F_z_GLN7rVg90H21EOLACvtfcHk0lhgsCTujUPlgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosV2gt7k%253D&md5=7ee72b62ea14ebd2a9208009a1ec907e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fmp.2013.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2013.91%26sid%3Dliteratum%253Aachs%26aulast%3DScott-Van%2BZeeland%26aufirst%3DA.%2BA.%26aulast%3DBloss%26aufirst%3DC.%2BS.%26aulast%3DTewhey%26aufirst%3DR.%26aulast%3DBansal%26aufirst%3DV.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DLibiger%26aufirst%3DO.%26aulast%3DDuvvuri%26aufirst%3DV.%26aulast%3DWineinger%26aufirst%3DN.%26aulast%3DGalvez%26aufirst%3DL.%26aulast%3DDarst%26aufirst%3DB.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BN.%26aulast%3DCarson%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DP.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DVillarasa%26aufirst%3DN.%26aulast%3DTisch%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DBerenson%26aufirst%3DG.%26aulast%3DBrandt%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DCrow%26aufirst%3DS.%26aulast%3DFichter%26aufirst%3DM.%2BM.%26aulast%3DHalmi%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DA.%2BS.%26aulast%3DLa%2BVia%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DJ.%2BE.%26aulast%3DStrober%26aufirst%3DM.%26aulast%3DRotondo%26aufirst%3DA.%26aulast%3DTreasure%26aufirst%3DJ.%26aulast%3DWoodside%26aufirst%3DD.%2BB.%26aulast%3DBulik%26aufirst%3DC.%2BM.%26aulast%3DKeel%26aufirst%3DP.%26aulast%3DKlump%26aufirst%3DK.%2BL.%26aulast%3DLilenfeld%26aufirst%3DL.%26aulast%3DPlotnicov%26aufirst%3DK.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DShih%26aufirst%3DP.%2BB.%26aulast%3DMagistretti%26aufirst%3DP.%26aulast%3DBergen%26aufirst%3DA.%2BW.%26aulast%3DBerrettini%26aufirst%3DW.%26aulast%3DKaye%26aufirst%3DW.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520EPHX2%2520gene%2520variants%2520in%2520anorexia%2520nervosa%26jtitle%3DMol.%2520Psychiatry%26date%3D2014%26volume%3D19%26spage%3D724%26epage%3D732%26doi%3D10.1038%2Fmp.2013.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy</span>. <i>Am. J. Physiol. Renal. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">F1283</span>– <span class="NLM_lpage">F1290</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00733.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajprenal.00733.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21429967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=F1283-F1290&author=J.+P.+Leeauthor=S.+H.+Yangauthor=D.+K.+Kimauthor=H.+Leeauthor=B.+Kimauthor=J.+Y.+Choauthor=K.+S.+Yuauthor=J.+H.+Paikauthor=M.+Kimauthor=C.+S.+Limauthor=Y.+S.+Kim&title=In+vivo+activity+of+epoxide+hydrolase+according+to+sequence+variation+affects+the+progression+of+human+IgA+nephropathy&doi=10.1152%2Fajprenal.00733.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00733.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00733.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DYu%26aufirst%3DK.%2BS.%26aulast%3DPaik%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DIn%2520vivo%2520activity%2520of%2520epoxide%2520hydrolase%2520according%2520to%2520sequence%2520variation%2520affects%2520the%2520progression%2520of%2520human%2520IgA%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal.%2520Physiol.%26date%3D2011%26volume%3D300%26spage%3DF1283%26epage%3DF1290%26doi%3D10.1152%2Fajprenal.00733.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarriello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuazon, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incontri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borlongan, C. V.</span></span> <span> </span><span class="NLM_article-title">Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2018.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pneurobio.2018.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30447256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKmu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2019&pages=23-39&author=S.+Zarrielloauthor=J.+P.+Tuazonauthor=S.+Coreyauthor=S.+Schimmelauthor=M.+Rajaniauthor=A.+Gorskyauthor=D.+Incontriauthor=B.+D.+Hammockauthor=C.+V.+Borlongan&title=Humble+beginnings+with+big+goals%3A+Small+molecule+soluble+epoxide+hydrolase+inhibitors+for+treating+CNS+disorders&doi=10.1016%2Fj.pneurobio.2018.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders</span></div><div class="casAuthors">Zarriello, Sydney; Tuazon, Julian P.; Corey, Sydney; Schimmel, Samantha; Rajani, Mira; Gorsky, Anna; Incontri, Diego; Hammock, Bruce D.; Borlongan, Cesar V.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sol. epoxide hydrolase (sEH) degrades epoxides of fatty acids including epoxyeicosatrienoic acid isomers (EETs), which are produced as metabolites of the cytochrome P 450 branch of the arachidonic acid pathway.  EETs exert a variety of largely beneficial effects in the context of inflammation and vascular regulation.  SEH inhibition is shown to be therapeutic in several cardiovascular and renal disorders, as well as in peripheral analgesia, via the increased availability of anti-inflammatory EETs.  The success of sEH inhibitors in peripheral systems suggests their potential in targeting inflammation in the central nervous system (CNS) disorders.  Here, we describe the current roles of sEH in the pathol. and treatment of CNS disorders such as stroke, traumatic brain injury, Parkinson's disease, epilepsy, cognitive impairment, dementia and depression.  In view of the robust anti-inflammatory effects of stem cells, we also outlined the potency of stem cell treatment and sEH inhibitors as a combination therapy for these CNS disorders.  This review highlights the gaps in current knowledge about the pathol. and therapeutic roles of sEH in CNS disorders, which should guide future basic science research towards translational and clin. applications of sEH inhibitors for treatment of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqdZcOhjwZrVg90H21EOLACvtfcHk0lj7GzJ1A3bSuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKmu7%252FE&md5=9886ffcff040fae7e960416c6f5d4f0e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2018.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2018.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DZarriello%26aufirst%3DS.%26aulast%3DTuazon%26aufirst%3DJ.%2BP.%26aulast%3DCorey%26aufirst%3DS.%26aulast%3DSchimmel%26aufirst%3DS.%26aulast%3DRajani%26aufirst%3DM.%26aulast%3DGorsky%26aufirst%3DA.%26aulast%3DIncontri%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBorlongan%26aufirst%3DC.%2BV.%26atitle%3DHumble%2520beginnings%2520with%2520big%2520goals%253A%2520Small%2520molecule%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520for%2520treating%2520CNS%2520disorders%26jtitle%3DProg.%2520Neurobiol.%26date%3D2019%26volume%3D172%26spage%3D23%26epage%3D39%26doi%3D10.1016%2Fj.pneurobio.2018.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afanador, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roltsch, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, D. B.</span></span> <span> </span><span class="NLM_article-title">The Ca<sup>2+</sup> sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer’s disease mouse model</span>. <i>Cell Calcium</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.ceca.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ceca.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24931125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=68-80&author=L.+Afanadorauthor=E.+A.+Roltschauthor=L.+Holcombauthor=K.+S.+Campbellauthor=D.+A.+Keelingauthor=Y.+Zhangauthor=D.+B.+Zimmer&title=The+Ca2%2B+sensor+S100A1+modulates+neuroinflammation%2C+histopathology+and+Akt+activity+in+the+PSAPP+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1016%2Fj.ceca.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model</span></div><div class="casAuthors">Afanador, Lauriaselle; Roltsch, Emily A.; Holcomb, Leigh; Campbell, Kerry S.; Keeling, David A.; Zhang, Yan; Zimmer, Danna B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Calcium</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-80</span>CODEN:
                <span class="NLM_cas:coden">CECADV</span>;
        ISSN:<span class="NLM_cas:issn">0143-4160</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The contribution of the Ca2+ sensor S100A1 to in vivo Alzheimer's disease (AD) pathobiol. has not been elucidated although S100A1 regulates numerous cellular processes linked to AD.  This study uses genetic ablation to ascertain the effects of S100A1 on neuroinflammation, beta-amyloid (Aβ) plaque deposition and Akt activity in the PSAPP AD mouse model.  PSAPP/S100A1-/- mice exhibited decreases in astrocytosis (GFAP burden), microgliosis (Iba1 burden) and plaque load/no. when compared to PSAPP/S100A1+/+ mice at six and twelve months of age.  The presence of detectable S100A1 staining in human AD specimens is consistent with a detrimental gain of S100A1 function in AD.  S100A1 ablation also reduced plaque assocd. and increased non-plaque assocd. PO4-Akt and PO4-GSK3β staining.  S100A1·Akt complexes were undetectable in PC12 cells and AD brain tissue suggesting that S100A1 indirectly modulates Akt activity.  In contrast, S100A1·RyR (ryanodine receptor) complexes were present in human/mouse AD brain and exhibited Ca2+-dependent formation in neuronal cells.  This is the first direct demonstration of an S100A1· target protein complex in tissue/cells and identifies the RyR as a primary S100A1 target protein in the brain.  Collectively, these data suggest that S100A1 inhibition may be a novel strategy for normalizing aberrant Ca2+ signaling in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDhoES9DBRbVg90H21EOLACvtfcHk0lj7GzJ1A3bSuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWntbk%253D&md5=c2bdb9ac0bac095b91e731b1e6b5ad62</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ceca.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceca.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DAfanador%26aufirst%3DL.%26aulast%3DRoltsch%26aufirst%3DE.%2BA.%26aulast%3DHolcomb%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DK.%2BS.%26aulast%3DKeeling%26aufirst%3DD.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZimmer%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Ca2%252B%2520sensor%2520S100A1%2520modulates%2520neuroinflammation%252C%2520histopathology%2520and%2520Akt%2520activity%2520in%2520the%2520PSAPP%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DCell%2520Calcium%26date%3D2014%26volume%3D56%26spage%3D68%26epage%3D80%26doi%3D10.1016%2Fj.ceca.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duflot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellien, J.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1517/17460441.2014.881354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1517%2F17460441.2014.881354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24490654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1agsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=229-243&author=T.+Duflotauthor=C.+Rocheauthor=F.+Lamoureuxauthor=D.+Guerrotauthor=J.+Bellien&title=Design+and+discovery+of+soluble+epoxide+hydrolase+inhibitors+for+the+treatment+of+cardiovascular+diseases&doi=10.1517%2F17460441.2014.881354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases</span></div><div class="casAuthors">Duflot, Thomas; Roche, Clothilde; Lamoureux, Fabien; Guerrot, Dominique; Bellien, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-243</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Cardiovascular diseases are a leading cause of death in developed countries.  Increasing evidence shows that the alteration in the normal functions of the vascular endothelium plays a major role in the development of cardiovascular diseases.  However, specific agents designed to prevent endothelial dysfunction and related cardiovascular complications are still lacking.  One emerging strategy is to increase the bioavailability of epoxyeicosatrienoic acids (EETs), synthesized by cytochrome P 450 epoxygenases from arachidonic acid.  EETs are endothelium-derived hyperpolarising and relaxing factors and display attractive anti-inflammatory and metabolic properties.  Genetic polymorphism studies in humans, and expts. in animal models of diseases, have identified sol. epoxide hydrolase (sEH), the major enzyme involved in EET degrdn., as a potential pharmacol. target.  Areas covered: This review presents EET pathway and its functions and summarises the data supporting the development of sEH inhibitors for the treatment of cardiovascular and metabolic diseases.  Furthermore, the authors present the different chem. families of sEH inhibitors developed and their effects in animal models of cardiovascular and metabolic diseases.  Expert opinion: Several generations of sEH inhibitors have now been designed to treat endothelial dysfunction and cardiovascular complications for a variety of diseases.  The safety of these drugs remains to be carefully investigated, particularly in relation to carcinogenesis.  The increasing knowledge of the biol. role of each of the EET isomers and of their metabolites may improve their pharmacol. profile.  This, in turn, could potentially lead to the identification of new pharmacol. agents that achieve the cellular effects needed without the deleterious side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm7bKJfYgr9LVg90H21EOLACvtfcHk0lj7GzJ1A3bSuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1agsb4%253D&md5=62a5437b9d54428cb3d73404cbc1faed</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.881354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.881354%26sid%3Dliteratum%253Aachs%26aulast%3DDuflot%26aufirst%3DT.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DLamoureux%26aufirst%3DF.%26aulast%3DGuerrot%26aufirst%3DD.%26aulast%3DBellien%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520discovery%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cardiovascular%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D229%26epage%3D243%26doi%3D10.1517%2F17460441.2014.881354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dileepan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastle-Simpson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijesinghe, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriramarao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span> <span> </span><span class="NLM_article-title">Effect of dual sEH/COX-2 inhibition on allergen-induced airway inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1118</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.01118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.01118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31611798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFahur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1118&author=M.+Dileepanauthor=S.+Rastle-Simpsonauthor=Y.+Greenbergauthor=D.+S.+Wijesingheauthor=N.+G.+Kumarauthor=J.+Yangauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=P.+Sriramaraoauthor=S.+P.+Rao&title=Effect+of+dual+sEH%2FCOX-2+inhibition+on+allergen-induced+airway+inflammation&doi=10.3389%2Ffphar.2019.01118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of dual sEH/COX-2 inhibition on allergen-induced airway inflammation</span></div><div class="casAuthors">Dileepan, Mythili; Rastle-Simpson, Stephanie; Greenberg, Yana; Wijesinghe, Dayanjan S.; Kumar, Naren Gajenthra; Yang, Jun; Hwang, Sung Hee; Hammock, Bruce D.; Sriramarao, P.; Rao, Savita P.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1118</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Arachidonic acid metabolites resulting from the cyclooxygenase (COX), lipoxygenase, and cytochrome P 450 oxidase enzymic pathways play pro- and anti-inflammatory roles in allergic airway inflammation (AAI) and asthma.  Expression of COX-2 and sol. epoxide hydrolase (sEH) are elevated in allergic airways and their enzymic products (e.g., prostaglandins and diols of epoxyeicosatrienoic acids, resp.) have been shown to participate in the pathogenesis of AAI.  Here, we evaluated the outcome of inhibiting the COX-2 and sEH enzymic pathways with a novel dual inhibitor, PTUPB, in A. alternata-induced AAI.  Allergen-challenged mice were administered with 10 or 30 mg/kg of PTUPB, celecoxib (selective COX-2 inhibitor), t-TUCB (selective sEH inhibitor) or vehicle daily by gavage and evaluated for various features of AAI.  PTUPB and t-TUCB at 30 mg/kg, but not celecoxib, inhibited eosinophilic infiltration and significantly increased levels of anti-inflammatory EETs in the lung tissue of allergen-challenged mice. t-TUCB significantly inhibited allergen-induced IL-4 and IL-13, while a less pronounced redn. was noted with PTUPB and celecoxib.  Addnl., t-TUCB markedly inhibited eotaxin-2, an eosinophil-specific chemokine, which was only marginally reduced by PTUPB and remained elevated in celecoxib-treated mice.  PTUPB or t-TUCB administration reversed allergen-induced redn. in levels of various lipid mediators in the lungs, with only a minimal effect noted with celecoxib.  Despite the anti-inflammatory effects, PTUPB or t-TUCB did not reduce allergen-induced airway hyperresponsiveness (AHR).  However, development of structural changes in the allergic airways, such as mucus hypersecretion and smooth muscle hypertrophy, was significantly inhibited by both inhibitors.  Celecoxib, on the other hand, inhibited only airway smooth muscle hypertrophy, but not mucus hypersecretion.  In conclusion, dual inhibition of COX-2 and sEH offers no addnl. advantage relative to sEH inhibition alone in attenuating various features assocd. with A. alternata-induced AAI, while COX-2 inhibition exerts only moderate or no effect on several of these features.  Dual sEH/COX-2 inhibition may be useful in treating conditions where eosinophilic inflammation co-exists with pain-assocd. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCUwbEbSa11rVg90H21EOLACvtfcHk0lhjJGxeHbN5sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFahur8%253D&md5=50e934c04de307d90dbe5de94278f4f8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.01118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.01118%26sid%3Dliteratum%253Aachs%26aulast%3DDileepan%26aufirst%3DM.%26aulast%3DRastle-Simpson%26aufirst%3DS.%26aulast%3DGreenberg%26aufirst%3DY.%26aulast%3DWijesinghe%26aufirst%3DD.%2BS.%26aulast%3DKumar%26aufirst%3DN.%2BG.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSriramarao%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DS.%2BP.%26atitle%3DEffect%2520of%2520dual%2520sEH%252FCOX-2%2520inhibition%2520on%2520allergen-induced%2520airway%2520inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D1118%26doi%3D10.3389%2Ffphar.2019.01118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30761004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlWktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=36&author=K.+Hashimoto&title=Role+of+soluble+epoxide+hydrolase+in+metabolism+of+PUFAs+in+psychiatric+and+neurological+disorders&doi=10.3389%2Ffphar.2019.00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders</span></div><div class="casAuthors">Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Inflammation plays a key role in the pathogenesis of a no. of psychiatric and neurol. disorders.  Sol. epoxide hydrolases (sEH), enzymes present in all living organisms, metabolize epoxy fatty acids (EpFAs) to corresponding 1,2-diols by the addn. of a mol. of water.  Accumulating evidence suggests that sEH in the metab. of polyunsatd. fatty acids (PUFAs) plays a key role in inflammation.  Preclin. studies demonstrated that protein expression of sEH in the prefrontal cortex, striatum, and hippocampus from mice with depression-like phenotype was higher than control mice.  Furthermore, protein expression of sEH in the parietal cortex from patients with major depressive disorder was higher than controls.  Interestingly, Ephx2 knockout (KO) mice exhibit stress resilience after chronic social defeat stress.  Furthermore, the sEH inhibitors have antidepressant effects in animal models of depression.  In addn., pharmacol. inhibition or gene KO of sEH protected against dopaminergic neurotoxicity in the striatum after repeated administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in an animal model of Parkinson's disease (PD).  Protein expression of sEH in the striatum from MPTP-treated mice was higher than control mice.  A no. of studies using postmortem brain samples showed that the deposition of protein aggregates of a-synuclein, termed Lewy bodies, is evident in multiple brain regions of patients from PD and dementia with Lewy bodies (DLB).  Moreover, the expression of the sEH protein in the striatum from patients with DLB was significantly higher compared with controls.  Interestingly, there was a pos. correlation between sEH expression and the ratio of phosphorylated a-synuclein to a-synuclein in the striatum.  In the review, the author discusses the role of sEH in the metab. of PUFAs in inflammation-related psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr772OTSLm0zrVg90H21EOLACvtfcHk0lhjJGxeHbN5sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlWktLfF&md5=8486be8b656715c9f89daed8bb6cacd2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00036%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520metabolism%2520of%2520PUFAs%2520in%2520psychiatric%2520and%2520neurological%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D36%26doi%3D10.3389%2Ffphar.2019.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Role of oxylipins in cardiovascular diseases</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1142</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1038/aps.2018.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Faps.2018.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29877318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOmsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=1142-1154&author=M.+A.+Nayeem&title=Role+of+oxylipins+in+cardiovascular+diseases&doi=10.1038%2Faps.2018.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxylipins in cardiovascular diseases</span></div><div class="casAuthors">Nayeem, Mohammed A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1142-1154</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Globally, cardiovascular diseases (CVDs) are the no. one cause of mortality.  Approx. 18 million people died from CVDs in 2015, representing more than 30% of all global deaths.  New diagnostic tools and therapies are eagerly required to decrease the prevalence of CVDs related to mortality and/or risk factors leading to CVDs.  Oxylipins are a group of metabolites, generated via oxygenation of polyunsatd. fatty acids that are involved in inflammation, immunity, and vascular functions, etc.  Thus far, over 100 oxylipins have been identified, and have overlapping and interconnected roles.  Important CVD pathologies such as hyperlipidemia, hypertension, thrombosis, hemostasis and diabetes have been linked to abnormal oxylipin signaling.  Oxylipins represent a new era of risk markers and/or therapeutic targets in several diseases including CVDs.  The role of many oxylipins in the progression or regression in CVD, however, is still not fully understood.  An increased knowledge of the role of these oxygenated polyunsatd. fatty acids in cardiovascular dysfunctions or CVDs including hypertension could possibly lead to the development of biomarkers for the detection and their treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJwUGqfuP5dbVg90H21EOLACvtfcHk0lhjJGxeHbN5sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOmsrrE&md5=847d5829a5906b5d6ed49d38e7ed3c54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Faps.2018.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2018.24%26sid%3Dliteratum%253Aachs%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DRole%2520of%2520oxylipins%2520in%2520cardiovascular%2520diseases%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2018%26volume%3D39%26spage%3D1142%26epage%3D1154%26doi%3D10.1038%2Faps.2018.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span> <span> </span><span class="NLM_article-title">Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone</span>. <i>J. Vasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1159/000159080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1159%2F000159080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7537544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2MXmslSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1995&pages=79-92&author=D.+R.+Harderauthor=W.+B.+Campbellauthor=R.+J.+Roman&title=Role+of+cytochrome+P-450+enzymes+and+metabolites+of+arachidonic+acid+in+the+control+of+vascular+tone&doi=10.1159%2F000159080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone</span></div><div class="casAuthors">Harder, D. R.; Campbell, W. B.; Roman, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Vascular Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-92</span>CODEN:
                <span class="NLM_cas:coden">JVREE9</span>;
        ISSN:<span class="NLM_cas:issn">1018-1172</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">A review, with 114 refs., the metab. of arachidonic acid (AA) into vasoactive products by cytochrome P 450 enzymes and the regulation of vascular tone by the arachidonic acid metabolites, epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids.  The authors also discuss the large diversity of P 450 enzyme isoforms and how such diversity can provide for precise physiol. control of vascular tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPjbLjTlJHurVg90H21EOLACvtfcHk0liRL2aGm4Q0Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmslSrtrs%253D&md5=4a8ba055d119550a7bb5f469e3606e11</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000159080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000159080%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DD.%2BR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26atitle%3DRole%2520of%2520cytochrome%2520P-450%2520enzymes%2520and%2520metabolites%2520of%2520arachidonic%2520acid%2520in%2520the%2520control%2520of%2520vascular%2520tone%26jtitle%3DJ.%2520Vasc.%2520Res.%26date%3D1995%26volume%3D32%26spage%3D79%26epage%3D92%26doi%3D10.1159%2F000159080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span> <span> </span><span class="NLM_article-title">P-450 metabolites of arachidonic acid in the control of cardiovascular function</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1152/physrev.00021.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fphysrev.00021.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11773611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFSisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=131-185&author=R.+J.+Roman&title=P-450+metabolites+of+arachidonic+acid+in+the+control+of+cardiovascular+function&doi=10.1152%2Fphysrev.00021.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-450 metabolites of arachidonic acid in the control of cardiovascular function</span></div><div class="casAuthors">Roman, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-185</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review on the metab. of arachidonic acid by cytochrome P 450 enzymes in the kidney, brain, lung, heart, and pancreas, and the effects of the 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acid metabolites on vascular tone and hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI7QTr-9S_k7Vg90H21EOLACvtfcHk0liRL2aGm4Q0Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFSisQ%253D%253D&md5=86db052d39f5cc50ed9c8cba1ae43466</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00021.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00021.2001%26sid%3Dliteratum%253Aachs%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26atitle%3DP-450%2520metabolites%2520of%2520arachidonic%2520acid%2520in%2520the%2520control%2520of%2520cardiovascular%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D131%26epage%3D185%26doi%3D10.1152%2Fphysrev.00021.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span> <span> </span><span class="NLM_article-title">Activation of K<sup>+</sup> channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(93)90805-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0014-2999%2893%2990805-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8422904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3sXhsVCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1993&pages=215-221&author=S.+Huauthor=H.+S.+Kim&title=Activation+of+K%2B+channel+in+vascular+smooth+muscles+by+cytochrome+P450+metabolites+of+arachidonic+acid&doi=10.1016%2F0014-2999%2893%2990805-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of potassium channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid</span></div><div class="casAuthors">Hu, Shiling; Kim, Helen S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-21</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Arachidonic acid can be oxidatively metabolized by cytochrome P 450 epoxygenase to 4 regioisomeric epoxyeicosatrienoic acids (5,6-, 8,9-, 11,12-, and 14,15-EET), which exhibit vasorelaxant effects in vivo and in vitro with unknown mechanisms.  In this study, the patch-clamp method was used to examine the effects of EETs on the Ca2+-activated K+ channel in cells from rabbit portal vein, rat caudal artery, guinea pig aorta, and porcine coronary artery.  In all 4 cell types, EETs in the bath activated the K+ channel in cell-attached patches by increasing the single channel open-state probability.  Potencies of the 4 EETs did not differ for each cell type.  The concns. for doubling open-state probability were 0.1 μM in portal vein and coronary artery, 0.3-1 μM in aorta, and 1-3 μM in caudal artery.  In caudal artery cells, K+ channel activation by 3 μM 5,6- and 1 μM 11,12-EET was blocked and reversed by glyburide at 0.5 μM.  In aorta, coronary artery, and caudal artery cells, micromolar EETs induced a dose-dependent and reversible augmentation of whole-cell K+ current by 50-120% and a 5-12 mV hyperpolarization.  EETs on the cytosolic side of inside-out patches produced little or no potentiation of K+ channels, implying an interaction of receptor-mediated nature.  Thus, EETs may promote vasodilation by functioning as endogenous K+ channel openers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ4dRW-WFFELVg90H21EOLACvtfcHk0liRL2aGm4Q0Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsVCht7c%253D&md5=eeb0d8ce1c0c9aad526621fbe9faf6e4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990805-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990805-R%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BS.%26atitle%3DActivation%2520of%2520K%252B%2520channel%2520in%2520vascular%2520smooth%2520muscles%2520by%2520cytochrome%2520P450%2520metabolites%2520of%2520arachidonic%2520acid%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D230%26spage%3D215%26epage%3D221%26doi%3D10.1016%2F0014-2999%2893%2990805-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 pathways of arachidonic acid metabolism</span>. <i>Curr. Opin. Lipidol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1097/00041433-200206000-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1097%2F00041433-200206000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12045397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlWjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=273-283&author=D.+L.+Kroetzauthor=D.+C.+Zeldin&title=Cytochrome+P450+pathways+of+arachidonic+acid+metabolism&doi=10.1097%2F00041433-200206000-00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 pathways of arachidonic acid metabolism</span></div><div class="casAuthors">Kroetz, Deanna L.; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-283</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450s metabolize arachidonic acid to hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.  These eicosanoids are formed in a tissue and cell-specific manner and have numerous biol. functions.  Of major interest are the opposing actions of hydroxyeicosatetraenoic and epoxyeicosatrienoic acids within the vasculature.  Regio- and stereoisomeric epoxyeicosatrienoic acids have potent vasodilatory properties while 20-hydroxyeicosatetraenoic acid is a potent vasoconstrictor.  Both effects are mediated through actions on large-conductance Ca2+-activated K+ channels.  Cytochrome P 450-derived eicosanoids are also important in the regulation of ion transport, and have recently been shown to influence a no. of fundamental biol. processes including cellular proliferation, apoptosis, inflammation, and hemostasis.  The formation of these functionally relevant eicosanoids is tightly controlled by the expression and activity of the cytochrome P 450 epoxygenases and hydroxylases.  In addn., sol. epoxide hydrolase catalyzes the hydrolysis of epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids, and the activity of this enzyme is a crit. determinant of tissue epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels.  The intracellular balance between epoxyeicosatrienoic, dihydroxyeicosatrienoic and hydroxyeicosatetraenoic acids influences the biol. response to these eicosanoids and alterations in their levels have recently been assocd. with certain pathol. conditions.  The involvement of the cytochrome P 450-derived eicosanoids in a wide array of biol. functions and the observation that levels are altered in pathol. conditions suggest that the enzymes involved in the formation and degrdn. of these fatty acids may be novel therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopORL4MTqm5LVg90H21EOLACvtfcHk0liRL2aGm4Q0Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlWjsbY%253D&md5=66b4494323d6c84517068b83b27b7574</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2F00041433-200206000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041433-200206000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DCytochrome%2520P450%2520pathways%2520of%2520arachidonic%2520acid%2520metabolism%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D2002%26volume%3D13%26spage%3D273%26epage%3D283%26doi%3D10.1097%2F00041433-200206000-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">15983</span>– <span class="NLM_lpage">15989</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100439200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M100439200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11279071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFaksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=15983-15989&author=K.+Nodeauthor=X.+L.+Ruanauthor=J.+Daiauthor=S.+X.+Yangauthor=L.+Grahamauthor=D.+C.+Zeldinauthor=J.+K.+Liao&title=Activation+of+Galpha+s+mediates+induction+of+tissue-type+plasminogen+activator+gene+transcription+by+epoxyeicosatrienoic+acids&doi=10.1074%2Fjbc.M100439200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Gαs mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Node, Koichi; Ruan, Xiu-Lu; Dai, Jianwu; Yang, Shui-Xiang; Graham, LeRae; Zeldin, Darryl C.; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">15983-15989</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 (CYP) epoxygenases that have vasodilatory and anti-inflammatory properties.  Here the authors report that EETs have addnl. fibrinolytic properties.  In vascular endothelial cells, physiol. concns. of EETs, particularly 11,12-EET, or overexpression of the endothelial epoxygenase, CYP2J2, increased tissue plasminogen activator (t-PA) expression by 2.5-fold without affecting plasminogen activator inhibitor-1 expression.  This increase in t-PA expression correlated with a 4-fold induction in t-PA gene transcription and a 3-fold increase in t-PA fibrinolytic activity and was blocked by the CYP inhibitor, SKF525A, but not by the calcium-activated potassium channel blocker, charybdotoxin, indicating a mechanism that does not involve endothelial cell hyperpolarization.  The t-PA promoter is cAMP-responsive, and induction of t-PA gene transcription by EETs correlated with increases in intracellular cAMP levels and, functionally, with cAMP-driven promoter activity.  To det. whether increases in intracellular cAMP levels were due to modulation of guanine nucleotide-binding proteins, the authors assessed the effects of EETs on Gαs and Gαi2.  Treatment with EETs increased Gαs, but not Gαi2, GTP-binding activity by 3.5-fold.  These findings indicate that EETs possess fibrinolytic properties through the induction of t-PA and suggest that endothelial CYP2J2 may play an important role in regulating vascular hemostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6rgEE-fndLVg90H21EOLACvtfcHk0lgNlHTEaIur1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFaksbc%253D&md5=8f3e5d6ed9b847453ac6372656024891</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100439200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100439200%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DK.%26aulast%3DRuan%26aufirst%3DX.%2BL.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DGraham%26aufirst%3DL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3DActivation%2520of%2520Galpha%2520s%2520mediates%2520induction%2520of%2520tissue-type%2520plasminogen%2520activator%2520gene%2520transcription%2520by%2520epoxyeicosatrienoic%2520acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D15983%26epage%3D15989%26doi%3D10.1074%2Fjbc.M100439200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munzenmaier, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span> <span> </span><span class="NLM_article-title">Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">H1163</span>– <span class="NLM_lpage">H1167</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.2000.278.4.H1163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.2000.278.4.H1163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10749710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2000&pages=H1163-H1167&author=D.+H.+Munzenmaierauthor=D.+R.+Harder&title=Cerebral+microvascular+endothelial+cell+tube+formation%3A+role+of+astrocytic+epoxyeicosatrienoic+acid+release&doi=10.1152%2Fajpheart.2000.278.4.H1163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release</span></div><div class="casAuthors">Munzenmaier, Diane H.; Harder, David R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">4, Pt. 2</span>),
    <span class="NLM_cas:pages">H1163-H1167</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Cerebral microvascular endothelial cells (CMVEC) form tubes when cocultured with astrocytes (AS).  Therefore, it appears that AS may be important in mediating angiogenesis in the brain.  We hypothesized that AS modulate CMVEC tube formation by releasing a sol. factor.  Thymidine incorporation in cultured CMVEC increased 305% when incubated with 50% conditioned AS medium for 24 h [control: 52,755 ± 4,838 counts per min (cpm) per well, conditioned 161,082 ± 12,099 cpm/well, n = 8].  Because our lab. has previously shown that AS can produce epoxyeicosatrienoic acids (EETs), which are known mitogens, we investigated whether release of EETs by AS is responsible for tube formation in the CMVEC-AS coculture.  AS were seeded on Lab-Tek slides, CMVEC were seeded on the AS the next day, and cultures were allowed to progress for another 5 days with and without cytochrome P 450 epoxygenase blockade by 17-octadecynoic acid (17-ODYA).  Tube formation in cocultures receiving 17-ODYA was significantly inhibited compared with control (93.8%).  These data suggest that tube formation requires the release of EETs by AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsN7dSjUuj77Vg90H21EOLACvtfcHk0lgNlHTEaIur1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSlur0%253D&md5=e1b57622a375c9085a382c7594278c53</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.2000.278.4.H1163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.2000.278.4.H1163%26sid%3Dliteratum%253Aachs%26aulast%3DMunzenmaier%26aufirst%3DD.%2BH.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26atitle%3DCerebral%2520microvascular%2520endothelial%2520cell%2520tube%2520formation%253A%2520role%2520of%2520astrocytic%2520epoxyeicosatrienoic%2520acid%2520release%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2000%26volume%3D278%26spage%3DH1163%26epage%3DH1167%26doi%3D10.1152%2Fajpheart.2000.278.4.H1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1276</span>– <span class="NLM_lpage">1279</span>, <span class="refDoi"> DOI: 10.1126/science.285.5431.1276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1126%2Fscience.285.5431.1276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10455056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Siur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1276-1279&author=K.+Nodeauthor=Y.+Huoauthor=X.+Ruanauthor=B.+Yangauthor=M.+Spieckerauthor=K.+Leyauthor=D.+C.+Zeldinauthor=J.+K.+Liao&title=Anti-inflammatory+properties+of+cytochrome+P450+epoxygenase-derived+eicosanoids&doi=10.1126%2Fscience.285.5431.1276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids</span></div><div class="casAuthors">Node, Koichi; Huo, Yuqing; Ruan, Z. Xiulu; Yang, Baichun; Spiecker, Martin; Ley, Klaus; Zeldin, Darryl C.; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5431</span>),
    <span class="NLM_cas:pages">1276-1279</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 epoxygenases that have vasodilatory properties similar to that of endothelium-derived hyperpolarizing factor.  The cytochrome P 450 isoform CYP2J2 was cloned and identified as a potential source of EETs in human endothelial cells.  Physiol. concns. of EETs or overexpression of CYP2J2 decreased cytokine-induced endothelial cell adhesion mol. expression, and EETs prevented leukocyte adhesion to the vascular wall by a mechanism involving inhibition of transcription factor NF-κB and IκB kinase.  The inhibitory effects of EETs were independent of their membrane-hyperpolarizing effects, suggesting that these mols. play an important nonvasodilatory role in vascular inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvTzrmgnTpJrVg90H21EOLACvtfcHk0lgNlHTEaIur1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Siur0%253D&md5=bab4dd51931632408fc7d43fbe87759f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5431.1276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5431.1276%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DK.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DSpiecker%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520cytochrome%2520P450%2520epoxygenase-derived%2520eicosanoids%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D1276%26epage%3D1279%26doi%3D10.1126%2Fscience.285.5431.1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">New role for epoxyeicosatrienoic acids as anti-inflammatory mediators</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(00)01472-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0165-6147%2800%2901472-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10740283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=125-127&author=W.+B.+Campbell&title=New+role+for+epoxyeicosatrienoic+acids+as+anti-inflammatory+mediators&doi=10.1016%2FS0165-6147%2800%2901472-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New role for epoxyeicosatrienoic acids as anti-inflammatory mediators</span></div><div class="casAuthors">Campbell, W. B.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">125-127</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 12 refs., on the autocrine role for epoxyeicosatrienoic acids in endothelial cells as anti-inflammatory mediators.  This autocrine effect is owing to inhibition of both IKK activity and cytokine-induced CAM expression, which reduces adhesion of inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_cyly58E3rVg90H21EOLACvtfcHk0li8hPn7dQDzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGgs7k%253D&md5=96c1c7411cfa631b19ef74438eb2952e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2800%2901472-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252800%252901472-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DNew%2520role%2520for%2520epoxyeicosatrienoic%2520acids%2520as%2520anti-inflammatory%2520mediators%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26spage%3D125%26epage%3D127%26doi%3D10.1016%2FS0165-6147%2800%2901472-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Epoxygenase pathways of arachidonic acid metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">36059</span>– <span class="NLM_lpage">36062</span>, <span class="refDoi"> DOI: 10.1074/jbc.R100030200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.R100030200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11451964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1yku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=36059-36062&author=D.+C.+Zeldin&title=Epoxygenase+pathways+of+arachidonic+acid+metabolism&doi=10.1074%2Fjbc.R100030200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxygenase pathways of arachidonic acid metabolism</span></div><div class="casAuthors">Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">36059-36062</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The author provides a general overview of the arachidonic acid epoxygenase pathway with emphasis on the P 450 enzymes involved in epoxyeicosatrienoic acids (EETs) biosynthesis, the metabolic fate of the EETs once they are formed, and the biol. relevance of the EETs in the kidney and cardiovascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKqDIvtxVoF7Vg90H21EOLACvtfcHk0li8hPn7dQDzhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1yku7o%253D&md5=65f033ed163b5daa30b10f767ab8d134</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R100030200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R100030200%26sid%3Dliteratum%253Aachs%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DEpoxygenase%2520pathways%2520of%2520arachidonic%2520acid%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D36059%26epage%3D36062%26doi%3D10.1074%2Fjbc.R100030200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navar, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Actions of epoxygenase metabolites on the preglomerular vasculature</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2364</span>– <span class="NLM_lpage">2370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=8959626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2sXltFylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=2364-2370&author=J.+D.+Imigauthor=L.+G.+Navarauthor=R.+J.+Romanauthor=K.+K.+Reddyauthor=J.+R.+Falck&title=Actions+of+epoxygenase+metabolites+on+the+preglomerular+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of epoxygenase metabolites on the preglomerular vasculature</span></div><div class="casAuthors">Imig, John D.; Navar, L. G.; Roman, Richard J.; Reddy, K. Kishta; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2364-2370</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow.  This study examd. the preglomerular actions of various epoxyeicosatrienoic acid (EET).  By use of the in vitro blood-perfused juxtamedullary nephron prepn., interlobular and different arteriolar diam. responses to 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET were detd.  Diams. of interlobular and afferent arterioles preconstricted with 0.5μM norepinephrine averaged 24±1 μM(N=27) and 17±1 μM(N=32), resp., at a renal perfusion pressure of 100 mm Hg.  Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diams. of the interlobular and afferent arterioles.  At a dose of 100 nM, 11,12-EET increased the diams. of the interlobular and afferent arterioles by 18±2% (N=10) and 20±3% (N=9), resp.  The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diams. of the interlobular and afferent arterioles.  14,15-EET had a much smaller effect and increased the diams. of the these vessels by 10%;8,9-EET did not significantly affect vascular diams.  In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16±3% (N=6) and 21±3% (N=7), resp.  The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diams. of the interlobular and afferent arterioles at concns. up to 1 μM.  The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin.  In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition.  The thromboxane/enderoxperoxide receptor inhibitor, SQ 29,548, resulted in 60% attenuation of the afferent arteriolar vasconstriction to 5,6-EET.  These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent ad requires an intact endothelium, whereas the vasodilation of 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoojB5As8pW77Vg90H21EOLACvtfcHk0lh7cUN1819Tuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltFylsw%253D%253D&md5=c312b42f5180f77fad282e9adf17b721</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DNavar%26aufirst%3DL.%2BG.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BK.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DActions%2520of%2520epoxygenase%2520metabolites%2520on%2520the%2520preglomerular%2520vasculature%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D1996%26volume%3D7%26spage%3D2364%26epage%3D2370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hittner, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">H337</span>– <span class="NLM_lpage">H349</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00831.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.00831.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12388250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvF2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=H337-H349&author=J.+R.+Falckauthor=U.+M.+Krishnaauthor=Y.+K.+Reddyauthor=P.+S.+Kumarauthor=K.+M.+Reddyauthor=S.+B.+Hittnerauthor=C.+Deeterauthor=K.+K.+Sharmaauthor=K.+M.+Gauthierauthor=W.+B.+Campbell&title=Comparison+of+vasodilatory+properties+of+14%2C15-EET+analogs%3A+structural+requirements+for+dilation&doi=10.1152%2Fajpheart.00831.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of vasodilatory properties of 14,15-EET analogs: Structural requirements for dilation</span></div><div class="casAuthors">Falck, J. R.; Krishna, U. Murali; Reddy, Y. Krishna; Kumar, P. Srinagesh; Reddy, K. Malla; Hittner, Sarah B.; Deeter, Christine; Sharma, Kamalesh K.; Gauthier, Kathryn M.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">H337-H349</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are endothelium-derived eicosanoids that activate potassium channels, hyperpolarize the membrane, and cause relaxation.  The authors tested 19 analogs of 14,15-EET on vascular tone to det. the structural features required for activity.  14,15-EET relaxed bovine coronary arterial rings in a concn.-related manner (ED50 = 10-6 M).  Changing the carboxyl to an alc. eliminated dilator activity, whereas 14,15-EET-Me ester and 14,15-EET-methylsulfonimide retained full activity.  Shortening the distance between the carboxyl and epoxy groups reduced the agonist potency and activity.  Removal of all three double bonds decreased potency.  An analog with a Δ8 double bond had full activity and potency.  However, the analogs with only a Δ5 or Δ11 double bond had reduced potency.  Conversion of the epoxy oxygen to a sulfur or nitrogen resulted in loss of activity.  14(S),15(R)-EET was more potent than 14(R),15(S)-EET, and 14,15-(cis)-EET was more potent than 14,15-(trans)-EET.  These studies indicate that the structural features of 14,15-EET required for relaxation of the bovine coronary artery include a carbon-1 acidic group, a Δ8 double bond, and a 14(S),15(R)-(cis)-epoxy group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogeldh5uWxr7Vg90H21EOLACvtfcHk0lh7cUN1819Tuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvF2hsw%253D%253D&md5=3026bb96cd495fa7d18b5e132a864665</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00831.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00831.2001%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DKrishna%26aufirst%3DU.%2BM.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DKumar%26aufirst%3DP.%2BS.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DHittner%26aufirst%3DS.%2BB.%26aulast%3DDeeter%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DK.%2BK.%26aulast%3DGauthier%26aufirst%3DK.%2BM.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DComparison%2520of%2520vasodilatory%2520properties%2520of%252014%252C15-EET%2520analogs%253A%2520structural%2520requirements%2520for%2520dilation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DH337%26epage%3DH349%26doi%3D10.1152%2Fajpheart.00831.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, E. F.</span></span> <span> </span><span class="NLM_article-title">Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1111/j.1469-7793.1999.0153o.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1469-7793.1999.0153o.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10432346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=1999&pages=153-168&author=H.+C.+Leeauthor=T.+Luauthor=N.+L.+Weintraubauthor=M.+VanRollinsauthor=A.+A.+Spectorauthor=E.+F.+Shibata&title=Effects+of+epoxyeicosatrienoic+acids+on+the+cardiac+sodium+channels+in+isolated+rat+ventricular+myocytes&doi=10.1111%2Fj.1469-7793.1999.0153o.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes</span></div><div class="casAuthors">Lee, Hon-Chi; Lu, Tong; Weintraub, Neal L.; VanRollins, Mike; Spector, Arthur A.; Shibata, Erwin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">1. Whole-cell Na+ currents (holding potential, -80 mV; test potential, -30 mV) in rat myocytes were inhibited by 8,9-epoxyeicosatrienoic acid (8,9-EET) in a dose-dependent manner with 22±4% inhibition at 0.5 μM, 48±5% at 1 μM, and 73±5% at 5 μM (mean ± S.E.M., n = 10, P < 0.05 for each dose vs. control).  Similar results were obtained with 5,6-, 11,12-, and 14,15-EETs, while 8,9-dihydroxyeicosatrienoic acid (DHET) was 3-fold less potent and arachidonic acid was 10- to 20-fold less potent.  2. 8,9-EET produced a dose-dependent, hyperpolarized shift in the steady-state membrane potential at half-max. inactivation (V1/2), without changing the slope factor.  8,9-EET had no effect on the steady-state activation of Na+ currents.  3. Inhibition of Na+ currents by 8,9-EET was use dependent, and channel recovery was slowed.  The effects of 8,9-EET were greater at depolarized potentials.  4. Single channel recordings showed 8,9-EET did not change the conductance or the no. of active Na+ channels, but markedly decreased the probability of Na+ channel opening.  These results were assocd. with a decrease in the channel open time and an increase in the channel closed times.  5. Incubation of cultured cardiac myocytes with 1 μM [3H]8,9-EET showed that 25% of the radioactivity was taken up by the cells over a 2 h period, and most of the uptake was incorporated into phospholipids, principally phosphatidylcholine.  Anal. of the medium after a 2 h incubation indicated that 86% of the radioactivity remained as [3H]8,9-EET while 13% was converted into [3H]8,9-DHET.  After a 30 min incubation, 1-2% of the [3H]8,9-EET uptake by cells remained as unesterified EET.  6. These results demonstrate that cardiac cells have a high capacity to take up and metabolize 8,9-EET.  8,9-EET is a potent use- and voltage-dependent inhibitor of the cardiac Na+ channels through modulation of the channel gating behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxMcbTRHpbDLVg90H21EOLACvtfcHk0lh7cUN1819Tuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVWisbg%253D&md5=82bd803dc816d4319d071a046eac4fa9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-7793.1999.0153o.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-7793.1999.0153o.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BC.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DShibata%26aufirst%3DE.%2BF.%26atitle%3DEffects%2520of%2520epoxyeicosatrienoic%2520acids%2520on%2520the%2520cardiac%2520sodium%2520channels%2520in%2520isolated%2520rat%2520ventricular%2520myocytes%26jtitle%3DJ.%2520Physiol.%26date%3D1999%26volume%3D519%26spage%3D153%26epage%3D168%26doi%3D10.1111%2Fj.1469-7793.1999.0153o.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">H2113</span>– <span class="NLM_lpage">H2121</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.1998.275.6.H2113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.1998.275.6.H2113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9843811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXht1yitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1998&pages=H2113-H2121&author=X.+Fangauthor=S.+A.+Mooreauthor=L.+L.+Stollauthor=G.+Richauthor=T.+L.+Kaduceauthor=N.+L.+Weintraubauthor=A.+A.+Spector&title=14%2C15-Epoxyeicosatrienoic+acid+inhibits+prostaglandin+E2+production+in+vascular+smooth+muscle+cells&doi=10.1152%2Fajpheart.1998.275.6.H2113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells</span></div><div class="casAuthors">Fang, Xiang; Moore, Steven A.; Stoll, Lynn L.; Rich, Gretchen; Kaduce, Terry L.; Weintraub, Neal L.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6, Pt. 2</span>),
    <span class="NLM_cas:pages">H2113-H2121</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">4,15-Epoxyeicosatrienoic acid (EET), a cytochrome P 450 epoxygenase product of arachidonic acid (AA), reduced PGE2 formation by 40-75% in porcine aortic and murine brain microvascular smooth muscle cells.  The inhibition was reversed 6-10 h after removal of 14,15-EET from the medium and was regioisomeric specific; 8,9-EET produced a smaller effect, whereas 11,12- and 5,6-EET were ineffective.  Although the cells converted 14,15-EET to 14,15-dihydroxyeicosatrienoic acid (14,15-DHET), 14,15-DHET did not inhibit PGE2 formation, and the 14,15-EET-induced inhibition was potentiated by 4-phenylchalcone oxide, an epoxide hydrolase inhibitor.  The inhibition occurred when substrate amts. of arachidonic acid (AA) were used and was not accompanied by enhanced prodn. of other prostaglandins, suggesting an effect on PGH synthase; however, in murine cells, 14,15-EET did not reduce PGH synthase mRNA or protein.  Moreover, the 14,15-EET-induced decrease in PGE2 prodn. was overcome by increasing the concn. of AA, but not oleic acid (which is not a substrate for PGH synthase).  These findings suggest that 14,15-EET competitively inhibits PGH synthase activity in vascular smooth muscle cells.  The 14,15-EET-induced inhibition of PGE2 prodn. resulted in potentiation of platelet-derived growth factor-induced smooth muscle cell proliferation, suggesting that the competitive inhibition of PGH synthase by 14,15-EET can affect growth responses in smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHmZqUjnUjPrVg90H21EOLACvtfcHk0lgDVxqzV7atOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1yitA%253D%253D&md5=5dc07fab2eb568f0ca12fab74c7a5dc9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.1998.275.6.H2113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.1998.275.6.H2113%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DStoll%26aufirst%3DL.%2BL.%26aulast%3DRich%26aufirst%3DG.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3D14%252C15-Epoxyeicosatrienoic%2520acid%2520inhibits%2520prostaglandin%2520E2%2520production%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1998%26volume%3D275%26spage%3DH2113%26epage%3DH2121%26doi%3D10.1152%2Fajpheart.1998.275.6.H2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.34.6.1242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.34.6.1242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10601125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=1242-1246&author=X.+Fangauthor=N.+L.+Weintraubauthor=L.+L.+Stollauthor=A.+A.+Spector&title=Epoxyeicosatrienoic+acids+increase+intracellular+calcium+concentration+in+vascular+smooth+muscle+cells&doi=10.1161%2F01.HYP.34.6.1242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells</span></div><div class="casAuthors">Fang, Xiang; Weintraub, Neal L.; Stoll, Lynn L.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1242-1246</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are cytochrome P 450-derived metabolites of arachidonic acid.  They are potent endogenous vasodilator compds. produced by vascular cells, and EET-induced vasodilation has been attributed to activation of vascular smooth muscle cell (SMC) K+ channels.  However, in some cells, EETs activate Ca2+ channels, resulting in Ca2+ influx and increased intracellular Ca2+ concn. ([Ca2+]i).  We investigated whether EETs also can activate Ca2+ channels in vascular SMC and whether the resultant Ca2+ influx can influence vascular tone.  The 4 EET regioisomers (1 μmol/L) increased porcine aortic SMC [CA2+]i by 52% to 81%, whereas arachidonic acid, dihydroxyeicosatrienoic acids, and 15-hydroxyeicosatetraenoic acid (1 μmol/L) produced little effect.  The increases in [Ca2+]i produced by 14,15-EET were abolished by removal of extracellular Ca2+ and by pretreatment with verapamil (10 μmol/L), an inhibitor of voltage-dependent (L-type) Ca2+ channels.  14,15-EET did not alter Ca2+ signaling induced by norepinephrine and thapsigargin.  When administered to porcine coronary artery rings precontracted with a thromboxane mimetic, 14,15-EET produced relaxation.  However, when administered to rings precontracted with acetylcholine or KCl, 14,15-EET produced addnl. contractions.  In rings exposed to 10 mmol/L KCl, a concn. that did not affect resting ring tension, 14,15-EET produced small contractions that were abolished by EGTA (3 mmol/L) or verapamil (10 μmol/L).  These observations indicate that 14,15-EET enhances [Ca2+]i influx in vascular SMC through voltage-dependent Ca2+ channels.  This 14,15-EET-induced increase in [Cai2+] can produce vasoconstriction and therefore may act to modulate EET-induced vasorelaxation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0F6mR09qP3LVg90H21EOLACvtfcHk0lgDVxqzV7atOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFCksQ%253D%253D&md5=b3f0d1cfe635ce9c05f5e7fc54f53818</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.34.6.1242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.34.6.1242%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DStoll%26aufirst%3DL.%2BL.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520increase%2520intracellular%2520calcium%2520concentration%2520in%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DHypertension%26date%3D1999%26volume%3D34%26spage%3D1242%26epage%3D1246%26doi%3D10.1161%2F01.HYP.34.6.1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirt, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, H. R.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1805</span>– <span class="NLM_lpage">1812</span>, <span class="refDoi"> DOI: 10.1172/JCI114365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1172%2FJCI114365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=2556446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1989&pages=1805-1812&author=D.+L.+Hirtauthor=J.+Capdevilaauthor=J.+R.+Falckauthor=M.+D.+Breyerauthor=H.+R.+Jacobson&title=Cytochrome+P450+metabolites+of+arachidonic+acid+are+potent+inhibitors+of+vasopressin+action+on+rabbit+cortical+collecting+duct&doi=10.1172%2FJCI114365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct</span></div><div class="casAuthors">Hirt, Darrell L.; Capdevila, Jorge; Falck, J. R.; Breyer, Matthew D.; Jacobson, Harry R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1805-12</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">Arachidonic acid is metabolized by a cytochrome P 450, NADPH-dependent epoxygenase to 4 regioisomeric epoxyeicosatrienoic acids (EETs).  The EETs are further hydrated enzymically to their resp. diols, vic-dihydroxyeicosatrienoic acids (DHETs).  The effect of pretreatment with DHETs on 10 microunits AVP/cm2-stimulated hydraulic cond. (Lp) (Lp × 10-7 cm/atm/s) was studied in rabbit cortical collecting ducts perfused in vitro at 37°.  At 10-6M, all 4 DHETs were potent inhibitors of the hydroosmotic effect of AVP.  14,15-DHET was the most potent isomer; it reduced AVP-induced Lp from a control value of 234.75 to a value of 95.2, a redn. of AVP-mediated water flow of 60%.  The inhibitory effect of 14,15-DHET was dose dependent and significant to nanomolar concns.  14,15-DHET at 10-7M was as potent an inhibitor of AVP's activity as was 10-7M PGE2.  AVP's hydroosmotic effect is mediated through its intracellular 2nd messenger, cAMP.  The cAMP analog 8-p-chlorophenylthio-cAMP (CcAMP) at 10-4M induced a peak Lp of 189.6; pretreatment with 10-6M 14,15-DHET reduced the CcAMP-peak Lp to 132.0, demonstrating a post-cAMP effect.  Gas chromatog./mass spectroscopy suggests that EETs are present in exts. purified from cortical collecting ducts.  Cytochrome P 450 epoxygenase eicosanoids are apparently potent inhibitors of the hydroosmotic effect of vasopressin and are endogenous constituents of normal cortical collecting ducts, the major target tissue for AVP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftqQ_9IpgR7Vg90H21EOLACvtfcHk0lgDVxqzV7atOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFertQ%253D%253D&md5=42376245a9d0006f64028f26f669850e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1172%2FJCI114365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114365%26sid%3Dliteratum%253Aachs%26aulast%3DHirt%26aufirst%3DD.%2BL.%26aulast%3DCapdevila%26aufirst%3DJ.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26aulast%3DJacobson%26aufirst%3DH.%2BR.%26atitle%3DCytochrome%2520P450%2520metabolites%2520of%2520arachidonic%2520acid%2520are%2520potent%2520inhibitors%2520of%2520vasopressin%2520action%2520on%2520rabbit%2520cortical%2520collecting%2520duct%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1989%26volume%3D84%26spage%3D1805%26epage%3D1812%26doi%3D10.1172%2FJCI114365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1161/01.RES.81.2.258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.81.2.258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9242187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1997&pages=258-267&author=N.+L.+Weintraubauthor=X.+Fangauthor=T.+L.+Kaduceauthor=M.+VanRollinsauthor=P.+Chatterjeeauthor=A.+A.+Spector&title=Potentiation+of+endothelium-dependent+relaxation+by+epoxyeicosatrienoic+acids&doi=10.1161%2F01.RES.81.2.258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Weintraub, Neal L.; Fang, Xiang; Kaduce, Terry L.; Vanrollins, Mike; Chatterjee, Papri; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">American Heart Association</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are potent endothelium-derived vasodilators formed from cytochrome P 450 metab. of arachidonic acid.  EETs and their diol products (DHETs) are also avidly taken up by endothelial cells and incorporated into phospholipids that participate in signal transduction.  To investigate the possible functional significance of EET and DHET incorporation into cell lipids, we examd. the capacity of EETs and DHETs to relax porcine coronary arterial rings and detd. responses to bradykinin (which potently activates endothelial phospholipases) before and after incubating the rings with these eicosanoids.  14,15-EET and 11,12-EET (5 μmol/L) produced 75% and 52% relaxation, resp., of U 46619-contracted rings, whereas 8,9-EET and 5,6-EET did not produce significant relaxation.  The corresponding DHET regioisomers produced comparable relaxation responses.  Preincubation with 14,15-EET, 11,12-EET, 14,15-DHET, and 11,12-DHET augmented the magnitude and duration of bradykinin-induced relaxation, whereas endothelium-independent relaxations to aprikalim and sodium nitroprusside were not potentiated.  Pretreatment with 2 μmol/L triacsin C (an inhibitor of acyl CoA synthases) inhibited [3H]14,15-EET incorporation into endothelial phospholipids and blocked 11,12-EET- and 14,15-DHET-induced potentiation of relaxation to bradykinin.  Exposure of [3H]14,15-EET-labeled endothelial cells to the Ca2+ ionophore A 23187 (2 μmol/L) resulted in a 4-fold increased release of EET and DHET into the medium.  We conclude that incorporation of EETs and DHETs into cell lipids results in potentiation of bradykinin-induced relaxation in porcine coronary arteries, providing the first evidence that incorporated EETs and DHETs are capable of modulating vascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2nKS5VTwKBbVg90H21EOLACvtfcHk0lh7B9O6XI1ciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFyksb4%253D&md5=5b0e345d8abf5d99dc70d0252354ed21</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1161%2F01.RES.81.2.258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.81.2.258%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DP.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DPotentiation%2520of%2520endothelium-dependent%2520relaxation%2520by%2520epoxyeicosatrienoic%2520acids%26jtitle%3DCirc.%2520Res.%26date%3D1997%26volume%3D81%26spage%3D258%26epage%3D267%26doi%3D10.1161%2F01.RES.81.2.258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oltman, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellsperger, K. C.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1161/01.RES.83.9.932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.83.9.932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9797342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1yjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=932-939&author=C.+L.+Oltmanauthor=N.+L.+Weintraubauthor=M.+VanRollinsauthor=K.+C.+Dellsperger&title=Epoxyeicosatrienoic+acids+and+dihydroxyeicosatrienoic+acids+are+potent+vasodilators+in+the+canine+coronary+microcirculation&doi=10.1161%2F01.RES.83.9.932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation</span></div><div class="casAuthors">Oltman, Christine L.; Weintraub, Neal L.; VanRollins, Mike; Dellsperger, Kevin C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Cytochrome P450 epoxygenases convert arachidonic acid into 4 epoxyeicosatrienoic acid (EET) regioisomers, which were recently identified as endothelium-derived hyperpolarizing factors in coronary blood vessels.  Both EETs and their dihydroxyeicosatrienoic acid (DHET) metabolites have been shown to relax conduit coronary arteries at micromolar concns., whereas the plasma concns. of EETs are in the nanomolar range.  However, the effects of EETs and DHETs on coronary resistance arterioles have not been examd.  The authors administered EETs and DHETs to isolated canine coronary arterioles (diam., 90.0 μm; distending pressure, 20 mm Hg) preconstricted by 30% to 60% of the resting diam. with endothelin.  All 4 EET regioisomers produced potent, concn.-dependent vasodilation (EC50 values ranging from -12.7 to -10.1 log [M]) and were approx. 1000 times more potent than reported in conduit coronary arteries.  The vasodilation produced by 14,15-EET was not attenuated by removal of the endothelium and indicated a direct action of 14,15-EET on microvascular smooth muscle.  Likewise, 14,15-DHET, 11,12-DHET, 8,9-DHET, and the δ-lactone of 5,6-EET produced extremely potent vasodilation (EC50 values ranging from -15.8 to -13.1 log [M]).  The vasodilation produced by these eicosanoids was highly potent in comparison to that produced by other vasodilators, including arachidonic acid (EC50 = -7.5 log [M]).  The epoxide hydrolase inhibitor, 4-phenylchalone oxide, which blocked the conversion of [3H]14,15-EET to [3H]14,15-DHET by canine coronary arteries, did not alter arteriolar dilation to 11,12-EET; thus, the potent vasodilation induced by EETs does not require formation of DHETs.  In contrast, charybdotoxin (a KCa channel inhibitor) and KCl (a depolarizing agent) blocked vasodilation by 11,12-EET and 11,12-DHET.  The authors conclude that EETs and DHETs potently dilate canine coronary arterioles via activation of KCa channels.  The preferential ability of these compds. to dilate resistance blood vessels suggests that they may be important regulators of coronary circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxwoTXKoRAb7Vg90H21EOLACvtfcHk0lh7B9O6XI1ciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1yjurY%253D&md5=8f503829c63281cfbf790865bc2171a6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1161%2F01.RES.83.9.932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.83.9.932%26sid%3Dliteratum%253Aachs%26aulast%3DOltman%26aufirst%3DC.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DDellsperger%26aufirst%3DK.%2BC.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520and%2520dihydroxyeicosatrienoic%2520acids%2520are%2520potent%2520vasodilators%2520in%2520the%2520canine%2520coronary%2520microcirculation%26jtitle%3DCirc.%2520Res.%26date%3D1998%26volume%3D83%26spage%3D932%26epage%3D939%26doi%3D10.1161%2F01.RES.83.9.932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Epoxy-oxylipins and soluble epoxide hydrolase metabolic pathway as targets for NSAID-induced gastroenteropathy and inflammation-associated carcinogenesis</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">731</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31293429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt12itrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=731&author=R.+D.+Jonesauthor=J.+Liaoauthor=X.+Tongauthor=D.+D.+Xuauthor=L.+Y.+Sunauthor=H.+N.+Liauthor=G.+Y.+Yang&title=Epoxy-oxylipins+and+soluble+epoxide+hydrolase+metabolic+pathway+as+targets+for+NSAID-induced+gastroenteropathy+and+inflammation-associated+carcinogenesis&doi=10.3389%2Ffphar.2019.00731"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxy-oxylipins and soluble epoxide hydrolase metabolic pathway as targets for NSAID-induced gastroenteropathy and inflammation-associated carcinogenesis</span></div><div class="casAuthors">Jones, Ryan D.; Liao, Jie; Tong, Xin; Xu, Dandan; Sun, Leyu; Li, Haonan; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">731</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Polyunsatd. fatty acids (PUFAs) including epoxide-modified ω-3 and ω-6 fatty acids are made via oxidn. to create highly polarized carbon-oxygen bonds crucial to their function as signaling mols.  A crit. PUFA, arachidonic acid (ARA), is metabolized to a diverse set of lipids signaling mols. through cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P 450 epoxygenase, or cytochrome P 450 hydroxylase; however, the majority of ARA is metabolized into anti-inflammatory epoxides via cytochrome P 450 enzymes.  These short-lived epoxide lipids are rapidly metabolized or inactivated by the sol. epoxide hydrolase (sEH) into diol-contg. products. sEH inhibition or knockout has been a practical approach to study the biol. of the epoxide lipids, and has been shown to effectively treat inflammatory conditions in the preclin. models including gastrointestinal ulcers and colitis by shifting oxylipins to epoxide profiles, inhibiting inflammatory cell infiltration and activation, and enhancing epithelial cell defense via increased mucin prodn., thus providing further evidence for the role of sEH as a pro-inflammatory protein.  Non-steroidal anti-inflammatory drugs (NSAIDs) with COXinhibitor activity are among the most commonly used analgesics and have demonstrated applications in the management of cardiovascular disease and intriguingly cancer.  Major side effects of NSAIDs however are gastrointestinal ulcers which frequently precludes their long-term application.  In this review, we hope to bridge the gap between NSAID toxicity and sEH-mediated metabolic pathways to focus on the role of epoxy fatty acid metabolic pathway of PUFAs in NSAIDS-ulcer formation and healing as well as inflammation-related carcinogenesis.  Specifically we address the potential application of sEH inhibition to enhance ulcer healing at the site of inflammation via their activity on altered lipid signaling, mitochondrial function, and diminished reactive oxygen species, and further discuss the significance of dual COX and sEH inhibitor in anti-inflammation and carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdoAHzK6S3yrVg90H21EOLACvtfcHk0lh7B9O6XI1ciw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt12itrY%253D&md5=dd7d06befee0bdf3f4d0d192035ed3f4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00731%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BD.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DD.%2BD.%26aulast%3DSun%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DH.%2BN.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DEpoxy-oxylipins%2520and%2520soluble%2520epoxide%2520hydrolase%2520metabolic%2520pathway%2520as%2520targets%2520for%2520NSAID-induced%2520gastroenteropathy%2520and%2520inflammation-associated%2520carcinogenesis%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D731%26doi%3D10.3389%2Ffphar.2019.00731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase: gene structure, expression and deletion</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.gene.2013.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23701967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVahtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2013&pages=61-74&author=T.+R.+Harrisauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase%3A+gene+structure%2C+expression+and+deletion&doi=10.1016%2Fj.gene.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase: Gene structure, expression and deletion</span></div><div class="casAuthors">Harris, Todd R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">61-74</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mammalian sol. epoxide hydrolase (sEH) converts epoxides to their corresponding diols through the addn. of a water mol. sEH readily hydrolyzes lipid signaling mols., including the epoxyeicosatrienoic acids (EETs), epoxidized lipids produced from arachidonic acid by the action of cytochrome p450s.  Through its metab. of the EETs and other lipid mediators, sEH contributes to the regulation of vascular tone, nociception, angiogenesis and the inflammatory response.  Because of its central physiol. role in disease states such as cardiac hypertrophy, diabetes, hypertension, and pain sEH is being investigated as a therapeutic target.  This review begins with a brief introduction to sEH protein structure and function. sEH evolution and gene structure are then discussed before human small nucleotide polymorphisms and mammalian gene expression are described in the context of several disease models.  The review ends with an overview of studies that have employed the sEH knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN0pHtaHhQB7Vg90H21EOLACvtfcHk0lg55StuJMnFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVahtbo%253D&md5=a62cfc7c361b9515e618d5ba8dd31a61</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%253A%2520gene%2520structure%252C%2520expression%2520and%2520deletion%26jtitle%3DGene%26date%3D2013%26volume%3D526%26spage%3D61%26epage%3D74%26doi%3D10.1016%2Fj.gene.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McReynolds, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pharmthera.2017.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28642117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyntLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2017&pages=62-76&author=K.+M.+Wagnerauthor=C.+B.+McReynoldsauthor=W.+K.+Schmidtauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+as+a+therapeutic+target+for+pain%2C+inflammatory+and+neurodegenerative+diseases&doi=10.1016%2Fj.pharmthera.2017.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases</span></div><div class="casAuthors">Wagner, Karen M.; McReynolds, Cindy B.; Schmidt, William K.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-76</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Eicosanoids are biol. active lipid signaling mols. derived from polyunsatd. fatty acids.  Many of the actions of eicosanoid metabolites formed by cyclooxygenase and lipoxygenase enzymes have been characterized, however, the epoxy-fatty acids (EpFAs) formed by cytochrome P 450 enzymes are newly described by comparison.  The EpFA metabolites modulate a diverse set of physiol. functions that include inflammation and nociception among others.  Regulation of EpFAs occurs primarily via release, biosynthesis and enzymic transformation by the sol. epoxide hydrolase (sEH).  Targeting sEH with small mol. inhibitors has enabled observation of the biol. activity of the EpFAs in vivo in animal models, greatly contributing to the overall understanding of their role in the inflammatory response.  Their role in modulating inflammation has been demonstrated in disease models including cardiovascular pathol. and inflammatory pain, but extends to neuroinflammation and neuroinflammatory disease.  Moreover, while EpFAs demonstrate activity against inflammatory pain, interestingly, this action extends to blocking chronic neuropathic pain as well.  This review outlines the role of modulating sEH and the biol. action of EpFAs in models of pain and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpflNfJFI-LVg90H21EOLACvtfcHk0lg55StuJMnFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyntLzN&md5=cce7ef34908084360e85c153a0c428ee</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DMcReynolds%26aufirst%3DC.%2BB.%26aulast%3DSchmidt%26aufirst%3DW.%2BK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520as%2520a%2520therapeutic%2520target%2520for%2520pain%252C%2520inflammatory%2520and%2520neurodegenerative%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D180%26spage%3D62%26epage%3D76%26doi%3D10.1016%2Fj.pharmthera.2017.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.484804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1517%2F13543776.2010.484804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20429668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVyjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=941-956&author=H.+C.+Shen&title=Soluble+epoxide+hydrolase+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2010.484804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors: a patent review</span></div><div class="casAuthors">Shen, Hong C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-956</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Sol. epoxide hydrolase (sEH) inhibitors have been shown to effectively increase the levels of epoxyeicosatrienoic acids and reduce the levels of dihydroxyeicosatrienoic acids, which may be translated to therapeutic potentials for multiple disease indications.  It has been claimed that sEH inhibitors can be used to treat hypertension, diabetes, stroke, dyslipidemia, pain, immunol. disorders, eye diseases, neurol. diseases and other indications.Areas covered in this review: A comprehensive synopsis of patent literature on sEH inhibitors is provided.What the reader will gain: A total of more than 100 patent publications describing multiple classes of sEH inhibitors are analyzed.  These include amides, ureas, thioamides, thioureas, carbamates, acyl hydrazones, chalcone oxdies, etc.  In addn. to selected in vitro and in vivo data of representative sEH inhibitors, a wide range of proposed applications of sEH inhibitors are also summarized.Take home message: Several sEH inhibitors with potent in vitro and in vivo target inhibition appear promising, including one Phase II clin. candidate.  The clin. evaluation will be crit. to assess the proclaimed therapeutic utility of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWIUYe5yHfVLVg90H21EOLACvtfcHk0lg55StuJMnFuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVyjurs%253D&md5=01f393eb892f762b0fc1abf6fb26d829</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.484804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.484804%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%2BC.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D941%26epage%3D956%26doi%3D10.1517%2F13543776.2010.484804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Chalcone oxides - potent selective inhibitors of cytosolic epoxide hydrolase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(82)90231-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2F0003-9861%2882%2990231-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=7114846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL38XktlGht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=423-439&author=C.+A.+Mullinauthor=B.+D.+Hammock&title=Chalcone+oxides+-+potent+selective+inhibitors+of+cytosolic+epoxide+hydrolase&doi=10.1016%2F0003-9861%2882%2990231-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone oxides - potent selective inhibitors of cytosolic epoxide hydrolase</span></div><div class="casAuthors">Mullin, Christopher A.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-39</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The systematic screening of >150 compds. for inhibitory activity on mammalian cytosolic epoxide hydrolase (I) led to identification of chalcone oxide (trans-1-benzoyl-2-phenyloxirane) as an optimal inhibitory structure.  Important structural features for inhibition include 2 hydrophobic moieties preferably orientating in a trans manner from an electrophilic center such as an activated olefin or epoxide, with the epoxide giving max. activity.  Synthesis of chalcone oxide derivs. bearing a single p-substituent on either Ph ring has led to very potent inhibitors of the enzyme, the best being 4-phenylchalcone oxide (50% inhibition at 6.4 × 10-8M).  Multiple factorial anal. on the inhibition data for the 2 series of chalcone oxides prepd. (Ph or Bz substituted) revealed both the essentiality of hydrophobic interactions and the apparent nonequivalence of the 2 hydrophobic sites involved in the inhibitory process.  Steric factors were considerably less crucial, whereas electronic effects were unimportant in the compds. examd.  The chalcone oxides were either inactive or only weak inhibitors of the other major epoxide-metabolizing enzymes in mouse liver, cytosolic glutathione S-transferase and microsomal I.  The nature of the inhibition of cytosolic I by chalcone oxides was further investigated through steady-state kinetic anal. and the use of amino acid modifiers.  Chalcone oxides give a slowly reversible mixed-noncompetitive inhibition.  They may interact covalently with a cysteine residue possibly essential to the catalytic action of cytosolic I and may indeed be alternative substrates with very low turnover.  The cytosolic and microsomal I activities can be clearly distinguished by these inhibitors, further indicating different catalytic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquT5U7DvCzzLVg90H21EOLACvtfcHk0lgLeL3KcDX3xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktlGht70%253D&md5=88b432a3e831403e676c199e4f6ba0bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2882%2990231-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252882%252990231-4%26sid%3Dliteratum%253Aachs%26aulast%3DMullin%26aufirst%3DC.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DChalcone%2520oxides%2520-%2520potent%2520selective%2520inhibitors%2520of%2520cytosolic%2520epoxide%2520hydrolase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1982%26volume%3D216%26spage%3D423%26epage%3D439%26doi%3D10.1016%2F0003-9861%2882%2990231-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8854</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.16.8849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.96.16.8849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10430859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=8849-8854&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=D.+Dowdyauthor=J.+Zhengauthor=J.+F.+Greeneauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=Potent+urea+and+carbamate+inhibitors+of+soluble+epoxide+hydrolases&doi=10.1073%2Fpnas.96.16.8849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Potent urea and carbamate inhibitors of soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Dowdy, Deanna; Zheng, Jiang; Greene, Jessica F.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8849-8854</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations.  Herein, the authors report the discovery of substituted ureas and carbamates as potent inhibitors of sEH.  Some of these selective, competitive tight-binding inhibitors with nanomolar Ki values interacted stoichiometrically with the homogeneous recombinant murine and human sEHs.  These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol.  They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome.  These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chem. mediation in vitro or in vivo systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOIwuI01SYLVg90H21EOLACvtfcHk0lgLeL3KcDX3xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVeqsL8%253D&md5=eeff85f27c1a33e2da6fb7f8f2ae91de</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.16.8849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.16.8849%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DDowdy%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DJ.%2BF.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520urea%2520and%2520carbamate%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D8849%26epage%3D8854%26doi%3D10.1073%2Fpnas.96.16.8849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweitzer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galop, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurali, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnette, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth-Genthe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> characterization of a novel soluble epoxide hydrolase inhibitor</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104-105</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23434473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104-105&publication_year=2013&pages=25-31&author=P.+L.+Podolinauthor=B.+J.+Bologneseauthor=J.+F.+Foleyauthor=E.+Longauthor=B.+Peckauthor=S.+Umbrechtauthor=X.+Zhangauthor=P.+Zhuauthor=B.+Schwartzauthor=W.+Xieauthor=C.+Quinnauthor=H.+Qiauthor=S.+Sweitzerauthor=S.+Chenauthor=M.+Galopauthor=Y.+Dingauthor=S.+L.+Belyanskayaauthor=D.+I.+Israelauthor=B.+A.+Morganauthor=D.+J.+Behmauthor=J.+P.+Marinoauthor=E.+Kuraliauthor=M.+S.+Barnetteauthor=R.+J.+Mayerauthor=C.+L.+Booth-Gentheauthor=J.+F.+Callahan&title=In+vitro+and+in+vivo+characterization+of+a+novel+soluble+epoxide+hydrolase+inhibitor&doi=10.1016%2Fj.prostaglandins.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor</span></div><div class="casAuthors">Podolin, Patricia L.; Bolognese, Brian J.; Foley, Joseph F.; Long, Edward; Peck, Brian; Umbrecht, Sandra; Zhang, Xiaojun; Zhu, Penny; Schwartz, Benjamin; Xie, Wensheng; Quinn, Chad; Qi, Hongwei; Sweitzer, Sharon; Chen, Stephanie; Galop, Marc; Ding, Yun; Belyanskaya, Svetlana L.; Israel, David I.; Morgan, Barry A.; Behm, David J.; Marino, Joseph P.; Kurali, Edit; Barnette, Mary S.; Mayer, Ruth J.; Booth-Genthe, Catherine L.; Callahan, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104-105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH, EPHX2) metabolizes eicosanoid epoxides, including epoxyeicosatrienoic acids (EETs) to the corresponding dihydroxyeicosatrienoic acids (DHETs), and leukotoxin (LTX) to leukotoxin diol (LTX diol).  EETs, endothelium-derived hyperpolarizing factors, exhibit potentially beneficial properties, including anti-inflammatory effects and vasodilation.  A novel, potent, selective inhibitor of recombinant human, rat and mouse sEH, GSK2256294A, exhibited potent cell-based activity, a concn.-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET in human, rat and mouse whole blood in vitro, and a dose-dependent increase in the LTX/LTX diol ratio in rat plasma following oral administration.  Mice receiving 10 days of cigarette smoke exposure concomitant with oral administration of GSK2256294A exhibited significant, dose-dependent redns. in pulmonary leukocytes and keratinocyte chemoattractant (KC, CXCL1) levels.  Mice receiving oral administration of GSK2256294A following 10 days of cigarette smoke exposure exhibited significant redns. in pulmonary leukocytes compared to vehicle-treated mice.  These data indicate that GSK2256294A attenuates cigarette smoke-induced inflammation by both inhibiting its initiation and/or maintenance and promoting its resoln.  Collectively, these data indicate that GSK2256294A would be an appropriate agent to evaluate the role of sEH in clin. studies, for example in diseases where cigarette smoke is a risk factor, such as chronic obstructive pulmonary disease (COPD) and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXL0W8Yob67Vg90H21EOLACvtfcHk0lgLeL3KcDX3xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFCgu7s%253D&md5=e7842bc2d88795ef4a7fae1b0988454b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DFoley%26aufirst%3DJ.%2BF.%26aulast%3DLong%26aufirst%3DE.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGalop%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DKurali%26aufirst%3DE.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520a%2520novel%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D104-105%26spage%3D25%26epage%3D31%26doi%3D10.1016%2Fj.prostaglandins.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghardt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinchenkova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnyukova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhurilo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihalainen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auriola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leppanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoryelov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dar’in, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasavin, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2018.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30059891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=655-667&author=A.+Lukinauthor=J.+Kramerauthor=M.+Hartmannauthor=L.+Weizelauthor=V.+Hernandez-Olmosauthor=K.+Falahatiauthor=I.+Burghardtauthor=N.+Kalinchenkovaauthor=D.+Bagnyukovaauthor=N.+Zhuriloauthor=J.+Rautioauthor=M.+Forsbergauthor=J.+Ihalainenauthor=S.+Auriolaauthor=J.+Leppanenauthor=I.+Konstantinovauthor=D.+Pogoryelovauthor=E.+Proschakauthor=D.+Dar%E2%80%99inauthor=M.+Krasavin&title=Discovery+of+polar+spirocyclic+orally+bioavailable+urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bioorg.2018.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Lukin, Alexey; Kramer, Jan; Hartmann, Markus; Weizel, Lilia; Hernandez-Olmos, Victor; Falahati, Konstantin; Burghardt, Irene; Kalinchenkova, Natalia; Bagnyukova, Darya; Zhurilo, Nikolay; Rautio, Jarkko; Forsberg, Markus; Ihalainen, Jouni; Auriola, Seppo; Leppanen, Jukka; Konstantinov, Igor; Pogoryelov, Denys; Proschak, Ewgenij; Dar'in, Dmitry; Krasavin, Mikhail</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">655-667</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Spirocyclic 1-oxa-9-azaspiro[5.5]undecan-4-amine scaffold was explored as a basis for the design of potential inhibitors of sol. epoxide hydrolase (sEH).  Synthesis and testing of the initial SAR-probing library followed by biochem. testing against sEH allowed nominating a racemic lead compd. (±)-22.  The latter showed remarkable (> 0.5 mM) soly. in aq. phosphate buffer soln., unusually low (for sEH inhibitors) lipophilicity as confirmed by exptl. detd. logD7.4 of 0.99, and an excellent oral bioavailability in mice (as well as other pharmacokinetic characteristics).  Individual enantiomer profiling revealed that the inhibitory potency primarily resided with the dextrorotatory eutomer (+)-22 (IC50 4.9 ± 0.18 nM).  For the latter, a crystal structure of its complex with a C-terminal domain of sEH was obtained and resolved.  These data fully validate (+)-22 as a new non-racemic advanced lead compd. for further development as a potential therapeutic agent for use in such areas as cardiovascular disease, inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGfaRrJqIhJLVg90H21EOLACvtfcHk0lj_k3U8adKrwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVSqtL%252FP&md5=25e30e957e043e65cdc9463bbf2328f0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DLukin%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DFalahati%26aufirst%3DK.%26aulast%3DBurghardt%26aufirst%3DI.%26aulast%3DKalinchenkova%26aufirst%3DN.%26aulast%3DBagnyukova%26aufirst%3DD.%26aulast%3DZhurilo%26aufirst%3DN.%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DIhalainen%26aufirst%3DJ.%26aulast%3DAuriola%26aufirst%3DS.%26aulast%3DLeppanen%26aufirst%3DJ.%26aulast%3DKonstantinov%26aufirst%3DI.%26aulast%3DPogoryelov%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DDar%25E2%2580%2599in%26aufirst%3DD.%26aulast%3DKrasavin%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520polar%2520spirocyclic%2520orally%2520bioavailable%2520urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D80%26spage%3D655%26epage%3D667%26doi%3D10.1016%2Fj.bioorg.2018.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draper, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engler, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1161/01.RES.87.11.992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.87.11.992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11090543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslygsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2000&pages=992-998&author=Z.+Yuauthor=F.+Xuauthor=L.+M.+Huseauthor=C.+Morisseauauthor=A.+J.+Draperauthor=J.+W.+Newmanauthor=C.+Parkerauthor=L.+Grahamauthor=M.+M.+Englerauthor=B.+D.+Hammockauthor=D.+C.+Zeldinauthor=D.+L.+Kroetz&title=Soluble+epoxide+hydrolase+regulates+hydrolysis+of+vasoactive+epoxyeicosatrienoic+acids&doi=10.1161%2F01.RES.87.11.992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids</span></div><div class="casAuthors">Yu, Zhigang; Xu, Fengyun; Huse, Linn M.; Morisseau, Christophe; Draper, Alison J.; Newman, John W.; Parker, Carol; Graham, LeRae; Engler, Marguerite M.; Hammock, Bruce D.; Zeldin, Darryl C.; Kroetz, Deanna L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">992-998</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The cytochrome P 450-derived epoxyeicosatrienoic acids (EETs) have potent effects on renal vascular reactivity and tubular sodium and water transport; however, the role of these eicosanoids in the pathogenesis of hypertension is controversial.  The current study examd. the hydrolysis of the EETs to the corresponding dihydroxyeicosatrienoic acids (DHETs) as a mechanism for regulation of EET activity and blood pressure.  EET hydrolysis was increased 5- to 54-fold in renal cortical S9 fractions from the spontaneously hypertensive rat (SHR) relative to the normotensive Wistar-Kyoto (WKY) rat.  This increase was most significant for the 14,15-EET regioisomer, and there was a clear preference for hydrolysis of 14,15-EET over the 8,9- and 11,12-EETs.  Increased EET hydrolysis was consistent with increased expression of sol. epoxide hydrolase (sEH) in the SHR renal microsomes and cytosol relative to the WKY samples.  The urinary excretion of 14,15-DHET was 2.6-fold higher in the SHR than in the WKY rat, confirming increased EET hydrolysis in the SHR in vivo.  Blood pressure was decreased 22 mm Hg 6 h after treatment of SHRs with the selective sEH inhibitor N,N'-dicyclohexylurea; this treatment had no effect on blood pressure in the WKY rat.  These studies identify sEH as a novel therapeutic target for control of blood pressure.  The identification of a potent and selective inhibitor of EET hydrolysis will be invaluable in sepg. the vascular effects of the EET and DHET eicosanoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVhSHVOsx5QLVg90H21EOLACvtfcHk0lj_k3U8adKrwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslygsb8%253D&md5=ac79e222d25f48bbb570f6fe1b092f6a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1161%2F01.RES.87.11.992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.87.11.992%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DHuse%26aufirst%3DL.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DDraper%26aufirst%3DA.%2BJ.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DL.%26aulast%3DEngler%26aufirst%3DM.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520regulates%2520hydrolysis%2520of%2520vasoactive%2520epoxyeicosatrienoic%2520acids%26jtitle%3DCirc.%2520Res.%26date%3D2000%26volume%3D87%26spage%3D992%26epage%3D998%26doi%3D10.1161%2F01.RES.87.11.992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaduce, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesch, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span> <span> </span><span class="NLM_article-title">Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">14867</span>– <span class="NLM_lpage">14874</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011761200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M011761200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11278979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Orsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14867-14874&author=X.+Fangauthor=T.+L.+Kaduceauthor=N.+L.+Weintraubauthor=S.+Harmonauthor=L.+M.+Teeschauthor=C.+Morisseauauthor=D.+A.+Thompsonauthor=B.+D.+Hammockauthor=A.+A.+Spector&title=Pathways+of+epoxyeicosatrienoic+acid+metabolism+in+endothelial+cells.+Implications+for+the+vascular+effects+of+soluble+epoxide+hydrolase+inhibition&doi=10.1074%2Fjbc.M011761200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Fang, Xiang; Kaduce, Terry L.; Weintraub, Neal L.; Harmon, Shawn; Teesch, Lynn M.; Morisseau, Christophe; Thompson, David A.; Hammock, Bruce D.; Spector, Arthur A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">14867-14874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are products of cytochrome P 450 epoxygenase that possess important vasodilating and anti-inflammatory properties.  EETs are converted to the corresponding dihydroxyeicosatrienoic acid (DHET) by sol. epoxide hydrolase (sEH) in mammalian tissues, and inhibition of sEH has been proposed as a novel approach for the treatment of hypertension.  The authors obsd. that sEH is present in porcine coronary endothelial cells (PCEC), and the authors found that low concns. of N,N'-dicyclohexylurea (DCU), a selective sEH inhibitor, have profound effects on EET metab. in PCEC cultures.  Treatment with 3 μM DCU reduced cellular conversion of 14,15-EET to 14,15-DHET by 3-fold after 4 h of incubation, with a concomitant increase in the formation of the novel β-oxidn. products 10,11-epoxy-16:2 and 8,9-epoxy-14:1.  DCU also markedly enhanced the incorporation of 14,15-EET and its metabolites into PCEC lipids.  The most abundant product in DCU-treated cells was 16,17-epoxy-22:3, the elongation product of 14,15-EET.  Another novel metabolite, 14,15-epoxy-20:2, was present in DCU-treated cells.  DCU also caused a 4-fold increase in release of 14,15-EET when the cells were stimulated with a calcium ionophore.  Furthermore, DCU decreased the conversion of [3H]11,12-EET to 11,12-DHET, increased 11,12-EET retention in PCEC lipids, and produced an accumulation of the partial β-oxidn. product 7,8-epoxy-16:2 in the medium.  These findings suggest that in addn. to being metabolized by sEH, EETs are substrates for β-oxidn. and chain elongation in endothelial cells and that there is considerable interaction among the three pathways.  The modulation of EET metab. by DCU provides novel insight into the mechanisms by which pharmacol. or mol. inhibition of sEH effectively treats hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNH3CDy6ke5rVg90H21EOLACvtfcHk0lj_k3U8adKrwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Orsr8%253D&md5=23bcc4a615dc8806daa70ade0b6cbbf4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011761200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011761200%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKaduce%26aufirst%3DT.%2BL.%26aulast%3DWeintraub%26aufirst%3DN.%2BL.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DTeesch%26aufirst%3DL.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSpector%26aufirst%3DA.%2BA.%26atitle%3DPathways%2520of%2520epoxyeicosatrienoic%2520acid%2520metabolism%2520in%2520endothelial%2520cells.%2520Implications%2520for%2520the%2520vascular%2520effects%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14867%26epage%3D14874%26doi%3D10.1074%2Fjbc.M011761200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1110/ps.051720206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1110%2Fps.051720206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16322563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=58-64&author=G.+A.+Gomezauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Christianson&title=Human+soluble+epoxide+hydrolase%3A+structural+basis+of+inhibition+by+4-%283-cyclohexylureido%29-carboxylic+acids&doi=10.1110%2Fps.051720206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids</span></div><div class="casAuthors">Gomez, German A.; Morisseau, Christophe; Hammock, Bruce D.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">X-ray crystal structures of human sol. epoxide hydrolase (sEH) complexed with four different dialkylurea inhibitors bearing pendant carboxylate "tails" of varying length have been detd. at 2.3-3.0 Å resoln.  Similarities among inhibitor binding modes reinforce the proposed roles of Y381 and/or Y465 as general acids that protonate the epoxide ring of the substrate in concert with nucleophilic attack of D333 at the electrophilic epoxide carbon.  Addnl., the binding of these inhibitors allows us to model the binding mode of the endogenous substrate 14,15-epoxyeicosatrienoic acid.  Contrasts among inhibitor binding modes include opposite orientations of inhibitor binding in the active-site hydrophobic tunnel.  Alternative binding orientations obsd. for this series of inhibitors to human sEH, as well as the binding of certain dialkylurea inhibitors to human sEH and murine sEH, complicate the structure-based design of human sEH inhibitors with potential pharmaceutical applications in the treatment of hypertension.  Thus, with regard to the optimization of inhibitor designs targeting human sEH, it is crit. that human sEH and not murine sEH be utilized for inhibitor screening, and it is crit. that structures of human sEH-inhibitor complexes be detd. to verify inhibitor binding orientations that correlate with measured affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrqO7mSzRPrVg90H21EOLACvtfcHk0lhceasMG2IZTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktlSrsQ%253D%253D&md5=b16bb0c99a177acc885cbbb789374f2b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1110%2Fps.051720206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.051720206%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DG.%2BA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHuman%2520soluble%2520epoxide%2520hydrolase%253A%2520structural%2520basis%2520of%2520inhibition%2520by%25204-%25283-cyclohexylureido%2529-carboxylic%2520acids%26jtitle%3DProtein%2520Sci.%26date%3D2006%26volume%3D15%26spage%3D58%26epage%3D64%26doi%3D10.1110%2Fps.051720206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1021/jm030514j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030514j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitV2qtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2110-2122&author=I.+H.+Kimauthor=C.+Morisseauauthor=T.+Watanabeauthor=B.+D.+Hammock&title=Design%2C+synthesis%2C+and+biological+activity+of+1%2C3-disubstituted+ureas+as+potent+inhibitors+of+the+soluble+epoxide+hydrolase+of+increased+water+solubility&doi=10.1021%2Fjm030514j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of 1,3-Disubstituted Ureas as Potent Inhibitors of the Soluble Epoxide Hydrolase of Increased Water Solubility</span></div><div class="casAuthors">Kim, In-Hae; Morisseau, Christophe; Watanabe, Takaho; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2110-2122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of endogenous chem. mediators that play an important role in blood pressure regulation and inflammation.  1,3-Disubstituted ureas are potent inhibitors of sEH that are active both in vitro and in vivo.  However, their poor soly. in either water or lipid reduces their in vivo efficacy and makes them difficult to formulate.  To improve these phys. properties, the effect of incorporating polar functional groups into one of the alkyl chains was evaluated on their inhibitor potencies, water soly., octanol/water partition coeffs. (log P), and m.ps.  No loss of inhibition potency was obsd. when a polar functional group was incorporated at least five atoms (∼7.5 Å) from the central urea carbonyl.  In addn., the presence of a polar group at least 11 atoms away from the urea carbonyl group for the mouse and human sEHs, resp., did not alter the inhibitor potency.  The resulting compds. have better water soly. and generally lower log P values and m.ps. than nonfunctionalized lipophilic ureas.  These properties will make the compds. more bioavailable and more sol. in either water- or oil-based formulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDG4_y35pKLVg90H21EOLACvtfcHk0lhceasMG2IZTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitV2qtrs%253D&md5=d80753310c34a3374ad7e6c61e721e19</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm030514j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030514j%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%25201%252C3-disubstituted%2520ureas%2520as%2520potent%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%2520of%2520increased%2520water%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2110%26epage%3D2122%26doi%3D10.1021%2Fjm030514j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural refinement of inhibitors of urea-based souble epoxide hydrolases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(02)00952-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS0006-2952%2802%2900952-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12007563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=1599-1608&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=J.+W.+Newmanauthor=C.+E.+Wheelockauthor=D.+L.+Dowdyauthor=B.+D.+Hammock&title=Structural+refinement+of+inhibitors+of+urea-based+souble+epoxide+hydrolases&doi=10.1016%2FS0006-2952%2802%2900952-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Newman, John W.; Wheelock, Craig E.; Dowdy, Deanna L.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1599-1608</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of arachidonic, linoleic, and other fatty acid epoxides, endogenous chem. mediators that play an important role in blood pressure regulation and inflammation. 1,3-Disubstituted ureas, carbamates, and amides are new potent and stable inhibitors of sEH.  However, the poor soly. of the lead compds. limits their use.  Inhibitor structure-activity relationships were investigated to better define the structural requirements for inhibition and to identify points in the mol. topog. that could accept polar groups without diminishing inhibition potency.  Results indicate that lipophilicity is an important factor controlling inhibitor potency.  Polar groups could be incorporated into one of the alkyl groups without loss of activity if they were placed at a sufficient distance from the urea function.  The resulting compds. had a 2-fold higher water soly.  These findings will facilitate the rational design and optimization of sEH inhibitors with better phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZUVkekez5rVg90H21EOLACvtfcHk0lhceasMG2IZTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D&md5=9d9aa4d7254d7fe156719d17fb80e0ad</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2900952-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252900952-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DDowdy%26aufirst%3DD.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520refinement%2520of%2520inhibitors%2520of%2520urea-based%2520souble%2520epoxide%2520hydrolases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D1599%26epage%3D1608%26doi%3D10.1016%2FS0006-2952%2802%2900952-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1161/hy0202.103788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2Fhy0202.103788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11882632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1WqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=690-694&author=J.+D.+Imigauthor=X.+Zhaoauthor=J.+H.+Capdevilaauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+lowers+arterial+blood+pressure+in+angiotensin+II+hypertension&doi=10.1161%2Fhy0202.103788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension</span></div><div class="casAuthors">Imig, John D.; Zhao, Xueying; Capdevila, Jorge H.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">690-694</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) have antihypertensive properties and play a part in the maintenance of renal microvascular function.  A novel approach to increase EET levels is to inhibit epoxide hydrolase enzymes that are responsible for conversion of biol. active EETs to dihydroxyeicosatrienoic acids (DHETs) that are void of effects on the preglomerular vasculature.  We hypothesized that inhibition of sol. epoxide hydrolase (sEH) would lower blood pressure in angiotensin II (Ang II) hypertension.  Rat renal cortical tissue was harvested and urine collected 2 wk following implantation of an osmotic minipump contg. Ang II (60 ng/min).  Renal cortical sEH protein expression was significantly higher in Ang II hypertension compared with normotensive animals.  Likewise, urinary 14,15-DHET levels were significantly increased in hypertensive compared with normotensive animals and averaged 8.1±1.3 and 2.7±1.1 ng/d; resp.  In addnl. expts., the sEH inhibitor N-cyclohexyl-N-dodecyl urea (NCND; 3 mg/d) or vehicle (corn oil, 0.5 mL) was administered daily by i.p. injection starting on day 10.  Administration of NCND for 4 days lowered systolic blood pressure by 30 mm Hg in Ang II hypertensive animals, whereas the corn oil vehicle had no effect on blood pressure in normotensive or Ang II hypertensive animals.  Measurement of blood pressure by indwelling arterial catheters in conscious animals with free movement in their cages confirmed that NCND had antihypertensive properties.  Arterial blood pressure averaged 119±5 mm Hg in normotensive, 170±3 mm Hg in hypertensive and 149±10 mm Hg in NCND-treated, Ang II-infused animals.  Administration of the potential metabolite of NCND, N-cyclohexylformamide to Ang II hypertensive rats did not lower the systolic blood pressure.  These studies demonstrate that increased sEH expression in the Ang II hypertensive kidney leads to increased EET hydration.  Moreover, sEH plays a role in the regulation of blood pressure, and inhibition of sEH during Ang II hypertension is antihypertensive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou360SDFrqPrVg90H21EOLACvtfcHk0lgRrt3vdCZi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1WqurY%253D&md5=859488f03618128f22a259863526f658</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1161%2Fhy0202.103788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhy0202.103788%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520lowers%2520arterial%2520blood%2520pressure%2520in%2520angiotensin%2520II%2520hypertension%26jtitle%3DHypertension%26date%3D2002%26volume%3D39%26spage%3D690%26epage%3D694%26doi%3D10.1161%2Fhy0202.103788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honetschlagerova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporkova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopkan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huskova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kujal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernerova, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabova, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervenka, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats</span>. <i>J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1601</span>, <span class="refDoi"> DOI: 10.1097/HJH.0b013e328349062f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1097%2FHJH.0b013e328349062f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21720266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1590-1601&author=Z.+Honetschlagerovaauthor=A.+Sporkovaauthor=L.+Kopkanauthor=Z.+Huskovaauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=J.+D.+Imigauthor=H.+J.+Kramerauthor=P.+Kujalauthor=Z.+Vernerovaauthor=V.+C.+Chabovaauthor=V.+Tesarauthor=L.+Cervenka&title=Inhibition+of+soluble+epoxide+hydrolase+improves+the+impaired+pressure-natriuresis+relationship+and+attenuates+the+development+of+hypertension+and+hypertension-associated+end-organ+damage+in+Cyp1a1-Ren-2+transgenic+rats&doi=10.1097%2FHJH.0b013e328349062f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats</span></div><div class="casAuthors">Honetschlagerova, Zuzana; Sporkova, Alexandra; Kopkan, Libor; Huskova, Zuzana; Hwang, Sung H.; Hammock, Bruce D.; Imig, John D.; Kramer, Herbert J.; Kujal, Petr; Vernerova, Zdenka; Chabova, Vera C.; Tesar, Vladimir; Cervenka, Ludek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1590-1601</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: In the present study, we compared the effects of treatment with the novel sol. epoxide hydrolase (sEH) inhibitor (c-AUCB) with those of the AT1 receptor antagonist losartan on blood pressure (BP), autoregulation of renal blood flow (RBF) and on glomerular filtration rate (GFR) and the pressure-natriuresis relationship in response to stepwise redn. in renal arterial pressure (RAP) in Cyp1a1-Ren-2 transgenic rats.  Methods: Hypertension was induced in Cyp1a1-Ren-2 rats through dietary administration for 11 days of the natural xenobiotic indole-3-carbinol (I3C) which activates the renin gene.  Treatment with c-AUCB and losartan was started 48 h before initiating administration of the diet contg. I3C.  Rats were prepd. for renal functional studies to evaluate in-vivo renal autoregulatory efficiency when RAP was gradually decreased by an aortic clamp.  Results: I3C administration resulted in the development of severe hypertension which was assocd. with markedly lower basal RBF and GFR and substantially impaired autoregulatory efficiency as well as a suppression of the pressure-natriuresis relationship when compared with noninduced rats.  Treatment with c-AUCB significantly decreased BP, improved autoregulatory efficiency of RBF and GFR and the slope of pressure-natriuresis relationship.  Treatment with losartan completely prevented the impaired autoregulation and pressure-natriuresis relationship as well as the development of hypertension in I3C-induced rats.  Conclusion: Our present findings indicate that chronic treatment with the sEH inhibitor c-AUCB substantially attenuates the development of malignant hypertension in I3C-induced rats likely via improvement of the renal autoregulatory efficiency and the pressure-natriuresis relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdW_B7qIBQubVg90H21EOLACvtfcHk0lgRrt3vdCZi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOisbk%253D&md5=7c30f9615c4c4dbebeb321b8a1755d07</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e328349062f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e328349062f%26sid%3Dliteratum%253Aachs%26aulast%3DHonetschlagerova%26aufirst%3DZ.%26aulast%3DSporkova%26aufirst%3DA.%26aulast%3DKopkan%26aufirst%3DL.%26aulast%3DHuskova%26aufirst%3DZ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DKramer%26aufirst%3DH.%2BJ.%26aulast%3DKujal%26aufirst%3DP.%26aulast%3DVernerova%26aufirst%3DZ.%26aulast%3DChabova%26aufirst%3DV.%2BC.%26aulast%3DTesar%26aufirst%3DV.%26aulast%3DCervenka%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520improves%2520the%2520impaired%2520pressure-natriuresis%2520relationship%2520and%2520attenuates%2520the%2520development%2520of%2520hypertension%2520and%2520hypertension-associated%2520end-organ%2520damage%2520in%2520Cyp1a1-Ren-2%2520transgenic%2520rats%26jtitle%3DJ.%2520Hypertens.%26date%3D2011%26volume%3D29%26spage%3D1590%26epage%3D1601%26doi%3D10.1097%2FHJH.0b013e328349062f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gross, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nithipatikom, K.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase: a new target for cardioprotection</span>. <i>Curr. Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19333883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=253-258&author=G.+J.+Grossauthor=K.+Nithipatikom&title=Soluble+epoxide+hydrolase%3A+a+new+target+for+cardioprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase: a new target for cardioprotection</span></div><div class="casAuthors">Gross, Garrett J.; Nithipatikom, Kasem</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (BioMed Central)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-258</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">2040-3429</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Arachidonic acid is metabolized to a no. of bioactive eicosanoid mols. by several enzymes, including enzymes of the COX, lipoxygenase and cytochrome P 450 (CYP) monooxygenase pathways.  Inhibition of the CYP ω-hydroxylase pathway, stimulation of the CYP-epoxygenase pathway and administration of exogenous epoxyeicosatrienoic acids resulted in cardioprotection in animal models of ischemia; contractile function was improved in mouse hearts subjected to global ischemia/reperfusion, and infarct size was reduced in canine and rat hearts.  Cardioprotective effects were also achieved when metab. of the endogenous epoxyeicosatrienoic acids (EETs) by their major enzymic hydrolysis pathway was blocked in gene knockout mice (EPHX2-/-) or by inhibitors of sol. epoxide hydrolase (sEH), such as 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA).  Pretreatment of canine hearts with AUDA dose-dependently reduced infarct size, and AUDA enhanced the infarct-sparing effect of treatment with exogenous EETs.  The preliminary results of studies in rodent hearts have also demonstrated that AUDA and AUDA-Bu ester reduce infarct size.  These results and others obtained in models of myocardial stunning and hypertrophy suggest that inhibitors of EPHX2 or sEH have therapeutic potential in a broad range of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-c5zaWj8cOLVg90H21EOLACvtfcHk0lgRrt3vdCZi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Kitbg%253D&md5=53b740a39cd790438f3f8760c4a54bc6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DNithipatikom%26aufirst%3DK.%26atitle%3DSoluble%2520epoxide%2520hydrolase%253A%2520a%2520new%2520target%2520for%2520cardioprotection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D253%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiserich, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase is a therapeutic target for acute inflammation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">9772</span>– <span class="NLM_lpage">9777</span>, <span class="refDoi"> DOI: 10.1073/pnas.0503279102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0503279102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15994227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9772-9777&author=K.+R.+Schmelzerauthor=L.+Kubalaauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=J.+P.+Eiserichauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+is+a+therapeutic+target+for+acute+inflammation&doi=10.1073%2Fpnas.0503279102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase is a therapeutic target for acute inflammation</span></div><div class="casAuthors">Schmelzer, Kara R.; Kubala, Lukas; Newman, John W.; Kim, In-Hae; Eiserich, Jason P.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9772-9777</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">As of 2004, >73 million people were prescribed antiinflammatory medication.  Despite the extensive no. of current products, many people still suffer from their diseases or the pharmacol. properties (side effects) of the medications.  Therefore, developing therapeutic strategies to treat inflammation remains an important endeavor.  Here, we demonstrate that the sol. epoxide hydrolase (sEH) is a key pharmacol. target for treating acute systemic inflammation.  Lipopolysaccharide-induced mortality, systemic hypotension, and histol. evaluated tissue injury were substantially diminished by administration of urea-based, small-mol. inhibitors of sEH to C57BL/6 mice.  Moreover, sEH inhibitors decreased plasma levels of proinflammatory cytokines and nitric oxide metabolites while promoting the formation of lipoxins, thus supporting inflammatory resoln.  These data suggest that sEH inhibitors have therapeutic efficacy in the treatment and management of acute inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-XGKhNB1YLrVg90H21EOLACvtfcHk0lhDZjeMNeTU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFartb0%253D&md5=4abeedd569a3d36e20e06bfcc94b6a98</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503279102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503279102%26sid%3Dliteratum%253Aachs%26aulast%3DSchmelzer%26aufirst%3DK.%2BR.%26aulast%3DKubala%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DEiserich%26aufirst%3DJ.%2BP.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520is%2520a%2520therapeutic%2520target%2520for%2520acute%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D9772%26epage%3D9777%26doi%3D10.1073%2Fpnas.0503279102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurs, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1021/jm020269o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020269o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Ont7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1066-1080&author=N.+R.+McElroyauthor=P.+C.+Jursauthor=C.+Morisseauauthor=B.+D.+Hammock&title=QSAR+and+classification+of+murine+and+human+soluble+epoxide+hydrolase+inhibition+by+urea-like+compounds&doi=10.1021%2Fjm020269o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR and Classification of Murine and Human Soluble Epoxide Hydrolase Inhibition by Urea-Like Compounds</span></div><div class="casAuthors">McElroy, Nathan R.; Jurs, Peter C.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1066-1080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A data set of 348 urea-like compds. that inhibit the sol. epoxide hydrolase enzyme in mice and humans is examd.  Compds. having IC50 values ranging from 0.06 to >500 μM (murine) and 0.10 to >500 μM (human) are categorized as active or inactive for classification, while quantitation is performed on smaller compd. subsets ranging from 0.07 to 431 μM (murine) and 0.11 to 490 μM (human).  Each compd. is represented by calcd. structural descriptors that encode topol., geometrical, electronic, and polar surface features.  Multiple linear regression (MLR) and computational neural networks (CNNs) are employed for quant. models.  Three classification algorithms, k-nearest neighbor (kNN), linear discriminant anal. (LDA), and radial basis function neural networks (RBFNN), are used to categorize compds. as active or inactive based on selected data split points.  Quant. modeling of human enzyme inhibition results in a nonlinear, five-descriptor model with root-mean-square errors (log units of IC50 [μM]) of 0.616 (r2 = 0.66), 0.674 (r2 = 0.61), and 0.914 (r2 = 0.33) for training, cross-validation, and prediction sets, resp.  The best classification results for human and murine enzyme inhibition are found using kNN.  Human classification rates using a seven-descriptor model for training and prediction sets are 89.1% and 91.4%, resp.  Murine classification rates using a five-descriptor model for training and prediction sets are 91.5% and 88.6%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLn1CSySMibVg90H21EOLACvtfcHk0lhDZjeMNeTU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Ont7Y%253D&md5=c969df03fb82e707476baddd884676c3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm020269o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020269o%26sid%3Dliteratum%253Aachs%26aulast%3DMcElroy%26aufirst%3DN.%2BR.%26aulast%3DJurs%26aufirst%3DP.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DQSAR%2520and%2520classification%2520of%2520murine%2520and%2520human%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520by%2520urea-like%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1066%26epage%3D1080%26doi%3D10.1021%2Fjm020269o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5212</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2006.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16870439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslCnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5212-5216&author=P.+D.+Jonesauthor=H.+J.+Tsaiauthor=Z.+N.+Doauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Synthesis+and+SAR+of+conformationally+restricted+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2006.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Jones, Paul D.; Tsai, Hsing-Ju; Do, Zung N.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5212-5216</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of conformationally restricted inhibitors of human sol. epoxide hydrolase (sEH) was synthesized.  Inhibition potency of the described compds. was studied against recombinant sEH.  N-(1-Acetylpiperidin-4-yl)-N'-(adamant-1-yl) urea (I) was found to be a potent inhibitor that was also orally bioavailable in canines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-6I7WMkpm7Vg90H21EOLACvtfcHk0lhDZjeMNeTU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslCnur0%253D&md5=d18b1510f26ea62837a63e93556d20a0</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520conformationally%2520restricted%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5212%26epage%3D5216%26doi%3D10.1016%2Fj.bmcl.2006.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neschen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarioglu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaisbauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span> <span> </span><span class="NLM_article-title">The epoxyeicosatrienoic acid pathway enhances hepatic insulin signaling and is repressed in insulin-resistant mouse liver</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2764</span>– <span class="NLM_lpage">2774</span>, <span class="refDoi"> DOI: 10.1074/mcp.M115.049064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fmcp.M115.049064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26070664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GkurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2764-2774&author=A.+Schaferauthor=S.+Neschenauthor=M.+Kahleauthor=H.+Sariogluauthor=T.+Gaisbauerauthor=A.+Imhofauthor=J.+Adamskiauthor=S.+M.+Hauckauthor=M.+Ueffing&title=The+epoxyeicosatrienoic+acid+pathway+enhances+hepatic+insulin+signaling+and+is+repressed+in+insulin-resistant+mouse+liver&doi=10.1074%2Fmcp.M115.049064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The Epoxyeicosatrienoic Acid Pathway Enhances Hepatic Insulin Signaling and is Repressed in Insulin-Resistant Mouse Liver</span></div><div class="casAuthors">Schafer, Alexander; Neschen, Susanne; Kahle, Melanie; Sarioglu, Hakan; Gaisbauer, Tobias; Imhof, Axel; Adamski, Jerzy; Hauck, Stefanie M.; Ueffing, Marius</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Proteomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2764-2774</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9484</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Here we employed time resolved quant. proteomic profiling of mice fed a high fat diet to det. which pathways were affected during the transition of the liver to an insulin-resistant state.  We identified several metabolic pathways underlying altered protein expression.  In order to test the functional impact of a crit. subset of these alterations, we focused on the epoxyeicosatrienoic acid (EET) eicosanoid pathway, whose deregulation coincided with the onset of hepatic insulin resistance.  These results suggested that EETs may be pos. modulators of hepatic insulin signaling.  Analyzing EET activity in primary hepatocytes, we found that EETs enhance insulin signaling on the level of Akt.  In contrast, EETs did not influence insulin receptor or insulin receptor substrate-1 phosphorylation.  This effect was mediated through the eicosanoids, as overexpression of the deregulated enzymes in absence of arachidonic acid had no impact on insulin signaling.  The stimulation of insulin signaling by EETs and depression of the pathway in insulin resistant liver suggest a likely role in hepatic insulin resistance.  Our findings support therapeutic potential for inhibiting EET degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2OVPK7i_ebVg90H21EOLACvtfcHk0lhpjfO_lB5APQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GkurzM&md5=7a8ebdf0ecec9f2cb1dcb3d2982d5067</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M115.049064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M115.049064%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DA.%26aulast%3DNeschen%26aufirst%3DS.%26aulast%3DKahle%26aufirst%3DM.%26aulast%3DSarioglu%26aufirst%3DH.%26aulast%3DGaisbauer%26aufirst%3DT.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DAdamski%26aufirst%3DJ.%26aulast%3DHauck%26aufirst%3DS.%2BM.%26aulast%3DUeffing%26aufirst%3DM.%26atitle%3DThe%2520epoxyeicosatrienoic%2520acid%2520pathway%2520enhances%2520hepatic%2520insulin%2520signaling%2520and%2520is%2520repressed%2520in%2520insulin-resistant%2520mouse%2520liver%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2015%26volume%3D14%26spage%3D2764%26epage%3D2774%26doi%3D10.1074%2Fmcp.M115.049064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.+J.+Tsaiauthor=J.+Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0lhpjfO_lB5APQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors, <i>t</i>-AUCB, downregulated miR-133 in a mouse model of myocardial infarction</span>. <i>Lipids Health Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">129</span>, <span class="refDoi"> DOI: 10.1186/s12944-018-0780-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12944-018-0780-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29843720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=129&author=Y.+Guiauthor=D.+Liauthor=J.+Chenauthor=Y.+Wangauthor=J.+Huauthor=C.+Liaoauthor=L.+Dengauthor=Q.+Xiangauthor=T.+Yangauthor=X.+Duauthor=S.+Zhangauthor=D.+Xu&title=Soluble+epoxide+hydrolase+inhibitors%2C+t-AUCB%2C+downregulated+miR-133+in+a+mouse+model+of+myocardial+infarction&doi=10.1186%2Fs12944-018-0780-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction</span></div><div class="casAuthors">Gui, Yajun; Li, Da; Chen, Jingyuan; Wang, Yating; Hu, Jiahui; Liao, Caixiu; Deng, Limin; Xiang, Qunyan; Yang, Tao; Du, Xiao; Zhang, Shilan; Xu, Danyan</div><div class="citationInfo"><span class="NLM_cas:title">Lipids in Health and Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129/1-129/10</span>CODEN:
                <span class="NLM_cas:coden">LHDIA7</span>;
        ISSN:<span class="NLM_cas:issn">1476-511X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: It has been demonstrated that sol. epoxide hydrolase inhibitors (sEHIs) are protective against ischemia-induced lethal arrhythmias, but the mechanisms involved are unknown.  Previously, we showed that sEHIs might reduce the incidence of ischemic arrhythmias by suppressing microRNA-1 (miR-1) in the myocardium.  As miR-1 and miR-133 have the same proarrhythmic effects in the heart, we assumed that the beneficial effects of sEHIs might also relate to the regulation of miR-133.  Methods: A mouse model of myocardial infarction (MI) was established by ligating the coronary artery.  The sEHI t- AUCB (trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid) was administered daily for 7 days before MI.  Myocardial infarct size and cardiac function was assessed at 24 h post-MI.  The miRNA expression profiles of sham and MI mice treated with or without t-AUCB were detd. by microarray and verified by real-time PCR.  The incidence of arrhythmias was assessed by in vivo electrophysiol. studies.  The mRNA levels of miR-133, its target genes (KCNQ1 [potassium voltage-gated channel subfamily Q member 1] and KCNH2 [potassium voltage-gated channel subfamily H member 2]), and serum response factor (SRF) were measured by real-time PCR; KCNQ1, KCNH2, and SRF protein levels were assessed by western blotting.  Results: We demonstrated that the treatment with sEHIs could reduce infarct size, improve cardia function, and prevent the development of cardiac arrhythmias in MI mice.  The expression levels of 14 miRNAs differed between the sham and MI groups. t-AUCB treatment altered the expression of eight miRNAs: two were upregulated and six were downregulated.  Of these, the muscle-specific miR-133 was downregulated in the ischemic myocardium.  In line with this, up-regulation of miR-133 and down-regulation of KCNQ1 and KCNH2 mRNA/protein were obsd. in ischemic myocaridum, whereas administration of sEHIs produced an opposite effect.  In addn., miR-133 overexpression inhibited expression of the target mRNA, whereas t-AUCB reversed the effects.  Furthermore, SRF might participate in the neg. regulation of miR-133 by t-AUCB.  Conclusions: In MI mice, sEHI t-AUCB can repress miR-133, consequently stimulating KCNQ1 and KCNH2 mRNA and protein expression, suggesting a possible mechanism for its potential therapeutic application in ischemic arrhythmias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYp18zlN7pVbVg90H21EOLACvtfcHk0lhpjfO_lB5APQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFKmsrw%253D&md5=aef126bbfe174902a1d5d21b610edf04</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12944-018-0780-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12944-018-0780-y%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%252C%2520t-AUCB%252C%2520downregulated%2520miR-133%2520in%2520a%2520mouse%2520model%2520of%2520myocardial%2520infarction%26jtitle%3DLipids%2520Health%2520Dis.%26date%3D2018%26volume%3D17%26spage%3D129%26doi%3D10.1186%2Fs12944-018-0780-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin sensitizes glioblastoma to <i>t</i>-AUCB by dual inhibition of Hsp27 and COX-2 <i>in vitro</i> and <i>in vivo</i></span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0331-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs13046-016-0331-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27039073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGitL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=61&author=J.+Liauthor=C.+Tangauthor=L.+Liauthor=R.+Liauthor=Y.+Fan&title=Quercetin+sensitizes+glioblastoma+to+t-AUCB+by+dual+inhibition+of+Hsp27+and+COX-2+in+vitro+and+in+vivo&doi=10.1186%2Fs13046-016-0331-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo</span></div><div class="casAuthors">Li, Junyang; Tang, Chao; Li, Liwen; Li, Rujun; Fan, Youwu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/11</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Evidences indicate that inflammatory process plays pivotal role in tumor disease.  Sol. epoxide hydrolase inhibitors (sEHIs) have been shown to participate in anti-inflammation and tumorigenesis by protecting epoxyeicosatrienoic acids (EETs).  Although we have previously revealed some effects of t-AUCB on glioma in vitro, further investigations are needed to demonstrate its effects on glioblastoma growth in vivo and how to strengthen its antitumor effect.  Methods: CCK-8 kit was used to test cell growth.  Cell migration capacity was performed by wound healing assays.  Transwell assay was used to test cell invasion potency.  Cell-cycle anal. and cell apoptosis was performed by flow cytometry.  The activity of caspase-3 in cells was measured using caspase-3 activity assay kits.  Total RNA was extd. from cells lysated by TRIzol reagent. qRT-PCR was performed by ABI 7500 fast RT- PCR system.  Lipofectamine RNAiMAX Transfection Reagent (Invitrogen) was used for siRNA transfection.  Western blotting was used to test protein expression.  Tumor cell xenograft mouse models were used for in vivo study.  The SPSS version 17.0 software was applied for statistical anal.  Results: Our data shown that t-AUCB inhibits cell proliferation, migration and invasion and induces cell cycle G1 phase arrest in vitro but induces no cell apoptosis; increased Hsp27 activation and following COX-2 overexpression confer resistance to t-AUCB treatment in glioblastoma both in vitro and in vivo; quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo.  Conclusions: These results indicate that combination of t-AUCB and quercetin may be a potential approach to treating glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3JNFecgv377Vg90H21EOLACvtfcHk0lg3mzxNc7CrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGitL3J&md5=dcd89a7e2609469dd83718a218d391a7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0331-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0331-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DY.%26atitle%3DQuercetin%2520sensitizes%2520glioblastoma%2520to%2520t-AUCB%2520by%2520dual%2520inhibition%2520of%2520Hsp27%2520and%2520COX-2%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D61%26doi%3D10.1186%2Fs13046-016-0331-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. Y.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, <i>t</i>-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes <i>in vitro</i></span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1515/hsz-2013-0251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1515%2Fhsz-2013-0251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24225128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFOlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2014&pages=443-451&author=L.+Shenauthor=H.+C.+Pengauthor=S.+P.+Zhaoauthor=D.+Y.+Xu&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+modulates+cholesterol+balance+and+oxidized+low+density+lipoprotein+metabolism+in+adipocytes+in+vitro&doi=10.1515%2Fhsz-2013-0251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro</span></div><div class="casAuthors">Shen, Li; Peng, Hongchun; Zhao, Shuiping; Xu, Danyan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">The cholesterol metab. in adipose tissue is dependent on the balance between cholesterol uptake and efflux.  Adipocytes dysfunction and its cholesterol imbalance are assocd. with obesity.  Adipocytes are the site for clearance of oxidized low d. lipoprotein (oxLDL) in blood.  Sol. epoxide hydrolase (sEH) is highly expressed in adipocytes. sEH converts epoxyeicosatrienoic acids (EETs) into less bioactive dihydroxyeicosatrienoic acids, which regulate cholesterol metab. in adipocytes and block the development of atherosclerosis.  In vitro, 3T3-L1 differentiated adipocytes were incubated with the sEH inhibitor t-AUCB (0, 1, 10, 50 or 100 mmol/l) for 24 h with or without the PPARγ inhibitor GW9662.  To det. the effect of t-AUCB on oxLDL endocytosis, degrdn. and cholesterol efflux from adipocytes, we demonstrated that t-AUCB enhances the CD36-mediated recognition and degrdn. of oxLDL and improves cholesterol efflux via the upregulation of ABCA1 expression.  Furthermore, t-AUCB blocked TNF-α secretion and increased adiponectin levels found in adipocytes culture medium.  We provide evidence that these effects are PPARγ-dependent.  These results suggest that an increase in EETs because of sEH inhibition could maintain cellular cholesterol homeostasis by the regulation of oxLDL clearance and cholesterol efflux via the EETs-PPARγ pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2317pOOoVa7Vg90H21EOLACvtfcHk0lg3mzxNc7CrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFOlu70%253D&md5=9d01e225885316057102fdd916f56438</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2013-0251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2013-0251%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%2BC.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DXu%26aufirst%3DD.%2BY.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520modulates%2520cholesterol%2520balance%2520and%2520oxidized%2520low%2520density%2520lipoprotein%2520metabolism%2520in%2520adipocytes%2520in%2520vitro%26jtitle%3DBiol.%2520Chem.%26date%3D2014%26volume%3D395%26spage%3D443%26epage%3D451%26doi%3D10.1515%2Fhsz-2013-0251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harouki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duflot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remy-Jouet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumesnil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellien, J.</span></span> <span> </span><span class="NLM_article-title">Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2015&pages=148-154&author=C.+Rocheauthor=D.+Guerrotauthor=N.+Haroukiauthor=T.+Duflotauthor=M.+Besnierauthor=I.+Remy-Jouetauthor=S.+Renetauthor=A.+Dumesnilauthor=A.+Lejeuneauthor=C.+Morisseauauthor=V.+Richardauthor=J.+Bellien&title=Impact+of+soluble+epoxide+hydrolase+inhibition+on+early+kidney+damage+in+hyperglycemic+overweight+mice&doi=10.1016%2Fj.prostaglandins.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice</span></div><div class="casAuthors">Roche, Clothilde; Guerrot, Dominique; Harouki, Najah; Duflot, Thomas; Besnier, Marie; Remy-Jouet, Isabelle; Renet, Sylvanie; Dumesnil, Anais; Lejeune, Annie; Morisseau, Christophe; Richard, Vincent; Bellien, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study addressed the hypothesis that inhibition of the EETs degrading enzyme sol. epoxide hydrolase affords renal protection in the early stage of diabetic nephropathy.  The renal effects of the sEH inhibitor t-AUCB (10 mg/l in drinking water) were compared to those of the sulfonylurea glibenclamide (80 mg/l), both administered for 8 wk in FVB mice subjected to a high-fat diet (HFD, 60% fat) for 16 wk.  Mice on control chow diet (10% fat) and non-treated HFD mice served as controls.  Compared with non-treated HFD mice, HFD mice treated with t-AUCB had a decreased EET degrdn., as shown by their higher plasma EETs-to-DHETs ratio, and an increased EET prodn., as shown by the increase in EETs + DHETs levels, which was assocd. with induction of CYP450 epoxygenase expression.  Both agents similarly reduced fasting glycemia but only t-AUCB prevented the increase in the urinary albumine-to-creatinine ratio in HFD mice.  Histopathol. anal. showed that t-AUCB reduced renal inflammation, which was assocd. with an increased mRNA expression of the NFκB inhibitor Iκ≃ and related decrease in MCP-1, COX2 and VCAM-1 expressions.  Finally, there was a marginally significant increase in reactive oxygen species prodn. in HFD mice, together with an enhanced NOX2 expression.  Both agents did not modify these parameters but t-AUCB increased the expression of the antioxidant enzyme superoxide dismutase 1.  These results demonstrate that, independently from its glucose-lowering effect, sEH inhibition prevents microalbuminuria and renal inflammation in overweight hyperglycemic mice, suggesting that this pharmacol. strategy could be useful in the management of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCcbQQhKm_LbVg90H21EOLACvtfcHk0lg3mzxNc7CrwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOlu7o%253D&md5=d4ed470d0b4e35f4a5b61059ea95ea90</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DGuerrot%26aufirst%3DD.%26aulast%3DHarouki%26aufirst%3DN.%26aulast%3DDuflot%26aufirst%3DT.%26aulast%3DBesnier%26aufirst%3DM.%26aulast%3DRemy-Jouet%26aufirst%3DI.%26aulast%3DRenet%26aufirst%3DS.%26aulast%3DDumesnil%26aufirst%3DA.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DRichard%26aufirst%3DV.%26aulast%3DBellien%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520on%2520early%2520kidney%2520damage%2520in%2520hyperglycemic%2520overweight%2520mice%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2015%26volume%3D120%26spage%3D148%26epage%3D154%26doi%3D10.1016%2Fj.prostaglandins.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">758614</span>, <span class="refDoi"> DOI: 10.1155/2012/758614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1155%2F2012%2F758614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22007192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=758614&author=A.+Iyerauthor=K.+Kauterauthor=M.+A.+Alamauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=L.+Brown&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+ameliorates+diet-induced+metabolic+syndrome+in+rats&doi=10.1155%2F2012%2F758614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span></div><div class="casAuthors">Iyer Abishek; Kauter Kathleen; Alam Md Ashraful; Hwang Sung Hee; Morisseau Christophe; Hammock Bruce D; Brown Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">758614</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signs of metabolic syndrome following chronic excessive macronutrient intake include body weight gain, excess visceral adipose deposition, hyperglycaemia, glucose and insulin intolerances, hypertension, dyslipidaemia, endothelial damage, cardiovascular hypertrophy, inflammation, ventricular contractile dysfunction, fibrosis, and fatty liver disease.  Recent studies show increased activity of soluble epoxide hydrolase (sEH) during obesity and metabolic dysfunction.  We have tested whether sEH inhibition has therapeutic potential in a rat model of diet-induced metabolic syndrome.  In these high-carbohydrate, high-fat-fed rats, chronic oral treatment with trans-4-[4-(3-adamantan-1-ylureido)-cyclohexyloxy]-benzoic acid (t-AUCB), a potent sEH inhibitor, alleviated the signs of metabolic syndrome in vivo including glucose, insulin, and lipid abnormalities, changes in pancreatic structure, increased systolic blood pressure, cardiovascular structural and functional abnormalities, and structural and functional changes in the liver.  The present study describes the pharmacological responses to this selective sEH inhibitor in rats with the signs of diet-induced metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1vi0lpx2a9IJKJbLTgsvCfW6udTcc2eYJDrMQ5kk07bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D&md5=225f1e58564b2942facc133619680a62</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1155%2F2012%2F758614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F758614%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DKauter%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBrown%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520diet-induced%2520metabolic%2520syndrome%2520in%2520rats%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D758614%26doi%3D10.1155%2F2012%2F758614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danilov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalinger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatsadze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shkineva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5514</span>– <span class="NLM_lpage">5519</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2015.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26520661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5514-5519&author=V.+Burmistrovauthor=C.+Morisseauauthor=D.+Danilovauthor=T.+R.+Harrisauthor=I.+Dalingerauthor=I.+Vatsadzeauthor=T.+Shkinevaauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=1%2C3-Disubstituted+and+1%2C3%2C3-trisubstituted+adamantyl-ureas+with+isoxazole+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2015.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Danilov, Dmitry; Harris, Todd R.; Dalinger, Igor; Vatsadze, Irina; Shkineva, Tatiana; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5514-5519</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adamantyl ureas are good sol. epoxide hydrolase (sEH) inhibitors; however they have limited soly. and rapid metab., thus limiting their usefulness in some therapeutic indications.  Herein, we test the hypothesis that nodal substitution on the adamantane will help solubilize and stabilize the compds.  A series of compds. contg. adamantane derivs. and isoxazole functional groups were developed.  Overall, the presence of Me on the nodal positions of adamantane yields higher water soly. than previously reported urea-based sEH inhibitors while maintaining high inhibition potency.  However, it did not improve microsomal stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-QXbYS1fQArVg90H21EOLACvtfcHk0lgw2cJKDoFFHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCms7nL&md5=b379bfe223ec4e7c2f85f84159d15bc9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DDanilov%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DDalinger%26aufirst%3DI.%26aulast%3DVatsadze%26aufirst%3DI.%26aulast%3DShkineva%26aufirst%3DT.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1%252C3-Disubstituted%2520and%25201%252C3%252C3-trisubstituted%2520adamantyl-ureas%2520with%2520isoxazole%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5514%26epage%3D5519%26doi%3D10.1016%2Fj.bmcl.2015.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2017.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29310082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2018&pages=510-527&author=V.+Burmistrovauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=G.+Butovauthor=B.+D.+Hammock&title=Effects+of+adamantane+alterations+on+soluble+epoxide+hydrolase+inhibition+potency%2C+physical+properties+and+metabolic+stability&doi=10.1016%2Fj.bioorg.2017.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Harris, Todd R.; Butov, Gennady; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">510-527</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adamantyl groups are widely used in medicinal chem.  However, metab. limits their usage.  Herein, the authors report the first systematic study of adamantyl ureas and diureas bearing substituents in bridgehead positions of adamantane and/or spacers between urea groups and adamantane group, and tested their effects on sol. epoxide hydrolase inhibitor potency and metabolic stability.  Interestingly, the effect on activity against human and murine sEH varied in opposite ways with each new Me group introduced into the mol.  Compds. with three Me substituents in adamantane were very poor inhibitors of murine sEH while still very potent against human sEH.  In addn., diureas with terminal groups bigger than sEH catalytic tunnel diam. were still good inhibitors suggesting that the active site of sEH opens to capture the substrate or inhibitor mol.  The introduction of one Me group leads to 4-fold increase in potency without noticeable loss of metabolic stability compared to the unsubstituted adamantane.  However, introduction of two or three Me groups leads to 8-fold and 98-fold decrease in stability in human liver microsomes for the corresponding compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-EeWH8Z5rnrVg90H21EOLACvtfcHk0lgw2cJKDoFFHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslynsg%253D%253D&md5=99606b28e4cfb186d40c19f553c60ef1</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DButov%26aufirst%3DG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DEffects%2520of%2520adamantane%2520alterations%2520on%2520soluble%2520epoxide%2520hydrolase%2520inhibition%2520potency%252C%2520physical%2520properties%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D76%26spage%3D510%26epage%3D527%26doi%3D10.1016%2Fj.bioorg.2017.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7067</span>– <span class="NLM_lpage">7075</span>, <span class="refDoi"> DOI: 10.1021/jm100691c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100691c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7067-7075&author=T.+E.+Roseauthor=C.+Morisseauauthor=J.+Y.+Liuauthor=B.+Inceogluauthor=P.+D.+Jonesauthor=J.+R.+Sanbornauthor=B.+D.+Hammock&title=1-Aryl-3-%281-acylpiperidin-4-yl%29urea+inhibitors+of+human+and+murine+soluble+epoxide+hydrolase%3A+structure-activity+relationships%2C+pharmacokinetics%2C+and+reduction+of+inflammatory+pain&doi=10.1021%2Fjm100691c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain</span></div><div class="casAuthors">Rose, Tristan E.; Morisseau, Christophe; Liu, Jun-Yan; Inceoglu, Bora; Jones, Paul D.; Sanborn, James R.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7067-7075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,3-Disubstituted ureas possessing a piperidyl moiety have been synthesized to investigate their structure-activity relationships as inhibitors of the human and murine sol. epoxide hydrolase (sEH).  Oral administration of 13 1-aryl-3-(1-acylpiperidin-4-yl)urea inhibitors in mice revealed substantial improvements in pharmacokinetic parameters over previously reported 1-adamantylurea based inhibitors.  For example, 1-(1-(cyclopropanecarbonyl)piperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea showed a 7-fold increase in potency, a 65-fold increase in Cmax, and a 3300-fold increase in AUC over its adamantane analog 1-(1-adamantyl)-3-(1-propionylpiperidin-4-yl)urea.  This novel sEH inhibitor showed a 1000-fold increase in potency when compared to morphine by reducing hyperalgesia as measured by mech. withdrawal threshold using the in vivo carrageenan induced inflammatory pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokUmpG9nURobVg90H21EOLACvtfcHk0lj52KvZa3eS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb%252FL&md5=bc2b151553d732942c1ac7e2e963d524</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm100691c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100691c%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DT.%2BE.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DSanborn%26aufirst%3DJ.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1-Aryl-3-%25281-acylpiperidin-4-yl%2529urea%2520inhibitors%2520of%2520human%2520and%2520murine%2520soluble%2520epoxide%2520hydrolase%253A%2520structure-activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520reduction%2520of%2520inflammatory%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7067%26epage%3D7075%26doi%3D10.1021%2Fjm100691c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasagami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2010.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejps.2010.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20359531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVCru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=222-238&author=H.+J.+Tsaiauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=J.+Yangauthor=P.+D.+Jonesauthor=T.+Kasagamiauthor=I.+H.+Kimauthor=B.+D.+Hammock&title=Pharmacokinetic+screening+of+soluble+epoxide+hydrolase+inhibitors+in+dogs&doi=10.1016%2Fj.ejps.2010.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs</span></div><div class="casAuthors">Tsai, Hsing-Ju; Hwang, Sung Hee; Morisseau, Christophe; Yang, Jun; Jones, Paul D.; Kasagami, Takeo; Kim, In-Hae; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-238</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids that have anti-hypertensive and anti-inflammatory properties are mainly metabolized by sol. epoxide hydrolase (sEH, EC 3.3.2.3).  Therefore, sEH has emerged as a therapeutic target for treating various cardiovascular diseases and inflammatory pain.  N,N'-Disubstituted ureas are potent sEH inhibitors in vitro.  However, in vivo usage of early sEH inhibitors has been limited by their low bioavailability and poor physiochem. properties.  Therefore, a group of highly potent compds. with more drug-like physiochem. properties were evaluated by monitoring their plasma profiles in dogs treated orally with sEH inhibitors.  Urea compds. with an adamantyl or a 4-trifluoromethoxyphenyl group on one side and a piperidyl or a cyclohexyl ether group on the other side of the urea function showed pharmacokinetic profiles with high plasma concns. and long half lives.  In particular, the inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB) not only is very potent with good physiochem. properties, but also shows high oral bioavailability for doses ranging from 0.01 to 1 mg/kg.  This compd. is also very potent against the sEH of several mammals, suggesting that t-AUCB will be an excellent tool to evaluate the biol. of sEH in multiple animal models.  Such compds. may also be a valuable lead for the development of veterinary therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5KDRLd00iLbVg90H21EOLACvtfcHk0lj52KvZa3eS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVCru7c%253D&md5=c078acc807d5bcffeeac0b77df28c4e3</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2010.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2010.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DKasagami%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPharmacokinetic%2520screening%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520in%2520dogs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D40%26spage%3D222%26epage%3D238%26doi%3D10.1016%2Fj.ejps.2010.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakhomova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mara, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Optimized inhibitors of soluble epoxide hydrolase improve <i>in vitro</i> target residence time and <i>in vivo</i> efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7016</span>– <span class="NLM_lpage">7030</span>, <span class="refDoi"> DOI: 10.1021/jm500694p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500694p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7016-7030&author=K.+S.+Leeauthor=J.+Y.+Liuauthor=K.+M.+Wagnerauthor=S.+Pakhomovaauthor=H.+Dongauthor=C.+Morisseauauthor=S.+H.+Fuauthor=J.+Yangauthor=P.+Wangauthor=A.+Uluauthor=C.+A.+Mateauthor=L.+V.+Nguyenauthor=S.+H.+Hwangauthor=M.+L.+Edinauthor=A.+A.+Maraauthor=H.+Wulffauthor=M.+E.+Newcomerauthor=D.+C.+Zeldinauthor=B.+D.+Hammock&title=Optimized+inhibitors+of+soluble+epoxide+hydrolase+improve+in+vitro+target+residence+time+and+in+vivo+efficacy&doi=10.1021%2Fjm500694p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy</span></div><div class="casAuthors">Lee, Kin Sing Stephen; Liu, Jun-Yan; Wagner, Karen M.; Pakhomova, Svetlana; Dong, Hua; Morisseau, Christophe; Fu, Samuel H.; Yang, Jun; Wang, Peng; Ulu, Arzu; Mate, Christina A.; Nguyen, Long V.; Hwang, Sung Hee; Edin, Matthew L.; Mara, Alexandria A.; Wulff, Heike; Newcomer, Marcia E.; Zeldin, Darryl C.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7016-7030</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diabetes is affecting the life of millions of people.  A large proportion of diabetic patients suffer from severe complications such as neuropathic pain, and current treatments for these complications have deleterious side effects.  Thus, alternate therapeutic strategies are needed.  Recently, the elevation of epoxy-fatty acids through inhibition of sol. epoxide hydrolase (sEH) was shown to reduce diabetic neuropathic pain in rodents.  In this report, the authors describe a series of newly synthesized sEH inhibitors I [R1 = 4-CF3C6H4, 4-CF3OC6H4; (CF3)2CFC6H4, etc.; R2 = MeCO, MeCH2CO, MeCH2CH2CO, etc.] with at least 5-fold higher potency and doubled residence time inside both the human and rodent sEH enzyme than previously reported inhibitors.  These inhibitors also have better phys. properties and optimized pharmacokinetic profiles.  The optimized inhibitor selected from this new series displayed improved efficacy of almost 10-fold in relieving pain perception in diabetic neuropathic rats as compared to the approved drug, gabapentin, and previously published sEH inhibitors.  Therefore, these new sEH inhibitors could be an attractive alternative to treat diabetic neuropathy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_j6x9O0dsd7Vg90H21EOLACvtfcHk0lj52KvZa3eS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77K&md5=1f57ad6909389ac8d101fb548b64c2e2</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm500694p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500694p%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DMate%26aufirst%3DC.%2BA.%26aulast%3DNguyen%26aufirst%3DL.%2BV.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DMara%26aufirst%3DA.%2BA.%26aulast%3DWulff%26aufirst%3DH.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOptimized%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520improve%2520in%2520vitro%2520target%2520residence%2520time%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7016%26epage%3D7030%26doi%3D10.1021%2Fjm500694p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manickam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillaiyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswararao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalani, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2016.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27092411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1els7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=113-124&author=M.+Manickamauthor=T.+Pillaiyarauthor=P.+Bogguauthor=E.+Venkateswararaoauthor=H.+B.+Jalaniauthor=N.+D.+Kimauthor=S.+K.+Leeauthor=J.+S.+Jeonauthor=S.+K.+Kimauthor=S.+H.+Jung&title=Discovery+of+enantioselectivity+of+urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.ejmech.2016.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Manickam, Manoj; Pillaiyar, Thanigaimalai; Boggu, PullaReddy; Venkateswararao, Eeda; Jalani, Hitesh B.; Kim, Nam-Doo; Lee, Seul Ki; Jeon, Jang Su; Kim, Sang Kyum; Jung, Sang-Hun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) hydrolyzes epoxyeicosatrienoic acids (EETs) in the metabolic pathway of arachidonic acid and has been considered as an important therapeutic target for chronic diseases such as hypertension, diabetes and inflammation.  Although many urea derivs. are known as sEH inhibitors, the enantioselectivity of the inhibitors is not highlighted in spite of the stereoselective hydrolysis of EETs by sEH.  In an effort to explore the importance of enantioselectivity in the urea scaffold, a series of enantiomers with the stereocenter adjacent to the urea nitrogen atom were prepd.  The selectivity of enantiomers of 1-(α-alkyl-α-phenylmethyl)-3-(3-phenylpropyl)ureas showed wide range differences up to 125 fold with the low IC50 value up to 13 nM.  The S-configuration with planar Ph and small alkyl groups at α-position is crucial for the activity and selectivity.  However, restriction of the free rotation of two α-groups with indan-1-yl or 1,2,3,4-tetrahydronaphthalen-1-yl moiety abolishes the selectivity between the enantiomers, despite the increase in activity up to 13 nM.  The hydrophilic group like sulfonamido group at para position of 3-phenylpropyl motif of 1-(α-alkyl-α-phenylmethyl-3-(3-phenylpropyl))urea improves the activity as well as enantiomeric selectivity.  All these ureas are proved to be specific inhibitor of sEH without inhibition against microsomal EH (mEH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwGD384-NtQLVg90H21EOLACvtfcHk0lhMABDCO0KuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1els7o%253D&md5=5a6e7123953136c74243b09de211acc3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DManickam%26aufirst%3DM.%26aulast%3DPillaiyar%26aufirst%3DT.%26aulast%3DBoggu%26aufirst%3DP.%26aulast%3DVenkateswararao%26aufirst%3DE.%26aulast%3DJalani%26aufirst%3DH.%2BB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DJeon%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DJung%26aufirst%3DS.%2BH.%26atitle%3DDiscovery%2520of%2520enantioselectivity%2520of%2520urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D113%26epage%3D124%26doi%3D10.1016%2Fj.ejmech.2016.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burmistrov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitushkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayzullin, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butov, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Adamantyl thioureas as soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2302</span>– <span class="NLM_lpage">2313</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2018.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29803731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgtbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2302-2313&author=V.+Burmistrovauthor=C.+Morisseauauthor=D.+Pitushkinauthor=D.+Karlovauthor=R.+R.+Fayzullinauthor=G.+M.+Butovauthor=B.+D.+Hammock&title=Adamantyl+thioureas+as+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2018.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Adamantyl thioureas as soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry; Karlov, Dmitry; Fayzullin, Robert R.; Butov, Gennady M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2302-2313</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of inhibitors of the sol. epoxide hydrolase (sEH) contg. one or two thiourea groups has been developed.  Inhibition potency of the described compds. ranges from 50 μM to 7.2 nM.  1,7-(Heptamethylene)bis[(adamant-1-yl)thiourea] (6f) was found to be the most potent sEH inhibitor, among the thioureas tested.  The inhibitory activity of the thioureas against the human sEH is closer to the value of activity against rat sEH rather than murine sEH.  While being less active, thioureas are up to 7-fold more sol. than ureas, which makes them more bioavailable and thus promising as sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRaEGaCWfq7Vg90H21EOLACvtfcHk0lhMABDCO0KuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgtbnN&md5=81d98ca6f15c96140ee9bd95da868ca8</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DBurmistrov%26aufirst%3DV.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DPitushkin%26aufirst%3DD.%26aulast%3DKarlov%26aufirst%3DD.%26aulast%3DFayzullin%26aufirst%3DR.%2BR.%26aulast%3DButov%26aufirst%3DG.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DAdamantyl%2520thioureas%2520as%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2302%26epage%3D2313%26doi%3D10.1016%2Fj.bmcl.2018.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heirtzler, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3621</span>– <span class="NLM_lpage">3629</span>, <span class="refDoi"> DOI: 10.1021/jm0500929</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0500929" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVGgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3621-3629&author=I.+H.+Kimauthor=F.+R.+Heirtzlerauthor=C.+Morisseauauthor=K.+Nishiauthor=H.+J.+Tsaiauthor=B.+D.+Hammock&title=Optimization+of+amide-based+inhibitors+of+soluble+epoxide+hydrolase+with+improved+water+solubility&doi=10.1021%2Fjm0500929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water Solubility</span></div><div class="casAuthors">Kim, In-Hae; Heirtzler, Fenton R.; Morisseau, Christophe; Nishi, Kosuke; Tsai, Hsing-Ju; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3621-3629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) plays an important role in the metab. of endogenous chem. mediators involved in the regulation of blood pressure and inflammation.  1,3-Disubstituted ureas with a polar group located on the fifth atom from the carbonyl group of urea function are active inhibitors of sEH both in vitro and in vivo.  However, their limited soly. in water and relatively high m.p. lead to difficulties in formulating the compds. and poor in vivo efficacy.  To improve these phys. properties, the effect of structural modification of the urea pharmacophore on the inhibition potencies, water solubilities, octanol/water partition coeffs. (log P), and m.ps. of a series of compds. was evaluated.  For murine sEH, no loss of inhibition potency was obsd. when the urea pharmacophore was modified to an amide function, while for human sEH 2.5-fold decreased inhibition was obtained in the amide compds.  In addn., a NH group on the right side of carbonyl group of the amide pharmacophore substituted with an adamantyl group (such as compd. 14) and a methylene carbon present between the adamantyl and amide groups were essential to produce potent inhibition of sEH.  The resulting amide inhibitors have 10-30-fold better soly. and lower m.p. than the corresponding urea compds.  These findings will facilitate synthesis of sEH inhibitors that are easier to formulate and more bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJIRSgHMUoULVg90H21EOLACvtfcHk0lhMABDCO0KuxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVGgtrs%253D&md5=b0bcc8346e1bdb1ba6ca5d80bb425923</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0500929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500929%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHeirtzler%26aufirst%3DF.%2BR.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNishi%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOptimization%2520of%2520amide-based%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520with%2520improved%2520water%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3621%26epage%3D3629%26doi%3D10.1021%2Fjm0500929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleymanzadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKellop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5880</span>– <span class="NLM_lpage">5895</span>, <span class="refDoi"> DOI: 10.1021/jm9005302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9005302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWqurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5880-5895&author=A.+B.+Eldrupauthor=F.+Soleymanzadehauthor=S.+J.+Taylorauthor=I.+Mueggeauthor=N.+A.+Farrowauthor=D.+Josephauthor=K.+McKellopauthor=C.+C.+Manauthor=A.+Kukulkaauthor=S.+De+Lombaert&title=Structure-based+optimization+of+arylamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1021%2Fjm9005302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Eldrup, Anne B.; Soleymanzadeh, Fariba; Taylor, Steven J.; Muegge, Ingo; Farrow, Neil A.; Joseph, David; McKellop, Keith; Man, Chuk C.; Kukulka, Alison; De Lombaert, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5880-5895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylamides, particularly N-diarylethyl arylamides such as I, are prepd. as sol. epoxide hydrolase (sEH) inhibitors for potential use as antiinflammatory agents; their inhibition of human and rat sol. epoxide hydrolases and their half-lives on exposure to microsomes are detd., and the in vivo concns. in rats for selected compds. are detd.  While N-(3,3-diphenyl-propyl)nicotinamide (II) is found to be a potent inhibitor of sEH, it has short metabolic half-lives in microsomes and is cleared rapidly from the bodies of rats; the in vitro metabolic profile of II in rat liver microsomes shows extensive oxidative metab. and a propensity for metabolite switching.  The conformation of N-(3,3-diphenyl-propyl)-3-pyridinesulfonamide bound to sEH is detd. to understand its lack of activity and for further structure optimization; the conformation of N-(3,3-diphenyl-propyl)-2-pyridinecarboxamide bound to human sEH is also detd.  Based on the calcd. structures of compds. bound to sEH, N-diarylethyl arylamides such as I are prepd.  The racemate of I shows an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration; the structure of racemic I bound to sEH is also detd. by X-ray crystallog.  I and its enantiomer differ significantly in sEH-inhibiting activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm33erk-C157Vg90H21EOLACvtfcHk0lgHpX8zqSIQXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWqurvL&md5=ceedf0d50217a4bb8b6fc87c34a65b27</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm9005302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005302%26sid%3Dliteratum%253Aachs%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DMcKellop%26aufirst%3DK.%26aulast%3DMan%26aufirst%3DC.%2BC.%26aulast%3DKukulka%26aufirst%3DA.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26atitle%3DStructure-based%2520optimization%2520of%2520arylamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5880%26epage%3D5895%26doi%3D10.1021%2Fjm9005302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. B.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation and myelin status in Alzheimer’s disease, Parkinson’s disease, and normal aging brains: a small sample study</span>. <i>Parkinson's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">7975407</span>, <span class="refDoi"> DOI: 10.1155/2019/7975407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1155%2F2019%2F7975407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31354934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3Mvit1ersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=7975407&author=F.+Hanauthor=R.+J.+Perrinauthor=Q.+Wangauthor=Y.+Wangauthor=J.+S.+Perlmutterauthor=J.+C.+Morrisauthor=T.+L.+S.+Benzingerauthor=J.+B.+Xu&title=Neuroinflammation+and+myelin+status+in+Alzheimer%E2%80%99s+disease%2C+Parkinson%E2%80%99s+disease%2C+and+normal+aging+brains%3A+a+small+sample+study&doi=10.1155%2F2019%2F7975407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study</span></div><div class="casAuthors">Han Fei; Wang Qing; Wang Yong; Perlmutter Joel S; Benzinger Tammie L S; Xu Jinbin; Perrin Richard J; Perrin Richard J; Perlmutter Joel S; Morris John C; Perlmutter Joel S; Perlmutter Joel S; Perlmutter Joel S</div><div class="citationInfo"><span class="NLM_cas:title">Parkinson's disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7975407</span>
        ISSN:<span class="NLM_cas:issn">2090-8083</span>.
    </div><div class="casAbstract">Microglia and astrocytes play important roles in mediating the immune processes and nutritional support in the central nervous system (CNS).  Neuroinflammation has been indicated in the progression of neurodegenerative diseases Alzheimer's disease (AD) and Parkinson's disease (PD).  Chronic neuroinflammation with sustained activation of microglia and astrocytes may affect white matter tracts and disrupt communication between neurons.  Recent studies indicate astrogliosis may inhibit remyelination in demyelinating disorders such as multiple sclerosis.  In this study, we investigated the relationship between neuroinflammation and myelin status in postmortem human brain tissue (n = 15 including 6 AD, 5 PD, and 4 age-matched, neurologically normal controls (NC)).  We conducted systematic and quantitative immunohistochemistry for glial fibrillary acidic protein (GFAP), ionized calcium-binding adaptor molecule 1 (Iba1), amyloid beta, and highly phosphorylated tau (tauopathy).  White matter intactness was evaluated by myelin and axon staining in adjacent brain tissue sections.  Eight of 15 cases (4 AD, 3 PD, and 1 NC) showed increased immunoreactivity for microglia and astrocytes in the white matter that connects striatum and cortex.  Quantitative analysis of these 8 cases showed a significant negative correlation between GFAP (but not Iba-1) and myelin (but not axon) staining in white matter (r(2) = 0.78, p < 0.005).  Tau, but not amyloid beta plaques, is significantly higher in AD vs.  PD and NC.  Tau burden increases with age in AD cases.  These observations indicate that astrocytosis in white matter is associated with loss of myelin in AD, PD, and normal aging and that tau is a potent biomarker for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIewER0TWRce_Q9URG6Dx8fW6udTcc2eYxCMX8xvMHoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mvit1ersA%253D%253D&md5=3d2111e601d1c9a8d9aabed3c4c632b0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1155%2F2019%2F7975407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F7975407%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DF.%26aulast%3DPerrin%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DXu%26aufirst%3DJ.%2BB.%26atitle%3DNeuroinflammation%2520and%2520myelin%2520status%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520and%2520normal%2520aging%2520brains%253A%2520a%2520small%2520sample%2520study%26jtitle%3DParkinson%2527s%2520Dis.%26date%3D2019%26volume%3D2019%26spage%3D7975407%26doi%3D10.1155%2F2019%2F7975407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleymanzadeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldrup, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukulka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabcenell, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lombaert, S.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5864</span>– <span class="NLM_lpage">5868</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.08.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19758802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5864-5868&author=S.+J.+Taylorauthor=F.+Soleymanzadehauthor=A.+B.+Eldrupauthor=N.+A.+Farrowauthor=I.+Mueggeauthor=A.+Kukulkaauthor=A.+K.+Kabcenellauthor=S.+De+Lombaert&title=Design+and+synthesis+of+substituted+nicotinamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2009.08.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Taylor, Steven J.; Soleymanzadeh, Fariba; Eldrup, Anne B.; Farrow, Neil A.; Muegge, Ingo; Kukulka, Alison; Kabcenell, Alisa K.; DeLombaert, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5864-5868</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of potent nicotinamide inhibitors, e.g., I, of sol. epoxides hydrolase (sEH) is disclosed.  This series was designed using structure-based deconstruction and a combination of two HTS hit series, resulting in hybrid analogs that retained the optimal potency from one series, and acceptable in vitro metabolic stability from the other.  Structure-guided optimization of these analogs gave rise to nanomolar inhibitors of human sEH that had acceptable plasma exposure to qualify them as probes to det. the in vivo phenotypic consequences of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-17dcwxDBr7Vg90H21EOLACvtfcHk0ljPfep9VcCXTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurvM&md5=1c070392280c569fcf4d6149f2f643b3</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.074%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BJ.%26aulast%3DSoleymanzadeh%26aufirst%3DF.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DKukulka%26aufirst%3DA.%26aulast%3DKabcenell%26aufirst%3DA.%2BK.%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520substituted%2520nicotinamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5864%26epage%3D5868%26doi%3D10.1016%2Fj.bmcl.2009.08.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R. D.</span></span> <span> </span><span class="NLM_article-title">Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19168352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1WrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1066-1070&author=S.+K.+Anandanauthor=Z.+N.+Doauthor=H.+K.+Webbauthor=D.+V.+Patelauthor=R.+D.+Gless&title=Non-urea+functionality+as+the+primary+pharmacophore+in+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.bmcl.2009.01.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Anandan, Sampath-Kumar; Do, Zung N.; Webb, Heather K.; Patel, Dinesh V.; Gless, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1066-1070</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of sol. epoxide hydrolase has been proposed as a promising new pharmaceutical target for diseases involving hypertension and vascular inflammation.  The most potent sEH inhibitors reported to date contain a urea or amide moiety as the central or 'primary' pharmacophore.  We evaluated replacing the urea pharmacophore with other functional groups such as thiourea, sulfonamide, sulfonylurea, aminomethylene amide, hydroxyamide, and ketoamide to identify novel and potent inhibitors.  The hydroxyamide moiety was identified as a novel pharmacophore affording potency comparable to urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFPHiTb2V57Vg90H21EOLACvtfcHk0lgVVo0u7bM8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1WrtrY%253D&md5=b93de8c049e914d71cb6655a0edc4968</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DGless%26aufirst%3DR.%2BD.%26atitle%3DNon-urea%2520functionality%2520as%2520the%2520primary%2520pharmacophore%2520in%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1066%26epage%3D1070%26doi%3D10.1016%2Fj.bmcl.2009.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R. D.</span></span> <span> </span><span class="NLM_article-title">Unsymmetrical non-adamantyl N,N’-diaryl urea and amide inhibitors of soluble expoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4259</span>– <span class="NLM_lpage">4263</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2009.05.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19520575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4259-4263&author=S.+K.+Anandanauthor=H.+K.+Webbauthor=Z.+N.+Doauthor=R.+D.+Gless&title=Unsymmetrical+non-adamantyl+N%2CN%E2%80%99-diaryl+urea+and+amide+inhibitors+of+soluble+expoxide+hydrolase&doi=10.1016%2Fj.bmcl.2009.05.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Anandan, Sampath-Kumar; Webb, Heather K.; Do, Zung N.; Gless, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4259-4263</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Incorporation of an adamantyl group in prototypical sol. epoxide hydrolase (sEH) inhibitors afforded improved enzyme potency.  Replacement of the adamantyl group in unsym. ureas and amides with substituted aryl rings to identify equipotent and metabolically stable sEH inhibitors, e.g., I and II, is explored.  Aryl rings, esp. those substituted in the para position with a strongly electron withdrawing substituent, afforded enzyme IC50 values comparable to the adamantyl compds. in an ether substituted, unsym. N,N'-diaryl urea or amide scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZK8ABpNO59bVg90H21EOLACvtfcHk0lgVVo0u7bM8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGmtbw%253D&md5=3b3988eb23541b04bb854a84cef0bc86</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.102%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DDo%26aufirst%3DZ.%2BN.%26aulast%3DGless%26aufirst%3DR.%2BD.%26atitle%3DUnsymmetrical%2520non-adamantyl%2520N%252CN%25E2%2580%2599-diaryl%2520urea%2520and%2520amide%2520inhibitors%2520of%2520soluble%2520expoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4259%26epage%3D4263%26doi%3D10.1016%2Fj.bmcl.2009.05.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piirainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalueff, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landreth, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span> <span> </span><span class="NLM_article-title">Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer’s disease: the emerging role for microglia?</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2017.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.neubiorev.2017.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28185874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVGlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=148-164&author=S.+Piirainenauthor=A.+Youssefauthor=C.+Songauthor=A.+V.+Kalueffauthor=G.+E.+Landrethauthor=T.+Malmauthor=L.+Tian&title=Psychosocial+stress+on+neuroinflammation+and+cognitive+dysfunctions+in+Alzheimer%E2%80%99s+disease%3A+the+emerging+role+for+microglia%3F&doi=10.1016%2Fj.neubiorev.2017.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?</span></div><div class="casAuthors">Piirainen, Sami; Youssef, Andrew; Song, Cai; Kalueff, Allan V.; Landreth, Gary E.; Malm, Tarja; Tian, Li</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-164</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chronic psychosocial stress is increasingly recognized as a risk factor for late-onset Alzheimer's disease (LOAD) and assocd. cognitive deficits.  Chronic stress also primes microglia and induces inflammatory responses in the adult brain, thereby compromising synapse-supportive roles of microglia and deteriorating cognitive functions during aging.  Substantial evidence demonstrates that failure of microglia to clear abnormally accumulating amyloid-beta (Aβ) peptide contributes to neuroinflammation and neurodegeneration in AD.  Moreover, genome-wide assocn. studies have linked variants in several immune genes, such as TREM2 and CD33, the expression of which in the brain is restricted to microglia, with cognitive dysfunctions in LOAD.  Thus, inflammation-promoting chronic stress may create a vicious cycle of aggravated microglial dysfunction accompanied by increased Aβ accumulation, collectively exacerbating neurodegeneration.  Surprisingly, however, little is known about whether and how chronic stress contributes to microglia-mediated neuroinflammation that may underlie cognitive impairments in AD.  This review aims to summarize the currently available clin. and preclin. data and outline potential mol. mechanisms linking stress, microglia and neurodegeneration, to foster future research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvSXjK7P3fObVg90H21EOLACvtfcHk0lgVVo0u7bM8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVGlu7g%253D&md5=bcfee6d599b5a35064e1875371153a8c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2017.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2017.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DPiirainen%26aufirst%3DS.%26aulast%3DYoussef%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DKalueff%26aufirst%3DA.%2BV.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26aulast%3DMalm%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DL.%26atitle%3DPsychosocial%2520stress%2520on%2520neuroinflammation%2520and%2520cognitive%2520dysfunctions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520emerging%2520role%2520for%2520microglia%253F%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2017%26volume%3D77%26spage%3D148%26epage%3D164%26doi%3D10.1016%2Fj.neubiorev.2017.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboury, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, S. A.</span></span> <span> </span><span class="NLM_article-title">Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1007/s00249-016-1188-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00249-016-1188-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27928588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyjt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=445-459&author=L.+Karamiauthor=A.+A.+Sabouryauthor=E.+Rezaeeauthor=S.+A.+Tabatabai&title=Investigation+of+the+binding+mode+of+1%2C+3%2C+4-oxadiazole+derivatives+as+amide-based+inhibitors+for+soluble+epoxide+hydrolase+%28sEH%29+by+molecular+docking+and+MM-GBSA&doi=10.1007%2Fs00249-016-1188-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA</span></div><div class="casAuthors">Karami, Leila; Saboury, Ali Akbar; Rezaee, Elham; Tabatabai, Sayyed Abbas</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-459</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) enzyme plays an important role in the metab. of endogenous chem. mediators involved in the regulation of blood pressure and inflammation.  Inhibition of sEH provides a new approach to the treatment of inflammation, hypertension and atherosclerosis.  In this study, the binding modes and inhibition mechanisms of the new oxadiazole-based amide inhibitors of the human sol. epoxide hydrolase were investigated by mol. docking and mol. dynamics (MD) simulation followed by the MM-GBSA method to calc. the binding free energy of each inhibitor to sEH.  The results obtained from the binding free energy (ΔGbinding) calcn. and normal mode anal. indicate that the major favorable contributors are the van der Waals and electrostatic terms, whereas the polar solvation term opposes binding.  In addn., a good agreement between the calcd. ΔGbinding and the exptl. IC50 was obtained [correlation coeff., r2 = 0.89 (with) and 0.87 (without) entropy].  Besides, comparison of the enthalpy changes (ΔGMM-GBSA) with entropy changes (-TΔS) indicates that binding process of all inhibitors to sEH is enthalpy-driven.  Based on the ΔGbinding on per residue decompn., Asp335 and Tyr383 residues from the active site and Trp336, Leu499 and His524 residues from hydrophobic pockets contribute the most to ΔGbinding.  Moreover, hydrogen bond anal. reveals that Tyr383, Tyr466 and Asp335 residues have an important role in the binding to inhibitors by forming hydrogen bonds with high occupancies.  Our obtained results are useful for the understanding of the sEH-inhibitor interactions and may have great importance in the design of future sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_b1ej0nkjwbVg90H21EOLACvtfcHk0ljOAG3CFFTajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyjt7%252FO&md5=c60209daa424f0a66cf80dd192a04d1c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs00249-016-1188-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-016-1188-0%26sid%3Dliteratum%253Aachs%26aulast%3DKarami%26aufirst%3DL.%26aulast%3DSaboury%26aufirst%3DA.%2BA.%26aulast%3DRezaee%26aufirst%3DE.%26aulast%3DTabatabai%26aufirst%3DS.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520binding%2520mode%2520of%25201%252C%25203%252C%25204-oxadiazole%2520derivatives%2520as%2520amide-based%2520inhibitors%2520for%2520soluble%2520epoxide%2520hydrolase%2520%2528sEH%2529%2520by%2520molecular%2520docking%2520and%2520MM-GBSA%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2017%26volume%3D46%26spage%3D445%26epage%3D459%26doi%3D10.1007%2Fs00249-016-1188-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1163</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2013.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24433964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1163-1175&author=I.+H.+Kimauthor=I.+H.+Leeauthor=H.+Nishiwakiauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+substituted+oxyoxalamides+as+inhibitors+of+the+human+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmc.2013.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Lee, In-Hee; Nishiwaki, Hisashi; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1163-1175</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We explored both structure-activity relationships among substituted oxyoxalamides used as the primary pharmacophore of inhibitors of the human sEH and as a secondary pharmacophore to improve water soly. of inhibitors.  When the oxyoxalamide function was modified with a variety of alkyls or substituted alkyls, compd. 6 with a 2-adamantyl group and a benzyl group was found to be a potent sEH inhibitor, suggesting that the substituted oxyoxalamide function is a promising primary pharmacophore for the human sEH, and compd. 6 can be a novel lead structure for the development of further improved oxyoxalamide or other related derivs.  In addn., introduction of substituted oxyoxalamide to inhibitors with an amide or urea primary pharmacophore produced significant improvements in inhibition potency and water soly.  In particular, the N,N,O-trimethyloxyoxalamide group in amide or urea inhibitors (26 and 31) was most effective among those tested for both inhibition and soly.  The results indicate that substituted oxyoxalamide function incorporated into amide or urea inhibitors is a useful secondary pharmacophore, and the resulting structures will be an important basis for the development of bioavailable sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wDMYplfb-bVg90H21EOLACvtfcHk0ljOAG3CFFTajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWitbk%253D&md5=044f7ff87270757ad55a0496d735b791</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BH.%26aulast%3DNishiwaki%26aufirst%3DH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520substituted%2520oxyoxalamides%2520as%2520inhibitors%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1163%26epage%3D1175%26doi%3D10.1016%2Fj.bmc.2013.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiwaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7199</span>– <span class="NLM_lpage">7210</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2015.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26507430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7199-7210&author=I.+H.+Kimauthor=Y.+K.+Parkauthor=H.+Nishiwakiauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+amide-phosphonate+derivatives+as+inhibitors+of+the+human+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmc.2015.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Park, Yong-Kyu; Nishiwaki, Hisashi; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7199-7210</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure-activity relationships of amide-phosphonate derivs. as inhibitors of the human sol. epoxide hydrolase (sEH) were investigated.  First, a series of alkyl or aryl groups were substituted on the carbon alpha to the phosphonate function in amide compds. to see whether substituted phosphonates can act as a secondary pharmacophore.  A tert-Bu group (16) on the alpha carbon was found to yield most potent inhibition on the target enzyme.  A 4-50-fold drop in inhibition was induced by other substituents such as aryls, substituted aryls, cycloalkyls, and alkyls.  Then, the modification of the O-substituents on the phosphonate function revealed that di-Et groups were preferable for inhibition to other longer alkyls or substituted alkyls.  In amide compds. with the optimized diethylphosphonate moiety and an alkyl substitution such as adamantane, tetrahydronaphthalene, or adamantanemethane, highly potent inhibitions were gained.  In addn., the resulting potent amide-phosphonate compds. had reasonable water soly., suggesting that substituted phosphonates in amide inhibitors are effective for both inhibition potency on the human sEH and water soly. as a secondary pharmacophore.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40fqBW177KrVg90H21EOLACvtfcHk0ljOAG3CFFTajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWhurzF&md5=e23ca5c7f90bd0d699cff12e720d432f</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DNishiwaki%26aufirst%3DH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520amide-phosphonate%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520human%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7199%26epage%3D7210%26doi%3D10.1016%2Fj.bmc.2015.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zavareh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedayati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahhosseini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabai, S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of some oxadiazole derivatives as novel amide-based inhibitors of soluble epoxide hydrolase</span>. <i>Lett. Drug Des. Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.2174/1570180811666140220005530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1570180811666140220005530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=721-730&author=E.+Zavarehauthor=M.+Hedayatiauthor=L.+Radauthor=A.+Kianiauthor=S.+Shahhosseiniauthor=M.+Faiziauthor=S.+Tabatabai&title=Design%2C+synthesis+and+biological+evaluation+of+some+oxadiazole+derivatives+as+novel+amide-based+inhibitors+of+soluble+epoxide+hydrolase&doi=10.2174%2F1570180811666140220005530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis and Biological Evaluation of Some Oxadiazole Derivatives as Novel Amide-Based Inhibitors of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Zavareh, Elham Rezaee; Hedayati, Mahdi; Rad, Laleh Hoghooghi; Kiani, Azin; Shahhosseini, Soraya; Faizi, Mehrdad; Tabatabai, Sayyed Abbas</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-730</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1875-628X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) enzyme plays an important role in the metab. of endogenous chem. mediators which are involved in the regulation of blood pressure and inflammation.  Although the most reported potent sEH inhibitors are urea derivs., these compds. have limited pharmacokinetic profile.  In order to improve physicochem. properties, besides having favorable potency, amide non-urea derivs. with oxadiazole ring as a novel secondary pharmacophore against sEH enzyme were developed.  Most of the novel compds. with appropriate phys. properties, had comparable in vitro sEH inhibitory activity to 12-(3-Adamantan-1-yl-ureido)-dodecanoic acid (AUDA), a potent urea-based sEH inhibitor.  The IC50 value of the most potent compd. (15c) was 0.43 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_yCqx_odqkrVg90H21EOLACvtfcHk0ljO71aCB8MsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVakur8%253D&md5=5a8f726e1ee2f3d16c23be94ce483de4</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.2174%2F1570180811666140220005530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180811666140220005530%26sid%3Dliteratum%253Aachs%26aulast%3DZavareh%26aufirst%3DE.%26aulast%3DHedayati%26aufirst%3DM.%26aulast%3DRad%26aufirst%3DL.%26aulast%3DKiani%26aufirst%3DA.%26aulast%3DShahhosseini%26aufirst%3DS.%26aulast%3DFaizi%26aufirst%3DM.%26aulast%3DTabatabai%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520some%2520oxadiazole%2520derivatives%2520as%2520novel%2520amide-based%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2014%26volume%3D11%26spage%3D721%26epage%3D730%26doi%3D10.2174%2F1570180811666140220005530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1021/jm101431v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101431v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1Gis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1752-1761&author=I.+H.+Kimauthor=Y.+K.+Parkauthor=B.+D.+Hammockauthor=K.+Nishi&title=Structure-activity+relationships+of+cycloalkylamide+derivatives+as+inhibitors+of+the+soluble+epoxide+hydrolase&doi=10.1021%2Fjm101431v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Cycloalkylamide Derivatives as Inhibitors of the Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Kim, In-Hae; Park, Yong-Kyu; Hammock, Bruce D.; Nishi, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1752-1761</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationships of cycloalkylamide compds. as inhibitors of human sEH were investigated.  When the left side of amide function was modified by a variety of cycloalkanes, at least a C6 like cyclohexane was necessary to yield reasonable inhibition potency on the target enzyme.  In compds. with a smaller cycloalkane or with a polar group on the left side of amide function, no inhibition was obsd.  Increased hydrophobicity dramatically improved inhibition potency.  Esp., a tetrahydronaphthalene (20) effectively increased the potency.  When a series of alkyl or aryl derivs. of cycloalkylamide were investigated to continuously optimize the right side of the amide pharmacophore, a benzyl moiety functionalized with a polar group produced highly potent inhibition.  A nonsubstituted benzyl, alkyl, aryl, or biaryl structure present on the right side of the cycloalkylamide function induced a big decrease in inhibition potency.  Also, the resulting potent cycloalkylamide (32) showed reasonable phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwCVBettgWDLVg90H21EOLACvtfcHk0ljO71aCB8MsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1Gis7s%253D&md5=517ef48a514f6aaaf35b6b52729b7305</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm101431v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101431v%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DNishi%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationships%2520of%2520cycloalkylamide%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1752%26epage%3D1761%26doi%3D10.1021%2Fjm101431v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinderspacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent non-urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2354</span>– <span class="NLM_lpage">2359</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2008.09.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19303288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2354-2359&author=Y.+Xieauthor=Y.+Liuauthor=G.+Gongauthor=D.+H.+Smithauthor=F.+Yanauthor=A.+Rinderspacherauthor=Y.+Fengauthor=Z.+Zhuauthor=X.+Liauthor=S.+X.+Dengauthor=L.+Brandenauthor=D.+Vidovicauthor=C.+Chungauthor=S.+Schurerauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Landry&title=Discovery+of+potent+non-urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2008.09.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent non-urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Xie, Yuli; Liu, Yidong; Gong, Gangli; Smith, Deborah H.; Yan, Fang; Rinderspacher, Alison; Feng, Yan; Zhu, Zhengxiang; Li, Xiangpo; Deng, Shi-Xian; Branden, Lars; Vidovic, Dusica; Chung, Caty; Schuerer, Stephan; Morisseau, Christophe; Hammock, Bruce D.; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2354-2359</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation.  A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chem. modification.  IC50s of the most potent compds. range from micromolar to low nanomolar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKbATsv12p_bVg90H21EOLACvtfcHk0ljO71aCB8MsNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sjur4%253D&md5=b8ad4e02402338154feb22e56eb662c3</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.066%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%2BH.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DRinderspacher%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DBranden%26aufirst%3DL.%26aulast%3DVidovic%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DSchurer%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520non-urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2354%26epage%3D2359%26doi%3D10.1016%2Fj.bmcl.2008.09.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pecic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">605</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2011.10.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22079754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=601-605&author=S.+Pecicauthor=S.+X.+Dengauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=D.+W.+Landry&title=Design%2C+synthesis+and+evaluation+of+non-urea+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2011.10.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Pecic, Stevan; Deng, Shi-Xian; Morisseau, Christophe; Hammock, Bruce D.; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">601-605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of sol. epoxide hydrolase (sEH) has been proposed as a new pharmaceutical approach for treating hypertension and vascular inflammation.  The most potent sEH inhibitors reported in literature to date are urea derivs.  However, these compds. have limited pharmacokinetic profiles.  We investigated non-urea amide derivs. as sEH inhibitors and identified a potent human sEH inhibitor I having potency comparable to urea-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9kGoa5StNQLVg90H21EOLACvtfcHk0ljQuvrRTxZwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVyrtA%253D%253D&md5=e1c2ff96b9a2546e2869258787451cdb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DPecic%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520non-urea%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D601%26epage%3D605%26doi%3D10.1016%2Fj.bmcl.2011.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolodziej, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberds, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1021/jm101382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1211-1222&author=L.+Xingauthor=J.+J.+McDonaldauthor=S.+A.+Kolodziejauthor=R.+G.+Kurumbailauthor=J.+M.+Williamsauthor=C.+J.+Warrenauthor=J.+M.+O%E2%80%99Nealauthor=J.+E.+Skepnerauthor=S.+L.+Roberds&title=Discovery+of+potent+inhibitors+of+soluble+epoxide+hydrolase+by+combinatorial+library+design+and+structure-based+virtual+screening&doi=10.1021%2Fjm101382t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening</span></div><div class="casAuthors">Xing, Li; McDonald, Joseph J.; Kolodziej, Steve A.; Kurumbail, Ravi G.; Williams, Jennifer L.; Warren, Chad J.; O'Neal, Janet M.; Skepner, Jill E.; Roberds, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1211-1222</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based virtual screening was applied to design combinatorial libraries to discover novel and potent sol. epoxide hydrolase (sEH) inhibitors.  X-ray crystal structures revealed unique interactions for a benzoxazole template in addn. to the conserved hydrogen bonds with the catalytic machinery of sEH.  By exploitation of the favorable binding elements, two iterations of library design based on amide coupling were employed, guided principally by the docking results of the enumerated virtual products.  Biol. screening of the libraries demonstrated as high as 90% hit rate, of which over two dozen compds. were single digit nanomolar sEH inhibitors by IC50 detn.  In total the library design and synthesis produced more than 300 submicromolar sEH inhibitors.  In cellular systems consistent activities were demonstrated with biochem. measurements.  The SAR understanding of the benzoxazole template provides valuable insights into discovery of novel sEH inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tpDmXCJWBLVg90H21EOLACvtfcHk0ljQuvrRTxZwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cqu7s%253D&md5=01775ad103a3a5e153b77157ef184608</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm101382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101382t%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DKolodziej%26aufirst%3DS.%2BA.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DWarren%26aufirst%3DC.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DJ.%2BM.%26aulast%3DSkepner%26aufirst%3DJ.%2BE.%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520potent%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520by%2520combinatorial%2520library%2520design%2520and%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1211%26epage%3D1222%26doi%3D10.1021%2Fjm101382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7061</span>– <span class="NLM_lpage">7079</span>, <span class="refDoi"> DOI: 10.1021/jm300449x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300449x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7061-7079&author=H.+Dengauthor=H.+O%E2%80%99Keefeauthor=C.+P.+Davieauthor=K.+E.+Lindauthor=R.+A.+Acharyaauthor=G.+J.+Franklinauthor=J.+Larkinauthor=R.+Maticoauthor=M.+Neebauthor=M.+M.+Thompsonauthor=T.+Lohrauthor=J.+W.+Grossauthor=P.+A.+Centrellaauthor=G.+K.+O%E2%80%99Donovanauthor=K.+L.+Bedardauthor=K.+van+Vlotenauthor=S.+Mataruseauthor=S.+R.+Skinnerauthor=S.+L.+Belyanskayaauthor=T.+Y.+Carpenterauthor=T.+W.+Shearerauthor=M.+A.+Clarkauthor=J.+W.+Cuozzoauthor=C.+C.+Arico-Muendelauthor=B.+A.+Morgan&title=Discovery+of+highly+potent+and+selective+small+molecule+ADAMTS-5+inhibitors+that+inhibit+human+cartilage+degradation+via+encoded+library+technology+%28ELT%29&doi=10.1021%2Fjm300449x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT)</span></div><div class="casAuthors">Deng, Hongfeng; O'Keefe, Heather; Davie, Christopher P.; Lind, Kenneth E.; Acharya, Raksha A.; Franklin, G. Joseph; Larkin, Jonathan; Matico, Rosalie; Neeb, Michael; Thompson, Monique M.; Lohr, Thomas; Gross, Jeffrey W.; Centrella, Paolo A.; O'Donovan, Gary K.; Bedard, Katie L.; van Vloten, Kurt; Mataruse, Sibongile; Skinner, Steven R.; Belyanskaya, Svetlana L.; Carpenter, Tiffany Y.; Shearer, Todd W.; Clark, Matthew A.; Cuozzo, John W.; Arico-Muendel, Christopher C.; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7061-7079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metalloprotease ADAMTS-5 is considered a potential target for the treatment of osteoarthritis.  To identify selective inhibitors of ADAMTS-5, the authors employed encoded library technol. (ELT), which enables affinity selection of small mol. binders from complex mixts. by DNA tagging.  Selection of ADAMTS-5 against a four-billion member ELT library led to a novel inhibitor scaffold not contg. a classical zinc-binding functionality.  One exemplar, (R)-N-((1-(4-(but-3-en-1-ylamino)-6-(((2-(thiophen-2-yl)thiazol-4-yl)methyl)amino)-1,3,5-triazin-2-yl)pyrrolidin-2-yl)methyl)-4-propylbenzenesulfonamide (I), inhibited ADAMTS-5 with IC50 = 30 nM, showing >50-fold selectivity against ADAMTS-4 and >1000-fold selectivity against ADAMTS-1, ADAMTS-13, MMP-13, and TACE.  Extensive SAR studies showed that potency and physicochem. properties of the scaffold could be further improved.  Furthermore, in a human osteoarthritis cartilage explant study, compds. I and II inhibited aggrecanase-mediated 374ARGS neoepitope release from aggrecan and glycosaminoglycan in response to IL-1β/OSM stimulation.  This study provides the first small mol. evidence for the crit. role of ADAMTS-5 in human cartilage degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOEaetEOSWLVg90H21EOLACvtfcHk0ljQuvrRTxZwVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM&md5=9f7d1a265c7f8089f9fa505f9974483e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm300449x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300449x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DNeeb%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DM.%2BM.%26aulast%3DLohr%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DG.%2BK.%26aulast%3DBedard%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DCarpenter%26aufirst%3DT.%2BY.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small%2520molecule%2520ADAMTS-5%2520inhibitors%2520that%2520inhibit%2520human%2520cartilage%2520degradation%2520via%2520encoded%2520library%2520technology%2520%2528ELT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7061%26epage%3D7079%26doi%3D10.1021%2Fjm300449x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering drugs with DNA-encoded library technology: from concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+drugs+with+DNA-encoded+library+technology%3A+from+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0lgjBBrFLl7lpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520drugs%2520with%2520DNA-encoded%2520library%2520technology%253A%2520from%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thalji, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costell, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisennagel, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fries, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolivette, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krosky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandichak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roethke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnackenberg, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shewchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3584</span>– <span class="NLM_lpage">3588</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2013.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23664879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3584-3588&author=R.+K.+Thaljiauthor=J.+J.+McAteeauthor=S.+Belyanskayaauthor=M.+Brandtauthor=G.+D.+Brownauthor=M.+H.+Costellauthor=Y.+Dingauthor=J.+W.+Dodsonauthor=S.+H.+Eisennagelauthor=R.+E.+Friesauthor=J.+W.+Grossauthor=M.+R.+Harpelauthor=D.+A.+Holtauthor=D.+I.+Israelauthor=L.+J.+Jolivetteauthor=D.+Kroskyauthor=H.+Liauthor=Q.+Luauthor=T.+Mandichakauthor=T.+Roethkeauthor=C.+G.+Schnackenbergauthor=B.+Schwartzauthor=L.+M.+Shewchukauthor=W.+Xieauthor=D.+J.+Behmauthor=S.+A.+Douglasauthor=A.+L.+Shawauthor=J.+P.+Marino&title=Discovery+of+1-%281%2C3%2C5-triazin-2-yl%29piperidine-4-carboxamides+as+inhibitors+of+soluble+epoxide+hydrolase&doi=10.1016%2Fj.bmcl.2013.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase</span></div><div class="casAuthors">Thalji, Reema K.; McAtee, Jeff J.; Belyanskaya, Svetlana; Brandt, Martin; Brown, Gregory D.; Costell, Melissa H.; Ding, Yun; Dodson, Jason W.; Eisennagel, Steve H.; Fries, Rusty E.; Gross, Jeffrey W.; Harpel, Mark R.; Holt, Dennis A.; Israel, David I.; Jolivette, Larry J.; Krosky, Daniel; Li, Hu; Lu, Quinn; Mandichak, Tracy; Roethke, Theresa; Schnackenberg, Christine G.; Schwartz, Benjamin; Shewchuk, Lisa M.; Xie, Wensheng; Behm, David J.; Douglas, Stephen A.; Shaw, Ami L.; Marino, Joseph P., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3584-3588</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1-(1,3,5-Triazin-yl)piperidine-4-carboxamide inhibitors of sol. epoxide hydrolase were identified from high through-put screening using encoded library technol.  The triazine heterocycle proved to be a crit. functional group, essential for high potency and P 450 selectivity.  Ph group substitution was important for reducing clearance, and establishing good oral exposure.  Based on this lead optimization work, 1-[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]-N-{[[4-bromo-2-(trifluoromethoxy)]-phenyl]methyl}-4-piperidinecarboxamide (27) was identified as a useful tool compd. for in vivo investigation.  Robust effects on a serum biomarker, 9, 10-epoxyoctadec-12(Z)-enoic acid (the epoxide derived from linoleic acid) were obsd., which provided evidence of robust in vivo target engagement and the suitability of 27 as a tool compd. for study in various disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCLHfTPGdnzrVg90H21EOLACvtfcHk0lgjBBrFLl7lpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVyjt7c%253D&md5=1062478cb50db4ce0046992545428753</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DThalji%26aufirst%3DR.%2BK.%26aulast%3DMcAtee%26aufirst%3DJ.%2BJ.%26aulast%3DBelyanskaya%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DCostell%26aufirst%3DM.%2BH.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DDodson%26aufirst%3DJ.%2BW.%26aulast%3DEisennagel%26aufirst%3DS.%2BH.%26aulast%3DFries%26aufirst%3DR.%2BE.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26aulast%3DJolivette%26aufirst%3DL.%2BJ.%26aulast%3DKrosky%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DMandichak%26aufirst%3DT.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSchnackenberg%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DDouglas%26aufirst%3DS.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BL.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%25201-%25281%252C3%252C5-triazin-2-yl%2529piperidine-4-carboxamides%2520as%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3584%26epage%3D3588%26doi%3D10.1016%2Fj.bmcl.2013.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span> <span> </span><span class="NLM_article-title">Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2018.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2018.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2019&pages=31-39&author=K.+Hiesingerauthor=K.+M.+Wagnerauthor=B.+D.+Hammockauthor=E.+Proschakauthor=S.+H.+Hwang&title=Development+of+multitarget+agents+possessing+soluble+epoxide+hydrolase+inhibitory+activity&doi=10.1016%2Fj.prostaglandins.2018.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity</span></div><div class="casAuthors">Hiesinger, Kerstin; Wagner, Karen M.; Hammock, Bruce D.; Proschak, Ewgenij; Hwang, Sung Hee</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Over the last two decades polypharmacol. has emerged as a new paradigm in drug discovery, even though developing drugs with high potency and selectivity toward a single biol. target is still a major strategy.  Often, targeting only a single enzyme or receptor shows lack of efficacy.  High levels of inhibitor of a single target also can lead to adverse side effects.  A second target may offer additive or synergistic effects to affecting the first target thereby reducing on- and off-target side effects.  Therefore, drugs that inhibit multiple targets may offer a great potential for increased efficacy and reduced the adverse effects.  In this review we summarize recent findings of rationally designed multitarget compds. that are aimed to improve efficacy and safety profiles compared to those that target a single enzyme or receptor.  We focus on dual inhibitors/modulators that target the sol. epoxide hydrolase (sEH) as a common part of their design to take advantage of the beneficial effects of sEH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV_jK3eUex7bVg90H21EOLACvtfcHk0lifJ-dJLGEQGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsg%253D%253D&md5=1aca2c841ac683c62de22c93155394d0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2018.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2018.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26atitle%3DDevelopment%2520of%2520multitarget%2520agents%2520possessing%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2019%26volume%3D140%26spage%3D31%26epage%3D39%26doi%3D10.1016%2Fj.prostaglandins.2018.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakhomova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29366648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOrtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=762-768&author=S.+D.+Kodaniauthor=S.+Bhaktaauthor=S.+H.+Hwangauthor=S.+Pakhomovaauthor=M.+E.+Newcomerauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Identification+and+optimization+of+soluble+epoxide+hydrolase+inhibitors+with+dual+potency+towards+fatty+acid+amide+hydrolase&doi=10.1016%2Fj.bmcl.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase</span></div><div class="casAuthors">Kodani, Sean D.; Bhakta, Saavan; Hwang, Sung Hee; Pakhomova, Svetlana; Newcomer, Marcia E.; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">762-768</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multi-target inhibitors have become increasing popular as a means to leverage the advantages of poly-pharmacol. while simplifying drug delivery.  Here, we describe dual inhibitors for sol. epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH), two targets known to synergize when treating inflammatory and neuropathic pain.  The structure activity relationship (SAR) study described herein initially started with t-TUCB (trans-4-[4-(3-trifluoromethoxyphenyl-l-ureido)-cyclohexyloxy]-benzoic acid), a potent sEH inhibitor that was previously shown to weakly inhibit FAAH.  Inhibitors with a 6-fold increase of FAAH potency while maintaining high sEH potency were developed by optimization.  Interestingly, compared to most FAAH inhibitors that inhibit through time-dependent covalent modification, t-TUCB and related compds. appear to inhibit FAAH through a time-independent, competitive mechanism.  These inhibitors are selective for FAAH over other serine hydrolases.  In addn., FAAH inhibition by t-TUCB appears to be higher in human FAAH over other species; however, the new dual sEH/FAAH inhibitors have improved cross-species potency.  These dual inhibitors may be useful for future studies in understanding the therapeutic application of dual sEH/FAAH inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpATW2xwOkDr7Vg90H21EOLACvtfcHk0lifJ-dJLGEQGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOrtbs%253D&md5=adca53fce25060a570e20b1cd81d6199</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DPakhomova%26aufirst%3DS.%26aulast%3DNewcomer%26aufirst%3DM.%2BE.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520with%2520dual%2520potency%2520towards%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D762%26epage%3D768%26doi%3D10.1016%2Fj.bmcl.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Computer-aided fragment growing strategies to design dual inhibitors of soluble epoxide hydrolase and LTA4 hydrolase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXms1yjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1244-1249&author=L.+Hefkeauthor=K.+Hiesingerauthor=W.+F.+Zhuauthor=J.+S.+Kramerauthor=E.+Proschak&title=Computer-aided+fragment+growing+strategies+to+design+dual+inhibitors+of+soluble+epoxide+hydrolase+and+LTA4+hydrolase&doi=10.1021%2Facsmedchemlett.0c00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase</span></div><div class="casAuthors">Hefke, Lena; Hiesinger, Kerstin; Zhu, W. Felix; Kramer, Jan S.; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1244-1249</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitarget ligands are interesting candidates for drug discovery and development due to improved safety and efficacy.  However, rational design and optimization of multitarget ligands is tedious because affinity optimization for two or more targets has to be performed simultaneously.  In this study, we demonstrate that, given a mol. fragment, which binds to two targets of interest, computer-aided fragment growing can be applied to optimize compd. potency, relying on either ligand- or structure-derived information.  This methodol. is applied to the design of dual inhibitors of sol. epoxide hydrolase and leukotriene A4 hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOGBsqvMSsZLVg90H21EOLACvtfcHk0ljYDywU33K6wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXms1yjtr4%253D&md5=ac22514a975d2ff66d41234aa8844307</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00102%26sid%3Dliteratum%253Aachs%26aulast%3DHefke%26aufirst%3DL.%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DW.%2BF.%26aulast%3DKramer%26aufirst%3DJ.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DComputer-aided%2520fragment%2520growing%2520strategies%2520to%2520design%2520dual%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520LTA4%2520hydrolase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1244%26epage%3D1249%26doi%3D10.1021%2Facsmedchemlett.0c00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahakian, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettersten, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1410432111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1410432111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25024195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=11127-11132&author=G.+Zhangauthor=D.+Panigrahyauthor=S.+H.+Hwangauthor=J.+Yangauthor=L.+M.+Mahakianauthor=H.+I.+Wetterstenauthor=J.+Y.+Liuauthor=Y.+Wangauthor=E.+S.+Inghamauthor=S.+Tamauthor=M.+W.+Kieranauthor=R.+H.+Weissauthor=K.+W.+Ferraraauthor=B.+D.+Hammock&title=Dual+inhibition+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase+synergistically+suppresses+primary+tumor+growth+and+metastasis&doi=10.1073%2Fpnas.1410432111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis</span></div><div class="casAuthors">Zhang, Guodong; Panigrahy, Dipak; Hwang, Sung Hee; Yang, Jun; Mahakian, Lisa M.; Wettersten, Hiromi I.; Liu, Jun-Yan; Wang, Yanru; Ingham, Elizabeth S.; Tam, Sarah; Kieran, Mark W.; Weiss, Robert H.; Ferrara, Katherine W.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">11127-11132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandins derived from the cyclooxygenase (COX) pathway and epoxyeicosatrienoic acids (EETs) from the cytochrome P 450/sol. epoxide hydrolase (sEH) pathway are important eicosanoids that regulate angiogenesis and tumorigenesis.  COX-2 inhibitors, which block the formation of prostaglandins, suppress tumor growth, whereas sEH inhibitors, which increase endogenous EETs, stimulate primary tumor growth and metastasis.  However, the functional interactions of these two pathways in cancer are unknown.  Using pharmacol. inhibitors as probes, we show here that dual inhibition of COX-2 and sEH synergistically inhibits primary tumor growth and metastasis by suppressing tumor angiogenesis.  COX-2/sEH dual pharmacol. inhibitors also potently suppress primary tumor growth and metastasis by inhibiting tumor angiogenesis via selective inhibition of endothelial cell proliferation.  These results demonstrate a crit. interaction of these two lipid metab. pathways on tumorigenesis and suggest dual inhibition of COX-2 and sEH as a potential therapeutic strategy for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96zPXS3W5_LVg90H21EOLACvtfcHk0ljYDywU33K6wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyqtb3J&md5=928fc9973909898ae94dbf2f3e087677</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1410432111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1410432111%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMahakian%26aufirst%3DL.%2BM.%26aulast%3DWettersten%26aufirst%3DH.%2BI.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIngham%26aufirst%3DE.%2BS.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDual%2520inhibition%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%2520synergistically%2520suppresses%2520primary%2520tumor%2520growth%2520and%2520metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D11127%26epage%3D11132%26doi%3D10.1073%2Fpnas.1410432111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">la Buscato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10771</span>– <span class="NLM_lpage">10775</span>, <span class="refDoi"> DOI: 10.1021/jm301194c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301194c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3s7htlelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10771-10775&author=E.+la+Buscatoauthor=R.+Blocherauthor=C.+Lamersauthor=F.+M.+Klinglerauthor=S.+Hahnauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=E.+Proschak&title=Design+and+synthesis+of+dual+modulators+of+soluble+epoxide+hydrolase+and+peroxisome+proliferator-activated+receptors&doi=10.1021%2Fjm301194c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors</span></div><div class="casAuthors">la Buscato Estel; Blocher Rene; Lamers Christina; Klingler Franca-Maria; Hahn Steffen; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Proschak Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10771-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome is a complex condition which often requires the use of multiple medications as a treatment.  The resulting problems of polypharmacy are increase in side effects, drug-drug interactions, and its high economic cost.  Development of multitarget compounds is a promising strategy to avoid the complications arising from administration of multiple drugs.  Modulators of peroxisome proliferator-activated receptors (PPARs) are established agents in the treatment of dyslipidaemia, hyperglycaemia, and insulin resistance.  Inhibitors of soluble epoxide hydrolase (sEH) are under evaluation for their use in cardiovascular diseases.  In the present study, a series of dual sEH/PPAR modulators containing a pyrrole acidic headgroup and a urea pharmacophore were designed, synthesized, and evaluated in vitro using recombinant enzyme and cell-based assays.  Compounds with different activity profiles were obtained which could be used in the treatment of metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ44wz9IvHE-f3jf77P2BG3fW6udTcc2eZdoGKBT1bSjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7htlelug%253D%253D&md5=50f42905d28bce4b6298d098408b3532</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm301194c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301194c%26sid%3Dliteratum%253Aachs%26aulast%3Dla%2BBuscato%26aufirst%3DE.%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520modulators%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520peroxisome%2520proliferator-activated%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10771%26epage%3D10775%26doi%3D10.1021%2Fjm301194c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodl, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewska, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buscato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berressem, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1777</span>– <span class="NLM_lpage">1781</span>, <span class="refDoi"> DOI: 10.1021/jm301617j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301617j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1777-1781&author=K.+Meirerauthor=C.+B.+Rodlauthor=J.+M.+Wisniewskaauthor=S.+Georgeauthor=A.+K.+Hafnerauthor=E.+Buscatoauthor=F.+M.+Klinglerauthor=S.+Hahnauthor=D.+Berressemauthor=S.+K.+Wittmannauthor=D.+Steinhilberauthor=B.+Hofmannauthor=E.+Proschak&title=Synthesis+and+structure-activity+relationship+studies+of+novel+dual+inhibitors+of+soluble+epoxide+hydrolase+and+5-lipoxygenase&doi=10.1021%2Fjm301617j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase</span></div><div class="casAuthors">Meirer, Karin; Roedl, Carmen B.; Wisniewska, Joanna M.; George, Sven; Haefner, Ann-Kathrin; Buscato, Estel·la; Klingler, Franca-Maria; Hahn, Steffen; Berressem, Dirk; Wittmann, Sandra K.; Steinhilber, Dieter; Hofmann, Bettina; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1777-1781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current research leads to the assumption that drugs affecting more than one target could result in a more efficient treatment of diseases and fewer safety concerns.  Administration of drugs inhibiting only one branch of the arachidonic acid cascade is usually accompanied by side effects.  We therefore designed and synthesized a library of hybrid mols. incorporating an imidazo[1,2-a]pyridine and an urea moiety as novel sol. epoxide hydrolase (sEH)/5-lipoxygenase (5-LO) dual inhibitors.  Evaluation of the compds. was accomplished by in vitro testing using recombinant enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7_8oVx_4lw7Vg90H21EOLACvtfcHk0lhM5q9Q92_7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqu7s%253D&md5=d7aa0212864592ccdff5b431004a010a</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm301617j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301617j%26sid%3Dliteratum%253Aachs%26aulast%3DMeirer%26aufirst%3DK.%26aulast%3DRodl%26aufirst%3DC.%2BB.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DHafner%26aufirst%3DA.%2BK.%26aulast%3DBuscato%26aufirst%3DE.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DBerressem%26aufirst%3DD.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520novel%2520dual%2520inhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1777%26epage%3D1781%26doi%3D10.1021%2Fjm301617j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wecksler, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3037</span>– <span class="NLM_lpage">3050</span>, <span class="refDoi"> DOI: 10.1021/jm2001376</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2001376" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlOrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3037-3050&author=S.+H.+Hwangauthor=K.+M.+Wagnerauthor=C.+Morisseauauthor=J.+Y.+Liuauthor=H.+Dongauthor=A.+T.+Weckslerauthor=B.+D.+Hammock&title=Synthesis+and+structure-activity+relationship+studies+of+urea-containing+pyrazoles+as+dual+inhibitors+of+cyclooxygenase-2+and+soluble+epoxide+hydrolase&doi=10.1021%2Fjm2001376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase</span></div><div class="casAuthors">Hwang, Sung Hee; Wagner, Karen M.; Morisseau, Christophe; Liu, Jun-Yan; Dong, Hua; Wecksler, Aaron T.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3037-3050</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of dual inhibitors contg. a 1,5-diarylpyrazole and a urea were designed, synthesized, and evaluated as novel COX-2/sEH dual inhibitors in vitro using recombinant enzyme assays and in vivo using a lipopolysaccharide (LPS) induced model of pain in rats.  The best inhibition potencies and selectivity for sEH and COX-2 over COX-1 were obtained with compds. I (R = 3-CF3, 4-CF3, 4-OCF3) in which both the 1,5-diaryl-pyrazole group and the urea group are linked with a three-methylene group.  Compd. I (R = 4-CF3) showed the best pharmacokinetic profiles in both mice and rats (higher AUC and longer half-life).  Following s.c. administration at 10 mg/kg, compd. I (R = 4-CF3) exhibited antiallodynic activity that is more effective than the same dose of either a COX-2 inhibitor (celecoxib) or a sEH inhibitor (t-AUCB) alone, as well as coadministration of both inhibitors.  Thus, these novel dual inhibitors exhibited enhanced in vivo antiallodynic activity in a nociceptive behavioral assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlGixCVsv09bVg90H21EOLACvtfcHk0lgDR_vOquPjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlOrtL8%253D&md5=f32356bf3f1d3f4237e1674a961680c8</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm2001376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2001376%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWecksler%26aufirst%3DA.%2BT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520urea-containing%2520pyrazoles%2520as%2520dual%2520inhibitors%2520of%2520cyclooxygenase-2%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3037%26epage%3D3050%26doi%3D10.1021%2Fjm2001376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2019.12.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bbrc.2019.12.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31973813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2020&pages=1020-1026&author=C.+C.+Sunauthor=C.+Y.+Zhangauthor=J.+X.+Duanauthor=X.+X.+Guanauthor=H.+H.+Yangauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guanauthor=S.+K.+Liuauthor=J.+Zhang&title=PTUPB+ameliorates+high-fat+diet-induced+non-alcoholic+fatty+liver+disease+via+inhibiting+NLRP3+inflammasome+activation+in+mice&doi=10.1016%2Fj.bbrc.2019.12.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice</span></div><div class="casAuthors">Sun, Chen-Chen; Zhang, Chen-Yu; Duan, Jia-Xi; Guan, Xin-Xin; Yang, Hui-Hui; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang; Liu, Shao-Kun; Zhang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1020-1026</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-alc. fatty liver disease (NAFLD) affects 25% of the global adult population, and no effective pharmacol. treatment has been found.  Products of arachidonic acid metab. have been developed into a novel therapy for metabolic syndrome and diabetes.  It has been demonstrated that protective actions of a novel dual cyclooxygenase-2 (COX-2) and sol. epoxide hydrolase (sEH) inhibitor, PTUPB, on the metabolic abnormalities.  Here, we investigated the effects of PTUPB on hepatic steatosis in high-fat diet (HFD)-induced obese mice, as well as in hepatocytes in vitro.  We found that PTUPB treatment reduced body wt., liver wt., liver triglyceride and cholesterol content, and the expression of lipolytic/lipogenic and lipid uptake related genes (Acc, Cd36, and Cidec) in HFD mice.  In addn., PTUPB treatment arrested fibrotic progression with a decrease of collagen deposition and expression of Col1a1, Col1a3, and a-SMA.  In vitro, PTUPB decreased palmitic acid-induced lipid deposition and downregulation of lipolytic/lipogenic genes (Acc and Cd36) in hepatocytes.  Addnl., we found that PTUPB reduced the prodn. of pro-inflammatory cytokines and suppressed the NLRP3 inflammasome activation in HFD mice and hepatocytes.  In conclusion, dual inhibition of COX-2/sEH attenuates hepatic steatosis by inhibiting the NLRP3 inflammasome activation.  PTUPB might be a promising potential therapy for liver steatosis assocd. with obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEB3zkrRaw27Vg90H21EOLACvtfcHk0lgDR_vOquPjeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKqtb0%253D&md5=942c4c8f06613309adccee2d36413428</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2019.12.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2019.12.131%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26aulast%3DLiu%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DPTUPB%2520ameliorates%2520high-fat%2520diet-induced%2520non-alcoholic%2520fatty%2520liver%2520disease%2520via%2520inhibiting%2520NLRP3%2520inflammasome%2520activation%2520in%2520mice%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2020%26volume%3D523%26spage%3D1020%26epage%3D1026%26doi%3D10.1016%2Fj.bbrc.2019.12.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span> <span> </span><span class="NLM_article-title">A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">109907</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2020.109907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.biopha.2020.109907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32114358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFejsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2020&pages=109907&author=Y.+F.+Zhangauthor=C.+C.+Sunauthor=J.+X.+Duanauthor=H.+H.+Yangauthor=C.+Y.+Zhangauthor=J.+B.+Xiongauthor=W.+J.+Zhongauthor=C.+Zuauthor=X.+X.+Guanauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guan&title=A+COX-2%2FsEH+dual+inhibitor+PTUPB+ameliorates+cecal+ligation+and+puncture-induced+sepsis+in+mice+via+anti-inflammation+and+anti-oxidative+stress&doi=10.1016%2Fj.biopha.2020.109907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress</span></div><div class="casAuthors">Zhang, Yan-Feng; Sun, Chen-Chen; Duan, Jia-Xi; Yang, Hui-Hui; Zhang, Chen-Yu; Xiong, Jian-Bing; Zhong, Wen-Jing; Zu, Cheng; Guan, Xin-Xin; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109907</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Arachidonic acid can be metabolized to prostaglandins and epoxyeicosatrienoic acids (EETs) by cyclooxygenase-2 (COX-2) and cytochrome P 450 (CYP), resp.  While protective EETs are degraded by sol. epoxide hydrolase (sEH) very fast.  We have reported that dual inhibition of COX-2 and sEH with specific inhibitor PTUPB shows anti-pulmonary fibrosis and renal protection.  However, the effect of PTUPB on cecal ligation and puncture (CLP)-induced sepsis remains unclear.  The current study aimed to investigate the protective effects of PTUPB against CLP-induced sepsis in mice and the underlying mechanisms.  We found that COX-2 expressions were increased, while CYPs expressions were decreased in the liver, lung, and kidney of mice undergone CLP.  PTUPB treatment significantly improved the survival rate, reduced the clin. scores and systemic inflammatory response, alleviated liver and kidney dysfunction, and ameliorated the multiple-organ injury of the mice with sepsis.  Besides, PTUPB treatment reduced the expression of hypoxia-inducible factor-1α in the liver, lung, and kidney of septic mice.  Importantly, we found that PTUPB treatment suppressed the activation of NLRP3 inflammasome in the liver and lung of septic mice.  Meanwhile, we found that PTUPB attenuated the oxidative stress, which contributed to the activation of NLRP3 inflammasome.  Altogether, our data, for the first time, demonstrate that dual inhibition of COX-2 and sEH with PTUPB ameliorates the multiple organ dysfunction in septic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkHstn3Uty0rVg90H21EOLACvtfcHk0lioO82sLf7MYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFejsrk%253D&md5=75cd4f705fedbcdf7b2a21dc0782b3f6</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2020.109907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2020.109907%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BF.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DXiong%26aufirst%3DJ.%2BB.%26aulast%3DZhong%26aufirst%3DW.%2BJ.%26aulast%3DZu%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26atitle%3DA%2520COX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520ameliorates%2520cecal%2520ligation%2520and%2520puncture-induced%2520sepsis%2520in%2520mice%2520via%2520anti-inflammation%2520and%2520anti-oxidative%2520stress%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2020%26volume%3D126%26spage%3D109907%26doi%3D10.1016%2Fj.biopha.2020.109907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, C. X.</span></span> <span> </span><span class="NLM_article-title">COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1111/febs.15105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Ffebs.15105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31646730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFaku77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2020&pages=1666-1680&author=C.+Y.+Zhangauthor=J.+X.+Duanauthor=H.+H.+Yangauthor=C.+C.+Sunauthor=W.+J.+Zhongauthor=J.+H.+Taoauthor=X.+X.+Guanauthor=H.+L.+Jiangauthor=B.+D.+Hammockauthor=S.+H.+Hwangauthor=Y.+Zhouauthor=C.+X.+Guan&title=COX-2%2FsEH+dual+inhibitor+PTUPB+alleviates+bleomycin-induced+pulmonary+fibrosis+in+mice+via+inhibiting+senescence&doi=10.1111%2Ffebs.15105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence</span></div><div class="casAuthors">Zhang, Chen-Yu; Duan, Jia-Xi; Yang, Hui-Hui; Sun, Chen-Chen; Zhong, Wen-Jing; Tao, Jia-Hao; Guan, Xin-Xin; Jiang, Hui-Ling; Hammock, Bruce D.; Hwang, Sung Hee; Zhou, Yong; Guan, Cha-Xiang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1666-1680</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pulmonary fibrosis (PF) is a senescence-assocd. disease with poor prognosis.  Currently, there is no effective therapeutic strategy for preventing and treating the disease process.  Mounting evidence suggests that arachidonic acid (ARA) metabolites are involved in the pathogenesis of various fibrosis.  However, the relationship between the metab. of ARA and PF is still elusive.  In this study, we obsd. a disorder in the cyclooxygenase-2/cytochrome P 450 (COX-2/CYP) metab. of ARA in the lungs of PF mice induced by bleomycin (BLM).  Therefore, we aimed to explore the role of COX-2/CYP-derived ARA metabolic disorders in PF.  PTUPB, a dual COX-2 and sol. epoxide hydrolase (sEH) inhibitor, was used to restore the balance of COX-2/CYP metab. sEH is an enzyme hydrolyzing epoxyeicosatrienoic acids derived from ARA by CYP.  We found that PTUPB alleviated the pathol. changes in lung tissue and collagen deposition, as well as reduced senescence marker mols. (p16Ink4a and p53-p21Waf1/Cip1) in the lungs of mice treated by BLM.  In vitro, we found that PTUPB pretreatment remarkably reduced the expression of senescence-related mols. in the alveolar epithelial cells (AECs) induced by BLM.  In conclusion, our study supports the notion that the COX-2/CYP-derived ARA metabolic disorders may be a potential therapeutic target for PF via inhibiting the cellular senescence in AECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpWBjLnA38k7Vg90H21EOLACvtfcHk0lioO82sLf7MYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFaku77J&md5=4f5e7ee2ac5db669455c6133e17b418e</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Ffebs.15105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.15105%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BY.%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DYang%26aufirst%3DH.%2BH.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DZhong%26aufirst%3DW.%2BJ.%26aulast%3DTao%26aufirst%3DJ.%2BH.%26aulast%3DGuan%26aufirst%3DX.%2BX.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DC.%2BX.%26atitle%3DCOX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520alleviates%2520bleomycin-induced%2520pulmonary%2520fibrosis%2520in%2520mice%2520via%2520inhibiting%2520senescence%26jtitle%3DFEBS%2520J.%26date%3D2020%26volume%3D287%26spage%3D1666%26epage%3D1680%26doi%3D10.1111%2Ffebs.15105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakkappa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamjala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2017.11.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.jpba.2017.11.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29169114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=457-464&author=N.+Lakkappaauthor=P.+T.+Krishnamurthyauthor=K.+Yamjalaauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=B.+Babu&title=Evaluation+of+antiparkinson+activity+of+PTUPB+by+measuring+dopamine+and+its+metabolites+in+Drosophila+melanogaster%3A+LC-MS%2FMS+method+development&doi=10.1016%2Fj.jpba.2017.11.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development</span></div><div class="casAuthors">Lakkappa, Navya; Krishnamurthy, Praveen T.; Yamjala, Karthik; Hwang, Sung Hee; Hammock, Bruce D.; Babu, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">457-464</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) inhibition is reported to elevate endogenous epoxyeicosatrienoic acids (EET's), which are known to play an important role in neuroprotection by inhibiting oxidative stress and neuroinflammation.  In the present study, PTUPB, a dual inhibitor of sEH and COX-2, has been tested for its antiparkinson activity against rotenone (ROT) induced neurodegeneration in Drosophila model of Parkinson's disease (PD).  To det. the efficacy and brain bioavailability of PTUPB a simple, rapid and sensitive LC-MS/MS method was developed and validated for the estn. of PTUPB (Method-I), dopamine (DA) and its metabolites (Method-II) in fly head.  Mass spectrometric acquisitions of analytes signals were performed in pos. and neg. electron spray ionization MRM mode by monitoring the daughter ions.  The isocratic elution using formic acid (0.1% vol./vol.) and acetonitrile (20:80 vol./vol.) (for method I), and acetic acid (0.1% vol./vol.) and methanol (for method II) on Jones C18 was carried out to achieve the sepn.  The results of brain PTUPB, DA and its metabolites estn. shows a dose dependent increase in PTUPB concn. and a dose dependent prevention of ROT induced changes in DA and its metabolites levels (p < 0.05), indicating a significant neuroprotection activity of PTUPB.  In the present study, the authors have successfully developed and validated LC-MS/MS methods to identify and quantify PTUPB, DA and its metabolites using a UFLC-ESI-QqQ mass spectrometer for the screening of neuroprotective agents in Drosophila Melanogaster.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFJ7KK-XDYu7Vg90H21EOLACvtfcHk0lgw-dSAa70lZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrsb7E&md5=bbde36476ec5fe6778a7740032fbb29b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2017.11.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2017.11.043%26sid%3Dliteratum%253Aachs%26aulast%3DLakkappa%26aufirst%3DN.%26aulast%3DKrishnamurthy%26aufirst%3DP.%2BT.%26aulast%3DYamjala%26aufirst%3DK.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBabu%26aufirst%3DB.%26atitle%3DEvaluation%2520of%2520antiparkinson%2520activity%2520of%2520PTUPB%2520by%2520measuring%2520dopamine%2520and%2520its%2520metabolites%2520in%2520Drosophila%2520melanogaster%253A%2520LC-MS%252FMS%2520method%2520development%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2018%26volume%3D149%26spage%3D457%26epage%3D464%26doi%3D10.1016%2Fj.jpba.2017.11.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">87353</span>– <span class="NLM_lpage">87363</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.18632%2Foncotarget.20928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29152086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1M3is1CjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=87353-87363&author=J.+Liauthor=Y.+Zhouauthor=H.+Wangauthor=Y.+Gaoauthor=L.+Liauthor=S.+H.+Hwangauthor=X.+Jiauthor=B.+D.+Hammock&title=COX-2%2FsEH+dual+inhibitor+PTUPB+suppresses+glioblastoma+growth+by+targeting+epidermal+growth+factor+receptor+and+hyaluronan+mediated+motility+receptor&doi=10.18632%2Foncotarget.20928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor</span></div><div class="casAuthors">Li Junyang; Zhou Yali; Wang Handong; Gao Yongyue; Li Liwen; Ji Xiangjun; Hwang Sung Hee; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">87353-87363</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aims:  Cyclooxygenase-2 (COX-2)/soluble epoxide hydrolase (sEH) dual inhibitor, PTUPB, has been demonstrated to inhibit angiogenesis, primary tumor growth and metastasis.  The aim of this study is to investigate the effects of PTUPB on glioblastoma cells and xenograft model.  Results:  We show here that PTUPB inhibits glioblastoma cell proliferation and G1 phase cell cycle arrest in vitro, and suppresses the tumor growth and angiogenesis in vivo.  The expression and activation of epidermal growth factor receptor (EGFR) and its downstream kinases, ERK1/2 and AKT, are reduced by PTUPB, indicating that the EGF/EGFR signaling pathway is a potential target.  Moreover, PTUPB dramatically suppresses expression of hyaluronan mediated motility receptor (HMMR) in the glioblastoma cell lines and xenograft mouse model, suggesting that the HMMR is the other potential target.  Materials and Methods:  Cellular immunofluorescence assays were used for cell staining of actin fibers and HMMR.  CCK-8 kit was used for cell proliferation assay.  Cell-cycle analysis was performed by flow cytometry.  Quantitative real-time PCR assay was performed to test mRNA level.  Western blot analysis was used to test protein expression.  Immunohistochemical staining assay was used for xenograft tumor tissue staining of Ki-67, CD31 and HMMR.  The SPSS version 17.0 software was applied for statistical analysis.  Conclusions:  Our data demonstrate that PTUPB is a potential therapeutic agent to treat glioblastomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtczqLBkChQEwlCcfExbvbfW6udTcc2eZZK_zuZpq-4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3is1CjtA%253D%253D&md5=234bb48f0d09fa40cf925012af0c2aaf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20928%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DCOX-2%252FsEH%2520dual%2520inhibitor%2520PTUPB%2520suppresses%2520glioblastoma%2520growth%2520by%2520targeting%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520hyaluronan%2520mediated%2520motility%2520receptor%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D87353%26epage%3D87363%26doi%3D10.18632%2Foncotarget.20928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gartung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhatme, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielenberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurakowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span> <span> </span><span class="NLM_article-title">Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1073/pnas.1803999116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1803999116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30647111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVylsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=1698-1703&author=A.+Gartungauthor=J.+Yangauthor=V.+P.+Sukhatmeauthor=D.+R.+Bielenbergauthor=D.+Fernandesauthor=J.+Changauthor=B.+A.+Schmidtauthor=S.+H.+Hwangauthor=D.+Zurakowskiauthor=S.+Huangauthor=M.+W.+Kieranauthor=B.+D.+Hammockauthor=D.+Panigrahy&title=Suppression+of+chemotherapy-induced+cytokine%2Flipid+mediator+surge+and+ovarian+cancer+by+a+dual+COX-2%2FsEH+inhibitor&doi=10.1073%2Fpnas.1803999116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor</span></div><div class="casAuthors">Gartung, Allison; Yang, Jun; Sukhatme, Vikas P.; Bielenberg, Diane R.; Fernandes, Djanira; Chang, Jaimie; Schmidt, Birgitta A.; Hwang, Sung Hee; Zurakowski, David; Huang, Sui; Kieran, Mark W.; Hammock, Bruce D.; Panigrahy, Dipak</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1698-1703</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although chemotherapy is a conventional cancer treatment, it may induce a protumorigenic microenvironment by triggering the release of proinflammatory mediators.  In this study, we demonstrate that ovarian tumor cell debris generated by first-line platinum- and taxane-based chemotherapy accelerates tumor progression by stimulating a macrophage-derived "surge" of proinflammatory cytokines and bioactive lipids.  Thus, targeting a single inflammatory mediator or pathway is unlikely to prevent therapy-induced tumor progression.  Here, we show that combined pharmacol. abrogation of the cyclooxygenase-2 (COX-2) and sol. epoxide hydrolase (sEH) pathways prevented the debris-induced surge of both cytokines and lipid mediators by macrophages.  In animal models, the dual COX-2/sEH inhibitor PTUPB delayed the onset of debris-stimulated ovarian tumor growth and ascites leading to sustained survival over 120 days postinjection.  Therefore, dual inhibition of COX-2/sEH may be an approach to suppress debris-stimulated ovarian tumor growth by preventing the therapy-induced surge of cytokines and lipid mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-do9HWwkQRrVg90H21EOLACvtfcHk0ljXhE6NayXOrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVylsLk%253D&md5=0fc650b42181286a0efaefc882efe214</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803999116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803999116%26sid%3Dliteratum%253Aachs%26aulast%3DGartung%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26aulast%3DBielenberg%26aufirst%3DD.%2BR.%26aulast%3DFernandes%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DB.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZurakowski%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPanigrahy%26aufirst%3DD.%26atitle%3DSuppression%2520of%2520chemotherapy-induced%2520cytokine%252Flipid%2520mediator%2520surge%2520and%2520ovarian%2520cancer%2520by%2520a%2520dual%2520COX-2%252FsEH%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D1698%26epage%3D1703%26doi%3D10.1073%2Fpnas.1803999116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meirer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glatzel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and cellular characterization of a dual inhibitor of 5-lipoxygenase and soluble epoxide hydrolase</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3390/molecules22010045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fmolecules22010045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=45&author=K.+Meirerauthor=D.+Glatzelauthor=S.+Kretschmerauthor=S.+K.+Wittmannauthor=M.+Hartmannauthor=R.+Bl%C3%B6cherauthor=C.+Angioniauthor=G.+Geisslingerauthor=D.+Steinhilberauthor=B.+Hofmannauthor=R.+F%C3%BCrstauthor=E.+Proschak&title=Design%2C+synthesis+and+cellular+characterization+of+a+dual+inhibitor+of+5-lipoxygenase+and+soluble+epoxide+hydrolase&doi=10.3390%2Fmolecules22010045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and cellular characterization of a dual inhibitor of 5-lipoxygenase and soluble epoxide hydrolase</span></div><div class="casAuthors">Meirer, Karin; Glatzel, Daniel; Kretschmer, Simon; Wittmann, Sandra K.; Hartmann, Markus; Bloecher, Rene; Angioni, Carlo; Geisslinger, Gerd; Steinhilber, Dieter; Hofmann, Bettina; Fuerst, Robert; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45/1-45/10</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A novel prototype of a dual 5-lipoxygenase (5-LO)/sol. epoxide hydrolase inhibitor (I) was rationally designed and synthesized.  Compd. I was evaluated in enzyme activity assays with recombinant enzymes.  Furthermore, activity of compd. I in human whole blood and endothelial cells was investigated.  Compd. I potently inhibited both enzymes in-vitro and attenuated the formation of leukotrienes in human whole blood.  Compd. I was also tested in a cell function-based assay.  Compd. I significantly inhibited the LPS-induced adhesion of leukocytes to endothelial cells by blocking leukocyte activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkS9gBTWQ-LVg90H21EOLACvtfcHk0lj2TYae-wzGKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlWntrc%253D&md5=24c1b299a3d583a6771c9f8fe1f94f50</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22010045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22010045%26sid%3Dliteratum%253Aachs%26aulast%3DMeirer%26aufirst%3DK.%26aulast%3DGlatzel%26aufirst%3DD.%26aulast%3DKretschmer%26aufirst%3DS.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%2520and%2520cellular%2520characterization%2520of%2520a%2520dual%2520inhibitor%2520of%25205-lipoxygenase%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D45%26doi%3D10.3390%2Fmolecules22010045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewska, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buscató, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1021/ml200286e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200286e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=155-158&author=D.+Moserauthor=J.+M.+Wisniewskaauthor=S.+Hahnauthor=J.+Achenbachauthor=E.+L.+Buscat%C3%B3author=F.+M.+Klinglerauthor=B.+Hofmannauthor=D.+Steinhilberauthor=E.+Proschak&title=Dual-target+virtual+screening+by+pharmacophore+elucidation+and+molecular+shape+filtering&doi=10.1021%2Fml200286e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Target Virtual Screening by Pharmacophore Elucidation and Molecular Shape Filtering</span></div><div class="casAuthors">Moser, Daniel; Wisniewska, Joanna M.; Hahn, Steffen; Achenbach, Janosch; Buscato, Estella; Klingler, Franca-Maria; Hofmann, Bettina; Steinhilber, Dieter; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-158</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual-target inhibitors gained increased attention in the past years.  A novel in silico approach was employed for the discovery of dual 5-lipoxygenase/sol. epoxide hydrolase inhibitors.  The ligand-based approach uses excessive pharmacophore elucidation and pharmacophore alignment in conjunction with shape-based scoring.  The virtual screening results were verified in vitro, leading to nine novel inhibitors including a dual-target compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUfWwnhy-PbVg90H21EOLACvtfcHk0lj2TYae-wzGKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWqtA%253D%253D&md5=c3b1f98838976f54cc1a38c82096443d</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fml200286e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200286e%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DHahn%26aufirst%3DS.%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DBuscat%25C3%25B3%26aufirst%3DE.%2BL.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DDual-target%2520virtual%2520screening%2520by%2520pharmacophore%2520elucidation%2520and%2520molecular%2520shape%2520filtering%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D155%26epage%3D158%26doi%3D10.1021%2Fml200286e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häfner, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rödl, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Löhr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Exploring the chemical space of multitarget ligands using aligned self-organizing maps</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1021/ml4002562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kkt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1169-1172&author=J.+Achenbachauthor=F.+M.+Klinglerauthor=R.+Bl%C3%B6cherauthor=D.+Moserauthor=A.+K.+H%C3%A4fnerauthor=C.+B.+R%C3%B6dlauthor=S.+Kretschmerauthor=B.+Kr%C3%BCgerauthor=F.+L%C3%B6hrauthor=H.+Starkauthor=B.+Hofmannauthor=D.+Steinhilberauthor=E.+Proschak&title=Exploring+the+chemical+space+of+multitarget+ligands+using+aligned+self-organizing+maps&doi=10.1021%2Fml4002562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the Chemical Space of Multitarget Ligands Using Aligned Self-Organizing Maps</span></div><div class="casAuthors">Achenbach, Janosch; Klingler, Franca-Maria; Bloecher, Rene; Moser, Daniel; Haefner, Ann-Kathrin; Roedl, Carmen B.; Kretschmer, Simon; Krueger, Bjoern; Loehr, Frank; Stark, Holger; Hofmann, Bettina; Steinhilber, Dieter; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1169-1172</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Design of multitarget drugs and polypharmacol. compds. has become popular during the past decade.  However, the main approach to design such compds. is to link two selective ligands via a flexible linker.  Although such chimeric ligands often have reasonable potency in vitro, the in vivo efficacy is low due to high mol. wt., low ligand efficiency, and poor pharmacokinetic profile.  We developed an unprecedented in silico approach for fragment-based design of multitarget ligands.  It relies on superposition of the chem. spaces related to the affinity on single targets represented by self-organizing maps.  We used this approach for screening of mol. fragments, which bind to the enzymes 5-lipoxygenase (5-LO) and sol. epoxide hydrolase (sEH).  Using STD-NMR and activity-based assays, we were able to identify fragments binding to both targets.  Furthermore, we were able to expand one of the fragments to a potent dual inhibitor bearing a reasonable mol. wt. (MW = 446) and high affinity to both targets (IC50 of 0.03 μM toward 5-LO and 0.17 μM toward sEH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp120TeMy83c7Vg90H21EOLACvtfcHk0li6QVjbiJkW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kkt7fL&md5=4231074e150dd7db7b92242d4c1664ff</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fml4002562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002562%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DKlingler%26aufirst%3DF.%2BM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DH%25C3%25A4fner%26aufirst%3DA.%2BK.%26aulast%3DR%25C3%25B6dl%26aufirst%3DC.%2BB.%26aulast%3DKretschmer%26aufirst%3DS.%26aulast%3DKr%25C3%25BCger%26aufirst%3DB.%26aulast%3DL%25C3%25B6hr%26aufirst%3DF.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DExploring%2520the%2520chemical%2520space%2520of%2520multitarget%2520ligands%2520using%2520aligned%2520self-organizing%2520maps%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1169%26epage%3D1172%26doi%3D10.1021%2Fml4002562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nandha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramareddy, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuntal, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>351</i></span>, <span class="NLM_elocation-id">1800030</span> <span class="refDoi"> DOI: 10.1002/ardp.201800030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fardp.201800030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2018&author=B.+Nandhaauthor=S.+A.+Ramareddyauthor=H.+Kuntal&title=Synthesis+of+substituted+fluorobenzimidazoles+as+inhibitors+of+5-lipoxygenase+and+soluble+epoxide+hydrolase+for+anti-inflammatory+activity&doi=10.1002%2Fardp.201800030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fardp.201800030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201800030%26sid%3Dliteratum%253Aachs%26aulast%3DNandha%26aufirst%3DB.%26aulast%3DRamareddy%26aufirst%3DS.%2BA.%26aulast%3DKuntal%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520substituted%2520fluorobenzimidazoles%2520as%2520inhibitors%2520of%25205-lipoxygenase%2520and%2520soluble%2520epoxide%2520hydrolase%2520for%2520anti-inflammatory%2520activity%26jtitle%3DArch.%2520Pharm.%26date%3D2018%26volume%3D351%26doi%3D10.1002%2Fardp.201800030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klegeris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeer, P. L.</span></span> <span> </span><span class="NLM_article-title">Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1189/jlb.1002482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1189%2Fjlb.1002482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12629151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=369-378&author=A.+Klegerisauthor=P.+L.+McGeer&title=Toxicity+of+human+monocytic+THP-1+cells+and+microglia+toward+SH-SY5Y+neuroblastoma+cells+is+reduced+by+inhibitors+of+5-lipoxygenase+and+its+activating+protein+FLAP&doi=10.1189%2Fjlb.1002482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP</span></div><div class="casAuthors">Klegeris, Andis; McGeer, Patrick L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-378</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">To explore whether the proinflammatory products of the 5-lipoxygenase (5-LOX) pathway are involved in microglia-mediated toxicity toward neuronal cells, we evaluated the effects of 5-LOX inhibitors using an in vitro assay system where human neuronal SH-SY5Y cells are exposed to toxic secretions from THP-1 monocytic cells or human microglia.  The specific 5-LOX inhibitors, REV 5901, zileuton, and 5-hydroxyeicosatetraenoic acid lactone; the nonselective LOX inhibitors, phenidone and dapsone; the dual 5-LOX/cyclooxygenase inhibitor, tepoxalin; and the selective inhibitor of the 5-LOX-activating protein (FLAP), MK-886, inhibited such toxicity.  The toxicity was enhanced by the 5-LOX product leukotriene (LT)D4 and reduced by the selective cysteinyl LT receptor (CysLT1) antagonist MK-571.  The mRNAs for 5-LOX and FLAP were detected in THP-1 cells and human microglia but not in SH-SY5Y cells.  The data suggest that inhibition of proinflammatory LT prodn. by 5-LOX inhibition could selectively reduce toxicity of microglial cells and thus be beneficial in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4lbvgfThT7Vg90H21EOLACvtfcHk0li6QVjbiJkW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCgtLc%253D&md5=7c9ce845548c856db4e6b86137ac41f3</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1189%2Fjlb.1002482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.1002482%26sid%3Dliteratum%253Aachs%26aulast%3DKlegeris%26aufirst%3DA.%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26atitle%3DToxicity%2520of%2520human%2520monocytic%2520THP-1%2520cells%2520and%2520microglia%2520toward%2520SH-SY5Y%2520neuroblastoma%2520cells%2520is%2520reduced%2520by%2520inhibitors%2520of%25205-lipoxygenase%2520and%2520its%2520activating%2520protein%2520FLAP%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2003%26volume%3D73%26spage%3D369%26epage%3D378%26doi%3D10.1189%2Fjlb.1002482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kent, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamant, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saggu, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, S.</span></span> <span> </span><span class="NLM_article-title">The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma</span>. <i>Clin. Exp. Allergy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1111/cea.12002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fcea.12002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23331559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Chtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=177-186&author=S.+E.+Kentauthor=M.+Boyceauthor=Z.+Diamantauthor=D.+Singhauthor=B.+J.+O%E2%80%99Connorauthor=P.+S.+Sagguauthor=S.+Norris&title=The+5-lipoxygenase-activating+protein+inhibitor%2C+GSK2190915%2C+attenuates+the+early+and+late+responses+to+inhaled+allergen+in+mild+asthma&doi=10.1111%2Fcea.12002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma</span></div><div class="casAuthors">Kent, S. E.; Boyce, M.; Diamant, Z.; Singh, D.; O'Connor, B. J.; Saggu, P. S.; Norris, V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Allergy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">CLEAEN</span>;
        ISSN:<span class="NLM_cas:issn">0954-7894</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">GSK2190915, a potent 5-lipoxygenase-activating protein inhibitor, prevents the synthesis of leukotrienes and 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE).  To assess the effect of GSK2190915 on the allergen-induced asthmatic responses.  Nineteen eligible male subjects with mild asthma were enrolled in and completed this four-center, double-blind, two-way crossover study (ClinicalTrials.gov NCT00748306).  Subjects took GSK2190915 100 mg and placebo orally once daily for 5 days in randomized order.  On Day 1 and 4 they had a methacholine challenge, on Day 3 they had an inhaled allergen challenge, and on Days 4 and 6 they had sputum induction.  GSK2190915 attenuated the early (0-2 h) and late (4-10 h) asthmatic responses to inhaled allergen compared with placebo.  There was a statistically significant attenuation of the early asthmatic response (EAR) by GSK2190915; treatment difference of GSK2190915 vs. placebo for the min. FEV1 EAR was 0.408 L (0.205, 0.611).  There was a statistically significant attenuation of the late asthmatic response (LAR) by GSK2190915; the treatment difference of GSK2190915 vs. placebo for the min. FEV1 LAR was 0.229 L (0.041, 0.417).  There was a statistically significant attenuation of allergen-induced sputum eosinophil count on Day 4 following GSK2190915: mean treatment difference (95% CI) between GSK2190915 and placebo was -9.95% (-18.15%, -1.77%).  Compared with placebo, GSK2190915 100 mg reduced median sputum LTB4 by > 90% on Days 4 and 6.  There was no effect on methacholine PC20 post allergen.  GSK2190915 was generally well tolerated.  GSK2190915 shows potential as a treatment for patients with asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXmDUnaRPW2bVg90H21EOLACvtfcHk0lh9xuQk0Wc8Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Chtr0%253D&md5=22e222700ebee90a001fa921342ff500</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1111%2Fcea.12002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcea.12002%26sid%3Dliteratum%253Aachs%26aulast%3DKent%26aufirst%3DS.%2BE.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DDiamant%26aufirst%3DZ.%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BJ.%26aulast%3DSaggu%26aufirst%3DP.%2BS.%26aulast%3DNorris%26aufirst%3DS.%26atitle%3DThe%25205-lipoxygenase-activating%2520protein%2520inhibitor%252C%2520GSK2190915%252C%2520attenuates%2520the%2520early%2520and%2520late%2520responses%2520to%2520inhaled%2520allergen%2520in%2520mild%2520asthma%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2013%26volume%3D43%26spage%3D177%26epage%3D186%26doi%3D10.1111%2Fcea.12002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bcp.2009.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19896470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=880-887&author=J.+Y.+Liuauthor=J.+Yangauthor=B.+Inceogluauthor=H.+Qiuauthor=A.+Uluauthor=S.+H.+Hwangauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=Inhibition+of+soluble+epoxide+hydrolase+enhances+the+anti-inflammatory+effects+of+aspirin+and+5-lipoxygenase+activation+protein+inhibitor+in+a+murine+model&doi=10.1016%2Fj.bcp.2009.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model</span></div><div class="casAuthors">Liu, Jun-Yan; Yang, Jun; Inceoglu, Bora; Qiu, Hong; Ulu, Arzu; Hwang, Sung-Hee; Chiamvimonvat, Nipavan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">880-887</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inflammation is a multi-staged process whose expansive phase is thought to be driven by acutely released arachidonic acid (AA) and its metabolites.  Inhibition of cyclooxygenase (COX), lipoxygenase (LOX), or sol. epoxide hydrolase (sEH) is known to be anti-inflammatory.  Inhibition of sEH stabilizes the cytochrome P 450 (CYP450) products epoxyeicosatrienoic acids (EETs).  Here we used a non-selective COX inhibitor aspirin, a 5-lipoxygenase activation protein (FLAP) inhibitor MK886, and a sEH inhibitor t-AUCB to selectively modulate the branches of AA metab. in a lipopolysaccharide (LPS)-challenged murine model.  We used metabolomic profiling to simultaneously monitor representative AA metabolites of each branch.  In addn. to the significant crosstalk among branches of the AA cascade during selective modulation of COX, LOX, or sEH, we demonstrated that co-administration of t-AUCB enhanced the anti-inflammatory effects of aspirin or MK886, which was evidenced by the observations that co-administration resulted in favorable eicosanoid profiles and better control of LPS-mediated hypotension as well as hepatic protein expression of COX-2 and 5-LOX.  Targeted disruption of the sEH gene displayed a parallel profile to that produced by t-AUCB.  These observations demonstrate a significant level of crosstalk among the three major branches of the AA cascade and that they are not simply parallel pathways.  These data illustrate that inhibition of sEH by both pharmacol. intervention and gene knockout enhances the anti-inflammatory effects of aspirin and MK886, suggesting the possibility of modulating multiple branches to achieve better therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNys3Qohu2SbVg90H21EOLACvtfcHk0lh9xuQk0Wc8Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFGjsA%253D%253D&md5=b2c07c47ac46c982c996c4a7e136ebdb</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DUlu%26aufirst%3DA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520enhances%2520the%2520anti-inflammatory%2520effects%2520of%2520aspirin%2520and%25205-lipoxygenase%2520activation%2520protein%2520inhibitor%2520in%2520a%2520murine%2520model%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D880%26epage%3D887%26doi%3D10.1016%2Fj.bcp.2009.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garscha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temml, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstmeier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liening, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinigel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scriba, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautebin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">9398</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-09795-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fs41598-017-09795-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28839250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1cbhsVOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=9398&author=U.+Garschaauthor=E.+Rompauthor=S.+Paceauthor=A.+Rossiauthor=V.+Temmlauthor=D.+Schusterauthor=S.+K%C3%B6nigauthor=J.+Gerstmeierauthor=S.+Lieningauthor=M.+Wernerauthor=H.+Atzeauthor=S.+Wittmannauthor=C.+Weinigelauthor=S.+Rummlerauthor=G.+K.+Scribaauthor=L.+Sautebinauthor=O.+Werz&title=Pharmacological+profile+and+efficiency+in+vivo+of+diflapolin%2C+the+first+dual+inhibitor+of+5-lipoxygenase-activating+protein+and+soluble+epoxide+hydrolase&doi=10.1038%2Fs41598-017-09795-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase</span></div><div class="casAuthors">Garscha Ulrike; Romp Erik; Pace Simona; Konig Stefanie; Gerstmeier Jana; Liening Stefanie; Werner Markus; Atze Heiner; Scriba Gerhard K; Werz Oliver; Rossi Antonietta; Sautebin Lidia; Temml Veronika; Schuster Daniela; Wittmann Sandra; Weinigel Christina; Rummler Silke</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9398</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Arachidonic acid (AA) is metabolized to diverse bioactive lipid mediators.  Whereas the 5-lipoxygenase-activating protein (FLAP) facilitates AA conversion by 5-lipoxygenase (5-LOX) to pro-inflammatory leukotrienes (LTs), the soluble epoxide hydrolase (sEH) degrades anti-inflammatory epoxyeicosatrienoic acids (EETs).  Accordingly, dual FLAP/sEH inhibition might be advantageous drugs for intervention of inflammation.  We present the in vivo pharmacological profile and efficiency of N-[4-(benzothiazol-2-ylmethoxy)-2-methylphenyl]-N'-(3,4-dichlorophenyl)urea (diflapolin) that dually targets FLAP and sEH.  Diflapolin inhibited 5-LOX product formation in intact human monocytes and neutrophils with IC50 = 30 and 170 nM, respectively, and suppressed the activity of isolated sEH (IC50 = 20 nM).  Characteristic for FLAP inhibitors, diflapolin (I) failed to inhibit isolated 5-LOX, (II) blocked 5-LOX product formation in HEK cells only when 5-LOX/FLAP was co-expressed, (III) lost potency in intact cells when exogenous AA was supplied, and (IV) prevented 5-LOX/FLAP complex assembly in leukocytes.  Diflapolin showed target specificity, as other enzymes related to AA metabolism (i.e., COX1/2, 12/15-LOX, LTA4H, LTC4S, mPGES1, and cPLA2) were not inhibited.  In the zymosan-induced mouse peritonitis model, diflapolin impaired vascular permeability, inhibited cysteinyl-LTs and LTB4 formation, and suppressed neutrophil infiltration.  Diflapolin is a highly active dual FLAP/sEH inhibitor in vitro and in vivo with target specificity to treat inflammation-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxLyW0tp5b8IvKgEt20y1XfW6udTcc2eZJSrCbyxQnlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbhsVOntw%253D%253D&md5=d6c11708cd9ac8cba4d2828b9d7ce6d9</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-09795-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-09795-w%26sid%3Dliteratum%253Aachs%26aulast%3DGarscha%26aufirst%3DU.%26aulast%3DRomp%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DS.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DTemml%26aufirst%3DV.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DK%25C3%25B6nig%26aufirst%3DS.%26aulast%3DGerstmeier%26aufirst%3DJ.%26aulast%3DLiening%26aufirst%3DS.%26aulast%3DWerner%26aufirst%3DM.%26aulast%3DAtze%26aufirst%3DH.%26aulast%3DWittmann%26aufirst%3DS.%26aulast%3DWeinigel%26aufirst%3DC.%26aulast%3DRummler%26aufirst%3DS.%26aulast%3DScriba%26aufirst%3DG.%2BK.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DWerz%26aufirst%3DO.%26atitle%3DPharmacological%2520profile%2520and%2520efficiency%2520in%2520vivo%2520of%2520diflapolin%252C%2520the%2520first%2520dual%2520inhibitor%2520of%25205-lipoxygenase-activating%2520protein%2520and%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D9398%26doi%3D10.1038%2Fs41598-017-09795-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vieider, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temml, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garscha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszczak, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and structure-activity relationships of diflapolin analogues as dual sEH/FLAP inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlOksL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=62-66&author=L.+Vieiderauthor=E.+Rompauthor=V.+Temmlauthor=J.+Fischerauthor=C.+Kretzerauthor=M.+Schoenthalerauthor=A.+Tahaauthor=V.+Hern%C3%A1ndez-Olmosauthor=S.+Sturmauthor=D.+Schusterauthor=O.+Werzauthor=U.+Garschaauthor=B.+Matuszczak&title=Synthesis%2C+biological+evaluation+and+structure-activity+relationships+of+diflapolin+analogues+as+dual+sEH%2FFLAP+inhibitors&doi=10.1021%2Facsmedchemlett.8b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors</span></div><div class="casAuthors">Vieider, Lisa; Romp, Erik; Temml, Veronika; Fischer, Jana; Kretzer, Christian; Schoenthaler, Martin; Taha, Abdulla; Hernandez-Olmos, Victor; Sturm, Sonja; Schuster, Daniela; Werz, Oliver; Garscha, Ulrike; Matuszczak, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-66</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of derivs. of the potent dual sol. epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesized, and characterized by 1H NMR, 13C NMR, and elemental anal.  These novel compds. were biol. evaluated for their inhibitory activity against sEH and FLAP.  Mol. modeling tools were applied to analyze structure-activity relationships (SAR) on both targets.  Results show that even small modifications on the lead compd. diflapolin markedly influence the inhibitory potential, esp. on FLAP, suggesting very narrow SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptGWh-lGghCLVg90H21EOLACvtfcHk0liqi3McuUsQsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlOksL7M&md5=78cba7e08adb5604350570d2a61d5e79</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00415%26sid%3Dliteratum%253Aachs%26aulast%3DVieider%26aufirst%3DL.%26aulast%3DRomp%26aufirst%3DE.%26aulast%3DTemml%26aufirst%3DV.%26aulast%3DFischer%26aufirst%3DJ.%26aulast%3DKretzer%26aufirst%3DC.%26aulast%3DSchoenthaler%26aufirst%3DM.%26aulast%3DTaha%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez-Olmos%26aufirst%3DV.%26aulast%3DSturm%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DGarscha%26aufirst%3DU.%26aulast%3DMatuszczak%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520structure-activity%2520relationships%2520of%2520diflapolin%2520analogues%2520as%2520dual%2520sEH%252FFLAP%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D62%26epage%3D66%26doi%3D10.1021%2Facsmedchemlett.8b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Design and potency of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">14076</span>– <span class="NLM_lpage">14086</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b01625</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b01625" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFymsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=14076-14086&author=S.+D.+Kodaniauthor=D.+Wanauthor=K.+M.+Wagnerauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Design+and+potency+of+dual+soluble+epoxide+hydrolase%2Ffatty+acid+amide+hydrolase+inhibitors&doi=10.1021%2Facsomega.8b01625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors</span></div><div class="casAuthors">Kodani, Sean D.; Wan, Debin; Wagner, Karen M.; Hwang, Sung Hee; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">14076-14086</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is responsible for regulating concns. of the endocannabinoid arachidonoyl ethanolamide (AEA).  Multiple FAAH inhibitors have been developed for clin. trials and have failed to demonstrate efficacy at treating pain, despite promising preclin. data.  One approach towards increasing the efficacy of FAAH inhibitors is to concurrently inhibit other targets responsible for regulating pain.  Here, the authors designed dual inhibitors targeting the enzymes FAAH and sol. epoxide hydrolase (sEH), which are targets previously shown to synergize at reducing inflammatory and neuropathic pain.  Exploration of the sEH/FAAH inhibitor structure activity relationship started with PF-750, a FAAH inhibitor (IC50 = 19 nM) that weakly inhibited sEH (IC50 = 640 nM).  Potency was optimized resulting in an inhibitor with improved potency on both targets (11, sEH IC50 = 5 nM, FAAH IC50 = 8 nM).  This inhibitor demonstrated good target selectivity, pharmacokinetic properties (AUC = 1200 h*nM, t1/2=4.9 h in mice) and in vivo target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7TM5odPLPg7Vg90H21EOLACvtfcHk0liqi3McuUsQsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFymsrbN&md5=0d864e41ccf5c70800d399f89801d23e</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b01625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b01625%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DWan%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DK.%2BM.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDesign%2520and%2520potency%2520of%2520dual%2520soluble%2520epoxide%2520hydrolase%252Ffatty%2520acid%2520amide%2520hydrolase%2520inhibitors%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D14076%26epage%3D14086%26doi%3D10.1021%2Facsomega.8b01625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.phrs.2015.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25882247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslCqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=7-15&author=O.+Sassoauthor=K.+Wagnerauthor=C.+Morisseauauthor=B.+Inceogluauthor=B.+D.+Hammockauthor=D.+Piomelli&title=Peripheral+FAAH+and+soluble+epoxide+hydrolase+inhibitors+are+synergistically+antinociceptive&doi=10.1016%2Fj.phrs.2015.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive</span></div><div class="casAuthors">Sasso, Oscar; Wagner, Karen; Morisseau, Christophe; Inceoglu, Bora; Hammock, Bruce D.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-15</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We need better medicines to control acute and chronic pain.  Fatty acid amide hydrolase (FAAH) and sol. epoxide hydrolase (sEH) catalyze the deactivating hydrolysis of two classes of bioactive lipid mediators - fatty acid ethanolamides (FAEs) and epoxidized fatty acids (EpFAs), resp. - which are biogenetically distinct but share the ability to attenuate pain responses and inflammation.  In these expts., we evaluated the antihyperalgesic activity of small-mol. inhibitors of FAAH and sEH, administered alone or in combination, in two pain models: carrageenan-induced hyperalgesia in mice and streptozocin-induced allodynia in rats.  When administered sep., the sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea (TPPU) and the peripherally restricted FAAH inhibitor URB937 were highly active in the two models.  The combination TPPU plus URB937 was markedly synergistic, as assessed using isobolog. analyses.  The results of these expts. reveal the existence of a possible functional crosstalk between FAEs and EpFAs in regulating pain responses.  Addnl., the results suggest that combinations of sEH and FAAH inhibitors might be exploited therapeutically to achieve greater analgesic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KqHflti6UbVg90H21EOLACvtfcHk0ligPhSgRcPG2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslCqt7s%253D&md5=541ae75edcabea753005fafa96d3dc76</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPeripheral%2520FAAH%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520are%2520synergistically%2520antinociceptive%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D97%26spage%3D7%26epage%3D15%26doi%3D10.1016%2Fj.phrs.2015.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spector, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, A. W.</span></span> <span> </span><span class="NLM_article-title">Action of epoxyeicosatrienoic acids on cellular function</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">C996</span>– <span class="NLM_lpage">C1012</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00402.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpcell.00402.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16987999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFeqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C996-C1012&author=A.+A.+Spectorauthor=A.+W.+Norris&title=Action+of+epoxyeicosatrienoic+acids+on+cellular+function&doi=10.1152%2Fajpcell.00402.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Action of epoxyeicosatrienoic acids on cellular function</span></div><div class="casAuthors">Spector, Arthur A.; Norris, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">C996-C1012</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Epoxyeicosatrienoic acids (EETs), which function primarily as autocrine and paracrine mediators in the cardiovascular and renal systems, are synthesized from arachidonic acid by cytochrome P 450 epoxygenases.  They activate smooth muscle large-conductance Ca2+-activated K+ channels, producing hyperpolarization and vasorelaxation.  EETs also have anti-inflammatory effects in the vasculature and kidney, stimulate angiogenesis, and have mitogenic effects in the kidney.  Many of the functional effects of EETs occur through activation of signal transduction pathways and modulation of gene expression, events probably initiated by binding to a putative cell surface EET receptor.  However, EETs are rapidly taken up by cells and are incorporated into and released from phospholipids, suggesting that some functional effects may occur through a direct interaction between the EET and an intracellular effector system.  In this regard, EETs and several of their metabolites activate peroxisome proliferator-activated receptor α (PPARα) and PPARγ, suggesting that some functional effects may result from PPAR activation.  EETs are metabolized primarily by conversion to dihydroxyeicosatrienoic acids (DHETs), a reaction catalyzed by sol. epoxide hydrolase (sEH).  Many potentially beneficial actions of EETs are attenuated upon conversion to DHETs, which do not appear to be essential under routine conditions.  Therefore, sEH is considered a potential therapeutic target for enhancing the beneficial functions of EETs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYZxuyWlpL_LVg90H21EOLACvtfcHk0ligPhSgRcPG2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFeqs74%253D&md5=6ef20b6f3eefdcb1c54d62f1cb10904d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00402.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00402.2006%26sid%3Dliteratum%253Aachs%26aulast%3DSpector%26aufirst%3DA.%2BA.%26aulast%3DNorris%26aufirst%3DA.%2BW.%26atitle%3DAction%2520of%2520epoxyeicosatrienoic%2520acids%2520on%2520cellular%2520function%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC996%26epage%3DC1012%26doi%3D10.1152%2Fajpcell.00402.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hye Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian-Shaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span>. <i>Exp. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1258/ebm.2012.012225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1258%2Febm.2012.012225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=1402-1412&author=J.+D.+Imigauthor=K.+A.+Walshauthor=M.+A.+Hye+Khanauthor=T.+Nagasawaauthor=M.+Cherian-Shawauthor=S.+M.+Shawauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+and+peroxisome+proliferator+activated+receptor+%CE%B3+agonist+improve+vascular+function+and+decrease+renal+injury+in+hypertensive+obese+rats&doi=10.1258%2Febm.2012.012225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span></div><div class="casAuthors">Imig, John D.; Walsh, Katie A.; Abdul Hye Khan, Md; Nagasawa, Tasuku; Cherian-Shaw, Mary; Shaw, Sean M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1402-1412</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Cardiometabolic syndrome occurs with obesity and consists of pathophysiol. factors that increase the risk for cardiovascular events.  Sol. epoxide hydrolase inhibition (sEHi) is a novel therapeutic approach that exerts renal and cardiovascular protection.  Although sEHi as a therapeutic approach is promising, it could be more effective for the treatment of cardiometabolic syndrome when combined with peroxisome proliferator activated receptor γ (PPARγ) agonists.  We hypothesized that the PPARγ agonist, rosiglitazone in combination with a sEHi (tAUCB) will provide synergistic actions to decrease blood pressure, improve vascular function, decrease inflammation, and prevent renal damage in spontaneously hypertensive obese rats (SHROB).  SHROB were treated with rosiglitazone, tAUCB or the combination of tAUCB and rosiglitazone for four-weeks and compared with spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats.  Blood pressure increased in SHROB (164 ± 7 mmHg) and decreased 10 mmHg when treated with rosiglitazone, tAUCB, or tAUCB and rosiglitazone.  Mesenteric artery dilation to the KATP channel opener pinacidil was attenuated in SHROB (EMax = 77 ± 7%), compared with WKY (EMax = 115 ± 19) and SHR (EMax = 93 ± 12%).  Vasodilation to pinacidil was improved by rosiglitazone (EMax = 92 ± 14%) but not tAUCB.  Renal macrophage infiltration increased in SHROB and significantly decreased with rosiglitazone or tAUCB and rosiglitazone treatment.  Albuminuria was increased in SHROB (90 ± 20 mg/d) and was significantly decreased by the combination of tAUCB and rosiglitazone (37 ± 9 mg/d).  Glomerular injury in SHROB was also significantly decreased by tAUCB and rosiglitazone.  These results indicate that even though sEHi or PPARγ agonist have benefits when used individually, the combination is more beneficial for the multidisease features in cardiometabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq2SjZgeqAHrVg90H21EOLACvtfcHk0ljvxyWqN22j0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D&md5=d22fb0c9e2e8acf30dd6ce7614ad403c</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.012225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.012225%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DWalsh%26aufirst%3DK.%2BA.%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DCherian-Shaw%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DS.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520and%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%25CE%25B3%2520agonist%2520improve%2520vascular%2520function%2520and%2520decrease%2520renal%2520injury%2520in%2520hypertensive%2520obese%2520rats%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2012%26volume%3D237%26spage%3D1402%26epage%3D1412%26doi%3D10.1258%2Febm.2012.012225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggerhoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor gamma modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=61-81&author=R.+Blocherauthor=C.+Lamersauthor=S.+K.+Wittmannauthor=D.+Merkauthor=M.+Hartmannauthor=L.+Weizelauthor=O.+Diehlauthor=A.+Bruggerhoffauthor=M.+Bossauthor=A.+Kaiserauthor=T.+Schaderauthor=T.+Gobelauthor=M.+Grundmannauthor=C.+Angioniauthor=J.+Heeringauthor=G.+Geisslingerauthor=M.+Wurglicsauthor=E.+Kostenisauthor=B.+Bruneauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=A.+S.+Kahntauthor=E.+Proschak&title=N-Benzylbenzamides%3A+a+novel+merged+scaffold+for+orally+available+dual+soluble+epoxide+hydrolase%2Fperoxisome+proliferator-activated+receptor+gamma+modulators&doi=10.1021%2Facs.jmedchem.5b01239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators</span></div><div class="casAuthors">Blocher Rene; Lamers Christina; Wittmann Sandra K; Merk Daniel; Hartmann Markus; Weizel Lilia; Diehl Olaf; Bruggerhoff Astrid; Kaiser Astrid; Schader Tim; Gobel Tamara; Wurglics Mario; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Kahnt Astrid S; Proschak Ewgenij; Boss Marcel; Brune Bernhard; Grundmann Manuel; Kostenis Evi; Angioni Carlo; Geisslinger Gerd; Heering Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome (MetS) is a multifactorial disease cluster that consists of dyslipidemia, cardiovascular disease, type 2 diabetes mellitus, and obesity.  MetS patients are strongly exposed to polypharmacy; however, the number of pharmacological compounds required for MetS treatment can be reduced by the application of multitarget compounds.  This study describes the design of dual-target ligands that target soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type γ (PPARγ).  Simultaneous modulation of sEH and PPARγ can improve diabetic conditions and hypertension at once.  N-Benzylbenzamide derivatives were determined to fit a merged sEH/PPARγ pharmacophore, and structure-activity relationship studies were performed on both targets, resulting in a submicromolar (sEH IC50 = 0.3 μM/PPARγ EC50 = 0.3 μM) modulator 14c.  In vitro and in vivo evaluations revealed good ADME properties qualifying 14c as a pharmacological tool compound for long-term animal models of MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEKlCRcJ5_1JcXNb62YGmbfW6udTcc2eaY3itdO4K9v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D&md5=86c5861a77820ae8878382eae893b116</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01239%26sid%3Dliteratum%253Aachs%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DDiehl%26aufirst%3DO.%26aulast%3DBruggerhoff%26aufirst%3DA.%26aulast%3DBoss%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DGobel%26aufirst%3DT.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DBrune%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DN-Benzylbenzamides%253A%2520a%2520novel%2520merged%2520scaffold%2520for%2520orally%2520available%2520dual%2520soluble%2520epoxide%2520hydrolase%252Fperoxisome%2520proliferator-activated%2520receptor%2520gamma%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D61%26epage%3D81%26doi%3D10.1021%2Facs.jmedchem.5b01239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hye Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skibba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blocher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">A novel dual PPAR-gamma agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2235</span>– <span class="NLM_lpage">2246</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4685-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00125-018-4685-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30032428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2235-2246&author=M.+A.+Hye+Khanauthor=L.+Kolbauthor=M.+Skibbaauthor=M.+Hartmannauthor=R.+Blocherauthor=E.+Proschakauthor=J.+D.+Imig&title=A+novel+dual+PPAR-gamma+agonist%2FsEH+inhibitor+treats+diabetic+complications+in+a+rat+model+of+type+2+diabetes&doi=10.1007%2Fs00125-018-4685-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span></div><div class="casAuthors">Hye Khan, Md Abdul; Kolb, Lauren; Skibba, Melissa; Hartmann, Markus; Blocher, Rene; Proschak, Ewgenij; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2235-2246</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes.  The present study aims to evaluate a novel mol. with a dual action against the metabolic syndrome and type 2 diabetes.  Methods: We developed and tested a novel dual modulator, RB394, which acts as a sol. epoxide hydrolase (sEH) inhibitor and a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist in rat models of the metabolic syndrome-the obese spontaneously hypertensive (SHROB) rat and the obese diabetic Zucker fatty/spontaneously hypertensive heart failure F1 hybrid (ZSF1) rat.  In SHROB rats we studied the ability of RB394 to prevent metabolic syndrome phenotypes, while in ZSF1 obese diabetic rats we compared RB394 with the ACE inhibitor enalapril in the treatment of type 2 diabetes and assocd. comorbid conditions.  RB394 (10 mg/kg daily) and enalapril (10 mg/kg daily) were administered orally for 8 wk.  Results: RB394 blunted the development of hypertension, insulin resistance, hyperlipidemia and kidney injury in SHROB rats and reduced fasting blood glucose and HbA1c, improved glucose tolerance, reduced blood pressure and improved lipid profiles in obese ZSF1 rats.  A redn. in liver fibrosis and hepatosteatosis was evident in RB394-treated obese ZSF1 rats.  Unlike RB394, enalapril did not demonstrate any pos. effects in relation to diabetes, hyperlipidemia or liver dysfunction in obese ZSF1 rats.  RB394 ameliorated diabetic nephropathy by reducing renal interstitial fibrosis and renal tubular and glomerular injury in obese diabetic ZSF1 rats.  Intriguingly, enalapril demonstrated a weaker action against diabetic nephropathy in obese ZSF1 rats.  Conclusions/interpretation: These findings demonstrate that a novel sHE inhibitor/PPAR-γ agonist mol. targets multiple risk factors of the metabolic syndrome and is a glucose-lowering agent with a strong ability to treat diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbjByYxgOqLVg90H21EOLACvtfcHk0lip8unG_JOESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL&md5=b5c538cfa9fe0b8040e19fe230547202</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4685-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4685-0%26sid%3Dliteratum%253Aachs%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DKolb%26aufirst%3DL.%26aulast%3DSkibba%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBlocher%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DA%2520novel%2520dual%2520PPAR-gamma%2520agonist%252FsEH%2520inhibitor%2520treats%2520diabetic%2520complications%2520in%2520a%2520rat%2520model%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26spage%3D2235%26epage%3D2246%26doi%3D10.1007%2Fs00125-018-4685-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flauaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovati, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Boosting anti-inflammatory potency of zafirlukast by designed polypharmacology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5758</span>– <span class="NLM_lpage">5764</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00458</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVylur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5758-5764&author=S.+Schierleauthor=C.+Flauausauthor=P.+Heitelauthor=S.+Willemsauthor=J.+Schmidtauthor=A.+Kaiserauthor=L.+Weizelauthor=T.+Goebelauthor=A.+S.+Kahntauthor=G.+Geisslingerauthor=D.+Steinhilberauthor=M.+Wurglicsauthor=G.+E.+Rovatiauthor=A.+Schmidtkoauthor=E.+Proschakauthor=D.+Merk&title=Boosting+anti-inflammatory+potency+of+zafirlukast+by+designed+polypharmacology&doi=10.1021%2Facs.jmedchem.8b00458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology</span></div><div class="casAuthors">Schierle, Simone; Flauaus, Cathrin; Heitel, Pascal; Willems, Sabine; Schmidt, Jurema; Kaiser, Astrid; Weizel, Lilia; Goebel, Tamara; Kahnt, Astrid S.; Geisslinger, Gerd; Steinhilber, Dieter; Wurglics, Mario; Rovati, G. Enrico; Schmidtko, Achim; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5758-5764</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitarget design offers access to bioactive small mols. with potentially superior efficacy and safety.  Particularly multifactorial chronic inflammatory diseases demand multiple pharmacol. interventions for stable treatment.  By minor structural changes, we have developed a close analog of the cysteinyl-leukotriene receptor antagonist zafirlukast that simultaneously inhibits sol. epoxide hydrolase and activates peroxisome proliferator-activated receptor γ.  The triple modulator exhibits robust anti-inflammatory activity in vivo and highlights the therapeutic potential of designed multitarget agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLILgsL-gje7Vg90H21EOLACvtfcHk0lip8unG_JOESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVylur%252FJ&md5=7a4f670bb356f8db33957b80de57eee3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00458%26sid%3Dliteratum%253Aachs%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DFlauaus%26aufirst%3DC.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DWillems%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DSchmidtko%26aufirst%3DA.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DBoosting%2520anti-inflammatory%2520potency%2520of%2520zafirlukast%2520by%2520designed%2520polypharmacology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5758%26epage%3D5764%26doi%3D10.1021%2Facs.jmedchem.8b00458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Highly potent non-steroidal FXR agonists protostane-type triterpenoids: structure-activity relationship and mechanism</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">111652</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2019.111652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31494470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslGntLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2019&pages=111652&author=Z.+L.+Luanauthor=X.+K.+Huoauthor=P.+P.+Dongauthor=X.+G.+Tianauthor=C.+P.+Sunauthor=X.+Lvauthor=L.+Fengauthor=J.+Ningauthor=C.+Wangauthor=B.+J.+Zhangauthor=X.+C.+Ma&title=Highly+potent+non-steroidal+FXR+agonists+protostane-type+triterpenoids%3A+structure-activity+relationship+and+mechanism&doi=10.1016%2Fj.ejmech.2019.111652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism</span></div><div class="casAuthors">Luan, Zhi-Lin; Huo, Xiao-Kui; Dong, Pei-Pei; Tian, Xiang-Ge; Sun, Cheng-Peng; Lv, Xia; Feng, Lei; Ning, Jing; Wang, Chao; Zhang, Bao-Jing; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111652</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Farnesoid X receptor (FXR) is a key regulator in charge of bile acid synthesis, transport, and metab.  Activation of FXR represses bile acid synthesis and increases its excretion and transport, consequently protecting the liver functions.  Thus, FXR is considered as a crit. therapeutic target of cholestasis and nonalcoholic steatohepatitis.  Herein, we isolated and identified fourteen new protostane-type triterpenoids (1-14) and four known analogs (15-18) from Alisma orientale, and finally constructed a small library of protostane-type triterpenoids (1-70) to investigate their structure-activity relationship with FXR, further leading to obtain compd. 15 with potent agonistic activity against FXR (EC50 = 90 nM).  Extensive in vitro investigation confirmed high efficacy of compd. 15 against FXR in living cell, and revealed its underlying mechanism for FXR activation (amino acid residues Arg331 and Ser332) by mol. docking and site-directed mutagenesis technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5y6EOmYrwZbVg90H21EOLACvtfcHk0lhLyH7n8a8bpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslGntLrI&md5=71514c7aa4bcbfbcafb8243175158344</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111652%26sid%3Dliteratum%253Aachs%26aulast%3DLuan%26aufirst%3DZ.%2BL.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DDong%26aufirst%3DP.%2BP.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DLv%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DHighly%2520potent%2520non-steroidal%2520FXR%2520agonists%2520protostane-type%2520triterpenoids%253A%2520structure-activity%2520relationship%2520and%2520mechanism%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D182%26spage%3D111652%26doi%3D10.1016%2Fj.ejmech.2019.111652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmstädter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Dual farnesoid X receptor/soluble epoxide hydrolase modulators derived from zafirlukast</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fcmdc.201900576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31670489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOru7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=50-67&author=S.+Schierleauthor=M.+Helmst%C3%A4dterauthor=J.+Schmidtauthor=M.+Hartmannauthor=M.+Horzauthor=A.+Kaiserauthor=L.+Weizelauthor=P.+Heitelauthor=A.+Proschakauthor=V.+Hernandez-Olmosauthor=E.+Proschakauthor=D.+Merk&title=Dual+farnesoid+X+receptor%2Fsoluble+epoxide+hydrolase+modulators+derived+from+zafirlukast&doi=10.1002%2Fcmdc.201900576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast</span></div><div class="casAuthors">Schierle, Simone; Helmstaedter, Moritz; Schmidt, Jurema; Hartmann, Markus; Horz, Maximiliane; Kaiser, Astrid; Weizel, Lilia; Heitel, Pascal; Proschak, Anna; Hernandez-Olmos, Victor; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-67</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear farnesoid X receptor (FXR) and the enzyme sol. epoxide hydrolase (sEH) are validated mol. targets to treat metabolic disorders such as non-alc. steatohepatitis (NASH).  Their simultaneous modulation in vivo has demonstrated a triad of anti-NASH effects and thus may generate synergistic efficacy.  Here we report dual FXR activators/sEH inhibitors derived from the anti-asthma drug Zafirlukast.  Systematic structural optimization of the scaffold has produced favorable dual potency on FXR and sEH while depleting the original cysteinyl leukotriene receptor antagonism of the lead drug.  The resulting polypharmacol. activity profile holds promise in the treatment of liver-related metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiiU9ia6YqjLVg90H21EOLACvtfcHk0lhLyH7n8a8bpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOru7zK&md5=e9342428c2654ee1072bb0045b7719a7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900576%26sid%3Dliteratum%253Aachs%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DHelmst%25C3%25A4dter%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DHorz%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DProschak%26aufirst%3DA.%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DDual%2520farnesoid%2520X%2520receptor%252Fsoluble%2520epoxide%2520hydrolase%2520modulators%2520derived%2520from%2520zafirlukast%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D50%26epage%3D67%26doi%3D10.1002%2Fcmdc.201900576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7703</span>– <span class="NLM_lpage">7724</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2ls73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7703-7724&author=J.+Schmidtauthor=M.+Rotterauthor=T.+Weiserauthor=S.+Wittmannauthor=L.+Weizelauthor=A.+Kaiserauthor=J.+Heeringauthor=T.+Goebelauthor=C.+Angioniauthor=M.+Wurglicsauthor=A.+Paulkeauthor=G.+Geisslingerauthor=A.+Kahntauthor=D.+Steinhilberauthor=E.+Proschakauthor=D.+Merk&title=A+dual+modulator+of+farnesoid+X+receptor+and+soluble+epoxide+hydrolase+to+counter+nonalcoholic+steatohepatitis&doi=10.1021%2Facs.jmedchem.7b00398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis</span></div><div class="casAuthors">Schmidt, Jurema; Rotter, Marco; Weiser, Tim; Wittmann, Sandra; Weizel, Lilia; Kaiser, Astrid; Heering, Jan; Goebel, Tamara; Angioni, Carlo; Wurglics, Mario; Paulke, Alexander; Geisslinger, Gerd; Kahnt, Astrid; Steinhilber, Dieter; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7703-7724</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonalcoholic steatohepatitis arising from Western diet and lifestyle is characterized by accumulation of fat in liver causing inflammation and fibrosis.  It evolves as serious health burden with alarming incidence, but there is no satisfying pharmacol. therapy to date.  Considering the disease's multifactorial nature, modulation of multiple targets might provide superior therapeutic efficacy.  In particular, farnesoid X receptor (FXR) activation that revealed antisteatotic and antifibrotic effects in clin. trials combined with inhibition of sol. epoxide hydrolase (sEH) as anti-inflammatory strategy promises synergies.  To exploit this dual concept, we developed agents exerting partial FXR agonism and sEH inhibitory activity.  Merging known pharmacophores and systematic exploration of the structure-activity relationship on both targets produced dual modulators with low nanomolar potency.  Extensive in vitro characterization confirmed high dual efficacy in cellular context combined with low toxicity, and pilot in vivo data revealed favorable pharmacokinetics as well as engagement on both targets in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUx3OFEKCgyrVg90H21EOLACvtfcHk0ljdoFjg3Ak-LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2ls73J&md5=a35ceea141c78ed9885d7f9a99f4852b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00398%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DRotter%26aufirst%3DM.%26aulast%3DWeiser%26aufirst%3DT.%26aulast%3DWittmann%26aufirst%3DS.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DKahnt%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DA%2520dual%2520modulator%2520of%2520farnesoid%2520X%2520receptor%2520and%2520soluble%2520epoxide%2520hydrolase%2520to%2520counter%2520nonalcoholic%2520steatohepatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7703%26epage%3D7724%26doi%3D10.1021%2Facs.jmedchem.7b00398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, T.</span></span> <span> </span><span class="NLM_article-title">Activation of rat and human c-raf(-1) by rearrangement</span>. <i>Princess Takamatsu Symp.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=3332022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADyaL1czjtVOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1986&pages=75-84&author=M.+Nagaoauthor=F.+Ishikawaauthor=T.+Tahiraauthor=M.+Ochiaiauthor=T.+Sugimura&title=Activation+of+rat+and+human+c-raf%28-1%29+by+rearrangement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of rat and human c-raf(-1) by rearrangement</span></div><div class="casAuthors">Nagao M; Ishikawa F; Tahira T; Ochiai M; Sugimura T</div><div class="citationInfo"><span class="NLM_cas:title">Princess Takamatsu symposia</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activated c-raf(-1) gene was found in three transformants obtained by transfecting DNAs from rat hepatocellular carcinoma, metastasis of human colon cancer in mesocolon and normal mucosa from a different colon cancer patient.  Rat and human activated c-raf(-1) genes were cloned into cosmid vectors; restriction enzyme mapping revealed both activated c-raf(-1) genes to have rearrangement in the center of the normal form of the gene, and the upstream sequences were replaced by unrelated sequences.  Using genomic DNA fragments located immediately downstream of the recombination points, the activations of all these c-raf(-1) were shown to have occurred during the transfection process.  The recombination points in both the rat and human clones isolated were located in the intron between exons 7 and 8, and nucleotide sequencing around these recombination points showed there to be an inverted repeat which could be involved in inducing in vitro recombination.  Nucleotide sequencing of rat and human c-raf(-1) cDNAs revealed the upstream sequences, recombined to the 3' half of c-raf(-1), to be expressed as fusion mRNAs; the production of fused proteins was predicted from a long open reading frame, which is in-frame with the kinase domain encoded from the 3' half of the c-raf(-1) gene.  There is a cysteine clustering region in an N-terminal region of the c-raf(-1) product deduced from the nucleotide sequence, and this cysteine clustering region was found to be highly homologous to that present in an N-terminal region of protein kinase C, although, in the latter cysteine clusters are present in duplicate.  From analogy with the activation mechanism of protein kinase C, the N-terminal region of serine/threonine kinase coded by the c-raf(-1) gene is suggested to be a regulatory part of the enzyme activity, and it proposed that the replacement or truncation of this regulatory part could be the mechanism whereby c-raf(-1) is activated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5bkb48VdTX7GbPKh4T9eAfW6udTcc2eYN7-JAnnyrAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1czjtVOhtg%253D%253D&md5=1d024622fcd8c54a7321e5d497a20ff8</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagao%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DF.%26aulast%3DTahira%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DM.%26aulast%3DSugimura%26aufirst%3DT.%26atitle%3DActivation%2520of%2520rat%2520and%2520human%2520c-raf%2528-1%2529%2520by%2520rearrangement%26jtitle%3DPrincess%2520Takamatsu%2520Symp.%26date%3D1986%26volume%3D17%26spage%3D75%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steelman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navolanic, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blalock, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCubrey, J. A.</span></span> <span> </span><span class="NLM_article-title">Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review)</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12579299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslKrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=469-480&author=F.+Changauthor=L.+S.+Steelmanauthor=J.+G.+Sheltonauthor=J.+T.+Leeauthor=P.+M.+Navolanicauthor=W.+L.+Blalockauthor=R.+Franklinauthor=J.+A.+McCubrey&title=Regulation+of+cell+cycle+progression+and+apoptosis+by+the+Ras%2FRaf%2FMEK%2FERK+pathway+%28review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review)</span></div><div class="casAuthors">Chang, Fumin; Steelman, Linda S.; Shelton, John G.; Lee, John T.; Navolanic, Patrick M.; Blalock, William L.; Franklin, Richard; McCubrey, James A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-480</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  The Ras/Raf/MEK/ERK signal transduction pathway regulates cell cycle progression and apoptosis in diverse types of cells.  Mutations in this pathway are often obsd. in transformed cell lines and frequently linked with human cancers.  The Ras/Raf/MEK/ERK pathway can induce events both assocd. with cell proliferation and cell cycle arrest.  The particular course chosen may depend on the strength and the particular Raf gene activated by Ras.  This pathway also is involved in maintaining cell survival by modulating the activity of apoptotic mols. including Bad and Bcl-2.  This review will discuss the regulation of the Ras/Raf/MEK/ERK pathway and how it modulates cell cycle progression and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkNzwwNV5N1LVg90H21EOLACvtfcHk0lhXS9NjQs9iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslKrtbo%253D&md5=7edac4057b0506e100b773af70378a3a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DF.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DShelton%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DNavolanic%26aufirst%3DP.%2BM.%26aulast%3DBlalock%26aufirst%3DW.%2BL.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26atitle%3DRegulation%2520of%2520cell%2520cycle%2520progression%2520and%2520apoptosis%2520by%2520the%2520Ras%252FRaf%252FMEK%252FERK%2520pathway%2520%2528review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2003%26volume%3D22%26spage%3D469%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, D. S.</span></span> <span> </span><span class="NLM_article-title">BAY 43-9006: Preclinical data</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2255</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.2174/1381612023393026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1381612023393026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12369853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2255-2257&author=S.+Wilhelmauthor=D.+S.+Chien&title=BAY+43-9006%3A+Preclinical+data&doi=10.2174%2F1381612023393026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 43-9006: Preclinical data</span></div><div class="casAuthors">Wilhelm, Scott; Chien, Du-Shieng</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2255-2257</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  The drug design and discovery efforts described in the previous section led to the development of a novel, small mol. Raf-1 kinase inhibitor, BAY 43-9006, which belongs to a class that can be broadly described as bis-aryl ureas.  BAY 43-9006 was identified during a large medicinal chem. optimization program, and this compd. was selected for further pharmacol. characterization based on its potent inhibition of Raf-1 (IC50 12 nM) and its favorable kinase selectivity profile [2, 3].  In vitro and in vivo expts. were designed to demonstrate effective blockade of the Raf/MEK/ERK signaling pathway in tumor cells and for antitumor efficacy in human xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZVjpBzRa6BbVg90H21EOLACvtfcHk0lhXS9NjQs9iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrs%253D&md5=687511d0a99c9d9cf4960be714b55ff5</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2174%2F1381612023393026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393026%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%2BS.%26atitle%3DBAY%252043-9006%253A%2520Preclinical%2520data%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2255%26epage%3D2257%26doi%3D10.2174%2F1381612023393026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, R. H.</span></span> <span> </span><span class="NLM_article-title">Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile <i>in vivo</i></span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2203</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1158%2F1535-7163.MCT-09-0119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19671760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2193-2203&author=J.+Y.+Liuauthor=S.+H.+Parkauthor=C.+Morisseauauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=R.+H.+Weiss&title=Sorafenib+has+soluble+epoxide+hydrolase+inhibitory+activity%2C+which+contributes+to+its+effect+profile+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo</span></div><div class="casAuthors">Liu, Jun-Yan; Park, See-Hyoung; Morisseau, Christophe; Hwang, Sung Hee; Hammock, Bruce D.; Weiss, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2193-2203</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The advent of multikinase inhibitors targeting the vascular endothelial growth factor (VEGF) receptor has revolutionized the treatment of highly angiogenic malignancies such as renal cell carcinoma.  Interestingly, several such inhibitors are com. available, and they each possess diverse specific beneficial and adverse effect profiles.  In examg. the structure of sorafenib, it was hypothesized that this compd. would possess inhibitory effects on the sol. epoxide hydrolase, an enzyme with pleiotropic effects on inflammation and vascular disease.  We now show that sorafenib but not another VEGF receptor targeted inhibitor sunitinib is a potent inhibitor of the human sol. epoxide hydrolase in vitro (Ki = 17±4 nmol/L).  Furthermore, sorafenib causes the expected in vivo shift in oxylipid profile resulting from sol. epoxide hydrolase inhibition, evidence of a redn. in the acute inflammatory response.  Lipopolysaccharide-induced hypotension was reversed with sorafenib but not sunitinib treatment, suggesting that sol. epoxide hydrolase inhibition accounts for at least part of the anti-inflammatory effect of sorafenib.  The pharmacokinetic studies presented here in light of the known potency of sorafenib as a sol. epoxide hydrolase inhibitor indicate that the sol. epoxide hydrolase will be largely inhibited at therapeutic doses of sorafenib.  Thus, it is likely that sol. epoxide hydrolase inhibition contributes to the beneficial effects from the inhibition of the VEGF receptor and other kinases during treatment with sorafenib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtvp4vXxyXgLVg90H21EOLACvtfcHk0lgr4prsSdMCQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCnu70%253D&md5=68eba7f914d5d71157744320bb253da3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0119%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DR.%2BH.%26atitle%3DSorafenib%2520has%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%252C%2520which%2520contributes%2520to%2520its%2520effect%2520profile%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2193%26epage%3D2203%26doi%3D10.1158%2F1535-7163.MCT-09-0119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wecksler, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.11.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.canlet.2015.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26683769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSkur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2016&pages=187-193&author=J.+Liaoauthor=S.+H.+Hwangauthor=H.+Liauthor=Y.+Yangauthor=J.+Yangauthor=A.+T.+Weckslerauthor=J.+Y.+Liuauthor=B.+D.+Hammockauthor=G.+Y.+Yang&title=Inhibition+of+mutant+KrasG12D-initiated+murine+pancreatic+carcinoma+growth+by+a+dual+c-Raf+and+soluble+epoxide+hydrolase+inhibitor+t-CUPM&doi=10.1016%2Fj.canlet.2015.11.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM</span></div><div class="casAuthors">Liao, Jie; Hwang, Sung Hee; Li, Haonan; Yang, Yihe; Yang, Jun; Wecksler, Aaron T.; Liu, Jun-Yan; Hammock, Bruce D.; Yang, Guang-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutant Kras and chronic pancreatitis are the most common pathol. events involved in human pancreatic cancer.  It has been demonstrated that c-Raf is responsible for transmitting signals from mutant Ras to its downstream signals including MEK-ERK and for initiating carcinogenesis.  The sol. epoxide hydrolase (sEH), a pro-inflammatory enzyme, generally inactivates anti-inflammatory and anti-pain epoxyeicosatrienoic acids (EETs).  Herein, we have synthesized a novel compd. of trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide (t-CUPM) via modifying the central Ph ring of sorafenib and confirmed its dual inhibition of sEH and c-Raf by recombinant kinase activity assay.  Pharmacokinetic anal. revealed that oral dosing of t-CUPM resulted in higher blood levels than that of sorafenib throughout the complete time course (48 h).  The effect of t-CUPM on the inhibition of mutant KrasG12D-initiated murine pancreatic cancer cell growth was detd. using the mouse pancreatic carcinoma cell model obtained from LSL-KrasG12D/Pdx1-Cre mice and showed that t-CUPM significantly inhibited this murine pancreatic carcinoma cell growth both in vitro and in mice in vivo.  Inhibition of mutant Kras-transmitted phosphorylations of cRAF/MEK/ERK was demonstrated in these pancreatic cancer cells using Western blot assay and immunohistochem. approach.  Modulation of oxylipin profile, particularly increased EETs/DHET ratio by sEH inhibition, was obsd. in mice treated with t-CUPM.  These results indicate that t-CUPM is a highly potential agent to treat pancreatic cancer via simultaneously targeting c-Raf and sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFbI76KQDKrVg90H21EOLACvtfcHk0lgr4prsSdMCQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSkur%252FF&md5=e55e1f92fb55e534bba78d245c97b042</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWecksler%26aufirst%3DA.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DG.%2BY.%26atitle%3DInhibition%2520of%2520mutant%2520KrasG12D-initiated%2520murine%2520pancreatic%2520carcinoma%2520growth%2520by%2520a%2520dual%2520c-Raf%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520t-CUPM%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D371%26spage%3D187%26epage%3D193%26doi%3D10.1016%2Fj.canlet.2015.11.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0lg_lBt11_KuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span> <span> </span><span class="NLM_article-title">The role of natural product chemistry in drug discovery</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2153</span>, <span class="refDoi"> DOI: 10.1021/np040106y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np040106y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSmtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=2141-2153&author=M.+S.+Butler&title=The+role+of+natural+product+chemistry+in+drug+discovery&doi=10.1021%2Fnp040106y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Natural Product Chemistry in Drug Discovery</span></div><div class="casAuthors">Butler, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2141-2153</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although traditionally natural products have played an important role in drug discovery, in the past few years most Big Pharma companies have either terminated or considerably scaled down their natural product operations.  This is despite a significant no. of natural product-derived drugs being ranked in the top 35 worldwide selling ethical drugs in 2000, 2001, and 2002.  There were 15 new natural product-derived drugs launched from 2000 to 2003, as well as 15 natural product-derived compds. in Phase III clin. trials or registration at the end of 2003.  Recently, there has been a renewed interest in natural product research due to the failure of alternative drug discovery methods to deliver many lead compds. in key therapeutic areas such as immunosuppression, anti-infectives, and metabolic diseases.  To continue to be competitive with other drug discovery methods, natural product research needs to continually improve the speed of the screening, isolation, and structure elucidation processes, as well addressing the suitability of screens for natural product exts. and dealing with issues involved with large-scale compd. supply.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8J4i-bFUB77Vg90H21EOLACvtfcHk0lg_lBt11_KuHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSmtLvK&md5=0e072912f9070bc24fddb28dcb5555df</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fnp040106y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp040106y%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520natural%2520product%2520chemistry%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D2141%26epage%3D2153%26doi%3D10.1021%2Fnp040106y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of soluble epoxide hydrolase inhibitors from natural products</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2013.11.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.fct.2013.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24309146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=225-230&author=G.+H.+Leeauthor=S.+J.+Ohauthor=S.+Y.+Leeauthor=J.+Y.+Leeauthor=J.+Y.+Maauthor=Y.+H.+Kimauthor=S.+K.+Kim&title=Discovery+of+soluble+epoxide+hydrolase+inhibitors+from+natural+products&doi=10.1016%2Fj.fct.2013.11.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of soluble epoxide hydrolase inhibitors from natural products</span></div><div class="casAuthors">Lee, Gwan Ho; Oh, Soo Jin; Lee, Sang Yoon; Lee, Ji-Yoon; Ma, Jin Yeul; Kim, Young Ho; Kim, Sang Kyum</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">With the goal of developing sol. epoxide hydrolase (sEH) inhibitors with novel chem. structures, the sEH inhibitory activities of 30 natural compds. were evaluated using both a fluorescent substrate, 3-phenyl-cyano(6-methoxy-2-naphthalenyl)methyl ester- 2-oxiraneacetic acid, and a physiol. substrate, 14,15-epoxyeicosatrienoic acid.  To evaluate the selectivity of sEH inhibition, the inhibition of microsomal epoxide hydrolase (mEH), which plays a crit. role in detoxification of toxic epoxides, was detd. using human liver microsomes.  Honokiol and β-amyrin acetate, isolated from Magnolia officinalis and Acer mandshuricum, resp., displayed strong inhibition of sEH activity, with resp. IC50 values of 0.57 μM and 3.4 μM detd. using the fluorescent substrate, and 1.7 μM and 6.1 μM detd. using 14,15-epoxyeicosatrienoic acid. mEH activity was decreased to 49% or 61% of control activity by 25 μM honokiol or β-amyrin acetate, resp.  These results suggest that β-amyrin acetate and honokiol exhibit sEH inhibitory activity, although their sEH selectivity should be improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8LJIETEfy7Vg90H21EOLACvtfcHk0lgKcNTYryl61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVygsLw%253D&md5=31bc18c54cb12c3a10d693c5a933d504</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2013.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2013.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DDiscovery%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520natural%2520products%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2014%26volume%3D64%26spage%3D225%26epage%3D230%26doi%3D10.1016%2Fj.fct.2013.11.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span> <span> </span><span class="NLM_article-title">Phytochemical constituents from <i>Scutellaria baicalensis</i> in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2019.04.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2019.04.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30980876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=1187-1193&author=Z.+B.+Liuauthor=C.+P.+Sunauthor=J.+X.+Xuauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=F.+Qiu&title=Phytochemical+constituents+from+Scutellaria+baicalensis+in+soluble+epoxide+hydrolase+inhibition%3A+Kinetics+and+interaction+mechanism+merged+with+simulations&doi=10.1016%2Fj.ijbiomac.2019.04.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations</span></div><div class="casAuthors">Liu, Zhong-Bo; Sun, Cheng-Peng; Xu, Jian-Xia; Morisseau, Christophe; Hammock, Bruce D.; Qiu, Feng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our search for sol. epoxide hydrolase (sEH) inhibitors from plants, we found that water exts. of Scutellaria baicalensis Georgi displayed significant inhibitory activity against sEH in vitro.  Exts. of S. baicalensiswere sepd., resulting in the isolation of thirty compds. (1-30), including six lignins (1-6), sixteen flavones (7-22), and five amides (23-27).  Their structures were detd. on the basis of1H and13C NMR and MS spectra.  Compds. 1-6 were first reported in the genus Scutellaria.  All the isolated compds. were assayed for their inhibitory activities against sEH.  Compds. 25-27 showed significant inhibitory activities against sEH with IC50 values of 6.06 ± 0.12, 7.83 ± 0.52, and 6.32 ± 0.31 μM, resp., and compds. 3-6, 12, 18, and 22 displayed moderate inhibitory activities against sEH with IC50 values from 20.82 ± 0.78 μM to 56.61 ± 0.98 μM.  The inhibition kinetic anal. results indicated that compds. 25-27 were all uncompetitive.  Mol. docking studies were performed to get insights into inhibition mechanisms of compds. 25-27 against sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCmQN70ArDTbVg90H21EOLACvtfcHk0lgKcNTYryl61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFWgu7k%253D&md5=155098de905fecd11272f3f87875487a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2019.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2019.04.055%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BB.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BX.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DQiu%26aufirst%3DF.%26atitle%3DPhytochemical%2520constituents%2520from%2520Scutellaria%2520baicalensis%2520in%2520soluble%2520epoxide%2520hydrolase%2520inhibition%253A%2520Kinetics%2520and%2520interaction%2520mechanism%2520merged%2520with%2520simulations%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2019%26volume%3D133%26spage%3D1187%26epage%3D1193%26doi%3D10.1016%2Fj.ijbiomac.2019.04.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition potential of phenolic constituents from the aerial parts of <i>Tetrastigma hemsleyanum</i> against soluble epoxide hydrolase and nitric oxide synthase</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1584621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F14756366.2019.1584621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30829084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktVKqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=753-760&author=C.+Y.+Wangauthor=S.+Leeauthor=H.+J.+Jangauthor=X.+D.+Suauthor=H.+S.+Wangauthor=Y.+H.+Kimauthor=S.+Y.+Yang&title=Inhibition+potential+of+phenolic+constituents+from+the+aerial+parts+of+Tetrastigma+hemsleyanum+against+soluble+epoxide+hydrolase+and+nitric+oxide+synthase&doi=10.1080%2F14756366.2019.1584621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase</span></div><div class="casAuthors">Wang, Cai Yi; Lee, Sunggun; Jang, Hyun-Jae; Su, Xiang Dong; Wang, Heng-Shan; Kim, Young Ho; Yang, Seo Young</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">753-760</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aerial parts of Tetrastigma hemsleyanum (APTH) have been used as a functional tea in China.  The purpose of the current study was to identify the bioactive constituents with inhibitory activity against sol. epoxide hydrolase (sEH) and inducible nitric oxide synthase (iNOS), which are jointly considered potential therapeutic targets for vascular system diseases.  In the present study, 39 compds. (-) were isolated from the APTH.  Among them, compds. 8,10,12,16,17,19,32 displayed potential activities, with IC50 values ranging from 4.5 to 9.5 μM, resp., and all in non-competitive inhibition mode.  Compds. 5, 10, 12, 19, 32 displayed potent iNOS inhibitory effects, with IC50 values ranging from 15.6 to 47.3 μM.  The results obtained in this work contribute to a better understanding of the pharmacol. activities of T. hemsleyanum and its potential application as a functional food.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqczoEgwjqBLVg90H21EOLACvtfcHk0liUhhWefQf_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktVKqsLs%253D&md5=dfc2f271c7dedc5f0ed43be6ad01badb</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1584621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1584621%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DH.%2BJ.%26aulast%3DSu%26aufirst%3DX.%2BD.%26aulast%3DWang%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DInhibition%2520potential%2520of%2520phenolic%2520constituents%2520from%2520the%2520aerial%2520parts%2520of%2520Tetrastigma%2520hemsleyanum%2520against%2520soluble%2520epoxide%2520hydrolase%2520and%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26spage%3D753%26epage%3D760%26doi%3D10.1080%2F14756366.2019.1584621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyet, N. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from <i>Polygala tenuifolia</i> and in silico approach</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">726</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-2096-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-017-2096-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yhtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=726-734&author=L.+B.+Vinhauthor=J.+H.+Kimauthor=J.+S.+Leeauthor=N.+T.+M.+Nguyetauthor=S.+Y.+Yangauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+phenolic+glycosides+from+Polygala+tenuifolia+and+in+silico+approach&doi=10.1007%2Fs00044-017-2096-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from Polygala tenuifolia and in silico approach</span></div><div class="casAuthors">Vinh, Le Ba; Kim, Jang Hoon; Lee, Ji Sun; Nguyet, Nguyen Thi Minh; Yang, Seo Young; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">726-734</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The goal of this study was to identify sol. epoxide hydrolase (sEH) inhibitors from plants.  The authors' efforts led to the isolation of nine phenolic glycosides from the roots of Polygala tenuifolia Willd.  The structures of compds. were detd. by spectroscopic methods, including mass spectroscopy and one-dimensional and two-dimensional NMR, and compared with published data.  All the isolated compds. were evaluated for their inhibitory activity against sEH.  The IC50 values for inhibition ranged 6.4±0.4 to 27.2±0.3 μM.  Inhibitors were confirmed the interaction with receptor as competitive type.  Mol. docking demonstrated that inhibitors could bind sufficiently to the right pocket.  Addnl., potential inhibitors (tenuifoliside A, 6-O-(O-methyl-p-benzoyl)-3'-O-(O-methylsinapoyl)sucrose, and 6,3'-di-O-sinapoylsucrose) were confirmed to show the flexible movement with the protein in these sites of receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SFiZRnYUhrVg90H21EOLACvtfcHk0liUhhWefQf_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yhtbrJ&md5=a005b5f2508d62687a5081de17afb657</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-2096-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-2096-2%26sid%3Dliteratum%253Aachs%26aulast%3DVinh%26aufirst%3DL.%2BB.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNguyet%26aufirst%3DN.%2BT.%2BM.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520phenolic%2520glycosides%2520from%2520Polygala%2520tenuifolia%2520and%2520in%2520silico%2520approach%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2018%26volume%3D27%26spage%3D726%26epage%3D734%26doi%3D10.1007%2Fs00044-017-2096-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamita, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Nicola, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyegue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Potent natural soluble epoxide hydrolase inhibitors from <i>Pentadiplandra brazzeana</i> Baillon: Synthesis, quantification, and measurement of biological activities <i>in vitro</i> and <i>in vivo</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0117438</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0117438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0117438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25659109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGrs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=S.+Kitamuraauthor=C.+Morisseauauthor=B.+Inceogluauthor=S.+G.+Kamitaauthor=G.+R.+De+Nicolaauthor=M.+Nyegueauthor=B.+D.+Hammock&title=Potent+natural+soluble+epoxide+hydrolase+inhibitors+from+Pentadiplandra+brazzeana+Baillon%3A+Synthesis%2C+quantification%2C+and+measurement+of+biological+activities+in+vitro+and+in+vivo&doi=10.1371%2Fjournal.pone.0117438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Potent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivo</span></div><div class="casAuthors">Kitamura, Seiya; Morisseau, Christophe; Inceoglu, Bora; Kamita, Shizuo G.; De Nicola, Gina R.; Nyegue, Maximilienne; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0117438/1-e0117438/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We describe here three urea-based sol. epoxide hydrolase (sEH) inhibitors from the root of the plant Pentadiplandra brazzeana.  The concn. of these ureas in the root was quantified by LC-MS/MS, showing that 1, 3-bis (4-methoxybenzyl) urea (MMU) is the most abundant (42.3 μg/g dry root wt.).  All of the ureas were chem. synthesized, and their inhibitory activity toward recombinant human and recombinant rat sEH was measured.  The most potent compd., MMU, showed an IC50 of 92 nM via fluorescent assay and a Ki of 54 nM via radioactivity-based assay on human sEH.  MMU effectively reduced inflammatory pain in a rat nociceptive pain assay.  These compds. are among the most potent sEH inhibitors derived from natural sources.  Moreover, inhibition of sEH by these compds. may mechanistically explain some of the therapeutic effects of P. brazzeana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofZxftJl6ePrVg90H21EOLACvtfcHk0li67sRauva9Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGrs77O&md5=4e4a1da5430babd48d88388d8e604b98</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0117438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0117438%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DKamita%26aufirst%3DS.%2BG.%26aulast%3DDe%2BNicola%26aufirst%3DG.%2BR.%26aulast%3DNyegue%26aufirst%3DM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DPotent%2520natural%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520Pentadiplandra%2520brazzeana%2520Baillon%253A%2520Synthesis%252C%2520quantification%252C%2520and%2520measurement%2520of%2520biological%2520activities%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0117438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsopmo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngnokam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngamga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayafor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, O.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives from <i>Pentadiplandra brazzeana</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1021/np990111f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np990111f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXmt12nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=1435-1436&author=A.+Tsopmoauthor=D.+Ngnokamauthor=D.+Ngamgaauthor=J.+F.+Ayaforauthor=O.+Sterner&title=Urea+derivatives+from+Pentadiplandra+brazzeana&doi=10.1021%2Fnp990111f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Urea derivatives from Pentadiplandra brazzeana</span></div><div class="casAuthors">Tsopmo, Apollinaire; Ngnokam, David; Ngamga, Dieudonne; Ayafor, Johnson F.; Sterner, Olov</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1435-1436</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four urea derivs. were isolated from the roots of Pentadiplandra brazzeana, and their structures were elucidated by spectroscopic techniques.  N-Benzyl-N'-(4-methoxybenzyl)urea is a new compd., although N,N'-di-(4-methoxybenzyl)urea , N,N'-dibenzylurea, and p-methoxythiobenzaldehyde are reported from a natural source for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytu3GPukR-rVg90H21EOLACvtfcHk0li67sRauva9Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt12nu7s%253D&md5=f2290b3c42fca5ed4f4acde5912a932f</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fnp990111f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp990111f%26sid%3Dliteratum%253Aachs%26aulast%3DTsopmo%26aufirst%3DA.%26aulast%3DNgnokam%26aufirst%3DD.%26aulast%3DNgamga%26aufirst%3DD.%26aulast%3DAyafor%26aufirst%3DJ.%2BF.%26aulast%3DSterner%26aufirst%3DO.%26atitle%3DUrea%2520derivatives%2520from%2520Pentadiplandra%2520brazzeana%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1999%26volume%3D62%26spage%3D1435%26epage%3D1436%26doi%3D10.1021%2Fnp990111f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, S. C.</span></span> <span> </span><span class="NLM_article-title">Salvadourea: New urea derivative from <i>Salvadora persica</i></span>. <i>Chem. Ind.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1975&pages=517-518&author=A.+Rayauthor=L.+Chandauthor=S.+C.+Dutta&title=Salvadourea%3A+New+urea+derivative+from+Salvadora+persica"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DA.%26aulast%3DChand%26aufirst%3DL.%26aulast%3DDutta%26aufirst%3DS.%2BC.%26atitle%3DSalvadourea%253A%2520New%2520urea%2520derivative%2520from%2520Salvadora%2520persica%26jtitle%3DChem.%2520Ind.%26date%3D1975%26volume%3D12%26spage%3D517%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahroun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damak, M.</span></span> <span> </span><span class="NLM_article-title">Contribution to the study of <i>Lepidium sativum</i> (Cruciferae). Structure of a new compound isolated from the seed: lepidine</span>. <i>J. Soc. Chim. Tunis.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaL28XmsF2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1985&pages=15-24&author=A.+Bahrounauthor=M.+Damak&title=Contribution+to+the+study+of+Lepidium+sativum+%28Cruciferae%29.+Structure+of+a+new+compound+isolated+from+the+seed%3A+lepidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution to the study of Lepidium sativum (Cruciferae). Structure of a new compound isolated from the seed: lepidine</span></div><div class="casAuthors">Bahroun, A.; Damak, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal de la Societe Chimique de Tunisie</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">JSCTDP</span>;
        ISSN:<span class="NLM_cas:issn">0253-1208</span>.
    </div><div class="casAbstract">Seeds of L. sativum afforded sinapic acid Et ester, N,N'-dibenzylthiourea, N,N'-dibenzylurea, and the new alkaloid lepidine (I).  Structures were assigned from spectral characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB80yh0aLdhrVg90H21EOLACvtfcHk0lgYi9x-CHKUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmsF2isg%253D%253D&md5=180c288a0f1d0b0e931cd4440d6665e9</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBahroun%26aufirst%3DA.%26aulast%3DDamak%26aufirst%3DM.%26atitle%3DContribution%2520to%2520the%2520study%2520of%2520Lepidium%2520sativum%2520%2528Cruciferae%2529.%2520Structure%2520of%2520a%2520new%2520compound%2520isolated%2520from%2520the%2520seed%253A%2520lepidine%26jtitle%3DJ.%2520Soc.%2520Chim.%2520Tunis.%26date%3D1985%26volume%3D2%26spage%3D15%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sashidhara, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosaiah, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghubir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, S. M.</span></span> <span> </span><span class="NLM_article-title">Rare dipeptide and urea derivatives from roots of <i>Moringa oleifera</i> as potential anti-inflammatory and antinociceptive agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">436</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ejmech.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=18243423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=432-436&author=K.+V.+Sashidharaauthor=J.+N.+Rosaiahauthor=E.+Tyagiauthor=R.+Shuklaauthor=R.+Raghubirauthor=S.+M.+Rajendran&title=Rare+dipeptide+and+urea+derivatives+from+roots+of+Moringa+oleifera+as+potential+anti-inflammatory+and+antinociceptive+agents&doi=10.1016%2Fj.ejmech.2007.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents</span></div><div class="casAuthors">Sashidhara, Koneni V.; Rosaiah, Jammikuntla N.; Tyagi, Ethika; Shukla, Rakesh; Raghubir, Ram; Rajendran, Siron M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">432-436</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the course of our studies on the isolation of bioactive compds. from the roots of Moringa oleifera, a traditional herb in southeast Asia, rare aurantiamide acetate 4 and 1,3-dibenzyl urea 5 have been isolated and characterized.  And also, this is the first report of isolation from this genus.  Isolated compd. inhibited the prodn. of TNF-α and IL-2; further compd. 5 showed significant analgesic activities in a dose dependant manner.  These findings may help in understanding the mechanism of action of this traditional plant leading to control of activated mast cells on inflammatory conditions like arthritis, for which the crude ext. has been used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0QgUv1wZHz7Vg90H21EOLACvtfcHk0lgYi9x-CHKUZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFal&md5=85a13626a3c9162703e002608c1a29c1</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DSashidhara%26aufirst%3DK.%2BV.%26aulast%3DRosaiah%26aufirst%3DJ.%2BN.%26aulast%3DTyagi%26aufirst%3DE.%26aulast%3DShukla%26aufirst%3DR.%26aulast%3DRaghubir%26aufirst%3DR.%26aulast%3DRajendran%26aufirst%3DS.%2BM.%26atitle%3DRare%2520dipeptide%2520and%2520urea%2520derivatives%2520from%2520roots%2520of%2520Moringa%2520oleifera%2520as%2520potential%2520anti-inflammatory%2520and%2520antinociceptive%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D432%26epage%3D436%26doi%3D10.1016%2Fj.ejmech.2007.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0176571</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0176571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0176571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28472063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wjt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=S.+Kitamuraauthor=C.+Morisseauauthor=T.+R.+Harrisauthor=B.+Inceogluauthor=B.+D.+Hammock&title=Occurrence+of+urea-based+soluble+epoxide+hydrolase+inhibitors+from+the+plants+in+the+order+Brassicales&doi=10.1371%2Fjournal.pone.0176571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales</span></div><div class="casAuthors">Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0176571/1-e0176571/25</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Recently, dibenzylurea-based potent sol. epoxide hydrolase (sEH) inhibitors were identified in Pentadiplandra brazzeana, a plant in the order Brassicales.  In an effort to generalize the concept, we hypothesized that plants that produce benzyl glucosinolates and corresponding isothiocyanates also produce these dibenzylurea derivs.  Our overall aim here was to examine the occurrence of urea derivs. in Brassicales, hoping to find biol. active urea derivs. from plants.  First, plants in the order Brassicales were analyzed for the presence of 1, 3-dibenzylurea (compd. 1), showing that three addnl. plants in the order Brassicales produce the urea derivs.  Based on the hypothesis, three dibenzylurea derivs. with sEH inhibitory activity were isolated from maca (Lepidium meyenii) roots.  Topical application of one of the identified compds. (compd. 3, human sEH IC50 = 222 nM) effectively reduced pain in rat inflammatory pain model, and this compd. was bioavailable after oral administration in mice.  The biosynthetic pathway of these urea derivs. was investigated using papaya (Carica papaya) seed as a model system.  Finally, a small collection of plants from the Brassicales order was grown, collected, extd. and screened for sEH inhibitory activity.  Results show that several plants of the Brassicales order could be potential sources of urea-based sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMA3Grmjmt4bVg90H21EOLACvtfcHk0lgfrHNt5BRRyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wjt7nI&md5=3396219c1e211d67267a992c40f4dbaf</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0176571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0176571%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOccurrence%2520of%2520urea-based%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%2520from%2520the%2520plants%2520in%2520the%2520order%2520Brassicales%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0176571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C. H.</span></span> <span> </span><span class="NLM_article-title">Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from <i>Capsicum chinense</i> Jacq. cv. Habanero</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1207</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2019.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2019.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31175899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFOrs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2019&pages=1202-1207&author=J.+H.+Kimauthor=Y.+D.+Joauthor=C.+H.+Jin&title=Isolation+of+soluble+epoxide+hydrolase+inhibitor+of+capsaicin+analogs+from+Capsicum+chinense+Jacq.+cv.+Habanero&doi=10.1016%2Fj.ijbiomac.2019.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from Capsicum chinense Jacq. cv. Habanero</span></div><div class="casAuthors">Kim, Jang Hoon; Jo, Yeong Deuk; Jin, Chang Hyun</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1202-1207</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Capsaicin (1) and dihydrocapsaicin (2) were isolated from the aerial parts of Capsicum chinense Jacq. cv.  Habanero. In in vitro studies, the exhibited potent inhibitory activity against sol. epoxide hydrolase (sEH), with IC50 values of 5.6 ± 1.2 and 7.3 ± 0.7μM.  Enzyme kinetics suggested that the two compds. (1 and 2) were competitive inhibitors with Ki values of 2.5 ± 1.0 and 4.7 ± 2.3μM, resp.  Mol. docking and mol. dynamic studies showed that capsaicin analogs (1 and 2) bound strongly with Asp335, Tyr383, and Tyr466 residues in the active site.  These results suggest that the two inhibitors (1 and 2) represent potentially therapeutic inhibitors of sEH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhVuaTaeDTjbVg90H21EOLACvtfcHk0lgfrHNt5BRRyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFOrs7vP&md5=c54f042dc0bbce2c1ffbcebb47549fb9</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2019.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2019.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJo%26aufirst%3DY.%2BD.%26aulast%3DJin%26aufirst%3DC.%2BH.%26atitle%3DIsolation%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520of%2520capsaicin%2520analogs%2520from%2520Capsicum%2520chinense%2520Jacq.%2520cv.%2520Habanero%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2019%26volume%3D135%26spage%3D1202%26epage%3D1207%26doi%3D10.1016%2Fj.ijbiomac.2019.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of components isolated from <i>Apios americana</i> Medik</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1432</span>, <span class="refDoi"> DOI: 10.3390/molecules22091432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fmolecules22091432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1432&author=J.+H.+Kimauthor=H.+Y.+Kimauthor=S.+Y.+Kangauthor=Y.+H.+Kimauthor=C.+H.+Jin&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+components+isolated+from+Apios+americana+Medik&doi=10.3390%2Fmolecules22091432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of components isolated from Apios americana medik</span></div><div class="casAuthors">Kim, Jang Hoon; Kim, Hyo Young; Kang, Si Yong; Kim, Young Ho; Jin, Chang Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1432/1-1432/10</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A new compd. 1, 5-methoxy-2,5,7,4'-tetrahydroxy-coumaronochromone, along with seven known compds. (2-8), were isolated from Apios americana using open column chromatog.  Their structures were established based on an anal. of 1D and 2D NMR, and MS spectra.  Among these, two compds. 1 and 2 showed inhibitory activity on sol. epoxide hydrolase (sEH) at a concn. below 50μM.  The resp. competitive (1) and mixed (2) inhibitors were revealed to have Ki values of 21.0 ± 0.8 and 14.5 ± 1.5μM, based on the Dixon plot.  The potential inhibitor (2) was visually presented in a predicted binding pose in the receptor by mol. docking.  Addnl., mol. dynamics were performed for a detailed understanding of their complex by Gromacs 4.6.5 package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomg-I19YHxibVg90H21EOLACvtfcHk0lhLE6Of8XTYzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhsLzF&md5=335fd187086a9c091d8919b38d334e42</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091432%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DKang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DJin%26aufirst%3DC.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520components%2520isolated%2520from%2520Apios%2520americana%2520Medik%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1432%26doi%3D10.3390%2Fmolecules22091432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minh, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity by rhizomes of <i>Kaempferia parviflora</i> Wall. ex Baker</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1007/s00044-016-1525-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-016-1525-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=704-711&author=N.+P.+Thaoauthor=B.+T.+T.+Luyenauthor=J.+H.+Kimauthor=A.+R.+Joauthor=S.+Y.+Yangauthor=N.+T.+Datauthor=C.+V.+Minhauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+by+rhizomes+of+Kaempferia+parviflora+Wall.+ex+Baker&doi=10.1007%2Fs00044-016-1525-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1007%2Fs00044-016-1525-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-016-1525-y%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520by%2520rhizomes%2520of%2520Kaempferia%2520parviflora%2520Wall.%2520ex%2520Baker%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2016%26volume%3D25%26spage%3D704%26epage%3D711%26doi%3D10.1007%2Fs00044-016-1525-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">A new flavonol glycoside from the leaves of <i>Boscia senegalensis</i></span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3452</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2014.35.12.3447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.5012%2Fbkcs.2014.35.12.3447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1arsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=3447-3452&author=A.+M.+A.+Morganauthor=J.+H.+Kimauthor=S.+K.+Kimauthor=C.-H.+Limauthor=Y.+H.+Kim&title=A+new+flavonol+glycoside+from+the+leaves+of+Boscia+senegalensis&doi=10.5012%2Fbkcs.2014.35.12.3447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A new flavonol glycoside from the leaves of Boscia senegalensis</span></div><div class="casAuthors">Morgan, Abubaker M. A.; Kim, Jang Hoon; Kim, Sang Kyum; Lim, Chi-Hwan; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3447-3452</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Detailed chem. investigation of Boscia senegalensis (Per) Lam. ex Poir. led to the isolation of one new flavonol glycoside, rhamnocitrin-3-O-β-D-(6''-O-E-feruloyl)-glucopyranoside named bosenegaloside A (1), with seven known compds., rhamnocitrin-3-O-β-D-(6''-O-E-p-coumaroyl)-glucopyranoside (2), rhamnocitrin-3-O-β-D-glucopyranoside (3), 3,4,5-trimethoxyphenol-β-D-glucopyrinoside (4), lasianthionoside A (5), 3,7-dimethyl-1-octene-3,6,7-triol-6-O-β-D-glucopyranoside (6), syringin (7), and austroside B (8).  The chem. structures of these compds. were elucidated from spectroscopic data and by comparison of these data with previously published results.  The inhibitory activity of the isolated compds. on sol. epoxide hydrolase (sEH) was assessed.  Compds. 1-3 potently inhibited sEH activity with IC50 values of 12.8 ± 0.5, 18.4 ± 0.2, and 11.3 ± 0.9 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrux-0OoyAWXLVg90H21EOLACvtfcHk0lhLE6Of8XTYzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1arsb%252FI&md5=ff35aa0af29a16e05879f50ac12efa28</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2014.35.12.3447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2014.35.12.3447%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DA.%2BM.%2BA.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DLim%26aufirst%3DC.-H.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DA%2520new%2520flavonol%2520glycoside%2520from%2520the%2520leaves%2520of%2520Boscia%2520senegalensis%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2014%26volume%3D35%26spage%3D3447%26epage%3D3452%26doi%3D10.5012%2Fbkcs.2014.35.12.3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Prenyl-flavonoids from <i>Epimedium koreanum</i> Nakai and their soluble epoxide hydrolase and tyrosinase inhibitory activities</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2761</span>– <span class="NLM_lpage">2767</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-1975-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs00044-017-1975-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWktbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=2761-2767&author=X.+D.+Suauthor=W.+Liauthor=J.+E.+Kimauthor=S.+Y.+Yangauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Prenyl-flavonoids+from+Epimedium+koreanum+Nakai+and+their+soluble+epoxide+hydrolase+and+tyrosinase+inhibitory+activities&doi=10.1007%2Fs00044-017-1975-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Prenyl-flavonoids from Epimedium koreanum Nakai and their soluble epoxide hydrolase and tyrosinase inhibitory activities</span></div><div class="casAuthors">Su, Xiang Dong; Li, Wei; Kim, Ji Eun; Yang, Seo Young; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2761-2767</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A new 8-prenyl-flavonoid, epimedokoreanoside III (I), and 11 other flavonoids, were isolated from the aerial parts of Epimedium koreanum Nakai.  Their chem. structures were elucidated by NMR and mass analyses.  All isolates were evaluated for their sol. epoxide hydrolase and tyrosinase inhibitory activities.  Among the isolates, compds. 1, 5, 9, 10, and 12 exerted sol. epoxide hydrolase inhibitory activity in dose-dependent manner, with IC50 values ranging from 26.0 ± 1.2 to 37.6 ± 1.0 μM, whereas compds. 4 and 9 showed potent inhibition of tyrosinase in a dose-dependent manner, having IC50 values of 16.8 ± 2.7 and 8.7 ± 2.7 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCwlyM0Ubzn7Vg90H21EOLACvtfcHk0lglfFMYi1qelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWktbjK&md5=1e6832d376ef8887e23a5b1793c0ecb5</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-1975-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-1975-x%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DX.%2BD.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DPrenyl-flavonoids%2520from%2520Epimedium%2520koreanum%2520Nakai%2520and%2520their%2520soluble%2520epoxide%2520hydrolase%2520and%2520tyrosinase%2520inhibitory%2520activities%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D2761%26epage%3D2767%26doi%3D10.1007%2Fs00044-017-1975-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J. M.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory and anti-inflammatory components from the leaves of <i>Eucommia ulmoides</i> Oliver (duzhong)</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2198</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.5b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.5b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1KnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=2198-2205&author=M.+M.+Baiauthor=W.+Shiauthor=J.+M.+Tianauthor=M.+Leiauthor=J.+H.+Kimauthor=Y.+N.+Sunauthor=Y.+H.+Kimauthor=J.+M.+Gao&title=Soluble+epoxide+hydrolase+inhibitory+and+anti-inflammatory+components+from+the+leaves+of+Eucommia+ulmoides+Oliver+%28duzhong%29&doi=10.1021%2Facs.jafc.5b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Inhibitory and Anti-inflammatory Components from the Leaves of Eucommia ulmoides Oliver (Duzhong)</span></div><div class="casAuthors">Bai, Meng-Meng; Shi, Wei; Tian, Jun-Mian; Lei, Ming; Kim, Jang Hoon; Sun, Ya Nan; Kim, Young Ho; Gao, Jin-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2198-2205</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Eucommia ulmoides leaves have been used as a functional food and drink in China.  The purpose of this study was to identify the bioactive constituents with sol. epoxide hydrolase (sEH) inhibitory activity and anti-inflammatory properties.  Twenty-seven known compds. (1-27) were isolated from the leaves of E. ulmoides Oliver, and their structures were identified by NMR and ESIMS anal.; three of these, 2,5-dimethoxy-3-glucopyranosyl cinnamic alc. (11), foliasalacioside E2 (26), and icariside F2 (27), were obtained from this plant for the first time.  Compds. 1-7 exhibited sol. epoxide hydrolase (sEH) inhibitory activity at 100 μM; among them, quercetin (1) and kaempferol (5) displayed potential activities with IC50 values of 22.5 ± 0.9 and 31.3 ± 2.6 μM, resp., with noncompetitive inhibition mode.  Nuclear factor kappa B (NF-κB) inhibitory activity of the isolated compds. was evaluated by the NF-κB liciferase assay in HepG2 cells.  Compds. 1, 9, 20, and 27 displayed potent NF-κB inhibitory effects, with IC50 values of 15.14 ± 2.29, 15.23 ± 2.34, 16.88 ± 2.17, and 16.25 ± 2.19 μM, resp., whereas other compds. showed weak inhibition of NF-κB transcriptional activity ranging from 17.54 to 92.6 μM.  A structure-activity relationship of flavonoids 1-9 was also discussed.  The results obtained in this work might contribute to the understanding of pharmacol. activities of E. ulmoides leaves and further investigation on its potential application values for food and drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMYiBod8egnrVg90H21EOLACvtfcHk0lglfFMYi1qelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1KnsrY%253D&md5=2dc380f585eb20c13c4e835c3f148814</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.5b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.5b00055%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DM.%2BM.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DJ.%2BM.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DJ.%2BM.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520and%2520anti-inflammatory%2520components%2520from%2520the%2520leaves%2520of%2520Eucommia%2520ulmoides%2520Oliver%2520%2528duzhong%2529%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2015%26volume%3D63%26spage%3D2198%26epage%3D2205%26doi%3D10.1021%2Facs.jafc.5b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition potential of cycloartane-type glycosides from the roots of <i>Cimicifuga dahurica</i> against soluble epoxide hydrolase</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1867</span>– <span class="NLM_lpage">1875</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosFWrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=1867-1875&author=N.+P.+Thaoauthor=B.+T.+T.+Luyenauthor=J.+S.+Leeauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+H.+Kim&title=Inhibition+potential+of+cycloartane-type+glycosides+from+the+roots+of+Cimicifuga+dahurica+against+soluble+epoxide+hydrolase&doi=10.1021%2Facs.jnatprod.7b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition potential of cycloartane-type glycosides from the roots of Cimicifuga dahurica against soluble epoxide hydrolase</span></div><div class="casAuthors">Thao, Nguyen Phuong; Luyen, Bui Thi Thuy; Lee, Ji Sun; Kim, Jang Hoon; Dat, Nguyen Tien; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1867-1875</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A phytochem. assay-guided fractionation of the 95% ethanol ext. of Cimicifuga dahurica roots afforded 29 9,19-cycloartane triterpenoid glycosides, including the new cimiricasides A-F (1-6).  The structures of 1-6 were established using contemporary NMR methods and from the HRESIMS data, and the sugar moiety in each case was confirmed by acid hydrolysis and subsequent GC/MS anal.  Compds. 2, 4, 5, 7-9, 18, 25, and 29 showed sol. epoxide hydrolase inhibitory effects with IC50 values of 0.4 ± 0.1 to 24.0 ± 0.2 μM.  The compds. were analyzed by enzyme kinetic studies to explore the binding mode between the ligand and receptor.  Compds. 4 (mixed type), 8, 18, and 29 (noncompetitive type) bound to a preferred allosteric site, while compds. 2, 5, 7, 9, and 25 had competitive interactions at the active site.  The binding mechanism of selected inhibitors was investigated using mol. docking and dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxFdCmQJooirVg90H21EOLACvtfcHk0lglfFMYi1qelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosFWrs7s%253D&md5=6fd2db1e79bd92f20d41837f1b79a45f</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00166%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DInhibition%2520potential%2520of%2520cycloartane-type%2520glycosides%2520from%2520the%2520roots%2520of%2520Cimicifuga%2520dahurica%2520against%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D1867%26epage%3D1875%26doi%3D10.1021%2Facs.jnatprod.7b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy
Luyen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">In silico investigation of cycloartane triterpene derivatives from <i>Cimicifuga dahurica</i> (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2017.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijbiomac.2017.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28188798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1c3lvVKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2017&pages=526-534&author=N.+P.+Thaoauthor=J.+H.+Kimauthor=B.+T.+Thuy%0ALuyenauthor=N.+T.+Datauthor=Y.+H.+Kim&title=In+silico+investigation+of+cycloartane+triterpene+derivatives+from+Cimicifuga+dahurica+%28Turcz.%29+Maxim.+roots+for+the+development+of+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.ijbiomac.2017.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Thao Nguyen Phuong; Kim Jang Hoon; Thuy Luyen Bui Thi; Dat Nguyen Tien; Kim Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">International journal of biological macromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">526-534</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In our search for natural soluble epoxide hydrolase (sEH) inhibitors from plants, we found that an ethanolic extract of the roots of Cimicifuga dahurica (Turcz.) Maxim. significantly inhibits sEH in vitro.  A phytochemical study on the dichloromethane fraction of C. dahurica resulted in the isolation of two new cycloartane triterpenoids (1 and 6), together with 13 known cycloartane analogues (2-5 and 7-15).  The structures of compounds were determined by spectroscopic methods.  All of the triterpenoid derivatives inhibited sEH enzymatic activity in a concentration-dependent manner, and 13 of the tested compounds showed significant activity.  Among them, compounds 1, 3, 5, 7, 9, and 12 showed the highest levels of inhibitory activity, with IC50 values of about 5μM or less.  Kinetic analysis of compounds 1, 3, 5-9, 11, 12, and 14 revealed that compounds 3, 6, 7, 11, and 14 were non-competitive; 1, 5, 9, and 12 were mixed-type; and 8 was a competitive inhibitor.  Furthermore, in silico molecular docking indicated that compounds 3, 6-9, 11, 12, and 14 bound to sEH in a similar manner and had stable binding energies, as calculated by AutoDock 4.2 and processed in a 10,000-ps molecular dynamics simulation to assess the binding stability of compounds 5, 7, and 9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-nOOaOK18OkPI-fCgwosgfW6udTcc2eYv3pJn-VPF7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3lvVKjtQ%253D%253D&md5=0fb61588f55c85a5a0a850d9dba8dd99</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2017.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DThuy%2BLuyen%26aufirst%3DB.%2BT.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DIn%2520silico%2520investigation%2520of%2520cycloartane%2520triterpene%2520derivatives%2520from%2520Cimicifuga%2520dahurica%2520%2528Turcz.%2529%2520Maxim.%2520roots%2520for%2520the%2520development%2520of%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2017%26volume%3D98%26spage%3D526%26epage%3D534%26doi%3D10.1016%2Fj.ijbiomac.2017.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103637</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bioorg.2020.103637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32032849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103637&author=C.+P.+Sunauthor=J.+Zhangauthor=W.+Y.+Zhaoauthor=J.+Yiauthor=J.+K.+Yanauthor=Y.+L.+Wangauthor=C.+Morisseauauthor=Z.+B.+Liuauthor=B.+D.+Hammockauthor=X.+C.+Ma&title=Protostane-type+triterpenoids+as+natural+soluble+epoxide+hydrolase+inhibitors%3A+Inhibition+potentials+and+molecular+dynamics&doi=10.1016%2Fj.bioorg.2020.103637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics</span></div><div class="casAuthors">Sun, Cheng-Peng; Zhang, Juan; Zhao, Wen-Yu; Yi, Jing; Yan, Jian-Kun; Wang, Ya-Li; Morisseau, Christophe; Liu, Zhong-Bo; Hammock, Bruce D.; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103637</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of sol. epoxide hydrolase (sEH) is a promising therapeutic approach to treat inflammation and other disorders.  In our present investigation on searching for sEH inhibitors from traditional Chinese medicines, we found that Alisma orientale displayed inhibition of sEH.  We constructed a small library of protostane-type triterpenoids (1-25) isolated from A. orientale, and screened their inhibitory activities.  Alismanin B (1), 11-deoxy-25-anhydro alisol E (4), 11-deoxy alisol B (5), and 25-O-Et alisol A (15) displayed concn.-dependently inhibitory activities against sEH with IC50 values from 3.40 ± 0.57μM to 9.57 ± 0.88μM. 11-Deoxy-25-anhydro alisol E (4) and 11-deoxy alisol B (5) were defined as mixed-type competitive inhibitors with Ki values of 12.6 and 3.48μM, resp., based on the result of inhibition kinetics.  The potential interaction mechanism of 11-deoxy alisol B (5) with sEH was analyzed by mol. docking and mol. dynamics, revealing that amino acid residues Trp336 and Tyr466 were vital for its inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosmVe2j3nZnbVg90H21EOLACvtfcHk0lhmNDI0syy4zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7Y%253D&md5=47ac08fa371a13217b760ec41437d64e</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103637%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%2BY.%26aulast%3DYi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%2BB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DProtostane-type%2520triterpenoids%2520as%2520natural%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%253A%2520Inhibition%2520potentials%2520and%2520molecular%2520dynamics%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103637%26doi%3D10.1016%2Fj.bioorg.2020.103637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thao, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyen, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from <i>Cimicifuga dahurica</i> (Turcz.) Maxim</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1874</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2017.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28279529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1czkvVSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1874-1879&author=N.+P.+Thaoauthor=B.+T.+Luyenauthor=J.+S.+Leeauthor=J.+H.+Kimauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitors+of+indolinone+alkaloids+and+phenolic+derivatives+from+Cimicifuga+dahurica+%28Turcz.%29+Maxim&doi=10.1016%2Fj.bmcl.2017.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim</span></div><div class="casAuthors">Thao Nguyen Phuong; Luyen Bui Thi Thuy; Lee Ji Sun; Kim Young Ho; Kim Jang Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1874-1879</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this study was to search for potential therapeutic agents by identifying novel inhibitors of soluble epoxide hydrolase (sEH) from natural plants using an in silico approach.  We found that an ethanolic extract from the roots of Cimicifuga dahurica (Turcz.) Maxim. significantly inhibited sEH in vitro.  In a phytochemical investigation using assay-guided fractionation of the dichloromethane extract of C. dahurica, we isolated two new indolinone alkaloids (5 and 6) and five related constituents (1-4, and 7) and established their structures based on an extensive analysis using 1D and 2D NMR, and MS methods.  All of the isolated compounds inhibited sEH enzymatic activity in a dose-dependent manner, with IC50 values ranging from 0.8±0.0 to 2.8±0.4μM.  A kinetic analysis of compounds 1-7 revealed that compound 2 was non-competitive; 1, 3, and 7 were mixed-type; and 4-6 were competitive inhibitors.  Molecular docking was employed to further elucidate their receptor-ligand binding characteristics.  These results demonstrated that compounds from C. dahurica are potential sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlN7h30Bt1h1m8bhe6roZYfW6udTcc2ebG911J0hY4HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czkvVSltg%253D%253D&md5=a41740573fc8aeb41d71e32bacdaa1cc</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DThao%26aufirst%3DN.%2BP.%26aulast%3DLuyen%26aufirst%3DB.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%2520of%2520indolinone%2520alkaloids%2520and%2520phenolic%2520derivatives%2520from%2520Cimicifuga%2520dahurica%2520%2528Turcz.%2529%2520Maxim%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1874%26epage%3D1879%26doi%3D10.1016%2Fj.bmcl.2017.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of <i>Gentiana scabra</i></span>. <i>Biosci., Biotechnol., Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1080/09168451.2014.1002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F09168451.2014.1002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25588498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=907-911&author=W.+Liauthor=J.+H.+Kimauthor=W.+Zhouauthor=S.+H.+Shimauthor=J.+Y.+Maauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+phenolic+components+from+the+rhizomes+and+roots+of+Gentiana+scabra&doi=10.1080%2F09168451.2014.1002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of Gentiana scabra</span></div><div class="casAuthors">Li, Wei; Kim, Jang Hoon; Zhou, Wei; Shim, Sang Hee; Ma, Jin Yeul; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience, Biotechnology, and Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-911</span>CODEN:
                <span class="NLM_cas:coden">BBBIEJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-6947</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Two new (1 and 2) and seven known phenolic compds. were isolated from a methanol ext. of the rhizomes and roots of Gentiana scabra.  Their structures were identified by spectroscopic anal. and comparing with reported values.  The inhibitory effects of each compd. on sol. epoxide hydrolase (sEH) were evaluated.  Among them, compds. 2, 6, and 9 potently inhibited sEH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhROR5oSpBFrVg90H21EOLACvtfcHk0ljobEOBpy8ztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGjtro%253D&md5=3e76b4a4d4acb4ad7dab45cfd5cfe32d</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1080%2F09168451.2014.1002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09168451.2014.1002451%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShim%26aufirst%3DS.%2BH.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520phenolic%2520components%2520from%2520the%2520rhizomes%2520and%2520roots%2520of%2520Gentiana%2520scabra%26jtitle%3DBiosci.%252C%2520Biotechnol.%252C%2520Biochem.%26date%3D2015%26volume%3D79%26spage%3D907%26epage%3D911%26doi%3D10.1080%2F09168451.2014.1002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory activity of anthraquinone components from <i>Aloe</i></span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6659</span>– <span class="NLM_lpage">6665</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmc.2015.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26372074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6659-6665&author=Y.+N.+Sunauthor=J.+H.+Kimauthor=W.+Liauthor=A.+R.+Joauthor=X.+T.+Yanauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+activity+of+anthraquinone+components+from+Aloe&doi=10.1016%2Fj.bmc.2015.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe</span></div><div class="casAuthors">Sun, Ya Nan; Kim, Jang Hoon; Li, Wei; Jo, A. Reum; Yan, Xi Tao; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6659-6665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aloe is a short-stemmed succulent herb widely used in traditional medicine to treat various diseases and as raw material in cosmetics and heath foods.  In this study, we isolated and identified two new anthraquinone derivs., aloinoside C (6) and aloinoside D (7), together with six known compds. from an aq. dissolved Aloe exudate.  Their structures were identified by spectroscopic anal.  The inhibitory effects of the isolated compds. on sol. epoxide hydrolase (sEH) were evaluated.  Compds. 1-8 inhibited sEH activity potently, with IC50 values ranging from 4.1 ± 0.6 to 41.1 ± 4.2 μM.  A kinetic anal. of compds. 1-8 revealed that the inhibitory actions of compds. 1, 6 and 8 were non-competitive, whereas those of compds. 2-5 and 7 were the mixed-type.  Mol. docking increases our understanding of receptor-ligand binding of all compds.  These results demonstrate that compds. 1-8 from Aloe are potential sEH inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX__-X9hBtW7Vg90H21EOLACvtfcHk0ljobEOBpy8ztA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbnF&md5=d175ef822ea07ee1dfce9f2a9d14b082</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520of%2520anthraquinone%2520components%2520from%2520Aloe%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6659%26epage%3D6665%26doi%3D10.1016%2Fj.bmc.2015.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Chemical constituents from the root of <i>Polygonum multiflorum</i> and their soluble epoxide hydrolase inhibitory activity</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1007/s12272-014-0520-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12272-014-0520-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25413971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=998-1004&author=Y.+N.+Sunauthor=W.+Liauthor=J.+H.+Kimauthor=X.+T.+Yanauthor=J.+E.+Kimauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Chemical+constituents+from+the+root+of+Polygonum+multiflorum+and+their+soluble+epoxide+hydrolase+inhibitory+activity&doi=10.1007%2Fs12272-014-0520-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activity</span></div><div class="casAuthors">Sun, Ya Nan; Li, Wei; Kim, Jang Hoon; Yan, Xi Tao; Kim, Ji Eun; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">998-1004</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Fourteen compds. were isolated from a methanol ext. of Polygonum multiflorum roots, and their structures were elucidated by comparing spectroscopic data to published spectra.  The inhibitory effects of the isolated compds. on sol. epoxide hydrolase (sEH) were then evaluated.  Compds. 1-7 inhibited sEH activity potently, with IC50 values ranging from 6.2±0.5 to 48.6±3.1 μM.  Moreover, a kinetic anal. of compds. 1-7 revealed that the inhibitory actions of compds. 1, 3 and 4 were non-competitive, whereas those of compds. 2 and 5-7 were mixed-type.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjFYO-6MbvI7Vg90H21EOLACvtfcHk0lgiZ6tBNhIAyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtLrJ&md5=be2b2b3bc5d757d1feb5fe24aea808e7</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1007%2Fs12272-014-0520-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-014-0520-4%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BN.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DChemical%2520constituents%2520from%2520the%2520root%2520of%2520Polygonum%2520multiflorum%2520and%2520their%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2015%26volume%3D38%26spage%3D998%26epage%3D1004%26doi%3D10.1007%2Fs12272-014-0520-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitory components from <i>Rheum undulatum</i> and in silico approach</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1189421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1080%2F14756366.2016.1189421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27555350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=70-78&author=A.+R.+Joauthor=J.+H.+Kimauthor=X.+T.+Yanauthor=S.+Y.+Yangauthor=Y.+H.+Kim&title=Soluble+epoxide+hydrolase+inhibitory+components+from+Rheum+undulatum+and+in+silico+approach&doi=10.1080%2F14756366.2016.1189421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach</span></div><div class="casAuthors">Jo, Ah Reum; Kim, Jang Hoon; Yan, Xi-Tao; Yang, Seo Young; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup2</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Continuous efforts to identify sol. epoxide hydrolase (sEH) inhibitors using activity-guided fractionation revealed 12 known compds. from R. undulatum root.  The compds. were tested for inhibitory activity against sEH.  Eleven of the compds. were shown to have inhibitory activity, with IC50 values ranging from 2.5 ± 0.5 to 53.2 ± 4.4 μM.  They were subjected to enzyme kinetic studies to explore the binding mode between the ligand and receptor.  Based on these results, 10 compds. had a preferred allosteric site.  One compd. was identified as a competitive-type inhibitor.  Mol. docking studies revealed the interacting residues and binding energy between sEH and inhibitors.  Addnl., mol. dynamics simulation provided detailed information on the interaction between the ligand and receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8AAIlu7QmXLVg90H21EOLACvtfcHk0lgiZ6tBNhIAyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmt77P&md5=804f71a47e3b93b2c44a8c5a288b164a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1189421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1189421%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DYan%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitory%2520components%2520from%2520Rheum%2520undulatum%2520and%2520in%2520silico%2520approach%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D70%26epage%3D78%26doi%3D10.1080%2F14756366.2016.1189421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of <i>Glycosmis stenocarpa</i></span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1057719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3109%2F14756366.2015.1057719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26444316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFCmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=640-644&author=J.+H.+Kimauthor=A.+M.+Morganauthor=B.+H.+Taiauthor=D.+T.+Vanauthor=N.+M.+Cuongauthor=Y.+H.+Kim&title=Inhibition+of+soluble+epoxide+hydrolase+activity+by+compounds+isolated+from+the+aerial+parts+of+Glycosmis+stenocarpa&doi=10.3109%2F14756366.2015.1057719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of Glycosmis stenocarpa</span></div><div class="casAuthors">Kim, Jang Hoon; Morgan, Abubaker M. A.; Tai, Bui Huu; Doan, Thi Van; Nguyen, Manh Cuong; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">640-644</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aim of this study is to search for sol. epoxide hydrolase (sEH) inhibitors from natural plants, bioassay-guided fractionation of lipophilic n-hexane and chloroform layers of an ext. of the aerial parts of Glycosmis stenocarpa led to the isolation of 12 compds., including murrayafoline-A, isomahanine, bisisomahanine, saropeptate, (24S)-ergost-4-en-3,6-dione, stigmasta-4-en-3,6-dion, stigmast-4-en-3-one, β-sitosterol, 24-methylpollinastanol, trans-phytol, neosarmentol III and (+)-epiloliolide.  Their structures were elucidated on the basis of spectroscopic data.  Among them, neosarmentol III was isolated from nature for the first time.  All the isolated compds. were evaluated for their inhibitory activity against sEH.  Among isolated carbazole-type compds., isomahanine and bisisomahanine were identified as a potent inhibitor of sEH, with IC50 values of 22.5 ± 1.7 and 7.7 ± 1.2 μM, resp.  Moreover, the inhibitory action of and represented mixed-type enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDBFjf6_AnHLVg90H21EOLACvtfcHk0lgiZ6tBNhIAyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFCmu7w%253D&md5=3d2d257d7c8a3f1aeebfd73e1b934c71</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1057719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1057719%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMorgan%26aufirst%3DA.%2BM.%26aulast%3DTai%26aufirst%3DB.%2BH.%26aulast%3DVan%26aufirst%3DD.%2BT.%26aulast%3DCuong%26aufirst%3DN.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520activity%2520by%2520compounds%2520isolated%2520from%2520the%2520aerial%2520parts%2520of%2520Glycosmis%2520stenocarpa%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D640%26epage%3D644%26doi%3D10.3109%2F14756366.2015.1057719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanh, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duc, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huong, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, N. M.</span></span> <span> </span><span class="NLM_article-title">Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from <i>Callistemon citrinus</i></span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.fitote.2015.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26548595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeju7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=39-44&author=P.+N.+Khanhauthor=H.+V.+Ducauthor=T.+T.+Huongauthor=N.+T.+Sonauthor=V.+T.+Haauthor=D.+T.+Vanauthor=B.+H.+Taiauthor=J.+E.+Kimauthor=A.+R.+Joauthor=Y.+H.+Kimauthor=N.+M.+Cuong&title=Alkylphloroglucinol+derivatives+and+triterpenoids+with+soluble+epoxide+hydrolase+inhibitory+activity+from+Callistemon+citrinus&doi=10.1016%2Fj.fitote.2015.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from Callistemon citrinus</span></div><div class="casAuthors">Khanh, Pham Ngoc; Duc, Ho Viet; Huong, Tran Thu; Son, Ninh The; Ha, Vu Thi; Van, Doan Thi; Tai, Bui Huu; Kim, Ji Eun; Jo, Ah Reum; Kim, Young Ho; Cuong, Nguyen Manh</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-44</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phytochem. anal. of the leaves and stems of Callistemon citrinus (Curtis) Skeels led to the isolation of two new alkylphloroglucinols, gallomyrtucommulone E and F (1 and 2), along with four other known alkylphloroglucinol derivs., gallomyrtucommulone A (3), endoperoxide G3 (4), myrtucommulone B (5), callistenone B (6) and five known triterpenoids, including betulinic acid (7), 3β-acetylmorolic acid (8), 3β-hydroxy-urs-11-en-13(28)-olide (9), diospyrolide (10) and ursolic acid (11).  The structures of the natural compds. were detd. from the spectroscopic evidences including 1D-/2D-NMR and HR-MS spectrometry.  All the isolated compds. were assessed for the effects on the sEH inhibitory activity.  The acylphloroglucinols myrtucommulone B (5)/callistenone B (6) (in mixt.), and two triterpenoids, ursolic acid (11) and 3β-hydroxy-urs-11-en-13(28)-olide (9) displayed strong inhibition of sEH activity, with IC50 values of 0.7, 11.2 and 24.8 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7D9NUnZAaaLVg90H21EOLACvtfcHk0ljh0UuRq9PDmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeju7nO&md5=41029d900ae4c673e7e634e167f7ea8b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhanh%26aufirst%3DP.%2BN.%26aulast%3DDuc%26aufirst%3DH.%2BV.%26aulast%3DHuong%26aufirst%3DT.%2BT.%26aulast%3DSon%26aufirst%3DN.%2BT.%26aulast%3DHa%26aufirst%3DV.%2BT.%26aulast%3DVan%26aufirst%3DD.%2BT.%26aulast%3DTai%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DJo%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DCuong%26aufirst%3DN.%2BM.%26atitle%3DAlkylphloroglucinol%2520derivatives%2520and%2520triterpenoids%2520with%2520soluble%2520epoxide%2520hydrolase%2520inhibitory%2520activity%2520from%2520Callistemon%2520citrinus%26jtitle%3DFitoterapia%26date%3D2016%26volume%3D109%26spage%3D39%26epage%3D44%26doi%3D10.1016%2Fj.fitote.2015.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span> <span> </span><span class="NLM_article-title">Constituents of the seeds of <i>Cassia tora</i> with inhibitory activity on soluble expoxide hydrolease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5097</span>– <span class="NLM_lpage">5101</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.bmcl.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26483136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5097-5101&author=G.+Y.+Leeauthor=J.+H.+Kimauthor=S.+K.+Choiauthor=Y.+H.+Kim&title=Constituents+of+the+seeds+of+Cassia+tora+with+inhibitory+activity+on+soluble+expoxide+hydrolease&doi=10.1016%2Fj.bmcl.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Constituents of the seeds of Cassia tora with inhibitory activity on soluble epoxide hydrolase</span></div><div class="casAuthors">Lee, Ga Young; Kim, Jang Hoon; Choi, Seung-Kook; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5097-5101</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Efforts to ext. sol. epoxide hydrolase (sEH) inhibitors from food sources through bioactivity-guided fractionation of Cassia tora seed exts. led to the isolation of one new compd., 1, and 15 known compds., 2-16.  Structural elucidations were performed using 1D/2D NMR spectroscopy and mass spectrometry.  Compds. 1, 3, 4, 6, 10, 11, and 13-16 exhibited inhibitory activities on sEH with IC50 values of 2.2 ± 2.1-40.6 ± 3.4 μM.  Compd. 13 was particularly active and exhibited a reversible-uncompetitive behavior in enzyme kinetic studies.  A binding site on the enzyme for compd. 13 was also predicted by Autodock 4.2 simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhxuxzpaCQ0LVg90H21EOLACvtfcHk0ljh0UuRq9PDmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Kqu7%252FE&md5=66ed41806c4f9f7dbe556acac4fea7c6</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DConstituents%2520of%2520the%2520seeds%2520of%2520Cassia%2520tora%2520with%2520inhibitory%2520activity%2520on%2520soluble%2520expoxide%2520hydrolease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5097%26epage%3D5101%26doi%3D10.1016%2Fj.bmcl.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. L.</span></span> <span> </span><span class="NLM_article-title">Urea derivatives as anticancer agents</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.2174/1871520610909040471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.2174%2F1871520610909040471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19442045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=471-480&author=H.+Q.+Liauthor=P.+C.+Lvauthor=T.+Yanauthor=H.+L.+Zhu&title=Urea+derivatives+as+anticancer+agents&doi=10.2174%2F1871520610909040471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Urea derivatives as anticancer agents</span></div><div class="casAuthors">Li, Huan-Qiu; Lv, Peng-Cheng; Yan, Tao; Zhu, Hai-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-480</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Within the past ten years, a huge vol. of research on the synthesis, structure-activity relationships (SAR), and anticancer activities of the urea derivs. was reported.  Many arom. urea derivs. such as N-phenyl-N'-(2-chloroethyl)ureas (CEUs) and benzoylureas (BUs) show good anticancer activity, and these compds. have mainly been proved to be tubulin ligands that inhibit the polymn. of tubulin.  Heterocyclic urea derivs. play an important role in anticancer agents because of their good inhibitory activity against receptor tyrosine kinases (RTKs), raf kinases, protein tyrosine kinases (PTKs), and NADH oxidase, which play crit. roles in many aspects of tumorigenesis.  Thiourea derivs. are also of wide interest because of their diverse anticancer activity against various leukemias and solid tumors.  In this review, the anticancer activity of the urea derivs. mentioned above is summarized in detail.  It is hoped that increasing knowledge of the SAR and cellular processes underlying the antitumor-activity of urea derivs. will be beneficial to the rational design of new generation of urea anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2E0VPDqvojbVg90H21EOLACvtfcHk0ljh0UuRq9PDmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrc%253D&md5=028eb5bfbe09b8d9c34b1817ebc71c95</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.2174%2F1871520610909040471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909040471%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BQ.%26aulast%3DLv%26aufirst%3DP.%2BC.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DUrea%2520derivatives%2520as%2520anticancer%2520agents%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D471%26epage%3D480%26doi%3D10.2174%2F1871520610909040471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, C. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo-Semidey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span> <span> </span><span class="NLM_article-title">Pyrimidinyl biphenylureas act as allosteric modulators to activate cannabinoid receptor 1 and initiate beta-arrestin-dependent responses</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1124/mol.118.112854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fmol.118.112854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30322873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt1Shu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2019&pages=1-10&author=C.+A.+D.+Jaglaauthor=C.+E.+Scottauthor=Y.+Tangauthor=C.+Qiaoauthor=G.+E.+Mateo-Semideyauthor=G.+A.+Yudowskiauthor=D.+Luauthor=D.+A.+Kendall&title=Pyrimidinyl+biphenylureas+act+as+allosteric+modulators+to+activate+cannabinoid+receptor+1+and+initiate+beta-arrestin-dependent+responses&doi=10.1124%2Fmol.118.112854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimidinyl biphenylureas act as allosteric modulators to activate cannabinoid receptor 1 and initiate β-arrestin-dependent responses</span></div><div class="casAuthors">Jagla, Caitlin A. D.; Scott, Caitlin E.; Tang, Yaliang; Qiao, Changjiang; Mateo-Semidey, Gabriel E.; Yudowski, Guillermo A.; Lu, Dai; Kendall, Debra A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is a G-protein-coupled receptor that is abundant in the central nervous system.  It binds several compds. in its orthosteric site, including the endocannabinoids, arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol, and the plant-derived Δ9-tetrahydrocannabinol, one of the main psychoactive components of marijuana.  It primarily couples to Gi/oproteins to inhibit adenylate cyclase activity and typically induces downstream signaling that is Gi-dependent.  Since this receptor is implicated in several maladies, such as obesity, pain, and neurodegenerative disorders, there is interest in developing therapeutics that selectively target this receptor.  Allosteric modulators of CB1 offer one new approach that has tremendous therapeutic potential.  Here, we reveal receptor- and cellular-level properties consistent with receptor activation by a series of pyrimidinyl biphenylureas (LDK1285, LDK1288, LDK1305, and PSNCBAM1), including promoting binding of the agonist CP55940 with pos. cooperativity and inhibiting binding of the inverse agonist SR141716A with neg. cooperativity, demonstrated via radioligand binding studies.  Consistent with these findings, the allosteric modulators induced cellular internalization of the receptor and recruitment of β-arrestin 2 in human embryonic kidney cell line 293 cells monitored with confocal and total internal reflective fluorescence microscopy, resp.  These allosteric modulators, however, caused G-protein-independent but β-arrestin 1-dependent phosphorylation of the downstream kinases extracellular signal-regulated kinase 1/2, mitogen-activated protein kinase, and Src, shown by immunoblotting studies.  These results are consistent with the involvement of β-arrestin and suggest that these allosteric modulators induce biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbx4EnosiAJbVg90H21EOLACvtfcHk0lgU4uUE3hXgdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt1Shu78%253D&md5=461f0df03d21eaf43a6ccc4ab38c1135</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1124%2Fmol.118.112854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.118.112854%26sid%3Dliteratum%253Aachs%26aulast%3DJagla%26aufirst%3DC.%2BA.%2BD.%26aulast%3DScott%26aufirst%3DC.%2BE.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DMateo-Semidey%26aufirst%3DG.%2BE.%26aulast%3DYudowski%26aufirst%3DG.%2BA.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26atitle%3DPyrimidinyl%2520biphenylureas%2520act%2520as%2520allosteric%2520modulators%2520to%2520activate%2520cannabinoid%2520receptor%25201%2520and%2520initiate%2520beta-arrestin-dependent%2520responses%26jtitle%3DMol.%2520Pharmacol.%26date%3D2019%26volume%3D95%26spage%3D1%26epage%3D10%26doi%3D10.1124%2Fmol.118.112854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span> <span> </span><span class="NLM_article-title">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in Alzheimer’s signaling in human nerve cells</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4018</span>– <span class="NLM_lpage">4030</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00271</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00271" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4018-4030&author=Z.+Liangauthor=B.+Zhangauthor=M.+Xuauthor=C.+Morisseauauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=Q.+X.+Li&title=1-Trifluoromethoxyphenyl-3-%281-propionylpiperidin-4-yl%29+urea%2C+a+selective+and+potent+dual+inhibitor+of+soluble+epoxide+hydrolase+and+p38+kinase+intervenes+in+Alzheimer%E2%80%99s+signaling+in+human+nerve+cells&doi=10.1021%2Facschemneuro.9b00271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells</span></div><div class="casAuthors">Liang, Zhibin; Zhang, Bei; Xu, Meng; Morisseau, Christophe; Hwang, Sung Hee; Hammock, Bruce D.; Li, Qing X.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4018-4030</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disorder.  Neuroinflammation is a prevalent pathogenic stress leading to neuronal death in AD.  Targeting neuroinflammation to keep neurons alive is an attractive strategy for AD therapy.  1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) is a potent inhibitor of sol. epoxide hydrolase (sEH) and can enter into the brain.  It has a good efficacy on a wide range of chronic inflammatory diseases in preclin. animal models.  However, the anti-neuroinflammatory effects and mol. mechanisms of TPPU for potential AD interventions remain elusive.  With an aim to develop multi-target therapeutics for neurodegenerative diseases, we screened TPPU against sEH from different vertebrate species and a broad panel of human kinases in vitro for potential new targets relevant to neuroinflammation in AD.  TPPU inhibits both human sEH and p38β kinase, two key regulators of inflammation, with nanomolar potencies and distinct selectivity.  To further elucidate the mol. mechanisms, differentiated SH-SY5Y human neuroblastoma cells were used as an AD cell model and investigated the neuroprotection of TPPU against amyloid oligomers.  We found that TPPU effectively prevents neuronal death by mitigating amyloid neurotoxicity, tau hyperphosphorylation and mitochondrial dysfunction, promoting neurite outgrowth, and suppressing activation and nuclear translocation of NF-κB for inflammatory responses in human nerve cells.  The results indicate that TPPU is a potent and selective dual inhibitor of sEH and p38β kinase, showing a synergistic action in multiple AD signaling pathways.  Our study sheds light upon TPPU and other sEH/p38β dual inhibitors for potential pharmacol. interventions in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs0ueaFZwGrVg90H21EOLACvtfcHk0lgU4uUE3hXgdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7nM&md5=d48d3991aad60f484894618db9c1a70a</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00271%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26atitle%3D1-Trifluoromethoxyphenyl-3-%25281-propionylpiperidin-4-yl%2529%2520urea%252C%2520a%2520selective%2520and%2520potent%2520dual%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520p38%2520kinase%2520intervenes%2520in%2520Alzheimer%25E2%2580%2599s%2520signaling%2520in%2520human%2520nerve%2520cells%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4018%26epage%3D4030%26doi%3D10.1021%2Facschemneuro.9b00271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boardley, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tal-Singer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyan, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1111/bcp.12855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fbcp.12855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=26620151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=971-979&author=A.+L.+Lazaarauthor=L.+Yangauthor=R.+L.+Boardleyauthor=N.+S.+Goyalauthor=J.+Robertsonauthor=S.+J.+Baldwinauthor=D.+E.+Newbyauthor=I.+B.+Wilkinsonauthor=R.+Tal-Singerauthor=R.+J.+Mayerauthor=J.+Cheriyan&title=Pharmacokinetics%2C+pharmacodynamics+and+adverse+event+profile+of+GSK2256294%2C+a+novel+soluble+epoxide+hydrolase+inhibitor&doi=10.1111%2Fbcp.12855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor</span></div><div class="casAuthors">Lazaar, Aili L.; Yang, Lucy; Boardley, Rebecca L.; Goyal, Navin S.; Robertson, Jonathan; Baldwin, Sandra J.; Newby, David E.; Wilkinson, Ian B.; Tal-Singer, Ruth; Mayer, Ruth J.; Cheriyan, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-979</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Endothelial-derived epoxyeicosatrienoic acids may regulate vascular tone and are metabolized by sol. epoxide hydrolase enzymes (sEH).  GSK2256294 is a potent and selective sEH inhibitor that was tested in two phase I studies.  Single escalating doses of GSK2256294 2-20 mg or placebo were administered in a randomized crossover design to healthy male subjects or obese smokers.  Once daily doses of 6 or 18 mg or placebo were administered for 14 days to obese smokers.  Data were collected on safety, pharmacokinetics, sEH enzyme inhibition and blood biomarkers.  Single doses of GSK2256294 10 mg were also administered to healthy younger males or healthy elderly males and females with and without food.  Data on safety, pharmacokinetics and biliary metabolites were collected.  Results : GSK2256294 was well-tolerated with no serious adverse events (AEs) attributable to the drug.  The most frequent AEs were headache and contact dermatitis.  Plasma concns. of GSK2256294 increased with single doses, with a half-life averaging 25-43 h.  There was no significant effect of age, food or gender on pharmacokinetic parameters.  Inhibition of sEH enzyme activity was dose-dependent, from an av. of 41.9% on 2 mg (95% confidence interval [CI] -51.8, 77.7) to 99.8% on 20 mg (95% CI 99.3, 100.0) and sustained for up to 24 h.  There were no significant changes in serum VEGF or plasma fibrinogen.  GSK2256294 was well-tolerated and demonstrated sustained inhibition of sEH enzyme activity.  These data support further investigation in patients with endothelial dysfunction or abnormal tissue repair, such as diabetes, wound healing or COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr37PHmVvZ8A7Vg90H21EOLACvtfcHk0lijvWqgmbC1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls7w%253D&md5=085db35368f6acb60aef7aa05d4aaa1c</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12855%26sid%3Dliteratum%253Aachs%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBoardley%26aufirst%3DR.%2BL.%26aulast%3DGoyal%26aufirst%3DN.%2BS.%26aulast%3DRobertson%26aufirst%3DJ.%26aulast%3DBaldwin%26aufirst%3DS.%2BJ.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DTal-Singer%26aufirst%3DR.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DCheriyan%26aufirst%3DJ.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%2520and%2520adverse%2520event%2520profile%2520of%2520GSK2256294%252C%2520a%2520novel%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2016%26volume%3D81%26spage%3D971%26epage%3D979%26doi%3D10.1111%2Fbcp.12855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/bs.apha.2016.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fbs.apha.2016.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27451096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12hsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=105-141&author=J.+D.+Imig&title=Epoxyeicosatrienoic+acids+and+20-hydroxyeicosatetraenoic+acid+on+endothelial+and+vascular+function&doi=10.1016%2Fbs.apha.2016.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function</span></div><div class="casAuthors">Imig, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">Endothelium</span>),
    <span class="NLM_cas:pages">105-141</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Endothelial and vascular smooth cells generate cytochrome P 450 (CYP) arachidonic acid metabolites that can impact endothelial cell function and vascular homeostasis.  The objective of this review is to focus on the physiol. and pharmacol. of endothelial CYP metabolites.  The CYP pathway produces two types of eicosanoid products: epoxyeicosatrienoic acids (EETs), formed by CYP epoxygenases, and hydroxyeicosatetraenoic acids (HETEs), formed by CYP hydroxylases.  Advances in CYP enzymes, EETs, and 20-HETE by pharmacol. and genetic means have led to a more complete understanding of how these eicosanoids impact on endothelial cell function.  Endothelial-derived EETs were initially described as endothelial-derived hyperpolarizing factors.  It is now well recognized that EETs importantly contribute to numerous endothelial cell functions.  On the other hand, 20-HETE is the predominant CYP hydroxylase synthesized by vascular smooth muscle cells.  Like EETs, 20-HETE acts on endothelial cells and impacts importantly on endothelial and vascular function.  An important aspect for EETs and 20-HETE endothelial actions is their interactions with hormonal and paracrine factors.  These include interactions with the renin-angiotensin system, adrenergic system, puringeric system, and endothelin.  Alterations in CYP enzymes, 20-HETE, or EETs contribute to endothelial dysfunction and cardiovascular diseases such as ischemic injury, hypertension, and atherosclerosis.  Recent advances have led to the development of potential therapeutics that target CYP enzymes, 20-HETE, or EETs.  Thus, future investigation is required to obtain a more complete understanding of how CYP enzymes, 20-HETE, and EETs regulate endothelial cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTPKNgvl2zc7Vg90H21EOLACvtfcHk0lijvWqgmbC1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12hsLvO&md5=487b0bf840d6a7dadb5eca648e670dd2</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fbs.apha.2016.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.apha.2016.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DEpoxyeicosatrienoic%2520acids%2520and%252020-hydroxyeicosatetraenoic%2520acid%2520on%2520endothelial%2520and%2520vascular%2520function%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D105%26epage%3D141%26doi%3D10.1016%2Fbs.apha.2016.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. S.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">267</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1635-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1635-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31847859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyrsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=267&author=H.+T.+Leeauthor=K.+I.+Leeauthor=C.+H.+Chenauthor=T.+S.+Lee&title=Genetic+deletion+of+soluble+epoxide+hydrolase+delays+the+progression+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-019-1635-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease</span></div><div class="casAuthors">Lee, Hsueh-Te; Lee, Kuan-I.; Chen, Chia-Hui; Lee, Tzong-Shyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">267</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">To examine the role of sEH in pathogenesis of AD, we used wild-type (WT) mice, sol. epoxide hydrolase deficient (sEH-/-) and two mouse models of AD, including amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic (APP/PS1 Tg) and APP/PS1 Tg/sEH-/- mice.  The levels of interleukin (IL)-1β, IL-4, IL-6, and IL-10 and the activities of NF-κB and nuclear factor of activated T cells (NFAT) were measured by com. assay kits.  We demonstrated that the level of sEH was increased in the brain and predominantly appeared in hippocampal astrocytes of APP/PS1 Tg mice.  Genetic ablation of sEH in APP/PS1 Tg mice delayed the progression of AD as evidenced by the alleviation in behavior outcomes and Aβ plaque deposition.  In addn., loss of the function of sEH in APP/PS1 Tg mice increased astrogliosis and the prodn. of astrocyte-derived anti-inflammatory cytokines including IL-1β, IL-4, and IL-10, as well as the activity of NF-kB and NFAT.  Moreover, anal. of gene ontol. in the AD brain revealed that important signaling pathways and processes related to AD pathogenesis such as translational regulation, oxidative stress, cytoskeleton reorganization, and small GTPase signal transduction were altered in APP/PS1 Tg/sEH-/- mice compared with APP/PS1 Tg mice.  Our results suggest that sEH is a crucial regulator in the progression of AD and might be a potential therapeutic target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7pffaZ6WEn7Vg90H21EOLACvtfcHk0lijvWqgmbC1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyrsr7I&md5=ccf2fc448bbd021b9adada1d00d797e5</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1635-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1635-9%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BT.%26aulast%3DLee%26aufirst%3DK.%2BI.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BS.%26atitle%3DGenetic%2520deletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520delays%2520the%2520progression%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D267%26doi%3D10.1186%2Fs12974-019-1635-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodani, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span> <span> </span><span class="NLM_article-title">Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2019.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.biochi.2019.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30716359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2019&pages=59-65&author=S.+D.+Kodaniauthor=C.+Morisseau&title=Role+of+epoxy-fatty+acids+and+epoxide+hydrolases+in+the+pathology+of+neuro-inflammation&doi=10.1016%2Fj.biochi.2019.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation</span></div><div class="casAuthors">Kodani, Sean D.; Morisseau, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-65</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neuroinflammation is a physiol. response aimed at protecting the central nervous system during injury.  However, unresolved and chronic neuroinflammation can lead to long term damage and eventually neurol. disease including Parkinson's disease, Alzheimer's disease and dementia.  Recently, enhancing the concn. of epoxyeicosatrienoic acids (EETs) through blocking their hydrolytic degrdn. by sol. epoxide hydrolase (sEH) has been applied towards reducing the long-term damage assocd. with central neurol. insults.  Evidence suggests this protective effect is mediated, at least in part, through polarization of microglia to an anti-inflammatory phenotype that blocks the inflammatory actions of prostaglandins and promotes wound repair.  This mini-review overviews the epidemiol. basis for using sEH inhibition towards neuroinflammatory disease and pharmacol. studies testing sEH inhibition in several neurol. diseases.  Addnl., the combination of sEH inhibition with other eicosanoid signaling pathways is considered as an enhanced approach for developing potent neuroprotectants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHkm1AvVQT6LVg90H21EOLACvtfcHk0lijvWqgmbC1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVahtb8%253D&md5=7ff69c1886a8c5ca0f43b2a0e6fc91ed</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2019.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2019.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DKodani%26aufirst%3DS.%2BD.%26aulast%3DMorisseau%26aufirst%3DC.%26atitle%3DRole%2520of%2520epoxy-fatty%2520acids%2520and%2520epoxide%2520hydrolases%2520in%2520the%2520pathology%2520of%2520neuro-inflammation%26jtitle%3DBiochimie%26date%3D2019%26volume%3D159%26spage%3D59%26epage%3D65%26doi%3D10.1016%2Fj.biochi.2019.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2017.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2017.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWgu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=68-78&author=B.+Inceogluauthor=A.+Bettaiebauthor=F.+G.+Hajauthor=A.+V.+Gomesauthor=B.+D.+Hammock&title=Modulation+of+mitochondrial+dysfunction+and+endoplasmic+reticulum+stress+are+key+mechanisms+for+the+wide-ranging+actions+of+epoxy+fatty+acids+and+soluble+epoxide+hydrolase+inhibitors&doi=10.1016%2Fj.prostaglandins.2017.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Inceoglu, Bora; Bettaieb, Ahmed; Haj, Fawaz G.; Gomes, Aldrin V.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The arachidonic acid cascade is arguably the most widely known biol. regulatory pathway.  Decades after the seminal discoveries involving its cyclooxygenase and lipoxygenase branches, studies of this cascade remain an active area of research.  The third and less widely known branch, the cytochrome P 450 pathway leads to highly active oxygenated lipid mediators, epoxy fatty acids (EpFAs) and hydroxyeicosatetraenoic acids (HETEs), which are of similar potency to prostanoids and leukotrienes.  Unlike the COX and LOX branches, no pharmaceuticals currently are marketed targeting the P 450 branch.  However, data support therapeutic benefits from modulating these regulatory lipid mediators.  This is being approached by stabilizing or mimicking the EpFAs or even by altering the diet.  These approaches lead to predominantly beneficial effects on a wide range of apparently unrelated states resulting in an enigma of how this small group of natural chem. mediators can have such diverse effects.  EpFAs are degraded by sol. epoxide hydrolase (sEH) and stabilized by inhibiting this enzyme.  In this review, we focus on interconnected aspects of reported mechanisms of action of EpFAs and inhibitors of sol. epoxide hydrolase (sEHI).  The sEHI and EpFAs are commonly reported to maintain homeostasis under pathol. conditions while remaining neutral under normal physiol. conditions.  Here we provide a conceptual framework for the unique and broad range of biol. activities ascribed to epoxy fatty acids.  We argue that their mechanism of action pivots on their ability to prevent mitochondrial dysfunction, to reduce subsequent ROS formation and to block resulting cellular signaling cascades, primarily the endoplasmic reticulum stress.  By stabilizing the mitochondrial - ROS - ER stress axis, the range of activity of EpFAs and sEHI display an overlap with the disease conditions including diabetes, fibrosis, chronic pain, cardiovascular and neurodegenerative diseases, for which the above outlined mechanisms play key roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51H_f53xQdLVg90H21EOLACvtfcHk0lgWcLEgjiPDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWgu7vE&md5=b96bbc5c810fce2fbd7a15f8f4a91b25</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2017.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2017.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DHaj%26aufirst%3DF.%2BG.%26aulast%3DGomes%26aufirst%3DA.%2BV.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DModulation%2520of%2520mitochondrial%2520dysfunction%2520and%2520endoplasmic%2520reticulum%2520stress%2520are%2520key%2520mechanisms%2520for%2520the%2520wide-ranging%2520actions%2520of%2520epoxy%2520fatty%2520acids%2520and%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2017%26volume%3D133%26spage%3D68%26epage%3D78%26doi%3D10.1016%2Fj.prostaglandins.2017.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKevitt, C.</span></span> <span> </span><span class="NLM_article-title">Lay perspectives on hypertension and drug adherence: systematic review of qualitative research</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>345</i></span>, <span class="NLM_elocation-id">e3953</span> <span class="refDoi"> DOI: 10.1136/bmj.e3953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1136%2Fbmj.e3953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22777025" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2012&author=I.+J.+Marshallauthor=C.+D.+Wolfeauthor=C.+McKevitt&title=Lay+perspectives+on+hypertension+and+drug+adherence%3A+systematic+review+of+qualitative+research&doi=10.1136%2Fbmj.e3953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1136%2Fbmj.e3953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.e3953%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DI.%2BJ.%26aulast%3DWolfe%26aufirst%3DC.%2BD.%26aulast%3DMcKevitt%26aufirst%3DC.%26atitle%3DLay%2520perspectives%2520on%2520hypertension%2520and%2520drug%2520adherence%253A%2520systematic%2520review%2520of%2520qualitative%2520research%26jtitle%3DBMJ.%26date%3D2012%26volume%3D345%26doi%3D10.1136%2Fbmj.e3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1038/nrd2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2kurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=794-805&author=J.+D.+Imigauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+as+a+therapeutic+target+for+cardiovascular+diseases&doi=10.1038%2Fnrd2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases</span></div><div class="casAuthors">Imig, John D.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">794-805</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation, antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions.  These endogenous lipid mediators are broken down into diols by sol. epoxide hydrolase (sEH), and so inhibiting this enzyme would be expected to enhance the beneficial cardiovascular properties of EETs.  SEH inhibitors (sEHIs) that are based on 1,3-disubstituted urea were rapidly developed, and were shown to be antihypertensive and anti-inflammatory, and to protect the brain, heart and kidney from damage.  Although challenges for the future exist - including improving the drug-like properties of sEHIs and finding better ways to target sEHIs to specific tissues - the recent initiation of the first clin. trials of sEHIs has highlighted the therapeutic potential of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFEiIF428mLVg90H21EOLACvtfcHk0lgWcLEgjiPDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2kurnK&md5=fc2af5b4802701035998e0435c8d2699</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fnrd2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2875%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520as%2520a%2520therapeutic%2520target%2520for%2520cardiovascular%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D794%26epage%3D805%26doi%3D10.1038%2Fnrd2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebremedhin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanRollins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>263</i></span>,  <span class="NLM_fpage">H519</span>– <span class="NLM_lpage">H525</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.1992.263.2.H519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.1992.263.2.H519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1510149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK38XlvVyrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1992&pages=H519-H525&author=D.+Gebremedhinauthor=Y.+H.+Maauthor=J.+R.+Falckauthor=R.+J.+Romanauthor=M.+VanRollinsauthor=D.+R.+Harder&title=Mechanism+of+action+of+cerebral+epoxyeicosatrienoic+acids+on+cerebral+arterial+smooth+muscle&doi=10.1152%2Fajpheart.1992.263.2.H519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle</span></div><div class="casAuthors">Gebremedhin, Debebe; Ma, Yunn Hwa; Falck, John R.; Roman, Richard J.; VanRollins, Mike; Harder, David R.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">263</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">H519-H525</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    </div><div class="casAbstract">Microsomal prepns. of cat brain incubated with [14C]arachidonic acid produced epoxyeicosatrienoic acids (EETs) that eluted with the same retention times as synthetically prepd. 5,6-, 8,9-, and 11,12-EETs.  These compds. dilated serotonin-preconstricted, pressurized cat cerebral arteries in a dose-dependent fashion.  Epoxide formation was not found in mitochondrial fractions and was dependent on the presence of NADPH.  The max. effects of 8,9-EET and 11,12-EET were greater than those of 5,6-EET.  The cellular basis of this vasodilation was further investigated by examg. the effects of 8,9-EET and 11,12-EET on K+ channel activity in vascular muscle cells freshly isolated from cat cerebral arteries.  Both 8,9-EET and 11,12-EET increased the frequency of opening, mean open time, and open-state probability of a 98-pS K+ channel recorded in the cell-attached mode with 145 mM KCl in the pipet and 4.7 mM KCl in the bath.  Blockade of K+ channel activity with tetraethylammonium attenuated the vasodilatory effects of 11,12-EET on serotonin-preconstricted cat cerebral arteries.  Apparently, endogenously formed EETs may participate in local regulation of cerebral blood flow by dilating cerebral arteries through a mechanism that involves activation of K+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox7CgEUuTMxLVg90H21EOLACvtfcHk0likvJuCw6ufzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVyrsbk%253D&md5=45d176549dc8886dad3dc6e14f5dab01</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.1992.263.2.H519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.1992.263.2.H519%26sid%3Dliteratum%253Aachs%26aulast%3DGebremedhin%26aufirst%3DD.%26aulast%3DMa%26aufirst%3DY.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DRoman%26aufirst%3DR.%2BJ.%26aulast%3DVanRollins%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26atitle%3DMechanism%2520of%2520action%2520of%2520cerebral%2520epoxyeicosatrienoic%2520acids%2520on%2520cerebral%2520arterial%2520smooth%2520muscle%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1992%26volume%3D263%26spage%3DH519%26epage%3DH525%26doi%3D10.1152%2Fajpheart.1992.263.2.H519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">H1229</span>– <span class="NLM_lpage">H1236</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00736.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpheart.00736.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11893556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=H1229-H1236&author=P.+L.+Liauthor=D.+X.+Zhangauthor=Z.+D.+Geauthor=W.+B.+Campbell&title=Role+of+ADP-ribose+in+11%2C12-EET-induced+activation+of+K%28Ca%29+channels+in+coronary+arterial+smooth+muscle+cells&doi=10.1152%2Fajpheart.00736.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00736.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00736.2001%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%2BL.%26aulast%3DZhang%26aufirst%3DD.%2BX.%26aulast%3DGe%26aufirst%3DZ.%2BD.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DRole%2520of%2520ADP-ribose%2520in%252011%252C12-EET-induced%2520activation%2520of%2520K%2528Ca%2529%2520channels%2520in%2520coronary%2520arterial%2520smooth%2520muscle%2520cells%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D282%26spage%3DH1229%26epage%3DH1236%26doi%3D10.1152%2Fajpheart.00736.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1161/01.RES.85.4.349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.85.4.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10455063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXltlehurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=349-356&author=P.+L.+Liauthor=C.+L.+Chenauthor=R.+Bortellauthor=W.+B.+Campbell&title=11%2C12-Epoxyeicosatrienoic+acid+stimulates+endogenous+mono-ADP-ribosylation+in+bovine+coronary+arterial+smooth+muscle&doi=10.1161%2F01.RES.85.4.349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle</span></div><div class="casAuthors">Li, Pin-Lan; Chen, Cai-Lian; Bortell, Rita; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The role of endogenous ADP-ribosylation in mediating the activation of the Ca2+-activated K+ channels was detd. in bovine coronary arteries.  Endogenous ADP-ribosylation was examd. by incubating coronary arterial homogenates or lysates of cultured coronary arterial smooth muscle cells with [adenylate-32P]NAD.  Four 32P-labeled proteins were obsd. at 51, 52, 80, and 124 kDa in the homogenates and lysates.  This reaction was enhanced by the addn. of 11,12-epoxyeicosatrienoic acid (11,12-EET), a cytochrome P 450-derived eicosanoid, and GTP to the incubation.  By Western blot anal., 42- and 70-kDa proteins were recognized by specific antibodies against ADP-ribosyltransferase in the coronary arterial homogenates and smooth muscle cell lysate but not in the lysate of endothelial cells.  The 52-kDa acceptor protein of endogenous ADP-ribosylation comigrated with a protein ADP-ribosylated by cholera toxin and was recognized and immunopptd. by an anti-GSα antibody.  These results suggest that GSα is one of several acceptors of the ADP-ribose moiety.  As shown by the patch-clamp technique, 11,12-EET stimulated the activation of the K+ channels in the smooth muscle cells, and this activation was completely blocked by novobiocin, vitamin K1, 3-aminobenzamide, and m-iodobenzylguanidine, inhibitors of endogenous mono-ADP-ribosyltransferases.  We conclude that endogenous mono-ADP-ribosyltransferases are present in smooth muscle from bovine coronary arteries.  These enzymes transfer ADP-ribose to the cellular proteins such as GSα and may mediate intracellular signal transduction in coronary vascular smooth muscle.  In the coronary circulation, the ADP-ribosylation signaling pathway may play an important role in mediating the activation of the K+ channels induced by 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaMRxGXr6QfbVg90H21EOLACvtfcHk0likvJuCw6ufzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlehurs%253D&md5=79775c4feed224b0b17e7fc91e3915f2</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1161%2F01.RES.85.4.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.85.4.349%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%2BL.%26aulast%3DChen%26aufirst%3DC.%2BL.%26aulast%3DBortell%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D11%252C12-Epoxyeicosatrienoic%2520acid%2520stimulates%2520endogenous%2520mono-ADP-ribosylation%2520in%2520bovine%2520coronary%2520arterial%2520smooth%2520muscle%26jtitle%3DCirc.%2520Res.%26date%3D1999%26volume%3D85%26spage%3D349%26epage%3D356%26doi%3D10.1161%2F01.RES.85.4.349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gragasin, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platonov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E. D.</span></span> <span> </span><span class="NLM_article-title">Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000047278.28407.C2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.CIR.0000047278.28407.C2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12578883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=769-776&author=S.+L.+Archerauthor=F.+S.+Gragasinauthor=X.+Wuauthor=S.+Wangauthor=S.+McMurtryauthor=D.+H.+Kimauthor=M.+Platonovauthor=A.+Koshalauthor=K.+Hashimotoauthor=W.+B.+Campbellauthor=J.+R.+Falckauthor=E.+D.+Michelakis&title=Endothelium-derived+hyperpolarizing+factor+in+human+internal+mammary+artery+is+11%2C12-epoxyeicosatrienoic+acid+and+causes+relaxation+by+activating+smooth+muscle+BK%28Ca%29+channels&doi=10.1161%2F01.CIR.0000047278.28407.C2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels</span></div><div class="casAuthors">Archer, Stephen L.; Gragasin, Ferrante S.; Wu, Xichen; Wang, Shaohua; McMurtry, Sean; Kim, Daniel H.; Platonov, Michael; Koshal, Arvind; Hashimoto, Kyoko; Campbell, William B.; Falck, J. R.; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Left internal mammary arteries (LIMAs) synthesize endothelium-derived hyperpolarizing factor (EDHF), a short-lived K+ channel activator that persists after inhibition of nitric oxide (NO) and prostaglandin synthesis.  EDHF hyperpolarizes and relaxes smooth muscle cells (SMCs).  The identity of EDHF in humans is unknown.  The authors hypothesized that EDHF (1) is 11,12-epoxyeicosatrienoic acid (11,12-EET); (2) is generated by cytochrome P 450-2C, CYP450-2C; and (3) causes relaxation by opening SMC large-conductance Ca2+-activated K+ channels (BKCa).  Methods and Results: The identity of EDHF and its mechanism of action were assessed in 120 distal human LIMAs and 20 saphenous veins (SVs) obtained during CABG.  The predominant EET synthesized by LIMAs is 11,12-EET.  Relaxations to exogenous 11,12-EET and endogenous EDHF are of similar magnitudes.  Inhibition of EET synthesis by chem. distinct CYP450 inhibitors (17-octadecynoic acid, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide), or a selective EET antagonist (4,15-epoxyeicosa-5(Z)-enoic acid) impairs EDHF relaxation.  11,12-EET activates a BKCa current and hyperpolarizes LIMA SMCs.  Inhibitors of BKCa but not inward-rectifier or small-conductance KCa channels abolish relaxation to endogenous EDHF and exogenous 11,12-EET.  BKCa and CYP450-2C mRNA and proteins are more abundant in LIMAs than in SVs, perhaps explaining the lack of EDHF activity of the SV.  Laser capture microdissection and quant. RT-PCR demonstrate that BKCa channels are primarily in vascular SMCs, whereas the CYP450-2C enzyme is present in both the endothelium and SMCs.  Conclusions: In human LIMAs, EDHF is 11,12-EET produced by an EDHF synthase CYP450-2C and accounting for 40% of net endothelial relaxation.  11,12-EET causes relaxation by activating SMC BKCa channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKn_YYcs9fhbVg90H21EOLACvtfcHk0likvJuCw6ufzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12jtg%253D%253D&md5=dd7bd0ce8af7b343af75caa9b0afb470</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000047278.28407.C2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000047278.28407.C2%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DGragasin%26aufirst%3DF.%2BS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcMurtry%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DPlatonov%26aufirst%3DM.%26aulast%3DKoshal%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DEndothelium-derived%2520hyperpolarizing%2520factor%2520in%2520human%2520internal%2520mammary%2520artery%2520is%252011%252C12-epoxyeicosatrienoic%2520acid%2520and%2520causes%2520relaxation%2520by%2520activating%2520smooth%2520muscle%2520BK%2528Ca%2529%2520channels%26jtitle%3DCirculation%26date%3D2003%26volume%3D107%26spage%3D769%26epage%3D776%26doi%3D10.1161%2F01.CIR.0000047278.28407.C2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisslthaler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busse, R.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 2C is an EDHF synthase in coronary arteries</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1038/46816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2F46816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10519554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADyaK1MvkslSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=493-497&author=B.+Fisslthalerauthor=R.+Poppauthor=L.+Kissauthor=M.+Potenteauthor=D.+R.+Harderauthor=I.+Flemingauthor=R.+Busse&title=Cytochrome+P450+2C+is+an+EDHF+synthase+in+coronary+arteries&doi=10.1038%2F46816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2C is an EDHF synthase in coronary arteries</span></div><div class="casAuthors">Fisslthaler B; Popp R; Kiss L; Potente M; Harder D R; Fleming I; Busse R</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6752</span>),
    <span class="NLM_cas:pages">493-7</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase.  This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF).  Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation.  Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses.  Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSK44sB9FVPKPx2phytoz6_fW6udTcc2eY4XEtVK8Xc9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvkslSnsQ%253D%253D&md5=d89fed0c561e99c00e6cc456272046fc</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1038%2F46816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F46816%26sid%3Dliteratum%253Aachs%26aulast%3DFisslthaler%26aufirst%3DB.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DKiss%26aufirst%3DL.%26aulast%3DPotente%26aufirst%3DM.%26aulast%3DHarder%26aufirst%3DD.%2BR.%26aulast%3DFleming%26aufirst%3DI.%26aulast%3DBusse%26aufirst%3DR.%26atitle%3DCytochrome%2520P450%25202C%2520is%2520an%2520EDHF%2520synthase%2520in%2520coronary%2520arteries%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D493%26epage%3D497%26doi%3D10.1038%2F46816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inscho, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deichmann, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">408</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.33.1.408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.33.1.408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=9931138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADyaK1MXht1Ggtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=408-413&author=J.+D.+Imigauthor=E.+W.+Inschoauthor=P.+C.+Deichmannauthor=K.+M.+Reddyauthor=J.+R.+Falck&title=Afferent+arteriolar+vasodilation+to+the+sulfonimide+analog+of+11%2C+12-epoxyeicosatrienoic+acid+involves+protein+kinase+A&doi=10.1161%2F01.HYP.33.1.408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A</span></div><div class="casAuthors">Imig, John D.; Inscho, Edward W.; Deichmann, Paul C.; Reddy, K. Malla; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">408-413</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The current study detd. the contribution of protein kinase-A (PKA) and protein kinase-G (PKG) to the vasodilation elicited by the N-methylsulfonimide analog of 11,12-epoxyeicosatrienoic acid (11,12-EET).  Expts. were performed, in vitro, using the juxtamedullary nephron prepn. combined with videomicroscopy.  The response of afferent arterioles to the sulfonimide analog of 11,12-EET, was detd. before and after inhibition of PKA, PKG, or guanylyl cyclase.  Afferent arterioles, preconstricted with 0.5 μmol/L norepinephrine, averaged 18±1 μm (n=25) at a renal perfusion pressure of 100 mm Hg.  Superfusion with 0.01 to 100 nmol/L of the 11,12-EET analog caused a graded increase in diam. of the afferent arteriole.  Vessel diam. increased by 11±1% and 15±1%, resp., in response to 10 and 100 nmol/L of the 11,12-EET analog.  The afferent arteriolar response to 10 and 100 nmol/L of the 11,12-EET analog was significantly attenuated during inhibition of PKA with 10 μmol/L H-89 (n=7) or 5 μmol/L myristolated PKI (n=6), such that afferent arteriolar diam. increased by only 5±2% and 2±1%, resp., in response to 100 nmol/L of the 11,12-EET analog.  In contrast, the afferent arteriolar vasodilatory response to the 11,12-EET analog was unaffected by PKG or guanylyl cyclase inhibition.  In the presence of 200 μmol/L histone H2B (n=5) or 10 μmol/L ODQ (n=7), the afferent arteriolar diam. increased by 16±3% and 12±2%, resp., in response to 100 nmol/L of the 11,12-EET analog.  These results demonstrate that activation of PKA is an important mechanism responsible for the afferent arteriolar vasodilation elicited by the sulfonimide analog of 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNkyAnM3K-7Vg90H21EOLACvtfcHk0liPp3IBhCjkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1Ggtr8%253D&md5=1cbf3a9e272257ab5cdf895d4f92ad63</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.33.1.408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.33.1.408%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DInscho%26aufirst%3DE.%2BW.%26aulast%3DDeichmann%26aufirst%3DP.%2BC.%26aulast%3DReddy%26aufirst%3DK.%2BM.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DAfferent%2520arteriolar%2520vasodilation%2520to%2520the%2520sulfonimide%2520analog%2520of%252011%252C%252012-epoxyeicosatrienoic%2520acid%2520involves%2520protein%2520kinase%2520A%26jtitle%3DHypertension%26date%3D1999%26volume%3D33%26spage%3D408%26epage%3D413%26doi%3D10.1161%2F01.HYP.33.1.408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15100364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVCnu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=1244-1253&author=X.+Y.+Zhaoauthor=T.+Yamamotoauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=T.+Watanabeauthor=B.+D.+Hammockauthor=J.+Stewartauthor=J.+S.+Pollockauthor=D.+M.+Pollockauthor=J.+D.+Imig&title=Soluble+epoxide+hydrolase+inhibition+protects+the+kidney+from+hypertension-induced+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage</span></div><div class="casAuthors">Zhao, Xueying; Yamamoto, Tatsuo; Newman, John W.; Kim, In-Hae; Watanabe, Takaho; Hammock, Bruce D.; Stewart, Janet; Pollock, Jennifer S.; Pollock, David M.; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1244-1253</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EET) have antihypertensive and anti-inflammatory properties and play a role in the maintenance of renal vascular function.  A novel approach to increase EET levels is to inhibit epoxide hydrolase enzymes that are responsible for conversion of biol. active EET to dihydroxyeicosatrienoic acids (DHET).  We hypothesized that sol. epoxide hydrolase (SEH) inhibition would improve renal vascular function and ameliorate hypertension induced renal damage.  Chronic administration of the specific SEH inhibitor 1-cyclohexyl-3-dodecylurea (CDU, 3 mg/d) for 10 d lowered BP in angiotensin hypertensive rats.  The contribution of renal vascular SEH to afferent arteriolar function in angiotensin hypertension was also assessed.  SEH protein expression was increased in renal microvessels from hypertensive rats.  Although CDU did not change afferent arteriolar responsiveness to angiotensin in normotensive animals, CDU treatment significantly attenuated afferent arteriolar diam. responses to angiotensin in hypertensive kidneys from 51% ± 8% to 28% ± 7%.  Protection of the renal vasculature and glomerulus during chronic CDU administration was demonstrated by histol.  Urinary albumin excretion, an index of renal damage, was also lower in CDU-treated hypertensive rats.  These data demonstrate that SEH inhibition has antihypertensive and renal vascular protective effects in angiotensin hypertension and suggests that SEH inhibitors may be a useful therapeutic intervention for cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagPuSJeX7oLVg90H21EOLACvtfcHk0liPp3IBhCjkJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVCnu7s%253D&md5=a7c12f35296a5765bdc707a799d2e2c3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BY.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DPollock%26aufirst%3DJ.%2BS.%26aulast%3DPollock%26aufirst%3DD.%2BM.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520protects%2520the%2520kidney%2520from%2520hypertension-induced%2520damage%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2004%26volume%3D15%26spage%3D1244%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, S. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madkhali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamali, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverria, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreto, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, G. M.</span></span> <span> </span><span class="NLM_article-title">Inhibiting effect of zinc oxide nanoparticles on advanced glycation products and oxidative modifications: a potential tool to counteract oxidative stress in neurodegenerative diseases</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7438</span>– <span class="NLM_lpage">7452</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-0935-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12035-018-0935-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29423819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=7438-7452&author=J.+M.+Ashrafauthor=M.+A.+Ansariauthor=S.+Fatmaauthor=S.+M.+S.+Abdullahauthor=J.+Iqbalauthor=A.+Madkhaliauthor=A.+H.+Hamaliauthor=S.+Ahmadauthor=A.+Jerahauthor=V.+Echeverriaauthor=G.+E.+Barretoauthor=G.+M.+Ashraf&title=Inhibiting+effect+of+zinc+oxide+nanoparticles+on+advanced+glycation+products+and+oxidative+modifications%3A+a+potential+tool+to+counteract+oxidative+stress+in+neurodegenerative+diseases&doi=10.1007%2Fs12035-018-0935-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases</span></div><div class="casAuthors">Ashraf, Jalaluddin M.; Ansari, Mohammad Azam; Fatma, Sana; Abdullah, Saleh M. S.; Iqbal, Johar; Madkhali, Aymen; Hamali, Al Hassan; Ahmad, Saheem; Jerah, Ahmed; Echeverria, Valentina; Barreto, George E.; Ashraf, Ghulam Md.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7438-7452</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Advanced glycation end products (AGEs) are implicated in several central nervous system (CNS) pathologies including Alzheimer and Parkinson's diseases.  In the face-off of AGE menace, we have attempted to investigate the zinc oxide nanoparticle (ZnONP) role in inhibition of AGE formation.  Synthesized ZnONPs were used to investigate the inhibitory effects on AGE formation.  The inhibitory effects of ZnONPs on AGE formation were detd. by biophys. immunol. and biochem. techniques.  The results showed that ZnONP is a potential anti-glycating agent inhibiting AGE formation as well as protecting the protein structure from change.  Therefore, our findings suggest ZnONPs may be used as a therapeutic in resolving the AGE role in CNS-related complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEgK2TJRo7OLVg90H21EOLACvtfcHk0lgmWGyepbMk8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKgsLw%253D&md5=5d70cfe258cae502dba0dcce83bcd0b3</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-0935-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-0935-x%26sid%3Dliteratum%253Aachs%26aulast%3DAshraf%26aufirst%3DJ.%2BM.%26aulast%3DAnsari%26aufirst%3DM.%2BA.%26aulast%3DFatma%26aufirst%3DS.%26aulast%3DAbdullah%26aufirst%3DS.%2BM.%2BS.%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DMadkhali%26aufirst%3DA.%26aulast%3DHamali%26aufirst%3DA.%2BH.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DJerah%26aufirst%3DA.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DBarreto%26aufirst%3DG.%2BE.%26aulast%3DAshraf%26aufirst%3DG.%2BM.%26atitle%3DInhibiting%2520effect%2520of%2520zinc%2520oxide%2520nanoparticles%2520on%2520advanced%2520glycation%2520products%2520and%2520oxidative%2520modifications%253A%2520a%2520potential%2520tool%2520to%2520counteract%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D7438%26epage%3D7452%26doi%3D10.1007%2Fs12035-018-0935-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors</span>. <i>Cardiovasc. Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3466.2006.00169.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1527-3466.2006.00169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16961727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlalu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=169-188&author=J.+D.+Imig&title=Cardiovascular+therapeutic+aspects+of+soluble+epoxide+hydrolase+inhibitors&doi=10.1111%2Fj.1527-3466.2006.00169.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors</span></div><div class="casAuthors">Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Drug Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-188</span>CODEN:
                <span class="NLM_cas:coden">CDREEA</span>;
        ISSN:<span class="NLM_cas:issn">0897-5957</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Sol. epoxide hydrolase (sEH) is an enzyme responsible for the conversion of lipid epoxides to diols by the addn. of water.  Biol. actions on the cardiovascular system that are attributed to epoxides include vasodilation, antiinflammatory actions and vascular smooth muscle cell antimigratory actions.  Conversion of arachidonic acid epoxides to diols by sEH diminishes the beneficial cardiovascular properties of these epoxyeicosanoids.  Cardiovascular diseases in animal models and humans have been assocd. with decreased epoxygenase activity or increased sEH activity and these changes are responsible for the progression of the disease state.  More recently, sEH gene polymorphisms in the human population have been assocd. with increased risk for cardiovascular diseases.  Thus the biol. actions of epoxyeicosanoids and the sEH enzyme are ideal therapeutic targets for cardiovascular diseases.  The rapid development of 1,3-disubstituted urea based sEH inhibitors over the past five years has resulted in a no. of studies demonstrating cardiovascular protection.  SEH inhibitors have antihypertensive and antiinflammatory actions and have been demonstrated to decrease cerebral ischemic and renal injury in rat models of hypertension.  These findings of beneficial actions in animal models of disease position the sEH enzyme as a promising therapeutic target for cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA7y3oPtefp7Vg90H21EOLACvtfcHk0lgmWGyepbMk8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlalu7vF&md5=e0979b9dd04426648054e58585860c91</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3466.2006.00169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3466.2006.00169.x%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DCardiovascular%2520therapeutic%2520aspects%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2006%26volume%3D24%26spage%3D169%26epage%3D188%26doi%3D10.1111%2Fj.1527-3466.2006.00169.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1038/ki.2009.349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fki.2009.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19847158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Wm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=88-92&author=D.+Aiauthor=J.+Y.+Shyyauthor=Y.+Zhu&title=Linking+an+insect+enzyme+to+hypertension%3A+angiotensin+II-epoxide+hydrolase+interactions&doi=10.1038%2Fki.2009.349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions</span></div><div class="casAuthors">Ai, Ding; Shyy, John Y-J.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Derived from arachidonic acid, epoxyeicosatrienoic acids function as antihypertensive and antihypertrophic mediators in the cardiovascular system.  Epoxyeicosatrienoic acids are generated by sol. epoxide hydrolase, an enzyme hydrolyzing the epoxide moiety of juvenile hormones in insects, and are endothelium-derived hyperpolarizing factors that induce vessel dilation for cardioprotection.  Pharmacol. inhibition and genetic ablation of sol. epoxide hydrolase increases the level of epoxyeicosatrienoic acids.  Recent findings suggest that the level of sol. epoxide hydrolase in the heart and endothelium is upregulated by angiotensin II in vitro in cultured cardiomyocytes and vascular endothelial cells and in vivo in rodent models.  Treatment with sol. epoxide hydrolase-selective inhibitors in angiotensin II-infused hypertensive rats increases the level of epoxyeicosatrienoic acids, with attendant decrease in systolic blood pressure.  Shear stress, the physiol. stimulation of vessel dilation, downregulates sol. epoxide hydrolase and hence increases epoxyeicosatrienoic acid level in endothelial cells.  Because of the close assocn. of the angiotensin II/sol. epoxide hydrolase/epoxyeicosatrienoic acid system and blood pressure regulation, pharmacol. inhibition of sol. epoxide hydrolase would be a useful approach to prevent and treat angiotensin II-induced cardiac hypertrophy and hypertension, as well as vascular impairments.  Kidney International (2010) 77, 88-92; doi:10.1038/ki.2009.349; published online 21 Oct. 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAhpbZu7jNHbVg90H21EOLACvtfcHk0lgmWGyepbMk8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Wm&md5=713c37e2abe7190737e0c2be657e6d2d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Fki.2009.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2009.349%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DLinking%2520an%2520insect%2520enzyme%2520to%2520hypertension%253A%2520angiotensin%2520II-epoxide%2520hydrolase%2520interactions%26jtitle%3DKidney%2520Int.%26date%3D2010%26volume%3D77%26spage%3D88%26epage%3D92%26doi%3D10.1038%2Fki.2009.349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyy, J. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium <i>in vitro</i> and <i>in vivo</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">9018</span>– <span class="NLM_lpage">9023</span>, <span class="refDoi"> DOI: 10.1073/pnas.0703229104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.0703229104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=17495027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1ahtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9018-9023&author=D.+Aiauthor=Y.+Fuauthor=D.+L.+Guoauthor=H.+Tanakaauthor=N.+P.+Wangauthor=C.+S.+Tangauthor=B.+D.+Hammockauthor=J.+Y.+J.+Shyyauthor=Y.+Zhu&title=Angiotensin+II+up-regulates+soluble+epoxide+hydrolase+in+vascular+endothelium+in+vitro+and+in+vivo&doi=10.1073%2Fpnas.0703229104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo</span></div><div class="casAuthors">Ai, Ding; Fu, Yi; Guo, Deliang; Tanaka, Hiromasa; Wang, Nanping; Tang, Chaoshu; Hammock, Bruce D.; Shyy, John Y.-J.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9018-9023</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs), as metabolites of arachidonic acid, may function as antihypertensive and antiatherosclerotic mediators for vasculature.  EETs are degraded by sol. epoxide hydrolase (sEH).  Pharmacol. inhibition and genetic ablation of sEH have been shown to increase the level of EETs, and treating angiotensin II (Ang II)-infused hypertension rats with sEH-selective inhibitors increased the levels of EETs, with attendant decrease in systolic blood pressure.  To elucidate the mechanisms by which Ang II regulates sEH expression, we treated human umbilical vein endothelial cells (ECs) and bovine aortic ECs with Ang II and found increased sEH expression at both the mRNA and protein levels.  Transient transfection assays showed that the activity of the human sEH promoter was increased in ECs in response to Ang II.  Further anal. of the promoter region of the sEH gene demonstrated that treatment with Ang II, like overexpression of c-Jun/c-Fos, activates the sEH promoter through an AP-1-binding motif.  The binding of c-Jun to the AP-1 site of the sEH promoter was confirmed by chromatin immunopptn. assays.  In contrast, adenovirus overexpression of the dominant-neg. mutant of c-Jun significantly attenuated the effects of Ang II on sEH induction.  An elevated level of sEH was found in the aortic intima of both spontaneously hypertensive rats and Ang Il-infused Wistar rats.  Blocking Ang II binding to Ang II receptor 1 by losartan abolished the sEH induction.  Thus, AP-1 activation is involved in the transcriptional up-regulation of sEH by Ang II in ECs, which may contribute to Ang II-induced hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqeypLpuIxC7Vg90H21EOLACvtfcHk0lipzHpG6AtQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1ahtLs%253D&md5=71a3cc4cc434b30590e76c87a6668be6</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0703229104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0703229104%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%2BL.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DN.%2BP.%26aulast%3DTang%26aufirst%3DC.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DShyy%26aufirst%3DJ.%2BY.%2BJ.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DAngiotensin%2520II%2520up-regulates%2520soluble%2520epoxide%2520hydrolase%2520in%2520vascular%2520endothelium%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D9018%26epage%3D9023%26doi%3D10.1073%2Fpnas.0703229104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sinal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bend, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">40504</span>– <span class="NLM_lpage">40510</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008106200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1074%2Fjbc.M008106200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=11001943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=40504-40510&author=C.+J.+Sinalauthor=M.+Miyataauthor=M.+Tohkinauthor=K.+Nagataauthor=J.+R.+Bendauthor=F.+J.+Gonzalez&title=Targeted+disruption+of+soluble+epoxide+hydrolase+reveals+a+role+in+blood+pressure+regulation&doi=10.1074%2Fjbc.M008106200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation</span></div><div class="casAuthors">Sinal, Christopher J.; Miyata, Masaaki; Tohkin, Masahiro; Nagata, Kiyoshi; Bend, John R.; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">40504-40510</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Renal microsomal cytochrome P 450 monooxygenase-dependent metab. of arachidonic acid generates a series of regioisomeric epoxyeicosatrienoic acids that can be further metabolized by sol. epoxide hydrolase to the corresponding dihydroxyeicosatrienoic acids.  Evidence exists that these metabolites affect renal function and, in particular, blood pressure regulation.  To examine this possibility, blood pressure and renal arachidonic acid metab. were examd. in mice with a targeted disruption of the sol. epoxide hydrolase gene.  Systolic blood pressure of male sol. epoxide hydrolase-null mice was lower compared with wild-type mice in both the absence and presence of dietary salt loading.  Both female sol. epoxide hydrolase-null and wild-type female mice also had significantly lower systolic blood pressure than male wild-type mice.  Renal formation of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids was markedly lower for sol. epoxide hydrolase-null vs. wild-type mice of both sexes.  Although disruption of sol. epoxide hydrolase in female mice had minimal effects on blood pressure, deletion of this gene feminized male mice by lowering systolic blood pressure and altering arachidonic acid metab.  These data provide the first direct evidence for a role for sol. epoxide hydrolase in blood pressure regulation and identify this enzyme as a novel and attractive target for therapeutic intervention in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCXG0fIAkoHrVg90H21EOLACvtfcHk0lipzHpG6AtQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFeqsQ%253D%253D&md5=ef3f3902a2d357987ff650ed5f52b3ed</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008106200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008106200%26sid%3Dliteratum%253Aachs%26aulast%3DSinal%26aufirst%3DC.%2BJ.%26aulast%3DMiyata%26aufirst%3DM.%26aulast%3DTohkin%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DBend%26aufirst%3DJ.%2BR.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DTargeted%2520disruption%2520of%2520soluble%2520epoxide%2520hydrolase%2520reveals%2520a%2520role%2520in%2520blood%2520pressure%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D40504%26epage%3D40510%26doi%3D10.1074%2Fjbc.M008106200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukhari, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alorainey, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Motrefi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmoud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats</span>. <i>Eur. Rev. Med. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">8143</span>– <span class="NLM_lpage">8150</span>, <span class="refDoi"> DOI: 10.26355/eurrev_202008_22501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.26355%2Feurrev_202008_22501" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=8143-8150&author=I.+A.+Bukhariauthor=B.+I.+Aloraineyauthor=A.+A.+Al-Motrefiauthor=A.+Mahmoudauthor=W.+B.+Campbellauthor=B.+D.+Hammock&title=1-Trifluoromethoxyphenyl-3-%281-propionylpiperidin-4-yl%29+urea+%28TPPU%29%2C+a+soluble+epoxide+hydrolase+inhibitor%2C+lowers+L-NAME-induced+hypertension+through+suppression+of+angiotensin-converting+enzyme+in+rats&doi=10.26355%2Feurrev_202008_22501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.26355%2Feurrev_202008_22501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26355%252Feurrev_202008_22501%26sid%3Dliteratum%253Aachs%26aulast%3DBukhari%26aufirst%3DI.%2BA.%26aulast%3DAlorainey%26aufirst%3DB.%2BI.%26aulast%3DAl-Motrefi%26aufirst%3DA.%2BA.%26aulast%3DMahmoud%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3D1-Trifluoromethoxyphenyl-3-%25281-propionylpiperidin-4-yl%2529%2520urea%2520%2528TPPU%2529%252C%2520a%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520lowers%2520L-NAME-induced%2520hypertension%2520through%2520suppression%2520of%2520angiotensin-converting%2520enzyme%2520in%2520rats%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2020%26volume%3D15%26spage%3D8143%26epage%3D8150%26doi%3D10.26355%2Feurrev_202008_22501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharis, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olearczyk, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000176237.74820.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.HYP.0000176237.74820.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16157792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=975-981&author=J.+D.+Imigauthor=X.+Zhaoauthor=C.+Z.+Zaharisauthor=J.+J.+Olearczykauthor=D.+M.+Pollockauthor=J.+W.+Newmanauthor=I.+H.+Kimauthor=T.+Watanabeauthor=B.+D.+Hammock&title=An+orally+active+epoxide+hydrolase+inhibitor+lowers+blood+pressure+and+provides+renal+protection+in+salt-sensitive+hypertension&doi=10.1161%2F01.HYP.0000176237.74820.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension</span></div><div class="casAuthors">Imig, John D.; Zhao, Xueying; Zaharis, Constantine Z.; Olearczyk, Jeffrey J.; Pollock, David M.; Newman, John W.; Kim, In-Hae; Watanabe, Takaho; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4, Pt. 2</span>),
    <span class="NLM_cas:pages">975-981</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The present study tested the hypothesis that increasing epoxyeicosatrienoic acids by inhibition of sol. epoxide hydrolase (sEH) would lower blood pressure and ameliorate renal damage in salt-sensitive hypertension.  Rats were infused with angiotensin and fed a normal-salt diet or an 8% NaCl diet for 14 days.  The sEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), was given orally to angiotensin-infused animals during the 14-day period.  Plasma AUDA metabolite levels were measured, and they averaged 10±2 ng/mL in normal-salt angiotensin hypertension and 19±3 ng/mL in high-salt angiotensin hypertension on day 14 in the animals administered the sEH inhibitor.  Mean arterial blood pressure averaged 161±4 mm Hg in normal-salt and 172±5 mm Hg in the high-salt angiotensin hypertension groups on day 14.  EH inhibitor treatment significantly lowered blood pressure to 140±5 mm Hg in the normal-salt angiotensin hypertension group and to 151±6 mm Hg in the high-salt angiotensin hypertension group on day 14.  The lower arterial blood pressures in the AUDA-treated groups were assocd. with increased urinary epoxide-to-diol ratios.  Urinary microalbumin levels were measured, and ED-1 staining was used to det. renal damage and macrophage infiltration in the groups.  Two weeks of AUDA treatment decreased urinary microalbumin excretion in the normal-salt and high-salt angiotensin hypertension groups and macrophage no. in the high-salt angiotensin hypertension group.  These data demonstrate that sEH inhibition lowers blood pressure and ameliorates renal damage in angiotensin-dependent, salt-sensitive hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhzsWUX9rfrVg90H21EOLACvtfcHk0lgLnVpqgqmvnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeksbfK&md5=b19bcc6a8a222afd99c3d81c0382f0b9</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000176237.74820.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000176237.74820.75%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZaharis%26aufirst%3DC.%2BZ.%26aulast%3DOlearczyk%26aufirst%3DJ.%2BJ.%26aulast%3DPollock%26aufirst%3DD.%2BM.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DAn%2520orally%2520active%2520epoxide%2520hydrolase%2520inhibitor%2520lowers%2520blood%2520pressure%2520and%2520provides%2520renal%2520protection%2520in%2520salt-sensitive%2520hypertension%26jtitle%3DHypertension%26date%3D2005%26volume%3D46%26spage%3D975%26epage%3D981%26doi%3D10.1161%2F01.HYP.0000176237.74820.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aga, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span> <span> </span><span class="NLM_article-title">Chemical constituents from the aerial parts of <i>Codonopsis nervosa</i></span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(12)60073-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2FS1875-5364%2812%2960073-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=366-369&author=E.+B.+Agaauthor=H.+J.+Liauthor=J.+Chenauthor=P.+Li&title=Chemical+constituents+from+the+aerial+parts+of+Codonopsis+nervosa&doi=10.1016%2FS1875-5364%2812%2960073-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2812%2960073-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252812%252960073-9%26sid%3Dliteratum%253Aachs%26aulast%3DAga%26aufirst%3DE.%2BB.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DChemical%2520constituents%2520from%2520the%2520aerial%2520parts%2520of%2520Codonopsis%2520nervosa%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D366%26epage%3D369%26doi%3D10.1016%2FS1875-5364%2812%2960073-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(−/−) mice</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.yjmcc.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27496380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlansr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2016&pages=128-137&author=D.+Liauthor=Y.+Liuauthor=X.+Zhangauthor=H.+Lvauthor=W.+Pangauthor=X.+Sunauthor=L.+M.+Ganauthor=B.+D.+Hammockauthor=D.+Aiauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+alleviated+atherosclerosis+by+reducing+monocyte+infiltration+in+Ldlr%28%E2%88%92%2F%E2%88%92%29+mice&doi=10.1016%2Fj.yjmcc.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr-/- mice</span></div><div class="casAuthors">Li, Dan; Liu, Yajin; Zhang, Xu; Lv, Huizhen; Pang, Wei; Sun, Xiaoli; Gan, Li-Ming; Hammock, Bruce D.; Ai, Ding; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-137</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Circulating monocytes play pivotal roles in chronic inflammatory diseases.  Epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid, are known to have anti-inflammatory effects and are hydrolyzed by sol. epoxide hydrolase (sEH).  We aimed to investigate the effect of sEH inhibition in atherogenesis.  Mice with low-d. lipoprotein receptor deficiency (Ldlr-/-) with or without sEH inhibitor, and Ldlr/sEH double-knockout (DK) mice were fed a Western-type diet (WTD) for 6 wk to induce arteriosclerosis.  Both sEH inhibition and gene depletion decreased the WTD-induced hyperlipidemia, plaque area and macrophage infiltration in mice arterial wall.  Ly6Chi infiltration of monocytes remained similar in blood, spleen and bone marrow of DK mice, but was decreased in aortic lesions.  To further assess the role of sEH or EETs in monocyte/macrophage infiltration in atherogenesis, we transplanted DK bone marrow into Ldlr-/- recipients, and then fed mice the WTD.  Aortic lesions and Ly6Chi monocyte infiltration were reduced in mice with transplanted bone marrow of DK mice without diminishing the cholesterol level.  Furthermore, sEH inhibition or gene depletion increased the ratio of EETs/DHETs and diminished the expression of P-selectin glycoprotein ligand 1 (PSGL-1) in mice peripheral-blood mononuclear cells.  Monocyte adhesion to P-selectin and to tumor necrosis factor α-activated endothelial cells was also diminished by sEH inhibition.  SEH inhibition and gene depletion attenuated atherosclerosis in mice by decreasing the infiltration of monocytes into the artery wall.  EET and PSGL-1 may play pivotal roles in monocyte/macrophage infiltration and atherogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe40bnwHuNPLVg90H21EOLACvtfcHk0lgLnVpqgqmvnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlansr7J&md5=bd1ea263423e48ce4694a842170ec4d7</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGan%26aufirst%3DL.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520alleviated%2520atherosclerosis%2520by%2520reducing%2520monocyte%2520infiltration%2520in%2520Ldlr%2528%25E2%2588%2592%252F%25E2%2588%2592%2529%2520mice%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2016%26volume%3D98%26spage%3D128%26epage%3D137%26doi%3D10.1016%2Fj.yjmcc.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincelette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anandan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gless, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. X.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.109.186064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2FATVBAHA.109.186064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19667112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFyktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1265-1270&author=L.+N.+Zhangauthor=J.+Vinceletteauthor=Y.+Chengauthor=U.+Mehraauthor=D.+Chenauthor=S.+K.+Anandanauthor=R.+Glessauthor=H.+K.+Webbauthor=Y.+X.+Wang&title=Inhibition+of+soluble+epoxide+hydrolase+attenuated+atherosclerosis%2C+abdominal+aortic+aneurysm+formation%2C+and+dyslipidemia&doi=10.1161%2FATVBAHA.109.186064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia</span></div><div class="casAuthors">Zhang, Le-Ning; Vincelette, Jon; Cheng, Ying; Mehra, Upasana; Chen, Dawn; Anandan, Sampath-Kumar; Gless, Richard; Webb, Heather K.; Wang, Yi-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Epoxyeicosatrienoic acids (EETs) have been shown to have antiinflammatory effects and therefore may play a role in preventing vascular inflammatory and atherosclerotic diseases.  Sol. epoxide hydrolase (s-EH) converts EETs into less bioactive dihydroxyeicosatrienoic acids.  Thus, inhibition of s-EH can prevent degrdn. of EETs and prolong their effects.  The present study aimed to test the hypothesis that inhibition of s-EH has vascular protective effects.  Methods and Results: Six-month-old apolipoprotein E-deficient mice were chronically infused with angiotensin II (1.44 mg/kg/d) for 4 wk to induce abdominal aortic aneurysm (AAA), accelerate atherosclerosis development and carotid artery ligation-induced vascular remodeling.  The mice were treated with a novel s-EH inhibitor, AR9276 (1.5 g/L in drinking water) or vehicle for 4 wk.  The results demonstrated that AR9276 significantly reduced the rate of AAA formation and atherosclerotic lesion area, but had no effect on ligation-induced carotid artery remodeling.  These effects were assocd. with a redn. of serum lipid, IL-6, murine IL-8-KC, and IL-1α, and downregulation of gene expressions of ICAM-1, VCAM-1, and IL-6 in the arterial wall.  Conclusions: The present data demonstrate that treatment with an s-EH inhibitor attenuates AAA formation and atherosclerosis development.  The attendant downregulation of inflammatory mediators and lipid lowering effects may both contribute to the obsd. vascular protective effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfzqTd6qxwbVg90H21EOLACvtfcHk0lgLnVpqgqmvnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFyktrk%253D&md5=ae1c4ed1fc69269b8697bed5803d8500</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.186064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.186064%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%2BN.%26aulast%3DVincelette%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DMehra%26aufirst%3DU.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DAnandan%26aufirst%3DS.%2BK.%26aulast%3DGless%26aufirst%3DR.%26aulast%3DWebb%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BX.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520attenuated%2520atherosclerosis%252C%2520abdominal%2520aortic%2520aneurysm%2520formation%252C%2520and%2520dyslipidemia%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1265%26epage%3D1270%26doi%3D10.1161%2FATVBAHA.109.186064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, <i>t</i>-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2012.03.167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijcard.2012.03.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22525341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=1298-1304&author=D.+Y.+Xuauthor=B.+B.+Davisauthor=Z.+H.+Wangauthor=S.+P.+Zhaoauthor=B.+Wastiauthor=Z.+L.+Liuauthor=N.+Liauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+acts+through+PPARgamma+to+modulate+the+function+of+endothelial+progenitor+cells+from+patients+with+acute+myocardial+infarction&doi=10.1016%2Fj.ijcard.2012.03.167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span></div><div class="casAuthors">Xu Dan-yan; Davis Benjamin B; Wang Zhen-he; Zhao Shui-ping; Wasti Binaya; Liu Zhe-liang; Li Ning; Morisseau Christophe; Chiamvimonvat Nipavan; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1298-304</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epoxyeicosatrienoic acids (EETs) are natural angiogenic mediators regulated by soluble epoxide hydrolase (sEH).  Inhibitors of sEH can stabilize EETs levels and were reported to reduce atherosclerosis and inhibit myocardial infarction in animal models.  In this work, we investigated whether increasing EETs with the sEH inhibitor t-AUCB would increase angiogenesis related function in endothelial progenitor cells (EPCs) from patients with acute myocardial infarction (AMI).  METHODS AND RESULTS:  EPCs were isolated from 50 AMI patients and 50 healthy subjects (control).  EPCs were treated with different concentrations of t-AUCB for 24h with or without peroxisome proliferator activated receptor γ (PPARγ) inhibitor GW9662.  Migration of EPCs was assayed in trans-well chambers.  Angiogenesis assays were performed using a Matrigel-Matrix in vitro model.  The expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1α (HIF-1α) mRNA and protein in EPCs was measured by real-time PCR or Western blot, respectively.  Also, the concentration of EETs in the culture supernatant was detected by ELISA.  The activity of EPCs in the AMI patient group was reduced compared to healthy controls.  Whereas increasing EET levels with t-AUCB promoted a dose dependent angiogenesis and migration in EPCs from AMI patients.  Additionally, the t-AUCB dose dependently increased the expression of the angiogenic factors VEGF and HIF-α.  Lastly, we provide evidence that these effects were PPARγ dependent.  CONCLUSION:  The results demonstrate that the sEH inhibitor positively modulated the functions of EPCs in patients with AMI through the EETs-PPARγ pathway.  The present study suggests the potential utility of sEHi in the therapy of ischemic heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvyM8pXNI2_xKDYG3bNImrfW6udTcc2eZAeCk10uGai7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D&md5=664e589b7aba463a46d40a45ef424ef8</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2012.03.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2012.03.167%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%2BY.%26aulast%3DDavis%26aufirst%3DB.%2BB.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DWasti%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520acts%2520through%2520PPARgamma%2520to%2520modulate%2520the%2520function%2520of%2520endothelial%2520progenitor%2520cells%2520from%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26spage%3D1298%26epage%3D1304%26doi%3D10.1016%2Fj.ijcard.2012.03.167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis</span>. <i>Atherosclerosis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>239</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.atherosclerosis.2015.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.atherosclerosis.2015.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25733327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVShtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2015&pages=557-65&author=L.+Shenauthor=H.+Pengauthor=R.+Pengauthor=Q.+Fanauthor=S.+Zhaoauthor=D.+Xuauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=Inhibition+of+soluble+epoxide+hydrolase+in+mice+promotes+reverse+cholesterol+transport+and+regression+of+atherosclerosis&doi=10.1016%2Fj.atherosclerosis.2015.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis</span></div><div class="casAuthors">Shen, Li; Peng, Hongchun; Peng, Ran; Fan, Qingsong; Zhao, Shuiping; Xu, Danyan; Morisseau, Christophe; Chiamvimonvat, Nipavan; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Atherosclerosis (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">557-565</span>CODEN:
                <span class="NLM_cas:coden">ATHSBL</span>;
        ISSN:<span class="NLM_cas:issn">0021-9150</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipose tissue is the body largest free cholesterol reservoir and abundantly expresses ATP binding cassette transporter A1 (ABCA1), which maintains plasma high-d. lipoprotein (HDL) levels.  HDLs have a protective role in atherosclerosis by mediating reverse cholesterol transport (RCT).  Sol. epoxide hydrolase (sEH) is a cytosolic enzyme whose inhibition has various beneficial effects on cardiovascular disease.  The sEH is highly expressed in adipocytes, and it converts epoxyeicosatrienoic acids (EETs) into less bioactive dihydroxyeicosatrienoic acids.  We previously showed that increasing EETs levels with a sEH inhibitor (sEHI) (t-AUCB) resulted in elevated ABCA1 expression and promoted ABCA1-mediated cholesterol efflux from 3T3-L1 adipocytes.  The present study investigates the impacts of t-AUCB in mice deficient for the low d. lipoprotein (LDL) receptor (Ldlr-/- mice) with established atherosclerotic plaques.  The sEH inhibitor delivered in vivo for 4 wk decreased the activity of sEH in adipose tissue, enhanced ABCA1 expression and cholesterol efflux from adipose depots, and consequently increased HDL levels.  Furthermore, t-AUCB enhanced RCT to the plasma, liver, bile and feces.  It also showed the redn. of plasma LDL-C levels.  Consistently, t-AUCB-treated mice showed redns. in the size of atherosclerotic plaques.  These studies establish that raising adipose ABCA1 expression, cholesterol efflux, and plasma HDL levels with t-AUCB treatment promotes RCT, decreasing LDL-C and atherosclerosis regression, suggesting that sEH inhibition may be a promising strategy to treat atherosclerotic vascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3h2phoX68BrVg90H21EOLACvtfcHk0lhdQYkSznh03g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVShtb8%253D&md5=37cd3c83c6659fbbb770c9b97483579d</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.atherosclerosis.2015.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.atherosclerosis.2015.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520mice%2520promotes%2520reverse%2520cholesterol%2520transport%2520and%2520regression%2520of%2520atherosclerosis%26jtitle%3DAtherosclerosis%26date%3D2015%26volume%3D239%26spage%3D557%26epage%3D65%26doi%3D10.1016%2Fj.atherosclerosis.2015.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitors and heart failure</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/j.1755-5922.2010.00150.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fj.1755-5922.2010.00150.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20433684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=99-111&author=H.+Qiuauthor=N.+Liauthor=J.+Y.+Liuauthor=T.+R.+Harrisauthor=B.+D.+Hammockauthor=N.+Chiamvimonvat&title=Soluble+epoxide+hydrolase+inhibitors+and+heart+failure&doi=10.1111%2Fj.1755-5922.2010.00150.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitors and heart failure</span></div><div class="casAuthors">Qiu, Hong; Li, Ning; Liu, Jun-Yan; Harris, Todd R.; Hammock, Bruce D.; Chiamvimonvat, Nipavan</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-111</span>CODEN:
                <span class="NLM_cas:coden">CTAHCA</span>;
        ISSN:<span class="NLM_cas:issn">1755-5914</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cardiovascular disease remains one of the leading causes of death in the Western societies.  Heart failure (HF) is due primarily to progressive myocardial dysfunction accompanied by myocardial remodeling.  Once HF develops, the condition is, in most cases, irreversible and is assocd. with a very high mortality rate.  Sol. epoxide hydrolase (sEH) is an enzyme that catalyzes the hydrolysis of epoxyeicosatrienoic acids (EETs), which are lipid mediators derived from arachidonic acid through the cytochrome P 450 epoxygenase pathway.  EETs have been shown to have vasodilatory, antiinflammatory, and cardioprotective effects.  When EETs are hydrolyzed by sEH to corresponding dihydroxyeicosatrienoic acids, their cardioprotective activities become less pronounced.  In line with the recent genetic study that has identified sEH as a susceptibility gene for HF, the sEH enzyme has received considerable attention as an attractive therapeutic target for cardiovascular diseases.  Indeed, sEH inhibition has been demonstrated to have antihypertensive and antiinflammatory actions, presumably due to the increased bioavailability of endogenous EETs and other epoxylipids, and several potent sEH inhibitors have been developed and tested in animal models of cardiovascular disease including hypertension, cardiac hypertrophy, and ischemia/reperfusion injury.  SEH inhibitor treatment has been shown to effectively prevent pressure overload- and angiotensin II-induced cardiac hypertrophy and reverse the pre-established cardiac hypertrophy caused by chronic pressure overload.  Application of sEH inhibitors in several cardiac ischemia/reperfusion injury models reduced infarct size and prevented the progressive cardiac remodeling.  Moreover, the use of sEH inhibitors prevented the development of elec. remodeling and ventricular arrhythmias assocd. with cardiac hypertrophy and ischemia/reperfusion injury.  The data published to date support the notion that sEH inhibitors may represent a promising therapeutic approach for combating detrimental cardiac remodeling and HF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSY3C1ubMuwbVg90H21EOLACvtfcHk0liBMz1cDHHQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVehsbo%253D&md5=56a3f56718eb2efed1536b82fc4a1804</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5922.2010.00150.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5922.2010.00150.x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%2BY.%26aulast%3DHarris%26aufirst%3DT.%2BR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitors%2520and%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2011%26volume%3D29%26spage%3D99%26epage%3D111%26doi%3D10.1111%2Fj.1755-5922.2010.00150.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goralski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000237390.92932.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1161%2F01.RES.0000237390.92932.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=16857962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVGktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=442-450&author=J.+M.+Seubertauthor=C.+J.+Sinalauthor=J.+Gravesauthor=L.+M.+DeGraffauthor=J.+A.+Bradburyauthor=C.+R.+Leeauthor=K.+Goralskiauthor=M.+A.+Careyauthor=A.+Luriaauthor=J.+W.+Newmanauthor=B.+D.+Hammockauthor=J.+R.+Falckauthor=H.+Robertsauthor=H.+A.+Rockmanauthor=E.+Murphyauthor=D.+C.+Zeldin&title=Role+of+soluble+epoxide+hydrolase+in+postischemic+recovery+of+heart+contractile+function&doi=10.1161%2F01.RES.0000237390.92932.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function</span></div><div class="casAuthors">Seubert, John M.; Sinal, Christopher J.; Graves, Joan; DeGraff, Laura M.; Bradbury, J. Alyce; Lee, Craig R.; Goralski, Kerry; Carey, Michelle A.; Luria, Ayala; Newman, John W.; Hammock, Bruce D.; Falck, John R.; Roberts, Holly; Rockman, Howard A.; Murphy, Elizabeth; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Cytochrome P 450 epoxygenases metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs) which are converted to dihydroxyeicosatrienoic acids (DHETs) by sol. epoxide hydrolase (Ephx2, sEH).  To examine the functional role of sEH in the heart, mice with targeted disruption of the Ephx2 gene were studied.  Hearts from sEH null mice have undetectable levels of sEH mRNA and protein and cannot convert EETs to DHETs.  SEH null mice have normal heart anatomy and basal contractile function, but have higher fatty acid epoxide:diol ratios in plasma and cardiomyocyte cell culture media compared with wild type (WT).  SEH null hearts have improved recovery of left ventricular developed pressure (LVDP) and less infarction compared with WT hearts after 20 min ischemia.  Perfusion with the putative EET receptor antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (10 to 100 nmol/L) before ischemia abolishes this cardioprotective phenotype.  Inhibitor studies demonstrate that perfusion with phosphatidylinositol-3 kinase (PI3K) inhibitors wortmannin (200 nmol/L) or LY294002 (5 μmol/L), the ATP-sensitive K+ channel (KATP) inhibitor glibenclamide (1 μmol/L), the mitochondrial KATP (mitoKATP) inhibitor 5-hydroxydecanoate (100 to 200 μmol/L), or the Ca2+-sensitive K+ channel (KCa) inhibitor paxilline (10 μmol/L) abolishes the cardioprotection in sEH null hearts.  Consistent with increased activation of the PI3K cascade, sEH null mice exhibit increased cardiac expression of glycogen synthase kinase-3β (GSK-3β) phospho-protein after ischemia.  Together, these data suggest that targeted disruption of sEH increases the availability of cardioprotective EETs that work by activating PI3K signaling pathways and K+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxztpXZpUoh7Vg90H21EOLACvtfcHk0liBMz1cDHHQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVGktr0%253D&md5=54be10f8fbe659c7155a8566f4184781</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000237390.92932.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000237390.92932.37%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DJ.%2BM.%26aulast%3DSinal%26aufirst%3DC.%2BJ.%26aulast%3DGraves%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DL.%2BM.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DGoralski%26aufirst%3DK.%26aulast%3DCarey%26aufirst%3DM.%2BA.%26aulast%3DLuria%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DH.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520postischemic%2520recovery%2520of%2520heart%2520contractile%2520function%26jtitle%3DCirc.%2520Res.%26date%3D2006%26volume%3D99%26spage%3D442%26epage%3D450%26doi%3D10.1161%2F01.RES.0000237390.92932.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kompa, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisennagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalji, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behm, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krum, H.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2011.12.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.ijcard.2011.12.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22236509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC38vgt1Shug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=210-219&author=A.+R.+Kompaauthor=B.+H.+Wangauthor=G.+Xuauthor=Y.+Zhangauthor=P.+Y.+Hoauthor=S.+Eisennagelauthor=R.+K.+Thaljiauthor=J.+P.+Marinoauthor=D.+J.+Kellyauthor=D.+J.+Behmauthor=H.+Krum&title=Soluble+epoxide+hydrolase+inhibition+exerts+beneficial+anti-remodeling+actions+post-myocardial+infarction&doi=10.1016%2Fj.ijcard.2011.12.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction</span></div><div class="casAuthors">Kompa Andrew R; Wang Bing H; Xu Guoying; Zhang Yuan; Ho Pei-Yu; Eisennagel Stephen; Thalji Reema K; Marino Joseph P Jr; Kelly Darren J; Behm David J; Krum Henry</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  A contributory role for soluble epoxide hydrolase (sEH) in cardiac remodeling post-myocardial infarction (MI) has been suggested; however effects of sEH inhibition following MI have not been evaluated.  In this study, we examined in vivo post-MI anti-remodeling effects of a novel sEH inhibitor (GSK2188931B) in the rat, and evaluated its direct in vitro effects on hypertrophy, fibrosis and inflammation.  METHODS AND RESULTS:  Post-MI administered GSK2188931B (80 mg/kg/d in chow) for 5 weeks improved left ventricular (LV) ejection fraction compared to vehicle-treated (Veh) rats (P<0.01; Sham 65 ± 2%, MI+Veh 30 ± 2%, MI+GSK 43 ± 2%) without affecting systolic blood pressure.  Percentage area of LV tissue sections stained positive for picrosirius red (PS) and collagen I (CI) were elevated in LV non-infarct zone (P<0.05; NIZ; PS: Sham 1.46 ± 0.13%, MI+Veh 2.14 ± 0.22%, MI+GSK 1.28 ± 0.14%; CI: Sham 2.57 ± 0.17%, MI+Veh 5.06 ± 0.58%, MI+GSK 2.97 ± 0.34%) and peri-infarct zone (P<0.001; PIZ; PS: Sham 1.46 ± 0.13%, MI+Veh 9.06 ± 0.48%, MI+GSK 6.31 ± 0.63%; CI: Sham 2.57±0.17%, MI+Veh 10.51 ± 0.64%, MI+GSK 7.77 ± 0.57%); GSK2188931B attenuated this increase (P<0.05).  GSK2188931B reduced macrophage infiltration into the PIZ (P<0.05).  GSK2188931B reduced AngII- and TNFα-stimulated myocyte hypertrophy, AngII- and TGFβ-stimulated cardiac fibroblast collagen synthesis, including markers of gene expression ANP, β-MHC, CTGF and CI (P<0.05).  GSK2188931B reduced TNFα gene expression in lipopolysaccharide (LPS)-stimulated monocytes (P<0.05).  CONCLUSION:  sEH inhibition exerts beneficial effects on cardiac function and ventricular remodeling post-MI, and direct effects on fibrosis and hypertrophy in cardiac cells.  These findings suggest that sEH is an important contributor to the pathological remodeling following MI, and may be a useful target for therapeutic blockade in this setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTn2zWSRyKzFjToTC3aBaesfW6udTcc2eabTp-ieJ0xVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgt1Shug%253D%253D&md5=576dd1ea415dc3a2a144f89110b296af</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2011.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2011.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DKompa%26aufirst%3DA.%2BR.%26aulast%3DWang%26aufirst%3DB.%2BH.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DP.%2BY.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DThalji%26aufirst%3DR.%2BK.%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DKelly%26aufirst%3DD.%2BJ.%26aulast%3DBehm%26aufirst%3DD.%2BJ.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520exerts%2520beneficial%2520anti-remodeling%2520actions%2520post-myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26spage%3D210%26epage%3D219%26doi%3D10.1016%2Fj.ijcard.2011.12.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1300</span>, <span class="refDoi"> DOI: 10.1111/jphp.13113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fjphp.13113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31215026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyktLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=1291-1300&author=H.+Zhangauthor=K.+Zhangauthor=J.+Liangauthor=W.+Yanauthor=F.+Wuauthor=W.+Xuauthor=Z.+Wuauthor=Y.+Chenauthor=R.+Panauthor=G.+Wu&title=Soluble+epoxide+hydrolase+inhibitor%2C+TUPS%2C+attenuates+isoproterenol%2Fangiotensin+II-induced+cardiac+hypertrophy+through+mammalian+target+of+rapamycin-mediated+autophagy+inhibition&doi=10.1111%2Fjphp.13113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition</span></div><div class="casAuthors">Zhang, Huanji; Zhang, Kun; Liang, Jianwen; Yan, Wen; Wu, Fensheng; Xu, Wenmin; Wu, Zhiwen; Chen, Yixi; Pan, Rongquan; Wu, Guifu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1291-1300</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : To investigate the potential role and mechanism of TUPS, a sol. epoxide hydrolase inhibitor, in cardiac hypertrophy.  Methods : Rat and H9C2 cell models of cardiac hypertrophy were induced by isoproterenol and angiotensin II, resp., followed by TUPS treatment.  The expression of hypertrophic markers, ANP and BNP, was detd. by quant. real-time PCR.  The abundance of Beclin-1, LC3, p-AMPK and phosphorylated-mammalian target of rapamycin (p-mTOR) proteins was analyzed by Western blot and immunohistocytol.  Cell morphol. and viability were evaluated by F-actin staining and MTS.  H9C2 cells were transfected with GFP-LC3 to evaluate autophagy flux.  Key findings : TUPS significantly inhibited rat heart size, heart wt.-to-body wt. ratio, heart wall thickness, hypertrophic H9C2 cell swelling and viability suppression as well as the expression of ANP and BNP genes in hypertrophic models.  In addn., autophagic markers Beclin-1 and LC3 were elevated in both cellular and animal models, which were suppressed by TUPS, with corresponding changes of autophagy flux.  The abundance of p-AMPK was increased, while p-mTOR was decreased in hypertrophic cells, which were abolished by TUPS.  Rapamycin decreased p-mTOR level, increased Beclin-1 and LC3 expression and induced cell size enlargement and cell viability inhibition in hypertrophic H9C2 cells treated with TUPS.  Conclusions : TUPS inhibits cardiac hypertrophy by regulating mTOR/autophagy axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY8mBL1HPrLVg90H21EOLACvtfcHk0lg7SSzdckgWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyktLfM&md5=360e06ce9c16eccd1cb31bbdfc50996a</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1111%2Fjphp.13113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.13113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DG.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520TUPS%252C%2520attenuates%2520isoproterenol%252Fangiotensin%2520II-induced%2520cardiac%2520hypertrophy%2520through%2520mammalian%2520target%2520of%2520rapamycin-mediated%2520autophagy%2520inhibition%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2019%26volume%3D71%26spage%3D1291%26epage%3D1300%26doi%3D10.1111%2Fjphp.13113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title"><i>Uncaria rhynchophylla</i> ameliorates Parkinson’s disease by inhibiting HSP90 expression: insights from quantitative proteomics</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1159/000490837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1159%2F000490837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29940559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2hu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=1453-1464&author=Y.+L.+Lanauthor=J.+J.+Zhouauthor=J.+Liuauthor=X.+K.+Huoauthor=Y.+L.+Wangauthor=J.+H.+Liangauthor=J.+C.+Zhaoauthor=C.+P.+Sunauthor=Z.+L.+Yuauthor=L.+L.+Fangauthor=X.+G.+Tianauthor=L.+Fengauthor=J.+Ningauthor=B.+J.+Zhangauthor=C.+Wangauthor=X.+Y.+Zhaoauthor=X.+C.+Ma&title=Uncaria+rhynchophylla+ameliorates+Parkinson%E2%80%99s+disease+by+inhibiting+HSP90+expression%3A+insights+from+quantitative+proteomics&doi=10.1159%2F000490837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Uncaria rhynchophylla Ameliorates Parkinson's Disease by Inhibiting HSP90 Expression: Insights from Quantitative Proteomics</span></div><div class="casAuthors">Lan, Yu-Long; Zhou, Jun-Jun; Liu, Jing; Huo, Xiao-Kui; Wang, Ya-Li; Liang, Jia-Hao; Zhao, Jian-Chao; Sun, Cheng-Peng; Yu, Zhen-Long; Fang, Lin-Lin; Tian, Xiang-Ge; Feng, Lei; Ning, Jing; Zhang, Bao-Jing; Wang, Chao; Zhao, Xin-Yu; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1453-1464</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Uncaria rhynchophylla, known as "Gou-teng", is a traditional Chinese medicine (TCM) used to extinguish wind, clear heat, arrest convulsions, and pacify the liver.  Although U. rhynchophylla has a long history of being often used to treat central nervous system (CNS) diseases, its efficacy and potential mechanism are still uncertain.  This study investigated neuroprotective effect and the underlying mechanism of U. rhynchophylla ext. (URE) in MPP+-induced SH-SY5Y cells and MPTP-induced mice.  Methods: MPP+-induced SH-SY5Y cells and MPTP-induced mice were used to established Parkinson's disease (PD) models.  Quant. proteomics and bioinformatics were used to uncover proteomics changes of URE.  Western blotting was used to validate main differentially expressed proteins and test HSP90 client proteins (apoptosis-related, autophagy-related, MAPKs, PI3K, and AKT proteins).  Flow cytometry and JC-1 staining assay were further used to confirm the effect of URE on MPP+-induced apoptosis in SH-SY5Y cells.  Gait anal. was used to detect the behavioral changes in MPTP-induced mice.  The levels of dopamine (DA) and their metabolites were examd. in striatum (STR) by HPLC-EC.  The pos. expression of tyrosine hydroxylase (TH) was detected by immunohischem. staining and Western blotting.  Results: URE dose-dependently increased the cell viability in MPP+-induced SH-SY5Y cells.  Quant. proteomics and bioinformatics results confirmed that HSP90 was an important differentially expressed protein of URE.  URE inhibited the expression of HSP90, which further reversed MPP+-induced cell apoptosis and autophagy by increasing the expressions of Bcl-2, Cyclin D1, p-ERK, p-PI3K p85, PI3K p110α, p-AKT, and LC3-I and decreasing cleaved caspase 3, Bax, p-JNK, p-p38, and LC3-II.  URE also markedly decreased the apoptotic ratio and elevated mitochondrial transmembrane potential (DΨm).  Furthermore, URE treatment ameliorated behavioral impairments, increased the contents of DA and its metabolites and elevated the pos. expressions of TH in SN and STR as well as the TH protein.  Conclusions: URE possessed the neuroprotective effect in vivo and in vitro, regulated MAPK and PI3K-AKT signal pathways, and inhibited the expression of HSP90.  U. rhynchophylla has potentials as therapeutic agent in PD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbYuhIDXQlKLVg90H21EOLACvtfcHk0lg7SSzdckgWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2hu73L&md5=88cba9544261590d04d368aadfd686d3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1159%2F000490837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000490837%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DY.%2BL.%26aulast%3DZhou%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DLiang%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DYu%26aufirst%3DZ.%2BL.%26aulast%3DFang%26aufirst%3DL.%2BL.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNing%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%2BY.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DUncaria%2520rhynchophylla%2520ameliorates%2520Parkinson%25E2%2580%2599s%2520disease%2520by%2520inhibiting%2520HSP90%2520expression%253A%2520insights%2520from%2520quantitative%2520proteomics%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D47%26spage%3D1453%26epage%3D1464%26doi%3D10.1159%2F000490837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. C.</span></span> <span> </span><span class="NLM_article-title">Uncarialins A-I, monoterpenoid indole alkaloids from <i>Uncaria rhynchophylla</i> as natural agonists of the 5-HT<sub>1A</sub> receptor</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3310</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b00532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b00532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1KisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2019&pages=3302-3310&author=J.+H.+Liangauthor=Z.+L.+Luanauthor=X.+G.+Tianauthor=W.+Y.+Zhaoauthor=Y.+L.+Wangauthor=C.+P.+Sunauthor=X.+K.+Huoauthor=S.+Dengauthor=B.+J.+Zhangauthor=Z.+J.+Zhangauthor=X.+C.+Ma&title=Uncarialins+A-I%2C+monoterpenoid+indole+alkaloids+from+Uncaria+rhynchophylla+as+natural+agonists+of+the+5-HT1A+receptor&doi=10.1021%2Facs.jnatprod.9b00532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Uncarialins A-I, Monoterpenoid Indole Alkaloids from Uncaria rhynchophylla as Natural Agonists of the 5-HT1A Receptor</span></div><div class="casAuthors">Liang, Jia-Hao; Luan, Zhi-Lin; Tian, Xiang-Ge; Zhao, Wen-Yu; Wang, Ya-Li; Sun, Cheng-Peng; Huo, Xiao-Kui; Deng, Sa; Zhang, Bao-Jing; Zhang, Zhan-Jun; Ma, Xiao-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3302-3310</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Nine new monoterpenoid indole alkaloids, uncarialins A-I (I-9), were isolated from Uncaria rhynchophylla as well as 14 known analogs (10-23).  Their structures were detd. by HRESIMS, 1D and 2D NMR, and exptl. and calcd. electronic CD data.  Compds. 5, 7, 15, and 22 displayed significant agonistic effects against the 5-HT1A receptor with EC50 values of 2.2 ± 0.1, 0.1 ± 0.1, 1.6 ± 0.3, and 2.0 ± 0.5 μM, resp.  The mechanisms of action of these four compds. with the 5-HT1A receptor were investigated by mol. docking, and the results suggested that amino acid residues Asp116, Thr196, Asn386, and Tyr390 played crit. roles in the obsd. activity of the above-mentioned compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruKY-NjorYwrVg90H21EOLACvtfcHk0lg7SSzdckgWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1KisLjL&md5=025281c63a225d830e5ace7e3237cd3c</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b00532%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BH.%26aulast%3DLuan%26aufirst%3DZ.%2BL.%26aulast%3DTian%26aufirst%3DX.%2BG.%26aulast%3DZhao%26aufirst%3DW.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BL.%26aulast%3DSun%26aufirst%3DC.%2BP.%26aulast%3DHuo%26aufirst%3DX.%2BK.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BJ.%26aulast%3DMa%26aufirst%3DX.%2BC.%26atitle%3DUncarialins%2520A-I%252C%2520monoterpenoid%2520indole%2520alkaloids%2520from%2520Uncaria%2520rhynchophylla%2520as%2520natural%2520agonists%2520of%2520the%25205-HT1A%2520receptor%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2019%26volume%3D82%26spage%3D3302%26epage%3D3310%26doi%3D10.1021%2Facs.jnatprod.9b00532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Noort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span> <span> </span><span class="NLM_article-title">Schizophrenia and depression: a systematic review of the effectiveness and the working mechanisms behind acupuncture</span>. <i>Explore</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.explore.2015.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.explore.2015.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC2MfntVSnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=281-291&author=P.+Boschauthor=M.+van+den+Noortauthor=H.+Staudteauthor=S.+Lim&title=Schizophrenia+and+depression%3A+a+systematic+review+of+the+effectiveness+and+the+working+mechanisms+behind+acupuncture&doi=10.1016%2Fj.explore.2015.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia and Depression: A systematic Review of the Effectiveness and the Working Mechanisms Behind Acupuncture</span></div><div class="casAuthors">Bosch Peggy; van den Noort Maurits; Staudte Heike; Lim Sabina</div><div class="citationInfo"><span class="NLM_cas:title">Explore (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  This systematic review assessed clinical evidence for the use of acupuncture as an add-on treatment in patients with depression and schizophrenia and for its underlying working mechanisms.  DATA SOURCES:  Four databases (Medline, Scopus, ERIC, and the Cochrane Library) were searched with a cutoff date of March 31, 2014.  STUDY SELECTION:  Systematic reviews and meta-analyses of acupuncture treatment for depression and schizophrenia were considered for inclusion.  The scarcity of acupuncture research involving schizophrenia led to the inclusion of randomized controlled trials and case studies.  DATA EXTRACTION:  The primary and secondary aims of this study were to evaluate the effects of acupuncture in treating patients with depression or schizophrenia and the possible working mechanisms underlying acupuncture through a systematic literature review.  DATA SYNTHESIS:  The overall clinical results on using acupuncture to treat depression are promising, but only limited evidence for its effectiveness in treating schizophrenia was found.  Acupuncture improves the quality of life, particularly that of sleep, in psychiatric patients.  Brain research has revealed that acupuncture has a modulating and normalizing effect on the limbic-paralimbic-neocortical network (LPNN), including the default mode network.  Because the LPNN is related to sleep and emotions, this might explain the improved qualities of life and sleep after acupuncture.  CONCLUSIONS:  From the evidence found in this study, acupuncture seems to be an effective add-on treatment in patients with depression and, to a lesser degree, in patients with schizophrenia, but large well-designed studies are needed to confirm that evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8il2-x50o0Ff1XRtfYM0dfW6udTcc2eYWSeIZNZyyOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfntVSnsQ%253D%253D&md5=061e5acdfdff334a93f911814edb98aa</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.explore.2015.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.explore.2015.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BNoort%26aufirst%3DM.%26aulast%3DStaudte%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DS.%26atitle%3DSchizophrenia%2520and%2520depression%253A%2520a%2520systematic%2520review%2520of%2520the%2520effectiveness%2520and%2520the%2520working%2520mechanisms%2520behind%2520acupuncture%26jtitle%3DExplore%26date%3D2015%26volume%3D11%26spage%3D281%26epage%3D291%26doi%3D10.1016%2Fj.explore.2015.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akamatsu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E5815</span>– <span class="NLM_lpage">E5823</span>, <span class="refDoi"> DOI: 10.1073/pnas.1802179115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1802179115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29735655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFGks7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E5815-E5823&author=Q.+Renauthor=M.+Maauthor=J.+Yangauthor=R.+Nonakaauthor=A.+Yamaguchiauthor=K.-i.+Ishikawaauthor=K.+Kobayashiauthor=S.+Murayamaauthor=S.+H.+Hwangauthor=S.+Saikiauthor=W.+Akamatsuauthor=N.+Hattoriauthor=B.+D.+Hammockauthor=K.+Hashimoto&title=Soluble+epoxide+hydrolase+plays+a+key+role+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease&doi=10.1073%2Fpnas.1802179115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Ren, Qian; Maa, Min; Yang, Jun; Nonaka, Risa; Yamaguchi, Akihiro; Ishikawa, Kei-ichi; Kobayashi, Kenta; Murayama, Shigeo; Hwang, Sung Hee; Saiki, Shinji; Akamatsu, Wado; Hattori, Nobutaka; Hammock, Bruce D.; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">E5815-E5823</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized as a chronic and progressive neurodegenerative disorder, and the deposition of specific protein aggregates of α-synuclein, termed Lewy bodies, is evident in multiple brain regions of PD patients.  Although there are several available medications to treat PD symptoms, these medications do not prevent the progression of the disease.  Sol. epoxide hydrolase (sEH) plays a key role in inflammation assocd. with the pathogenesis of PD.  Here we found that MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neurotoxicity in the mouse striatum was attenuated by subsequent repeated administration of TPPU, a potent sEH inhibitor.  Furthermore, deletion of the sEH gene protected against MPTP-induced neurotoxicity, while overexpression of sEH in the striatum significantly enhanced MPTP-induced neurotoxicity.  Moreover, the expression of the sEH protein in the striatum from MPTP-treated mice or postmortem brain samples from patients with dementia of Lewy bodies (DLB) was significantly higher compared with control groups.  Interestingly, there was a pos. correlation between sEH expression and phosphorylation of α-synuclein in the striatum.  Oxylipin anal. showed decreased levels of 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid in the striatum of MPTP-treated mice, suggesting increased activity of sEH in this region.  Interestingly, the expression of sEH mRNA in human PARK2 iPSC-derived neurons was higher than that of healthy control.  Treatment with TPPU protected against apoptosis in human PARK2 iPSC-derived dopaminergic neurons.  These findings suggest that increased activity of sEH in the striatum plays a key role in the pathogenesis of neurodegenerative disorders such as PD and DLB.  Therefore, sEH may represent a promising therapeutic target for α-synuclein-related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqunwmVJR-oHrVg90H21EOLACvtfcHk0liAD96cTCxIaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFGks7bJ&md5=104bee1f86772dd4061061d2f4eac5ff</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1802179115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1802179115%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DNonaka%26aufirst%3DR.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DIshikawa%26aufirst%3DK.-i.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DMurayama%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DSaiki%26aufirst%3DS.%26aulast%3DAkamatsu%26aufirst%3DW.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520plays%2520a%2520key%2520role%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE5815%26epage%3DE5823%26doi%3D10.1073%2Fpnas.1802179115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase deficiency or inhibition attenuates MPTP-induced parkinsonism</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-8833-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs12035-014-8833-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25128026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2015&pages=187-195&author=X.+Qinauthor=Q.+Wuauthor=L.+Linauthor=A.+Sunauthor=S.+Liuauthor=X.+Liauthor=X.+Caoauthor=T.+Gaoauthor=P.+Luoauthor=X.+Zhuauthor=X.+Wang&title=Soluble+epoxide+hydrolase+deficiency+or+inhibition+attenuates+MPTP-induced+parkinsonism&doi=10.1007%2Fs12035-014-8833-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism</span></div><div class="casAuthors">Qin, Xiaocui; Wu, Qiaoqi; Lin, Lifang; Sun, Aimin; Liu, Shuhu; Li, Xiaowen; Cao, Xiong; Gao, Tianming; Luo, Pengcheng; Zhu, Xinhong; Wang, Xuemin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) inhibition has been demonstrated to have beneficial effects on various diseases, such as hypertension, diabetes, and brain ischemia.  However, whether sEH inhibition has therapeutic potential in Parkinson's disease is still unknown.  In this paper, we found that sEH expression is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine (MPTP)-treated mice, and sEH deficiency and inhibition significantly attenuated tyrosine hydroxylase (TH)-pos. cell loss and improved rotarod performance.  The substrate of sEH, 14,15-epoxyeicosatrienoic acid (14,15-EET), protected TH-pos. cells and alleviated the rotarod performance deficits of wild-type mice but not sEH-knockout mice.  Moreover, the 14,15-EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE) abolished the neuronal protective effects of sEH deficiency.  In primary cultured cortical neurons, MPP+ induced significant Akt inactivation in neurons from sEH wild-type mice, and this effect was not obsd. in neurons from knockout mice.  Our data indicate that sEH deficiency and inhibition increased 14,15-EET in MPTP-treated mice, which activated the Akt-mediated protection of TH-pos. neurons and behavioral functioning.  We also found that sEH deficiency attenuated TH-pos. cell loss in a paraquat-induced mouse model of Parkinson's.  Our data suggest that sEH inhibition might be a powerful tool to protect dopaminergic neurons in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMcbwqJua_LVg90H21EOLACvtfcHk0ljUQ9Z2G3z7gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOrtr%252FM&md5=2a6f214388fcea30b27e049278aac5c3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-8833-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-8833-3%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520deficiency%2520or%2520inhibition%2520attenuates%2520MPTP-induced%2520parkinsonism%26jtitle%3DMol.%2520Neurobiol.%26date%3D2015%26volume%3D52%26spage%3D187%26epage%3D195%26doi%3D10.1007%2Fs12035-014-8833-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krstic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuesel, I.</span></span> <span> </span><span class="NLM_article-title">Deciphering the mechanism underlying late-onset Alzheimer disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2012.236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrneurol.2012.236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23183882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlaj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=25-34&author=D.+Krsticauthor=I.+Knuesel&title=Deciphering+the+mechanism+underlying+late-onset+Alzheimer+disease&doi=10.1038%2Fnrneurol.2012.236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the mechanism underlying late-onset Alzheimer disease</span></div><div class="casAuthors">Krstic, Dimitrije; Knuesel, Irene</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite tremendous investments in understanding the complex mol. mechanisms underlying Alzheimer disease (AD), recent clin. trials have failed to show efficacy.  A potential problem underlying these failures is the assumption that the mol. mechanism mediating the genetically detd. form of the disease is identical to the one resulting in late-onset AD.  Here, we integrate exptl. evidence outside the 'spotlight' of the genetic drivers of amyloid-β (Aβ) generation published during the past two decades, and present a mechanistic explanation for the pathophysiol. changes that characterize late-onset AD.  We propose that chronic inflammatory conditions cause dysregulation of mechanisms to clear misfolded or damaged neuronal proteins that accumulate with age, and concomitantly lead to tau-assocd. impairments of axonal integrity and transport.  Such changes have several neuropathol. consequences: focal accumulation of mitochondria, resulting in metabolic impairments; induction of axonal swelling and leakage, followed by destabilization of synaptic contacts; deposition of amyloid precursor protein in swollen neurites, and generation of aggregation-prone peptides; further tau hyperphosphorylation, ultimately resulting in neurofibrillary tangle formation and neuronal death.  The proposed sequence of events provides a link between Aβ and tau-related neuropathol., and underscores the concept that degenerating neurites represent a cause rather than a consequence of Aβ accumulation in late-onset AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYYv4uqHLyLLVg90H21EOLACvtfcHk0ljUQ9Z2G3z7gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlaj&md5=353d51652349e91d799cd59cbbbc413f</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2012.236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2012.236%26sid%3Dliteratum%253Aachs%26aulast%3DKrstic%26aufirst%3DD.%26aulast%3DKnuesel%26aufirst%3DI.%26atitle%3DDeciphering%2520the%2520mechanism%2520underlying%2520late-onset%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D25%26epage%3D34%26doi%3D10.1038%2Fnrneurol.2012.236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calsolaro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edison, P.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation in Alzheimer’s disease: current evidence and future directions</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2016.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.jalz.2016.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27179961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC28bpvVyhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=719-732&author=V.+Calsolaroauthor=P.+Edison&title=Neuroinflammation+in+Alzheimer%E2%80%99s+disease%3A+current+evidence+and+future+directions&doi=10.1016%2Fj.jalz.2016.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation in Alzheimer's disease: Current evidence and future directions</span></div><div class="casAuthors">Calsolaro Valeria; Edison Paul</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results.  It is clear that the "amyloid cascade hypothesis" alone cannot fully explain the neuronal damage in AD, as evidenced both by autopsy and imaging studies.  Neuroinflammation plays a significant role in neurodegenerative diseases, whereas the debate is ongoing about its precise role, whether it is protective or harmful.  In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease progression.  We focus on neuroinflammation in AD, especially in the earliest stages, a vicious cycle of glial priming, release of pro-inflammatory factors, and neuronal damage.  We review the evidence from imaging studies, regarding the temporal relationship between amyloid deposition and neuroinflammation, the influence of systemic inflammation on glial activation, both in acute and chronic stimulation and the relevance of inflammation as a diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhSnzpo3gNWsAKB7Fa-xrUfW6udTcc2eYh98kfM8Jl3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bpvVyhtg%253D%253D&md5=455f22ccbc7a16b20131d4d834935205</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2016.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2016.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DCalsolaro%26aufirst%3DV.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DNeuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520current%2520evidence%2520and%2520future%2520directions%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2016%26volume%3D12%26spage%3D719%26epage%3D732%26doi%3D10.1016%2Fj.jalz.2016.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, N. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">872</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWitLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=872-879&author=W.+Y.+Fuauthor=X.+J.+Wangauthor=N.+Y.+Ip&title=Targeting+neuroinflammation+as+a+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease%3A+mechanisms%2C+drug+candidates%2C+and+new+opportunities&doi=10.1021%2Facschemneuro.8b00402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities</span></div><div class="casAuthors">Fu, Wing-Yu; Wang, Xiujiao; Ip, Nancy Y.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">872-879</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is a progressive neurodegenerative disease, and its incidence is expected to increase owing to the aging population worldwide.  Current therapies merely provide symptomatic relief.  Therefore, interventions for AD that delay the disease onset or progression are urgently required.  Recent genomics and functional studies suggest that immune/inflammatory pathways are involved in the pathogenesis of AD.  Although many anti-inflammatory drug candidates have undergone clin. trials, most have failed.  This might be because of our limited understanding of the pathol. mechanisms of neuroinflammation in AD.  However, recent advances in the understanding of immune/inflammatory pathways in AD and their regulatory mechanisms could open up new avenues for drug development targeting neuroinflammation.  In this Review, we discuss the mechanisms and status of different anti-inflammatory drug candidates for AD that have undergone or are undergoing clin. trials and explore new opportunities for targeting neuroinflammation in AD drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgqX4Qot5fsLVg90H21EOLACvtfcHk0ljUQ9Z2G3z7gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWitLnI&md5=dbb4bb413daea0fdbd9e936cd68db52d</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00402%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DW.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DIp%26aufirst%3DN.%2BY.%26atitle%3DTargeting%2520neuroinflammation%2520as%2520a%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520mechanisms%252C%2520drug%2520candidates%252C%2520and%2520new%2520opportunities%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D872%26epage%3D879%26doi%3D10.1021%2Facschemneuro.8b00402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodamullil, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zekri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann-Apitius, M.</span></span> <span> </span><span class="NLM_article-title">Trial watch: tracing investment in drug development for Alzheimer disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">819</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd.2017.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29056749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslansbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=819&author=A.+T.+Kodamullilauthor=F.+Zekriauthor=M.+Soodauthor=B.+Hengererauthor=L.+Canardauthor=D.+McHaleauthor=M.+Hofmann-Apitius&title=Trial+watch%3A+tracing+investment+in+drug+development+for+Alzheimer+disease&doi=10.1038%2Fnrd.2017.169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Trial watch Tracing investment in drug development for Alzheimer disease</span></div><div class="casAuthors">Kodamullil, Alpha Tom; Zekri, Firas; Sood, Meemansa; Hengerer, Bastian; Canard, Luc; McHale, Duncan; Hofmann-Apitius, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">819</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotQcwkb2HD4LVg90H21EOLACvtfcHk0ljcMCrwJ3i8bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslansbzE&md5=ab3115a6db345227776badc5a4d74cb3</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.169%26sid%3Dliteratum%253Aachs%26aulast%3DKodamullil%26aufirst%3DA.%2BT.%26aulast%3DZekri%26aufirst%3DF.%26aulast%3DSood%26aufirst%3DM.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DCanard%26aufirst%3DL.%26aulast%3DMcHale%26aufirst%3DD.%26aulast%3DHofmann-Apitius%26aufirst%3DM.%26atitle%3DTrial%2520watch%253A%2520tracing%2520investment%2520in%2520drug%2520development%2520for%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D819%26doi%3D10.1038%2Fnrd.2017.169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonnies, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trushina, E.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, synaptic dysfunction, and Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.3233/JAD-161088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3233%2FJAD-161088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28059794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ivFyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=1105-1121&author=E.+Tonniesauthor=E.+Trushina&title=Oxidative+stress%2C+synaptic+dysfunction%2C+and+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-161088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease</span></div><div class="casAuthors">Tonnies Eric; Trushina Eugenia; Trushina Eugenia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1105-1121</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disorder without a cure.  Most AD cases are sporadic where age represents the greatest risk factor.  Lack of understanding of the disease mechanism hinders the development of efficacious therapeutic approaches.  The loss of synapses in the affected brain regions correlates best with cognitive impairment in AD patients and has been considered as the early mechanism that precedes neuronal loss.  Oxidative stress has been recognized as a contributing factor in aging and in the progression of multiple neurodegenerative diseases including AD.  Increased production of reactive oxygen species (ROS) associated with age- and disease-dependent loss of mitochondrial function, altered metal homeostasis, and reduced antioxidant defense directly affect synaptic activity and neurotransmission in neurons leading to cognitive dysfunction.  In addition, molecular targets affected by ROS include nuclear and mitochondrial DNA, lipids, proteins, calcium homeostasis, mitochondrial dynamics and function, cellular architecture, receptor trafficking and endocytosis, and energy homeostasis.  Abnormal cellular metabolism in turn could affect the production and accumulation of amyloid-β (Aβ) and hyperphosphorylated Tau protein, which independently could exacerbate mitochondrial dysfunction and ROS production, thereby contributing to a vicious cycle.  While mounting evidence implicates ROS in the AD etiology, clinical trials with antioxidant therapies have not produced consistent results.  In this review, we will discuss the role of oxidative stress in synaptic dysfunction in AD, innovative therapeutic strategies evolved based on a better understanding of the complexity of molecular mechanisms of AD, and the dual role ROS play in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0B3ieG-NrRbt7lRqEFUJVfW6udTcc2eanQxN0ZxnCfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ivFyjsQ%253D%253D&md5=55605343ed0fa8d474ee49f7fb192ef6</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.3233%2FJAD-161088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-161088%26sid%3Dliteratum%253Aachs%26aulast%3DTonnies%26aufirst%3DE.%26aulast%3DTrushina%26aufirst%3DE.%26atitle%3DOxidative%2520stress%252C%2520synaptic%2520dysfunction%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D57%26spage%3D1105%26epage%3D1121%26doi%3D10.3233%2FJAD-161088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Neurodegenerative diseases and oxidative stress</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+diseases+and+oxidative+stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0ljcMCrwJ3i8bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520diseases%2520and%2520oxidative%2520stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Dennis, S.</span></span> <span> </span><span class="NLM_article-title">Review of rethinking health care ethics by Stephen Scher and Kasia Kozlowska</span>. <i>Monash. Bioeth. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1007/s40592-020-00107-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs40592-020-00107-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32306202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB38zmvVSrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=83-86&author=S.+Reis-Dennis&title=Review+of+rethinking+health+care+ethics+by+Stephen+Scher+and+Kasia+Kozlowska&doi=10.1007%2Fs40592-020-00107-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Review of Rethinking Health Care Ethics by Stephen Scher and Kasia Kozlowska : Palgrave Macmillan, available open access: https://link.springer.com/content/pdf/10.1007/978-981-13-0830-7.pdf</span></div><div class="casAuthors">Reis-Dennis Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Monash bioethics review</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPY3i6lDJ8sgwxfk_AGB-EfW6udTcc2eZkHM_wZc8wMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zmvVSrug%253D%253D&md5=6e1777cebc35773d41cf3cdd29116053</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1007%2Fs40592-020-00107-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40592-020-00107-z%26sid%3Dliteratum%253Aachs%26aulast%3DReis-Dennis%26aufirst%3DS.%26atitle%3DReview%2520of%2520rethinking%2520health%2520care%2520ethics%2520by%2520Stephen%2520Scher%2520and%2520Kasia%2520Kozlowska%26jtitle%3DMonash.%2520Bioeth.%2520Rev.%26date%3D2020%26volume%3D38%26spage%3D83%26epage%3D86%26doi%3D10.1007%2Fs40592-020-00107-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, J. F.</span></span> <span> </span><span class="NLM_article-title">Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1006/nlme.2001.4047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1006%2Fnlme.2001.4047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=12071671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD38XksF2gtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2002&pages=125-138&author=J.+E.+Morleyauthor=S.+A.+Farrauthor=J.+F.+Flood&title=Antibody+to+amyloid+beta+protein+alleviates+impaired+acquisition%2C+retention%2C+and+memory+processing+in+SAMP8+mice&doi=10.1006%2Fnlme.2001.4047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice</span></div><div class="casAuthors">Morley, John E.; Farr, Susan A.; Flood, James F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-138</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">SAMP8 (senescence-accelerated mouse, P8 strain) mice overproduce amyloid precursor protein and β-amyloid and have learning and memory deficits.  Preliminary data have indicated that overprodn. of β-amyloid plays a role in the pathogenesis of acquisition and retention deficits in SAMP8 mice.  In the studies reported here, the authors examd. the effects of polyclonal and monoclonal antibodies to β-amyloid on acquisition and retention in an aversive T-maze testing paradigm when injected intracerebroventricularly (ICV) into 12-mo SAMP8/TaJF mice.  Both the polyclonal and monoclonal antibodies improved acquisition and retention when injected ICV 1 to 14 days prior to acquisition testing.  Injection of all 3 antibodies intrahippocampally immediately following training improved retention on the T-maze when mice were tested 7 days later.  The authors next studied the effect of monoclonal β-amyloid antibody injected 48 h prior to training on the effect on retention in the T-maze of drugs modulating classical neurotransmitters.  Arecoline and glutamate were injected directly into the hippocampus, and ketanserin, methiothepen, bicuculline, and OH-saclofen were injected into the septum.  Previously, the authors have found that the doses of these drugs required to improve retention are markedly altered in 12-mo SAMP8/TkJF mice compared to 4-mo P8 mice.  In these studies, it was demonstrated that antibody to β-amyloid resulted in these drugs improving retention at doses that improved memory in 4-mo SAMP8/TaJF mice.  Based on these findings, the authors conclude that β-amyloid overprodn. is at least in part responsible for the acquisition and memory deficits in 12-mo-old SAMP8/TaJF mice.  Antibody to β-amyloid restores the retention response to neurotransmitter manipulation to that seen in 4-mo-old mice.  β-Amyloid appears to play a key role in the loss of acquisition and retention seen in SAMP8/TaJF mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0xNSYwEN4rVg90H21EOLACvtfcHk0lhN2xF4KiIdoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksF2gtL8%253D&md5=57b39d4b2f759e189a845b2c9d291e9c</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1006%2Fnlme.2001.4047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnlme.2001.4047%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BE.%26aulast%3DFarr%26aufirst%3DS.%2BA.%26aulast%3DFlood%26aufirst%3DJ.%2BF.%26atitle%3DAntibody%2520to%2520amyloid%2520beta%2520protein%2520alleviates%2520impaired%2520acquisition%252C%2520retention%252C%2520and%2520memory%2520processing%2520in%2520SAMP8%2520mice%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2002%26volume%3D78%26spage%3D125%26epage%3D138%26doi%3D10.1006%2Fnlme.2001.4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, T.</span></span> <span> </span><span class="NLM_article-title">Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1007/s11064-009-9922-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs11064-009-9922-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19199030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=639-659&author=T.+Takeda&title=Senescence-accelerated+mouse+%28SAM%29+with+special+references+to+neurodegeneration+models%2C+SAMP8+and+SAMP10+mice&doi=10.1007%2Fs11064-009-9922-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice</span></div><div class="casAuthors">Takeda, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-659</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The SAM strains, a group of related inbred strains consisting of senescence-prone inbred strains (SAMP) and senescence-resistant inbred strains (SAMR), have been successfully developed by selective inbreeding of the AKR/J strain of mice donated by the Jackson lab. in 1968.  The characteristic feature of aging common to the SAMP and SAMR is accelerated senescence and normal aging, resp.  Furthermore, SAMP and SAMR strains of mice manifest various pathobiol. phenotypes spontaneously.  Among SAMP strains, SAMP8 and SAMP10 mice show age-related behavioral deterioration such as deficits in learning and memory, emotional disorders (reduced anxiety-like behavior and depressive behavior) and altered circadian rhythm assocd. with certain pathol., biochem. and pharmacol. changes.  Here, the previous and recent literature on SAM mice are reviewed with an emphasis on SAMP8 and SAMP10 mice.  A spontaneous model like SAM with distinct advantages over the gene-modified model is hoped by investigators to be used more widely as a biogerontol. resource to explore the etiopathogenesis of accelerated senescence and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozvIt6wzmXFbVg90H21EOLACvtfcHk0lhN2xF4KiIdoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOkurk%253D&md5=e3c4a35ba7e61740626f1ab31be0241a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-9922-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-9922-y%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DT.%26atitle%3DSenescence-accelerated%2520mouse%2520%2528SAM%2529%2520with%2520special%2520references%2520to%2520neurodegeneration%2520models%252C%2520SAMP8%2520and%2520SAMP10%2520mice%26jtitle%3DNeurochem.%2520Res.%26date%3D2009%26volume%3D34%26spage%3D639%26epage%3D659%26doi%3D10.1007%2Fs11064-009-9922-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akiguchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span> <span> </span><span class="NLM_article-title">SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda’s legacy and future directions</span>. <i>Neuropathology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1111/neup.12373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1111%2Fneup.12373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28261874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSrsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=293-305&author=I.+Akiguchiauthor=M.+Pallasauthor=H.+Budkaauthor=H.+Akiyamaauthor=M.+Uenoauthor=J.+Hanauthor=H.+Yagiauthor=T.+Nishikawaauthor=Y.+Chibaauthor=H.+Sugiyamaauthor=R.+Takahashiauthor=K.+Unnoauthor=K.+Higuchiauthor=M.+Hosokawa&title=SAMP8+mice+as+a+neuropathological+model+of+accelerated+brain+aging+and+dementia%3A+Toshio+Takeda%E2%80%99s+legacy+and+future+directions&doi=10.1111%2Fneup.12373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions</span></div><div class="casAuthors">Akiguchi, Ichiro; Pallas, Merce; Budka, Herbert; Akiyama, Haruhiko; Ueno, Masaki; Han, Jingxian; Yagi, Hideo; Nishikawa, Tomohumi; Chiba, Yoichi; Sugiyama, Hiroshi; Takahashi, Ryoya; Unno, Keiko; Higuchi, Keiichi; Hosokawa, Masanori</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-305</span>CODEN:
                <span class="NLM_cas:coden">NOPAFH</span>;
        ISSN:<span class="NLM_cas:issn">1440-1789</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Senescence accelerated mice P8 (SAMP8) show significant age-related deteriorations in memory and learning ability in accordance with early onset and rapid advancement of senescence.  Brains of SAMP8 mice reveal an age-assocd. increase of PAS-pos. granular structures in the hippocampal formation and astrogliosis in the brain stem and hippocampus.  A spongy degeneration in the brain stem appears at 1 mo of age and reaches a max. at 4-8 mo.  In addn., clusters of activated microglia also appear around the vacuoles in the brain stem.  β/A4(Aβ) protein-like immunoreactive granular structures are obsd. in various regions and increase in no. markedly with age.  Other age-assocd. histol. changes include cortical atrophy, neuronal cell loss in locus coeruleus and lateral tegmental nuclei, intraneuronal accumulation of lipopigments in Purkinje cells and eosinophilic inclusion bodies in thalamic neurons.  A blood-brain barrier dysfunction and astrogliosis are also prominent with advancing age in the hippocampus.  These changes are generally similar to the pathomorphol. of aging human brains and characterized by their assocn. with some specific glioneuronal reactions.  As for the hallmarks of Alzheimer brains, tau morphol. has not yet been confirmed regardless of the age-related increase in phosphorylated tau in SAMP8 mice brains, but early age-related Aβ deposition in the hippocampus has recently been published.  SAMP8 mice are, therefore, not only a senescence-accelerated model but also a promising model for Alzheimer's disease and other cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcUZZ9pccDLbVg90H21EOLACvtfcHk0lhN2xF4KiIdoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSrsr%252FJ&md5=53441e182ca9f48176db13f129435fb0</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1111%2Fneup.12373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fneup.12373%26sid%3Dliteratum%253Aachs%26aulast%3DAkiguchi%26aufirst%3DI.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBudka%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DYagi%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DT.%26aulast%3DChiba%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DUnno%26aufirst%3DK.%26aulast%3DHiguchi%26aufirst%3DK.%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DSAMP8%2520mice%2520as%2520a%2520neuropathological%2520model%2520of%2520accelerated%2520brain%2520aging%2520and%2520dementia%253A%2520Toshio%2520Takeda%25E2%2580%2599s%2520legacy%2520and%2520future%2520directions%26jtitle%3DNeuropathology%26date%3D2017%26volume%3D37%26spage%3D293%26epage%3D305%26doi%3D10.1111%2Fneup.12373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinan-Ferre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomera-Avalos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porquet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pla, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span> <span> </span><span class="NLM_article-title">Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.exger.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.exger.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=27094468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=57-69&author=C.+Grinan-Ferreauthor=V.+Palomera-Avalosauthor=D.+Puigoriol-Illamolaauthor=A.+Caminsauthor=D.+Porquetauthor=V.+Plaauthor=F.+Aguadoauthor=M.+Pallas&title=Behaviour+and+cognitive+changes+correlated+with+hippocampal+neuroinflammaging+and+neuronal+markers+in+female+SAMP8%2C+a+model+of+accelerated+senescence&doi=10.1016%2Fj.exger.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence</span></div><div class="casAuthors">Grinan-Ferre, Christian; Palomera-Avalos, Veronica; Puigoriol-Illamola, Dolors; Camins, Antoni; Porquet, David; Pla, Virginia; Aguado, Fernando; Pallas, Merce</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Senescence accelerated mice P8 (SAMP8) is a phenotypic model of age, characterized by deficits in memory and altered behavior.  Here, we detd. the effect of age in SAMP8, and compared with the resistant strain, SAMR1, in behavior and learning parameters linking these disturbances with oxidative stress environment.  We found impairment in emotional behavior with regard to fear and anxiety in young SAMP8 vs. age-mated SAMR1.  Differences were attenuated with age.  In contrast, learning capabilities are worse in SAMP8, both in young and aged animals, with regard to SAMR1.  These waves in behavior and cognition were correlated with an excess of oxidative stress (OS) in SAMP8 at younger ages that diminished with age.  In this manner, we found changes in the hippocampal expression of ALDH2, IL-6, HMOX1, COX2, CXCL10, iNOS, and MCP-1 with an altered amyloidogenic pathway by increasing the Amyloid beta precursor protein (APP) and BACE1, and reduced ADAM10 expression; in addn., astrogliosis and neuronal markers decreased.  Moreover, Superoxide dismutase 1 (SOD1) and Nuclear factor-kappa beta (NF-kβ) expression and protein levels were higher in younger SAMP8 than in SAMR1.  In conclusion, the accelerated senescence process present in SAMP8 can be linked with an initial deregulation in redox homeostasis, named neuroinflammaging, by inducing mol. changes that lead to neuroinflammation and the neurodegenerative process.  These changes are reflected in the emotional and cognitive behavior of SAMP8 that differs from that of SAMR1 and that highlighted the importance of earlier oxidative processes in the onset of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMTDQUp7e47Vg90H21EOLACvtfcHk0lg1fPkASqPMcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWltrY%253D&md5=9c9430d1048fe3bb93b072ae4ba09213</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DGrinan-Ferre%26aufirst%3DC.%26aulast%3DPalomera-Avalos%26aufirst%3DV.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPorquet%26aufirst%3DD.%26aulast%3DPla%26aufirst%3DV.%26aulast%3DAguado%26aufirst%3DF.%26aulast%3DPallas%26aufirst%3DM.%26atitle%3DBehaviour%2520and%2520cognitive%2520changes%2520correlated%2520with%2520hippocampal%2520neuroinflammaging%2520and%2520neuronal%2520markers%2520in%2520female%2520SAMP8%252C%2520a%2520model%2520of%2520accelerated%2520senescence%26jtitle%3DExp.%2520Gerontol.%26date%3D2016%26volume%3D80%26spage%3D57%26epage%3D69%26doi%3D10.1016%2Fj.exger.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span> <span> </span><span class="NLM_article-title">Senescence-accelerated mice P8: a tool to study brain aging and Alzheimer’s disease in a mouse model</span>. <i>ISRN Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">917167</span>, <span class="refDoi"> DOI: 10.5402/2012/917167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.5402%2F2012%2F917167" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=917167&author=M.+Pall%C3%A0s&title=Senescence-accelerated+mice+P8%3A+a+tool+to+study+brain+aging+and+Alzheimer%E2%80%99s+disease+in+a+mouse+model&doi=10.5402%2F2012%2F917167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.5402%2F2012%2F917167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5402%252F2012%252F917167%26sid%3Dliteratum%253Aachs%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26atitle%3DSenescence-accelerated%2520mice%2520P8%253A%2520a%2520tool%2520to%2520study%2520brain%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520a%2520mouse%2520model%26jtitle%3DISRN%2520Cell%2520Biol.%26date%3D2012%26volume%3D2012%26spage%3D917167%26doi%3D10.5402%2F2012%2F917167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grinan-Ferre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Companys-Alemany, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corpas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanfeliu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s disease</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s13311-020-00854-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1007%2Fs13311-020-00854-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=32488482" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+Grinan-Ferreauthor=S.+Codonyauthor=E.+Pujolauthor=J.+Yangauthor=R.+Leivaauthor=C.+Escolanoauthor=D.+Puigoriol-Illamolaauthor=J.+Companys-Alemanyauthor=R.+Corpasauthor=C.+Sanfeliuauthor=B.+Perezauthor=M.+I.+Lozaauthor=J.+Breaauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=S.+Vazquezauthor=M.+Pallasauthor=C.+Galdeano&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+as+a+new+therapy+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs13311-020-00854-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1007%2Fs13311-020-00854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-020-00854-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrinan-Ferre%26aufirst%3DC.%26aulast%3DCodony%26aufirst%3DS.%26aulast%3DPujol%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLeiva%26aufirst%3DR.%26aulast%3DEscolano%26aufirst%3DC.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DCompanys-Alemany%26aufirst%3DJ.%26aulast%3DCorpas%26aufirst%3DR.%26aulast%3DSanfeliu%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DVazquez%26aufirst%3DS.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DGaldeano%26aufirst%3DC.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520as%2520a%2520new%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2020%26doi%3D10.1007%2Fs13311-020-00854-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shie, F. S.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1508-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1508-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31176371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ksV2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=123&author=C.+C.+Hungauthor=Y.+H.+Leeauthor=Y.+M.+Kuoauthor=P.+C.+Hsuauthor=H.+J.+Tsayauthor=Y.+T.+Hsuauthor=C.+C.+Leeauthor=J.+J.+Liangauthor=F.+S.+Shie&title=Soluble+epoxide+hydrolase+modulates+immune+responses+in+activated+astrocytes+involving+regulation+of+STAT3+activity&doi=10.1186%2Fs12974-019-1508-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity</span></div><div class="casAuthors">Hung Chia-Chi; Lee Yi-Hsuan; Kuo Yi-Min; Hsu Pei-Chien; Hung Chia-Chi; Lee Chih-Chin; Liang Jia-Jun; Shie Feng-Shiun; Tsay Huey-Jen; Hsu Ying-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Astrocyte activation is a common pathological feature in many brain diseases with neuroinflammation, and revealing the underlying mechanisms might shed light on the regulatory processes of the diseases.  Recently, soluble epoxide hydrolase (sEH) has been proposed to affect neuroinflammation in brain injuries.  However, the roles of astrocytic sEH in brains with neurodegeneration remain unclear.  METHODS:  The expression of astrocytic sEH in the brains of APPswe/PSEN1dE9 (APP/PS1) mice developing Alzheimer's disease (AD)-like pathology was evaluated by confocal imaging.  LPS-activated primary astrocytes with mRNA silencing or overexpression of sEH were used to investigate its regulatory roles in astrocyte activation and the induction of pro-inflammatory markers.  Primary astrocytes isolated from a sEH knockout (sEH(-/-)) background were also applied.  RESULTS:  The immunoreactivity of sEH was increased in activated astrocytes in parallel with the progression of AD in APP/PS1 mice.  Our data from primary astrocyte cultures further demonstrate that the overexpression of sEH ameliorated, while the silencing of sEH mRNA enhanced, the lipopolysaccharides (LPS)-induced expression of pro-inflammatory markers, such as inducible nitric oxide, cyclooxygenase 2 (COX-2), and pro-inflammatory cytokines.  These findings suggest that sEH negatively regulates astrocyte immune responses.  Enhanced immune responses found in LPS-activated sEH(-/-) astrocytes also support the notion that the expression of sEH could suppress the immune responses during astrocyte activation.  Similarly, sEH(-/-) mice that received intraperitoneal injection of LPS showed exacerbated astrocyte activation in the brain, as observed by the elevated expression of glial fibrillary acidic protein (GFAP) and pro-inflammatory markers.  Moreover, our data show that the phosphorylation of the signal transducer and activator of transcription 3 (STAT3) was upregulated in activated astrocytes from sEH mouse brains, and the pharmacological blockade of STAT3 activity alleviated the pro-inflammatory effects of sEH deletion in LPS-activated primary astrocytes.  CONCLUSIONS:  Our results provide evidence, for the first time, showing that sEH negatively regulates astrocytic immune responses and GFAP expression, while the underlying mechanism at least partly involves the downregulation of STAT3 phosphorylation.  The discovery of a novel function for sEH in the negative control of astrocytic immune responses involving STAT3 activation confers further insights into the regulatory machinery of astrocyte activation during the development of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLgYTGAfXc8DW1zwg2yUK5fW6udTcc2eZ9Irdt6GQju7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ksV2nsQ%253D%253D&md5=48f947f9461821dc141d03274e3c523e</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1508-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1508-2%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DKuo%26aufirst%3DY.%2BM.%26aulast%3DHsu%26aufirst%3DP.%2BC.%26aulast%3DTsay%26aufirst%3DH.%2BJ.%26aulast%3DHsu%26aufirst%3DY.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DLiang%26aufirst%3DJ.%2BJ.%26aulast%3DShie%26aufirst%3DF.%2BS.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520modulates%2520immune%2520responses%2520in%2520activated%2520astrocytes%2520involving%2520regulation%2520of%2520STAT3%2520activity%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D123%26doi%3D10.1186%2Fs12974-019-1508-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibitor: a novel potential therapeutic or prophylactic drug for psychiatric disorders</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">420</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31105566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=420&author=Q.+Ren&title=Soluble+epoxide+hydrolase+inhibitor%3A+a+novel+potential+therapeutic+or+prophylactic+drug+for+psychiatric+disorders&doi=10.3389%2Ffphar.2019.00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibitor: a novel potential therapeutic or prophylactic drug for psychiatric disorders</span></div><div class="casAuthors">Ren, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">420</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Psychiatric disorders, including depression and schizophrenia, affect millions of individuals worldwide.  However, the precise neurobiol. of psychiatric disorders remains unclear.  Accumulating evidence suggests that various inflammatory processes play a key role in depression and schizophrenia, and that anti-inflammatory drugs exert a therapeutic effect in patients with psychiatric disorders.  Epoxyeicosatrienoic acids (EETs) and epoxydocosapentaenoic acids (EDPs) have potent anti-inflammatory properties.  These mediators are broken down into their corresponding diols by sol. epoxide hydrolase (sEH), and inhibition of sEH enhances the anti-inflammatory effects of EETs.  Therefore, sEH may play a key role in inflammation, which is involved in psychiatric disorders.  Recent studies have shown that abnormal levels of sEH may be involved in the pathogenesis of certain psychiatric diseases, and that sEH inhibitors exhibit antidepressant and antipsychotic activity.  The present review discusses the extensive evidence supporting sEH as a therapeutic target for psychiatric diseases, and the clin. value of sEH inhibitors as therapeutic or prophylactic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolbBcQseGZ0LVg90H21EOLACvtfcHk0ljgi-jr13_bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksb3F&md5=15922b2274fffd81baf098c021e53954</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00420%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DQ.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibitor%253A%2520a%2520novel%2520potential%2520therapeutic%2520or%2520prophylactic%2520drug%2520for%2520psychiatric%2520disorders%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D420%26doi%3D10.3389%2Ffphar.2019.00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Q.</span></span> <span> </span><span class="NLM_article-title">The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2483</span>– <span class="NLM_lpage">2492</span>, <span class="refDoi"> DOI: 10.1002/jnr.24080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1002%2Fjnr.24080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=28699310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCqsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=2483-2492&author=Q.+Wuauthor=H.+Caiauthor=J.+Songauthor=Q.+Chang&title=The+effects+of+sEH+inhibitor+on+depression-like+behavior+and+neurogenesis+in+male+mice&doi=10.1002%2Fjnr.24080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice</span></div><div class="casAuthors">Wu, Qiong; Cai, Hongyang; Song, Jingfang; Chang, Quanzhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2483-2492</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Currently antidepressants take several weeks to be effective, which is one of the main reasons why patients with depression quit therapy.  In the present study, we examine the acute and subacute effects of sol. epoxide hydolase (sEH) inhibitor (sEHI), a compd. shown to have antidepressant effects, on mice.  We found that acute administration of sEHI TPPU decreases immobility time in the forced swimming test and reduces latency to feed in the novelty suppressed-feeding test in adult male mice.  I.p. administration of TPPU for seven days also increased interaction time of socially defeated mice in the social defeat test.  Hippocampal BDNF expression and cell proliferation in the dentate gyrus increased six and 24 h after TPPU treatment, resp.  Improvement in antidepressant behavior and cell proliferation were inhibited by BDNF-trkB antagonist K252a, which suggests that anti-depressant effects of sEHI may be involved in BDNF signaling.  Taken together, our findings suggest that sEHI may provide a rapid antidepressant effect through alterations to BDNF-trkB signaling in the hippocampus and may provide an alternative to current slow-acting antidepressants. cpr 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUYklCoVXfbVg90H21EOLACvtfcHk0ljgi-jr13_bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCqsrfI&md5=5111a3cf5c1c369fadf6bc4ea688608f</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1002%2Fjnr.24080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.24080%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DQ.%26atitle%3DThe%2520effects%2520of%2520sEH%2520inhibitor%2520on%2520depression-like%2520behavior%2520and%2520neurogenesis%2520in%2520male%2520mice%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2017%26volume%3D95%26spage%3D2483%26epage%3D2492%26doi%3D10.1002%2Fjnr.24080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2013.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.pbb.2013.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23792539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kis7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=98-103&author=M.+Maauthor=Q.+Renauthor=Y.+Fujitaauthor=T.+Ishimaauthor=J.+C.+Zhangauthor=K.+Hashimoto&title=Effects+of+AS2586114%2C+a+soluble+epoxide+hydrolase+inhibitor%2C+on+hyperlocomotion+and+prepulse+inhibition+deficits+in+mice+after+administration+of+phencyclidine&doi=10.1016%2Fj.pbb.2013.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine</span></div><div class="casAuthors">Ma, Min; Ren, Qian; Fujita, Yuko; Ishima, Tamaki; Zhang, Ji-Chun; Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-103</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that sol. epoxide hydrolase (sEH) plays a key role in controlling levels of lipid signaling mols., and that the potent sEH inhibitors may be potential therapeutic drugs for a no. of diseases assocd. with metab. of epoxyeicosatrienoic acids (EETs).  This study was undertaken to examine whether the potent sEH inhibitor AS2586114 could attenuate behavioral abnormalities (e.g., hyperlocomotion and prepulse inhibition (PPI) deficits) in male ddY mice after a single administration of the N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (PCP).  A single oral administration of AS2586114 (10, 30, or 100 mg/kg) attenuated the hyperlocomotion in mice after the administration of PCP (3.0 mg/kg, s.c.), in a dose dependent manner.  Furthermore, a single oral administration of AS2586114 (10, 30, or 100 mg/kg) improved the PPI deficits in mice after the administration of PCP (3.0 mg/kg, s.c.), in a dose dependent manner.  In addn., the atypical antipsychotic drug clozapine (10 mg/kg, p.o.) significantly attenuated hyperlocomotion and PPI deficits after the administration of PCP (3.0 mg/kg, s.c.).  In conclusion, this study suggests that AS2586114 may have antipsychotic activity in PCP models of schizophrenia.  Therefore, it is likely that the sEH inhibitors may be potential therapeutic drugs for neuropsychiatric diseases such as schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVi2yfQqcf-bVg90H21EOLACvtfcHk0ljgi-jr13_bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kis7bF&md5=bbc953d7a79a7c78289ef242911c3340</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%2BC.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DEffects%2520of%2520AS2586114%252C%2520a%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520on%2520hyperlocomotion%2520and%2520prepulse%2520inhibition%2520deficits%2520in%2520mice%2520after%2520administration%2520of%2520phencyclidine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D110%26spage%3D98%26epage%3D103%26doi%3D10.1016%2Fj.pbb.2013.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swardfager, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennebelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, A. Y.</span></span> <span> </span><span class="NLM_article-title">Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.neubiorev.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29407524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=56-66&author=W.+Swardfagerauthor=M.+Hennebelleauthor=D.+Yuauthor=B.+D.+Hammockauthor=A.+J.+Levittauthor=K.+Hashimotoauthor=A.+Y.+Taha&title=Metabolic%2Finflammatory%2Fvascular+comorbidity+in+psychiatric+disorders%3B+soluble+epoxide+hydrolase+%28sEH%29+as+a+possible+new+target&doi=10.1016%2Fj.neubiorev.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target</span></div><div class="casAuthors">Swardfager, W.; Hennebelle, M.; Yu, D.; Hammock, B. D.; Levitt, A. J.; Hashimoto, K.; Taha, A. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-66</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The common and severe psychiatric disorders, including major depressive disorder (MDD) and bipolar disorder (BD), are assocd. with inflammation, oxidative stress and changes in peripheral and brain lipid metab.  Those pathways are implicated in the premature development of vascular and metabolic comorbidities, which account for considerable morbidity and mortality, including increased dementia risk.  During endoplasmic reticulum stress, the sol. epoxide hydrolase (sEH) enzyme converts anti-inflammatory fatty acid epoxides generated by cytochrome P 450 enzymes into their corresponding and generally less anti-inflammatory, or even pro-inflammatory, diols, slowing the resoln. of inflammation.  The sEH enzyme and its oxylipin products are elevated post-mortem in MDD, BD and schizophrenia.  Preliminary clin. data suggest that oxylipins increase with symptoms in seasonal MDD and anorexia nervosa, requiring confirmation in larger studies and other cohorts.  In rats, a sol. sEH inhibitor mitigated the development of depressive-like behaviors.  We discuss sEH inhibitors under development for cardiovascular diseases, post-ischemic brain injury, neuropathic pain and diabetes, suggesting new possibilities to address the mood and cognitive symptoms of psychiatric disorders, and their most common comorbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUERCAn0wF7Vg90H21EOLACvtfcHk0litX044Aj6wkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegs7k%253D&md5=f8d461a3573c6011b2d552b7bcbab78d</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DSwardfager%26aufirst%3DW.%26aulast%3DHennebelle%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLevitt%26aufirst%3DA.%2BJ.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTaha%26aufirst%3DA.%2BY.%26atitle%3DMetabolic%252Finflammatory%252Fvascular%2520comorbidity%2520in%2520psychiatric%2520disorders%253B%2520soluble%2520epoxide%2520hydrolase%2520%2528sEH%2529%2520as%2520a%2520possible%2520new%2520target%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D87%26spage%3D56%26epage%3D66%26doi%3D10.1016%2Fj.neubiorev.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapirstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, R. C.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5279</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-23504-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fs41598-018-23504-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29588470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmtVegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=5279&author=R.+Tuauthor=J.+Armstrongauthor=K.+S.+S.+Leeauthor=B.+D.+Hammockauthor=A.+Sapirsteinauthor=R.+C.+Koehler&title=Soluble+epoxide+hydrolase+inhibition+decreases+reperfusion+injury+after+focal+cerebral+ischemia&doi=10.1038%2Fs41598-018-23504-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia</span></div><div class="casAuthors">Tu Ranran; Tu Ranran; Armstrong Jillian; Sapirstein Adam; Koehler Raymond C; Lee Kin Sing Stephen; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5279</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) are produced by cytochrome P450 epoxygenases from arachidonic acid, and their rapid metabolism is mainly through soluble epoxide hydrolase (sEH).  EETs exert vasodilatory, anti-inflammatory, anti-apoptotic, and pro-angiogenic effects.  Administration of sEH inhibitors before or at the onset of stroke is protective, but the effects of post-treatment at reperfusion, when inflammation is augmented, has not been as well studied.  We tested the hypothesis that 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea (TPPU), a potent and highly selective sEH inhibitor, suppresses inflammation and protects the brain when administered at reperfusion.  Vehicle or 1 mg/kg TPPU was administered at reperfusion after 90 minutes of focal ischemia and again 24 hours later.  Protein expression and activity of sEH increased after reperfusion and activity was decreased by TPPU administration.  TPPU decreased infarct volume by 50%, reduced neurologic deficits and improved performance on sensorimotor tasks.  Furthermore, TPPU significantly lowered the mRNA expression of interleukin-1beta by 3.5-fold and tumor necrosis factor-alpha by 2.2-fold, increased transforming growth factor-beta mRNA by 1.8-fold, and augmented immunostaining of vascular endothelial growth factor in peri-infarct cortex.  Thus, inhibition of sEH at reperfusion significantly reduces infarction and improves sensorimotor function, possibly by suppressing early proinflammatory cytokines and promoting reparative cytokines and growth factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVZj-7SBOHm6__Jf7-eMvJfW6udTcc2eYY40NlTp8OUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmtVegug%253D%253D&md5=74d3330625341d8d0f6c90282d1678ab</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-23504-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-23504-1%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DR.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%2BS.%2BS.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DSapirstein%26aufirst%3DA.%26aulast%3DKoehler%26aufirst%3DR.%2BC.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520decreases%2520reperfusion%2520injury%2520after%2520focal%2520cerebral%2520ischemia%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D5279%26doi%3D10.1038%2Fs41598-018-23504-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finneran, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K. R.</span></span> <span> </span><span class="NLM_article-title">Neuroinflammation and fractalkine signaling in Alzheimer’s disease</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">30</span>, <span class="refDoi"> DOI: 10.1186/s12974-019-1412-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1186%2Fs12974-019-1412-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30744705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3cfhsFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=30&author=D.+J.+Finneranauthor=K.+R.+Nash&title=Neuroinflammation+and+fractalkine+signaling+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs12974-019-1412-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinflammation and fractalkine signaling in Alzheimer's disease</span></div><div class="casAuthors">Finneran Dylan J; Nash Kevin R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive, neurodegenerative disorder, and the most common form of dementia.  As the understanding of AD has progressed, it is now believed that AD is an amyloid-initiated tauopathy with neuroinflammation serving as the link between amyloid deposition, tau pathology, and neurodegeneration.  As microglia are the main immune effectors in the central nervous system, they have been the focus of attention in studies investigating the neuroinflammatory component of AD.  Therefore, recent work has focused on immunomodulators, which can alter microglial activation without suppressing activity, as potential therapeutics for AD.  Fractalkine (CX3CL1; FKN), a unique chemokine with a one-to-one relationship with its receptor, signals through its cognate receptor (CX3CR1) to reduce expression of pro-inflammatory genes in activated microglia.  Disrupting FKN signaling has opposing effects on the two hallmark pathologies of AD, but over-expressing a soluble FKN has been shown to reduce tau pathology while not altering amyloid pathology.  Recently, differential signaling has been reported when comparing two cleavage variants of soluble FKN.  These differential effects may explain recent studies reporting seemingly conflicting results regarding the effect of FKN over expression on AD pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd6w3buPoNnDEwO064Z95rfW6udTcc2eYY40NlTp8OUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfhsFarsw%253D%253D&md5=ec9145e5cd1e4cb91ce6b6d0dfeaa323</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1186%2Fs12974-019-1412-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-019-1412-9%26sid%3Dliteratum%253Aachs%26aulast%3DFinneran%26aufirst%3DD.%2BJ.%26aulast%3DNash%26aufirst%3DK.%2BR.%26atitle%3DNeuroinflammation%2520and%2520fractalkine%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2019%26volume%3D16%26spage%3D30%26doi%3D10.1186%2Fs12974-019-1412-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jouihan, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuloaga, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangraw, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasnow, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkayed, N. J.</span></span> <span> </span><span class="NLM_article-title">Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1650</span>– <span class="NLM_lpage">1656</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2013.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fjcbfm.2013.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23899929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1650-1656&author=S.+A.+Jouihanauthor=K.+L.+Zuloagaauthor=W.+Zhangauthor=R.+E.+Shangrawauthor=S.+M.+Krasnowauthor=D.+L.+Marksauthor=N.+J.+Alkayed&title=Role+of+soluble+epoxide+hydrolase+in+exacerbation+of+stroke+by+streptozotocin-induced+type+1+diabetes+mellitus&doi=10.1038%2Fjcbfm.2013.130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus</span></div><div class="casAuthors">Jouihan, Sari A.; Zuloaga, Kristen L.; Zhang, Wenri; Shangraw, Robert E.; Krasnow, Stephanie M.; Marks, Daniel L.; Alkayed, Nabil J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1650-1656</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hyperglycemia worsens stroke, yet rigorous glycemic control does not improve neurol. outcome.  An alternative is to target downstream mol. mediator(s) triggered by hyperglycemia but independent of prevailing glycemia.  Sol. epoxide hydrolase (sEH) is a potential mediator of injury via its metab. of neuroprotective epoxyeicosatrienoic acids (EETs).  We tested whether hyperglycemia exacerbates cerebral injury by upregulating sEH and decreasing brain EET levels.  Type 1 diabetes mellitus was modeled by streptozotocin (STZ; 50 mg/kg per day i.p., 5 days) in male mice.  At 4 wk, STZ-treated and control mice underwent 45-min middle cerebral artery occlusion (MCAO) with or without sEH blockade by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB; 1 mg/kg i.p. daily for 6 days before MCAO).  The STZ-treated mice had increased sEH mRNA expression in cerebral vessels and decreased EET concns. in brain.  There was no difference in cortical perfusion between groups.  The STZ-treated mice sustained larger brain infarct than controls.  Pretreatment with t-AUCB eliminated the difference in infarct size and EETs concn. between STZ-treated mice and controls, without altering glycemia.  We conclude that type 1 diabetes mellitus upregulates sEH mRNA and decreases concns. of neuroprotective EETs within the brain, leading to worse stroke outcome.  The data indicate that sEH antagonism may be beneficial in the setting of hyperglycemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK3rKIoYlxubVg90H21EOLACvtfcHk0liuVIeoa_PMLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs7fI&md5=ae6f335e36445588b99cda76b435110c</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2013.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2013.130%26sid%3Dliteratum%253Aachs%26aulast%3DJouihan%26aufirst%3DS.%2BA.%26aulast%3DZuloaga%26aufirst%3DK.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DShangraw%26aufirst%3DR.%2BE.%26aulast%3DKrasnow%26aufirst%3DS.%2BM.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DAlkayed%26aufirst%3DN.%2BJ.%26atitle%3DRole%2520of%2520soluble%2520epoxide%2520hydrolase%2520in%2520exacerbation%2520of%2520stroke%2520by%2520streptozotocin-induced%2520type%25201%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2013%26volume%3D33%26spage%3D1650%26epage%3D1656%26doi%3D10.1038%2Fjcbfm.2013.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzdev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. W.</span></span> <span> </span><span class="NLM_article-title">Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">E563</span>– <span class="NLM_lpage">E575</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00591.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpendo.00591.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22739108" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=E563-E575&author=G.+Z.+Chenauthor=R.+F.+Xuauthor=Y.+N.+Wangauthor=P.+H.+Wangauthor=G.+Zhaoauthor=X.+Z.+Xuauthor=A.+Gruzdevauthor=D.+C.+Zeldinauthor=D.+W.+Wang&title=Genetic+disruption+of+soluble+epoxide+hydrolase+is+protective+against+streptozotocin-induced+diabetic+nephropathy&doi=10.1152%2Fajpendo.00591.2011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00591.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00591.2011%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%2BZ.%26aulast%3DXu%26aufirst%3DR.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DP.%2BH.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DX.%2BZ.%26aulast%3DGruzdev%26aufirst%3DA.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DD.%2BW.%26atitle%3DGenetic%2520disruption%2520of%2520soluble%2520epoxide%2520hydrolase%2520is%2520protective%2520against%2520streptozotocin-induced%2520diabetic%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D303%26spage%3DE563%26epage%3DE575%26doi%3D10.1152%2Fajpendo.00591.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmarakby, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulkner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shabrawey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddipati, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes</span>. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">R1307</span>– <span class="NLM_lpage">R1317</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00759.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpregu.00759.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21832210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BC3MblvFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=R1307-R1317&author=A.+A.+Elmarakbyauthor=J.+Faulknerauthor=M.+Al-Shabraweyauthor=M.+H.+Wangauthor=K.+R.+Maddipatiauthor=J.+D.+Imig&title=Deletion+of+soluble+epoxide+hydrolase+gene+improves+renal+endothelial+function+and+reduces+renal+inflammation+and+injury+in+streptozotocin-induced+type+1+diabetes&doi=10.1152%2Fajpregu.00759.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes</span></div><div class="casAuthors">Elmarakby Ahmed A; Faulkner Jessica; Al-Shabrawey Mohammed; Wang Mong-Heng; Maddipati Krishna Rao; Imig John D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of physiology. Regulatory, integrative and comparative physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">R1307-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Studies suggest that soluble epoxide hydrolase (sEH) inhibition reduces end-organ damage in cardiovascular diseases.  We hypothesize that sEH gene (Ephx2) knockout (KO) improves endothelial function and reduces renal injury in streptozotocin-induced diabetes.  After 6 wk of diabetes, afferent arteriolar relaxation to acetylcholine was impaired in diabetic wild-type (WT) mice, as the maximum relaxation was 72% of baseline diameter in the WT but only 31% in the diabetic mice.  Ephx2 KO improved afferent arteriolar relaxation to acetylcholine in diabetes as maximum relaxation was 58%.  Urinary monocyte chemoattractant protein-1 (MCP-1) excretion significantly increased in diabetic WT mice compared with control (868 ± 195 vs. 31.5 ± 7 pg/day), and this increase was attenuated in diabetic Ephx2 KO mice (420 ± 98 pg/day).  The renal phospho-IKK-to-IKK ratio and nuclear factor-κB were significantly decreased, and hemeoxygenase-1 (HO-1) expression increased in diabetic Ephx2 KO compared with diabetic WT mice.  Renal NADPH oxidase and urinary thiobarbituric acid reactive substances excretion were reduced in diabetic Ephx2 KO compared with diabetic WT mice.  Albuminuria was also elevated in diabetic WT mice compared with control (170 ± 43 vs. 37 ± 13 μg/day), and Ephx2 KO reduced this elevation (50 ± 15 μg/day).  Inhibition of sEH using trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (tAUCB) also reduced renal inflammation and injury in diabetic WT mice.  Furthermore, inhibition of HO with stannous mesoporphyrin negated the reno-protective effects of tAUCB or Ephx2 KO during diabetes.  These data demonstrate that Ephx2 KO improves endothelial function and reduces renal injury during diabetes.  Additionally, our data also suggest that activation of HO-1 contributes to improved renal injury in diabetic Ephx2 KO mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEtImsudl8SJPlX7E30qdzfW6udTcc2eYc7Fet9Vzowrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MblvFeiuw%253D%253D&md5=26c1954f440e622a0433a928dddd862f</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00759.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00759.2010%26sid%3Dliteratum%253Aachs%26aulast%3DElmarakby%26aufirst%3DA.%2BA.%26aulast%3DFaulkner%26aufirst%3DJ.%26aulast%3DAl-Shabrawey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%2BH.%26aulast%3DMaddipati%26aufirst%3DK.%2BR.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DDeletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520gene%2520improves%2520renal%2520endothelial%2520function%2520and%2520reduces%2520renal%2520inflammation%2520and%2520injury%2520in%2520streptozotocin-induced%2520type%25201%2520diabetes%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2011%26volume%3D301%26spage%3DR1307%26epage%3DR1317%26doi%3D10.1152%2Fajpregu.00759.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzmann, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. V.</span></span> <span> </span><span class="NLM_article-title">Proteomic analysis of hearts from akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3920</span>– <span class="NLM_lpage">3933</span>, <span class="refDoi"> DOI: 10.1021/pr4004739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr4004739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2kt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=3920-3933&author=S.+Deweyauthor=X.+Y.+Laiauthor=F.+A.+Witzmannauthor=M.+Sohalauthor=A.+V.+Gomes&title=Proteomic+analysis+of+hearts+from+akita+mice+suggests+that+increases+in+soluble+epoxide+hydrolase+and+antioxidative+programming+are+key+changes+in+early+stages+of+diabetic+cardiomyopathy&doi=10.1021%2Fpr4004739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy</span></div><div class="casAuthors">Dewey, Shannamar; Lai, Xianyin; Witzmann, Frank A.; Sohal, Mandeep; Gomes, Aldrin V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3920-3933</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cardiovascular disease is the leading cause of diabetic morbidity with more than 10% of type 1 diabetes mellitus (T1DM) patients dying before they are 40 years old.  This study utilized Akita mice, a murine model with T1DM progression analogous to that of humans.  Diabetic cardiomyopathy in Akita mice presents as cardiac atrophy and diastolic impairment at 3 mo of age, but we obsd. cardiac atrophy in hearts from recently diabetic mice (5 wk old).  Hearts from 5 wk old mice were analyzed with a rigorous label-free quant. proteomic approach to identify proteins that may play a crit. role in the early pathophysiol. of diabetic cardiomyopathy.  Eleven proteins were differentially expressed in diabetic hearts: products of GANC, PLEKHN1, COL1A1, GSTK1, ATP1A3, RAP1A, ACADS, EEF1A1, HRC, EPHX2, and PKP2 (gene names).  These proteins are active in cellular defense, metab., insulin signaling, and calcium handling.  Further anal. of Akita hearts using biochem. assays showed that the cellular defenses against oxidative stress were increased, including antioxidant capacity (2-3-fold) and glutathione levels (20%).  Immunoblots of five and twelve week old Akita heart homogenates showed 30% and 145% increases in expression of sol. epoxide hydrolase (sEH (gene name EPHX2)), resp., and an approx. 100% increase in sEH was seen in gastrocnemius tissue of 12 wk old Akita mice.  In contrast, 12 wk old Akita livers showed no change in sEH expression.  Our results suggest that increases in sEH and antioxidative programming are key factors in the development of type 1 diabetic cardiomyopathy in Akita mice and reveal several other proteins whose expression may be important in this complex pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsuFn_MeiqcLVg90H21EOLACvtfcHk0ljZBie2wIsgxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2kt7fP&md5=8965e31b556e5ccd6afc807f0666063d</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fpr4004739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr4004739%26sid%3Dliteratum%253Aachs%26aulast%3DDewey%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DX.%2BY.%26aulast%3DWitzmann%26aufirst%3DF.%2BA.%26aulast%3DSohal%26aufirst%3DM.%26aulast%3DGomes%26aufirst%3DA.%2BV.%26atitle%3DProteomic%2520analysis%2520of%2520hearts%2520from%2520akita%2520mice%2520suggests%2520that%2520increases%2520in%2520soluble%2520epoxide%2520hydrolase%2520and%2520antioxidative%2520programming%2520are%2520key%2520changes%2520in%2520early%2520stages%2520of%2520diabetic%2520cardiomyopathy%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2013%26volume%3D12%26spage%3D3920%26epage%3D3933%26doi%3D10.1021%2Fpr4004739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e39165</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1371%2Fjournal.pone.0039165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=22720061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=Y.+Liuauthor=H.+Dangauthor=D.+Liauthor=W.+Pangauthor=B.+D.+Hammockauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+attenuates+high-fat-diet-induced+hepatic+steatosis+by+reduced+systemic+inflammatory+status+in+mice&doi=10.1371%2Fjournal.pone.0039165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice</span></div><div class="casAuthors">Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Hammock, Bruce D.; Zhu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e39165</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Non-alc. fatty liver disease is assocd. with obesity and considered an inflammatory disease.  Sol. epoxide hydrolase (sEH) is a major enzyme hydrolyzing epoxyeicosatrienoic acids and attenuates their cardiovascular protective and anti-inflammatory effects.  We examd. whether sEH inhibition can protect against high-fat (HF)-diet-induced fatty liver in mice and the underlying mechanism.  Compared with wild-type littermates, sEH-null mice showed lower diet-induced lipid accumulation in liver, as seen by Oil-red O staining and triglycerides levels.  We studied the effect of sEH inhibition on diet-induced fatty liver by feeding C57BL/6 mice an HF diet for 8 wk (short-term) or 16 wk (long-term) and administering t-AUCB, a selective sEH inhibitor.  SEH inhibition had no effect on the HF-diet-increased body and adipose tissue wt. or impaired glucose tolerance but alleviated the diet-induced hepatic steatosis.  Adenovirus-mediated overexpression of sEH in liver increased the level of triglycerides in liver and the hepatic inflammatory response.  Surprisingly, the induced expression of sEH in liver occurred only with the long-term but not short-term HF diet, which suggests a secondary effect of HF diet on regulating sEH expression.  Furthermore, sEH inhibition attenuated the HF-diet-induced increase in plasma levels of proinflammatory cytokines and their mRNA upregulation in adipose tissue, which was accompanied by increased macrophage infiltration.  Therefore, sEH inhibition could alleviate HF-diet-induced hepatic steatosis, which might involve its anti-inflammatory effect in adipose tissue and direct inhibition in liver.  SEH may be a therapeutic target for HF-diet-induced hepatic steatosis in inhibiting systemic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_Zg0migDv7Vg90H21EOLACvtfcHk0ljZBie2wIsgxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVOjsbw%253D&md5=9354ab4e573593006cdd3dda5d71aa2e</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039165%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520attenuates%2520high-fat-diet-induced%2520hepatic%2520steatosis%2520by%2520reduced%2520systemic%2520inflammatory%2520status%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0039165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing beta-oxidation of fatty acid in mice</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">G527</span>– <span class="NLM_lpage">G538</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00148.2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1152%2Fajpgi.00148.2018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=30789748" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2019&pages=G527-G538&author=L.+Yaoauthor=B.+Caoauthor=Q.+Chengauthor=W.+Caiauthor=C.+Yeauthor=J.+Liangauthor=W.+Liuauthor=L.+Tanauthor=M.+Yanauthor=B.+Liauthor=J.+Heauthor=S.+H.+Hwangauthor=X.+Zhangauthor=C.+Wangauthor=D.+Aiauthor=B.+D.+Hammockauthor=Y.+Zhu&title=Inhibition+of+soluble+epoxide+hydrolase+ameliorates+hyperhomocysteinemia-induced+hepatic+steatosis+by+enhancing+beta-oxidation+of+fatty+acid+in+mice&doi=10.1152%2Fajpgi.00148.2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00148.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00148.2018%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DAi%26aufirst%3DD.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520hyperhomocysteinemia-induced%2520hepatic%2520steatosis%2520by%2520enhancing%2520beta-oxidation%2520of%2520fatty%2520acid%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2019%26volume%3D316%26spage%3DG527%26epage%3DG538%26doi%3D10.1152%2Fajpgi.00148.2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira da Silva, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gaitani, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes de Oliveira, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires Bueno, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalheiro, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peporine Lopes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterweck, V.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the intestinal absorption mechanism of casearin X in Caco-2 cells with modified carboxylesterase activity</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1084</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC28XksV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=1084-1090&author=R.+Moreira+da+Silvaauthor=S.+Verjeeauthor=C.+M.+de+Gaitaniauthor=A.+R.+Moraes+de+Oliveiraauthor=P.+C.+Pires+Buenoauthor=A.+J.+Cavalheiroauthor=N.+Peporine+Lopesauthor=V.+Butterweck&title=Evaluation+of+the+intestinal+absorption+mechanism+of+casearin+X+in+Caco-2+cells+with+modified+carboxylesterase+activity&doi=10.1021%2Facs.jnatprod.5b01139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Intestinal Absorption Mechanism of Casearin X in Caco-2 Cells with Modified Carboxylesterase Activity</span></div><div class="casAuthors">Moreira da Silva, Rodrigo; Verjee, Sheela; de Gaitani, Cristiane Masetto; Moraes de Oliveira, Anderson Rodrigo; Pires Bueno, Paula Carolina; Cavalheiro, Alberto Jose; Peporine Lopes, Norberto; Butterweck, Veronika</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1084-1090</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The clerodane diterpene casearin X (1), isolated from the leaves of Casearia sylvestris, is a potential new drug candidate due to its potent in vitro cytotoxic activity.  In this work, the intestinal absorption mechanism of 1 was evaluated using Caco-2 cells with and without active carboxylesterases (CES).  An LC-MS method was developed and validated for the quantification of 1.  The estn. of permeability coeffs. was possible only under CES-inhibited conditions in which 1 is able to cross the Caco-2 cell monolayer.  The mechanism is probably by active transport, with no significant efflux, but with a high retention of the compd. inside the cells.  The enzymic hydrolysis assay demonstrates the susceptibility of 1 to first-pass metab. as substrate for specific CES expressed in human intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyG40bsMFw5rVg90H21EOLACvtfcHk0lhWSskFL5b3EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksV2gtrg%253D&md5=9aa0dee57449ff39d7f797ab3c138b8f</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01139%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%2Bda%2BSilva%26aufirst%3DR.%26aulast%3DVerjee%26aufirst%3DS.%26aulast%3Dde%2BGaitani%26aufirst%3DC.%2BM.%26aulast%3DMoraes%2Bde%2BOliveira%26aufirst%3DA.%2BR.%26aulast%3DPires%2BBueno%26aufirst%3DP.%2BC.%26aulast%3DCavalheiro%26aufirst%3DA.%2BJ.%26aulast%3DPeporine%2BLopes%26aufirst%3DN.%26aulast%3DButterweck%26aufirst%3DV.%26atitle%3DEvaluation%2520of%2520the%2520intestinal%2520absorption%2520mechanism%2520of%2520casearin%2520X%2520in%2520Caco-2%2520cells%2520with%2520modified%2520carboxylesterase%2520activity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D1084%26epage%3D1090%26doi%3D10.1021%2Facs.jnatprod.5b01139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddipati, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2012.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1016%2Fj.prostaglandins.2012.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=42-48&author=L.+Chenauthor=C.+Fanauthor=Y.+Zhangauthor=M.+Bakriauthor=H.+Dongauthor=C.+Morisseauauthor=K.+R.+Maddipatiauthor=P.+Luoauthor=C.+Y.+Wangauthor=B.+D.+Hammockauthor=M.+H.+Wang&title=Beneficial+effects+of+inhibition+of+soluble+epoxide+hydrolase+on+glucose+homeostasis+and+islet+damage+in+a+streptozotocin-induced+diabetic+mouse+model&doi=10.1016%2Fj.prostaglandins.2012.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model</span></div><div class="casAuthors">Chen, Lingdan; Fan, Cheng; Zhang, Yi; Bakri, Mahinur; Dong, Hua; Morisseau, Christophe; Maddipati, Krishna Rao; Luo, Pengcheng; Wang, Cong-Yi; Hammock, Bruce D.; Wang, Mong-Heng</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">104-105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in the metab. of endogenous inflammatory and anti-apoptotic mediators.  In the present study, we detd. the effects of the inhibition of sEH on glucose homeostasis and islet damage in mice treated with streptozotocin (STZ), a model of chem.-induced diabetes.  STZ increased daily water intake and decreased visceral (spleen and pancreas) wt. in mice; sEH inhibition in STZ mice decreased water intake, but did not affect visceral wt.  Hyperglycemia induced by STZ treatment in mice was attenuated by inhibiting sEH.  The beneficial effects of sEH inhibition were accompanied, after 2 and 4 wk of initial administration, by improving glucose tolerance.  In contrast, sEH inhibition did not affect insulin tolerance.  Using LC/MS anal., neither STZ nor STZ plus sEH inhibition affected pancreatic and plasma ratios of epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), an index of EETs levels.  Western blot anal. showed that mouse cytochrome P 450 (CYP) 2C enzymes are the major epoxygenases in islets.  On day 5 after initial STZ treatment, STZ induced islet cell apoptosis, while sEH inhibition in STZ mice significantly reduced islet cell apoptosis.  These studies provide pharmacol. evidence that inhibiting sEH activity provides significant protection against islet β-cell damage and improves glucose homeostasis in STZ-induced diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAWRWZ8qcJgLVg90H21EOLACvtfcHk0lhWSskFL5b3EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFWg&md5=1ad099f3584763740f8960a25360ef2b</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBakri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DMaddipati%26aufirst%3DK.%2BR.%26aulast%3DLuo%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DBeneficial%2520effects%2520of%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520on%2520glucose%2520homeostasis%2520and%2520islet%2520damage%2520in%2520a%2520streptozotocin-induced%2520diabetic%2520mouse%2520model%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D104%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.prostaglandins.2012.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardeshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolshette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadhave, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arfeen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S. K.</span></span> <span> </span><span class="NLM_article-title">Docosahexaenoic acid increases the potency of soluble epoxide hydrolase inhibitor in alleviating streptozotocin-induced Alzheimer’s disease-like complications of diabetes</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">288</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3389%2Ffphar.2019.00288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=31068802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jslymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=288&author=R.+Pardeshiauthor=N.+Bolshetteauthor=K.+Gadhaveauthor=M.+Arfeenauthor=S.+Ahmedauthor=R.+Jamwalauthor=B.+D.+Hammockauthor=M.+Lahkarauthor=S.+K.+Goswami&title=Docosahexaenoic+acid+increases+the+potency+of+soluble+epoxide+hydrolase+inhibitor+in+alleviating+streptozotocin-induced+Alzheimer%E2%80%99s+disease-like+complications+of+diabetes&doi=10.3389%2Ffphar.2019.00288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes</span></div><div class="casAuthors">Pardeshi Rohit; Bolshette Nityanand; Lahkar Mangala; Gadhave Kundlik; Arfeen Mohammad; Ahmed Sahabuddin; Jamwal Rohitash; Hammock Bruce D; Goswami Sumanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">288</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Diabetes is a risk factor for Alzheimer's disease and it is associated with significant memory loss.  In the present study, we hypothesized that the soluble epoxide hydrolase (sEH) inhibitor N-[1-(1-oxopropyl)-4-piperidinyl]-N'-[4-(trifluoromethoxy)phenyl)-urea (also known as TPPU) could alleviate diabetes-aggravated Alzheimer's disease-like symptoms by improving memory and cognition, and reducing the oxidative stress and inflammation associated with this condition.  Also, we evaluated the effect of edaravone, an antioxidant on diabetes-induced Alzheimer's-like complications and the additive effect of docosahexaenoic acid (DHA) on the efficacy of TPPU.  Diabetes was induced in male Sprague-Dawley rats by intraperitoneally administering streptozotocin (STZ).  Six weeks after induction of diabetes, animals were either treated with vehicle, edaravone (3 or 10 mg/kg), TPPU (1 mg/kg) or TPPU (1 mg/kg) + DHA (100 mg/kg) for 2 weeks.  The results demonstrate that the treatments increased the memory response of diabetic rats, in comparison to untreated diabetic rats.  Indeed, DHA + TPPU were more effective than TPPU alone in reducing the symptoms monitored.  All drug treatments reduced oxidative stress and minimized inflammation in the brain of diabetic rats.  Expression of the amyloid precursor protein (APP) was increased in the brain of diabetic rats.  Treatment with edaravone (10 mg/kg), TPPU or TPPU + DHA minimized the level of APP.  The activity of acetylcholinesterase (AChE) which metabolizes acetylcholine was increased in the brain of diabetic rats.  All the treatments except edaravone (3 mg/kg) were effective in decreasing the activity of AChE and TPPU + DHA was more efficacious than TPPU alone.  Intriguingly, the histological changes in hippocampus after treatment with TPPU + DHA showed significant protection of neurons against STZ-induced neuronal damage.  Overall, we found that DHA improved the efficacy of TPPU in increasing neuronal survival and memory, decreasing oxidative stress and inflammation possibly by stabilizing anti-inflammatory and neuroprotective epoxides of DHA.  In the future, further evaluating the detailed mechanisms of action of sEH inhibitor and DHA could help to develop a strategy for the management of Alzheimer's-like complications in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ95Ts_1DsHYrYtC3U5jeOifW6udTcc2ebZiEApE7S9Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jslymug%253D%253D&md5=5f754569f70f90e6e911ae7601eec4ea</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00288%26sid%3Dliteratum%253Aachs%26aulast%3DPardeshi%26aufirst%3DR.%26aulast%3DBolshette%26aufirst%3DN.%26aulast%3DGadhave%26aufirst%3DK.%26aulast%3DArfeen%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DJamwal%26aufirst%3DR.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLahkar%26aufirst%3DM.%26aulast%3DGoswami%26aufirst%3DS.%2BK.%26atitle%3DDocosahexaenoic%2520acid%2520increases%2520the%2520potency%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%2520in%2520alleviating%2520streptozotocin-induced%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520complications%2520of%2520diabetes%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D288%26doi%3D10.3389%2Ffphar.2019.00288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inscho, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.167544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fjpet.110.167544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=20439437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=430-438&author=P.+C.+Luoauthor=H.+H.+Changauthor=Y.+Q.+Zhouauthor=S.+L.+Zhangauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=C.+Y.+Wangauthor=E.+W.+Inschoauthor=B.+D.+Hammockauthor=M.+H.+Wang&title=Inhibition+or+deletion+of+soluble+epoxide+hydrolase+prevents+hyperglycemia%2C+promotes+insulin+secretion%2C+and+reduces+islet+apoptosis&doi=10.1124%2Fjpet.110.167544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis</span></div><div class="casAuthors">Luo, Pengcheng; Chang, Hsin-Hsin; Zhou, Yiqiang; Zhang, Shali; Hwang, Sung Hee; Morisseau, Christophe; Wang, Cong-Yi; Inscho, Edward W.; Hammock, Bruce D.; Wang, Mong-Heng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an enzyme involved in the metab. of endogenous inflammatory and antiapoptotic mediators.  However, the roles of sEH in diabetes and the pancreas are unknown.  Our aims were to det. whether sEH is involved in the regulation of hyperglycemia in diabetic mice and to investigate the reasons for the regulation of insulin secretion by sEH deletion or inhibition in islets.  We used two sep. approaches, targeted disruption of Ephx2 gene [sEH knockout (KO)] and a selective inhibitor of sEH [trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB)], to assess the role of sEH in glucose and insulin homeostasis in streptozotocin (STZ) mice.  We also examd. the effects of sEH KO or t-AUCB on glucose-stimulated insulin secretion (GSIS) and intracellular calcium levels in islets.  Hyperglycemia in STZ mice was prevented by both sEH KO and t-AUCB.  In addn., STZ mice with sEH KO had important, glucose tolerance.  More important, when insulin levels were assessed by hyperglycemic clamp study, sEH KO was found to promote insulin secretion.  In addn., sEH KO and t-AUCB treatment augmented islet GSIS.  Islets with sEH KO had a greater intracellular calcium influx when challenged with high glucose or KCl in the presence of diazoxide.  Moreover, sEH KO reduced islet cell apoptosis in STZ mice.  These results show not only that sEH KO and its inhibition prevent hyperglycemia in diabetes, but also that sEH KO enhances islet GSIS through the amplifying pathway and decreases islet cell apoptosis in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof6-vSBYqyirVg90H21EOLACvtfcHk0lisRUq9Et81kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KisLfO&md5=d3bde930a877c1b01b3f69805737877a</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167544%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DP.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BH.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DInscho%26aufirst%3DE.%2BW.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DM.%2BH.%26atitle%3DInhibition%2520or%2520deletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520hyperglycemia%252C%2520promotes%2520insulin%2520secretion%252C%2520and%2520reduces%2520islet%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D430%26epage%3D438%26doi%3D10.1124%2Fjpet.110.167544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">9038</span>– <span class="NLM_lpage">9043</span>, <span class="refDoi"> DOI: 10.1073/pnas.1103482108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1103482108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=21571638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsV2gsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=9038-9043&author=A.+Luriaauthor=A.+Bettaiebauthor=Y.+N.+Xiauthor=G.+J.+Shiehauthor=H.+C.+Liuauthor=H.+Inoueauthor=H.+J.+Tsaiauthor=J.+D.+Imigauthor=F.+G.+Hajauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+deficiency+alters+pancreatic+islet+size+and+improves+glucose+homeostasis+in+a+model+of+insulin+resistance&doi=10.1073%2Fpnas.1103482108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance</span></div><div class="casAuthors">Luria, Ayala; Bettaieb, Ahmed; Xi, Yannan; Shieh, Guang-Jong; Liu, Hsin-Chen; Inoue, Hiromi; Tsai, Hsing-Ju; Imig, John D.; Haj, Fawaz G.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9038-9043, S9038/1-S9038/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease.  Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects.  The availability of EETs is limited primarily by the sol. epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols.  In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance.  To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor.  When wild-type mice are fed a high fat diet, insulin resistance develops.  However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose.  These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade.  In addn., pancreatic islets were larger when sEH was disrupted.  This effect was assocd. with an increase in vasculature.  These observations were supported by pharmacol. inhibition of sEH.  These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw_cNpjhoXGLVg90H21EOLACvtfcHk0li80WNrERxKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsV2gsbc%253D&md5=348c8eb003b1154a1d991a12fffee70c</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1103482108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1103482108%26sid%3Dliteratum%253Aachs%26aulast%3DLuria%26aufirst%3DA.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DY.%2BN.%26aulast%3DShieh%26aufirst%3DG.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTsai%26aufirst%3DH.%2BJ.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHaj%26aufirst%3DF.%2BG.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520deficiency%2520alters%2520pancreatic%2520islet%2520size%2520and%2520improves%2520glucose%2520homeostasis%2520in%2520a%2520model%2520of%2520insulin%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D9038%26epage%3D9043%26doi%3D10.1073%2Fpnas.1103482108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frömel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1084/jem.20131494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1084%2Fjem.20131494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=24446488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=281-295&author=J.+Huauthor=R.+Poppauthor=T.+Fr%C3%B6melauthor=M.+Ehlingauthor=K.+Awwadauthor=R.+H.+Adamsauthor=H.+P.+Hammesauthor=I.+Fleming&title=M%C3%BCller+glia+cells+regulate+Notch+signaling+and+retinal+angiogenesis+via+the+generation+of+19%2C20-dihydroxydocosapentaenoic+acid&doi=10.1084%2Fjem.20131494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Mueller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid</span></div><div class="casAuthors">Hu, Jiong; Popp, Ruediger; Froemel, Timo; Ehling, Manuel; Awwad, Khader; Adams, Ralf H.; Hammes, Hans-Peter; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-295</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP) epoxygenases generate bioactive lipid epoxides which can be further metabolized to supposedly less active diols by the sol. epoxide hydrolase (sEH).  As the role of epoxides and diols in angiogenesis is unclear, we compared retinal vasculature development in wild-type and sEH-/- mice.  Deletion of the sEH significantly delayed angiogenesis, tip cell, and filopodia formation, a phenomenon assocd. with activation of the Notch signaling pathway.  In the retina, sEH was localized in Mueller glia cells, and Mueller cell-specific sEH deletion reproduced the sEH-/- retinal phenotype.  Lipid profiling revealed that sEH deletion decreased retinal and Mueller cell levels of 19,20-dihydroxydocosapentaenoic acid (DHDP), a diol of docosahexenoic acid (DHA).  19,20-DHDP suppressed endothelial Notch signaling in vitro via inhibition of the γ-secretase and the redistribution of presenilin 1 from lipid rafts.  Moreover, 19,20-DHDP, but not the parent epoxide, was able to rescue the defective angiogenesis in sEH-/- mice as well as in animals lacking the Fbxw7 ubiquitin ligase, which demonstrate strong basal activity of the Notch signaling cascade.  These studies demonstrate that retinal angiogenesis is regulated by a novel form of neuroretina-vascular interaction involving the sEH-dependent generation of a diol of DHA in Mueller cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPTkpLQr0v_rVg90H21EOLACvtfcHk0li80WNrERxKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFaru78%253D&md5=91fc93eb94d1e44b60b210d53489466c</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131494%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFr%25C3%25B6mel%26aufirst%3DT.%26aulast%3DEhling%26aufirst%3DM.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DHammes%26aufirst%3DH.%2BP.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DM%25C3%25BCller%2520glia%2520cells%2520regulate%2520Notch%2520signaling%2520and%2520retinal%2520angiogenesis%2520via%2520the%2520generation%2520of%252019%252C20-dihydroxydocosapentaenoic%2520acid%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26spage%3D281%26epage%3D295%26doi%3D10.1084%2Fjem.20131494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziumbla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhart, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/nature25013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1038%2Fnature25013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=29211719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=248-252&author=J.+Huauthor=S.+Dziumblaauthor=J.+Linauthor=S.+I.+Bibliauthor=S.+Zukunftauthor=J.+de+Mosauthor=K.+Awwadauthor=T.+Fromelauthor=A.+Jungmannauthor=K.+Devrajauthor=Z.+Chengauthor=L.+Wangauthor=S.+Fauserauthor=C.+G.+Eberhartauthor=A.+Sodhiauthor=B.+D.+Hammockauthor=S.+Liebnerauthor=O.+J.+Mullerauthor=C.+Glaubitzauthor=H.+P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Inhibition+of+soluble+epoxide+hydrolase+prevents+diabetic+retinopathy&doi=10.1038%2Fnature25013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span></div><div class="casAuthors">Hu, Jiong; Dziumbla, Sarah; Lin, Jihong; Bibli, Sofia-Iris; Zukunft, Sven; de Mos, Julian; Awwad, Khader; Froemel, Timo; Jungmann, Andreas; Devraj, Kavi; Cheng, Zhixing; Wang, Liya; Fauser, Sascha; Eberhart, Charles G.; Sodhi, Akrit; Hammock, Bruce D.; Liebner, Stefan; Mueller, Oliver J.; Glaubitz, Clemens; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">248-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Diabetic retinopathy is an important cause of blindness in adults, and is characterized by progressive loss of vascular cells and slow dissoln. of inter-vascular junctions, which result in vascular leakage and retinal edema.  Later stages of the disease are characterized by inflammatory cell infiltration, tissue destruction and neovascularization.  Here we identify sol. epoxide hydrolase (sEH) as a key enzyme that initiates pericyte loss and breakdown of endothelial barrier function by generating the diol 19,20-dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.  The expression of sEH and the accumulation of 19,20-dihydroxydocosapentaenoic acid were increased in diabetic mouse retinas and in the retinas and vitreous humor of patients with diabetes.  Mechanistically, the diol targeted the cell membrane to alter the localization of cholesterol-binding proteins, and prevented the assocn. of presenilin 1 with N-cadherin and VE-cadherin, thereby compromising pericyte-endothelial cell interactions and inter-endothelial cell junctions.  Treating diabetic mice with a specific sEH inhibitor prevented the pericyte loss and vascular permeability that are characteristic of non-proliferative diabetic retinopathy.  Conversely, overexpression of sEH in the retinal Muller glial cells of non-diabetic mice resulted in similar vessel abnormalities to those seen in diabetic mice with retinopathy.  Thus, increased expression of sEH is a key determinant in the pathogenesis of diabetic retinopathy, and inhibition of sEH can prevent progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmkpvr75AMbVg90H21EOLACvtfcHk0lj4kfvemmSTHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ&md5=9006381439cc2662b20d97160bfce71b</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1038%2Fnature25013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDziumbla%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.%2BI.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3Dde%2BMos%26aufirst%3DJ.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DFromel%26aufirst%3DT.%26aulast%3DJungmann%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26aulast%3DSodhi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLiebner%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DO.%2BJ.%26aulast%3DGlaubitz%26aufirst%3DC.%26aulast%3DHammes%26aufirst%3DH.%2BP.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520diabetic%2520retinopathy%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D248%26epage%3D252%26doi%3D10.1038%2Fnature25013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011112-140244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1146%2Fannurev-pharmtox-011112-140244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=23020295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1WgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=37-58&author=C.+Morisseauauthor=B.+D.+Hammock&title=Impact+of+soluble+epoxide+hydrolase+and+epoxyeicosanoids+on+human+health&doi=10.1146%2Fannurev-pharmtox-011112-140244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health</span></div><div class="casAuthors">Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-58</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The presence of epoxyeicosatrienoic acids (EETs) in tissues and their metab. by sol. epoxide hydrolase (sEH) to 1,2-diols were first reported 30 years ago.  However, appreciation of their importance in cell biol. and physiol. has greatly accelerated over the past decade with the discovery of metabolically stable inhibitors of sEH, the com. availability of EETs, and the development of anal. methods for the quantification of EETs and their diols.  Numerous roles of EETs in regulatory biol. now are clear, and the value of sEH inhibition in various animal models of disease has been demonstrated.  Here, we review these results and discuss how the pharmacol. stabilization of EETs and other natural epoxy-fatty acids could lead to possible disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcgC0VYHparVg90H21EOLACvtfcHk0lj4kfvemmSTHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1WgtLk%253D&md5=00b058792fbbe4856b5a8508bf37c514</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011112-140244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011112-140244%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DImpact%2520of%2520soluble%2520epoxide%2520hydrolase%2520and%2520epoxyeicosanoids%2520on%2520human%2520health%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D37%26epage%3D58%26doi%3D10.1146%2Fannurev-pharmtox-011112-140244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlinger, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canestraro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanella, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthati, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koduru, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, N. G.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">916</span>, <span class="refDoi"> DOI: 10.1124/jpet.109.157545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1124%2Fjpet.109.157545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=19717790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=906-916&author=K.+Sodhiauthor=K.+Inoueauthor=K.+H.+Gotlingerauthor=M.+Canestraroauthor=L.+Vanellaauthor=D.+H.+Kimauthor=V.+L.+Manthatiauthor=S.+R.+Koduruauthor=J.+R.+Falckauthor=M.+L.+Schwartzmanauthor=N.+G.+Abraham&title=Epoxyeicosatrienoic+acid+agonist+rescues+the+metabolic+syndrome+phenotype+of+HO-2-null+mice&doi=10.1124%2Fjpet.109.157545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice</span></div><div class="casAuthors">Sodhi, Komal; Inoue, Kazuyoshi; Gotlinger, Katherine H.; Canestraro, Martina; Vanella, Luca; Kim, Dong Hyun; Manthati, Vijay L.; Koduru, Sreenivasulu Reddy; Falck, John R.; Schwartzman, Michal L.; Abraham, Nader G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-916</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Heme oxygenase (HO) and cytochrome P 450-derived epoxyeicosatrienoic acids (EETs) participate in vascular protection, and recent studies suggest these two systems are functionally linked.  We examd. the consequences of HO deficiency on P 450-derived EETs with regard to body wt., adiposity, insulin resistance, blood pressure, and vascular function in HO-2-null mice.  The HO-2-null mice were obese, displayed insulin resistance, and had high blood pressure.  HO-2 deficiency was assocd. with decreases in cyp2c expression, EET levels, HO-1 expression, and HO activity and with an increase in superoxide prodn. and an impairment in the relaxing response to acetylcholine.  In addn., HO-2-null mice exhibited increases in serum levels of tumor necrosis factor (TNF)-α and macrophage chemoattractant protein (MCP)-1 and a decrease in serum adiponectin levels.  Treatment of HO-2-null mice with a dual-activity EET agonist/sol. epoxide hydrolase inhibitor increased renal and vascular EET levels and HO-1 expression, lowered blood pressure, prevented body wt. gain, increased insulin sensitivity, reduced s.c. and visceral fat, and decreased serum TNF-α and MCP-1, while increasing adiponectin and restoring the relaxing responses to acetylcholine.  The decrease in cyp2c expression and EETs levels in HO-2-null mice underscores the importance of the HO system in the regulation of epoxygenase levels and suggests that protection against obesity-induced cardiovascular complications requires interplay between these two systems.  A deficiency in one of these protective systems may contribute to the adverse manifestations assocd. with the clin. progression of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2GVlGgqEn7Vg90H21EOLACvtfcHk0liIMgGgNJ3XHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsL3E&md5=55ff5783f76153dada03790467a12f6e</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.157545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.157545%26sid%3Dliteratum%253Aachs%26aulast%3DSodhi%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGotlinger%26aufirst%3DK.%2BH.%26aulast%3DCanestraro%26aufirst%3DM.%26aulast%3DVanella%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DManthati%26aufirst%3DV.%2BL.%26aulast%3DKoduru%26aufirst%3DS.%2BR.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DSchwartzman%26aufirst%3DM.%2BL.%26aulast%3DAbraham%26aufirst%3DN.%2BG.%26atitle%3DEpoxyeicosatrienoic%2520acid%2520agonist%2520rescues%2520the%2520metabolic%2520syndrome%2520phenotype%2520of%2520HO-2-null%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D906%26epage%3D916%26doi%3D10.1124%2Fjpet.109.157545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardesty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirnheld, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpich, I.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition in liver diseases: a review of current research and knowledge gaps</span>. <i>Biology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.3390/biology9060124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.3390%2Fbiology9060124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BB3cXis1SnsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=124&author=J.+Warnerauthor=J.+Hardestyauthor=K.+Zirnheldauthor=C.+McClainauthor=D.+Warnerauthor=I.+Kirpich&title=Soluble+epoxide+hydrolase+inhibition+in+liver+diseases%3A+a+review+of+current+research+and+knowledge+gaps&doi=10.3390%2Fbiology9060124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition in liver diseases: a review of current research and knowledge gaps</span></div><div class="casAuthors">Warner, Jeffrey; Hardesty, Josiah; Zirnheld, Kara; McClain, Craig; Warner, Dennis; Kirpich, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Biology (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">124</span>CODEN:
                <span class="NLM_cas:coden">BBSIBX</span>;
        ISSN:<span class="NLM_cas:issn">2079-7737</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Emerging evidence suggests that sol. epoxide hydrolase (sEH) inhibition is a valuable therapeutic strategy for the treatment of numerous diseases, including those of the liver. sEH rapidly degrades cytochrome P 450-produced epoxygenated lipids (epoxy-fatty acids), which are synthesized from omega-3 and omega-6 polyunsatd. fatty acids, that generally exert beneficial effects on several cellular processes. sEH hydrolysis of epoxy-fatty acids produces dihydroxy-fatty acids which are typically less biol. active than their parent epoxide.  Efforts to develop sEH inhibitors have made available numerous compds. that show therapeutic efficacy and a wide margin of safety in a variety of different diseases, including non-alc. fatty liver disease, liver fibrosis, portal hypertension, and others.  This review summarizes research efforts which characterize the applications, underlying effects, and mol. mechanisms of sEH inhibitors in these liver diseases and identifies gaps in knowledge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJTjtB0ao1rVg90H21EOLACvtfcHk0liIMgGgNJ3XHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXis1SnsLrN&md5=7d48e2790643d39378c19a9588313378</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.3390%2Fbiology9060124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiology9060124%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DJ.%26aulast%3DHardesty%26aufirst%3DJ.%26aulast%3DZirnheld%26aufirst%3DK.%26aulast%3DMcClain%26aufirst%3DC.%26aulast%3DWarner%26aufirst%3DD.%26aulast%3DKirpich%26aufirst%3DI.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520in%2520liver%2520diseases%253A%2520a%2520review%2520of%2520current%2520research%2520and%2520knowledge%2520gaps%26jtitle%3DBiology%26date%3D2020%26volume%3D9%26spage%3D124%26doi%3D10.3390%2Fbiology9060124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Vicario, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz-Quiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Alonso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rius, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopategi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arroyo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claria, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1073/pnas.1422590112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=10.1073%2Fpnas.1422590112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=25550510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=536-541&author=C.+Lopez-Vicarioauthor=J.+Alcaraz-Quilesauthor=V.+Garcia-Alonsoauthor=B.+Riusauthor=S.+H.+Hwangauthor=E.+Titosauthor=A.+Lopategiauthor=B.+D.+Hammockauthor=V.+Arroyoauthor=J.+Claria&title=Inhibition+of+soluble+epoxide+hydrolase+modulates+inflammation+and+autophagy+in+obese+adipose+tissue+and+liver%3A+role+for+omega-3+epoxides&doi=10.1073%2Fpnas.1422590112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides</span></div><div class="casAuthors">Lopez-Vicario, Cristina; Alcaraz-Quiles, Jose; Garcia-Alonso, Veronica; Rius, Bibiana; Hwang, Sung H.; Titos, Esther; Lopategi, Aritz; Hammock, Bruce D.; Arroyo, Vicente; Claria, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sol. epoxide hydrolase (sEH) is an emerging therapeutic target in a no. of diseases that have inflammation as a common underlying cause. sEH limits tissue levels of cytochrome P 450 (CYP) epoxides derived from omega-6 and omega-3 polyunsatd. fatty acids (PUFA) by converting these antiinflammatory mediators into their less active diols.  Here, we explored the metabolic effects of a sEH inhibitor (t-TUCB) in fat-1 mice with transgenic expression of an omega-3 desaturase capable of enriching tissues with endogenous omega-3 PUFA.  These mice exhibited increased CYP1A1, CYP2E1, and CYP2U1 expression and abundant levels of the omega-3-derived epoxides 17,18-epoxyeicosatetraenoic acid (17,18-EEQ) and 19,20-epoxydocosapentaenoic (19,20-EDP) in insulin-sensitive tissues, esp. liver, as detd. by LC-ESI-MS/MS.  In obese fat-1 mice, t-TUCB raised hepatic 17,18-EEQ and 19,20-EDP levels and reinforced the omega-3-dependent redn. obsd. in tissue inflammation and lipid peroxidn. t-TUCB also produced a more intense antisteatotic action in obese fat-1 mice, as revealed by magnetic resonance spectroscopy.  Notably, t-TUCB skewed macrophage polarization toward an antiinflammatory M2 phenotype and expanded the interscapular brown adipose tissue vol.  Moreover, t-TUCB restored hepatic levels of Atg12-Atg5 and LC3-II conjugates and reduced p62 expression, indicating up-regulation of hepatic autophagy. t-TUCB consistently reduced endoplasmic reticulum stress demonstrated by the attenuation of IRE-1α and eIF2α phosphorylation.  These actions were recapitulated in vitro in palmitate-primed hepatocytes and adipocytes incubated with 19,20-EDP or 17,18-EEQ.  Relatively similar but less pronounced actions were obsd. with the omega-6 epoxide, 14,15-EET, and nonoxidized DHA.  Together, these findings identify omega-3 epoxides as important regulators of inflammation and autophagy in insulin-sensitive tissues and postulate sEH as a druggable target in metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoea5tQ9MK3HLVg90H21EOLACvtfcHk0li3YqPzhM6Sbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlym&md5=2797787a822238a9d966ae13dfb5a630</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422590112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422590112%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Vicario%26aufirst%3DC.%26aulast%3DAlcaraz-Quiles%26aufirst%3DJ.%26aulast%3DGarcia-Alonso%26aufirst%3DV.%26aulast%3DRius%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTitos%26aufirst%3DE.%26aulast%3DLopategi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DArroyo%26aufirst%3DV.%26aulast%3DClaria%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520modulates%2520inflammation%2520and%2520autophagy%2520in%2520obese%2520adipose%2520tissue%2520and%2520liver%253A%2520role%2520for%2520omega-3%2520epoxides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D536%26epage%3D541%26doi%3D10.1073%2Fpnas.1422590112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZD4','PDB','1ZD4'); return false;">PDB: 1ZD4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3I1Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3I1Y','PDB','3I1Y'); return false;">PDB: 3I1Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PDC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PDC','PDB','3PDC'); return false;">PDB: 3PDC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JNC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JNC','PDB','4JNC'); return false;">PDB: 4JNC</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01507&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01507%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01507" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998c0baca13d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
